
<html lang="en"     class="pb-page"  data-request-id="35a0e705-17f3-4f47-b06f-724f5c4fc168"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-21;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.6b00442;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum Trypanosomacides" /></meta><meta name="dc.Creator" content="Stephanie  Russell" /></meta><meta name="dc.Creator" content="Raphaël  Rahmani" /></meta><meta name="dc.Creator" content="Amy J.  Jones" /></meta><meta name="dc.Creator" content="Harriet L.  Newson" /></meta><meta name="dc.Creator" content="Kevin  Neilde" /></meta><meta name="dc.Creator" content="Ignacio  Cotillo" /></meta><meta name="dc.Creator" content="Marzieh  Rahmani Khajouei" /></meta><meta name="dc.Creator" content="Lori  Ferrins" /></meta><meta name="dc.Creator" content="Sana  Qureishi" /></meta><meta name="dc.Creator" content="Nghi  Nguyen" /></meta><meta name="dc.Creator" content="Maria S.  Martinez-Martinez" /></meta><meta name="dc.Creator" content="Donald F.  Weaver" /></meta><meta name="dc.Creator" content="Marcel  Kaiser" /></meta><meta name="dc.Creator" content="Jennifer  Riley" /></meta><meta name="dc.Creator" content="John  Thomas" /></meta><meta name="dc.Creator" content="Manu  De Rycker" /></meta><meta name="dc.Creator" content="Kevin D.  Read" /></meta><meta name="dc.Creator" content="Gavin R.  Flematti" /></meta><meta name="dc.Creator" content="Eileen  Ryan" /></meta><meta name="dc.Creator" content="Scott  Tanghe" /></meta><meta name="dc.Creator" content="Ana  Rodriguez" /></meta><meta name="dc.Creator" content="Susan A.  Charman" /></meta><meta name="dc.Creator" content="Albane  Kessler" /></meta><meta name="dc.Creator" content="Vicky M.  Avery" /></meta><meta name="dc.Creator" content="Jonathan B.  Baell" /></meta><meta name="dc.Creator" content="Matthew J.  Piggott" /></meta><meta name="dc.Description" content="The parasitic trypanosomes Trypanosoma brucei and T. cruzi are responsible for significant human suffering in the form of human African trypanosomiasis (HAT) and Chagas disease. Drugs currently ava..." /></meta><meta name="Description" content="The parasitic trypanosomes Trypanosoma brucei and T. cruzi are responsible for significant human suffering in the form of human African trypanosomiasis (HAT) and Chagas disease. Drugs currently ava..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 19, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00442" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00442" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00442" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00442" /></link>
        
    
    

<title>Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum Trypanosomacides | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00442" /></meta><meta property="og:title" content="Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum Trypanosomacides" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0032.jpeg" /></meta><meta property="og:description" content="The parasitic trypanosomes Trypanosoma brucei and T. cruzi are responsible for significant human suffering in the form of human African trypanosomiasis (HAT) and Chagas disease. Drugs currently available to treat these neglected diseases leave much to be desired. Herein we report optimization of a novel class of N-(2-(2-phenylthiazol-4-yl)ethyl)amides, carbamates, and ureas, which rapidly, selectively, and potently kill both species of trypanosome. The mode of action of these compounds is unknown but does not involve CYP51 inhibition. They do, however, exhibit clear structure–activity relationships, consistent across both trypanosome species. Favorable physicochemical parameters place the best compounds in CNS drug-like chemical space but, as a class, they exhibit poor metabolic stability. One of the best compounds (64a) cleared all signs of T. cruzi infection in mice when CYP metabolism was inhibited, with sterile cure achieved in one mouse. This family of compounds thus shows significant promise for trypanosomiasis drug discovery." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00442"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00442">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00442&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00442&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00442&amp;href=/doi/10.1021/acs.jmedchem.6b00442" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9686-9720</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00723" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00576" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum Trypanosomacides</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephanie++Russell">Stephanie Russell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rapha%C3%ABl++Rahmani">Raphaël Rahmani</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amy+J.++Jones">Amy J. Jones</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Harriet+L.++Newson">Harriet L. Newson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Neilde">Kevin Neilde</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ignacio++Cotillo">Ignacio Cotillo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marzieh++Rahmani+Khajouei">Marzieh Rahmani Khajouei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lori++Ferrins">Lori Ferrins</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sana++Qureishi">Sana Qureishi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nghi++Nguyen">Nghi Nguyen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+S.++Martinez-Martinez">Maria S. Martinez-Martinez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+F.++Weaver">Donald F. Weaver</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol "><sup>+</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marcel++Kaiser">Marcel Kaiser</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Riley">Jennifer Riley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Thomas">John Thomas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manu++De+Rycker">Manu De Rycker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+D.++Read">Kevin D. Read</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gavin+R.++Flematti">Gavin R. Flematti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eileen++Ryan">Eileen Ryan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott++Tanghe">Scott Tanghe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ana++Rodriguez">Ana Rodriguez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+A.++Charman">Susan A. Charman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Albane++Kessler">Albane Kessler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vicky+M.++Avery">Vicky M. Avery</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+B.++Baell">Jonathan B. Baell</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+J.++Piggott">Matthew J. Piggott</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">School of Chemistry and Biochemistry, The University of Western Australia, 35 Stirling Highway, Crawley, Perth 6009, Western Australia, Australia</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Eskitis Institute for Drug Discovery, Griffith University, Brisbane Innovation Park, Don Young Road, Nathan, Queensland 4111, Australia</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">GlaxoSmithKline, 28760 Tres Cantos, Spain</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Chemistry, Dalhousie University, Halifax Nova Scotia B3H 4R2, Canada</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Swiss Tropical and Public Health Institute, Socinstrasse, 4051 Basel, Switzerland</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∇</span> <span class="aff-text">University of Basel, Petesplatz 1, 4003 Basel, Switzerland</span></div><div class="aff-info" id="aff8"><span class="aff-symbol">○</span> <span class="aff-text">Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, DD1 5EH Dundee, U.K.</span></div><div class="aff-info" id="aff9"><span class="aff-symbol">◆</span> <span class="aff-text">Centre for Drug Candidate Optimisation, Monash University, Parkville, Victoria 3052, Australia</span></div><div class="aff-info" id="aff10"><span class="aff-symbol">¶</span> <span class="aff-text">Anti-Infectives Screening Core, New York University School of Medicine, New York, New York 10010, United States</span></div><div class="corresp-info"><strong>*</strong>For M.J.P.: phone, +61 8 6488 3170; E-mail, <a href="/cdn-cgi/l/email-protection#9bf6faefeff3feecb5ebf2fcfcf4efefdbeeecfab5feffeeb5faee"><span class="__cf_email__" data-cfemail="9ef3ffeaeaf6fbe9b0eef7f9f9f1eaeadeebe9ffb0fbfaebb0ffeb">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For J.B.B.: phone, +61 3 9903 9044; E-mail, <a href="/cdn-cgi/l/email-protection#4b2124252a3f232a2565292a2e27270b2624252a3823652e2f3e"><span class="__cf_email__" data-cfemail="5c3633323d28343d32723e3d3930301c3133323d2f3472393829">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For R.R.: phone, +61 3 9903 9561; E-mail, <a href="/cdn-cgi/l/email-protection#c0b2a1b0a8a1a5aceeb2a1a8ada1aea980adafaea1b3a8eea5a4b5"><span class="__cf_email__" data-cfemail="512330213930343d7f2330393c303f38113c3e3f3022397f343524">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00442&amp;href=/doi/10.1021%2Facs.jmedchem.6b00442" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9686–9720</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 22, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 March 2016</li><li><span class="item_label"><b>Published</b> online</span>19 September 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 November 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00442" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00442</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9686%26pageCount%3D35%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DStephanie%2BRussell%252C%2BRapha%25C3%25ABl%2BRahmani%252C%2BAmy%2BJ.%2BJones%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D21%26contentID%3Dacs.jmedchem.6b00442%26title%3DHit-to-Lead%2BOptimization%2Bof%2Ba%2BNovel%2BClass%2Bof%2BPotent%252C%2BBroad-Spectrum%2BTrypanosomacides%26numPages%3D35%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9720%26publicationDate%3DNovember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00442"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3001</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00442" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Hit-to-Lead Optimization of a Novel Class of Potent, Broad-Spectrum Trypanosomacides&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Stephanie&quot;,&quot;last_name&quot;:&quot;Russell&quot;},{&quot;first_name&quot;:&quot;Raphaël&quot;,&quot;last_name&quot;:&quot;Rahmani&quot;},{&quot;first_name&quot;:&quot;Amy&quot;,&quot;last_name&quot;:&quot;J. Jones&quot;},{&quot;first_name&quot;:&quot;Harriet&quot;,&quot;last_name&quot;:&quot;L. Newson&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Neilde&quot;},{&quot;first_name&quot;:&quot;Ignacio&quot;,&quot;last_name&quot;:&quot;Cotillo&quot;},{&quot;first_name&quot;:&quot;Marzieh&quot;,&quot;last_name&quot;:&quot;Rahmani Khajouei&quot;},{&quot;first_name&quot;:&quot;Lori&quot;,&quot;last_name&quot;:&quot;Ferrins&quot;},{&quot;first_name&quot;:&quot;Sana&quot;,&quot;last_name&quot;:&quot;Qureishi&quot;},{&quot;first_name&quot;:&quot;Nghi&quot;,&quot;last_name&quot;:&quot;Nguyen&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;S. Martinez-Martinez&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;F. Weaver&quot;},{&quot;first_name&quot;:&quot;Marcel&quot;,&quot;last_name&quot;:&quot;Kaiser&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Riley&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Thomas&quot;},{&quot;first_name&quot;:&quot;Manu&quot;,&quot;last_name&quot;:&quot;De Rycker&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;D. Read&quot;},{&quot;first_name&quot;:&quot;Gavin&quot;,&quot;last_name&quot;:&quot;R. Flematti&quot;},{&quot;first_name&quot;:&quot;Eileen&quot;,&quot;last_name&quot;:&quot;Ryan&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Tanghe&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;Rodriguez&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;A. Charman&quot;},{&quot;first_name&quot;:&quot;Albane&quot;,&quot;last_name&quot;:&quot;Kessler&quot;},{&quot;first_name&quot;:&quot;Vicky&quot;,&quot;last_name&quot;:&quot;M. Avery&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;B. Baell&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;J. Piggott&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;9686-9720&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00442&quot;},&quot;abstract&quot;:&quot;The parasitic trypanosomes Trypanosoma brucei and T. cruzi are responsible for significant human suffering in the form of human African trypanosomiasis (HAT) and Chagas disease. Drugs currently available to treat these neglected diseases leave much to be desired. Herein we report optimization of a novel class of N-(2-(2-phenylthiazol-4-yl)ethyl)amides, carbamates, and ureas, which rapidly, selectively, and potently kill both species of trypanosome. The mode of action of these compounds is unknown but does not involve CYP51 inhibition. They do, however, exhibit clear structure–activity relationships, consistent across both trypanosome species. Favorable physicochemical parameters place the best compounds in CNS drug-like chemical space but, as a class, they exhibit poor metabolic stability. One of the best compounds (64a) cleared all signs of T. cruzi infection in mice when CYP metabolism was inhibited, with sterile cure achieved in one mouse. This family of compounds thus shows significant promise for trypano&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00442&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00442" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00442&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00442" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00442&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00442" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00442&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00442&amp;href=/doi/10.1021/acs.jmedchem.6b00442" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00442" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00442" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00442%26sid%3Dliteratum%253Aachs%26pmid%3D27548560%26genre%3Darticle%26aulast%3DRussell%26date%3D2016%26atitle%3DHit-to-Lead%2BOptimization%2Bof%2Ba%2BNovel%2BClass%2Bof%2BPotent%252C%2BBroad-Spectrum%2BTrypanosomacides%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D21%26spage%3D9686%26epage%3D9720%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292271" title="Urea">Urea</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/jmcmar.2016.59.issue-21/20161110/jmcmar.2016.59.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0032.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The parasitic trypanosomes <i>Trypanosoma brucei</i> and <i>T. cruzi</i> are responsible for significant human suffering in the form of human African trypanosomiasis (HAT) and Chagas disease. Drugs currently available to treat these neglected diseases leave much to be desired. Herein we report optimization of a novel class of <i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)amides, carbamates, and ureas, which rapidly, selectively, and potently kill both species of trypanosome. The mode of action of these compounds is unknown but does not involve CYP51 inhibition. They do, however, exhibit clear structure–activity relationships, consistent across both trypanosome species. Favorable physicochemical parameters place the best compounds in CNS drug-like chemical space but, as a class, they exhibit poor metabolic stability. One of the best compounds (<b>64a</b>) cleared all signs of <i>T. cruzi</i> infection in mice when CYP metabolism was inhibited, with sterile cure achieved in one mouse. This family of compounds thus shows significant promise for trypanosomiasis drug discovery.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15175" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15175" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Human African trypanosomiasis (HAT, African sleeping sickness) and Chagas disease (American trypanosomiasis) are related parasitic diseases causing significant morbidity and mortality in sub-Saharan Africa and South America, respectively.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> There is a critical need for new treatment options for these diseases, which affect millions of the world’s poorest people.</div><div class="NLM_p">HAT is caused by the protozoans <i>Trypanosoma brucei gambiense</i> and <i>Trypanosoma brucei rhodesiense</i>, transmitted by the bite of infected tsetse flies. <i>T. b. gambiense</i> is prevalent in Western and Central Africa, accounting for 98% of reported cases. It causes chronic human infection and has long symptom-free periods that can last several years.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a><i>T. b. rhodesiense</i> infection occurs primarily in Eastern and Southern Africa and results in acute illness, leading to death within months if treatment is not received.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Indeed, both forms of the disease are usually fatal if left untreated.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a></div><div class="NLM_p">In 2013, HAT was estimated to be responsible for approximately 6900 deaths<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and 390000 disability-adjusted life years (DALYs).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Fortunately, the number of infections has reduced in recent times, with less than 4000 confirmed new cases in 2014, although the actual number is estimated to be around 20000.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> However, over 60 million people are thought to be at risk of infection,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and it is worth noting that historical epidemics have arisen from a base of low prevalence.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Livestock are also susceptible to trypanosomiasis, adding to the burden of the disease and acting as a parasite reservoir.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">HAT consists of two stages: the first is characterized by the spread of the parasite in the blood and the lymphatic system; the second stage of the disease occurs when the parasite crosses the blood–brain barrier. Early symptoms include fever, itchiness, joint pain, and headache and often go undiagnosed until the parasite has already entered the brain, where it causes dramatic mood swings, poor coordination, soft tissue swelling, confusion, convulsions, and the changed sleep patterns for which the disease is commonly named.<a onclick="showRef(event, 'ref3 ref8'); return false;" href="javascript:void(0);" class="ref ref3 ref8">(3, 8)</a> Coma and eventual death ensue.</div><div class="NLM_p">Treatment of HAT is difficult, especially in the CNS stage. Only a few drugs are available (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>): suramin and pentamidine for the early, peripheral stage of the disease (stage I) and melarsoprol, eflornithine, and its combination therapy with nifurtimox (NECT) for stage II. These drugs are difficult to administer, toxic, and expensive. As an example of the issues associated with the current therapies, melarsoprol was introduced for the treatment of HAT in 1949 and is still being used, even though it must be administered intravenously for 10–26 days, has side effects that often result in patient noncompliance, and causes fatal reactive encephalopathy in 3–10% of patients.<a onclick="showRef(event, 'ref3 ref9'); return false;" href="javascript:void(0);" class="ref ref3 ref9">(3, 9)</a> The more recently approved drug eflornithine, and NECT, are only active against <i>T. b. gambiense</i>. Pafuramidine (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) was recently taken to clinical trial,<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> but development was abandoned due to renal toxicity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Oxaborole (SCYX-7158) is scheduled to enter clinical trials in 2016,<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> and a phase II/III clinical trial on fexinidazole is underway.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> However, some cross resistance is expected for fexinidazole because its mode of action is similar to that of nifurtimox.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of drugs investigated or currently used for the treatment of HAT and/or Chagas disease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><i>T. cruzi</i>, spread by infected triatomine (“kissing”) bugs, is the causative agent of Chagas disease and is endemic in 21 countries in Latin America, affecting as many as 6–7 million people.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The 2013 Global Burden of Disease Study estimated that Chagas disease was responsible for 10600 deaths<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and 339000 DALYs.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> As with HAT, Chagas disease develops in two stages. During the acute phase, the parasite multiplies and spreads in the patient’s blood, without symptoms in most cases. The chronic stage is characterized by cardiac disorders and digestive alterations due to the accumulation of the parasite in the relevant organs and, if left untreated, can be fatal. It is worth noting that Chagas disease has been reported to be one of the leading worldwide causes of myocarditis;<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> indeed, it is predicted that as many as 200000 people will die from Chagasic cardiomyopathy over the next five years.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Only two drugs are currently available to treat Chagas disease, nifurtimox and benznidazole (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), but these also have adverse side effects and neither can treat chronic Chagas disease.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> Cure is possible during the early acute phase<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and indeterminate phase<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (chronic infection without signs of cardiac disease), but disease diagnosis at these stages is rare.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Clearly, there is an urgent need for alternative, safer, and orally available treatments for trypanosomiasis. However, due to the poor market, there is little incentive for pharmaceutical companies to invest in the development of drugs for these diseases. Collaborative initiatives between Pharma and academic groups with a focus on neglected third world diseases have emerged and are becoming more common. For example, the Tres Cantos Open Lab Foundation, which is supported by GSK, recently published the results of a high-throughput screen (HTS) against several kinetoplastid parasites, including <i>T. brucei</i> and <i>T. cruzi</i>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Philanthropic organizations such as the Drugs for Neglected Diseases <i>initiative</i> (DND<i>i</i>) also play a major role in the discovery and development of new drugs for these diseases, funding projects and making assays more available to the research community.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">The efforts of organizations like the DND<i>i</i> and Tres Cantos Open Lab Foundation have increased awareness about neglected parasitic diseases and inspired many new trypanosomiasis drug discovery programs. Most campaigns have focused on either <i>T. brucei</i><a onclick="showRef(event, 'ref13 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref13 ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36">(13, 26-36)</a> or <i>T. cruzi</i>;<a onclick="showRef(event, 'ref37 ref38 ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40 ref41 ref42">(37-42)</a> fewer have involved a concerted effort to discover leads that are effective against both pathogenic species<a onclick="showRef(event, 'ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53">(43-53)</a> despite the economies of broad-spectrum drug development, especially for neglected diseases.</div><div class="NLM_p">We previously reported the results of a DND<i>i</i>-sponsored high-throughput screen (HTS) of the ∼80000-strong Walter and Eliza Hall Institute (WEHI) stage 1 compound library for compounds inhibiting the growth of <i>T. b. brucei</i>, a human noninfective species that is commonly used in drug discovery as a surrogate for the human pathogens.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Eleven hits with novel, drug-like structures and physicochemical properties were identified. We have already published the hit-to-lead optimization of five of these hits.<a onclick="showRef(event, 'ref55 ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref55 ref56 ref57 ref58 ref59">(55-59)</a> Herein we report our work based on hit <b>1</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> This compound offers a very attractive starting point for hit-to-lead optimization because it exhibits good physicochemical properties, including a low molecular weight (306 g·mol<sup>–1</sup>), a low polar surface area (41 Å<sup>2</sup>), which is necessary for CNS penetration<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> in order to treat the second stage of HAT, and a relatively simple structure amenable to analogue synthesis. Importantly, it is also modestly active against <i>T. cruzi</i>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hit from a HTS of the WEHI compound library against <i>T. b. brucei</i><a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> providing the inspiration for this study. SI = selectivity index = IC<sub>50</sub> mammalian cell line/IC<sub>50</sub> trypanosome; HEK = human embryonic kidney cells, L6 is a rat skeletal muscle cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17644" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17644" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis</h3><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i4" class="anchor-spacer"></div><h4 class="article-section__title" id="_i4"> Acyl Modifications</h4><div class="NLM_p">One of the appealing qualities of HTS hit <b>1</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) is the possibility of rapid access to amide analogues to allow optimization of the acyl substituent. A Gabriel-like synthesis of the primary amine <b>8</b><a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> required for this purpose was used initially (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Thus, conjugate addition of phthalimide (<b>3</b>) to methyl vinyl ketone (<b>2</b>) gave adduct <b>4</b>. Regioselective bromination followed by condensation with thiobenzamide (<b>6</b>) provided the thiazole <b>7</b>. Deprotection was inefficient, possibly because of difficulties isolating the primary amine <b>8</b>, which was unusually polar, difficult to extract from aqueous solutions, and chromatograph. For this reason, alternative routes to <b>8</b> were explored.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Initial Literature Synthesis<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> of Key Primary Amine <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) NaOH, EtOAc, 50%; (b) Br<sub>2</sub>, MeOH 48%; (c) <i>i</i>-PrOH, HCl, 75%; (d) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, 48%.</p></p></figure><div class="NLM_p">An improved synthesis was devised (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), providing <b>13</b>, the hydrochloride salt of <b>8</b>, which was considerably more efficient than the original route. Condensation of thiobenzamide (<b>6</b>) and 1,3-dichloroacetone (<b>9</b>) as reported<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> gave the chloromethylthiazole <b>10</b>, which was converted to the corresponding nitrile <b>11</b>.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Attempts to reduce the nitrile with LiAlH<sub>4</sub>, BH<sub>3</sub>, or cobalt(II) chloride/sodium borohydride<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> suffered, in some cases, from competing reduction of the thiazole but more generally from the difficulty in isolating the primary amine <b>8</b>, as noted earlier. Ultimately, an in situ protection of the primary amine obtained by nickel boride reduction<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> of nitrile <b>11</b> provided the <i>t</i>-butyl carbamate <b>12</b>, which was much easier to isolate and purify in good yield. Protonolysis then provided the dihydrochloride <b>13</b>, which was used directly in subsequent steps.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Improved Synthesis of Primary Amine Hydrochloride <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) (1) acetone, (2) H<sub>2</sub>SO<sub>4</sub>, 85%; (b) KCN, DMF, 90%; (c) (1) NaBH<sub>4</sub>, NiCl<sub>2</sub>·H<sub>2</sub>O, Boc<sub>2</sub>O, MeOH, (2) NEt<sub>3</sub>, 82%; (d) HCl/H<sub>2</sub>O, dioxane, quant</p></p></figure><div class="NLM_p">In parallel, an alternative preparation of <b>8</b> that avoids the use of cyanide was investigated based on a previously described synthesis of a methylthiazole (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Again, this synthesis starts with a cyclocondensation of thiobenzamide (<b>6</b>), in this case with ethyl chloroacetoacetonate (<b>14</b>). The resulting ester <b>15</b> was reduced to the primary alcohol <b>16</b>, which was activated by mesylation. Because of its reactivity, the mesylate <b>17</b> was not purified or characterized but immediately subjected to nucleophilic substitution to give azide <b>18</b>, which was reduced to yield the primary amine <b>8</b> under conditions that did not require an aqueous workup.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Alternative Synthesis of Primary Amine <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) NaHCO<sub>3</sub>, EtOH, reflux, 76%; (b) LiAlH<sub>4</sub>, THF, −78 °C, 71%; (c) MsCl, NEt<sub>3</sub>, THF, 96% (crude); (d) NaN<sub>3</sub>, THF, reflux, 86%; (e) Pd/C, H<sub>2</sub>, MeOH, 99%.</p></p></figure><div class="NLM_p">The primary amine <b>8</b>, or dihydrochloride <b>13</b>, was acylated to give a series of amides <b>21</b>, either by condensation with acid chlorides <b>19</b> or carboxylic acids <b>20</b> in the presence of a coupling agent (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The yields for the DCC couplings were compromised by difficult separations from the byproduct DCU, hence the move to the “friendlier” coupling agents HBTU or EDCI. The <i>m</i>-ethynylbenzamides (see <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) were prepared by Sonogashira coupling of the corresponding iodide to give <b>21Bu</b>, followed by desilylation, affording <b>21Bv</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Target Amides, Carbamates, Ureas, Sulfonamide, and Sulfamide<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) <b>19</b>, NEt<sub>3</sub>, DCM, 57–85%*; (b) <b>20</b>, DCC, HOBt, or <b>20</b>, HBTU, 24–87%*; (c) <b>22</b>, n = 1, NEt<sub>3</sub>, DCM, 92%, <b>22</b>, n = 2, NEt<sub>3</sub>, DCM, 71%; (d) PhSO<sub>2</sub>Cl, NEt<sub>3</sub>, DCM, 40%, DIPEA, DCM, 32%; (e) <b>26</b>, NEt<sub>3</sub>, DCM, 41%; (f) CDI, MeCN, DMF, 69%; (g) ROH, NaH, DMF, 32–55%*; (h) HNR<sup>1</sup>R<sup>2</sup>, NEt<sub>3</sub>, DCM, 55–68%*. *See <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for individual reaction yields. Isopropylmethylamine was prepared by reductive amination of acetone.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></p></p></figure><div class="NLM_p last">The phenylsulfonamide <b>25</b>, sulfamide <b>27</b>, and exocyclic ureas <b>23</b> were prepared by condensation of <b>8</b> or <b>13</b> with benzenesulfonyl chloride (<b>24</b>), pyrrolidine-1-sulfonyl chloride (<b>26</b>), or the appropriate carbamoyl chloride <b>22</b>, respectively. To access a wider range of ureas and carbamates more efficiently, the aminium hydrochloride <b>13</b> was converted into the activated imidazole-<i>N</i>-carboxamide <b>28</b>, which is chromatographically stable and could be stockpiled but was easily transformed to urea <b>30</b> or carbamate <b>29</b> targets by reaction with an amine or alkoxide, respectively.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Variation of the Thiazole-2 Substituent</h4><div class="NLM_p">Initial efforts in this area (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>) commenced with similar strategies to those outlined above. Commercial 2-pyridinethioamide (<b>31</b>) condensed with 1,3-dichloroacetone (<b>9</b>) to give the chloromethylthiazole <b>32</b> in modest yield. We were concerned about the propensity of this compound to polymerize, and indeed the analogous reactions of 3- (<b>36</b>) and 4-pyridinethioamide (<b>38</b>) produced complex mixtures, which were abandoned. However, it was possible to convert <b>32</b> to the corresponding nitrile <b>33</b>. Borane reduction (the superior reduction/in situ protection described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> had not been developed yet) provided the required primary amine <b>34</b> in low yield, which was then acylated to give the target amides <b>35a</b> and <b>b</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Initial Route to 2-(2-Pyridyl)thiazole Targets<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) (1) acetone, 1,3-dichloroacetone (<b>9</b>), (2) H<sub>2</sub>SO<sub>4</sub>, 33%; (b) KCN, DMF, 70 °C, 74%; (c) BH<sub>3</sub>-THF, MeOH, 25%, NEt<sub>3</sub>, PhCOCl, 84% <i>or</i> cyclopentanecarbonyl chloride, 59%.</p></p></figure><div class="NLM_p">To access the other pyridylthiazoles, an alternative route was devised (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). The α-bromoketone <b>40</b>,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> available in one step from levulinic acid, was condensed with several thioamides <b>41</b> to give the corresponding thiazoles <b>42</b>, and ammonolysis provided the primary amides <b>43</b>. The 2-(pyridyl)thiazoles <b>43a</b>/<b>b</b> were subjected to a (diacetoxyiodo)benzene-mediated Hofmann rearrangement<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> with capture of the intermediate isocyanates by the solvent to give the methyl carbamates <b>46</b>. Hydrolysis yielded the desired amines as their trihydrochlorides <b>47</b>, which were acylated to give the target amides <b>35</b>. In the case of the 2-(2-thienyl)thiazole <b>43c</b>, Hofmann rearrangement<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> in water gave the primary amine <b>44</b> directly, and acylation once again provided the target amides <b>45</b>.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Alternative Route to Target Amides Involving a Hofmann Rearrangement<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) MeOH, reflux, 22–60%*; (b) conc NH<sub>3</sub>, THF, 45–75%*; (c) PhI(OAc)<sub>2</sub>, H<sub>2</sub>O/dioxane, 85%; (d) PhI(OAc)<sub>2</sub>, MeOH, <b>46a</b> 59%, <b>46b</b> 70%; (e) 4 M HCl, reflux, quant; (f) NEt<sub>3</sub>, PhCOCl (41–89%) <i>or</i> cyclopentanecarbonyl chloride (31–54%)*. Py = pyridyl. *See <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for individual reaction yields.</p></p></figure><div class="NLM_p">The obvious deficiency of the two routes outlined above is their early divergent steps. We therefore targeted a synthon that could be elaborated later in the synthesis; specifically, we sought a 2-halothiazole such as <b>53</b> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>) to take advantage of late-stage transition metal-catalyzed coupling to introduce various substituents. Efforts began with 2-amino-4-chloromethylthiazole hydrochloride (<b>49</b>), readily prepared from thiourea (<b>48</b>) and 1,3-dichloroacetone (<b>9</b>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> A Sandmeyer reaction<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> was accompanied by partial halogen exchange, giving <b>50</b>, and chemoselective substitution of this mixture provided the nitrile <b>51</b>. However, attempted nickel boride reduction/in situ Boc-protection to give <b>53</b> was accompanied by dehalogenation, and it appeared (from the lack of aromatic signals in the <sup>1</sup>H NMR spectrum of the crude product) that borane reduced the thiazole moiety with no evidence for the desired primary amine <b>52</b>. In an attempt to circumvent the incompatibility of the bromothiazole with reductive conditions, the chloride <b>49</b> was converted to the corresponding nitrile <b>54</b>. Unfortunately, the nickel boride reduction/in situ Boc protection was again largely unsuccessful; although small amounts of the putative dicarbamate <b>55</b> were detected by <sup>1</sup>H NMR spectroscopy, it was not able to be purified.</div><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0012.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. First Attempted Synthesis of a 2-Bromothiazole Synthon<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) acetone, reflux, 82%; (b) (1) H<sub>2</sub>SO<sub>4</sub>, NaNO<sub>2</sub>, (2) HBr; (c) KCN, DMF, 31% (two steps); (d) (1) BH<sub>3</sub>–THF, MeOH, (2) HCl, 0%; (e) (1) NaBH<sub>4</sub>, NiCl<sub>2</sub>·H<sub>2</sub>O, Boc<sub>2</sub>O, MeOH, (2) NEt<sub>3</sub>, 0%.</p></p></figure><div class="NLM_p">Problems with the reduction of the nitrile prompted us to reinvestigate the phthalimide protecting group (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>). Thus, cyclocondensation of thiourea (<b>48</b>) with the bromoketone <b>5</b> gave the 2-aminothiazole hydrobromide <b>56</b> in excellent yield.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> However, attempted Sandmeyer reactions under various conditions were unsuccessful; in all cases the absence of the expected thiazole singlet in the <sup>1</sup>H NMR spectra of the crude products of these reactions points to electrophilic aromatic substitution at the 3-position, although the nature of the electrophile was not determined. Fortunately, the 2-bromothiazole <b>58</b> was accessible<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> via the thiocyanate <b>57</b>. Initial attempts to remove the phthalimide protecting group were unsuccessful, presumably due to competing S<sub>N</sub>Ar reactions of hydrazine at the thiazole 2-position. Thus, <b>58</b> was subjected to Suzuki couplings with a range of arylboronic acids to provide <b>59a</b>–<b>d</b>. Deprotection, followed immediately by treatment of the primary amine with CDI, gave the activated ureas <b>60a</b>–<b>d</b>, which were reacted with piperidine (at this point the potency boost afforded by the exocyclic ureas had been discovered), affording the target compounds <b>61</b>. Subsequently, conditions to effect the deprotection of <b>58</b> were developed, and carbamoylation of the primary amine <b>62</b> provided urea <b>63a</b>, allowing diversification by Suzuki coupling in the final step. In addition, carbamoylation, carboxylation, or acylation of crude <b>62</b> provided <i>N</i>,<i>N</i>-diethylurea <b>63b</b>, isopropyl carbamate <b>63c</b>, and 2,5-difluorobenzamide <b>63d</b>, respectively. Suzuki coupling then gave the 2-(2,4-difluorophenyl)thiazoles <b>64b</b>–<b>d</b>, which were targeted, primarily, to elucidate metabolism and improve stability (see below).</div><figure id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0013.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Divergent Synthesis of Variously 2-Arylated Thiazoles<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions and yields (a) thiourea (<b>48</b>), MeOH, reflux, 89%; (b) NaNO<sub>2</sub>, HBr <i>or</i> NaNO<sub>2</sub>, HCl, NaBr, 0%; (c) KSCN, EtOH, 78%; (d) HBr, AcOH, reflux, 86%; (e) ArB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, PhMe, H<sub>2</sub>O, 80 °C, 40–62%, <i>or</i> ArB(OH)<sub>2</sub>, PdCl<sub>2</sub>dppf, TBAB, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O 4:1, μw, 49–73%*; (f) (1) H<sub>2</sub>NNH<sub>2</sub>.H<sub>2</sub>O, MeOH, reflux, (2) CDI, MeCN/DMF, 30–70% (two steps); (g) piperidine, NEt<sub>3</sub>, 55–70%; (h) H<sub>2</sub>NNH<sub>2</sub>.H<sub>2</sub>O, EtOH, 69%; (i) (1) <i>p</i>-nitrophenyl chloroformate, NEt<sub>3</sub>, DCM, (2) piperidine, 84% (<b>63a</b>); (j) (1) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, EtOH, reflux, (2) ClCOR, NEt<sub>3</sub>, EtOAc*. *See <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for individual reaction yields.</p></p></figure></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Antitrypanosomal Activity</h3><div class="NLM_p">Target compounds were first screened at 10 μM in the Alamar Blue growth inhibition assay against <i>T. b. brucei</i> used to identify hit <b>1</b>.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Compounds causing 50% or greater inhibition at this concentration were then subjected to a concentration–response study, allowing determination of IC<sub>50</sub> values. In parallel, IC<sub>50</sub> values for cytotoxicity to human embryonic kidney (HEK) cells were measured for active compounds, and a selectivity index (SI) was calculated.</div><div class="NLM_p">On the basis of the promising activity of this series against <i>T. b. brucei</i>, target compounds were also screened against <i>T. cruzi</i> using an intracellular imaging assay with rat cardiomyocyte (H9c2) cells as the host.<a onclick="showRef(event, 'ref24 ref76'); return false;" href="javascript:void(0);" class="ref ref24 ref76">(24, 76)</a> Cytotoxicity to the host cells was assessed in parallel.</div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Potency Optimization in the Acyl Substituent</h4><div class="NLM_p">The first series of compounds investigated (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) explored the size of the acyl substituent (right-hand side [RHS] as drawn) and the significance of the fluorine atom in hit <b>1</b>. The synthetic precursors, phthalimide <b>7</b> and primary amine <b>8</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), were completely inactive against <i>T. b. brucei</i>, emphasizing the importance of the amide functional group. Small amides (<b>21a</b>–<b>c</b>) displayed little activity, but this improved with the size of the alkyl group, giving an early suggestion that the acyl substituent engages with a hydrophobic pocket in the biomolecular target. Alternatively, or perhaps in addition, a greater rate of enzymatic hydrolysis of the less sterically hindered amides might be responsible for the lack of activity, although we have no evidence to support this notion. As expected, the pivalamide <b>21e</b>, differing from hit <b>1</b> only in the lack of a <i>meta</i>-fluorine atom in the phenyl substituent, retained activity, although there was an approximate halving of potency. However, the benzamide <b>21f</b> bettered the potency of hit <b>1</b> against <i>T. b. brucei</i> and <i>T. cruzi</i>. Subsequent to the initiation of this project, the Tres Cantos open Lab Foundation/GSK HTS mentioned in the introduction also identified <b>21f</b> as being active against <i>T. brucei</i> and <i>T. cruzi</i>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Initial SAR around the Acyl Substituent</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0015.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0016.gif" alt="" id="GRAPHIC-d7e1717-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">All IC<sub>50</sub> values are the average of two independent experiments ± standard deviation.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">SI = selectivity index relative to HEK293 cells.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">SI = selectivity index relative to the host H9c2 cells. n.i. = no inhibition = <50% inhibition at 10 μM. “–” indicates that the compound was not tested.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">Lister 427 bloodstream form.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">Tulahuen strain engineered to express β-galactosidase.<a onclick="showRef(event, 'ref24 ref75'); return false;" href="javascript:void(0);" class="ref ref24 ref75">(24, 75)</a></p></div></div><div></div></div><div class="NLM_p">Alicyclic amides were also investigated with both the cyclopentyl-<b>21h</b> and cyclohexylcarboxamides <b>21g</b> being approximately equipotent with the benzamide <b>21f</b>. However, the introduction of an electronegative heteroatom at the 4-position in the tetrahydropyranyl derivate <b>21i</b> led to a substantial loss of potency, suggesting a preference for hydrophobic character at this position. The oxabicyclo[2.2.1]heptane <b>21j</b> has a similar potency to <b>21i</b>, and at this stage we cannot say whether the relatively poor activity is due to steric crowding or the common oxygen atom. However, extension (<b>21l</b>), ring-fusion (<b>21m</b>–<b>o</b>), or the incorporation of larger bicyclic acyl substituents (<b>21k</b>) led to substantial drops or a complete loss of activity, presumably because they are too large for the acyl-binding pocket.</div><div class="NLM_p">The clear SAR in this small series, activity against both trypanosome species, and excellent selectivity index of the more potent analogues, encouraged us to further explore this class of compounds, with an initial focus on stereoelectronic modifications to the RHS phenyl group, through the series of benzamides <b>21B</b> depicted in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. As in the first series, for simplicity and economy, 2-phenylthiazoles were targeted with the view that the potency boosting <i>meta</i>-fluorine (present in hit <b>1</b>) could be reinstalled once the acyl substituent had been optimized.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Substituted Benzamides <b>21Ba</b>–<b>21Bq</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0017.gif" alt="" id="GRAPHIC-d7e1810-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center"><i>ortho</i>-</th><th class="rowsep1 colsep0" colspan="3" align="center"><i>meta</i>-</th><th class="rowsep1 colsep0" colspan="3" align="center"><i>para</i>-</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center"><b>21B</b></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (SI<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a>) <i>T. b. brucei</i><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM (SI<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a>) <i>T. cruzi</i><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center"><b>21B</b></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM (SI) <i>T. b. brucei</i></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM (SI) <i>T. cruzi</i></th><th class="colsep0 rowsep0" align="center"><b>21B</b></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM (SI) <i>T. b. brucei</i></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM (SI)<i>T. cruzi</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="center"><b>a</b></td><td class="colsep0 rowsep0" align="center">0.47 ± 0.6</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center"><b>b</b></td><td class="colsep0 rowsep0" align="center">0.19 ± 0.01</td><td class="colsep0 rowsep0" align="center">0.50 ± 0.32</td><td class="colsep0 rowsep0" align="center"><b>c</b></td><td class="colsep0 rowsep0" align="center">0.77 ± 0.19</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(44)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(444)</td><td class="colsep0 rowsep0" align="center">(>100)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(54)</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="center"><b>d</b></td><td class="colsep0 rowsep0" align="center">1.5 ± 0.3</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center"><b>e</b></td><td class="colsep0 rowsep0" align="center">0.42 ± 0.04</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center"><b>f</b></td><td class="colsep0 rowsep0" align="center">n.i.</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(29)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(200)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="center"><b>g</b></td><td class="colsep0 rowsep0" align="center">3.3 ± 0.8</td><td class="colsep0 rowsep0" align="center">3.2 ± 0.5</td><td class="colsep0 rowsep0" align="center"><b>h</b></td><td class="colsep0 rowsep0" align="center">3.9 ± 0.8</td><td class="colsep0 rowsep0" align="center">6.3 ± 0.4</td><td class="colsep0 rowsep0" align="center"><b>i</b></td><td class="colsep0 rowsep0" align="center">n.i.</td><td class="colsep0 rowsep0" align="center">40 ± 12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(2.5)</td><td class="colsep0 rowsep0" align="center">(>15)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(21)</td><td class="colsep0 rowsep0" align="center">(>7.9)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(1.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center"><b>j</b></td><td class="colsep0 rowsep0" align="center">2.3 ± 0.1</td><td class="colsep0 rowsep0" align="center">7.9 ± 0.7</td><td class="colsep0 rowsep0" align="center"><b>k</b></td><td class="colsep0 rowsep0" align="center">n.i.</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(18)</td><td class="colsep0 rowsep0" align="center">(>3)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="center"><b>l</b></td><td class="colsep0 rowsep0" align="center">10.6 ± 3.6</td><td class="colsep0 rowsep0" align="center">10 ± 0.7</td><td class="colsep0 rowsep0" align="center"><b>m</b></td><td class="colsep0 rowsep0" align="center">1.9 ± 0.3</td><td class="colsep0 rowsep0" align="center">3.2 ± 0.4</td><td class="colsep0 rowsep0" align="center"><b>n</b></td><td class="colsep0 rowsep0" align="center">n.i.</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(2.0)</td><td class="colsep0 rowsep0" align="center">(>5)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(26)</td><td class="colsep0 rowsep0" align="center">(>15)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="center"><b>o</b></td><td class="colsep0 rowsep0" align="center">n.i.</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center"><b>p</b></td><td class="colsep0 rowsep0" align="center">0.13 ± 0.01</td><td class="colsep0 rowsep0" align="center">0.79 ± 0.09</td><td class="colsep0 rowsep0" align="center"><b>q</b></td><td class="colsep0 rowsep0" align="center">n.i.</td><td class="colsep0 rowsep0" align="center">0.40 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(387)</td><td class="colsep0 rowsep0" align="center">(>63)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(>126)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">All IC<sub>50</sub> values are the average of two independent experiments ± standard deviation.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">SI = selectivity index relative to HEK293 cells.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">SI = selectivity index relative to the host H9c2 cells. n.i. = no inhibition = <50% inhibition at 10 μM. “–” indicates that the compound was not tested.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Lister 427 bloodstream form.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Tulahuen strain engineered to express β-galactosidase.<a onclick="showRef(event, 'ref24 ref75'); return false;" href="javascript:void(0);" class="ref ref24 ref75">(24, 75)</a></p></div></div></div><div class="NLM_p">Against <i>T. b. brucei</i>, in all cases <i>para</i>-substitution in the benzamides was deleterious, with activity lost in all but the <i>p</i>-fluoro analogue <b>21Bc</b>. The halving of potency of this compound relative to the benzamide <b>21B</b> is most likely due to sterics (rather than electronics) as an <i>ortho</i>-fluorine <b>21Ba</b> had little effect on activity, while the <i>m</i>-fluorobenzamide <b>21Bb</b> was marginally more potent. Indeed, <i>meta</i>-substitution was generally best tolerated, albeit accompanied by a loss of potency when the substituent is electron-donating (<b>21Bh</b>, <b>21Bm</b>). The difference in activity of the isosteric <i>m</i>-methyl <b>21Bh</b> and <i>m</i>-chloro <b>21Be</b> analogues is telling and exemplifies a definite preference for electron-withdrawing substituents at the <i>meta</i>-position. Indeed, the nitrile <b>21Bp</b> is the most active of the substituted benzamides. In contrast to the other results, activity was lost in the phenol <b>21Bk</b>, fitting with the hypothesis discussed earlier, that the target biomolecule contains a hydrophobic acyl-binding pocket.</div><div class="NLM_p">In most cases, <i>ortho</i>-substitution was also tolerated, although associated with drops in potency. This could reflect a reduction in conformational freedom imparted by the <i>ortho</i>-substituent, as supported by the complete loss of activity in the nitrile <b>21Bo</b>, bearing the most restrictive cyano group. Interestingly, the salicylamide <b>21Bj</b> retained activity, possibly due to masking of the polarity of the phenolic hydroxyl by an intramolecular hydrogen bond.</div><div class="NLM_p">Given the apparent preference for an electron-withdrawing substituent at the <i>meta</i>-position, we decided to investigate an expanded series of 3-subsituted benzamides (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Somewhat surprisingly, a trifluoromethyl substituent (<b>21Br</b>) was deleterious to activity, being less potent than the corresponding toluamide <b>21Bh</b>. This probably reflects the slightly larger size of the trifluoromethyl group (isosteric with an isopropropyl group by some measures)<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> relative to methyl. There was a complete loss of activity with the larger pentafluorosulfanyl substituent (<b>21Bs</b>), and activity was also poor with the more polar methylsulfone <b>21Bt</b>. The ethynylbenzamide <b>21Bv</b> was the most potent in this small series, and even the TMS derivative <b>21Bu</b> retained activity. These results, along with those summarized in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, suggest that a combination of steric and electronic factors determine the affinity of <i>meta-</i>substituted benzamides and hint at a narrow neck in the binding site that can conformably accommodate a chlorine atom, and linear substituents like cyano and ethynyl but not the slightly bulkier trifluoromethyl group.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Additional 3-Substituted Benzamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0018.gif" alt="" id="GRAPHIC-d7e2461-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"><b>21B</b></th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (SI<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a>) <i>T. b. brucei</i><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM (SI<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a>) <i>T. cruzi</i><a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>r</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">11.6 ± 2.1 (1.8)</td><td class="colsep0 rowsep0" align="center">n.i.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>s</b></td><td class="colsep0 rowsep0" align="left">SF<sub>5</sub></td><td class="colsep0 rowsep0" align="center">n.i.</td><td class="colsep0 rowsep0" align="center">n.i.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>t</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="center">8.5 ± 1.8 (4.9)</td><td class="colsep0 rowsep0" align="center">40 ± 0.9 (>1.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>u</b></td><td class="colsep0 rowsep0" align="left">C≡CTMS</td><td class="colsep0 rowsep0" align="center">3.6 ± 0.9 (2.9)</td><td class="colsep0 rowsep0" align="center">2.0 ± 0.3 (>12)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>v</b></td><td class="colsep0 rowsep0" align="left">C≡CH</td><td class="colsep0 rowsep0" align="center">0.76 ± 0.14 (27)</td><td class="colsep0 rowsep0" align="center">–</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">All IC<sub>50</sub> values are the average of two independent experiments ± standard deviation.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">SI = selectivity index relative to HEK293 cells.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">SI = selectivity index relative to the host H9c2 cells. n.i. = no inhibition = <50% inhibition at 10 μM. “–” indicates that the compound was not tested.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Lister 427 bloodstream form.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">Tulahuen strain engineered to express β-galactosidase.<a onclick="showRef(event, 'ref24 ref75'); return false;" href="javascript:void(0);" class="ref ref24 ref75">(24, 75)</a></p></div></div></div><div class="NLM_p">The benzamides exhibited similar SAR against <i>T. cruzi</i>, although <i>meta</i>-substitution was slightly less well tolerated than in <i>T. b. brucei</i>. The biggest difference between the two species is in the activity of the <i>para</i>-substituted benzamides: the toluamide <b>21Bi</b> was very modestly active, but the nitrile <b>21Bq</b> was one of the more potent compounds tested. It is possible that the <i>T. cruzi</i> target tolerates a broader range of conformations/poses of the bound molecules, allowing the placement of small linear substituents at both the <i>meta</i> and <i>para</i>-positions into the narrow cleft mentioned above.</div><div class="NLM_p">Heteroaromatic amides <b>21H</b> were also investigated (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>); against <i>T. b. brucei</i>, the picolinamide <b>21Ha</b> was equipotent with the benzamide <b>21f</b>, and the nicotinamide <b>21Hb</b> retained significant activity, but the incorporation of an extra, diametrically opposed nitrogen, in pyrazine <b>21Hd</b>, led to a significant loss of potency, perhaps suggesting amphiphilic character on opposite sides of the acyl-binding pocket. The greatest drop in potency among these 6-membered <i>N</i>-heterocyclic amides was observed in the 4-pyridylamide <b>21Hc</b>, again indicating an aversion to hydrogen-bond acceptors at the 4-position.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Heteroaromatic Amides <b>21Ha</b>–<b>21Ho</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0019.gif" alt="" id="fx10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0020.gif" alt="" id="GRAPHIC-d7e2711-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">All IC<sub>50</sub> values are the average of two independent experiments ± standard deviation.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">SI = selectivity index relative to HEK293 cells.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">SI = selectivity index relative to the host H9c2 cells. n.i. = no inhibition = <50% inhibition at 10 μM. “–” indicates that the compound was not tested.</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">Lister 427 bloodstream form.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">Tulahuen strain engineered to express β-galactosidase.<a onclick="showRef(event, 'ref24 ref75'); return false;" href="javascript:void(0);" class="ref ref24 ref75">(24, 75)</a></p></div></div><div></div></div><div class="NLM_p">Five-membered heteroaromatic amides were then explored (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Unsurprisingly, the 2- and 3-thiophenecarboxamides (<b>21He</b> and <b>21Hf</b>, respectively) were approximately equipotent with the isosteric benzamide <b>21f</b> against <i>T. b. brucei</i>. The furans were also active, with the 3-furyl derivative <b>21Hi</b> being twice as potent as the 2-furyl <b>21Hh</b>, reinforcing a preference for electronegative/electron-withdrawing substituents 3-atoms from the amide carbonyl group. The approximate halving in potency of the 2-furyl derivative <b>21Hh</b> relative to the corresponding thiophene <b>21He</b> is likely due to inadequate filling of the acyl group binding pocket by the smaller furan, as the introduction of a 5-methyl substituent in <b>21Hj</b> saw a significant enhancement of activity. However, a 3-methyl as in <b>21Hl</b>, or the larger bromo substituent in <b>21Hk</b>, were not as well tolerated, suggestive of steric crowding in the region of these substituents and fitting with a putative hydrophobic pocket of limited depth.</div><div class="NLM_p">The introduction of additional heteroatoms into the acyl heteroaromatic substituent led to a drop in potency in the thiazole <b>21Ho</b> and a complete loss of activity in the more polar oxazole <b>21Hn</b>. In contrast, the 5-isoxazole <b>21Hm</b>, with electronegative atoms in the 2- and 3-positions relative to the amide, was only slightly less active than the benzamide <b>21f</b>, once again indicating a tolerance of, or preference for, electronegative atoms at these positions.</div><div class="NLM_p">Most of the polar heteroaromatic amides tested were substantially less potent against <i>T. cruzi</i>, perhaps suggesting less tolerance to polarity in the acyl-binding pocket of the biological target in this species. Alternatively, because in the <i>T. cruzi</i> assay the parasites are within mammalian host cells, the reduced potency of the heteroaromatic amides could be explained by poor uptake through the host cell membrane.</div><div class="NLM_p">A series of ureas and carbamates has also been investigated (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). The synthetic intermediate,  <i>tert-</i>butyl carbamate <b>12</b>, showed no activity against <i>T. b. brucei</i> at 10 μM, which was not unexpected given the lack of tolerance for large acyl substituents observed earlier. Indeed, the slightly smaller isopropyl <b>29a</b> and cyclopentyl carbamates <b>29b</b> had potencies similar to the most active amides against both species. In contrast to the carbamate <b>29a</b>, the <i>N</i>-isopropylurea <b>30a</b> was significantly less active, particularly against <i>T. cruzi</i>. We tentatively attributed this drop in potency to the additional hydrogen bond donor (NH), which presumably is well solvated and possibly not engaged in a target binding interaction. To examine this hypothesis, we tested the <i>N</i>,<i>N</i>-dialkylureas <b>30b</b> and <b>30c</b> and, indeed, activity was restored close to that of the carbamate <b>29a</b> in <i>T. b. brucei</i> but not <i>T. cruzi</i>. The diisopropyl derivative <b>30d</b>, on the other hand, is clearly too large. Exocyclic ureas proved to be the most potent of all compounds examined in this study, with the piperidine <b>23b</b> being optimal, among the 5- (<b>23a</b>), 6- (<b>23b</b>), and 7-membered (<b>30e</b>) rings, against both species. As before, the introduction of an oxygen at the 4-position in the morpholine-derived urea <b>23c</b> led to a dramatic loss of activity, especially against <i>T. cruzi</i>, supporting the hypothesis that the acyl-binding pocket in the biological target of this species is particularly hydrophobic. The enhanced potency of the ureas relative to the carbamates and amides could possibly be explained by enhanced hydrogen-bond donating ability of the carbonyl group in the former, although subtle steric/geometric effects due to the increased planarization of the urea nitrogen cannot be ruled out at this time. The dramatically reduced potency of the pyrrole-derived urea <b>30f</b> is somewhat surprising and could reflect a lack of hydrolytic stability under the reaction conditions. Alternatively (or in addition), this urea has comparable potency to the electronically analogous 5-membered heteroaromatic amides; the poor electron-donating ability of the heterocyclic nitrogen may be responsible for the drop in potency of <b>30f</b> relative to the other ureas.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Carbamates and Ureas</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0021.gif" alt="" id="fx11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0022.gif" alt="" id="GRAPHIC-d7e2900-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">All IC<sub>50</sub> values are the average of two independent experiments ± standard deviation.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">SI = selectivity index relative to HEK293 cells.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">SI = selectivity index relative to the host H9c2 cells. n.i. = no inhibition = <50% inhibition at 10 μM. “–” indicates that the compound was not tested.</p></div><div class="footnote" id="t5fn4"><sup>Table d</sup><p class="last">Lister 427 bloodstream form.</p></div><div class="footnote" id="t5fn5"><sup>Table e</sup><p class="last">Tulahuen strain engineered to express β-galactosidase.<a onclick="showRef(event, 'ref24 ref75'); return false;" href="javascript:void(0);" class="ref ref24 ref75">(24, 75)</a></p></div></div><div></div></div><div class="NLM_p last">The benzenesulfonamide analogue <b>25</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>) was also prepared and evaluated but demonstrated no activity against <i>T. b. brucei</i> at 10 μM and only weak activity against <i>T. cruzi</i> (IC<sub>50</sub> = 20 μM). We hypothesized that this could be due to lengthening the molecule as a result of incorporation of the large sulfur atom. To examine this possibility, and to better mimic the ureas, the slightly smaller sulfamide <b>27</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>) was prepared and tested, but this was also inactive against <i>T. b. brucei</i> and less potent than the sulfonamide against <i>T. cruzi</i> (IC<sub>50</sub> = 32 μM). These results suggest that it is the tetrahedral geometry of the sulfonamide and sulfamide functional groups that results in loss of activity.</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> SAR Concerning the Thiazole-2 Subsituent</h4><div class="NLM_p">Initial efforts in this area began in parallel with the optimization of the acyl substituent, hence the first compounds targeted were cyclopentanecarboxamides and benzamides (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). In contrast to the acyl modifications, replacement of the left-hand side (LHS) phenyl substituent with 2-thienyl (<b>45a</b>/<b>b</b>) led to a substantial drop in potency. Pyridyl substituents (<b>35a</b>–<b>f</b>) were also deleterious, especially against <i>T. cruzi</i>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Benzamides and Cyclopentanecarboxamides Bearing Heterocycles at the Thiazole 2-Position (The Corresponding 2-Phenylthiazoles Are Included for Comparison)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0023.gif" alt="" id="fx12" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0024.gif" alt="" id="GRAPHIC-d7e3002-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">All IC<sub>50</sub> values are the average of two independent experiments ± standard deviation.</p></div><div class="footnote" id="t6fn2"><sup>Table b</sup><p class="last">SI = selectivity index relative to HEK293 cells.</p></div><div class="footnote" id="t6fn3"><sup>Table c</sup><p class="last">SI = selectivity index relative to the host H9c2 cells. n.i. = no inhibition = <50% inhibition at 10 μM. “–” indicates that the compound was not tested.</p></div><div class="footnote" id="t6fn4"><sup>Table d</sup><p class="last">Lister 427 bloodstream form.</p></div><div class="footnote" id="t6fn5"><sup>Table e</sup><p class="last">Tulahuen strain engineered to express β-galactosidase.<a onclick="showRef(event, 'ref24 ref75'); return false;" href="javascript:void(0);" class="ref ref24 ref75">(24, 75)</a></p></div></div><div></div></div><div class="NLM_p">Subsequently, the potently antitrypanosomal piperidine-derived urea <b>23b</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>) had been discovered, and the remaining analogues with variation at the thiazole 2-position kept this RHS moiety constant (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). Additionally, target design was influenced by early metabolite identification studies (see below) that indicated the thiazole phenyl substituent was prone to CYP-mediated oxidation. Although a <i>meta</i>-fluoro substituent gave a potency boost in the HTS hit <b>1</b> (IC<sub>50</sub><i>T. b. brucei</i> = 0.48 μM vs 1.7 for the <i>des</i>-fluoro analogue <b>21e</b> [<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>]), the 2-(fluorophenyl)thiazoles <b>61a</b>–<b>c</b> and <b>64a</b> were of similar potency to the 2-phenylthiazole <b>23b</b>. Other modifications were unfavorable, although <i>ortho</i> and <i>meta</i>-substituted analogues still had submicromolar IC<sub>50</sub> values. The <i>para</i>-substituted analogues were considerably less potent, with the exception of the nitrile <b>61m</b>, which is perhaps better tolerated due to its linear geometry.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Variation of the Thiazole-2-Subsituent in Piperidine-Derived Ureas</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0025.gif" alt="" id="GRAPHIC-d7e3107-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center"><i>ortho</i>-</th><th class="rowsep1 colsep0" colspan="3" align="center"><i>meta</i>-</th><th class="rowsep1 colsep0" colspan="3" align="center"><i>para</i>-</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center"><b>61</b></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (SI<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a>) <i>T. b. brucei</i><a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM (SI<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a>) <i>T. cruzi</i><a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center"><b>61</b></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM (SI)<i>T. b. brucei</i></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM (SI)<i>T. cruzi</i></th><th class="colsep0 rowsep0" align="center"><b>61</b></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM (SI)<i>T. b. brucei</i></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> μM (SI)<i>T. cruzi</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="center"><b>a</b></td><td class="colsep0 rowsep0" align="center">0.016 ± 0.005</td><td class="colsep0 rowsep0" align="center">0.01 ± 0</td><td class="colsep0 rowsep0" align="center"><b>b</b></td><td class="colsep0 rowsep0" align="center">0.026 ± 0.00002</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center"><b>c</b></td><td class="colsep0 rowsep0" align="center">0.024 ± 0.0009</td><td class="colsep0 rowsep0" align="center">0.030 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(650)</td><td class="colsep0 rowsep0" align="center">(>3981)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(398)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(431)</td><td class="colsep0 rowsep0" align="center">(>1584)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center"><b>d</b></td><td class="colsep0 rowsep0" align="center">0.16 ± 0.04</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center"><b>e</b></td><td class="colsep0 rowsep0" align="center">1.5 ± 0.2</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(511)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(55)</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="center"><b>f</b></td><td class="colsep0 rowsep0" align="center">0.19 ± 0.07</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center"><b>g</b></td><td class="colsep0 rowsep0" align="center">3.7 ± 0.5</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(439)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(22)</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="center"><b>h</b></td><td class="colsep0 rowsep0" align="center">0.50 ± 0.07</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center"><b>i</b></td><td class="colsep0 rowsep0" align="center">0.67 ± 0.06</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center"><b>j</b></td><td class="colsep0 rowsep0" align="center">n.i.<a class="ref internalNav" href="#t7fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="center">n.i.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(168)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(62)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="center"><b>k</b></td><td class="colsep0 rowsep0" align="center">0.56 ± 0.11</td><td class="colsep0 rowsep0" align="center">0.79 ± 0.20</td><td class="colsep0 rowsep0" align="center"><b>l</b></td><td class="colsep0 rowsep0" align="center">0.28 ± 0.01</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center"><b>m</b></td><td class="colsep0 rowsep0" align="center">0.33 ± 0.06</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(148)</td><td class="colsep0 rowsep0" align="center">(>63)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(149)</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">(125)</td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">All IC<sub>50</sub> values are the average of two independent experiments ± standard deviation.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">SI = selectivity index relative to HEK293 cells.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">SI = selectivity index relative to the host H9c2 cells. n.i. = no inhibition = <50% inhibition at 10 μM. “–” indicates that the compound was not tested.</p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">Lister 427 bloodstream form.</p></div><div class="footnote" id="t7fn5"><sup>e</sup><p class="last">Tulahuen strain engineered to express β-galactosidase.<a onclick="showRef(event, 'ref24 ref75'); return false;" href="javascript:void(0);" class="ref ref24 ref75">(24, 75)</a></p></div><div class="footnote" id="t7fn6"><sup>f</sup><p class="last">>50% activity at 10 μM but did not reach 100% activity at 42 μM.</p></div></div></div><div class="NLM_p last">A diagram summarizing the SAR detailed in this paper is included in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00442/suppl_file/jm6b00442_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Activity against Other Parasites</h3><div class="NLM_p">A selection of compounds was assessed for activity against other protozoan parasites (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>), <i>T. b. rhodesiense</i>, <i>Plasmodium falciparum</i>, and <i>Leishmania donovani</i>, causative agents of HAT, malaria, and leishmaniasis, respectively, alongside known antiprotozoal drugs, and toxicity to the rat skeletal muscle cell line, L6. In addition, these compounds were reassessed for activity against <i>T. cruzi</i>, providing independent corroboration of the results presented above. All compounds showed only modest activity against <i>P. falciparum</i> and <i>L. donovani</i>, but it was encouraging to see that activity was maintained against the human pathogenic <i>T. b. rhodesiense</i>. As in the model trypanosome <i>T. b. brucei</i>, the thiazolylurea <b>23a</b> is particularly potent.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Activity of Selected Compounds against Other Pathogenic Protozoans</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0026.gif" alt="" id="fx13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>Table a</sup><p class="last">Values are means of two independent experiments ± standard deviation. All assays have been described previously.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></p></div><div class="footnote" id="t8fn2"><sup>Table b</sup><p class="last"><i>T. b. rhodesiense</i> strain STIB 900, bloodstream form (trypomastigotes).</p></div><div class="footnote" id="t8fn3"><sup>Table c</sup><p class="last"><i>T. cruzi</i> Tulahaen C4 strain, amastigote stage.</p></div><div class="footnote" id="t8fn4"><sup>Table d</sup><p class="last"><i>P. falciparum</i> K1 strain, erythrocytic stage.</p></div><div class="footnote" id="t8fn5"><sup>Table e</sup><p class="last"><i>L. donovani</i> MHOM-ET-67/L82 strain, amastigote stage.</p></div><div class="footnote" id="t8fn6"><sup>Table f</sup><p class="last">Rat skeletal myoblast L 6 cell line.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Time to Kill</h3><div class="NLM_p">Fast-acting trypanosomacidal drugs are preferred over trypanosomastatic drugs, as the former class allow for rapid treatment regimes, and reduce the risk of developed resistance, as mentioned in the DND<i>i</i> Target Product Profile for HAT.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> As our primary assays do not discriminate between growth inhibition and parasite death, selected compounds were assessed in a <i>T. cruzi</i> rate-of-kill assay (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>).<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> The amides <b>21Hj</b> and <b>21Bb</b> killed <i>T. cruzi</i> intracellular amastigotes rapidly, with rate-of-kill profiles similar to the fast-acting drug nifurtimox and faster than posaconazole (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b00442/suppl_file/jm6b00442_si_001.pdf" class="ext-link">Figure 3</a>). In addition, the extent of parasite clearance achieved by these amides is similar to nifurtimox. The IC<sub>50</sub> values determined in this assay are similar to those in the growth inhibition assays for <i>T. b. brucei</i> and <i>T. cruzi</i> and comparable to nifurtimox. These compounds also exhibited some level of toxicity at 50 and 17 μM, respectively. Given the excellent selectivity indices observed earlier (especially in the ureas), we do not see this as problematic, but it should be noted that toxicity of the ureas to Vero cells has not been assessed.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. <i>T. cruzi</i> Time-to-Kill Assay Results</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0027.gif" alt="" id="fx14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>Table a</sup><p class="last">Concentration at which toxicity to the host (Vero) cells was seen.</p></div><div class="footnote" id="t9fn2"><sup>Table b</sup><p class="last">Percent inhibition of infected cell number at 96 h normalized to DMSO control (0% effect) and nifurtimox (100% effect).</p></div></div><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Mode of Action</h3><div class="NLM_p last">A number of Chagas drug-discovery/development programs have focused on cytochrome P51 inhibitors.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> However, the drugability of CYP51 inhibitors has recently been questioned.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> They act by preventing the biosynthesis of the essential trypanosome membrane lipid ergosterol and, although trypanosomacidal, are slow-acting. CYP51 inhibitors also show variable <i>T. cruzi</i> strain-specific activity and, in one study, were unable to clear intracellular infections after 7 days of treatment.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> We were therefore pleased to find that <b>21Hj</b> and <b>21Bb</b> did not show any CYP51 inhibition using a recently published fluorescence assay.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The mode of action of this class is not known at this time.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Physicochemical Parameters and Metabolic Assays</h3><div class="NLM_p">Key physicochemical and metabolic parameters were determined for the most potently antitrypanosomal benzamide <b>21Bb</b> and ureas <b>23a</b>/<b>b</b>. When compared against the criteria set by the DND<i>i</i> for progression to in vivo studies (<a class="ref internalNav" href="#tbl10" aria-label="Table 10">Table 10</a>), the only problem is the solubility of <b>21Bb</b> at low pH. All of the compounds have a low polar surface area (below 85 Å<sup>2</sup>), suggesting they can passively traverse the blood–brain barrier. This property is crucial for the treatment of the second stage of HAT. Indeed, all compounds have a CNS multiparameter optimization (MPO) score around 5, placing them in similar chemical space to most marketed CNS drugs.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Key Physicochemical Parameters and Predicted Protein Binding<a class="ref internalNav" href="#t10fn6" aria-label="f">f</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0028.gif" alt="" id="fx15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>Table a</sup><p class="last">Calculated using ACD/Laboratories software, version 9.</p></div><div class="footnote" id="t10fn2"><sup>Table b</sup><p class="last">Measured chromatographically.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></p></div><div class="footnote" id="t10fn3"><sup>Table c</sup><p class="last">Kinetic solubility determined by nephelometry.</p></div><div class="footnote" id="t10fn4"><sup>Table d</sup><p class="last">Human plasma protein binding estimated using a chromatographic method.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></p></div><div class="footnote" id="t10fn5"><sup>Table e</sup><p class="last">p<i>K</i><sub>a</sub> and Log <i>P</i> for the CNS MPO calculation<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> were predicted using ACD/Laboratories software, version 9.</p></div><div class="footnote" id="t10fn6"><sup>Table f</sup><p class="last">*Could not be determined.</p></div></div><div></div></div><div class="NLM_p">In addition to dramatically boosting potency, the introduction of the urea functional group increases water solubility (compared to the benzamides), which is important for oral availability and the minimization of off-target effects. Plasma protein binding (cPPB) is well below the usually accepted limit of 99.5%<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> for all compounds.</div><div class="NLM_p">A consistent deficiency of this class of compounds is a lack of metabolic stability, as assessed in vitro, using mouse and human liver microsomes (<a class="ref internalNav" href="#tbl11" aria-label="Table 11">Table 11</a>). The first results obtained for <b>21Bb</b>, <b>23a</b>, and <b>23b</b>, indicated rapid metabolism by human liver microsomes.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Metabolic Stability Parameters Based on NADPH-Dependent Degradation Profiles in Human and Mouse Liver Microsomes</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0029.gif" alt="" id="fx16" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup>Table a</sup><p class="last">In vitro intrinsic clearance determined in human and mouse liver microsomes.</p></div><div class="footnote" id="t11fn2"><sup>Table b</sup><p class="last">Predicted hepatic extraction ratio calculated from in vitro data as previously described.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></p></div></div><div></div></div><div class="NLM_p">To shed light on the metabolic fate of <b>21Bb</b>, metabolite identification was undertaken (<a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>). When incubated with NADPH-supplemented human liver microsomes, <b>21Bb</b> was completely consumed over 60 min. A metabolite with a mass of 205 Da was detected, consistent with oxidative dealkylation of the amide to give alcohol <b>68</b>, presumably via hemiacetal <b>66</b> and aldehyde <b>67</b>. Two mono-oxygenated metabolites with mass [M + 16]<sup>+</sup> were also detected. MS/MS experiments suggest these are derived by hydroxylation of the ethylene linker and the phenyl group of the phenylthiazole moiety, and thus structures <b>65</b> and <b>69</b> seem most likely, although the regiochemistry of the phenyl hydroxylation reaction has not been confirmed. A secondary metabolite <b>70</b> having a mass of [M + 32]<sup>+</sup> was also detected, corresponding to a second hydroxylation of the phenyl group of <b>69</b> (again, as indicated by MS/MS).</div><figure id="sch9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0014.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Putative in Vitro Metabolism of <b>21Bb</b> in NADPH-Supplemented Human and Mouse Liver Microsomes, Based on LCMS and MS/MS Analysis (Stereochemistry of the sp<sup>3</sup>-C Hydroxylations Is Ignored in This Scheme)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To assess the potential for phase II glucuronidation, <b>21Bb</b> was incubated with microsomes in the presence of NADPH and UDPGA (uridine 5′-diphosphoglucuronic acid). Degradation followed by LCMS showed there was no difference in the rate/extent of parent loss compared to that with NADPH alone. However, the metabolite profiles differed in that a reduction in the amount of the M + 16 and M + 32 metabolites was observed, with a corresponding generation of putative secondary glucuronides. In microsomal samples devoid of cofactors, a minor loss (around 14% over 60 min) of <b>21Bb</b> was observed associated with the detection of <b>65</b> and <b>68</b>, indicating a minor contribution of non-NADPH mediated metabolism to the formation of these metabolites.</div><div class="NLM_p">The apparent hydroxylation of the LHS-phenyl substituent in <b>21Bb</b> encouraged us to examine the fluorinated analogues <b>63a</b>–<b>d</b> of the more potent ureas (<a class="ref internalNav" href="#tbl11" aria-label="Table 11">Table 11</a>). However, fluorination had no significant impact on metabolic stability. These studies indicated that the major metabolic liability of this class of compounds is the ethyl linker and/or that CYP-mediated hydroxylation switches to the nonfluorinated molecular terminus. To assess the second possibility and the importance of the piperidine moiety to metabolic stability, several 2,4-difluorophenylthiazoles <b>64a</b>–<b>d</b> were prepared and assessed (<a class="ref internalNav" href="#tbl12" aria-label="Table 12">Table 12</a>). At least against <i>T. cruzi</i>, these compounds were significantly more potent than their nonfluorinated congeners. The <i>N</i>,<i>N</i>-diethylurea <b>64b</b> was marginally more metabolically stable than the piperidine <b>64a</b>, and the isopropyl carbamate showed further improvement. However, the tetrafluoride <b>64d</b> has a degradation half-life comparable with its nonfluorinated counterpart <b>23b</b> (<a class="ref internalNav" href="#tbl11" aria-label="Table 11">Table 11</a>). It seems likely that the slight improvements in the metabolic stability of <b>64b</b> and <b>64c</b> are a result of increased polarity, and together the results suggest the flexible linker is the metabolic weak point in this class of compounds.</div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. 2-(2,4-Diphenylthiazoles): Antitrypanosomal Activity and in Vitro Metabolism in Human Liver Microsomes<a class="ref internalNav" href="#t12fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0030.gif" alt="" id="fx17" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0031.gif" alt="" id="GRAPHIC-d7e3997-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t12fn1"><div class="footnote" id="t12fn1"><sup>Table a</sup><p class="last">All IC<sub>50</sub> values are the average of two independent experiments ± standard deviation.</p></div><div class="footnote" id="t12fn2"><sup>Table b</sup><p class="last">SI = selectivity index relative to HEK293 cells.</p></div><div class="footnote" id="t12fn3"><sup>Table c</sup><p class="last">SI = selectivity index relative to the host H9c2 cells. n.i. = no inhibition = <50% inhibition at 10 μM. “–” indicates that the compound was not tested.</p></div><div class="footnote" id="t12fn4"><sup>Table d</sup><p class="last">Lister 427 bloodstream form.</p></div><div class="footnote" id="t12fn5"><sup>Table e</sup><p class="last">Tulahuen strain engineered to express β-galactosidase.<a onclick="showRef(event, 'ref24 ref75'); return false;" href="javascript:void(0);" class="ref ref24 ref75">(24, 75)</a></p></div><div class="footnote" id="t12fn6"><sup>Table f</sup><p class="last">In vitro intrinsic clearance determined in human and mouse liver microsomes.</p></div><div class="footnote" id="t12fn7"><sup>Table g</sup><p class="last">Predicted hepatic extraction ratio calculated from in vitro data as previously described.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></p></div></div><div></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> In Vivo Studies</h3><div class="NLM_p">When administered orally to mice, <b>64a</b> was absorbed but, as predicted by the in vitro assays, rapidly metabolized (<a class="ref internalNav" href="#tbl13" aria-label="Table 13">Table 13</a>). However, when the mice were pretreated with the nonselective CYP-inhibitor 1-aminobenzotriazole (ABT),<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86, 87)</a> exposure of <b>64a</b> increased by 2 orders of magnitude (<a class="ref internalNav" href="#tbl13" aria-label="Table 13">Table 13</a>). Tolerability was also found to be excellent in this study.</div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. In Vivo Pharmacokinetics of <b>64a</b> in Mice, With and Without 1-Aminobenzotriazole (ABT) Pretreatment<a class="ref internalNav" href="#t13fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">treatment<a class="ref internalNav" href="#t13fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>last</sub> (0–<i>t</i>) (h·ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±"><i>C</i><sub>max</sub>_D (kg·ng/mL/mg)</th><th class="colsep0 rowsep0" align="center">DNAUC<sub>last</sub><a class="ref internalNav" href="#t13fn3" aria-label="c">c</a> (h·ng/mL/mg/kg)<a class="ref internalNav" href="#t13fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64a</b></td><td class="colsep0 rowsep0" align="char" char="±">0.25 ± 0.00</td><td class="colsep0 rowsep0" align="char" char="±">212 ± 77</td><td class="colsep0 rowsep0" align="char" char="±">127 ± 31</td><td class="colsep0 rowsep0" align="char" char="±">4.3 ± 1.5</td><td class="colsep0 rowsep0" align="center">2.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ABT then <b>64a</b></td><td class="colsep0 rowsep0" align="char" char="±">0.50 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">7090 ± 1300</td><td class="colsep0 rowsep0" align="char" char="±">14792 ± 3988</td><td class="colsep0 rowsep0" align="char" char="±">142 ± 26</td><td class="colsep0 rowsep0" align="center">295</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t13fn1"><div class="footnote" id="t13fn1"><sup>a</sup><p class="last">Balb/c mice used, <i>n</i> = 3 ± SD.</p></div><div class="footnote" id="t13fn2"><sup>b</sup><p class="last">Blood analyzed following oral gavage administration of <b>64a</b> (50 mg/kg) in 2% methylcellulose +0.5% Tween 80.</p></div><div class="footnote" id="t13fn3"><sup>c</sup><p class="last">DNAUC, dose normalized.</p></div></div></div><div class="NLM_p">On the basis of the in vivo pharmacokinetics, compound <b>64a</b> was assessed for efficacy in <i>T. cruzi</i> infected mice pretreated with ABT, alongside the positive control benznidazole. After 5 days of twice daily treatment with <b>64a</b> (50 mg/kg), parasite load was halved and undetectable after 10 days (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).</div><figure id="fig3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vivo efficacy study. Balb/c mice infected with the trypomastigote form of transgenic <i>T. cruzi</i> Brazil strain expressing firefly luciferase<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> were treated by oral gavage with vehicle (PBS with 2% methylcellulose and 0.5% Tween 80, once daily) or twice daily <b>64a</b> (50 mg/kg, preceded by ip ABT 50 mg/kg 30 min prior) or benznidazole (100 mg/kg, once daily). (A) Parasite load from day 0 of treatment (5 days post infection). On imaging days, mice were anesthetized before being injected ip with 150 mg/kg of <span class="smallcaps smallerCapital">d</span>-luciferin potassium salt (Goldbio) dissolved in PBS. Mice were imaged 5–10 min after injection of luciferin with an IVIS 100 in vivo imaging system. The group of mice treated with <b>64a</b> and ABT are shown in panel B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While the demonstration of efficacy in this in vivo proof-of-concept study is very encouraging, it also raised some new challenges, in addition to metabolic lability, that will need to be addressed to progress this class of compounds. Following treatment, and after a recovery period, the mice were immune-suppressed, with mixed results: parasite rebound was observed in three/four mice, while the fourth remained parasite free. These results are promising, considering that, to date, only a few drugs have been able to induce parasitological cure (i.e., sterile clearance) of <i>T. cruzi</i> in mice,<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> an essential prerequisite for developing antichagasic drugs.</div><div class="NLM_p last">There were physical signs that <b>64a</b> is toxic to mice (hunched, ruffled fur, low resistance to handling, etc.). On suspension of treatment, the mice did appear to recover, however. Both the apparent toxicity and parasite rebound can possibly be addressed by improving metabolic stability, allowing lower doses that are effective over longer duration.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Compound Novelty and Related Work</h3><div class="NLM_p">Although a few of the amides described herein are commercially available and are members of large compound collections, to the best of our knowledge, no other significant biological activity has been described for this class of compounds. We were the first group to report this class of antitrypanosomal compounds.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> At the time we initiated this project, and prior to publication of our patent, there was no report of a systematic SAR study on this, or a closely related class of compounds, for any biological activity.</div><div class="NLM_p">During revision of this manuscript, Tidwell and co-workers reported work on the <i>T. b. rhodesiense</i> activity of a closely related series of compounds, mainly regioisomeric thiazoles.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Interestingly, they also honed in on piperidine-derived ureas (e.g., <b>70</b>) as the most potent compounds (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), suggesting a mode of action in common with the series described herein; they also encountered the same problems with metabolic stability. A comparison of the <i>T. brucei</i> activity of the isomeric compounds from both groups is included in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00442/suppl_file/jm6b00442_si_001.pdf" class="ext-link">Supporting Information</a>.</div><figure id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0005.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of isomeric thiazoles: <b>64a</b> from the current work and <b>70</b> from Tidwell and co-workers.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17488" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17488" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><i>Trypanosoma brucei brucei</i> growth inhibition-guided optimization of the HTS-hit <b>1</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) has unveiled a novel class of <i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)amides, carbamates, and ureas that are also active in vitro against <i>T. b. rhodesiense</i> and <i>T. cruzi</i>, causative agents of human African trypanosomiasis (HAT) and Chagas disease, respectively. Structure–activity relationships in the two species of parasite, while subtly different, are suggestive of an orthologous protein target. This target is not the commonly encountered CYP51, but at this time no more can be said about the mode of action of this class of compounds. Selected compounds were shown to be trypanosomacidal and to kill rapidly, desirable attributes in new drugs for trypanosomiasis.</div><div class="NLM_p">The best compounds within the series, piperidine-derived ureas, are potent in vitro, with IC<sub>50</sub> values below 20 nM, are well tolerated by several mammalian cell lines (selectivity indexes well above 1000), and have CNS drug-like physicochemical parameters. However, as a class, these compounds are highly susceptible to CYP-mediated metabolism. In an in vivo proof-of-concept experiment in which CYP metabolism was inhibited by 1-aminobenzotriazole, compound <b>64a</b> was able to reduce parasite load in <i>T. cruzi</i> infected mice to undetectable levels after 10 days of twice-daily treatment. One of four mice remained parasite free after immune suppression (i.e., sterile cure). There were some signs that <b>64a</b> is toxic to mice, although rapid recovery was observed post-treatment.</div><div class="NLM_p last">Preliminary metabolite identification of a selection of compounds within this class indicates that the flexible linker is a point of susceptibility. Attempts to address this problem are ongoing. Nonetheless, the excellent potency, broad spectrum activity, and likelihood that these compounds have a novel mode of action make them promising leads for further investigation.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06688" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06688" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> General</h3><div class="NLM_p">All target compounds (i.e., assessed in biological assays) were ≥95% pure by HPLC with 254 nm detection and sufficiently pure by <sup>1</sup>H NMR spectroscopy. None of the target compounds reported herein have substructures commonly associated with PAINS.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div><div class="NLM_p last">All biological assays have been reported previously, as cited in the <a class="ref internalNav" href="#sec2" aria-label="Results and Discussion">Results and Discussion</a>.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Synthesis</h3><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-(2-(2-Phenylthiazol-4-yl)ethyl)isoindoline-1,3-dione (<b>7</b>)</h4><div class="NLM_p last">Prepared as described previously in 60% yield.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a><sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.81–7.85 (m, 2H, 2 × Ar), 7.76–7.80 (m, 2H, 2 × Ar), 7.67–7.72 (m, 2H, 2 × Ar), 7.32–7.38 (3H, m, 3 × Ar), 6.99 (s, 1H, H5′), 4.11 (t, <i>J</i><sub>1</sub> = 6.6 Hz, 2H, H1′), 3.23 (t, <i>J</i><sub>1</sub> = 6.6 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.4 (C2″ or CO), 168.1 (C2″ or CO), 154.4 (C4″), 134.0, 133.8, 132.4, 130.0, 128.9, 126.6, 114.7 (C5″), 37.7 (C1′), 30.2 (C2′). The <sup>1</sup>H NMR data are similar to those reported at 60 MHz.</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-(2-Phenylthiazol-4-yl)ethanamine (<b>8</b>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></h4><div class="NLM_p last">Prepared as described previously in 50% yield. IR (cm<sup>–1</sup>): 3368 (NH). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.90–7.94 (m, 2H, H2″/H6″), 7.36–7.43 (m, 3H, H3″/H4″/H5″), 6.96 (t, <i>J</i> = 1.0 Hz, 1H, H5′), 3.07–3.17 (m, 2H, H2), 2.94 (t, <i>J</i><sub>1</sub> = 6.5 Hz, 2H, H1), 1.71 (br s, NH<sub>2</sub> + H<sub>2</sub>O). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.0 (C2′), 156.3 (C4′), 133.8 (C1″), 130.0 (C4″), 129.0 (2 × ArH), 126.6 (2 × ArH), 114.1 (C5′), 41.8 (C1), 35.7 (C2).</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 4-Chloromethyl-2-phenylthiazole (<b>10</b>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></h4><div class="NLM_p last">Thiobenzamide (<b>6</b>) (13.4 g, 97.7 mmol) was added to a stirred solution of 1,3-dichloroacetone (<b>9</b>) (16.6 g, 131 mmol) in acetone (250 mL), and the suspension was heated under reflux overnight. The reaction mixture was allowed to cool to room temperature then vacuum-filtered, and the white solid was washed with acetone (3 × 100 mL), then air-dried. The solid was dissolved in conc sulfuric acid (80 mL), and the solution was stirred for 30 min then poured onto ice and cold water was added until no more solid precipitated. The precipitate was collected by vacuum filtration, washed with water (3 × 100 mL), and air-dried to yield <b>10</b> as a white solid (17.4 g, 85%), mp = 43–45 °C [lit.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> 53–55 °C]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.94–7.96 (m, 2H, H2′/H6′), 7.43–7.45 (m, 3H, H3′/H4′/H5′), 7.30 (t, <i>J</i><sub>1</sub> = 0.8 Hz, 1H, H5), 4.75 (s, 2H, CH<sub>2</sub>). The <sup>1</sup>H NMR data matched those reported.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-(−2-Phenylthiazol-4-yl)acetonitrile (<b>11</b>)</h4><div class="NLM_p last">A mixture of KCN (13.2 g, 202 mmol), <b>9</b> (4.61 g, 20.0 mmol), and dry DMF (40 mL) under N<sub>2</sub> was stirred at 60 °C for 36 h. The mixture was allowed to cool, diluted with water (300 mL), and extracted with EtOAc (3 × 100 mL). The extract was washed with water (100 mL) and brine (2 × 100 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give the nitrile <b>11</b> as a brown solid (3.75 g, 94%) of sufficient purity for the next step. <sup>1</sup>H NMR (400 MHz) δ 7.91–7.94 (m, 2H, H2′/H6′), 7.44–7.46 (m, 3H, H3′/H4′/H5′), 7.29 (t, <i>J</i> = 1.0 Hz, 1H, H5), 3.95 (s, 2H, CH<sub>2</sub>). This compound was first reported before the advent of spectroscopic characterization.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div></div><div id="sec3_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>tert</i>-Butyl (2-(2-Phenylthiazol-4-yl)ethyl)carbamate (<b>12</b>)</h4><div class="NLM_p last">NaBH<sub>4</sub> (3.57 g, 94.4 mmol) was added slowly, over 30 min, to a solution of di-<i>tert</i>-butyl dicarbonate (5.88 g, 26.9 mmol), NiCl<sub>2</sub>·6H<sub>2</sub>O (0.320 g, 1.35 mmol), and nitrile <b>11</b> (2.62 g, 13.1 mmol) in dry methanol (100 mL) at 0 °C under N<sub>2</sub>. The reaction mixture was allowed to warm to room temperature, and stirring was continued for 90 min. NEt<sub>3</sub> (1.89 mL) was added, and the solution was stirred for 30 min before the volatiles were evaporated. The residue was extracted with EtOAc (3 × 300 mL), and the extract was washed with water (3 × 300 mL) and saturated NH<sub>4</sub>Cl (3 × 300 mL), dried, filtered, and evaporated to yield <b>12</b> as an orange oil (3.27 g, 82%). <i>R</i><sub>f</sub> 0.5 (2:3 EtOAc/hexanes + NEt<sub>3</sub>). IR (cm<sup>–1</sup>): 3337 (NH), 1693 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.91–7.94 (m, 2H, H2″/H6″), 7.39–7.46 (m, 3H, H3″/H4″/H5″), 6.96 (s, 1H, H5′), 5.09 (br s, 1H, NH), 3.54 (dt [app, q], <i>J</i><sub>1</sub>= <i>J</i><sub>2</sub> = 6.4 Hz, 2H, H1), 2.99 (t, <i>J</i><sub>1</sub> = 6.4 Hz, 2H, H2), 1.44 (s, 9H, CH<sub>3</sub>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.2 (C2′), 156.1 (C4′ or C═O), 155.6 (C4′ or C═O), 133.8 (C1″), 130.1 (C4″), 129.0 (2 × ArH), 126.6 (2 × ArH), 114.4 (C5′), 79.3 (O–C), 40.1 (C1), 31.9 (C2), 28.4 (CH<sub>3</sub>). HRMS (ESI) <i>m</i>/<i>z</i> observed: 305.1305, C<sub>16</sub>H<sub>21</sub>N<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 305.1318.</div></div><div id="sec3_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(2-Phenylthiazol-4-yl)ethanamine Dihydrochloride (<b>13</b>)</h4><div class="NLM_p last">Ice-cold conc HCl (3.0 mL) was slowly added to a solution of <b>12</b> (0.569 g, 1.87 mmol) in 1,4-dioxane (5 mL). After 2 h, the volatiles were evaporated under a stream of N<sub>2</sub> to yield <b>13</b> as a yellow solid (0.518 g, mmol, quant), mp = 140–142 °C. IR (cm<sup>–1</sup>): 2443–3986 (NH). <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.00–8.03 (m, 2H, H2″/H6″), 7.60 (s, 1H, H5′), 7.54–7.58 (m, 3H, H3″/H4″/H5″), 3.26 (t, <i>J</i><sub>1</sub> = 7.2 Hz, 2H, H2), 3.16 (t, <i>J</i><sub>1</sub> = 7.2 Hz, 2H, H1). <sup>1</sup>H NMR (DMSO, 500 MHz) δ 8.53 (br s, <sup>1</sup>H, NH), 8.26 (br s, 3H, NH<sub>3</sub>), 7.90–7.97 (m, 2H, H2″/H6″), 7.54 (s, 1H, H5′), 7.47–7.53 (m, 3H, H3″/H4″/H5″), 3.14–3.22 (m, 2H, H1), 3.08–3.13 (m, 2H, H2). <sup>13</sup>C NMR (126 MHz, DMSO) δ 167.1 (C2′), 153.0 (C4′), 132.9 (C1′), 130.3 (C4″), 129.2 (2 × ArH), 126.1 (2 × ArH), 116.3 (C5′), 38.1 (C1), 28.8 (C2). HRMS (ESI) <i>m</i>/<i>z</i> observed: 205.0802, C<sub>11</sub>H<sub>13</sub>N<sub>2</sub>S<sup>+</sup> [free base + H]<sup>+</sup> requires 205.0794. Titration with NaOH/phenolphthalein showed the salt to be the dihydrochloride.</div></div><div id="sec3_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Ethyl 2-(2-Phenylthiazol-4-yl)acetate (<b>15</b>)</h4><div class="NLM_p last">To a suspension of thiobenzamide (10 g, 73 mmol) in EtOH (100 mL) was added ethyl chloroacetoacetate (11.5 mL, 80.2 mmol, 1.1 equiv), and the reaction mixture was heated to reflux for 8 h. The EtOH was evaporated under vacuum and the residue dissolved in EtOAc (100 mL). The resulting solution was washed with water (60 mL), saturated NaHCO<sub>3</sub> (75 mL), and brine (50 mL). The organic layer was dried over MgSO<sub>4</sub> and concentrated under vacuum. The crude residue was then purified by column chromatography on silica (petroleum spirit/EtOAc gradient) to afford <b>15</b> (15.9 g, 88%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.90–8.01 (m, 2H), 7.40–7.70 (m, 3H), 7.13 (s, 1H), 3.98 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.7 Hz, 2H), 3.58 (s, 2H), 1.48 (t, <i>J</i> = 6.7 Hz, 3H). LRMS (ESI+) <i>m</i>/<i>z</i>: 248 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(2-Phenylthiazol-4-yl)ethan-1-ol (<b>16</b>)</h4><div class="NLM_p last">To a solution of <b>15</b> (1 g, 4 mmol) in dry THF (15 mL) cooled to −78 °C was added LiAlH<sub>4</sub> (306 mg, 8.09 mmol). The mixture was stirred at −78 °C for 1 h and then allowed to warm to room temperature. After completion of the reaction was indicated by TLC, 1 M HCl (10 mL) was carefully added to reaction mixture followed by EtOAc (15 mL). The organic layer was collected and the aqueous layer extracted with EtOAc (2 × 15 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under vacuum. The resulting material was purified by column chromatography on silica to afford <b>16</b> (759 mg, 91%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.89–8.05 (m, 2H), 7.50–7.75 (m, 3H), 7.07 (s, 1H), 5.02 (br s, 1H), 3.58 (t, <i>J</i> = 6.9 Hz, 2H), 2.96 (t, <i>J</i> = 6.9 Hz, 2H). LRMS (ESI+) <i>m/</i>z: 206 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-(2-Phenylthiazol-4-yl)ethylmethanesulfonate (<b>17</b>)</h4><div class="NLM_p last">To a solution of <b>16</b> (100 mg, 0.49 mmol) and NEt<sub>3</sub> (81 μL, 0.58 mmol) in DCM (1 mL) at 0 °C was added dropwise methanesulfonyl chloride (45 μL, 0.59 mmol). The reaction was stirred at rt until completion was indicated by TLC. The solution was partitioned between DCM (5 mL) and 1 M HCl (5 mL). The organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuum. This crude material (112 mg) was used in the next step without further purification or characterization.</div></div><div id="sec3_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 4-(2-Azidoethyl)-2-phenylthiazole (<b>18</b>)</h4><div class="NLM_p last">To a solution of <b>16</b> (100 mg, 0.353 mmol) in dry DMF (1 mL) was added NaN<sub>3</sub> (31 mg, 0.49 mmol). The mixture was heated to 60 °C. After TLC indicated completion of the reaction, the mixture was cooled to room temperature and diluted with EtOAc (10 mL). The solution was washed with water (3 × 10 mL) and brine (10 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuum. The crude material was purified by column chromatography on silica to afford <b>18</b> (71 mg, 87%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.89–8.10 (m, 2H), 7.50–7.78 (m, 3H), 6.99 (s, 1H), 2.48 (t, <i>J</i> = 7.0 Hz, 2H), 1.90 (t, <i>J</i> = 7.0 Hz, 2H). LRMS (ESI+) <i>m/</i>z: 231 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 4-(2-Aminoethyl)-2-phenylthiazole (<b>19</b>)</h4><div id="sec3_2_11_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> Method B</h5><div class="NLM_p last">To a solution of <b>16</b> (100 mg, 0.434 mmol) in MeOH (3 mL) was added 10% Pd/C (46 mg, 10 mol %). The suspension was placed under a hydrogen atmosphere and left stirring for 5 h. The mixture was then filtered and the solvents removed under vacuum. The resulting amine <b>8</b> (89 mg, quant), identical with the material described above, was used in the next step without further purification.</div></div></div><div id="sec3_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> General Procedure A for the Synthesis of Amides from <b>8</b> and Acid Chlorides</h4><div class="NLM_p last">Acid chloride (1.3 mmol) was added dropwise to a stirred solution of NEt<sub>3</sub> (0.2 mL) and <b>8</b> (0.21 g, 1.0 mmol) in DCM (2 mL) at 0 °C under N<sub>2</sub>. The ice bath was removed, and stirring was continued for 90 min. The reaction mixture was diluted with DCM (10 mL) and washed with H<sub>2</sub>O (10 mL) and brine (10 mL), dried (MgSO<sub>4</sub>), and evaporated. Unless otherwise indicated, the oily residue was dissolved in a minimum of DCM. Precipitation with hexanes gave the products as powders, which were collected and dried.</div></div><div id="sec3_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> General Procedure B for the Synthesis of Amides from <b>13</b> and Acid Chlorides</h4><div class="NLM_p last">Acid chloride (1.5–2 equiv) was added dropwise to a stirred mixture of NEt<sub>3</sub> (2.5 equiv) and <b>13</b> (1 equiv) in DCM (10 mL per mmol of <b>13</b>) at 0 °C under N<sub>2</sub>. The reaction mixture was allowed to warm to room temp, and stirring was continued overnight. The volatiles were evaporated, and the residue was purified by flash chromatography as described below.</div></div><div id="sec3_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> General Procedure C for the Synthesis of Amides from <b>13</b>, Carboxylic Acids and DCC</h4><div class="NLM_p last">1-Hydroxybenzotriazole hydrate (HOBT) (1.15 equiv) and 1,3-dicyclohexylcarbodiimide (DCC) (0.191 g, 0.924 mmol) were added to a solution of the carboxylic acid (1.05 equiv) in DCM (∼10 mL per mmol of <b>13</b>) at 0 °C under N<sub>2</sub>. After 1 h, <b>13</b> (1 equiv) was added and stirring was continued for 24 h or until TLC showed the reaction to be complete. The reaction mixture was diluted with EtOAc (150 mL), then washed with brine (3 × 100 mL), dried, and evaporated to give a residue, which was purified by flash chromatography as described below.</div></div><div id="sec3_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> General Procedure D for the Synthesis of Amides from <b>13</b>, Carboxylic Acids, and HBTU</h4><div class="NLM_p last">A mixture of carboxylic acid (∼1.2 equiv), HBTU (∼1.2 equiv), Hünig’s base (∼3.5 equiv), and primary amine dihydrochloride <b>13</b> (1 equiv) in 1:1 DMF/DCM or MeCN (∼10 mL per mmol of <b>13</b>), under N<sub>2</sub>, was stirred for 24 h or until the TLC showed the reaction to be complete [workup based on 1 mmol of <b>13</b>]. The solvent was evaporated, and the residue was partitioned between DCM (∼50 mL) and 10% citric acid (∼100 mL) and the aqueous phase was extracted with DCM (2 × 50 mL). The combined organic phase was washed with water (50 mL) and brine (50 mL), dried, and evaporated to give a residue, which was purified by flash chromatography as described below.</div></div><div id="sec3_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> General Procedure E for the Synthesis of Amides from <b>8</b>, Carboxylic Acids, and EDCI</h4><div class="NLM_p last">To a solution of the amine <b>8</b> (0.39 mmol) in DMF (0.5 M final concentration) was added the carboxylic acid (0.47 mmol), EDCI (0.47 mmol), and DMAP (0.04 mmol). The reaction mixture was stirred at 45 °C for 18 h then diluted with water (2 mL) and extracted with EtOAc (×3). The extract was dried and evaporated, and the residue was purified by column chromatography, eluting with 10% EtOAc/petroleum spirit to obtain the desired product.</div></div><div id="sec3_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)formamide (<b>21a</b>)</h4><div class="NLM_p last">A solution of <b>8</b> (0.21 g, 1.0 mmol) in ethyl formate (2 mL) was heated under reflux for 4 h. The excess ethyl formate was evaporated, and the residue was dissolved in a minimum of DCM. Precipitation with hexanes gave the formamide <b>21a</b> as an off-white powder (0.17 g, 71%), mp = 90–92 °C. IR (cm<sup>–1</sup>): 3274 (NH), 1651 (C═O). <sup>1</sup>H NMR (500 MHz, DMSO) δ 8.08 (br s, 1H, NH), 8.01 (d, <i>J</i> = 1.5 Hz, 1H, CHO), 7.90–7.95 (m, 2H, H2‴/H6‴), 7.46–7.52 (m, 3H, H3‴/H4‴/H5‴), 7.41 (s, 1H, H5″), 3.47 (dt [app, q] <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.0 Hz, 2H, H1′), 2.91 (t, <i>J</i> = 7.0 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, DMSO) δ 166.5 (C2″), 161.1 (C═O), 155.1 (C4″), 133.2 (C1‴), 130.1 (C4‴), 129.2 (2 × ArH), 126.0 (2 × ArH), 115.3 (C5″), 36.8 (C1′), 31.1 (C2′). HRMS (CI) <i>m</i>/<i>z</i> observed: 233.0744, C<sub>12</sub>H<sub>13</sub>N<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 233.0743.</div></div><div id="sec3_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)acetamide (<b>21b</b>)</h4><div class="NLM_p last">Following general procedure A with acetyl chloride gave <b>21b</b> as an off-white powder (0.18 g, 71%), mp = 80–82 °C. IR (cm<sup>–1</sup>): 3283 (NH), 1649 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.90–7.96 (m, 2H, H2‴/H6‴), 7.40–7.49 (m, 3H, H3‴/H4‴/H5‴), 6.98 (s, 1H, H5″), 6.36 (br s, 1H, NH), 3.65 (dt [app, q] <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.5 Hz, 2H, H1′), 3.01 (t, <i>J</i> = 6.5 Hz, 2H, H2′), 1.99 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.2 (CO), 168.4 (C2″), 155.6 (C4″), 133.7 (C1″), 130.3 (C4‴), 129.2 (2 × ArH), 126.5 (2 × ArH), 114.6 (C5″), 39.2 (C1′), 31.1 (C2′), 23.6 (CH<sub>3</sub>). HRMS (CI) <i>m</i>/<i>z</i> observed: 247.0899, C<sub>13</sub>H<sub>15</sub>N<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 247.0900.</div></div><div id="sec3_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)propionamide (<b>21c</b>)</h4><div class="NLM_p last">Following general procedure A with propionyl chloride gave <b>21c</b> as an off-white powder (0.21 g, 78%), mp = 78–80 °C. IR (cm<sup>–1</sup>): 3307 (NH), 1639 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.90–7.95 (m, 2H, H2‴/H6‴), 7.40–7.48 (m, 3H, H3‴/H4‴/H5‴), 6.97 (s, 1H, H5″), 6.40 (br s, 1H, NH), 3.66 (dt [app, q] <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.5 Hz, 2H, H1′), 3.00 (t, <i>J</i> = 6.5 Hz, 2H, H2′), 2.22 (q, <i>J</i> = 7.5 Hz, 2H, H2), 1.15 (t, <i>J</i> = 7.5 Hz, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 173.9 (CO), 168.4 (C2″), 155.7 (C4″), 133.7 (C1″), 130.2 (C4‴), 129.1 (2 × ArH), 126.5 (2 × ArH), 114.5 (C5″), 39.0 (C1′), 31.1 (C2′), 30.0 (C2), 10.0 (CH<sub>3</sub>). HRMS (CI) <i>m</i>/<i>z</i> observed: 261.1064, C<sub>13</sub>H<sub>15</sub>N<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 261.1056.</div></div><div id="sec3_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)isobutyramide (<b>21d</b>)</h4><div class="NLM_p last">Following general procedure A with isobutyryl chloride gave <b>21d</b> as an off-white powder (0.24 g, 85%), mp = 88–90 °C. IR (cm<sup>–1</sup>): 3299 (NH), 1639 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.86–7.91 (m, 2H, H2‴/H6‴), 7.42–7.48 (m, 3H, H3‴/H4‴/H5‴), 6.97 (s, 1H, H5″), 6.41 (br s, 1H, NH), 3.65 (dt [app, q] <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.0 Hz, 2H, H1′), 3.01 (t, <i>J</i> = 6.0 Hz, 2H, H2′), 2.35 (sept, <i>J</i> = 6.8 Hz, 1H, H2), 1.15 (d, <i>J</i> = 6.8 Hz, 6H, CH<sub>3</sub>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 177.0 (CO), 168.4 (C2″), 155.8 (C4″), 133.6 (C1″), 130.2 (C4‴), 129.1 (2 × ArH), 126.5 (2 × ArH), 114.5 (C5″), 38.9 (C1′), 35.9 (C2), 31.1 (C2′), 19.8 (2 × CH<sub>3</sub>). HRMS (CI) <i>m</i>/<i>z</i> observed: 275.1211, C<sub>15</sub>H<sub>19</sub>N<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 275.1213.</div></div><div id="sec3_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)pivalamide (<b>21e</b>)</h4><div class="NLM_p last">Following general procedure A with pivaloyl chloride gave <b>21e</b> as an off-white powder (0.17 g, 57%), mp = 62–64 °C. IR (cm<sup>–1</sup>): 3366 (NH), 1638 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92–7.96 (m, 2H, H2‴/H6‴), 7.42–7.46 (m, 3H, H3‴/H4‴/H5‴), 6.96 (s, 1H, H5″), 6.78 (br s, 1H, NH), 3.62 (dt [app, q] <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.2 Hz, 2H, H1′), 2.99 (t, <i>J</i> = 6.0 Hz, 2H, H2′), 1.19 (s, 9H, CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 178.6 (CO), 168.5 (C2″), 156.0 (C4″), 133.7 (C1″), 130.2 (C4‴), 129.1 (2 × ArH), 126.5 (2 × ArH), 114.5 (C5″), 39.2 (C1′), 38.8 (C2), 31.0 (C2′), 27.7 (3 × CH<sub>3</sub>). HRMS (CI) <i>m</i>/<i>z</i> observed: 289.1369, C<sub>15</sub>H<sub>19</sub>N<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 289.1369.</div></div><div id="sec3_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)benzamide (<b>21f</b>)</h4><div class="NLM_p last">Following general procedure A with benzoyl chloride gave <b>21f</b> as an off-white powder (0.19 g, 60%), mp = 90–92 °C. IR (cm<sup>–1</sup>): 3327 (NH), 1639 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92–7.98 (m, 2H, H2‴/H6‴), 7.82–7.86 (m, 2H, H2/6), 7.67 (br s, 1H, NH), 7.38–7.52 (m, 6H, ArH), 7.03 (s, 1H, H5″), 3.84 (dt [app, q] <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.8 Hz, 2H, H1′), 3.11 (t, <i>J</i> = 6.4 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.6 (CO or C2″), 167.4 (CO or C2″), 155.8 (C4″), 135.0 (C1), 133.5 (C1‴), 131.4 (C4 or C4‴), 130.4 (C4 or C4‴), 129.1 (2 × ArH), 128.6 (2 × ArH), 127.1 (2 × ArH), 126.6 (2 × ArH), 114.7 (C5″), 39.7 (C1′), 30.7 (C2′). HRMS (CI) <i>m</i>/<i>z</i> observed: 309.1063, C<sub>15</sub>H<sub>19</sub>N<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 309.1056.</div></div><div id="sec3_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)cyclohexanecarboxamide (<b>21g</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.253 g, 0.913 mmol) and cyclohexanecarboxylic acid (0.511 g, 1.18 mmol). Elution with 1:4 EtOAc/hexanes then 2:3 EtOAc/hexanes gave <b>21g</b> as a white solid (0.232 g, 80%), mp = 128–130 °C. <i>R</i><sub>f</sub> 0.3 (1:4 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3293 (NH), 1637 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.93 (m, 2H, H2‴/H6‴), 7.43 (m, 3H, H3‴/H4‴/H5‴), 6.95 (s, 1H, H5″), 6.55 (br s, 1H, NH), 3.62 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.2 Hz, 2H, H1′), 2.99 (t, <i>J</i><sub>1</sub> = 6.0 Hz, 2H, H2′), 2.08 (m, 1H, H1), 1.87 (m, 2H, H2a/H6a), 1.75 (m, 2H, H2b/H6b), 1.64 (m, 1H, H4a), 1.39 (m, 2H, H3a/H5a), 1.22 (m, 3H, H3b/H4b/H5b). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 176.2 (C═O), 168.3, (C2″), 155.8 (C4″), 133.7 (C1‴), 130.2 (C4‴), 129.1 (2 × ArH), 126.5 (2 × ArH), 114.5 (C5″), 45.6 (C1′), 38.9 (C1), 30.9 (C2′), 29.8 (C2/C6), 25.90 (C4), 25.87 (C3/C5). HRMS (CI) <i>m</i>/<i>z</i> observed: 315.1533, C<sub>18</sub>H<sub>23</sub>N<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 315.1531.</div></div><div id="sec3_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)cyclopentanecarboxamide (<b>21h</b>)</h4><div class="NLM_p last">Prepared according to general procedure E with cyclopentanecarboxylic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.09 (br s, 1H), 7.95–8.05 (m, 2H), 7.40–7.55 (m, 3H), 6.96 (s, 1H), 3.69 (dt [app, q] <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.5 Hz, 2H), 3.15 (t, <i>J</i> = 6.5 Hz, 2H), 2.42–2.55 (m, 1H), 1.48–1.80 (m, 8H). LRMS (ESI+) <i>m</i>/<i>z</i>: 301 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)tetrahydro-2<i>H</i>-pyran-4-carboxamide (<b>21i</b>)</h4><div class="NLM_p last">Prepared according to general procedure E with tetrahydro-2<i>H</i>-pyran-4-carboxylic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92–8.05 (m, 3H), 7.45–7.61 (m, 3H), 6.95 (s, 1H), 3.59–3.72 (m, 6H), 3.03 (t, <i>J</i> = 6.8 Hz, 2H), 2.56 (t, <i>J</i> = 7.2 Hz, 2H), 2.42–2.55 (m, 1H), 1.90–2.05 (m, 2H), 1.75–1.83 (m, 2H). LRMS (ESI+) <i>m</i>/<i>z</i>: 317 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (±)-(1<i>R*</i>,2<i>S*</i>,4<i>R*</i>)-<i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-carboxamide (<b>21j</b>)</h4><div class="NLM_p last">Prepared according to general procedure E with 7-oxabicyclo[2.2.1]hept-5-ene-2-carboxylic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.01 (s, 1H), 7.91–7.98 (m, 2H), 7.43–7.59 (m, 3H), 6.98 (s, 1H), 5.81 (dd, <i>J</i> = 10.9, 5.8 Hz, 1H), 5.76 (dd, <i>J</i> = 10.4, 6.1 Hz, 1H), 4.81 (dd, <i>J</i> = 6.9, 6.2 Hz, 1H), 4.35–4.41 (m, 1H), 3.59–3.72 (m, 6H), 3.12 (t, <i>J</i> = 6.6 Hz, 2H), 2.26–2.32 (m, 1H), 1.99–2.05 (m, 1H). LRMS (ESI+) <i>m</i>/<i>z</i>: 326 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (±)-2-((1<i>R*</i>,2<i>S*</i>,4<i>S*</i>)-Bicyclo[2.2.1]heptan-2-yl)-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)acetamide (<b>21k</b>)</h4><div class="NLM_p last">Prepared according to general procedure E with bicyclo[2.2.1]heptan-2-ylacetic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.04 (s, 1H), 7.90–7.95 (m, 2H), 7.48–7.61 (m, 3H), 6.97 (s, 1H), 3.58 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.8 Hz, 2H), 3.04 (t, <i>J</i> = 6.7 Hz, 2H), 1.95–2.25 (m, 4H), 1.20–1.70 (m, 11H). LRMS (ESI+) <i>m</i>/<i>z</i>: 340 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 2-Phenyl-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)acetamide (<b>21l</b>)</h4><div class="NLM_p last">General procedure B was followed with <b>13</b> (0.210 g, 0.758 mmol) and phenylacetyl chloride (0.172 mL, 1.30 mmol). Elution with 1:3 EtOAc/hexanes gave <b>21l</b> as a white solid (0.0782 g, 32%), mp = 113–118 °C. <i>R</i><sub>f</sub> 0.25 (1:3 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3290 (NH), 1657 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.81–7.84 (m, 2H, H2‴/H6‴), 7.41–7.43 (m, 3H, H3‴/H4‴/H5‴), 7.19–7.21 (m, 5H, benzyl Ar), 6.79 (s, 1H, H5″), 6.13 (br s, 1H, NH), 3.61 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.4 Hz, 2H, H1′), 3.53 (s, 2H, H2), 2.92 (t, <i>J</i> = 6.4 Hz, 2H, H2′). <sup>13</sup>C NMR (101) MHz, CDCl<sub>3</sub>) δ 171.1 (C═O), 168.2 (C2″), 155.3 (C4″), 135.0 (C1‴ or C1′′′′), 133.6 (C1‴ or C1′′′′), 130.1 (ArH), 129.4 (2 × ArH), 129.0 (2 × ArH), 129.0 (2 × ArH), 127.3 (ArH), 126.5 (2 × ArH), 114.5 (C5″), 44.1 (C2), 39.0 (C1′), 31.0 (C2′). HRMS (EI) <i>m</i>/<i>z</i> observed: 322.1147, C<sub>19</sub>H<sub>18</sub>N<sub>2</sub>OS [M<sup>•+</sup>] requires 322.1140.</div></div><div id="sec3_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)-1-naphthamide (<b>21m</b>)</h4><div class="NLM_p last">General procedure (C) was followed with <b>13</b> (0.218 g, 0.786 mmol) and 1-naphthoic acid (0.138 g, 0.802 mmol). Elution with 1:1 EtOAc/hexanes gave <b>21m</b> as an orange solid (0.214 g, 75%), mp = 104–106 °C. <i>R</i><sub>f</sub> 0.2 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3288 (NH), 1644 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.35–8.37 (m, 1H, H2), 7.91 (d, 1H, <i>J</i> = 8.4 Hz, H4), 7.85–7.89 (m, 1H, naphthyl), 7.78–7.81 (m, 2H, H2‴/H6‴), 7.66 (dd, <i>J</i><sub>1</sub> = 7.0 Hz, <i>J</i><sub>2</sub> = 1.0 Hz, 1H, H5 or H8), 7.48–7.52 (m, 2H, 2 × Ar), 7.33–7.45 (m, 4H, 4 × Ar), 7.24 (br s, 1H, NH), 7.02 (s, 1H, H5″), 3.96 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.2 Hz, 2H, H1′), 3.18 (t, <i>J</i> = 6.4 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 169.5 (C2″ or C═O), 168.4 (C2″ or C═O), 155.5 (C4″), 134.8 (Ar), 133.8 (Ar), 133.4 (Ar), 130.6 (ArH), 130.3 (Ar), 130.1 (ArH), 129.0 (2 × ArH), 128.3 (ArH), 127.1 (ArH), 126.43 (ArH), 126.39 (2 × ArH), 125.6 (ArH), 125.2 (ArH), 124.8 (ArH), 114.6 (C5″), 39.6 (C1′), 30.9 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 359.1204, C<sub>22</sub>H<sub>19</sub>N<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 359.1218.</div></div><div id="sec3_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)-2-naphthamide (<b>21n</b>)</h4><div class="NLM_p last">General procedure C was followed with <b>13</b> (0.218 g, 0.786 mmol) and 2-naphthoic acid (0.138 g, 0.802 mmol). Elution with 1:4 EtOAc/hexanes gave <b>21m</b> as an orange solid (0.217 g, 77%), mp = 124–125 °C. <i>R</i><sub>f</sub> 0.3 (1:4 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3301 (NH), 1644 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.35 (s, 1H, H1), 7.92–7.99 (m, 4H, Ar), 7.84–7.92 (m, 3H, NH + 2 × Ar), 7.51–7.58 (m, 2H, 2 × Ar), 7.41–7.50 (m, 3H, H3‴/H4‴/H5‴), 7.06 (s, 1H, H5″), 3.90 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.0 Hz, 2H, H1′), 3.16 (t, <i>J</i><sub>1</sub> = 6.0 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.7 (C═O or C2″), 167.5 (C═O or C2″), 156.0 (C4″), 134.9 (Ar), 133.6 (Ar), 132.8 (Ar), 132.3 (Ar), 130.4 (ArH), 129.2 (2 × ArH), 129.1 (ArH), 128.5 (ArH), 127.9 (ArH), 127.6 (ArH), 127.4 (ArH), 126.7 (ArH), 126.6 (2 × ArH), 124.0 (ArH), 114.8 (C5″), 39.9 (C1′), 30.7 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 359.1226, C<sub>22</sub>H<sub>19</sub>N<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 359.1218</div></div><div id="sec3_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)acetamide (<b>21o</b>)</h4><div class="NLM_p last">General procedure B was followed with <b>13</b> (0.213 g, 0.768 mmol) and benzo[1,3]dioxol-5-yl-acetyl chloride (0.400 mL, ∼ 2 mmol). Elution with 1:3 EtOAc/hexanes gave <b>21l</b> as a pale-orange solid (0.182 g, 65%), mp = 113–118 °C. <i>R</i><sub>f</sub> 0.15 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3295 (NH), 1647 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.81–7.85 (m, 2H, H2‴/H6‴), 7.41–7.45 (m, 3H, H3‴/H4‴/H5‴), 6.85 (s, 1H, H5″), 6.62–6.67 (m, 2H, H4′′′′/H7′′′′), 6.6 (dd, <i>J</i> = 8.2, 1.4 Hz, 1H, H6′′′′), 6.19 (br s,1H, NH), 5.81 (s, 2H, H2′′′′), 3.63 (dt [app, q], <i>J</i> = 6.0 Hz, 2H, H1′), 3.44 (s, 2H, H2), 2.94 (t, <i>J</i> = 6.0 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 171.2 (C═O), 168.2 (C2″), 155.3 (C4″), 148.0 (ArO), 146.8 (ArO), 133.6 (C1‴), 130.1 (C4‴), 129.0 (2 × ArH), 128.6 (C5′′′′), 126.4 (2 × ArH), 122.6 (ArH), 114.5 (C5″), 109.7 (ArH), 108.6 (ArH), 101.1 (CH<sub>2</sub>O<sub>2</sub>), 43.6 (C2), 38.9 (C1′), 31.0 (C2′). HRMS (EI) <i>m</i>/<i>z</i> observed: 366.1042, C<sub>20</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>S [M<sup>•+</sup>] requires 366.1038.</div></div><div id="sec3_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 2-Fluoro-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Ba</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.138 g, 0.499 mmol) and 2-fluorobenzoic acid (0.100 g, 0.714 mmol). Elution with 1:4 EtOAc/hexanes gave <b>21Ba</b> as a yellow solid (0.111 g, 68%), mp = 80–82 °C. IR (cm<sup>–1</sup>): 3317 (NH), 1644 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.08 (ddd [app dt], <i>J</i><sub>1</sub> = 8.0 Hz, <i>J</i><sub>2</sub> = 2.0 Hz, 1H, H4), 7.93–7.97 (m, 2H, H2‴/H6‴), 7.57 (br s, 1H, NH), 7.40–7.47 (m, 4H, Ar), 7.24 (ddd [app dt], <i>J</i><sub>1</sub> = 7.8 Hz, <i>J</i><sub>2</sub> = 1.0 Hz, 1H, H5), 7.09 (ddd, <i>J</i> = 12.0, 8.4, 1.2 Hz, 1H, H3), 7.02 (t, <i>J</i> = 0.8 Hz,1H, H5″), 3.91 (pseudo q, 2H, H1′), 3.12 (t, <i>J</i> = 6.4 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.5 (C2″), 163.4 (d, <i>J</i> = 3 Hz, C═O), 160.7 (d, <i>J</i> = 249 Hz, C2F), 155.5 (C4″), 133.7 (C1‴), 133.2 (d, <i>J</i> = 9 Hz, C6), 132.1 (d, <i>J</i> = 3 Hz, C4), 130.1 (C4‴), 129.0 (2 × ArH), 126.6 (2 × ArH), 124.8 (d, <i>J</i> = 3 Hz, C5), 121.5 (d, <i>J</i> = 11 Hz, C1), 116.1 (d, <i>J</i> = 25 Hz, C3), 114.5 (C5″), 39.7 (C1′), 31.1 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 327.0982, C<sub>18</sub>H<sub>16</sub>FN<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires: 327.0967.</div></div><div id="sec3_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 3-Fluoro-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bb</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.225 g, 0.812 mmol) and 3-fluorobenzoic acid (0.144 g, 1.03 mmol). Elution with 3:10 EtOAc/hexanes gave <b>21Bb</b> as a pale-yellow oil (0.109 g, 41%). <i>R</i><sub>f</sub> 0.5 (3:10 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3332 (NH), 1644 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.94–7.96 (m, 2H, H2‴/H6‴), 7.88 (br s, 1H, NH), 7.57–7.63 (m, 2H, H2/H6), 7.44–7.47 (m, 3H, H3‴/H4‴/H5‴), 7.35–7.40 (m, 1H, H4 or H5), 7.19 (dddd [app ddt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.4, <i>J</i><sub>3</sub> = 2.6, <i>J</i><sub>4</sub> = 1.0 Hz, 1H, H4), 7.03 (t, <i>J</i> = 0.8 Hz, 1H, H5″), 3.82 (pseudo q, 2H, H1′), 3.10 (dt, <i>J</i> = 6.0, 0.8 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.8 (C2″), 166.1 (d, <i>J</i> = 2 Hz, C═O), 162.9 (d, <i>J</i> = 249 Hz, C3F), 155.8 (C4″), 137.3 (d, <i>J</i> = 7 Hz, C3), 133.5 (C1‴), 130.4 (C4‴), 130.3 (d, <i>J</i> = 8 Hz, C5), 129.2 (2 × ArH), 126.6 (2 × ArH), 122.7 (d, <i>J</i> = 3 Hz, C6), 118.4 (d, <i>J</i> = 22 Hz, C2 or C4), 114.8 (C5″), 114.4 (<i>J</i> = 23 Hz, C2 or C4), 114.3 (C2), 40.0 (C1′), 30.5 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 327.0982, C<sub>18</sub>H<sub>16</sub>FN<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 327.0967.</div></div><div id="sec3_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 4-Fluoro-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bc</b>)</h4><div class="NLM_p last">General procedure B was followed with <b>13</b> (0.249 g, 0.898 mmol) and 4-fluorobenzoyl chloride (0.177 mL, 1.50 mmol). Elution with 1:3 EtOAc/hexanes gave <b>21Bc</b> as a white solid (0.224 g, 76%), mp = 123–124 °C. <i>R</i><sub>f</sub> 0.20 (1:3 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3333 (NH) 1651 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92–7.95 (m, 2H, H2/H6 or H2‴/H6‴), 7.83–7.87 (m, 2H, H2/H6 or H2‴/H6‴), 7.72 (br s, 1H, NH), 7.45–7.47 (m, 3H, H3‴/H4‴/H5‴), 7.03 (dd [appt], <i>J</i><sub><i>ortho</i></sub> = <i>J</i><sub>H–F</sub> = 8.6 Hz, 2H, H3/H5), 7.03 (s, 1H, H5″), 3.78 (dt [app, q], <i>J</i> = 5.6 Hz, 2H, H1′), 3.08 (t, <i>J</i> = 5.6 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.5 (C2″ of C═O), 166.4 (C2″ of C═O), 164.6 (d, <i>J</i> = 250 Hz, C4), 155.6 (C4″), 133.5 (C1‴), 131.0 (d, <i>J</i> = 10 Hz, C1), 130.3 (C4‴), 129.4 (d, <i>J</i> = 10 Hz, C2/C6), 129.0 (2 × ArH), 126.4 (2 × ArH), 115.4 (d, <i>J</i> = 22 Hz, C3/C5), 114.7 (C5″), 39.8 (C1′), 30.5 (C2′). HRMS (EI) <i>m</i>/<i>z</i> observed: 326.0880, C<sub>18</sub>H<sub>15</sub>FN<sub>2</sub>OS [M<sup>•+</sup>] requires 326.0889.</div></div><div id="sec3_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 2-Chloro-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bd</b>)</h4><div class="NLM_p last">Prepared according to general procedure E with 2-chlorobenzoic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.85–7.91 (m, 2H), 7.64 (dd, <i>J</i> = 7.6, 1.8 Hz, 1H), 7.28–7.42 (m, 6H), 7.11 (br s, 1H), 7.03 (s, 1H), 3.90 (dt [app, q], <i>J</i> = 5.8 Hz, 2H), 3.14 (t, <i>J</i> = 6.3 Hz, 2H). LRMS (ESI+) <i>m</i>/<i>z</i>: 343/345 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 3-Chloro-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Be</b>)</h4><div class="NLM_p last">Prepared according to general procedure E with 3-chlorobenzoic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.95–8.02 (m, 2H), 7.90–7.95 (m, 2H), 7.65–7.70 (m, 1H), 7.45–7.55 (m, 3H), 7.30–7.35 (m, 1H), 7.05 (s, 1H), 3.86 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.6 Hz, 2H), 3.15 (t, <i>J</i> = 6.8 Hz, 2H). LRMS (ESI+) <i>m</i>/<i>z</i>: 343/345 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 4-Chloro-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bf</b>)</h4><div class="NLM_p last">Prepared according to general procedure E with 4-chlorobenzoic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.90–8.00 (m, 2H), 7.75–7.90 (m, 3H), 7.35–7.42 (m, 3H), 7.45–7.55 (m, 3H), 7.38 (d, <i>J</i> = 8.6 Hz, 1H), 7.05 (s, 1H), 3.85 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.7 Hz, 2H), 3.13 (t, <i>J</i> = 6.7 Hz, 2H). LRMS (ESI+) <i>m</i>/<i>z</i>: 343/345 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 2-Methyl-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bg</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.327 g, 1.18 mmol) and <i>o</i>-toluic acid (0.164 g, 1.20 mmol). Elution with 2:3 EtOAc/hexanes gave <b>21Bg</b> as a pale-yellow solid (0.282 g, 74%), mp = 104–105 °C. <i>R</i><sub>f</sub> 0.5 (2:3 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3289 (NH), 1621 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.86–7.87 (m, 2H, H2‴/H6‴), 7.39–7.41 (m, 4H, H3‴/H4‴/H5‴/H6), 7.25 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.6 Hz, <i>J</i><sub>3</sub> = 1.6 Hz, 1H, H4 or H5), 7.15–7.21 (m, 2H, 2 × ArH), 6.92 (br s, 1H, NH), 6.90 (s, 1H, C5″), 3.85 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.0 Hz, 2H, C1′), 3.12 (t, <i>J</i><sub>1</sub> = 6.4 Hz, 2H, C2′), 2.45 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 170.1 (C═O or C2″), 168.3 (C═O or C2″), 155.5 (C4″), 136.6 (C1‴), 136.2 (C1 or C2), 133.5 (C1 or C2), 131.0 (ArH), 130.1 (ArH), 129.8 (ArH), 129.0 (2 × ArH), 126.9 (ArH), 126.4 (2 × ArH), 125.7 (ArH), 114.5 (C5″), 39.3 (C1′), 30.9 (C2′), 19.9 (CH<sub>3</sub>). HRMS (ESI) <i>m</i>/<i>z</i> observed: 323.1211, C<sub>19</sub>H<sub>19</sub>N<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 323.1218.</div></div><div id="sec3_2_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 3-Methyl-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bh</b>)</h4><div class="NLM_p last">General procedure B was followed with <b>13</b> (0.144 g, 0.519 mmol) and <i>m</i>-toluoyl chloride (0.132 mL, 1.00 mmol). Elution with 1:3 EtOAc/hexanes gave <b>21Bh</b> as a light-brown solid (0.151 g, 90%), mp = 67–70 °C. <i>R</i><sub>f</sub> 0.25 (1:3 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3329 (NH), 1640 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92–7.96 (m, 2H, H2/H6 or H2‴/H6‴), 7.64 (br s, 1H, NH), 7.62–7.65 (m, 2H, H2/H6 or H2‴/H6‴), 7.41–7.45 (m, 3H, H3‴/H4‴/H5‴), 7.28–7.29 (m, 2H, H4/H5), 7.01 (s, 1H, H5″), 3.81–3.85 (pseudo q, 2H, H1′), 3.09 (t, <i>J</i> = 6.0 Hz, 2H, H2′), 2.36 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.5 (C2″ or C═O), 167.6 (C2″ or C═O), 155.9 (C4″), 138.4 (C1‴ or C1 or C3), 134.9 (C1‴ or C1 or C3), 133.6 (C1‴ or C1 or C3), 132.1 (ArH), 130.2 (ArH), 129.1 (2 × ArH), 128.4 (ArH), 127.7 (ArH), 126.5 (2 × ArH), 124.2 (ArH), 114.6 (C5″), 39.7 (C1′), 30.7 (C2′), 21.5 (CH<sub>3</sub>). HRMS (EI) <i>m</i>/<i>z</i> observed: 322.1144, C<sub>19</sub>H<sub>18</sub>N<sub>2</sub>OS [M<sup>•+</sup>] requires 322.1140.</div></div><div id="sec3_2_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 4-Methyl-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bi</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.200 g, 0.721 mmol) and <i>p</i>-toluic acid (0.091 g, 0.754 mmol). Elution with 2:3 EtOAc/hexanes gave <b>21Bi</b> as a yellow solid (0.112 g, 48%), mp = 104–105 °C. <i>R</i><sub>f</sub> 0.5 (2:3 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3268 (NH), 1626 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.94–7.97 (m, 2H, H2‴/H6‴), 7.73 (d, <i>J</i> = 8.4 Hz, 2H, H2/H6), 7.59 (br s, 1H, NH), 7.44–7.47 (m, 3H, H3‴/H4‴/H5‴), 7.20 (d, <i>J</i> = 8.4 Hz, 2H, H3/H5), 7.03 (s, 1H, H5″), 3.83 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.8 Hz, 2H, H1′), 3.12 (t, <i>J</i> = 6.4 Hz, 2H, H2′), 2.36 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.3 (C═O or C2″), 167.4 (C═O or C2″), 155.7 (C4″), 141.7 (C4), 133.5 (C1‴), 132.0 (C1), 130.2 (ArH), 129.1 (2 × ArH), 129.0 (2 × ArH), 127.0 (2 × ArH), 126.5 (2 × ArH), 114.6 (C5″), 39.6 (C1′), 30.7 (C2′), 21.5 (CH<sub>3</sub>). HRMS (ESI) <i>m</i>/<i>z</i> observed: 323.1209, C<sub>19</sub>H<sub>19</sub>N<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 323.1218.</div></div><div id="sec3_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 2-Hydroxy-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bj</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.167 g, 0.602 mmol) and salicylic acid (0.108 g, 0.782 mmol). Elution with 1:4 EtOAc/hexanes gave <b>21Bi</b> as a white solid (0.131 g, 67%), mp = 96–98 °C. <i>R</i><sub>f</sub> 0.35 (1.4 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3359 (NH), 2583–3099 (OH), 1605 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 12.48 (br s, 1H, OH), 8.25 (br s, 1H, NH), 7.97 (m, 2H, H2‴/H6‴), 7.53 (d, <i>J</i> = 7.2 Hz, 1H, H6), 7.47 (m, 3H, H3‴/H4‴/H5‴), 7.37 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.0 Hz, 1H, H4), 7.05 (s, 1H, H5″), 6.97 (d, <i>J</i> = 8.0 Hz, 1H, H3), 6.79 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.2 Hz, 1H, H4), 3.81 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.9 Hz, 2H, H2′), 3.11 (t, <i>J</i> = 6.4 Hz, 2H, H1′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.0 (C═O or C2″), 168.9 (C═O or C2″), 161.7 (C2), 155.4 (C4″), 134.1 (C3), 133.4 (C1‴), 130.5 (ArH), 129.2 (2 × ArH), 126.6 (2 × ArH), 125.9 (ArH), 118.61 (C3 or C5), 118.58 (C3 or C5), 115.0 (C5″), 114.8 (C1), 39.3 (C1′), 30.2 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 325.1024, C<sub>18</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 325.1011.</div></div><div id="sec3_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 3-Hydroxy-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bk</b>)</h4><div class="NLM_p last">Prepared according to general procedure E with 3-hydroxybenzoic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (s, <sup>1</sup>H), 7.93–8.00 (m, 2H), 7.53–7.59 (m, 5H), 7.29–7.35 (br s, 1H), 7.20–7.27 (m, 1H), 6.99 (s, 1H), 3.84 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.6 Hz, 2H), 3.15 (t, <i>J</i> = 6.6 Hz, 2H). LRMS (ESI+) <i>m</i>/<i>z</i>: 325 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 2-Methoxy-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bl</b>)</h4><div class="NLM_p last">General procedure C was followed with <b>13</b> (0.200 g, 0.721 mmol) and <i>o</i>-anisic acid (0.115 g, 0.0.754 mmol). Elution with 1:9 then 2:3 EtOAc/hexanes gave <b>21Bl</b> as an orange oil (0.164 g, 74%). <i>R</i><sub>f</sub> 0.3 (3:7 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3341 (NH), 1638 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.20–8.23 (m, 1H, H6), 8.17 (br s, 1H, NH), 7.94–7.97 (m, 2H, H2‴/H6‴), 7.40–7.46 (m, 4H, ArH), 7.07 (pseudo t, 1H, H4 or H5), 7.01 (s, 1H, H5″), 6.91 (d, <i>J</i> = 8.4 Hz, 1H, H3), 3.92 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.4 Hz, 2H, H1′), 3.76 (s, 1H, OMe), 3.14 (t, <i>J</i><sub>1</sub> = 6.4 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.1 (C2″), 165.4 (C═O), 157.6 (C2), 155.9 (C4″), 133.9 (C1‴), 132.7 (ArH), 132.3 (ArH), 130.1 (ArH), 129.1 (2 × ArH), 126.6 (2 × ArH), 121.9 (C1), 121.4 (ArH), 114.6 (C5″), 111.4 (C3), 55.9 (OMe), 39.2 (C1′), 31.6 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 339.1165, C<sub>19</sub>H<sub>19</sub>N<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 339.1162.</div></div><div id="sec3_2_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 3-Methoxy-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bm</b>)</h4><div class="NLM_p last">General procedure B was followed with <b>13</b> (0.311 g, 1.12 mmol) and <i>m</i>-anisoyl chloride (0.29 mL, 2.0 mmol). Elution with 2:3 EtOAc/hexanes gave <b>21Bm</b> as a yellow solid (0.266 g 70%), mp = 70–72 °C. <i>R</i><sub>f</sub> 0.5 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3332 (NH), 1644 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.92–7.95 (m, 2H, H2‴/H6‴), 7.69 (br s, 1H, NH), 7.41–7.45 (m, 4H, H3‴/H4‴/H5‴/H2), 7.36 (ddd [app dt], <i>J</i><sub>1</sub> = 7.6, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 1.4 Hz, 1H, H6), 7.28 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.0 Hz, 1H, H5), 7.01 (s, 1H, H5″), 7.02 (ddd, <i>J</i> = 8.2, 2.6, 1.0 Hz, 1H, H4), 3.81 (s, 3H, CH<sub>3</sub>), 3.83 (pseudo q, 2H, H1′), 3.09 (t, <i>J</i><sub>1</sub> = 6.0 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.3 (C2″), 159.9 (C3 or C═O), 155.8 (C3 or C═O), 136.5 (C4″), 133.5 (C1‴), 130.2 (ArH), 129.5 (ArH), 129.1 (2 × ArH), 126.6 (2 × ArH), 118.9 (ArH), 117.6 (ArH), 114.6 (C5″), 112.4 (ArH), 55.5 (CH<sub>3</sub>), 39.7 (C1′), 30.7 (C2′). HRMS (EI) <i>m</i>/<i>z</i> observed: 338.1077, C<sub>19</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub>S [M<sup>•+</sup>] requires 338.1089.</div></div><div id="sec3_2_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 4-Methoxy-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bn</b>)</h4><div class="NLM_p last">General procedure C was followed with <b>13</b> (0.200 g, 0.721 mmol) and <i>p</i>-anisic acid (0.103 g, 0.754 mmol). Elution with 1:9 then 2:3 EtOAc/hexanes gave <b>21Bn</b> as a white solid (0.0756 g, 31%), mp = 94–98 °C. <i>R</i><sub>f</sub> 0.35 (2:3 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3384 (NH), 1650 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.93–7.97 (m, 2H, H2‴/H6‴), 7.78–7.81 (m [AB], 2H, H2/H6), 7.75 (br s, 1H, NH), 7.43–7.47 (m, 3H, H3‴/H4‴/H5‴), 7.02 (s, 1H, H5″), 6.87–6.91 (m [AB], 2H, H3/H5), 3.83 (s, 3H, OMe), 3.80–3.84 (m, 2H, H1′), 3.10 (t, <i>J</i><sub>1</sub> = 5.6 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.0 (C2″), 165.4 (C═O), 157.6 (C4), 155.8 (C4″), 133.8 (C1‴), 132.7 (ArH), 132.3 (ArH), 130.1 (ArH), 129.0 (2 × ArH), 126.6 (2 × ArH), 121.8 (C1), 121.3 (ArH), 114.5 (C5″), 111.4 (C3/C5), 55.9 (OMe), 39.2 (C1′), 31.6 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 339.1167, C<sub>19</sub>H<sub>19</sub>N<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 339.1162.</div></div><div id="sec3_2_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 2-Cyano-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bo</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.350 g, 1.26 mmol) and 2-cyanobenzoic acid (0.235 g, 1.59 mmol). Elution with 2:3 EtOAc/hexanes gave <b>21Bo</b> as a light-yellow oil (0.168 g, 40%). <i>R</i><sub>f</sub> 0.4 (2:3 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3276 (NH), 2227 (CN), 1650 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.00 (v br s, NH), 7.81–7.85 (m, 3H, H3/H2‴/H6‴), 7.75 (br d, <i>J</i><sub>1</sub> = 8.0 Hz, H6), 7.59–7.67 (m, 2H, H4/H5), 7.35–7.38 (m, 3H, H3‴/H4‴/H5‴), 6.98 (s, 1H, H5″), 4.23 (t, <i>J</i><sub>1</sub> = 7.2 Hz, 2H, H1′), 3.24 (t, <i>J</i><sub>1</sub> = 7.2 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.2 (C2″ or C═O), 168.0 (C2″ or C═O), 154.5 (C4″), 133.7, 133.0 (ArH), 132.3 (ArH), 131.2, 130.0 (ArH), 129.0 (2 × ArH), 126.6 (2 × ArH), 126.5 (ArH), 123.3 (ArH), 121.2 (br CN), 114.8 (C5″), 37.8 (C1′), 30.1 (C2′). Two pairs of signals are isochronous or too broad to be observed. HRMS (ESI) <i>m</i>/<i>z</i> observed: 334.1028, C<sub>19</sub>H<sub>16</sub>N<sub>3</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 334.1014.</div></div><div id="sec3_2_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 3-Cyano-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bp</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.309 g, 1.11 mmol) and 3-cyanobenzoic acid (0.207 g, 1.41 mmol). Elution with 2:3 EtOAc/hexanes gave <b>21Bp</b> as a yellow oil (0.234 g, 63%). <i>R</i><sub>f</sub> 0.3 (2:3 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3322 (NH), 2231 (CN), 1644 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.13 (m, 1H, H2), 8.09 (br s, 1H, NH), 8.08 (ddd, <i>J</i> = 8.0 Hz, 1.5, 1.0 Hz, 1H, H4 or H6), 7.88–7.90 (m, 2H, H2‴/H6‴), 7.74 (ddd, <i>J</i> = 7.5, 1.5, 1.0 Hz, 1H, H4 or H6), 7.50 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.5, <i>J</i><sub>3</sub> = 0.5 Hz, 1H, H5), 7.47 (m, 3H, H3‴/H4‴/H5‴), 7.03 (s, 1H, H5″), 3.82 (pseudo q, 2H, H1′), 3.11 (t, <i>J</i> = 6.0 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.9 (C2″), 165.1 (C═O), 155.4 (C4″), 136.1 (C1‴), 134.6 (ArH), 133.1, 131.6 (ArH), 130.7 (ArH), 130.6 (ArH), 129.6 (ArH), 129.3 (2 × ArH), 126.4 (2 × ArH), 118.9 (CN), 115.0 (C5″), 112.9 (C3), 40.0 (C1′), 30.3 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 334.1006, C<sub>19</sub>H<sub>16</sub>N<sub>3</sub>O<sup>+</sup> [M + H]<sup>+</sup> requires 334.1014.</div></div><div id="sec3_2_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 4-Cyano-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21 Bq</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.253 g, 0.913 mmol) and 4-cyanobenzoic acid (0.170 g, 1.16 mmol). Elution with 3:10 EtOAc/hexanes gave <b>21 Bq</b> as a pale-green solid (0.265 g, 87%), mp = 148–150 °C. <i>R</i><sub>f</sub> 0.3 (3:10 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3309 (NH) 2227 (CN), 1631 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.06 (br unresolved t, 1H NH), 7.87–7.93 (m, 4H, 4 × ArH), 7.64–7.67 (m, 2 × ArH), 7.39–7.47 (m, 3H, H3‴/H4‴/H5‴), 7.02 (s, 1H, H5″), 3.80 (pseudo q, 2H, H1′), 3.08 (t, <i>J</i> = 6.0 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.6 (C2″ or C═O), 165.4 (C2″ or C═O), 155.4 (C4″), 138.8 (C1‴), 133.4 (C4), 132.4 (2 × ArH), 130.5 (C4‴), 129.1 (2 × ArH), 127.8 (2 × ArH), 126.4 (2 × ArH), 118.2 (CN), 114.88 (C5″), 114.88 (C1), 39.9 (C1′), 30.3 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 334.1018, C<sub>19</sub>H<sub>16</sub>N<sub>3</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 334.1014.</div></div><div id="sec3_2_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)-3-(trifluoromethyl)benzamide (<b>21Br</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.061 g, 0.25 mmol) and 3-trifluoromethylbenzoic acid (0.072 g, 0.38 mmol). Elution with DCM gave <b>21Br</b> as a yellow gum that solidified at −20 °C as pale-brown needles (47 mg, 57%), mp = 88–91 °C. <i>R</i><sub>f</sub> = 0.55 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3295 (NH), 1637 (CO). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) two rotamers, 10:3, * = major, ∧ = minor: δ 8.36 (s, 1H, H2)<sup>∧</sup>, 8.27 (d, <i>J</i> = 8.0 Hz, <sup>1</sup>H, H6) 8.11 (s, 1H, H2)*, 8.04 (dd, <i>J</i> = 7.8, 0.4 Hz 1H, H6)* 7.88 (br s, <sup>1</sup>H, NH)*<sup>∧</sup>, 7.83–7.86 (m, 2H, H2‴/H6‴)*<sup>∧</sup>, 7.82 (d, <i>J</i> = 7.6 Hz, 1H, H4)<sup>∧</sup>, 7.74 (ddd [app dt], <i>J</i><sub>1</sub> = 7.6, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 0.8 Hz, H4)*, 7.59 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.0 Hz, 1H, H5)<sup>∧</sup>, 7.59 (ddd, <i>J</i> = 8.4, 7.6, 0.4 Hz, 1H, H5)*, 7.40–7.43 (m, 3H, H3‴/H4‴/H5‴), 7.03 (s, <sup>1</sup>H, H5″)*<sup>∧</sup>, 3.83–3.88 (m [pseudo q]), 2H, H1′), 3.10–3.14 (m [pseudo t], 2H, H2′). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz) δ (major rotamer only) 169.0 (C═O), 166.1 (C2″), 155.7 (C4″), 135.7 (C1‴ or C1), 133.4 (C1‴ or C1), 131.2 (q, <i>J</i> = 32 Hz, C3), 130.6 (ArH), 130.4 (ArH), 129.3 (ArH), 129.2 (2 × ArH), 128.1 (q, <i>J</i> = 4 Hz, C2 or C4), 126.5 (2 × ArH), 124.0 (q, <i>J</i> = 4 Hz, C2 or C4), 123.9 (q, <i>J</i> = 273 Hz, CF<sub>3</sub>), 114.8 (C5″), 40.0 (C1′), 30.5 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 377.0934, C<sub>19</sub>H<sub>16</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires: 377.0930.</div></div><div id="sec3_2_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)-3-(pentafluorosulfonyl)benzamide (<b>21Bs</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.060 g, 0.25 mmol) and 3-(pentafluorosulfanyl)benzoic acid (0.095 g, 0.38 mmol), giving a pale-yellow gum (0.129 g), which was vacuum-filtered through a column of silica and eluted with DCM. The filtrate was subjected to flash chromatography. Elution with 1:24 MeOH/DCM gave benzamide <b>21Bs</b> as a pale-yellow gum (0.058 g, 60%). <i>R</i><sub>f</sub> = 0.35 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3311 (NH), 1641 (CO). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) two rotamers, 21:4, * = major, ∧ = minor: δ 8.48 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 1.8 Hz, 1H, H2)<sup>∧</sup>, 8.26 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 1.8 Hz, 1H, H2)*, 8.22 (d, <i>J</i> = 8.0 Hz, 1H, H4 or H6)<sup>∧</sup>, 7.80 (d, <i>J</i> = 7.5 Hz, 1H, H4 or H6), 7.85–7.95 (m, 4H, 3 × ArH + NH)*<sup>∧</sup>, 7.57 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.0 Hz, <sup>1</sup>H, H5)<sup>∧</sup>, 7.50 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.0 Hz, <sup>1</sup>H, H5)*, 7.40–7.47 (m, 3H, H3‴/H4‴/H5‴)*<sup>∧</sup>, 7.04 (s, 1H, H5″)*<sup>∧</sup>, 3.85 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.5 Hz, 2H, H1′)*<sup>∧</sup>, 3.12 (t, <i>J</i> = 5.5 Hz, 2H, H2′). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 126 MHz) major rotamer only: δ 168.9 (C═O or C2″), 165.6 (C═O or C2″), 155.6 (C4″), 154.2 (app t, CSF<sub>5</sub>) 136.0 (Ar), 133.4 (Ar), 130.5, (ArH), 130.0 (ArH), 129.2 (2 × ArH), 129.1 (ArH), 128.7 (app t, C2 or C4′, 126.5 (2 × ArH), 125.1 (app t, C2 or C4), 114.9 (C5″), 40.1 (C1′), 30.4 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 435.0643, C<sub>18</sub>H<sub>16</sub>F<sub>5</sub>N<sub>2</sub>OS<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup> requires: 435.0619.</div></div><div id="sec3_2_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 3-(Methylsulfonyl)-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bt</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.060 g, 0.22 mmol) and 3-methylsulfonylbenzoic acid (0.076 g, 0.38 mmol), giving a pale-brown gum (0.092 g), which was subjected to flash chromatography. Elution with 1:49 MeOH/DCM gave benzamide <b>21Bt</b> as a colorless gum (0.058 g, 68%). <i>R</i><sub>f</sub> = 0.05 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3320 (NH), 1644 (CO). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz) δ 8.40 (dd [appt.], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 1.8 Hz, 1H, H2), 8.13 (ddd, <i>J</i> = 7.8, 1.8, 1.2 Hz, 1H, H4 or H6), 8.13 (ddd, <i>J</i> = 7.8, 1.5, 1.0 Hz, 1H, H4 or H6), 7.92–7.94 (m, 2H, H2‴/H6‴), 7.87 (br unresolved t, 1H, NH), 7.63 (ddd [app dt], <i>J</i> = 7.8, <0.6 Hz, 1H, H5), 7.42–7.48 (m, 3H, H3‴/H4‴/H5‴), 7.04 (s, 1H, H5″), 3.85 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.0 Hz, 2H, H1′), 3.12 (t, <i>J</i> = 6.0 Hz, 2H, H2′), 3.04 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 151 MHz) δ 168.8 (C═O or C2″), 165.5 (C═O or C2″), 155.6 (C4″), 141.2 (Ar), 136.5 (Ar), 133.4 (Ar), 132.5 (ArH), 130.4 (2 × ArH), 129.3 (ArH), 126.5 (2 × ArH), 126.0 (ArH), 114.8 (C5″), 44.5 (CH<sub>3</sub>), 40.0 (C1′), 30.5 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 387.0848, C<sub>18</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub>S<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup> requires: 387.0832.</div></div><div id="sec3_2_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 3-Iodo-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.164 g, 0.592 mmol) and 3-iodobenzoic acid (0.197 g, 0.794 mmol), giving a brown oil (0.292 g), which was subjected to flash chromatography. Elution with 1:4 EtOAc/hexanes gave the title benzamide as white solid (0.124 g, 48%). <i>R</i><sub>f</sub> = 0.55 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3276 (NH), 1626 (C═O). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz) δ 8.19 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 1.3 Hz, 1H, H2), 7.92–7.95 (m, 2H, H2‴/H6‴), 7.82 (ddd, <i>J</i> = 7.8, 1.5, 0.6 Hz, 1H, H4 or H6), 7.80 (ddd, <i>J</i> = 7.8, 1.8, 1.2 Hz, 1H, H4 or H6), 7.77 (br s, 1H, NH), 7.42–7.50 (m, 3H, H3‴/H4‴/H5‴), 7.15 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.8 Hz, 1H, H5), 7.03 (t, <i>J</i> = 0.6 Hz, 1H, H5″), 3.82 (pseudo q, 2H, H1′), 3.10 (dt, <i>J</i> = 6.0 Hz, 0.6 Hz, 2H, H2′).</div></div><div id="sec3_2_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)-3-((trimethylsilyl)ethynyl)benzamide (<b>21Bu</b>)</h4><div class="NLM_p last">PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (5 mg, 3 mol %), copper iodide (2 mg, 5 mol %), and trimethylsilylacetylene (0.07 mL, 0.5 mmol) were added to a stirred, degassed solution of 3-iodo-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (0.10 g, 0.23 mmol) in NEt<sub>3</sub> (1 mL) and acetonitrile (1 mL) under N<sub>2</sub>. After 21 h, the reaction mixture was diluted with DCM (50 mL) and filtered through a pad of silica to give a brown oil (0.118 g), which was subjected to flash chromatography. Elution with 1:9 EtOAc/hexanes gave benzamide <b>21Bu</b> as a yellow gum (0.067 g, 74%). <i>R</i><sub>f</sub> = 0.5 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3321 (NH), 2160 (C≡C), 1640 (C═O). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz) δ 7.92–7.95 (m, 3H, H2‴/H6‴/H2), 7.79 (ddd, <i>J</i> = 7.8, 1.8, 1.2 Hz, 1H, H4 or H6), 7.75 (br s, 1H, NH), 7.58 (ddd, [app dt] <i>J</i><sub>1</sub> = 7.8, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 1.2 Hz, 1H, H4 or H6), 7.40–7.48 (m, 3H, H3‴/H4‴/H5‴), 7.35 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.2, <i>J</i><sub>3</sub> = 0.6 Hz, 1H, H5), 7.01 (t, <i>J</i> = 0.6 Hz, 1H, H5″), 3.83 (pseudo q, 2H, H1′), 3.10 (dt, <i>J</i> = 6.2, 0.6 Hz, 2H, H2′), 0.23 (s, 9H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 126 MHz) δ 168.7 (C2″), 166.7 (C═O), 155.8 (C4″), 135.3 (C1‴ or C1), 134.7 (ArH), 133.5 (C1‴ or C1), 130.4 (ArH), 130.3 (ArH), 129.2 (2 × ArH), 128.6 (ArH), 127.3 (ArH), 126.5 (2 × ArH), 123.8 (C3), 114.6 (C5″), 104.3 (≡C), 95.4 (≡C), 39.8 (C1′), 30.7 (C2′), 0.02 (CH<sub>3</sub>).</div></div><div id="sec3_2_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 3-Ethynyl-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)benzamide (<b>21Bv</b>)</h4><div class="NLM_p last">A saturated solution/suspension of K<sub>2</sub>CO<sub>3</sub> in MeOH (0.5 mL) was added to a stirred solution of <b>21Bu</b> (0.060 g, 0.15 mmol) in CHCl<sub>3</sub> (0.5 mL) under N<sub>2</sub>. After 4 h, the reaction mixture was diluted with water (30 mL) and extracted with CHCl<sub>3</sub> (3 × 10 mL). The extract was washed with brine (10 mL), dried, and evaporated to give the terminal alkyne <b>21Bv</b> as a colorless gum (0.042 g, 42%). <i>R</i><sub>f</sub> = 0.4 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3286 (NH), 1639 (C═O). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz) δ 7.97 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 1.5 Hz, 1H, H2) 7.92–7.95 (m, 2H, H2‴/H6‴), 7.85 (br s, 1H, NH), 7.84 (ddd [app t], <i>J</i><sub>1</sub> = 7.8, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 1.5 Hz, 1H, H4 or H6), 7.59 (ddd, [app dt] <i>J</i><sub>1</sub> = 7.8, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 1.2 Hz, 1H, H4 or H6), 7.40–7.47 (m, 3H, H3‴/H4‴/H5‴), 7.37 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.8, <i>J</i><sub>3</sub> = 0.6 Hz, 1H, H5), 7.01 (s = 0.6 Hz, 1H, H5″), 3.82 (pseudo q, 2H, H1′), 3.10 (s, 1H, ≡CH), 3.09 (t, <i>J</i> = 5.7 Hz, 2H, H2′). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 151 MHz) δ 168.7 (C2″), 166.5 (C═O), 155.8 (C4″), 135.3 (C1‴ or C1), 134.8 (ArH), 133.5 (C1‴ or C1), 130.6 (ArH), 130.2 (ArH), 129.2 (2 × ArH), 128.7 (ArH), 127.7 (ArH), 126.5 (2 × ArH), 122.7 (C3), 114.7 (C5″), 82.9 (≡C), 78.2 (≡CH), 39.8 (C1′), 30.6 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 333.1048, C<sub>20</sub>H<sub>17</sub>N<sub>2</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 333.1056.</div></div><div id="sec3_2_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)picolinamide (<b>21Ha</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.097 g, 0.35 mmol) and picolinic acid (0.062 g, 0.50 mmol). Elution with 1:1 EtOAc/hexanes gave <b>21Ha</b> as a yellow oil (0.078 g, 72%). <i>R</i><sub>f</sub> 0.5 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3367 (NH), 1663 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.01 (br s, 1H, NH), 8.58–8.60 (m, 1H, H6), 8.21–8.23 (m, 1H, H3), 8.06–8.09 (m, 2H, H2‴/H6‴), 7.84 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.8 Hz, <i>J</i><sub>3</sub> = 1.8 Hz, 1H, H4 or H5), 7.41–7.48 (m, 4H, H4 or H5 and H3‴/H4‴/H5‴), 7.00 (s, 1H, H5″), 3.88 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.4 Hz, 2H, H1′), 3.13 (t, <i>J</i><sub>1</sub> = 6.4 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.3 (C2″), 164.5 (C═O), 155.6 (C4″), 150.3 (C2), 148.2 (C6), 137.6 (ArH), 133.8 (C1‴), 130.1 (ArH), 129.0 (2 × ArH), 126.7 (2 × ArH), 126.1 (ArH), 122.3 (ArH), 114.4 (C5″), 39.1 (C1′), 31.2 (C2′). HRMS (EI) <i>m</i>/<i>z</i> observed: 309.0942, C<sub>17</sub>H<sub>15</sub>N<sub>3</sub>OS [M]<sup>•+</sup> requires 309.0936.</div></div><div id="sec3_2_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)nicotinamide (<b>21Hb</b>)</h4><div class="NLM_p last">General procedure C was followed with <b>13</b> (0.200 g, 0.721 mmol) and nicotinic acid (0.093 g, 0.755 mmol). Elution with EtOAc gave <b>21Hb</b> as an orange solid (0.109 g, 49%), mp =86–88 °C. <i>R</i><sub>f</sub> 0.15 (EtOAc). IR (cm<sup>–1</sup>): 3331 (NH), 1607 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.03 (s, 1H, H2), 8.69 (br s, 1H, H6), 8.12 (d, <i>J</i> = 6.4 Hz, 1H, H4), 7.90–7.92 (m, 2H, H2‴/H6‴), 7.82 (br s, 1H, NH), 7.43–7.46 (m, 3H, H3‴/H4‴/H5‴), 7.33 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.0 Hz, 1H, H5), 7.01 (s, 1H, H5″), 3.85 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.4 Hz, 2H, H1′), 3.10 (t, <i>J</i> = 5.4 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.9 (C2″), 165.5 (C═O), 155.6 (C4″), 152.3 (C2), 148.2 (C6), 135.1 (ArH), 133.5, 130.6, 130.5 (ArH), 129.3 (2 × ArH), 126.5 (2 × ArH), 123.5 (ArH), 114.8 (C5″), 39.8 (C1′), 30.6 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 310.1002, C<sub>17</sub>H<sub>16</sub>N<sub>3</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 310.1014.</div></div><div id="sec3_2_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)isonicotinamide (<b>21Hc</b>)</h4><div class="NLM_p last">General procedure C was followed with <b>13</b> (0.200 g, 0.721 mmol) and isonicotinic acid (0.093 g, 0.755 mmol). Elution with 1:1 EtOAc/hexanes gave <b>21Hc</b> as a yellow solid (0.116 g, 52%), mp = 108–110 °C. <i>R</i><sub>f</sub> 0.3 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3323 (NH), 1607 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.71 (d, <i>J</i> = 4.4 Hz, 2H, H2/H6), 8.17 (br s, 1H, NH), 7.90–7.92 (m, 2H, H2‴/H6‴), 7.74 (d, <i>J</i> = 5.6 Hz, 2H, H3/H5), 7.44–7.48 (m, 3H, H3‴/H4‴/H5‴), 7.05 (s, 1H, H5″), 3.83 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.4 Hz, 2H, H1′), 3.11 (t, <i>J</i><sub>1</sub> = 6.4 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.7 (C2″), 165.3 (C═O), 155.5 (C4″), 150.5 (C2/C6), 142.1 (C4), 133.4 (C1‴), 130.4 (C4‴), 129.1 (2 × ArH), 126.5 (2 × ArH), 121.1 (C3/C5), 114.8 (C5″), 39.8 (C1′), 30.3 (C2′). HRMS (EI) <i>m</i>/<i>z</i> observed: 309.0931, C<sub>17</sub>H<sub>15</sub>N<sub>3</sub>OS [M]<sup>•+</sup> requires: 309.0936.</div></div><div id="sec3_2_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)pyrazine-2-carboxamide (<b>21Hd</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.179 g, 0.646 mmol) and pyrazinecarboxylic acid (0.137 g, 1.10 mmol). Elution with 2:3 EtOAc/hexanes gave <b>21Hd</b> as a brown solid (0.160 g, 80%), mp = 81–83 °C. <i>R</i><sub>f</sub> 0.19 (2:3 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3327 (NH), 1655 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.41 (d, <i>J</i> = 1.6 Hz, 1H, H3), 8.92 (br s, 1H, NH), 8.73 (d, <i>J</i> = 2.4 Hz, 1H, H6), 8.54 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 2.6 Hz, 1H, H5), 8.10–8.20 (m, 2H, H2‴/H6‴), 7.40–7.50 (m, 3H, H3‴/H4‴/H5‴), 7.04 (s, 1H, H5″), 3.89 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.3 Hz, 2H, H1′), 3.15 (t, <i>J</i> = 6.0 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.7 (C2″), 163.2 (C═O), 155.0 (C4″), 147.2 (pyrazine CH), 144.9 (C2), 144.5 (pyrazine CH), 142.7 (pyrazine CH), 133.1 (C1‴), 130.5 (C4‴), 129.1 (2 × ArH), 126.8 (2 × ArH), 114.6 (C5″), 39.1 (C1′), 30.7 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 311.1003, C<sub>16</sub>H<sub>15</sub>N<sub>4</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 311.0961.</div></div><div id="sec3_2_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)thiophene-2-carboxamide (<b>21He</b>)</h4><div class="NLM_p last">General procedure B was followed with <b>13</b> (0.216 g, 0.779 mmol) and 2-thiophenecarbonyl chloride (0.14 mL, 1.3 mmol). Elution with 1:4 EtOAc/hexanes gave <b>21He</b> as a white solid (0.100 g, 41%), mp = 116–119 °C. <i>R</i><sub>f</sub> 0.5 (1:4 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3319 (NH), 1625 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.96–7.98 (m, 2H, H2‴/H6‴), 7.52 (dd, <i>J</i> = 4.0, 1.2 Hz, 1H, C3 or C5), 7.43–7.47 (m, 4H, H3‴/H4‴/H5‴ + H3 or H5), 7.35 (br s, 1H, NH), 7.05 (dd, <i>J</i><sub>1</sub> = 5.0, <i>J</i><sub>2</sub> = 4.0 Hz, 1H, H4), 7.05 (t, <i>J</i> = 0.8 Hz, 1H, H5″), 3.83 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.4 Hz, 2H, H1′), 3.10 (t, <i>J</i><sub>1</sub> = 5.4 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.5 (C2″), 162.0 (C═O), 155.6 (C4″), 139.4 (C1‴), 133.5 (C2), 130.2 (C4‴), 129.7 (ArH), 129.1 (2 × ArH), 128.1 (ArH), 127.6 (ArH), 126.6 (2 × ArH), 114.7 (C5″), 39.6 (C1′), 30.8 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 315.0616, C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>OS<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup> requires 315.0626.</div></div><div id="sec3_2_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)thiophene-3-carboxamide (<b>21Hf</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.178 g, 0.642 mmol) and 3-thiophenecarboxylic acid (0.104 g, 0.818 mmol). Elution with 1:4 EtOAc/hexanes gave <b>21Hf</b> as a yellow oil (0.168 g, 83%). <i>R</i><sub>f</sub> 0.2 (1:4 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3321 (NH), 1633 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.93–7.96 (m, 2H, H2‴/H6‴), 7.89 (dd, <i>J</i> = 2.8, 1.2 Hz, 1H, H2), 7.44–7.46 (m, 4H, NH/H3‴/H4‴/H5‴), 7.42 (dd, <i>J</i> = 5.0, 2.8 Hz, 1H, H4 or H5), 7.30 (dd, <i>J</i> = 5.2, 2.8 Hz, 1H, H4 or H5), 7.03 (s, 1H, H5″), 3.80 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.8 Hz, 2H, H1′), 3.11 (t, <i>J</i> = 6.0 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.7 (C2″), 163.2 (C═O), 155.4 (C4″), 138.0 (C1‴), 133.2 (C3), 130.5 (C4‴), 129.2 (2 × ArH), 128.2 (ArH), 126.6 (2 × ArH), 126.4 (ArH), 126.2 (ArH), 114.8 (C5″), 39.4 (C1′), 30.6 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 315.0626, C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>OS<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup> requires 315.0626.</div></div><div id="sec3_2_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)-1<i>H</i>-pyrrole-2-carboxamide (<b>21Hg</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.255 g, 0.920 mmol) and 1<i>H</i>-pyrrole-2-carboxylic acid (0.131 g, 1.18 mmol). Elution with 3:7 EtOAc/hexanes gave <b>21Hg</b> as a pale-yellow solid (0.074 g, 27%), mp = 119–121 °C. <i>R</i><sub>f</sub> 0.45 (3:7 EtOAc/hexanes). IR (cm<sup>1</sup>): 3312 (NH), 1620 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.56 (br s, 1H, NH), 7.95–7.98 (m, 2H, H2‴/H6‴), 7.42–7.49 (m, 3H, H3‴/H4‴/H5‴), 7.07 (br s, 1H, NH), 7.00 (t, <i>J</i> = 0.8 Hz, 1H, H5″), 6.90–6.92 (m, 1H, pyrazole H), 6.56–6.58 (m, 1H, pyrazole H), 6.20–6.23 (m, 1H, pyrazole H), 3.82 (dt [appq], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.2 Hz, 2H, H1′), 3.08 (t, <i>J</i><sub>1</sub>= 6.0 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.5 (C2″), 161.4 (C═O), 155.7 (C4″), 133.7 (C1‴), 130.2 (C4‴), 129.1 (2 × ArH), 126.6 (2 × ArH), 126.4 (C2), 121.5 (C5), 114.6 (C5″), 109.7 (C3 or C4), 108.9 (C3 or C4), 39.0 (C1′), 31.2 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 298.1024, C<sub>16</sub>H<sub>16</sub>N<sub>3</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 298.1014.</div></div><div id="sec3_2_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)furan-2-carboxamide (<b>21Hh</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.255 g, 0.920 mmol) and 2-furoic acid (0.229 g, 0.826 mmol). Elution with 2:3 EtOAc/hexanes gave <b>21Hh</b> as a pale-yellow oil (0.192 g, 78%). <i>R</i><sub>f</sub> 0.45 (2:3 EtOAC/hexanes). IR (cm<sup>–1)</sup>: 3316 (NH), 1651 (C═O). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.97–8.01 (m, 2H, H2‴/H6‴), 7.69 (br s, 1H, NH), 7.39–7.45 (m, 4H, H5/H3‴/H4‴/H5‴), 7.10 (dd, <i>J</i> = 3.6, 1.0 Hz, 1H, H3), 6.97 (s, 1H, H5″), 6.46 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 3.6 Hz, 1H, H4), 3.79 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.4 Hz, 2H, H1′), 3.07 (t, <i>J</i> = 6.4 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.3 (C2″), 158.4 (C═O), 155.4 (C4″), 148.4 (C2), 143.7 (C5), 133.6 (C1‴), 130.1 (C4‴), 128.9 (2 × ArH), 126.5 (2 × ArH), 114.5 (C5″), 113.8 (C3 or C4), 112.1 (C3 or C4), 36.6 (C1′), 30.8 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 299.0850, C<sub>16</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 299.0854.</div></div><div id="sec3_2_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)furan-3-carboxamide (<b>21Hi</b>)</h4><div class="NLM_p last">Prepared according to general procedure E with 3-thiophenecarboxylic acid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 8.58 (s, 1H), 8.05 (d, <i>J</i> = 1.0 Hz, 1H), 7.80–7.95 (m, 2H), 7.45–7.59 (m, 3H), 7.25 (d, <i>J</i> = 8.0 Hz, 1H), 7.11 (d, <i>J</i> = 8.1 Hz, 1H), 3.60 (dt [app, q], <i>J</i><sub>1</sub><i>= J</i><sub>2</sub> = 7.2 Hz, 2H), 3.11 (t, <i>J</i> = 7.1 Hz, 2H). LRMS (ESI+) <i>m</i>/<i>z</i>: 299 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 3-Methyl-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)furan-2-carboxamide (<b>21Hj</b>)</h4><div class="NLM_p last">Prepared according to general procedure E with 3-methyl-2-furoic acid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 8.12 (br s, 1H), 7.99–8.09 (m, 2H), 7.80 (d, <i>J</i> = 7.0 Hz, 1H), 7.30–7.42 (m, 4H), 6.92 (s, 1H), 6.60 (d, <i>J</i> = 7.5 Hz, 1H), 3.69 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.5 Hz, 2H), 3.19 (t, <i>J</i> = 6.5 Hz, 2H), 2.66 (s, 3H). LRMS (ESI+) <i>m</i>/<i>z</i>: 313 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> 4-Bromo-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)furan-2-carboxamide (<b>21Hk</b>)</h4><div class="NLM_p last">Prepared according to general procedure E with 4-bromo-2-furoic acid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 8.62 (t, <i>J</i> = 5.7 Hz, 1H), 8.11 (d, <i>J</i> = 0.8 Hz, 1H), 7.81–7.99 (m, 2H), 7.45–7.59 (m, 3H), 7.42 (s, 1H), 7.24 (d, <i>J</i> = 0.8 Hz, 1H), 3.58 (dt [app, q] <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.1 Hz, 2H), 3.00 (t, <i>J</i> = 7.2 Hz, 2H). HRMS (ESI) <i>m</i>/<i>z</i> observed: 376.9960, C<sub>16</sub>H<sub>14</sub>Br<sup>79</sup>N<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires: 376.9954.</div></div><div id="sec3_2_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> 5-Methyl-<i>N</i>-(2-(2-phenylthiazol-4-yl)ethyl)furan-2-carboxamide <b>21Hl</b></h4><div class="NLM_p last">Prepared according to general procedure E with 5-methyl-2-furoic acid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 8.08 (br s, 1H), 7.95–8.04 (m, 2H), 7.29–7.39 (m, 4H), 6.51 (d, <i>J</i> = 8.1 Hz, 1H), 6.90 (s, 1H), 3.78 (dt [app, q], <i>J</i> = 7.2 Hz, 2H), 3.13 (t, <i>J</i> = 7.2 Hz, 2H), 2.59 (s, 3H). LRMS (ESI+) <i>m</i>/<i>z</i>: 313 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)isoxazole-3-carboxamide (<b>21Hm</b>)</h4><div class="NLM_p last">Prepared according to general procedure E with 3-isoxazolecarboxylic acid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.08 (d, <i>J</i> = 1.7 Hz, 1H), 8.94 (t, <i>J</i> = 5.6 Hz, 1H), 7.81–8.06 (m, 2H), 7.45–7.58 (m, 3H), 7.44 (s, 1H), 6.88 (d, <i>J</i> = 1.7 Hz, 1H), 3.63 (dt [app, q], <i>J</i><sub>1</sub><i>= J</i><sub>2</sub> = 7.2 Hz, 2H), 3.03 (t, <i>J</i> = 7.2 Hz, 2H). HRMS (ESI) <i>m</i>/<i>z</i> observed: 300.0802, C<sub>15</sub>H<sub>14</sub>N<sub>3</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires: 300.0801.</div></div><div id="sec3_2_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)oxazole-5-carboxamide (<b>21Hn</b>)</h4><div class="NLM_p last">General procedure D was followed with <b>13</b> (0.225 g, 0.812 mmol) and oxazole-5-carboxylic acid (0.119 g, 1.07 mmol). Elution with 1:1 EtOAc/hexanes gave <b>21Hg</b> as a white solid (0.097 g, 40%) mp =110–111 °C. <i>R</i><sub>f</sub> 0.15 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3360 (NH), 1629 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.97–7.99 (m, 2H, H2‴/H6‴), 7.88 (s, 1H, H2), 7.81 (br s, 1H, NH), 7.72 (s, 1H, H4), 7.46 (m, 3H, H3‴/H4‴/H5‴), 7.02 (t, <i>J</i> = 0.6 Hz, 1H, H5″), 3.82 (pseudo q, 2H, H1′), 3.09 (dt, <i>J</i> = 5.2, 0.6 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.7 (C2″), 156.9 (C═O or C4″), 155.1 (C═O or C4″), 151.4 (C2), 146.1 (C4), 133.3 (C1‴), 130.5 (C4‴), 130.1 (C5), 129.1 (2 × ArH), 126.6 (2 × ArH), 114.8 (C5″), 38.9 (C1′), 30.5 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 300.0816, C<sub>15</sub>H<sub>14</sub>N<sub>3</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 300.0807.</div></div><div id="sec3_2_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)thiazole-4-carboxamide (<b>21Ho</b>)</h4><div class="NLM_p last">Prepared according to general procedure E with thiazole-4-carboxylic acid. <sup>1</sup>H NMR (400 MHz, DMSO) δ 9.31 (s, 1H), 8.52 (s, 1H), 8.14 (br s, 1H), 7.95–8.10 (m, 2H), 7.30–7.42 (m, 4H), 6.94 (s, 1H), 3.81 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.2 Hz, 2H), 3.21 (t, <i>J</i> = 6.4 Hz, 2H). LRMS (ESI+) <i>m</i>/<i>z</i>: 316 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)pyrrolidine-1-carboxamide (<b>23a</b>)</h4><div class="NLM_p last">A solution of 1-pyrrolidinecarbonyl chloride (0.10 mL, 0.70 mmol) in dry DCM (5 mL) was added dropwise to a solution of <b>13</b> (0.201 g, 0.725 mmol) and NEt<sub>3</sub> (1.50 mL, 10.8 mmol) in dry DCM (20 mL) at 0 °C. The reaction mixture was allowed to warm to room temperature, and stirring was continued overnight. The reaction mixture was diluted with EtOAc (150 mL) and washed with water (3 × 50 mL), dried, and evaporated. The residue was subjected to flash chromatography. Elution with 3:7 EtOAc/hexanes gave <b>23a</b> as a yellow solid (0.201 g, 92%), mp = 101–103 °C. <i>R</i><sub>f</sub> 0.25 (3:7 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3355 (NH), 1629 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.89–7.91 (m, 2H, H2‴/H6‴), 7.39–7.42 (m, 3H, H3‴/H4‴/H5‴), 6.97 (s, 1H, H5″), 5.24 (br s, 1H, NH), 3.64 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.1 Hz, 2H, H1′), 3.32–3.35 (m, 4H, H2/H5), 3.03 (t, <i>J</i> = 6.1 Hz, 2H, H2′), 1.88 (m, 4H, H3/H4). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.0 (C2″), 157.0 (C═O or C4″), 156.3 (C═O or C4″), 133.7 (C1‴), 130.0 (C4‴), 129.0 (2 × ArH), 126.4 (2 × ArH), 114.3 (C5″), 45.5 (C2/C5), 40.2 (C1′), 31.8 (C2′), 25.6 (C3/C4). HRMS (ESI) <i>m</i>/<i>z</i> observed: 324.1132, C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>NaOS<sup>+</sup> [M + H]<sup>+</sup> requires 324.1141.</div></div><div id="sec3_2_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>23b</b>)</h4><div class="NLM_p last">Prepared as described for <b>23a</b> with <b>13</b> (0.472 g, 1.70 mmol) 1-piperidinecarbonyl chloride (0.15 mL, 1.1 mmol) to give <b>23b</b> as a yellow solid (0.381 g, 71%), mp = 80–81 °C. <i>R</i><sub>f</sub> 0.2 (3:7 EtOAc/hexanes). IR (cm<sup>–1</sup>): 1613 (C═O), 3335 (NH). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.88 (m, 2H, H2‴/H6‴), 7.39 (m, 3H, H3″/H4″/H5″), 6.94 (s, 1H, H5″), 5.80 (br s, 1H, NH), 3.56 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.9 Hz, 2H, H1′), 3.31 (m, 4H, H2/H6), 2.97 (t, <i>J</i><sub>1</sub> = 6.2 Hz, 2H, H2′), 1.51 (m, 6H, H3/H4/H5). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.1 (C2″), 157.9 (C═O or C4″), 156.44 (C═O or C4″), 133.7 (C1‴), 130.1 (C4‴), 129.0 (2 × ArH), 126.4 (2 × ArH), 114.4 (C5″), 44.9 (C2/C6), 40.7 (C1′), 31.4 (C2′), 25.7 (C3/C5), 24.6 (C4). HRMS (ESI) <i>m</i>/<i>z</i> observed: 338.1295, C<sub>17</sub>H<sub>21</sub>N<sub>3</sub>NaOS<sup>+</sup> [M + H]<sup>+</sup> requires 338.1298.</div></div><div id="sec3_2_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)morpholine-4-carboxamide (<b>23c</b>)</h4><div class="NLM_p last">Prepared as described for <b>23a</b> with <b>13</b> (0.219 g, 0.790 mmol) in 4-morpholinecarbonyl chloride (0.100 mL, 0.860 mmol) to give <b>23c</b> as a white solid (0.120 g, 48%), mp = 98–100 °C. <i>R</i><sub>f</sub> = 0.3 (EtOAc). IR (cm<sup>–1</sup>): 3313 (NH), 1610 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.86–7.90 (m, 2H, H2‴/H6‴), 7.41–7.43 (m, 3H, H3‴/H4‴/H5‴), 6.97 (t, <i>J</i> = 0.8 Hz, 1H, H5″), 5.94 (br unresolved t, 1H, NH), 3.62–3.65 (m, 4H, H2/H6), 3.57–3.60 (m, 2H, H1′), 3.34–3.36 (m, 4H, H3/H5), 2.99 (dt, <i>J</i> = 6.0, 0.8 Hz, 2H, H1′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.2 (C2″), 158.0 (C═O or C4″), 156.2 (C═O or C4″), 133.6 (C1‴), 130.2 (C4‴), 129.1 (2 × ArH), 126.4 (2 × ArH), 114.5 (C5″), 66.6 (C2/C6), 44.0 (C3/C5), 40.6 (C2′), 31.1 (C1′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 318.1279, C<sub>16</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 318.1276.</div></div><div id="sec3_2_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)benzenesulfonamide (<b>25</b>)</h4><div class="NLM_p last">Benzenesulfonyl chloride (0.15 mL, 1.2 mmol) was added dropwise to a stirred solution of Hünig’s base (0.50 mL, 2.87 mmol) and <b>13</b> (0.095 g, 0.35 mmol) in DCM (15 mL) at 0 °C. The solution was allowed to warm to room temperature, and stirring was continued overnight. The volatiles were evaporated, and the residue was subjected to flash chromatography. Elution with 1:4 EtOAc/hexanes and then 2:3 EtOAc/hexanes gave <b>25</b> as a yellow oil (0.039 g, 33%). IR (cm<sup>–1</sup>): 3277 (NH), 1158 (S═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.83–7.89 (m, <i>J</i> = 7.5 Hz, 4H, H2/H6/H2‴/H6‴), 7.42–7.53 (m, 6H, H3/H4/H5/H3‴/H4‴/H5‴), 6.87 (s, 1H, H5″), 5.75 (br t, <i>J</i><sub>1</sub> = 5.5 Hz, 1H, NH), 3.35 (dt [appq], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.5 Hz, 2H, H1′), 2.91 (t, <i>J</i> = 6.5 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.7 (C2″), 154.5 (C4″), 140.1 (C1), 133.34 (C1‴), 132.6 (ArH), 130.36 (ArH), 129.15 (2 × ArH), 129.15 (2 × ArH), 127.1 (2 × ArH), 126.5 (2 × ArH), 114.9 (C5″), 42.8 (C1′), 30.7 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 345.0731, C<sub>17</sub>H<sub>17</sub>N<sub>2</sub>O<sub>2</sub>S<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup> requires 345.0731.</div></div><div id="sec3_2_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> Pyrrolidine-1-sulfonyl Chloride (<b>26</b>)</h4><div class="NLM_p last">A solution of dry pyrrolidine (1.64 mL, 20.0 mmol) in dry Et<sub>2</sub>O was added dropwise to a stirred solution of sulfuryl chloride (0.81 mL, 10 mmol) and NEt<sub>3</sub> (2.50 mL, 20 mmol) in ether (10 mL) at −10 °C under N<sub>2</sub>. After 2 h, the reaction mixture was diluted with dry Et<sub>2</sub>O (5 mL) and vacuum-filtered through Celite. The filtrate was evaporated to give <b>26</b> as a colorless oil (0.186 g, 65%) of sufficient purity for the next step. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 3.27 (m, 4H, H2/5), 1.92 (m, 4H, H3/4). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz): δ 65.5 (C2/5), 25.1 (C3/4).</div></div><div id="sec3_2_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)pyrrolidine-1-sulfonamide (<b>27</b>)</h4><div class="NLM_p last">A solution of <b>26</b> (0.186 g, 1.20 mmol), NEt<sub>3</sub> (0.41 mL, 3.0 mmol), and <b>13</b> (0.121 g, 0.53 mmol) in DCM (1 mL) was stirred for 18 h. The reaction mixture was diluted with DCM (50 mL) and washed with 1 M HCl (20 mL), water (20 mL), and brine (20 mL), dried (MgSO<sub>4</sub>), and evaporated to give a brown oil (0.22 g), which was subjected to flash chromatography. Elution with 1:19 MeOH/DCM gave the sulfamide <b>27</b> as a yellow oil (0.071 g, 41%). IR (cm<sup>–1</sup>): 3250 (NH). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.80–7.90 (m, 2H, H2‴/H6‴), 7.40–7.46 (m, 3H, H3‴/H4‴/H5‴), 7.00 (s,1H, H5″), 5.30 (t, <i>J</i> = 5.6 Hz, 1H, NH), 3.49 (dt [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.1 Hz, 2H, H1′), 3.20–3.30 (m, 4H, H2/5), 3.01–3.10 (t, <i>J</i> = 6.2 Hz, 2H, H2′), 1.80–1.90 (m, 4H, H3/4). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz) δ 168.6 (C2″), 154.9 (C4″), 133.5 (C1‴), 130.3 (C4‴), 129.1 (2 × ArH), 126.5 (2 × ArH), 114.9 (C5″), 48.1 (C2/5), 43.0 (C1′), 31.2 (C2′), 25.7 (C3/4).</div></div><div id="sec3_2_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)-1<i>H</i>-imidazole-1-carboxamide (<b>28</b>)</h4><div class="NLM_p last">1,1-Carbonyldiimidazole (0.396 g, 2.44 mmol) was added to a solution of <b>13</b> (0.515 g, 1.86 mmol) in DMF (3 mL) and MeCN (9 mL). The solution was allowed to stir for 24 h, then the MeCN was evaporated and the residue was diluted with EtOAc (150 mL) and washed with brine (3 × 50 mL), dried, and evaporated. The residue was subjected to flash chromatography. Elution with 1:1 EtOAc/hexanes and then 7:3 EtOAc/hexanes gave <b>28</b> as an orange oil (0.438 g, 79%). <i>R</i><sub>f</sub> 0.15 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3219 (NH), 1712 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.29 (br t, <i>J</i> = 5.0 Hz, 1H, NH), 8.14 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 1.2 Hz, 1H, H2), 7.79–7.83 (m, 2H, H2‴/H6‴), 7.40 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 1.4 Hz 1H, H5), 7.35–7.38 (m, 3H, H3‴/H4‴/H5‴), 6.95 (s, 1H, H5″), 6.94 (dd, <i>J</i> = 1.6, 0.9 Hz, 1H, H4), 3.71 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.0 Hz, 2H, H1′), 3.04 (t, <i>J</i> = 6.5 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.6 (C2″), 154.8 (C═O), 149.0 (C4″), 135.9 (C2), 133.2 (C1‴), 130.2 (C4‴), 129.7 (C4), 129.0 (2 × ArH), 126.3 (2 × ArH), 116.2 (C5), 114.5 (C5″), 40.5 (C1′), 30.5 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 299.0971, C<sub>15</sub>H<sub>15</sub>N<sub>4</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 299.0967.</div></div><div id="sec3_2_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> General Procedure for the Synthesis of Carbamates from <b>28</b>.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></h4><div class="NLM_p last">NaH (60% dispersion in mineral oil, 1.1 equiv) was added to a stirred solution of alcohol (1.0 equiv) and <b>28</b> (1.0 equiv) in dry DMF (∼5 mL/mmol of <b>28</b>) under N<sub>2</sub>. When TLC indicated the reaction to be complete (generally after overnight), the solvent was evaporated under N<sub>2</sub>. Alternatively, the reaction mixture was diluted with water and extracted with EtOAc and the extract was dried and evaporated. The residue was purified by flash chromatography.</div></div><div id="sec3_2_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> Isopropyl (2-(2-Phenylthiazol-4-yl)ethyl)carbamate (<b>29a</b>)</h4><div class="NLM_p last">The general procedure was followed with <b>28</b> (0.320 g, 1.07 mmol) and 2-propanol (0.08 mL, 1.1 mmol). Elution with 1:4 EtOAc/hexanes gave <b>29a</b> as a white solid (0.099 g, 32%), mp = 55–57 °C. <i>R</i><sub>f</sub> 0.3 (1:4 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3330 (NH), 1690 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.91–7.93 (m, 2H, H2″/H6″), 7.39–7.44 (m, 3H, H3″/H4″/H5″), 6.94 (s, 1H, H5′), 5.20 (br s, 1H, NH), 4.90 (sept, <i>J</i> = 6.0 Hz, 1H, HC–O), 3.58 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.5 Hz, 2H, H1), 2.99 (t, <i>J</i> = 6.5 Hz, 2H, H2), 1.21 (d, <i>J</i> = 6.0 Hz, 6H, CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.2 (C2′), 156.4 (C═O or C4′), 155.4 (C═O or C4′), 133.7 (C1″), 130.0 (C4″), 129.0 (2 × ArH), 126.5 (2 × ArH), 114.4 (C5′), 68.0 (HC-O), 40.3 (C1), 31.8 (C2), 22.2 (CH<sub>3</sub>). HRMS (ESI) <i>m</i>/<i>z</i> observed: 291.1168, C<sub>15</sub>H<sub>19</sub>N<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 291.1167.</div></div><div id="sec3_2_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> Cyclopentyl (2-(2-Phenylthiazol-4-yl)ethyl)carbamate (<b>29b</b>)</h4><div class="NLM_p last">Following the general procedure with <b>28</b> (0.153 g, 0.513 mmol) and cyclopentanol gave the crude product as a brown oil (0.214 g), which was subjected to flash chromatography. Elution with 2:5 EtOAc/hexanes gave the <b>29b</b> as a yellow oil, which solidified at −20 °C as a pale-yellow solid (0.071 g, 44%), mp = 74–80 °C. <i>R</i><sub>f</sub> = 0.55 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3350 (NH), 1689 (C═O). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 7.93 (dd, <i>J</i> = 6.8, 1.3 Hz, 2H, H2″/H6″), 7.43 (m, 3H, H3‴/H4‴/H5‴), 6.96 (s, 1H, H5′), 5.16 (br s, 1H, NH), 5.09 (br app s, OCH), 3.59 (m, 2H, C1), 3.00 (t, <i>J</i> = 5.0 Hz, 2H, C2), 1.78–1.88 (m, 2H), 1.68 (app br s, 4H, CH<sub>2</sub>), 1.56 (m, 2H, CH<sub>2</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 126 MHz) δ 168.3, C2′), 156.7 (C═O or C4′), 155.5 (C═O or C4′), 133.7 (Ar), 130.1 (Ar), 129.1 (ArH), 126.6 (ArH), 114.5 (C5′), 77.5 (HC–O), 40.4 (C1), 32.9 (2 × CH<sub>2</sub>), 31.8 (C2), 23.8 (2 × CH<sub>2</sub>). LRMS (ESI+) <i>m/</i>z: 317 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> Cyclopropylmethyl (2-(2-Phenylthiazol-4-yl)ethyl)carbamate (<b>29c</b>)</h4><div class="NLM_p last">Following the general procedure with <b>28</b> (0.189 g, 0.634 mmol) and cyclopropanemethanol gave the crude product as a yellow gum (0.291 g), which was subjected to flash chromatography. Elution with 1:5 EtOAc/hexanes gave <b>29c</b> as a yellow oil, which solidified at −20 °C as a yellow solid (0.105 g, 73%), mp = 40–44 °C. <i>R</i><sub>f</sub> = 0.55 (50% EtOAc/hexanes). IR (cm<sup>–1</sup>): 3325 (NH), 1673 (C═O). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 7.88–7.94 (m, 2H, H2″/H6″), 7.37–7.45 (m, 3H, H3″/H4″/H5″), 6.96 (s, 1H, H5″), 5.24 (s, 1H, NH), 3.89 (d, <i>J</i> = 7.0 Hz, 2H, CH<sub>2</sub>O), 3.61 (dt [app, q] <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.5 Hz, 2H, H2), 3.01 (t, <i>J</i> = 6.5 Hz, 2H, OCH<sub>2</sub>), 1.10 (br s, 1H, cPr CH), 0.50–0.55 (m, 2H), 0.22–0.28 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz) δ 168.3 (C2′), 156.9 (C═O or C4′), 155.5 (C═O or C4′), 133.8 (Ar, C1″), 130.2 (Ar, C4″), 129.1 (ArH), 126.7 (ArH), 114.6 (C5′), 69.8 (CH<sub>2</sub>O), 40.5 (C1), 31.8 (C2), 10.3 (cPr CH), 3.3 (2 × cPr CH<sub>2</sub>). LRMS (ESI+) <i>m</i>/<i>z</i>: 303 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> General Procedure for the Synthesis of Ureas from <b>28</b>.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></h4><div class="NLM_p last">NEt<sub>3</sub> (1.1 equiv) and amine (1.0 equiv) were added to a stirred solution of <b>28</b> (1.0 equiv) in DCM (∼5 mL/mmol of <b>28</b>) under N<sub>2</sub>. When TLC indicated the reaction to be complete (generally after overnight), the solvent was evaporated under N<sub>2</sub> and the residue was purified by flash chromatography.</div></div><div id="sec3_2_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> 1-Isopropyl-3-(2-(2-phenylthiazol-4-yl)ethyl)urea (<b>30a</b>)</h4><div class="NLM_p last">The general procedure was followed with <b>28</b> (0.120 g, 0.402 mmol) and isopropylamine (0.03 mL, 0.40 mmol). Elution with 1:4 EtOAc/hexanes gave <b>30a</b> as a white solid, (0.064 g, 55%), mp = 139–140 °C. <i>R</i><sub>f</sub> 0.2 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3313 (NH), 2966 (NH), 1622 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.92–7.94 (m, 2H, H2″/H6″), 7.43–7.45 (m, 3H, H3″/H4″/H5″), 6.99 (s, 1H, H5′), 5.02 (br s, 1H, NH), 4.18 (br s, 1H, NH), 3.79 (sept, <i>J</i> = 6.5 Hz, 1H, HC-N), 3.60 (t, <i>J</i> = 6.0 Hz, 2H, H1), 3.01 (t, <i>J</i> = 6.0 Hz, 2H, H2), 1.10 (d, <i>J</i> = 6.5 Hz, 6H, CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.4 (C2′), 157.7 (C═O or C4′), 155.7 (C═O or C4′), 133.6 (C1″), 130.3 (C4″), 129.1 (2 × ArH), 126.6 (2 × ArH), 114.7 (C5′), 42.5 (HC-N), 40.1 (C1), 31.9 (C2), 23.6 (CH<sub>3</sub>). HRMS (ESI) <i>m</i>/<i>z</i> observed: 290.1318, C<sub>15</sub>H<sub>20</sub>N<sub>3</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires: 290.1327.</div></div><div id="sec3_2_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> Isopropylmethylamine Hydrochloride (<i>N</i>-Methylpropan-2-aminium Chloride)</h4><div class="NLM_p last">Acetic acid (30.0 mL, 525 mmol) was slowly added to a stirred solution of methylamine (33% in ethanol, 20.5 mL, 165 mmol) and acetone (3.75 mL, 51.1 mmol) with powdered 3A sieves (4.74 g) at 0 °C under N<sub>2</sub>. The mixture was allowed to warm to room temperature, and stirring was continued for 30 min. Sodium cyanoborohydride (3.32 g, 52.8 mmol) was added, and the suspension was stirred at room temperature overnight. The reaction mixture was poured onto ice-cold 1 M HCl (250 mL) and concentrated under N<sub>2</sub>. MeOH was added to the resulting slurry, and the suspension was filtered. The filtrate was evaporated to give a white slurry (18.2 g), which was suspended in hot CHCl<sub>3</sub>, filtered, and evaporated to give a brown gel (5.317 g) consisting of a mixture of the containing 55 mol % isopropylmethylamine hydrochloride (67% yield) and 45 mol % AcOH, which was used without further purification in the next step. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 9.3 (s, <sup>+</sup>NH<sub>2</sub> + OH), 3.15–3.23 (m, <sup>1</sup>H, CH), 2.54 (s, 3H, NMe), 1.92 (s, Ac), 1.33 (d, <i>J</i> = 6.5 Hz, 6H, 2 × Me) This compound has been described<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> previously, but no NMR data have been reported.</div></div><div id="sec3_2_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> 1-Isopropyl-1-methyl-3-(2-(2-phenylthiazol-4-yl)ethyl)urea (<b>30b</b>)</h4><div class="NLM_p last">Following the general procedure with <b>28</b> (0.149 g, 0.499 mmol), methylisopropylamine hydrochloride (0.08 g, 0.5 mmol) and an extra two equivalents of NEt<sub>3</sub> to account for the hydrochloride gave the crude product as a brown slurry (0.319 g), which was subjected to flash chromatography. Elution with EtOAc gave <b>30b</b> as a yellow oil (0.102 g, 67%), which solidified to an off-white solid at −20 °C, mp = 96–102 °C. <i>R</i><sub>f</sub> = 0.15 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3325 (NH), 1612 (C═O). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 7.90–7.94 (m, 2H, H2″/H6″), 7.40–7.45 (m, 3H, H3″/H4″/H4″), 6.97 (s, 1H, H5′), 5.51 (br s, 1H, NH), 4.48 (sept, <i>J</i> = 6.5 Hz, 1H, CHN), 3.62 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.5 Hz, 2H, H1), 3.01 (t, <i>J</i> = 6.0 Hz, 2H, H2), 2.69 (s, 3H, NCH<sub>3</sub>), 1.07 (d, <i>J</i> = 7.0 Hz, 6H, 2 × CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 126 MHz) δ 168.2 (C2′), 158.1 (C═O or C4′), 156.5 (C═O or C4′), 133.7 (C1″), 130.1 (C4″), 129.0 (2 × ArH), 126.4 (2 × ArH), 114.4 (C5′), 45.2 (NCH), 40.7 (C1), 31.6 (C2), 26.8 (NCH<sub>3</sub>), 20.1 (2 × CH<sub>3</sub>). HRMS (ESI) <i>m</i>/<i>z</i> observed: 342.1049, C<sub>16</sub>H<sub>21</sub>KN<sub>3</sub>OS<sup>+</sup> [M + K]<sup>+</sup> requires: 342.1037.</div></div><div id="sec3_2_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> 1,1-Diethyl-3-(2-(2-phenylthiazol-4-yl)ethyl)urea (<b>30c</b>)</h4><div class="NLM_p last">The general procedure was followed with <b>28</b> (0.120 g, 0.402 mmol) and diethylamine (0.04 mL, 0.40 mmol). Elution with 1:1 EtOAc/hexanes gave <b>30c</b> as a yellow oil (0.081 g, 66%). <i>R</i><sub>f</sub> 0.35 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3354 (NH), 1622 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.89–7.91 (m, 2H, H2″/H6″), 7.39–7.43 (m, 3H, H3″/H4″/H5″), 6.96 (s, 1H, H5′), 5.46 (br unresolved t, 1H, NH), 3.60 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.8 Hz, 2H, H1), 3.23 (q, <i>J</i> = 7.0 Hz, 4H, 2 × CH<sub>2</sub>), 3.00 (t, <i>J</i> = 6.2 Hz, 2H, H2), 1.08 (t, <i>J</i> = 7.0 Hz, 6H, CH<sub>3</sub>). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.2 (C2′), 157.5 (C═O or C4′), 156.5 (C═O or C4′), 133.7 (C1″), 130.1 (C4″), 129.0 (2 × ArH), 126.5 (2 × ArH), 114.4 (C5′), 41.2 (HC-N), 40.6 (C1), 31.6 (C2), 13.9 (CH<sub>3</sub>). HRMS (ESI) <i>m</i>/<i>z</i> observed: 304.1494, C<sub>16</sub>H<sub>22</sub>N<sub>3</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 304.1484.</div></div><div id="sec3_2_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> 1,1-Diisopropyl-3-(2-(2-phenylthiazol-4-yl)ethyl)urea (<b>30d</b>)</h4><div class="NLM_p last">Following the general procedure with <b>28</b> (0.195g, 0.654) and diisopropylamine gave the crude product as a brown oil (0.242 g), which was subjected to flash chromatography. Elution with 2:5 EtOAc/hexanes gave <b>30d</b> as off-white rhomboids (0.119 g, 55%), mp = 100–104 °C. <i>R</i><sub>f</sub> = 0.3 (1:1 EtOAc/hexanes). IR cm<sup>–1</sup>: 3391 (NH), 1630 (CO). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) δ 7.94–7.92 (m, 2H, H2″/H6″), 7.42 (m, 3H, H3″/H4″/H5″), 6.98 (s, 1H, H5′), 5.21 (s, 1H, NH), 3.88–3.85 (sept, <i>J</i> = 7.0 Hz, 2H, NCH), 3.64 (dt [apparent q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.0 Hz, 2H, H1), 3.03 (dt, <i>J</i> = 6.3, 0.7 Hz, 2H, H2), 1.20 (d, <i>J</i> = 7.0 Hz, 12H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 126 MHz) δ 168.2 (C2′), 157.3 (C═O or C4′), 156.6 (C═O or C4′), 133.7 (C1″), 130.0 (C4″), 128.9 (2 × ArH) 126.5 (2 × ArH), 114.4 (C5′), 45.0 (NCH), 40.3 (C1), 31.5 (C2), 21.3 (CH<sub>3</sub>). HRMS (ESI) <i>m</i>/<i>z</i> observed: 332.1771, C<sub>18</sub>H<sub>26</sub>N<sub>3</sub>OS<sup>+</sup> [M + H] <sup>+</sup> requires: 332.1792.</div></div><div id="sec3_2_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)azepane-1-carboxamide (<b>30e</b>)</h4><div class="NLM_p last">The general procedure was followed with <b>28</b> (0.160 g, 0.536 mmol) and azepane (0.060 mL, 0.54 mmol). Elution with 1:1 EtOAc/hexanes then 7:3 EtOAc/hexanes gave <b>30e</b> as a yellow oil (0.120 g, 68%). <i>R</i><sub>f</sub> 0.35 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 2931 (NH), 1627 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.88–7.91 (m, 2H, H2‴/H6‴), 7.33–7.41 (m, 3H, H3‴/H4‴/H5‴), 6.95 (s, 1H, H5″), 5.50 (br unresolved t, 1H, NH), 3.61 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.4 Hz, 2H, H1′), 3.37 (t, <i>J</i> = 6.0 Hz, 4H, H2/H7), 2.99 (t, <i>J</i> = 6.4 Hz, 2H, H2′), 1.64 (m, 4H, H4/H5), 1.50 (m, 4H, H3/H6). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.2 (C2″), 158.0 (C═O or C4″), 156.4 (C═O or C4″), 133.7 (C1‴), 130.1 (C4‴), 129.0 (2 × ArH), 126.4 (2 × ArH), 114.4 (C5″), 46.4 (C2/C7), 40.6 (C1′), 31.6 (C2′), 28.6 (C4/C5), 27.3 (C3/C6). HRMS (ESI) <i>m</i>/<i>z</i> observed: 330.1635, C<sub>18</sub>H<sub>24</sub>N<sub>3</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires: 330.1640.</div></div><div id="sec3_2_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> <i>N</i>-(2-(2-Phenylthiazol-4-yl)ethyl)-1<i>H</i>-pyrrole-1-carboxamide (<b>30f</b>)</h4><div class="NLM_p last">NaH (60% suspension in mineral oil, 0.013 g, 0.28 mmol) was added to a stirred solution of <b>28</b> (0.077 g, 0.25 mmol) and pyrrole (distilled immediately before use, 0.02 mL, 0.3 mmol) in dry DMF (2 mL) at room temperature under N<sub>2</sub>. The reaction mixture was stirred for 7 days then the solvent removed to give a brown gum (0.095 g), which was subjected to flash chromatography. Elution with 1:4 EtOAc/hexanes gave the urea <b>30i</b> as an off-white powder (0.033 g, 44%). <i>R</i><sub>f</sub> = 0.5 (1:1 EtOAc/hexanes). IR (cm<sup>–1</sup>): 3335 (NH), 1670 (C═O). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 600 MHz) δ 7.92–7.96 (m, 2H, H2‴/H6‴), 7.45–7.48 (m, 3H, H3‴/H4‴/H5‴), 7.34 (br s, 1H, NH), 7.27 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 1.2 Hz, 2H, H2/H5), 7.03 (s, 1H, H5″), 6.26 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 2.0 Hz, 2H, H3/H4), 3.79 (pseudo q, 2H, H1′), 3.10 (t, <i>J</i> = 6.0 Hz, 2H, H2′). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 151 MHz) δ 168.8 (C2″), 155.4 (C═O or C4″), 151.0 (C═O or C4″), 133.3 (C1‴), 130.3 (C4‴), 129.1 (2 × ArH), 126.5 (2 × ArH), 118.4 (C2/C5), 114.8 (C5″), 111.6 (C3/C4), 40.4 (C1′), 30.4 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 298.1000, C<sub>16</sub>H<sub>16</sub>N<sub>3</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires: 298.1009.</div></div><div id="sec3_2_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> 4-(Chloromethyl)-2-(pyridin-2-yl)thiazole (<b>32</b>)</h4><div class="NLM_p last">2-Pyridinethioamide (5.00 g, 36.2 mmol) was added to a stirred solution of 1,3-dichloroacetone (6.15 g, 48.0 mmol) in acetone (100 mL) under N<sub>2</sub>. The reaction mixture was heated under reflux overnight, then allowed to cool. The resulting yellow precipitate was collected by vacuum filtration and washed with acetone. The filtrate was dissolved in sulfuric acid (30 mL) and stirred for 30 min, then poured onto ice. The aqueous phase was extracted with EtOAc (3 × 250 mL), dried, and evaporated to give <b>32</b> as orange crystals (2.51 g, 33%), mp = 90–92 °C, pure enough for the following step. <i>R</i><sub>f</sub> 0.25 (1:4 EtOAc/hexanes). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.61 (d, <i>J</i> = 4.0 Hz, 1H, H6′), 8.20 (d, <i>J</i> = 7.6 Hz, 1H, H3′), 7.79 (dd, <i>J</i> = 6.8 Hz, 7.6 Hz, 1H, H4′), 7.33 (dd, <i>J</i> = 5.2, 6.4 Hz, 1H, H5′), 7.25 (s, 1H, H5), 4.59 (s, 2H, CH<sub>2</sub>). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>): δ 169.5 (C2), 153.2 (C2′ or C4), 150.6 (C2′ or C4), 149.3 (C6′), 136.9 (CH), 124.6 (CH), 119.8 (CH), 119.6 (CH), 40.9 (CH<sub>2</sub>). HRMS (ESI) <i>m</i>/<i>z</i> observed: 211.0106, C<sub>9</sub>H<sub>8</sub>ClN<sub>2</sub>S<sup>+</sup> [free base + H]<sup>+</sup> requires 211.0092.</div></div><div id="sec3_2_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> 2-(2-(Pyridin-2-yl)thiazol-4-yl)acetonitrile (<b>33</b>)</h4><div class="NLM_p last">A solution of KCN (0.839 g, 12.9 mmol) and <b>32</b> (2.51 g, 11.9 mmol) in dry DMF (30 mL) was stirred at 70 °C overnight, then allowed to cool, diluted with water (200 mL), and extracted with EtOAc (3 × 200 mL). The extract was washed with brine (3 × 200 mL), dried, and evaporated to yield <b>33</b> as a green oil (1.77 g, 74%), mp = 66–68 °C. <i>R</i><sub>f</sub> 0.3 (1:20:80 NEt<sub>3/</sub>EtOAc/hexanes). IR (cm<sup>–1</sup>): 2244 (C≡N). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.61 (d, <i>J</i> = 4.8 Hz, 1H, H6″), 8.17 (d, <i>J</i> = 8.0 Hz, 1H, H2″), 7.84 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.0 Hz, <i>J</i><sub>3</sub> = 1.6 Hz, 1H, H4″), 7.38 (s, 1H, H5′), 7.32–7.41 (m, 1H, H5″), 3.96 (s, 2H, CH<sub>2</sub>). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.4 (C2′), 150.8 (C2″ or C4′), 149.7 (C6″), 146.1 (C2″ or C4′), 137.3 (CH), 125.1 (CH), 119.9 (CH), 118.8 (CH), 116.9 (CN), 21.2 (CH<sub>2</sub>). HRMS (ESI) <i>m</i>/<i>z</i> observed: 202.0431, C<sub>10</sub>H<sub>8</sub>N<sub>3</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 202.0439.</div></div><div id="sec3_2_91" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> 2-(2-(Pyridin-2-yl)thiazol-4-yl)ethanamine (<b>34</b>)</h4><div class="NLM_p last">A 1 M BH<sub>3</sub>–THF solution (40 mL, 40 mmol) was slowly added to a stirred solution of <b>33</b> (1.50 g, 7.45 mmol) in anhydrous THF (10 mL) at 0 °C, under N<sub>2</sub>. The solution was allowed to warm yo room temperature and then heated under reflux for 2 h. The resulting black solution was cooled, quenched with MeOH (2 mL), and then acidified with conc HCl. The stirred reaction mixture was heated under reflux for 45 min. The THF was evaporated, and the residual aqueous phase was basified with K<sub>2</sub>CO<sub>3</sub> and extracted with EtOAc (3 × 50 mL). The extract was dried and evaporated to give <b>34</b> as a brown oil, (0.382 g, 25%), which was used without further purification or characterization in the next steps.</div></div><div id="sec3_2_92" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> <i>N</i>-(2-(2-(Pyridin-2-yl)thiazol-4-yl)ethyl)benzamide (<b>35a</b>)</h4><div class="NLM_p last">Following general procedure A with benzoyl chloride gave a brown oil, which was subjected to flash chromatography. Elution with 1:20:80 NEt<sub>3</sub>/EtOAc/hexanes gave benzamide <b>35a</b> as a yellow solid (0.148 g, 84%), mp = 103–105 °C. <i>R</i><sub>f</sub> 0.4 (1:50:50 NEt<sub>3</sub>/EtOAc/Hexanes). IR (cm<sup>–1</sup>): 3300 (NH), 1634 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.63 (d, <i>J</i> = 4.6 Hz, 1H, H6‴), 8.14 (d, <i>J</i> = 8.0 Hz, 1H, H3‴), 7.80 (d, <i>J</i> = 7.2 Hz, 2H, H2/H6), 7.78 (dd, <i>J</i> = 7.6, 1.6 Hz, 1H, H4‴), 7.50 (t, <i>J</i> = 7.4 Hz, 1H, H4), 7.42 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.4 Hz, 2H, H3/H5), 7.35 (br s, 1H, NH), 7.34 (dd, <i>J</i> = 7.4, 7.0 Hz, 1H, H5‴), 7.12 (s, 1H, H5″), 3.86 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.1 Hz, 2H, H1′), 3.14 (t, <i>J</i> = 6.2 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 169.3 (C2″ or C═O), 167.5 (C2″ or C═O), 156.1 (C2‴ or C4″), 151.3 (C2‴ or C4″), 149.7 (C6‴), 137.1 (CH), 135.0 (C1), 131.4 (CH), 128.6 (2 × ArH), 127.0 (2 × ArH), 124.9 (CH), 119.5 (CH), 117.4 (CH), 39.6 (C1′), 30.9 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 332.0813, C<sub>17</sub>H<sub>15</sub>N<sub>3</sub>NaOS<sup>+</sup> [M + Na]<sup>+</sup> requires 332.0828.</div></div><div id="sec3_2_93" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> <i>N</i>-(2-(2-(Pyridin-2-yl)thiazol-4-yl)ethyl)cyclopentanecarboxamide (<b>35b</b>)</h4><div class="NLM_p last">Following general procedure A with cyclopentanecarbonyl chloride gave a brown oil, which was subjected to flash chromatography. Elution with 1:20:80 NEt<sub>3</sub>/EtOAc/hexanes then 1:50:50 NEt<sub>3</sub>/EtOAc/hexanes gave <b>35b</b> as a white solid (0.091 g, 59%), mp = 133–135 °C. <i>R</i><sub>f</sub> 0.35 (1:50:50 NEt<sub>3</sub>/EtOAc/hexanes). IR (cm<sup>–1</sup>): 3294 (NH), 1639 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.60 (d, <i>J</i> = 4.6 Hz, 1H, H6‴), 8.12 (d, <i>J</i> = 8.0 Hz, 1H, H3‴), 7.78 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.8 Hz, <i>J</i><sub>2</sub> = 1.8 Hz, 1H, H4‴), 7.31–7.34 (m, 1H, H5‴), 7.07 (s, 1H, H5″), 6.27 (br s, 1H, NH), 3.65 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.2 Hz, 2H, H1′), 3.01 (t, <i>J</i> = 6.4 Hz, 2H, H2′), 2.48–2.54 (m, 1H, H1), 1.69–1.88 (m, 6H), 1.51–1.60 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 176.3 (C═O), 169.1 (C2″), 156.1 (C2‴ or C4″), 151.4 (C2‴ or C4″), 149.7 (C6‴), 137.1 (CH), 124.6 (CH), 119.6 (CH), 117.2 (CH), 46.1 (C1), 39.0 (C1′), 31.3 (C2′), 30.5 (C2/C5), 26.0 (C3/C4). HRMS (ESI) <i>m</i>/<i>z</i> observed: 324.1128, C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>NaOS requires 324.1141.</div></div><div id="sec3_2_94" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> <i>N</i>-(2-(2-(Pyridin-3-yl)thiazol-4-yl)ethyl)benzamide (<b>35c</b>)</h4><div class="NLM_p last">A solution of benzoyl chloride (0.10 mL, 0.86 mmol) in DCM (10 mL) was added to a stirred solution of <b>47a</b> (0.240, 0.863 mmol) and NEt<sub>3</sub> (3.0 mL) in DCM (10 mL) at 0 °C. After stirring overnight, the volatiles were evaporated and the residue was subjected to flash chromatography. Elution with 1:60:40 NEt<sub>3</sub>/EtOAc/hexanes then 1:99 NEt<sub>3</sub>/EtOAc yielded <b>35c</b> as a yellow oil (0.237 g, 89%). <i>R</i><sub>f</sub> 0.5 (1:50:50 NEt<sub>3</sub>/EtOAc/hexanes). IR (cm<sup>–1</sup>): 3237 (NH), 1645 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.17 (d, <i>J</i> = 2.0 Hz, 1H, H2‴), 8.60 (dd, <i>J</i> = 4.8, 1.4 Hz, 1H, H6‴), 8.15 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.0 Hz, <i>J</i><sub>3</sub> = 2.0 Hz, 1H, H4‴), 7.80 (d, <i>J</i> = 7.0 Hz, 2H, H2/H6), 7.48 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.4 Hz, 1H, H5‴), 7.37–7.44 (m, 3H, H3/H4/H5), 7.31 (br s, 1H, NH), 7.11 (s, 1H, H5″), 3.86 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.2 Hz, 2H, H1′), 3.14 (t, <i>J</i> = 6.2 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 167.6 (C2″ or C═O), 164.7 (C2″ or C═O), 156.2 (C4″), 150.7 (C2‴ or C6‴), 147.4 (C2‴ or C6‴), 134.7 (C1), 133.7 (CH), 131.5 (CH), 129.6 (C3‴), 128.6 (2 × ArH), 127.0 (2 × ArH), 123.9 (CH), 115.6 (C5″), 39.6 (C1′), 30.8 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 332.0833, C<sub>17</sub>H<sub>15</sub>N<sub>3</sub>NaOS<sup>+</sup> [free base + Na]<sup>+</sup> requires 332.0828.</div></div><div id="sec3_2_95" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> <i>N</i>-(2-(2-(Pyridin-3-yl)thiazol-4-yl)ethyl)cyclopentanecarboxamide (<b>35d</b>)</h4><div class="NLM_p last">A solution of cyclopentanecarbonyl chloride (0.036 mL, 0.300 mmol) in DCM (5 mL) was added to a stirred solution of <b>47a</b> (0.090 g, 0.324 mmol) and NEt<sub>3</sub> (3.0 mL) in DCM (10 mL) at 0 °C. After stirring overnight, the volatiles were evaporated and the residue was subjected to flash chromatography. Elution with 1:20:80 NEt<sub>3</sub>/EtOAc/hexanes then 1:50:50 NEt<sub>3</sub>/EtOAc/hexanes yielded <b>35d</b> as white crystals (0.050 g, 51%), mp =109–111 °C. <i>R</i><sub>f</sub> 0.25 (1:99 NEt<sub>3</sub>/EtOAc). IR (cm<sup>–1</sup>): 3244 (NH), 1637 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.16 (d, <i>J</i> = 1.8 Hz, 1H, H2‴), 8.66 (dd, <i>J</i> = 4.8, 1.4 Hz, 1H, H6‴), 8.20 (ddd [app dt], <i>J</i><sub>1</sub> = 8.0, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 1.8 Hz, 1H, H4‴), 7.39 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.0 Hz, 1H, H5‴), 7.05 (s, 1H, H5″), 6.18 (br s, 1H, NH), 3.66 (dt [appq], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.4 Hz, 2H, H1′), 3.03 (t, <i>J</i> = 6.4 Hz, 2H, H2′), 2.50–2.53 (m, 1H, H1), 1.82–1.86 (m, 6H), 1.70–1.78 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 176.4 (C═O), 164.8 (C2″), 156.4 (C4″), 150.9 (C2‴ or C6‴), 147.7 (C2‴ or C6‴), 133.6 (CH), 129.7 (CH), 123.9 (CH), 115.4 (C5″), 46.1 (C1), 39.0 (C1′), 31.2 (C2′), 30.5 (C2/C5), 26.0 (C3/C4). HRMS (ESI) <i>m</i>/<i>z</i> observed: 324.1138, C<sub>16</sub>H<sub>19</sub>N<sub>3</sub>NaOS<sup>+</sup> [M + Na]<sup>+</sup> requires 324.1141.</div></div><div id="sec3_2_96" class="NLM_sec NLM_sec_level_3"><div id="ac_i137" class="anchor-spacer"></div><h4 class="article-section__title" id="_i137"> <i>N</i>-(2-(2-(Pyridin-4-yl)thiazol-4-yl)ethyl)benzamide (<b>35e</b>)</h4><div class="NLM_p last">A solution of benzoyl chloride (0.060 mL, 0.52 mmol) in DCM (5 mL) was added to a stirred solution of <b>47b</b> (0.170 g, 0.611 mmol) and NEt<sub>3</sub> (2.0 mL) in DCM (20 mL) at 0 °C. After stirring overnight, the volatiles were evaporated and the residue was subjected to flash chromatography. Elution with 1:50:50 NEt<sub>3</sub>/EtOAc/hexanes then 1:99 NEt<sub>3</sub>/EtOAc yielded <b>35e</b> as white crystals (0.122 g, 66%), mp = 67–70 °C. IR (cm<sup>–1</sup>): 3438 (NH), 1634 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.69 (d, <i>J</i> = 4.8 Hz, 2H, H2‴/H6‴), 7.78–7.81 (m, 4H, H2/H6/H3‴/H5‴), 7.50 (t, <i>J</i> = 7.4 Hz, 1H, H4), 7.41(dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.4 Hz, 2H, H3/H5), 7.34 (br s, 1H, NH), 7.17 (s, 1H, H5″), 3.85 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.4 Hz, 2H, H1′), 3.15 (t, <i>J</i><sub>1</sub> = 6.0 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 167.5 (C2″ or C═O), 165.4 (C2″ or C═O), 156.7 (C4″), 150.8 (C2‴/C6‴), 140.2 (C4‴), 134.8 (C1), 131.6 (C4), 128.6 (2 × ArH), 127.0 (2 × ArH), 120.3 (2 × ArH), 116.7 (C5″), 39.5 (C1′), 30.8 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 332.0815, C<sub>17</sub>H<sub>15</sub>N<sub>3</sub>NaOS<sup>+</sup> [M + Na]<sup>+</sup> requires 332.0828.</div></div><div id="sec3_2_97" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> <i>N</i>-(2-(2-(Pyridin-4-yl)thiazol-4-yl)ethyl)cyclopentanecarboxamide (<b>35f</b>)</h4><div class="NLM_p last">A solution of cyclopentanecarbonyl chloride (0.121 mL, 1.00 mmol) in DCM (5 mL) was added to a stirred solution of <b>47b</b> (0.250 g, 0.899 mmol) and NEt<sub>3</sub> (2.0 mL) in DCM (20 mL) at 0 °C. After stirring overnight, the volatiles were evaporated and the residue was subjected to flash chromatography. Elution with 1:99 NEt<sub>3</sub>/EtOAc yielded <b>35f</b> as a white solid (0.136 g, 50%), mp = 110–112 °C. <i>R</i><sub>f</sub> 0.3 (1:50:50 NEt<sub>3</sub>/EtOAc/hexanes). IR (cm<sup>–1</sup>): 3241 (NH), 1600 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.71 (d, <i>J</i> = 5.6 Hz, 2H, H2‴/H6‴), 7.79 (d, <i>J</i> = 5.6 Hz, 2H, H3‴/H5‴), 7.12 (s, 1H, H5″), 6.12 (br s, 1H, NH), 3.68 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.1 Hz, 2H, H1′), 3.05 (t, <i>J</i><sub>1</sub> = 6.4 Hz, 2H, H2′), 2.48–2.52 (tt [app pent], <i>J</i><sub>1</sub><i>= J</i><sub>2</sub> = 7.8 Hz, 1H, H1), 1.82–1.85 (m, 2H), 1.70–1.79 (m, 4H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 176.4 (C═O), 165.2 (C2″), 156.8 (C4″), 150.7 (C2‴/C6‴), 140.4 (C4‴), 120.4 (C3‴/C5‴), 116.6 (C5″), 46.1 (C1), 38.9 (C1′), 31.3 (C2′), 30.5 (C2/C5), 26.0 (C3/C4). HRMS (ESI) <i>m</i>/<i>z</i> observed: 302.1309, C<sub>16</sub>H<sub>20</sub>N<sub>3</sub>OS<sup>+</sup> [M + H]<sup>+</sup> requires 302.1322.</div></div><div id="sec3_2_98" class="NLM_sec NLM_sec_level_3"><div id="ac_i139" class="anchor-spacer"></div><h4 class="article-section__title" id="_i139"> Methyl 3-(2-(Pyridin-3-yl)thiazol-4-yl)propanoate (<b>42a</b>)</h4><div class="NLM_p last">A stirred solution of methyl 5-bromo-4-oxopentanoate (<b>40</b> (3.00 g 14.4 mmol) and 3-pyridinethioamide (2.00 g, 14.5 mmol) in MeOH (50 mL) was heated under reflux overnight. The solvent was evaporated, and the residue was subjected to flash chromatography. Elution with 1:4 EtOAc/hexanes then 1:1 EtOAc/hexanes gave <b>42a</b> as a colorless oil (0.787 g, 22%). <i>R</i><sub>f</sub> 0.6 (1:50:50 NEt<sub>3</sub>/EtOAc/hexanes). IR (cm<sup>–1</sup>): 1727 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.10 (s, 1H, H2″), 8.60 (d, <i>J</i> = 4.3 Hz, 1H, H6″), 8.17 (dt, <i>J</i> = 8.0, 1.6 Hz, 1H, H4″), 7.33 (dd, <i>J</i> = 8.0, 4.9 Hz, 1H, H5″), 7.00 (s, 1H, H5′), 3.66 (s, 3H, CH<sub>3</sub>), 3.13 (t, <i>J</i> = 7.5 Hz, 2H, H3), 2.79 (t, <i>J</i> = 7.5 Hz, 2H, H2). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 173.3 (C═O), 164.2 (C2′), 157.0 (C4′), 150.6 (C2″ or C6″), 147.6 (C2″ or C6″), 133.6 (ArH), 129.8 (ArH), 123.8 (ArH), 114.6 (C5′), 51.8 (CH<sub>3</sub>), 33.4 (C3), 26.8 (C2). HRMS (ESI) <i>m</i>/<i>z</i> observed: 249.0685, C<sub>12</sub>H<sub>13</sub>N<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 249.0692.</div></div><div id="sec3_2_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> Methyl 3-(2-(Pyridin-4-yl)thiazol-4-yl)propanoate (<b>42b</b>)</h4><div class="NLM_p last">A stirred solution of methyl-5-bromo-4-oxopentanoate (1.43 g 6.84 mmol) and 4-pyridinethioamide (0.856 g, 6.19 mmol) in MeOH (40 mL) was heated under reflux overnight. The solvent was evaporated, and the residue was subjected to flash chromatography. Elution with 1:4 EtOAc/hexanes then 1:1 EtOAc/hexanes gave <b>42b</b> as an orange solid (0.907 g, 59%), mp = 55–57 °C. <i>R</i><sub>f</sub> 0.4 (1:1 EtOAc/hexanes). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.68 (d, <i>J</i> = 6.0 Hz, 2H, H2″/H6″), 7.78 (d, <i>J</i> = 6.0 Hz, 2H, H3″/H5″), 7.09 (s, 1H, H5′), 3.69 (s, 3H, CH<sub>3</sub>), 3.16 (t, <i>J</i> = 7.4 Hz, 2H, H3), 2.82 (t, <i>J</i> = 7.4 Hz, 2H, H2). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 173.3 (C═O), 164.9 (C2′), 157.5 (C4′), 150.8 (C2″/C6″), 140.5 (C4″), 120.4 (C3″/C5″), 115.8 (C5′), 51.9 (CH<sub>3</sub>), 33.5 (C3), 26.8 (C2). HRMS (ESI) <i>m</i>/<i>z</i> observed: 249.0691, C<sub>12</sub>H<sub>13</sub>N<sub>2</sub>O<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 249.0692.</div></div><div id="sec3_2_100" class="NLM_sec NLM_sec_level_3"><div id="ac_i141" class="anchor-spacer"></div><h4 class="article-section__title" id="_i141"> Methyl 3-(2-(Thiophen-2-yl)thiazol-4-yl)propanoate (<b>42c</b>)</h4><div class="NLM_p last">A stirred solution of methyl-5-bromo-4-oxopentanoate (1.88 g 8.99 mmol) and thiophene-2-carbothioamide (1.17 g, 8.20 mmol) in MeOH (40 mL) was heated under reflux overnight. The solvent was evaporated, and the residue was subjected to flash chromatography. Elution with 1:9 EtOAc/hexanes then 1:1 EtOAc/hexanes gave <b>42c</b> as a pale-pink solid (0.997 g, 48%), mp = 55–57 °C. <i>R</i><sub>f</sub> 0.5 (1:4 EtOAc/Hexanes). IR (cm<sup>–1</sup>): 1726 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.47 (d, <i>J</i> = 3.6 Hz, 1H, H3″), 7.36 (d, <i>J</i> = 5.0 Hz, 1H, H5″), 7.06 (pseudo t, 1H, H4″), 6.86 (s, 1H, H5′), 3.69 (s, 3H, CH<sub>3</sub>), 3.10 (t, <i>J</i> = 7.5 Hz, 2H, H3), 2.78 (t, <i>J</i> = 7.5 Hz, 2H, H2). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 173.4 (C═O), 161.6 (C2′), 156.1 (C4′), 137.6 (C2″), 127.9 (CH), 127.6 (CH), 126.5 (CH), 113.0 (C5′), 51.8 (CH<sub>3</sub>), 33.6 (C3), 26.8 (C2). HRMS (ESI) <i>m</i>/<i>z</i> observed: 276.0128, C<sub>11</sub>H<sub>11</sub>NNaO<sub>2</sub>S<sub>2</sub><sup>+</sup> [M + Na]<sup>+</sup> requires 276.0123.</div></div><div id="sec3_2_101" class="NLM_sec NLM_sec_level_3"><div id="ac_i142" class="anchor-spacer"></div><h4 class="article-section__title" id="_i142"> 3-(2-(Pyridin-3-yl)thiazol-4-yl)propanamide (<b>43a</b>)</h4><div class="NLM_p last">A solution of <b>42a</b> (0.800 g, 3.22 mmol) in THF (5 mL) and conc ammonium hydroxide (10 mL) was stirred for 48 h. The volatiles were evaporated, and the residue was triturated with EtOAc to yield <b>43a</b> as a yellow/brown solid (0.300 g, 40%), mp = 147–149 °C. <i>R</i><sub>f</sub> 0.2 (EtOAc). IR (cm<sup>–1</sup>): 3375 (NH), 3113 (NH), 1663 (C═O). <sup>1</sup>H NMR (500 MHz, MeOD) δ 9.90 (d, <i>J</i> = 1.8 Hz, 1H, H2″), 9.45 (dd, <i>J</i> = 4.8, 1.4 Hz, 1H, H6″), 9.07 (ddd [app dt], <i>J</i><sub>1</sub> = 8.0 Hz, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 1.8 Hz, 1H, H4″), 8.33 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H, H5″), 8.23 (s, 1H, H5′), 8.17 (br s, 1H, NH), 7.62 (br s, 1H, NH), 3.79 (t, <i>J</i> = 7.9 Hz, 2H, H3), 3.32 (t, 2H, H2). HRMS (ESI) <i>m</i>/<i>z</i> observed: 256.0509, C<sub>11</sub>H<sub>11</sub>N<sub>3</sub>NaOS<sup>+</sup> [M + Na]<sup>+</sup> requires 256.0515.</div></div><div id="sec3_2_102" class="NLM_sec NLM_sec_level_3"><div id="ac_i143" class="anchor-spacer"></div><h4 class="article-section__title" id="_i143"> 3-(2-(Pyridin-4-yl)thiazol-4-yl)propanamide (<b>43b</b>)</h4><div class="NLM_p last">A solution of <b>42b</b> (0.300 g, 1.21 mmol) in THF (6 mL) and conc ammonium hydroxide (10 mL) was stirred for 48 h. The volatiles were evaporated, and the residue was washed with DCM (3 × 20 mL) to yield <b>43b</b> as a pale-yellow solid (0.202 g, 72%), mp = 161–163 °C. <i>R</i><sub>f</sub> 0.7 (1:1:98 NEt<sub>3</sub>/MeOH/EtOAc). IR (cm<sup>–1</sup>): 3244 (NH), 3109 (NH), 1682 (C═O). <sup>1</sup>H NMR (500 MHz, DMSO) δ 8.69 (d, <i>J</i> = 6.0 Hz, 2H, H2″/H6″), 7.86 (d, <i>J</i> = 6.0 Hz, 2H, H3″/H5″), 7.52 (s, 1H, H5′), 7.37 (br s, 1H, NH), 6.82 (br s, 1H, NH), 3.00 (t, <i>J</i> = 7.6 Hz, 2H, H3), (H2 largely obscured by <i>d</i><sub>6</sub>-DMSO peak). <sup>13</sup>C NMR (126 MHz, DMSO) δ 173.2 (C═O), 163.7 (C2′), 158.0 (C4′), 150.8 (C2″/C6″), 139.6 (C4″), 119.9 (C3″/C5″), 116.8 (C5′), 34.3 (C3), 26.8 (C2). HRMS (ESI) <i>m</i>/<i>z</i> observed: 256.0513, C<sub>11</sub>H<sub>11</sub>N<sub>3</sub>NaOS<sup>+</sup> [M + Na]<sup>+</sup> requires 256.0515.</div></div><div id="sec3_2_103" class="NLM_sec NLM_sec_level_3"><div id="ac_i144" class="anchor-spacer"></div><h4 class="article-section__title" id="_i144"> 3-(2-(Thiophen-2-yl)thiazol-4-yl)propanamide (<b>43c</b>)</h4><div class="NLM_p last">A solution of <b>42c</b> (1.00 g, 3.94 mmol) in THF (6 mL) and conc ammonium hydroxide (15 mL) was stirred for 48 h. The volatiles were evaporated, and the solid residue was washed with DCM (3 × 50 mL), then subjected flash chromatography. Elution with 1:240:60 NEt<sub>3</sub>/EtOAc/hexanes, then 1:1:98 NEt<sub>3</sub>/MeOH/EtOAc gave <b>43c</b> as a white solid (0.338 g, 36%), mp = 103–105 °C. <i>R</i><sub>f</sub> 0.3 (1:99 MeOH/EtOAc). IR (cm<sup>–1</sup>): 3374 (NH), 3171 (NH), 1664 (C═O). <sup>1</sup>H NMR (500 MHz, DMSO) δ 7.68 (d, <i>J</i> = 5.1 Hz, 1H, H5″), 7.61 (d, <i>J</i> = 3.0 Hz, 1H, H3″), 7.38 (br s, 1H, NH), 7.24 (s, H5′), 7.15 (dd, <i>J</i> = 4.9, 3.9 Hz, 1H, H4″), 6.82 (br s, 1H, NH), 2.91 (t, <i>J</i> = 7.7 Hz, 2H, H3), 2.46 (t, <i>J</i> = 7.7 Hz, 2H, H2. <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 176.9 (C═O), 162.1 (C2′), 155.5 (C4′), 137.0 (C2″), 128.1 (CH), 128.0 (CH), 126.9 (CH′), 113.2 (C5′), 33.8 (C3), 26.2 (C2). HRMS (ESI) <i>m</i>/<i>z</i> observed: 261.0133, C<sub>10</sub>H<sub>10</sub>N<sub>2</sub>NaOS<sub>2</sub><sup>+</sup> [M + Na]<sup>+</sup> requires 261.0127.</div></div><div id="sec3_2_104" class="NLM_sec NLM_sec_level_3"><div id="ac_i145" class="anchor-spacer"></div><h4 class="article-section__title" id="_i145"> 2-(2-(Thiophen-2-yl)thiazol-4-yl)ethanamine (<b>44</b>)</h4><div class="NLM_p last">Diacetoxyiodobenzene (0.664 g, 2.00 mmol) was added to a solution of <b>43c</b> (0.330 g, 1.38 mmol) in distilled water (5 mL) and dioxane (5 mL), and the suspension was stirred for 48 h. The solvent was evaporated to yield <b>44</b> as a brown oil of sufficient purity for the following step (0.247 g, 85%). <i>R</i><sub>f</sub> 0.35 (1:99 MeOH/EtOAc). IR (cm<sup>–1</sup>): 3374 (NH), 3171 (NH), 1663 (C═O). <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.57 (d, <i>J</i> = 3.6 Hz, 1H, H3″ or H5″), 7.55 (d, <i>J</i> = 5.0 Hz, 1H, H3″ or H5″), 7.29 (s, 1H, H5′), 7.12 (dd, <i>J</i> = 4.8, 4.0 Hz, H4″), 5.15 (br s, 2H, NH), 3.36 (t, <i>J</i> = 5.8 Hz, 2H, H1), 3.16 (t, <i>J</i> = 5.8 Hz, 2H, H2). <sup>13</sup>C NMR (126 MHz, MeOD) δ 163.7 (C2′), 153.7 (C4′), 137.3 (C2″), 127.9 (C5″), 127.8 (C4″ or C3″), 126.8 (C4″ or C3″), 115.0 (C5′), 40.1 (C1), 29.8 (C2). HRMS (ESI) <i>m</i>/<i>z</i> observed: 211.0349, C<sub>9</sub>H<sub>11</sub>N<sub>2</sub>S<sub>2</sub><sup>+</sup> [M + H]<sup>+</sup> requires 211.0358.</div></div><div id="sec3_2_105" class="NLM_sec NLM_sec_level_3"><div id="ac_i146" class="anchor-spacer"></div><h4 class="article-section__title" id="_i146"> <i>N</i>-(2-(2-(Thiophen-2-yl)thiazol-4-yl)ethyl)benzamide (<b>45a</b>)</h4><div class="NLM_p last">A solution of benzoyl chloride (0.040 mL, 0.64 mmol) in DCM (2 mL) was added to a stirred solution of <b>44</b> (0.110 g, 0.523 mmol) and NEt<sub>3</sub> (2.0 mL) in DCM (10 mL) at 0 °C. After stirring overnight, the volatiles were evaporated and the residue was subjected to flash chromatography. Elution with 1:20:80 NEt<sub>3</sub>/EtOAc/hexanes then 1:50:50 NEt<sub>3</sub>/EtOAc/hexanes yielded <b>45a</b> as a brown oil (0.067 g, 41%). <i>R</i><sub>f</sub> 0.3 (1:30:70 NEt<sub>3</sub>/EtOAc/hexanes). IR (cm<sup>1</sup>): 3337 (NH), 1640 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.89 (d, <i>J</i> = 7.4 Hz, 2H, H2/H6), 7.69 (br s, 1H, NH), 7.50 (d, <i>J</i> = 3.2 Hz, 1H, H3‴), 7.48 (d, <i>J</i> = 7.2 Hz, 1H, H5‴), 7.40–7.46 (m, 3H, H3/H4/H5), 7.09 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 4.4 Hz, 1H, H4‴), 6.94 (s, 1H, H5″), 3.81 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.9 Hz, 2H, H1′), 3.06 (t, <i>J</i><sub>1</sub> = 6.0 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 167.3 (C2″ or C═O), 162.2 (C2″ or C═O), 155.5 (C4″), 137.3 (C1 or C2‴), 134.8 (C1 or C2‴), 131.4 (C4), 128.6 (2 × ArH), 128.1 (CH), 127.8 (CH), 127.2 (2 × ArH), 126.9 (CH), 113.9 (C5″), 39.6 (C1′), 30.6 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 337.0432, C<sub>16</sub>H<sub>14</sub>N<sub>2</sub>NaOS<sup>+</sup> [M + Na]<sup>+</sup> requires 337.0440.</div></div><div id="sec3_2_106" class="NLM_sec NLM_sec_level_3"><div id="ac_i147" class="anchor-spacer"></div><h4 class="article-section__title" id="_i147"> <i>N</i>-(2-(2-(Thiophen-2-yl)thiazol-4-yl)ethyl)cyclopentanecarboxamide (<b>45b</b>)</h4><div class="NLM_p last">A solution of cyclopentanecarbonyl chloride (0.110 mL, 0.900 mmol) in DCM (5 mL) was added to a stirred solution of <b>44</b> (0.240 g, 1.14 mmol) and NEt<sub>3</sub> (4.0 mL) in DCM (10 mL) at 0 °C. After stirring overnight, the volatiles were evaporated and the residue was subjected to flash chromatography. Elution with 1:4 EtOAc/hexanes then 1:1 EtOAc/hexanes yielded <b>45b</b> as colorless prisms (0.095 g, 34%), mp = 105–107 °C. <i>R</i><sub>f</sub> 0.3 (1:20:80 NEt<sub>3</sub>/EtOAc/hexanes). IR (cm<sup>–1</sup>): 3294 (NH), 1638 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.49 (dd, <i>J</i> = 3.8, 1.0 Hz, 1H, H3‴), 7.40 (dd, <i>J</i> = 5.0, 1.0 Hz, 1H, H5‴), 7.09 (dd, <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.0 Hz, 1H, H4‴), 6.88 (s, 1H, H5″), 6.46 (br s, 1H, NH), 3.63 (dt [app, q], <i>J</i> = 6.0 Hz, 2H, H1′), 2.96 (t, <i>J</i> = 6.2 Hz, 2H, H2′), 2.51–2.56 (m, 1H, H1), 1.85–1.89 (m, 2H), 1.71–1.80 (m, 4H), 1.55–1.59 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 176.3 (C═O), 161.9 (C2″), 155.5 (C4″), 137.5 (C2‴), 128.0 (CH), 127.7 (CH), 126.6 (CH), 113.7 (C5″), 46.2 (C1), 39.0 (C1′), 30.9 (C2′), 30.5 (C2/C5), 26.0 (C3/C4). HRMS (ESI) <i>m</i>/<i>z</i> observed: 329.0740, C<sub>15</sub>H<sub>18</sub>N<sub>2</sub>NaOS<sup>+</sup> [M + Na]<sup>+</sup> requires 329.0753.</div></div><div id="sec3_2_107" class="NLM_sec NLM_sec_level_3"><div id="ac_i148" class="anchor-spacer"></div><h4 class="article-section__title" id="_i148"> Methyl (2-(2-(Pyridin-3-yl)thiazol-4-yl)ethyl)carbamate (<b>46a</b>)</h4><div class="NLM_p last">A solution of diacetoxyiodobenzene (0.537 g, 1.62 mmol) and <b>43a</b> (0.300 g, 1.29 mmol) in dry MeOH (15 mL) was stirred overnight. The solvent was evaporated, and the residue was subjected to flash chromatography. Elution with 1:50:50 NEt<sub>3</sub>/EtOAc/hexanes gave <b>46a</b> as a clear oil (0.200 g, 59%). <i>R</i><sub>f</sub> 0.2 (1:99 NEt<sub>3</sub>/EtOAc). IR (cm<sup>–1</sup>): 3205 (NH), 1702 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.07 (d, <i>J</i> = 1.7 Hz, 1H, H2″), 8.58 (dd, <i>J</i> = 4.8, 1.3 Hz, 1H, H6″), 8.14 (d, <i>J</i> = 7.9 Hz, 1H H4″), 7.32 (dd, <i>J</i> = 7.9, 4.9, Hz, 1H, H5″), 7.01 (s, 1H, H5′), 5.49 (br s, 1H, NH), 3.62 (s, 3H, CH<sub>3</sub>), 3.57 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.2 Hz, 2H, H3), 2.98 (t, <i>J</i> = 6.3 Hz, 2H, H2). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 164.6 (C3″), 157.2 (C═O or C4′), 155.9 (C═O or C4′), 150.7 (C2″ or C6″), 147.6 (C2″ or C6″), 133.6 (C4″), 129.6 (C3″), 123.8 (C5″), 115.3 (C5′), 52.1 (CH<sub>3</sub>), 40.4 (C1), 31.6 (C2). HRMS (ESI) <i>m</i>/<i>z</i> observed: 286.0634, C<sub>12</sub>H<sub>13</sub>N<sub>3</sub>NaO<sub>2</sub>S<sup>+</sup> [M + Na]<sup>+</sup> requires 286.0621.</div></div><div id="sec3_2_108" class="NLM_sec NLM_sec_level_3"><div id="ac_i149" class="anchor-spacer"></div><h4 class="article-section__title" id="_i149"> Methyl (2-(2-(Pyridin-4-yl)thiazol-4-yl)ethyl)carbamate (<b>46b</b>)</h4><div class="NLM_p last">A mixture of diacetoxyiodobenzene (0.343 g, 1.03 mmol) and <b>43b</b> (0.200 g, 0.860 mmol) in dry MeOH (8 mL) was stirred overnight. The solvent was evaporated, and the residue was subjected to flash chromatography. Elution with 1:20:80 NEt<sub>3</sub>/EtOAc/hexanes then 1:50:50 NEt<sub>3</sub>/EtOAc/hexanes gave <b>46b</b> as a white solid (0.159 g, 70%), mp = 91–93 °C. <i>R</i><sub>f</sub> 0.6 (1:50:50 NEt<sub>3</sub>/EtOAc/hexanes). IR (cm<sup>–1</sup>): 3205 (NH), 1701 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.65 (d, <i>J</i> = 6.0 Hz, 2H, H2″/H6″), 7.74 (d, <i>J</i> = 5.9 Hz, 2H, H3″/H5″), 7.09 (s, 1H, H5′), 5.39 (br s, 1H, NH), 3.64 (s, 3H, CH<sub>3</sub>), 3.58 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.0 Hz, 2H, H1), 3.01 (t, <i>J</i> = 6.3 Hz, 2H, H2). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 165.1 (C2′), 157.5 (C═O or C4′), 156.4 (C═O or C4′), 150.7 (C2″/C6″), 140.2 (C4″), 120.3 (C3″/C5″), 116.5 (C5′), 52.1 (CH<sub>3</sub>), 40.4 (C1), 31.7 (C2). HRMS (ESI) <i>m</i>/<i>z</i> observed: 286.0621, C<sub>12</sub>H<sub>13</sub>N<sub>3</sub>NaO<sub>2</sub>S<sup>+</sup> [M + Na]<sup>+</sup> requires 286.0621</div></div><div id="sec3_2_109" class="NLM_sec NLM_sec_level_3"><div id="ac_i150" class="anchor-spacer"></div><h4 class="article-section__title" id="_i150"> 2-(2-(Pyridin-3-yl)thiazol-4-yl)ethanamine Dihydrochloride (<b>47a</b>)</h4><div class="NLM_p last">A stirred solution of <b>46a</b> (0.200 g, 0.751 mmol) in 4 M HCl (10 mL) was heated under reflux overnight. The solvent was evaporated to yield <b>47a</b> as a colorless oil (0.209 g, quant). IR (cm<sup>–1</sup>): 3366 (NH), 3030 (NH). <sup>1</sup>H NMR (500 MHz, MeOD) δ 9.52 (s, 1H, H2″), 9.16 (d, <i>J</i> = 7.8 Hz, 1H, H6″), 8.99 (d, <i>J</i> = 5.0 Hz, 1H, H4″), 8.28 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.4 Hz, 1H, H5″), 7.33 (s, 1H, H5′), 3.39 (t, <i>J</i><sub>1</sub> = 6.2 Hz, 2H, H1), 3.24 (t, <i>J</i><sub>1</sub> = 6.4 Hz, 2H, H2). <sup>13</sup>C NMR (126 MHz, MeOD) δ 162.0 (C2′), 155.7 (C4′), 144.7 (C2″ or C6″), 142.9 (C2″ or C6″), 140.5 (C4″), 134.5 (C3″), 129.3 (C5″), 121.2 (C5′), 40.1 (C1), 29.6 (C2). HRMS (ESI) <i>m</i>/<i>z</i> observed: 206.0745, C<sub>10</sub>H<sub>12</sub>N<sub>3</sub>S<sup>+</sup> [free base + H]<sup>+</sup> requires 206.0746.</div></div><div id="sec3_2_110" class="NLM_sec NLM_sec_level_3"><div id="ac_i151" class="anchor-spacer"></div><h4 class="article-section__title" id="_i151"> 2-(2-(Pyridin-4-yl)thiazol-4-yl)ethanaminium Chloride (<b>47b</b>)</h4><div class="NLM_p last">A stirred solution of <b>46b</b> (0.600 g, 2.25 mmol) in 4 M HCl (15 mL) was heated under reflux overnight. The solvent was evaporated to yield <b>47b</b> as yellow crystals (0.627 g, quant), mp = 147–150 °C. <i>R</i><sub>f</sub> 0.4 (1:99 MeOH/EtOAc). IR (cm<sup>–1</sup>): 3390 (NH). <sup>1</sup>H NMR (500 MHz, DMSO) δ 8.88 (s, 2H, H2″/H6″), 8.22 (s, 2H, H3″/H5″), 8.06 (br s, 3H, NH<sub>3</sub>), 7.88 (s, 1H, H5′), 3.22 (pseudo q, 2H, H1), 3.15 (t, 2H, <i>J</i> = 7.0 Hz, H2). <sup>13</sup>C NMR (126 MHz, MeOD) δ 162.8 (C2′), 157.2 (C4′), 150.2 (C4″), 143.9 (C2″/C6″), 124.8 (C3″/C5″), 124.4 (C5′), 40.3 (C1), 29.9 (C2). HRMS (ESI) <i>m</i>/<i>z</i> observed: 206.0745, C<sub>10</sub>H<sub>12</sub>N<sub>3</sub>S<sup>+</sup> [free base + H]<sup>+</sup> requires 206.0746.</div></div><div id="sec3_2_111" class="NLM_sec NLM_sec_level_3"><div id="ac_i152" class="anchor-spacer"></div><h4 class="article-section__title" id="_i152"> 2-Amino-4-(chloromethyl)thiazol-3-ium Chloride (<b>49</b>).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></h4><div class="NLM_p last">A solution of thiourea (6.49 g, 90.9 mmol) in MeOH (50 mL) was added dropwise over 1 h to a stirred solution of 1,3-dichloroacetone (12.8 g, 100.0 mmol) in acetone (100 mL). After stirring overnight, the solvent was evaporated and the residue was washed with acetone to give <b>49</b> as a white solid (13.6 g, 81%). <sup>1</sup>H NMR (500 MHz, DMSO) δ 9.13 (v br s, 2H, NH<sub>2</sub>), 6.96 (s, 1H, H5′), 4.66 (d, <i>J</i> = 0.5 Hz, 2H, H2), (thiazole NH not observed/obscured by/exchanging with H<sub>2</sub>O). The <sup>1</sup>H NMR data match those published (although the wrong isomer is reported in that paper).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div></div><div id="sec3_2_112" class="NLM_sec NLM_sec_level_3"><div id="ac_i153" class="anchor-spacer"></div><h4 class="article-section__title" id="_i153"> 2-(2-Bromothiazol-4-yl)acetonitrile (<b>51</b>)</h4><div class="NLM_p last">NaNO<sub>2</sub> (0.250 g, 3.67 mmol) was added to a solution of <b>49</b> (0.500 g, 3.16 mmol) and conc H<sub>2</sub>SO<sub>4</sub> (0.68 mL) in water (15 mL) at 0 °C, whereupon an orange foam evolved. The solution was allowed to stir at for 20 min, then 48% aqueous HBr (6.25 mL, 115 mmol) was slowly added.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> The solution was allowed to stir at room temperature for 1 h, then poured onto ice and extracted with EtOAc (3 × 100 mL). The extract was dried evaporated to give a red/brown oil (300 mg). <sup>1</sup>H NMR analysis of the crude product showed it to be a mixture of 2-chloro-4-(chloromethyl)thiazole and 2-bromo-4-(chloromethyl)thiazole (<b>50)</b>. A portion of this mixture (180 mg) was dissolved in DMF (10 mL) and treated with KCN (0.060 g, 0.929 mmol). The reaction mixture was stirred overnight, then diluted with water (100 mL) and extracted with EtOAc (3 × 20 mL). The extract was dried and evaporated to yield <b>51</b> as a brown oil (0.08 g, 31%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.28 (t, <i>J</i> = 1.2 Hz, H5′), 3.87 (d, <i>J</i> = 1.2 Hz, H2). The <sup>1</sup>H NMR data are similar to those reported.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div></div><div id="sec3_2_113" class="NLM_sec NLM_sec_level_3"><div id="ac_i154" class="anchor-spacer"></div><h4 class="article-section__title" id="_i154"> 2-(2-Aminothiazol-4-yl)acetonitrile (<b>54</b>)</h4><div class="NLM_p last">KCN (7.56 g, 116 mmol) was added to a stirred solution of <b>49</b> (9.1 g, 49 mmol) in DMF (50 mL). After 48 h the reaction was incomplete, additional KCN (3.2 g, 49 mmol) was added and stirring as continued overnight. The reaction mixture was diluted with water (200 mL), then extracted with EtOAc (3 × 50 mL). The extract was washed with water (2 × 50 mL) and brine (50 mL), dried, and evaporated to give <b>54</b> as a brown/red oil (3.0 g, 44%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.43 (s, 1H, H5′), 5.40 (br s, 2H, NH<sub>2</sub>), 3.62 (d, <i>J</i> = 1.2 Hz, 2H, H2).</div></div><div id="sec3_2_114" class="NLM_sec NLM_sec_level_3"><div id="ac_i155" class="anchor-spacer"></div><h4 class="article-section__title" id="_i155"> 2-(2-(2-Aminothiazol-4-yl)ethyl)isoindoline-1,3-dione hydrobromide (<b>56</b>)</h4><div class="NLM_p last">Thiourea (1.2 g, 17 mmol) was added to a stirred solution of <b>5</b> (5.50 g, 18.6 mmol) in MeOH (100 mL). The solution was heated under reflux for 7 h, then cooled. The resulting suspension was filtered, and the precipitate was washed with EtOAc (3 × 50 mL) to give <b>56</b> as a pale-brown solid (4.52 g, 89%). <sup>1</sup>H NMR (500 MHz, DMSO) δ 9.01 (br s, 2H, NH<sub>2</sub>), 7.82–7.87 (m, 4H, 4 × ArH), 6.57 (s, 1H, H5″), 3.84 (t, 2H, <i>J</i> = 6.3 Hz, H1), 2.83 (t, <i>J</i> = 6.3 Hz, 2H, H2). The imidazolium NH was not observed.</div></div><div id="sec3_2_115" class="NLM_sec NLM_sec_level_3"><div id="ac_i156" class="anchor-spacer"></div><h4 class="article-section__title" id="_i156"> 2-(3-Oxo-4-thiocyanatobutyl)isoindoline-1,3-dione (<b>57</b>)</h4><div class="NLM_p last">A solution of KSCN (1.89 g, 19.5 mmol) in dry acetone (20 mL) was added to a stirred solution of <b>5</b> (4.8 g, 16 mmol) in dry acetone (100 mL) under N<sub>2</sub>. The solution was allowed to stir for 2 h, then filtered (to remove precipitated KBr), and the filtrate was evaporated. The resulting yellow solid was partitioned between H<sub>2</sub>O and EtOAc, and the organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated. The resulting yellow oil (5.2 g) was purified by flash chromatography. Elution with cyclohexane/EtOAc 8:2 to 6:4) afforded <b>57</b> as a yellow solid (3.4 g, 76%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.85–7.87 (m, 2H, Ar), 7.73–7.75 (m, 2H, Ar), 4.09 (s, 2H, CH<sub>2</sub>S), 4.04 (t, <i>J</i> = 6.8 Hz, 2H, CH<sub>2</sub>N), 3.04 (t, <i>J</i> = 7.1 Hz, 2 H, CH<sub>2</sub>CO). <sup>13</sup>C NMR spectrum (CDCl<sub>3</sub>, 101 MHz) δ 198.5 (CO), 168.0 (2 × CO), 134.2 (2 × ArH), 131.8 (2 × Ar), 123.5 (2 × ArH), 111.0 (CN), 43.5 (CH<sub>2</sub>S), 39.6 (CH<sub>2</sub>N), 32.7 (CH<sub>2</sub>). LCMS (ESI) <i>m</i>/<i>z</i>: 275 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_116" class="NLM_sec NLM_sec_level_3"><div id="ac_i157" class="anchor-spacer"></div><h4 class="article-section__title" id="_i157"> 2-(2-(2-Bromothiazol-4-yl)ethyl)isoindoline-1,3-dione (<b>58</b>)</h4><div class="NLM_p last">A mixture of 33% HBr in acetic acid (30 mL), <b>57</b> (3.4 g, 12 mmol) and DCM (50 mL) was stirred for 24 h. Water (50 mL) was added, and the mixture was extracted with EtOAc (3 × 40 mL). The extract was washed with water (2 × 50 mL) and brine (2 × 50 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to afford <b>58</b> as yellow solid (3.6 g, 86%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.83–7.87 (m, 2H, ArH), 7.71–7.73 (m, 2H, ArH), 6.97 (s, 1H, CH) 4.04 (t, <i>J</i> = 7.1 Hz, 2 H, CH<sub>2</sub>N), 3.16 (t, <i>J</i> = 7.1 Hz, 2 H, CH<sub>2</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz) δ 168.1 (2 × CO), 153.8 (C4″), 135.5 (C2″), 133.9 (2 × ArH), 132.0 (2 × Ar), 123.3 (2 × ArH), 118.4 (C5″), 37.2 (C1′), 30.2 (C2′). LCMS (ESI) <i>m</i>/<i>z</i>: 337 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_117" class="NLM_sec NLM_sec_level_3"><div id="ac_i158" class="anchor-spacer"></div><h4 class="article-section__title" id="_i158"> 2-(2-(2-(2-Fluorophenyl)thiazol-4-yl)ethyl)isoindoline-1,3-dione (<b>59a</b>)</h4><div class="NLM_p last">N<sub>2</sub> was bubbled through a stirred mixture of <b>58</b> (0.620 g, 1.84 mmol) and 2-fluorophenylboronic acid (0.300 g, 2.14 mmol), toluene (20 mL), and 2 M Na<sub>2</sub>CO<sub>3</sub> (20 mL) for 20 min The reaction mixture was heated to 80 °C under N<sub>2</sub>, and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.070 g, 3 mol %) was added. After 6 h, TLC showed the reaction to be incomplete, so additional Pd(PPh<sub>3</sub>)<sub>4</sub> (0.100 g, 5 mol %) was added and the reaction mixture was stirred overnight at 80 °C. After cooling the reaction mixture was extracted with EtOAc (3 × 50 mL). The extract was washed with water (3 × 50 mL), dried, and evaporated, and the residue was subjected to flash chromatography. Elution with 1:9 EtOAc/hexanes and then 1:4 EtOAc/hexanes gave <b>59a</b> as a yellow crystalline solid (0.200 g, 31%), mp = 149–151 °C. IR (cm<sup>–1</sup>): 1771 (C═O), 1706 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.04 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.8 Hz, <i>J</i><sub>3</sub> = 1.8 Hz, 1H, H6‴), 7.79–7.82 (m, 2H, H3/H6), 7.66–7.69 (m, 2H, H4/H5), 7.29–7.33 (m, 1H, H4‴), 7.08–7.14 (m, 3H, H5″/H3‴/H5‴), 4.12 (t, <i>J</i> = 7.0 Hz, 2H, H1′), 3.25 (dt, <i>J</i> = 7.0, 0.8 Hz, 2H, H2′). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 168.4 (C═O), 160.3 (d, <i>J</i> = 4 Hz, C2″), 160.0 (d, <i>J</i> = 202 Hz, CF), 153.2 (C4″), 134.0 (C4/C7), 132.4, (C3a/C7a), 130.9 (d, <i>J</i> = 7 Hz, ArH), 128.8 (d, <i>J</i> = 2 Hz, ArH), 124.5 (d, <i>J</i> = 3 Hz, ArH), 123.4 (C5/C6), 121.5 (d, <i>J</i> = 9 Hz, C1‴), 116.3 (d, <i>J</i> = 7 Hz, C5″), 116.1 (d, <i>J</i> = 17 Hz, C3‴), 37.8 (C1′), 30.0 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 353.0757, C<sub>19</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>FS<sup>+</sup> [M + H]<sup>+</sup> requires 353.0755.</div></div><div id="sec3_2_118" class="NLM_sec NLM_sec_level_3"><div id="ac_i159" class="anchor-spacer"></div><h4 class="article-section__title" id="_i159"> 2-(2-(2-(3-Fluorophenyl)thiazol-4-yl)ethyl)isoindoline-1,3-dione (<b>59b</b>)</h4><div class="NLM_p last">Prepared as described for <b>59a</b> with <b>58</b> (0.213 g, 0.631 mmol) and 3-fluorophenylboronic acid (0.106 g, 0.758 mmol). Elution with 1:9 EtOAc/hexanes and then 1:4 EtOAc/hexanes gave <b>59b</b> as an orange solid (0.040 g, 18%), mp = 101–102 °C. IR (cm<sup>–1</sup>): 1770 (C═O), 1708 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.80–7.84 (m, 2H, H4/H7), 7.68–7.72 (m, 2H, H5/H6), 7.54 (ddd, <i>J</i><sub>1</sub> = 7.8, 1.6, 1.0 Hz, 1H, H6‴), 7.42 (ddd, <i>J</i><sub>1</sub> = 9.8 Hz, <i>J</i><sub>2</sub> = 2.6 Hz, <i>J</i><sub>3</sub> = 1.6 Hz, 1H, H2‴), 7.30 (ddd (app dt), <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.0 Hz, <i>J</i><sub>3</sub> = 5.8 Hz, 1H, H5‴), 7.04 (dddd [app ddt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.4 Hz, <i>J</i><sub>3</sub> = 2.6 Hz, <i>J</i><sub>4</sub> = 0.9 Hz, 1H, H4‴), 7.02 (s, 1H, H5″), 4.10 (t, <i>J</i><sub>1</sub> = 7.0 Hz, 2H, H1′), 3.21 (t, <i>J</i><sub>1</sub> = 7.0 Hz, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.4 (C═O), 166.5 (d, <i>J</i> = 2 Hz, C2″), 163.1 (d, <i>J</i> = 198 Hz, CF), 154.7 (C4″), 135.7 (d, <i>J</i> = 7 Hz, C1‴), 134.0 (C5/C6), 132.3 (C3a/C7a), 130.5 (d, <i>J</i> = 7 Hz, C5‴), 123.4 (C4/C7), 122.3 (d, <i>J</i> = 2 Hz, C6‴), 116.7 (d, <i>J</i> = 17 Hz, C2‴ or C4‴), 115.3 (C5″), 113.3 (d, <i>J</i> = 19 Hz, C2‴ or C4‴), 37.7 (C1′), 30.0 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 353.0743, C<sub>19</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>SF<sup>+</sup> [M + H]<sup>+</sup> requires 353.0760.</div></div><div id="sec3_2_119" class="NLM_sec NLM_sec_level_3"><div id="ac_i160" class="anchor-spacer"></div><h4 class="article-section__title" id="_i160"> 2-(2-(2-(4-Fluorophenyl)thiazol-4-yl)ethyl)isoindoline-1,3-dione (<b>59c</b>)</h4><div class="NLM_p last">Prepared as described for <b>59a</b> with <b>58</b> (0.500 g, 1.48 mmol) and 4-fluorophenylboronic acid (0.300 g, 2.14 mmol). Elution with 1:9 EtOAc/hexanes gave <b>59c</b> as a yellow solid (0.260 g, 50%), mp = 120–122 °C. IR (cm<sup>–1</sup>): 1772 (C═O), 1704 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.67–7.79 (m, 6H, H4/H7/H5/H6/H2‴/H6‴), 7.00 (dd [app t], 2H, <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.0 Hz, H3‴/H5‴), 6.96 (s, 1H, H5″), 4.08 (t, 2H, <i>J</i><sub>1</sub> = 6.4 Hz, H1′), 3.20 (t, 2H, <i>J</i><sub>1</sub> = 6.4 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.2 (C═O), 166.6 (C2″), 163.7 (d, <i>J</i> = 201 Hz, C4‴), 154.3 (C4″), 133.9 (C5/C6), 132.2 (C3a/C7a), 130.0 (d, <i>J</i> = 3 Hz, C1‴), 128.3 (d, <i>J</i> = 7 Hz, C2‴/C6‴), 123.2 (C4/C7), 115.8 (d, <i>J</i> = 18 Hz, C3‴/C5‴), 114.6 (C5″), 37.6 (C1′), 29.9 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 353.0716, C<sub>19</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>FS+ [M + H]<sup>+</sup> requires 353.0760.</div></div><div id="sec3_2_120" class="NLM_sec NLM_sec_level_3"><div id="ac_i161" class="anchor-spacer"></div><h4 class="article-section__title" id="_i161"> 2-(2-(2-(2,4-Difluorophenyl)thiazol-4-yl)ethyl)isoindoline-1,3-dione (<b>59d</b>)</h4><div class="NLM_p last">Prepared as described for <b>59a</b> with <b>58</b> (0.220 g, 0.650 mmol) and 2,4-difluorophenylboronic acid (0.200 g, 1.23 mmol). Elution with 1:9 EtOAc/hexanes gave <b>59d</b> as a white, crystalline solid (0.168 g, 70%), mp = 168–170 °C. IR (cm<sup>–1</sup>): 1769 (C═O), 1704 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.01 (m [pseudo q], 1H, H6‴), 7.80–7.81 (m, 2H, H4/H7), 7.68–7.70 (m, 2H, H5/H6), 7.09 (s, 1H, H5″), 6.82–6.90 (m, 2H, H3‴/H5‴), 4.10 (t, <i>J</i><sub>1</sub> = 7.0 Hz, H1′), 3.23 (t, <i>J</i><sub>1</sub> = 7.0 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 168.3 (C═O), 163.3 (dd, <i>J</i> = 203, 10 Hz, CF), 160.0 (dd, <i>J</i> = 204, 10 Hz, CF), 161.0 (d, <i>J</i> = 10 Hz, C2″), 159.3 (d, <i>J</i> = 4 Hz, C4″), 134.0 (C5/C6), 132.3 (C3a/C7a), 129.9 (dd, <i>J</i> = 8, 3 Hz, C6″), 123.3 (C4/C7), 118.0 (dd, <i>J</i> = 9, 3 Hz, C1‴), 115.8 (d, <i>J</i> = 7 Hz, C5″), 112.0 (dd, <i>J</i> = 17, 3 Hz, C5‴), 104.2 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 21 Hz, C3‴), 37.6 (C1′), 29.8 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 371.0648, C<sub>19</sub>H<sub>13</sub>N<sub>2</sub>O<sub>2</sub>F<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 371.0666.</div></div><div id="sec3_2_121" class="NLM_sec NLM_sec_level_3"><div id="ac_i162" class="anchor-spacer"></div><h4 class="article-section__title" id="_i162"> <i>N</i>-(2-(2-(2-Fluorophenyl)thiazol-4-yl)ethyl)-1<i>H</i>-imidazole-1-carboxamide (<b>60a</b>)</h4><div class="NLM_p last">A stirred solution of hydrazine hydrate (2.5 mL) and <b>59a</b> (0.200 g, 0.568 mmol) in MeOH (20 mL) under N<sub>2</sub> was heated under reflux overnight. The volatiles were evaporated, and the residue was dissolved in 1:1 MeCN/DMF (20 mL) and treated with 1,1-carbonyldiimidazole (CDI) (0.300 g, 1.85 mmol). After stirring overnight, the solvent was evaporated and the residue was diluted with EtOAc (150 mL) and washed with water (3 × 50 mL). The organic phase was dried and evaporated, and the residue was subjected to flash chromatography. Elution with 1:1 EtOAc/hexanes and then EtOAc have <b>60a</b> as a yellow oil, (0.700 g, 39%). IR (cm<sup>–1</sup>): 3222 (NH), 1712 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.14–8.16 (m, 1H, H2), 8.10 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.6 Hz, <i>J</i><sub>3</sub> = 1.6 Hz, 1H, H6‴), 7.72 (br s, 1H, NH), 7.41–7.45 (m, 1H, H4‴), 7.38 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 1.5 Hz, H5) 7.27 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.8, 1.2 Hz, 1H, H5‴), 7.22 (ddd, <i>J</i> = 11.7, 8.3, 1.0, 1H, H3‴), 7.16 (s, 1H, H5″), 7.06 (dd, <i>J</i><sub>1</sub> = 1.5 Hz, <i>J</i><sub>2</sub> = 1.0 Hz, 1H, H4), 3.80 (m [pseudo q], H1′), 3.13 (t, <i>J</i><sub>1</sub> = 6.0 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 161.7 (d, <i>J</i> = 4 Hz, C2″), 160.0 (d, <i>J</i> = 204 Hz, CF), 154.3 (C4″), 149.0 (C═O), 136.0 (C2), 131.7 (d, <i>J</i> = 7 Hz, C6‴), 130.5 (C4), 128.6 (d, <i>J</i> = 2 Hz, ArH), 124.9 (d, <i>J</i> = 2 Hz, ArH), 121.2 (d, <i>J</i> = 9 Hz, C1‴), 116.7 (d, <i>J</i> = 17 Hz, C3‴), 116.5 (d, <i>J</i> = 6 Hz, C5″), 116.0 (C5), 40.6 (C1′), 30.1 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 317.0867, C<sub>15</sub>H<sub>14</sub>N<sub>4</sub>OFS<sup>+</sup> [M + H]<sup>+</sup> requires 317.0872.</div></div><div id="sec3_2_122" class="NLM_sec NLM_sec_level_3"><div id="ac_i163" class="anchor-spacer"></div><h4 class="article-section__title" id="_i163"> <i>N</i>-(2-(2-(3-Fluorophenyl)thiazol-4-yl)ethyl)-1<i>H</i>-imidazole-1-carboxamide (<b>60b</b>)</h4><div class="NLM_p last">Prepared from <b>59b</b> (0.038 g, 0.171 mmol) as described for <b>60a</b>. Elution with 3:2 EtOAc/hexanes gave <b>60b</b> as a brown oil (0.021 g, 57%). IR (cm<sup>–1</sup>): 3115 (NH), 1710 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.15 (s, 1H, H2), 7.67 (br s, 1H, NH), 7.64–6.67 (m, 1H, H6‴), 7.60 (ddd [app dt], <i>J</i><sub>1</sub> = 9.4 Hz, <i>J</i><sub>2</sub> = <i>J</i><sub>3</sub> = 2.0 Hz, H2‴), 7.42 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.0 Hz, <i>J</i><sub>3</sub> = 5.7 Hz, 1H, H5‴), 7.37 (s, 1H, H5), 7.13 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.2 Hz, <i>J</i><sub>3</sub> = 2.8 Hz, H4‴), 7.05–7.08 (m, 2H, H4/H5″), 3.79 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.6 Hz, 2H, H1′), 3.10 (t, <i>J</i><sub>1</sub> = 6.0 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.4 (d, <i>J</i> = 3 Hz, C2″), 163.2 (d, <i>J</i> = 199 Hz, CF), 155.3 (C4″), 149.0 (C═O), 136.1 (C2), 135.3 (d, <i>J</i> = 6 Hz, C1‴), 130.9 (d, <i>J</i> = 7 Hz, C5‴), 130.6 (C4), 122.2 (d, <i>J</i> = 2 Hz, C6‴), 117.4 (d, <i>J</i> = 17 Hz, C2‴ or C4‴), 115.8 (C5″ or C5), 115.7 (C5″ or C5), 113.4 (d, <i>J</i> = 19 Hz, C2‴ or C4‴), 40.5 (C1′), 30.4 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 317.0863, C<sub>15</sub>H<sub>14</sub>N<sub>4</sub>OFS<sup>+</sup> [M + H]<sup>+</sup> requires 317.0872.</div></div><div id="sec3_2_123" class="NLM_sec NLM_sec_level_3"><div id="ac_i164" class="anchor-spacer"></div><h4 class="article-section__title" id="_i164"> <i>N</i>-(2-(2-(4-Fluorophenyl)thiazol-4-yl)ethyl)-1<i>H</i>-imidazole-1-carboxamide (<b>60c</b>)</h4><div class="NLM_p last">Prepared from <b>59b</b> (0.260 g, 0.738 mmol) as described for <b>60a</b>. Elution with 1:1 EtOAc/hexanes and then EtOAc gave <b>60c</b> as a pale-orange solid (0.070 g, 30%), mp = 35–37 °C. IR (cm<sup>–1</sup>): 3218 (NH), 1703 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.13 (dd, <i>J</i> = 1.2, 1.1 Hz, 1H, H2), 7.85–7.88 (m, 2H, H2‴/H6‴), 7.70 (br unresolved t, 1H, NH), 7.36 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 1.4 Hz, 1H, H5), 7.13–7.16 (m, 2H, H3‴/H5‴), 7.06 (dd, <i>J</i><sub>1</sub> = 1.6 Hz, 0.8 Hz, 1H, H4), 7.03 (t, <i>J</i> = 0.8 Hz, 1H, H5″), 3.77–3.80 (m [pseudo q], Hz, 2H, H1′), 3.09 (dt, <i>J</i> = 6.0, 0.5 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.9 (C2″), 164.2 (d, <i>J</i> = 202 Hz, C4‴), 155.1 (C4″), 149.0 (C═O), 136.0 (C2), 130.5 (C4), 129.7 (d, <i>J</i> = 3 Hz, C1‴), 128.4 (d, <i>J</i> = 7 Hz, C2‴/C6‴), 116.4 (d, <i>J</i> = 18 Hz, C3‴/C5‴), 115.9 (C5 or C5″), 115.1 (C5 or C5″), 40.6 (C1′), 30.3 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 317.0877, C<sub>15</sub>H<sub>14</sub>N<sub>4</sub>OFS<sup>+</sup> [M + H]<sup>+</sup> requires: 317.0872.</div></div><div id="sec3_2_124" class="NLM_sec NLM_sec_level_3"><div id="ac_i165" class="anchor-spacer"></div><h4 class="article-section__title" id="_i165"> <i>N</i>-(2-(2-(2,4-Difluorophenyl)thiazol-4-yl)ethyl)-1<i>H</i>-imidazole-1-carboxamide (<b>60d</b>)</h4><div class="NLM_p last">Prepared from <b>59d</b> (0.100 g, 0.270 mmol) as described for <b>60a</b>. Elution with 3:2 EtOAc/hexanes and then EtOAc gave <b>60d</b> as a yellow oil (0.060 g, 70%). IR (cm<sup>–1</sup>): 3351 (NH), 1616 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.14 (br s, 1H, H2), 8.08 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.6 Hz, <i>J</i><sub>3</sub> = 6.4 Hz, 1H, H6‴), 7.98 (br t, <i>J</i><sub>1</sub> = 4.6 Hz, 1H, NH), 7.39 (br s, H5), 7.11 (s, 1H, H5″), 6.99 (br s, 1H, H4), 6.90–6.97 (m, 2H, H3‴/H5‴), 3.76 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.2 Hz, 2H, H1′), 3.10 (t, <i>J</i><sub>1</sub> = 6.4 Hz, 2H, H2′). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 163.6 (dd, <i>J</i> = 204, 10 Hz, CF), 160.3 (d, <i>J</i> = 5 Hz, C2″), 160.1 (dd, <i>J</i> = 205, 10 Hz, CF), 154.0 (C4″), 149.0 (C═O), 136.0 (C2), 130.1 (C5), 129.8 (dd, <i>J</i> = 8, 3 Hz, C6‴), 117.8 (dd, <i>J</i> = 9, 3 Hz, C1‴), 116.11 (d, <i>J</i> = 6 Hz, C5″), 116.10 (C5), 112.3 (dd, <i>J</i> = 17, 3 Hz, C5‴), 104.8 (dd, app t] <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 21 Hz, C3‴), 40.5 (C1′), 30.4 (C2′). HRMS (ESI) <i>m</i>/<i>z</i> observed: 335.0766, C<sub>15</sub>H<sub>13</sub>N<sub>4</sub>OF<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 335.0778.</div></div><div id="sec3_2_125" class="NLM_sec NLM_sec_level_3"><div id="ac_i166" class="anchor-spacer"></div><h4 class="article-section__title" id="_i166"> <i>N</i>-(2-(2-(2-Fluorophenyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>61a</b>)</h4><div class="NLM_p last">Piperidine (0.10 mL, 0.978 mmol) was added to a stirred solution of NEt<sub>3</sub> (0.10 mL) and <b>60a</b> (0.070 g, 0.221 mmol) in DCM (5 mL) at 0 °C. The solution was allowed to warm to room temperature, and stirring was continued overnight. The solvent was evaporated, and the residue was subjected to flash chromatography. Elution with 3:2 EtOAc/hexanes then EtOAc gave <b>61a</b> as a yellow oil (0.030 g, 41%). IR (cm<sup>–1</sup>): 3351 (NH), 1616 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.19 (ddd [app dt], 1H, <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.6, <i>J</i><sub>3</sub> = 1.8 Hz, H6‴), 7.36–7.40 (m, 1H, H4‴), 7.16–7.24 (m, 2H, H3‴/H5‴), 7.10 (s, 1H, H5″), 5.65 (br s, 1H, NH), 3.60 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.0 Hz, 2H, H1′), 3.32 (m [pseudo t], 4H, H2/H6), 3.02 (t, <i>J</i><sub>1</sub> = 6.2 Hz, 2H, H2′), 1.48–1.57 (m, 6H, H3/H4/H5). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 160.5 (d, <i>J</i> = 4 Hz, C2″), 160.0 (d, <i>J</i> = 203 Hz, CF), 157.9 (C═O), 155.3 (C4″), 131.1 (d, <i>J</i> = 7 Hz, C6‴), 128.5 (d, <i>J</i> = 2 Hz, C4‴ or C5‴), 124.6 (d, <i>J</i> = 3 Hz, C4‴ or C5‴), 121.5 (d, <i>J</i> = 9 Hz, C1‴), 116.4 (d, <i>J</i> = 17 Hz, C3‴), 116.0 (d, <i>J</i> = 7 Hz, C5″), 44.9, (C2/C6), 40.7 (C1′), 31.3 (C2′), 25.7 (C3/C5), 24.6 (C4). HRMS (ESI) <i>m</i>/<i>z</i> observed: 334.1388, C<sub>17</sub>H<sub>21</sub>N<sub>3</sub>OFS<sup>+</sup> [M + H]<sup>+</sup> requires 334.1389.</div></div><div id="sec3_2_126" class="NLM_sec NLM_sec_level_3"><div id="ac_i167" class="anchor-spacer"></div><h4 class="article-section__title" id="_i167"> <i>N</i>-(2-(2-(3-Fluorophenyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>61b</b>)</h4><div class="NLM_p last">Prepared from <b>60b</b> (0.0200 g, 0.0632 mmol) as described for <b>61a</b>. Elution with 1:1 EtOAc/hexanes then EtOAc gave <b>61b</b> as a yellow oil (0.015 g, 71%). IR (cm<sup>–1</sup>): 3350 (NH), 1614 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.63–7.67 (m, 2H, H2‴/H6‴), 7.38 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.1 Hz, <i>J</i><sub>3</sub> = 6.2 Hz, 1H, H5‴), 7.09–7.13 (m, 1H, H4‴), 7.01 (s, 1H, H5″), 5.67 (br s, 1H, NH), 3.59 (dt [app, q], <i>J</i><sub>1</sub> = 5.9 Hz, 2H, H1′), 3.33 (m [pseudo t], 4H, H2/H6), 3.00 (t, <i>J</i><sub>1</sub> = 6.2 Hz, 2H, H2′), 1.49–1.58 (m, 6H, H3/H4/H5). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 166.6 (d, <i>J</i> = 3 Hz, C2″), 163.2 (d, <i>J</i> = 198 Hz, CF), 157.9 (C═O or C4″), 156.7 (C═O or C4″), 135.7 (d, <i>J</i> = 7 Hz, C1‴), 130.7 (d, <i>J</i> = 7 Hz, C5‴), 122.2 (d, <i>J</i> = C6‴), 117.0 (d, <i>J</i> = 17 Hz, C2‴ or C4‴), 115.0 (C5″), 113.2 (d, <i>J</i> = 19 Hz, C2‴ or C4‴), 45.0 (C2/C6), 40.7 (C1′), 31.4 (C2′), 25.7 (C3/C5), 24.6 (C4). HRMS (ESI) <i>m</i>/<i>z</i> observed: 334.1388, C<sub>17</sub>H<sub>21</sub>N<sub>3</sub>OFS<sup>+</sup> [M + H]<sup>+</sup> requires 334.1389.</div></div><div id="sec3_2_127" class="NLM_sec NLM_sec_level_3"><div id="ac_i168" class="anchor-spacer"></div><h4 class="article-section__title" id="_i168"> <i>N</i>-(2-(2-(4-Fluorophenyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>61c</b>)</h4><div class="NLM_p last">Prepared from <b>60c</b> (0.060 g, 0.190 mmol) as described for <b>61a</b>. Elution with 3:2 EtOAc/hexanes and then EtOAc gave <b>61c</b> as a yellow oil (0.040 g, 63%). IR (cm<sup>–1</sup>): 3360 (NH), 1623 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.87–7.90 (m, 2H, H2‴/H6‴), 7.09–7.12 (m, 2H, H3‴/H5‴), 6.95 (s, 1H, H5″), 5.64 (br s, 1H, NH), 3.57 (dt [app, q], <i>J</i><sub>1</sub> = 6.0 Hz, 2H, H1′), 3.31 (m [pseudo t], 4H, H2/H6), 2.98 (t, <i>J</i><sub>1</sub> = 6.2 Hz, 2H, H2′), 1.47–1.57 (m, 6H, H3/H4/H5). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 166.9 (C2″), 163.9 (d, <i>J</i> = 201 Hz, CF), 157.9 (C═O or C4″), 156.4 (C═O or C4″), 130.1 (d, <i>J</i> = 3 Hz, C1‴), 128.3 (d, <i>J</i> = 7 Hz, C2‴/C6‴), 116.1 (d, <i>J</i> = 18 Hz, C3‴/C5‴), 114.4 (C5″), 44.9 (C2/C6), 40.6 (C1′), 31.4 (C2′), 25.7 (C3/C5), 24.6 (C4). HRMS (ESI) <i>m</i>/<i>z</i> observed: 334.1382, C<sub>17</sub>H<sub>21</sub>N<sub>3</sub>OFS<sup>+</sup> [M + H]<sup>+</sup> requires 334.1389.</div></div><div id="sec3_2_128" class="NLM_sec NLM_sec_level_3"><div id="ac_i169" class="anchor-spacer"></div><h4 class="article-section__title" id="_i169"> General Procedure F for the Synthesis of Phenylthiazoles by Suzuki Coupling with <b>63a</b></h4><div class="NLM_p last">2-Bromothiazole <b>63a</b> (1.0 equiv), potassium carbonate (4.0 equiv), arylboronic acid (1.2 equiv), tetrabutylammonium bromide (0.1 equiv), PdCl<sub>2</sub> (0.05 equiv), and dppf (0.055 equiv) were combined in a microwave reactor vessel with 4:1 dioxane and water (0.5 M final concentration). The reaction mixture was irradiated in a CEM microwave at 130 °C for 30 min, then cooled, diluted with EtOAc, and filtered through Celite. The filtrate was evaporated, and the residue was purified by column chromatography, eluting with EtOAc/hexanes to give the desired product.</div></div><div id="sec3_2_129" class="NLM_sec NLM_sec_level_3"><div id="ac_i170" class="anchor-spacer"></div><h4 class="article-section__title" id="_i170"> <i>N</i>-(2-(2-(3-Chlorophenyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>61d</b>)</h4><div class="NLM_p last">Prepared according to general procedure F with 3-chlorophenylboronic acid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.01 (s, 1H), 7.94 (d, <i>J</i> = 8.4 Hz, 1H), 7.35 (d, <i>J</i> = 7.9 Hz, 1H), 7.27 (m, 1H), 6.93 (s, 1H), 5.63 (br s, 1H), 3.63 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.5 Hz, 2H), 3.35–3.42 (m, 4H), 3.09 (t, <i>J</i> = 6.5 Hz, 2H), 1.63–1.50 (m, 6H). LRMS (ESI+) <i>m</i>/<i>z</i> 350, 352 [M + H] <sup>+</sup>.</div></div><div id="sec3_2_130" class="NLM_sec NLM_sec_level_3"><div id="ac_i171" class="anchor-spacer"></div><h4 class="article-section__title" id="_i171"> <i>N</i>-(2-(2-(4-Chlorophenyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>61e</b>)</h4><div class="NLM_p last">Prepared according to general procedure F with 4-chlorophenylboronic acid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.09 (d, <i>J</i> = 8.7 Hz, 2H), 7.63 (d, <i>J</i> = 8.5 Hz, 2H), 6.97 (s, 1H), 5.59 (br s, 1H), 3.62 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.4 Hz, 2H), 3.35–3.42 (m, 4H), 3.10 (t, <i>J</i> = 6.5 Hz, 2H), 1.50–1.63 (m, 6H). LRMS (ESI+) <i>m</i>/<i>z</i> 350, 352 [M + H] <sup>+</sup>.</div></div><div id="sec3_2_131" class="NLM_sec NLM_sec_level_3"><div id="ac_i172" class="anchor-spacer"></div><h4 class="article-section__title" id="_i172"> <i>N</i>-(2-(2-(<i>o</i>-Tolyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>61f</b>)</h4><div class="NLM_p last">Prepared according to general procedure F with 2-tolylboronic acid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.85 (d, <i>J</i> = 9.0 z, 1H), 7.30–7.40 (m, 3H), 6.96 (s, 1H), 5.79 (br s, 1H), 3.63 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.5 Hz, 2H), 3.36–3.42 (m, 4H), 3.04 (t, <i>J</i> = 6.7 Hz, 2H), 2.55 (s, 3H), 1.53–1.63 (m, 6H). LRMS (ESI+) <i>m</i>/<i>z</i> 330 [M + H] <sup>+</sup>.</div></div><div id="sec3_2_132" class="NLM_sec NLM_sec_level_3"><div id="ac_i173" class="anchor-spacer"></div><h4 class="article-section__title" id="_i173"> <i>N</i>-(2-(2-(<i>p</i>-Tolyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>61g</b>)</h4><div class="NLM_p last">Prepared according to general procedure F with 4-tolylboronic acid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.83 (d, <i>J</i> = 9.0 Hz, 2H), 7.24 (d, <i>J</i> = 9.0 Hz, 2H), 6.96 (s, 1H), 5.83 (br s, 1H), 3.62 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.5 Hz, 2H), 3.35–3.40 (m, 4H), 3.02 (t, <i>J</i> = 6.6 Hz, 2H), 2.42 (s, 3H), 1.53–1.63 (m, 6H). LRMS (ESI+) <i>m</i>/<i>z</i> 330 [M + H] <sup>+</sup>.</div></div><div id="sec3_2_133" class="NLM_sec NLM_sec_level_3"><div id="ac_i174" class="anchor-spacer"></div><h4 class="article-section__title" id="_i174"> <i>N</i>-(2-(2-(2-Methoxyphenyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>61h</b>)</h4><div class="NLM_p last">Prepared according to general procedure F with 2-methoxyphenylboronic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.36 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.42 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.1 Hz, <i>J</i><sub>3</sub> = 1.7 Hz, 1H), 7.04–7.10 (m, 3H), 5.87 (br s, 1H), 4.05 (s, 3H), 3.62 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.2 Hz, 2H), 3.29–3.44 (m, 4H), 3.01–3.06 (m, 2H), 1.48–1.65 (m, 6H). LRMS (ESI+) <i>m</i>/<i>z</i> 346 [M + H] <sup>+</sup>.</div></div><div id="sec3_2_134" class="NLM_sec NLM_sec_level_3"><div id="ac_i175" class="anchor-spacer"></div><h4 class="article-section__title" id="_i175"> <i>N</i>-(2-(2-(3-Methoxyphenyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>61i</b>)</h4><div class="NLM_p last">Prepared according to general procedure F with 3-methoxyphenylboronic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.52 (m, 2H), 7.37 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.9 Hz, 1H), 6.97–7.02 (m, 2H), 5.68 (br s, 1H), 3.90 (s, 3H), 3.63 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.6 Hz, 2H), 3.31–3.42 (m, 4H), 3.03 (t, <i>J</i> = 6.1 Hz, 2H), 1.49–1.65 (m, 6H). LRMS (ESI+) <i>m</i>/<i>z</i> 346 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_135" class="NLM_sec NLM_sec_level_3"><div id="ac_i176" class="anchor-spacer"></div><h4 class="article-section__title" id="_i176"> <i>N</i>-(2-(2-(4-Methoxyphenyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>61j</b>)</h4><div class="NLM_p last">Prepared according to general procedure F with 4-methoxyphenylboronic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.85–7.91 (m, 2H), 6.94–6.99 (m, 2H), 6.92 (s, 1H), 5.79 (br s, 1H), 3.89 (s, 3H), 3.62 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.4 Hz, 2H), 3.31–3.43 (m, 4H), 2.92–3.09 (m, 2H), 1.49–1.66 (m, 6H). LRMS (ESI+) <i>m</i>/<i>z</i> 346 [M + H] <sup>+</sup>.</div></div><div id="sec3_2_136" class="NLM_sec NLM_sec_level_3"><div id="ac_i177" class="anchor-spacer"></div><h4 class="article-section__title" id="_i177"> <i>N</i>-(2-(2-(2-Cyanophenyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>61k</b>)</h4><div class="NLM_p last">Prepared according to general procedure F with 2-cyanophenylboronic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.94 (d, <i>J</i> = 7.9 Hz, 1H), 7.84 (d, <i>J</i> = 8.0 Hz, 1H), 7.70 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.2 Hz, 1H), 7.55 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 7.6 Hz, 1H), 7.16 (s, 1H), 5.53 (br s, 1H), 3.74 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.8 Hz, 2H), 3.27–3.35 (m, 4H), 3.12 (t, <i>J</i> = 5.9 Hz, 2H), 1.39–1.63 (m, 6H). LRMS (ESI+) <i>m</i>/<i>z</i> 341 [M + H] <sup>+</sup>.</div></div><div id="sec3_2_137" class="NLM_sec NLM_sec_level_3"><div id="ac_i178" class="anchor-spacer"></div><h4 class="article-section__title" id="_i178"> <i>N</i>-(2-(2-(3-Cyanophenyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>61l</b>)</h4><div class="NLM_p last">Prepared according to general procedure F with 3-cyanophenylboronic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.27 (s, 1H), 8.14 (d, <i>J</i> = 8.0 Hz, 1H), 7.72 (d, <i>J</i> = 7.7 Hz, 1H), 7.58 (t, <i>J</i> = 7.8 Hz, 1H), 7.10 (s, 1H), 5.45 (br s, 1H), 3.64 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.9 Hz, 2H), 3.33–3.45 (m, 4H), 3.06 (t, <i>J</i><sub>1</sub> = 6.2 Hz, 2H), 1.46–1.78 (m, 6H). LRMS (ESI+) <i>m</i>/<i>z</i> 341 [M + H] <sup>+</sup>.</div></div><div id="sec3_2_138" class="NLM_sec NLM_sec_level_3"><div id="ac_i179" class="anchor-spacer"></div><h4 class="article-section__title" id="_i179"> <i>N</i>-(2-(2-(4-Cyanophenyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>61m</b>)</h4><div class="NLM_p last">Prepared according to general procedure F with 4-cyanophenylboronic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.93–7.98 (m, 2H), 7.63–7.68 (m, 2H), 7.05 (s, 1H), 5.33 (br s, 1H), 3.55 (t, <i>J</i> = 6.0 Hz, 2H), 3.33–3.20 (m, 4H), 2.97 (t, <i>J</i><sub>1</sub> = 6.2 Hz, 2H), 1.40–1.58 (m, 6H). LRMS (ESI+) <i>m</i>/<i>z</i> 341 [M + H] <sup>+</sup>.</div></div><div id="sec3_2_139" class="NLM_sec NLM_sec_level_3"><div id="ac_i180" class="anchor-spacer"></div><h4 class="article-section__title" id="_i180"> <i>N</i>-(2-(2-Bromothiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>63a</b>)</h4><div class="NLM_p last">A mixture of <b>58</b> (1.0 g, 3.0 mmol), EtOH (50 mL) and hydrazine monohydrate (5 mL) was heated under reflux for 1 h, then cooled to 0 °C. The resulting suspension was filtered, and the filtrate was evaporated. The residue (crude amine <b>62</b>) was dissolved in EtOAc (50 mL) and treated with NEt<sub>3</sub> (3 mL) and piperidine-1-carbonyl chloride (0.56 mL, 4.5 mmol). The reaction mixture was stirred for 12 h, at which point TLC showed the reaction to be incomplete. Additional NEt<sub>3</sub> (1 mL) and piperidine-1-carbonyl chloride (0.19 mL, 1.5 mmol) were added, and the reaction mixture was stirred at 60 °C for 4 h, then cooled in an ice bath before being filtered. The filtrate was washed with water (2 × 30 mL), brine (2 × 30 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give a brown solid (1.2 g, which was purified by flash chromatography. Elution with cyclohexane/EtOAc 1:1 to 3:7) afforded <b>63a</b> (670 mg, 72%) as a yellow oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 6.94 (s, 1H, H5″), 5.30 (br s, <sup>1</sup>H, NH), 3.50 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.1 Hz, 2H, H1′), 3.28 (m [app t], <i>’J’</i> = 5.1 Hz, 4H, C2/6) 2.92 (t, <i>J</i> = 6.6 Hz, 2H, H2′), 1.47–1.58 (m, 6H, H3/4/5). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz) δ 157.6 (CO or C4″), 155.6 (CO or C4″), 135.3 (C2″) 118.1 (C5″) 44.7 (C2/6) 40.2 (C1′) 31.5 (C2′) 25.5 (C3/5), 24.3 (C4). LCMS (ESI) <i>m</i>/<i>z</i>: 306 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_140" class="NLM_sec NLM_sec_level_3"><div id="ac_i181" class="anchor-spacer"></div><h4 class="article-section__title" id="_i181"> 3-(2-(2-Bromothiazol-4-yl)ethyl)-1,1-diethylurea (<b>63b</b>)</h4><div class="NLM_p last">A stirred solution of crude <b>62</b>, prepared as described for <b>63a</b> from <b>58</b> (100 mg, 0.297 mmol) in EtOAc (5 mL), was treated with NEt<sub>3</sub> (1 mL) and diethylcarbamoyl chloride (0.113 mL, 0.890 mmol) and heated under reflux for 1 h. The reaction mixture was allowed to cool, then diluted with water (30 mL) and extracted with EtOAc (3 × 20 mL). The extract was washed with brine (3 × 30 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give a yellow oil (150 mg), which was purified by flash chromatography. Elution with cyclohexane/EtOAc 1:1 to 3:7) afforded <b>63b</b> as a colorless oil (50 mg, 55%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 6.94 (s, 1H, H5′), 5.19 (br s, 1H, NH), 3.52 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.9 Hz, 2H, H1), 3.23 (q, <i>J</i> = 7.1 Hz, 4H, NCH<sub>2</sub>), 2.93 (t, <i>J</i> = 6.2 Hz, 2H, C2), 1.10 (t, <i>J</i> = 7.1 Hz, 6H, CH<sub>3</sub>. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz) δ 157.2 (C═O or C4′) 155.8 (C═O or C4′) 135.3 (C2′) 118.1 (C5′) 41.1 (2 × NCH<sub>2</sub>), 40.0 (C1), 31.5 (2), 13.8 (2 × CH<sub>3</sub>). LCMS (ESI) <i>m</i>/<i>z</i>: 306 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_141" class="NLM_sec NLM_sec_level_3"><div id="ac_i182" class="anchor-spacer"></div><h4 class="article-section__title" id="_i182"> Isopropyl [(2-(2-bromothiazol-4-yl)ethyl])carbamate (<b>63c</b>)</h4><div class="NLM_p last">Crude <b>62</b>, prepared as described for <b>63a</b> from <b>58</b> (200 mg, 0.593 mmol), was dissolved in EtOAc (50 mL) and treated with NEt<sub>3</sub> (2 mL) and a 1 M solution of isopropyl chloroformate in toluene (0.89 mL, 890 mmol). The reaction mixture was stirred for 4 h at 60 °C, at which point TLC showed the reaction to be incomplete. Additional NEt<sub>3</sub> (1 mL) and isopropyl chloroformate solution (0.59 mL, 0.59 mmol) were added, and the reaction mixture was stirred at 60 °C for 2 h, then cooled in an ice bath and filtered. The filtrate was washed with water (2 × 30 mL) and brine (2 × 30 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give a yellow oil (100 mg), which was purified by flash chromatography. Elution with cyclohexane/EtOAc 1:0 to 7:3) afforded <b>63c</b> as a colorless oil (25 mg, 14%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 6.94 (s, 1H, H5′), 4.90 (m, 1H, OCH), 3.52 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 5.9 Hz, 2H, H1), 2.94 (t, <i>J</i> = 6.5 Hz, 2H, H2), 1.21 (d, <i>J</i> = 6.3 Hz, 6H, CH<sub>3</sub>). LCMS (ESI) <i>m</i>/<i>z</i> = 293 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_142" class="NLM_sec NLM_sec_level_3"><div id="ac_i183" class="anchor-spacer"></div><h4 class="article-section__title" id="_i183"> <i>N</i>-(2-(2-Bromothiazol-4-yl)ethyl)-3,5-difluorobenzamide (<b>63d</b>)</h4><div class="NLM_p last">Crude <b>62</b>, prepared as described for <b>63a</b> from <b>58</b> (200 mg, 0.593 mmol), was dissolved in EtOAc (5 mL) and treated with NEt<sub>3</sub> (0.5 mL) and 3,5-difluorobenzoyl chloride (314 mg, 1.78 mmol). The reaction mixture was stirred for 12 h then cooled in an ice bath before being filtered. The filtrate was diluted with EtOac (20 mL) and washed with water (2 × 30 mL) and brine (2 × 30 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give a yellow solid (600 mg), which was purified by flash chromatography. Elution with cyclohexane/EtOAc (1:0 to 7:3) afforded <b>63d</b> as a yellow solid (120 mg, 58%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 7.51 (br s, 1H, NH), 7.29–7.34 (m, 2H, H1/6), 6.99 (s, 1H, H5″); 6.88–6.93 (m, 1H, H4), 3.73 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.0 Hz, 2H, C2′); 3.03 (t, <i>J</i> = 6.2 Hz, 2H, C1′). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz) δ 164.9 (CO), 162.8 (dd, <i>J</i> = 250, 12 Hz, 2 × CF), 154.7 (C4″), 137.8 (t, <i>J</i> = 8 Hz, C1), 135.9 (CBr),118.5 (C5″), 110.2 (dd, <i>J</i> = 18, 8 Hz, C2/6), 106.6 (t, <i>J</i> = 25 Hz, C4), 39.4 (C1′), 30.5 (C2′). LCMS (ESI) <i>m</i>/<i>z</i>: 347 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_143" class="NLM_sec NLM_sec_level_3"><div id="ac_i184" class="anchor-spacer"></div><h4 class="article-section__title" id="_i184"> <i>N</i>-(2-(2-(2,4-Difluorophenyl)thiazol-4-yl)ethyl)piperidine-1-carboxamide (<b>64a</b>)</h4><div id="sec3_2_143_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i185" class="anchor-spacer"></div><h5 class="article-section__title" id="_i185"> Method A</h5><div class="NLM_p last">Prepared from <b>60d</b> (0.060 g, 0.179 mmol) as described for <b>61a</b>. Elution with 3:2 EtOAc/hexanes then EtOAc gave <b>64a</b> as a pale-amber solid (0.040 g, 64%), mp = 68–70 °C. IR (cm<sup>–1</sup>): 3341 (NH), 1614 (C═O). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.19 (ddd [app dt], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 8.5 Hz, <i>J</i><sub>3</sub> = 6.4 Hz, 1H, H6‴), 7.08 (s, 1H, H5″), 6.91–6.99 (m, 2H, H3‴/H5‴), 5.50 (br s, 1H, NH), 3.58 (dt [app, q], <i>J</i> = 6.0 Hz, 2H, H1′), 3.32 (m [pseudo t], 4H, H2/H6), 2.99 (t, <i>J</i><sub>1</sub> = 6.2 Hz, 2H, H2′), 1.47–1.59 (m, 6H, H3/H4/H5). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 163.6 (dd, <i>J</i> = 203, 10 Hz, CF), 160.2 (dd, <i>J</i> = 205, 10 Hz, CF), 159.8 (d, <i>J</i> = 5 Hz, C2″), 157.9 (C═O or C4″), 155.2 (C═O or C4″), 129.9 (dd, <i>J</i> = 8, 3 Hz, C6‴), 118.2 (d, <i>J</i> = 9 Hz, C1‴), 115.8 (d, <i>J</i> = 6 Hz, C5″), 112.2 (dd, <i>J</i> = 17, 3 Hz, C5‴), 104.7 (dd [app t], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 21 Hz, C3‴), 45.0 (C2/C6), 40.7 (C1′), 31.4 (C2′), 25.7 (C3/C5), 24.6 (C4). HRMS (ESI) <i>m</i>/<i>z</i> observed: 352.1309, C<sub>17</sub>H<sub>20</sub>N<sub>3</sub>OF<sub>2</sub>S<sup>+</sup> [M + H]<sup>+</sup> requires 352.1295.</div></div><div id="sec3_2_143_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i186" class="anchor-spacer"></div><h5 class="article-section__title" id="_i186"> Method B</h5><div class="NLM_p last">A mixture of <b>63a</b> (600 mg, 1.89 mmol), K<sub>2</sub>CO<sub>3</sub> (1.04 g, 7.54 mmol), (2,4-difluorophenyl)boronic acid (417 mg, 2.64 mmol), TBAB (61 mg, 10 mol %), PdCl<sub>2</sub>(dppf) (97 mg, 5 mol %), and 4:1 dioxane/water (20 mL) in a microwave reactor vessel was irradiated in a microwave at 110 °C (3 bar) for 1 h. The reaction mixture was cooled and diluted with EtOAc (30 mL), washed with water (2 × 25 mL) and brine (2 × 25 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give a brown oil (970 mg), which was purified by flash chromatography. Elution with cyclohexane/EtOAc 8:2 to 6:4) afforded <b>64a</b> as a brown solid (480 mg, 72%), identical with the material described above.</div></div></div><div id="sec3_2_144" class="NLM_sec NLM_sec_level_3"><div id="ac_i187" class="anchor-spacer"></div><h4 class="article-section__title" id="_i187"> 3-(2-(2-(2,4-Difluorophenyl)thiazol-4-yl)ethyl)-1,1-diethylurea (<b>64b</b>)</h4><div class="NLM_p last">A mixture of <b>63b</b> (50 mg, 0.16 mmol), K<sub>2</sub>CO<sub>3</sub> (90 mg, 0.65 mmol), (2,4-difluorophenyl)boronic acid (31 mg, 0.20 mmol), TBAB (5 mg, 10 mol %), PdCl<sub>2</sub>(dppf) (6 mg, 5 mol %), and 4:1 dioxane/water (5 mL) in a microwave reactor vessel was irradiated in a microwave at 120 °C (3 bar) for 45 min The reaction mixture was cooled and diluted with EtOAc (10 mL), washed with water (2 × 15 mL) and brine (2 × 15 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give a brown oil (55 mg), which was purified by flash chromatography. Elution with cyclohexane/EtOAc (1:1 to 3:7) afforded <b>64b</b> as yellow oil (27 mg, 49%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.19–8.25 (m, <sup>1</sup>H, H6″), 7.09 (s, <sup>1</sup>H, H5′), 6.92–7.00 (m, 2H, H3″/5″), 5.22 (br s, <sup>1</sup>H, NH), 3.63 (dt [app, q], <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.0 Hz, 2H, H1), 3.24 (q, <i>J</i> = 7.1 Hz, 4H, NCH<sub>2</sub>), 3.04 (t, <i>J</i> = 6.1 Hz, 2H, H2), 1.08 (t, <i>J</i> = 7.3 Hz, 6H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz) δ 163.4 (dd, <i>J</i> = 255, 12 Hz, CF), 160.0 (dd, <i>J</i> = 255, 12 Hz, CF, CF), 159.5 (C2″), 157.2 (C═O or C4′), 155.2 (C═O or C4′), 129.8 (dd, <i>J</i> = 10, 4 Hz, C6‴), 118.1 (dd, <i>J</i> = 12, 4 Hz, C1‴), 115.6 (115.8 (d, <i>J</i> = 8 Hz, C5″), 112.0 (dd, <i>J</i> = 22, 4 Hz, C5‴), 104.5 (dd [app t], <i>J</i><sub>1</sub><i>= J</i><sub>2</sub> = 26 Hz, C3‴), 41.1 (2 × NCH<sub>2</sub>), 40.4 (C1), 31.4 (C2), 13.8 (2 × CH<sub>3</sub>). LCMS (ESI) <i>m</i>/<i>z</i> = 340 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_145" class="NLM_sec NLM_sec_level_3"><div id="ac_i188" class="anchor-spacer"></div><h4 class="article-section__title" id="_i188"> Isopropyl (2-(2-(2,4-Difluorophenyl)thiazol-4-yl)ethyl)carbamate (<b>64c</b>)</h4><div class="NLM_p last">A mixture of <b>63c</b> (25 mg, 0.085 mmol), K<sub>2</sub>CO<sub>3</sub> (47 mg, 0.34 mmol), (2,4-difluorophenyl)boronic acid (16 mg, 0.10 mmol), TBAB (5 mg, 10 mol %), PdCl<sub>2</sub>(dppf) (6 mg, 5 mol %), and 4:1 dioxane/water (5 mL) in a microwave reactor vessel was irradiated in a microwave at 110 °C (3 bar) for 1 h. The reaction mixture was cooled and diluted with EtOAc (30 mL), washed with water (2 × 25 mL) and brine (2 × 25 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give a brown oil (70 mg), which was purified by flash chromatography. Elution with cyclohexane/EtOAc 8:2 to 6:4) afforded <b>64c</b> as white solid (19 mg, 66%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.24–8.30 (m, 1H, H6″), 7.09 (s, 1H, H5′), 6.92–7.02 (m, 2H, H3′/H5′), 5.10 (br s,1H, NH), 4.92 (sept, <i>J</i> = 6.2 Hz, 1H, OCH), 3.58–3.63 (dt [app, q] <i>J</i><sub>1</sub> = <i>J</i><sub>2</sub> = 6.0 Hz, 2H, H1), 3.03 (t, <i>J</i> = 6.3 Hz, 2H, H2), 1.23 (d, <i>J</i> = 6.1 Hz, 6H, CH<sub>3</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz) δ 163.4 (dd, <i>J</i> = 255, 12 Hz, CF), 160.0 (dd, <i>J</i> = 255, 12 Hz, CF), 159.5 (C2′); 156.3 (C═O or C4′), 154.2 (C═O or C4′), 130.0 (dd, <i>J</i> = 10, 4 Hz, C6″), 118.0 (dd, <i>J</i> = 12, 4 Hz, C1″), 115.6 (d, <i>J</i> = 8 Hz, C5′), 112.1 (dd, <i>J</i> = 22, 4 Hz, C5″), 104.4 (dd [app t], <i>J</i><sub>1</sub><i>= J</i><sub>2</sub> = 26 Hz, C3″), 68.0 (OCH), 40.2 (C1), 31.5 (C2), 22.2 (2 × CH<sub>3</sub>). LCMS (ESI) <i>m</i>/<i>z</i>: 327 [M + H]<sup>+</sup>.</div></div><div id="sec3_2_146" class="NLM_sec NLM_sec_level_3"><div id="ac_i189" class="anchor-spacer"></div><h4 class="article-section__title" id="_i189"> <i>N</i>-(2-(2-(2,4-Difluorophenyl)thiazol-4-yl)ethyl)-3,5-difluorobenzamide (<b>64d</b>)</h4><div class="NLM_p last">A mixture of <b>63d</b> (120 mg, 0.346 mmol) (25 mg, 0.085 mmol), K<sub>2</sub>CO<sub>3</sub> (191 mg, 1.38 mmol) (47 mg, 0.34 mmol), (2,4-difluorophenyl)boronic acid (76 mg, 0.484 mmol), TBAB (11 mg, 10 mol %), PdCl<sub>2</sub>(dppf) (18 mg, 5 mol %), and 4:1 dioxane/water (5 mL) in a microwave reactor vessel was irradiated in a microwave at 110 °C (3 bar) for 1 h. The reaction mixture was cooled and diluted with EtOAc (10 mL), washed with water (2 × 15 mL) and brine (2 × 15 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated to give a brown oil (140 mg), which was purified by flash chromatography. Elution with cyclohexane then 6:4 cyclohexane/EtOAc afforded <b>64d</b> as white solid (96 mg, 73%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) δ 8.17–8.23 (m, 1H, H6‴), 7.85 (br s, 1H, NH), 7.35–7.37 (m, 2H, ArH); 7.14 (s, 1H, H5″); 6.91–7.01 (m, 3H, ArH), 3.78–3.82 (m, 2H, H1′), 3.11 (t, <i>J</i> = 5.8 Hz, 2H, H2′). <sup>13</sup>C NMR (CDCl<sub>3</sub>, 101 MHz) δ 164.7 (t, <i>J</i> = 3 Hz, C═O), 163.5 (dd, <i>J</i> = 255, 12 Hz, C2‴F or C4‴F), 162.9 (<i>J</i> = 251, 12 Hz, C3F/C5F), 160.2 (dd, <i>J</i> = 6, 2 Hz, C2″), 160.0 (dd, <i>J</i> = 256, 12 Hz, C2‴F or C4‴F), 154.4 (C4″), 138.2 (t, <i>J</i> = 8 Hz, C1), 129.6 (dd, <i>J</i> = 10, 4 Hz, C6‴) 117.7 (dd, <i>J</i> = 12, 3 Hz, C1‴), 115.9 (d, <i>J</i> = 8 Hz, C5″), 112.2 (dd, <i>J</i> = 22, 4 Hz, C5‴), 110.3 (AA′X<sub>2</sub>, ∼ <i>J</i> = 19, 7 Hz, C2/6), 106.6 (t or dd [app t], <i>J</i> = 26 Hz, C4 or C3‴), 104.6 (t or dd [app t], <i>J</i> = 26 Hz, C4 or C3‴), 39.8 (C1′), 30.2 (C2′). LCMS (ESI) <i>m</i>/<i>z</i>: 381 [M + H]<sup>+</sup>.</div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i190" class="anchor-spacer"></div><h3 class="article-section__title" id="_i190"> In Vivo Anti-<i>T. cruzi</i> Activity Assessment</h3><div class="NLM_p last">Trypomastigote forms from transgenic <i>T. cruzi</i> Brazil strain expressing firefly luciferase<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> were purified, diluted in PBS, and injected ip in Balb/c mice (10<sup>7</sup> trypomastigotes per mouse). Four days after infection, the mice were anesthesized by inhalation of isofluorane (controlled flow of 1.5% isofluorane in air was administered through a nose cone via a gas anesthesia system). Mice were injected intraperitonealy with 150 mg/kg of <span class="smallcaps smallerCapital">d</span>-luciferin potassium salt (Goldbio) dissolved in PBS. Mice were imaged 5–10 min after injection of luciferin with an IVIS 100 (Xenogen, Alameda, CA), and the data acquisition and analysis were performed with the software LivingImage (Xenogen). One day later (5 days after infection), treatments started in three groups of mice. Group 1, vehicle alone (PBS with 2% methylcellulose and 0.5% Tween 80, administered by oral gavage); group 2, ABT (50 mg/kg 2× daily, administered intraperitonealy) and compound <b>64a</b> (50 mg/kg 2 × daily 30 min later, administered by oral gavage); group 3, benznidazole (100 mg/kg once daily administered by oral gavage). Treatments were continued for 10 days. On the days indicated in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, mice were imaged again after anesthesia and injection of luciferin as described above. Parasite load is expressed as the luciferase signal in arbitrary units. Mean values of all animals in each group ± SD were calculated. Immune-suppression was started 30 days after the last day of treatment. Mice were treated with cyclophosphamide (200 mg/kg once every 2–3 days, five doses total) and imaged 10 days after beginning of cyclophosphamide treatment.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i191"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00442">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23075" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23075" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00442" class="ext-link">10.1021/acs.jmedchem.6b00442</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SAR summary diagram, exemplar compound numbering schemes, intracellular <i>T. cruzi</i> rate-of-kill profiles, and comparison with related regioisomers (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00442/suppl_file/jm6b00442_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00442/suppl_file/jm6b00442_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00442/suppl_file/jm6b00442_si_001.pdf">jm6b00442_si_001.pdf (197.13 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00442/suppl_file/jm6b00442_si_002.csv">jm6b00442_si_002.csv (8.64 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00442" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50822" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50822" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raphaël Rahmani</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1a687b6a727b7f7634687b72777b74735a7775747b6972347f7e6f"><span class="__cf_email__" data-cfemail="f18390819990949ddf8390999c909f98b19c9e9f908299df949584">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan B. Baell</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#23494c4d42574b424d0d4142464f4f634e4c4d42504b0d464756"><span class="__cf_email__" data-cfemail="8be1e4e5eaffe3eae5a5e9eaeee7e7cbe6e4e5eaf8e3a5eeeffe">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew J. Piggott</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry and Biochemistry, The University
of Western Australia, 35 Stirling Highway, Crawley, Perth 6009, Western Australia, Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d9b4b8adadb1bcaef7a9b0bebeb6adad99acaeb8f7bcbdacf7b8ac"><span class="__cf_email__" data-cfemail="3b565a4f4f535e4c154b525c5c544f4f7b4e4c5a155e5f4e155a4e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephanie Russell</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry and Biochemistry, The University
of Western Australia, 35 Stirling Highway, Crawley, Perth 6009, Western Australia, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amy J. Jones</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Brisbane Innovation Park, Don Young
Road, Nathan, Queensland 4111, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harriet L. Newson</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry and Biochemistry, The University
of Western Australia, 35 Stirling Highway, Crawley, Perth 6009, Western Australia, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Neilde</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 28760 Tres Cantos, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ignacio Cotillo</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 28760 Tres Cantos, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marzieh Rahmani Khajouei</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry and Biochemistry, The University
of Western Australia, 35 Stirling Highway, Crawley, Perth 6009, Western Australia, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lori Ferrins</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sana Qureishi</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry and Biochemistry, The University
of Western Australia, 35 Stirling Highway, Crawley, Perth 6009, Western Australia, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nghi Nguyen</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria S. Martinez-Martinez</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 28760 Tres Cantos, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald F. Weaver</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Dalhousie University, Halifax Nova Scotia B3H 4R2, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcel Kaiser</span> - <span class="hlFld-Affiliation affiliation">Swiss Tropical
and Public Health Institute, Socinstrasse, 4051 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Basel, Petesplatz
1, 4003 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Riley</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, DD1 5EH Dundee, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Thomas</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, DD1 5EH Dundee, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manu De Rycker</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, DD1 5EH Dundee, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin D. Read</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Division of Biological Chemistry and Drug Discovery,
School of Life Sciences, University of Dundee, DD1 5EH Dundee, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gavin R. Flematti</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry and Biochemistry, The University
of Western Australia, 35 Stirling Highway, Crawley, Perth 6009, Western Australia, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eileen Ryan</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drug Candidate Optimisation, Monash
University, Parkville, Victoria 3052, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Tanghe</span> - <span class="hlFld-Affiliation affiliation">Anti-Infectives
Screening Core, New York University School
of Medicine, New York, New York 10010, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana Rodriguez</span> - <span class="hlFld-Affiliation affiliation">Anti-Infectives
Screening Core, New York University School
of Medicine, New York, New York 10010, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan A. Charman</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
for Drug Candidate Optimisation, Monash
University, Parkville, Victoria 3052, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Albane Kessler</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline, 28760 Tres Cantos, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vicky M. Avery</span> - <span class="hlFld-Affiliation affiliation">Eskitis
Institute for Drug Discovery, Griffith University, Brisbane Innovation Park, Don Young
Road, Nathan, Queensland 4111, Australia</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">All animal studies were ethically reviewed and carried out in accordance with Animals (Scientific Procedures) Act 1986 and the GSK Policy on the Care, Welfare and Treatment of Animals.<br /></br>The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e15109-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i194">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02534" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02534" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by the National Health and Medical Research Council of Australia (NHMRC), IRIISS grant no. 361646; NHMRC senior research fellowship 1020411 (J.B.B.), NHMRC project grant 1025581; NHMRC project grant 1079351; Victorian State Government OIS grant; the Tres Cantos Open Lab Foundation, Project grant TC150. M.d.R., K.R., and J.T. are supported by a Wellcome Trust Strategic grant 100476. We acknowledge the University of Western Australia for Ph.D. stipends (S.J.R., H.N.) and an international postgraduate student tuition fee waiver (S.J.R.) and the Australian Government for an Australian Postgraduate Award (L.F.). We thank Dr. Jason Dang for his assistance in obtaining some of the analytical data and DND<i>i</i> for allowing access to their parasite screening platform at STPHI. The assistance of Drs. Lindsay Byrne, Campbell Mackenzie, and Anthony Reeder of the Centre for Microscopy, Characterisation, and Analysis, UWA, is also gratefully acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i195" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i195"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i196" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i196"> Abbreviations Used</h2><tr><td class="NLM_term">ABT</td><td class="NLM_def"><p class="first last">1-aminobenzotriazole</p></td></tr><tr><td class="NLM_term">app</td><td class="NLM_def"><p class="first last">apparent (NMR signal multiplicity)</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">b</td><td class="NLM_def"><p class="first last">brucei</p></td></tr><tr><td class="NLM_term">br</td><td class="NLM_def"><p class="first last">broad (spectral)</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">carbonyldimidazole</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">peak plasma concentration</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub>_D</td><td class="NLM_def"><p class="first last"><i>C</i><sub>max</sub> divided by dose</p></td></tr><tr><td class="NLM_term">DALYs</td><td class="NLM_def"><p class="first last">disability-adjusted life years</p></td></tr><tr><td class="NLM_term">DCU</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-dicyclohexylurea</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DNAUC</td><td class="NLM_def"><p class="first last">oral dose-normalized AUC</p></td></tr><tr><td class="NLM_term">DNDi</td><td class="NLM_def"><p class="first last">Drugs for Neglected Diseases Initiative</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′-bis(diphenylphosphino)ferrocene</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term"><i>E</i><sub>H</sub></td><td class="NLM_def"><p class="first last">hepatic extraction ratio</p></td></tr><tr><td class="NLM_term">GSK</td><td class="NLM_def"><p class="first last">GlaxoSmithKline</p></td></tr><tr><td class="NLM_term">HAT</td><td class="NLM_def"><p class="first last">human African trypanosomiasis</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last"><i>N</i>-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">LHS</td><td class="NLM_def"><p class="first last">left-hand side (as drawn)</p></td></tr><tr><td class="NLM_term">LRMS</td><td class="NLM_def"><p class="first last">low resolution mass spectrum/spectrometry</p></td></tr><tr><td class="NLM_term">μw</td><td class="NLM_def"><p class="first last">microwave irradiation</p></td></tr><tr><td class="NLM_term">M</td><td class="NLM_def"><p class="first last">molecule (mass spectrometry)</p></td></tr><tr><td class="NLM_term">MPO</td><td class="NLM_def"><p class="first last">multiparameter optimization (score)</p></td></tr><tr><td class="NLM_term">NECT</td><td class="NLM_def"><p class="first last">nifurtimox/eflornithine combination therapy</p></td></tr><tr><td class="NLM_term">PAINS</td><td class="NLM_def"><p class="first last">pan assay interference compounds</p></td></tr><tr><td class="NLM_term">Phth</td><td class="NLM_def"><p class="first last">phthalimidyl</p></td></tr><tr><td class="NLM_term">RHS</td><td class="NLM_def"><p class="first last">right-hand side (as drawn)</p></td></tr><tr><td class="NLM_term">SI</td><td class="NLM_def"><p class="first last">selectivity index</p></td></tr><tr><td class="NLM_term">S<sub>N</sub>Ar</td><td class="NLM_def"><p class="first last">nucleophilic aromatic substitution</p></td></tr><tr><td class="NLM_term">T</td><td class="NLM_def"><p class="first last">Trypanosoma</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>max</sub></td><td class="NLM_def"><p class="first last">time to peak plasma concentration</p></td></tr><tr><td class="NLM_term">UDPGA</td><td class="NLM_def"><p class="first last">uridine 5′-diphosphoglucuronic acid</p></td></tr><tr><td class="NLM_term">WEHI</td><td class="NLM_def"><p class="first last">Walter and Eliza Hall Institute</p></td></tr><tr><td class="NLM_term">quant</td><td class="NLM_def"><p class="first last">quantitative</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i197">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05738" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05738" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 94 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>Trypanosomiasis, Human African (Sleeping Sickness), Fact Sheet; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.who.int/mediacentre/factsheets/fs259/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs259/en/</a> (accessed March 21, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Trypanosomiasis%2C+Human+African+%28Sleeping+Sickness%29%2C+Fact+Sheet%3B+World+Health+Organization%3A+Geneva%2C+2016%3B+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs259%2Fen%2F+%28accessed+March+21%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DTrypanosomiasis%252C%2520Human%2520African%2520%2528Sleeping%2520Sickness%2529%252C%2520Fact%2520Sheet%26pub%3DWorld%2520Health%2520Organization%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span>Chagas Disease (American Trypanosomiasis), Fact Sheet; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.who.int/mediacentre/factsheets/fs340/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs340/en/</a> (accessed March 21, 2106).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chagas+Disease+%28American+Trypanosomiasis%29%2C+Fact+Sheet%3B+World+Health+Organization%3A+Geneva%2C+2016%3B+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs340%2Fen%2F+%28accessed+March+21%2C+2106%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DChagas%2520Disease%2520%2528American%2520Trypanosomiasis%2529%252C%2520Fact%2520Sheet%26pub%3DWorld%2520Health%2520Organization%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Willyard, C.</span><span> </span><span class="NLM_article-title">Putting sleeping sickness to bed</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1038/nm0111-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1038%2Fnm0111-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=21217663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFWnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=14-17&author=C.+Willyard&title=Putting+sleeping+sickness+to+bed&doi=10.1038%2Fnm0111-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Putting sleeping sickness to bed</span></div><div class="casAuthors">Willyard, Cassandra</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-17</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">For most people, a single bite from a parasite-infected tsetse fly can trigger a slow, agonizing and sometimes fatal disease known as African sleeping sickness.  But new research shows that some people, as well as baboons and other great apes, are naturally resistant to infection.  Cassandra Willyard awakens to the possibility of using existing immunity to engineer new therapies and transgenic livestock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZo0JS5fan97Vg90H21EOLACvtfcHk0lhxHLsgQXgdDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFWnsQ%253D%253D&md5=b81f90a3257acde2f22cbd1843abba5e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm0111-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0111-14%26sid%3Dliteratum%253Aachs%26aulast%3DWillyard%26aufirst%3DC.%26atitle%3DPutting%2520sleeping%2520sickness%2520to%2520bed%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D14%26epage%3D17%26doi%3D10.1038%2Fnm0111-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span>East African Trypanosomiasis FAQs; <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.cdc.gov/parasites/sleepingsickness/gen_info/faqs-east.html" class="extLink">http://www.cdc.gov/parasites/sleepingsickness/gen_info/faqs-east.html</a> (accessed March 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=East+African+Trypanosomiasis+FAQs%3B+Centers+for+Disease+Control+and+Prevention%3A+Atlanta%2C+GA%2C+2012%3B+http%3A%2F%2Fwww.cdc.gov%2Fparasites%2Fsleepingsickness%2Fgen_info%2Ffaqs-east.html+%28accessed+March+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DEast%2520African%2520Trypanosomiasis%2520FAQs%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2012%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span>West African Trypanosomiasis FAQs; <span class="NLM_publisher-name">Centers for Disease Control</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.cdc.gov/parasites/sleepingsickness/gen_info/faqs-west.html" class="extLink">http://www.cdc.gov/parasites/sleepingsickness/gen_info/faqs-west.html</a> (accessed March 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=West+African+Trypanosomiasis+FAQs%3B+Centers+for+Disease+Control%3A+Atlanta%2C+GA%2C+2012%3B+http%3A%2F%2Fwww.cdc.gov%2Fparasites%2Fsleepingsickness%2Fgen_info%2Ffaqs-west.html+%28accessed+March+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DWest%2520African%2520Trypanosomiasis%2520FAQs%26pub%3DCenters%2520for%2520Disease%2520Control%26date%3D2012%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Naghavi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollset, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozgoren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdalla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abd-Allah, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel, A. MI.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboyans, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abuabara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abubakar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu-Raddad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu-Rmeileh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achoki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelekan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ademi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adofo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adsuar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ärnlov, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agardh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akena, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al Khabouri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alasfoor, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albittar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alegretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alemu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso-Cristancho, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alhabib, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al Lami, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allebeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">AlMazroa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shahi Salman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsharif, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alviz-Guzman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amankwaa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amare, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameli, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amini, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apfel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argeseanu Cunningham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arsic Arsenijevic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artaman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asghar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assadi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badawi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakfalouni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakrishnan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balalla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker-Collo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barquera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barregard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrientos-Gutierrez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basulaiman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beardsley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beghi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekele, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benjet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensenor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi-Villa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyene, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhala, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhutta, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikbov, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bin Abdulhak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biryukov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blyth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohensky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boufous, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brainin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brazinova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitborde, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukhman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, N. IR.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carabin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cárdenas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carapetis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caso, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castañeda-Orjuela, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalá-López, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalleri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimed-Ochir, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chugh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coggeshall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colistro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colquhoun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colomar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortinovis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courville, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criqui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuevas-Nasu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Costa Leite, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabhadkar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandona, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandona, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dargan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De la Cruz-Góngora, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Vega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Leo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degenhardt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Pozo-Cruz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellavalle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deribe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Des Jarlais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessalegn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deVeber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharmaratne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dherani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Ortega, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Torne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durrani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmond, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellenbogen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elshrek, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermakov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erskine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eshrati, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteghamati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estep, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fürst, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahimi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farzadfar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feigl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feigin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felicio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fereshtehnejad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foigt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forouzanfar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowkes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paleo, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaffikin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambashidze, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gankpé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Guerra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geleijnse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibney, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmour, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginawi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giroud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goenka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez Dantes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gona, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Medina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guinovart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graetz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gugnani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunnell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutiérrez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haagsma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafezi-Nejad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagstromer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halasa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamadeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamavid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hankey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harewood, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havmoeller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedayati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heredia, P. IB</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heydarpour, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hijar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosgood, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hossain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsairi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husseini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannarone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iburg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idrisov, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islami, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismayilova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jassal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jha, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabagambe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karimkhani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karthikeyan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassebaum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazanjan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kengne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kereselidze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khader, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalifa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieling, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinfu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivipelto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knibbs, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotagal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kravchenko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuate, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuipers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucuk, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakshmana, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalloo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallukka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansingh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavados, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrynowicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leasher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leigh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leinsalu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lima, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipshultz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lofgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logroscino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lortet-Tieulent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotufo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunevicius, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machado, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLachlan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magis-Rodriguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahdi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majdan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malekzadeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangalam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mapoma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marape, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcenes, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margono, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masci, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mashal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masiye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason-Jones, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzopolous, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazorodze, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meaney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehndiratta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mejia-Rodriguez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melaku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Memish, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meretoja, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mhimbira, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misganaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffitt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed Ibrahim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokdad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monasta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monis, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montañez Hernandez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradi-Lakeh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschandreas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moturi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mozaffarian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaigawara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullany, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustapha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naghavi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naheed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naidoo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nangia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nejjari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuhouser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neupane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngalesoni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norheim, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norrving, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyakarahuka, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olusanya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orisakwe, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortblad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otayza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panelo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panniyammakal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papachristou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paternina Caicedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peresson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Padilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Ruiz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perico, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervaiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesudovs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plass, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poenaru, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polinder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pourmalek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakaran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quezada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quistberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimi-Movaghar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakovac, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refaat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remuzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas-Rueda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronfani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Room, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothenbacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruhago, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rushton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambandam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Søreide, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeedi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahathevan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahraian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samonte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satpathy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawhney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saylan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöttker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwebel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepanlou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Servan-Mori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackelford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaheen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahraz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakh-Nazarova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangguan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikhbahaei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shishani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiue, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shivakoti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrime, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigfusdottir, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sindi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sioson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skirbekk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soljak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soneji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soshnikov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sposato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreeramareddy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanaway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathopoulou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steenland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stöckl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straif, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroumpoulis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturua, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunguya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaroop, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talongwa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavakkoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Templin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenkorang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terkawi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorne-Lyman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thrift, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurston, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirschwell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tleyjeh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topouzis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Towbin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truelsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trillini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsala, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsilimbaris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuzcu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubeda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchendu, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukwaja, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Undurraga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallely, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Vijver, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gool, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varakin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasankari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasconcelos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vavilala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venketasubramanian, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayakumar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalpando, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Violante, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlassov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warouw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weichenthal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiderpass, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weintraub, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzhi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werdecker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessells, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteford, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woldeyohannes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatsuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonemoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun Jin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaki Mel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamakhshary, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeeb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonies, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GBD 2013 Mortality and Causes of Death Collaborators</span><span> </span><span class="NLM_article-title">Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1016/S0140-6736(14)61682-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0140-6736%2814%2961682-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2015&pages=117-171&author=M.+Naghaviauthor=H.+Wangauthor=R.+Lozanoauthor=A.+Davisauthor=X.+Liangauthor=M.+Zhouauthor=S.+Vollsetauthor=A.+Ozgorenauthor=S.+Abdallaauthor=F.+Abd-Allahauthor=A.+MI.+Abdelauthor=S.+Aberaauthor=V.+Aboyansauthor=B.+Abrahamauthor=J.+Abrahamauthor=K.+Abuabaraauthor=I.+Abubakarauthor=L.+Abu-Raddadauthor=N.+Abu-Rmeilehauthor=T.+Achokiauthor=A.+Adelekanauthor=Z.+Ademiauthor=K.+Adofoauthor=A.+Adouauthor=J.+Adsuarauthor=J.+%C3%84rnlovauthor=E.+Agardhauthor=D.+Akenaauthor=M.+Al+Khabouriauthor=D.+Alasfoorauthor=M.+Albittarauthor=M.+Alegrettiauthor=A.+Alemanauthor=Z.+Alemuauthor=R.+Alfonso-Cristanchoauthor=S.+Alhabibauthor=M.+Aliauthor=R.+Aliauthor=F.+Allaauthor=F.+Al+Lamiauthor=P.+Allebeckauthor=M.+AlMazroaauthor=R.+Al-Shahi+Salmanauthor=U.+Alsharifauthor=E.+Alvarezauthor=N.+Alviz-Guzmanauthor=A.+Amankwaaauthor=A.+Amareauthor=O.+Ameliauthor=H.+Aminiauthor=W.+Ammarauthor=H.+Andersonauthor=B.+Andersonauthor=C.+Antonioauthor=P.+Anwariauthor=H.+Apfelauthor=S.+Argeseanu+Cunninghamauthor=V.+Arsic+Arsenijevicauthor=A.+Artamanauthor=M.+Asadauthor=R.+Asgharauthor=R.+Assadiauthor=L.+Atkinsauthor=C.+Atkinsonauthor=A.+Badawiauthor=M.+Bahitauthor=T.+Bakfalouniauthor=K.+Balakrishnanauthor=S.+Balallaauthor=A.+Banerjeeauthor=R.+Barberauthor=S.+Barker-Colloauthor=S.+Barqueraauthor=L.+Barregardauthor=L.+Barreroauthor=T.+Barrientos-Gutierrezauthor=A.+Basuauthor=S.+Basuauthor=M.+Basulaimanauthor=J.+Beardsleyauthor=N.+Bediauthor=E.+Beghiauthor=T.+Bekeleauthor=M.+Bellauthor=C.+Benjetauthor=D.+Bennettauthor=I.+Bensenorauthor=H.+Benzianauthor=A.+Bertozzi-Villaauthor=T.+Beyeneauthor=N.+Bhalaauthor=A.+Bhallaauthor=Z.+Bhuttaauthor=B.+Bikbovauthor=A.+Bin+Abdulhakauthor=S.+Biryukovauthor=J.+Bloreauthor=F.+Blythauthor=M.+Bohenskyauthor=G.+Borgesauthor=D.+Boseauthor=S.+Boufousauthor=R.+Bourneauthor=L.+Boyersauthor=M.+Braininauthor=M.+Brauerauthor=C.+Brayneauthor=A.+Brazinovaauthor=N.+Breitbordeauthor=H.+Brennerauthor=A.+Briggsauthor=J.+Brownauthor=T.+Brughaauthor=G.+Buckleauthor=L.+Buiauthor=G.+Bukhmanauthor=M.+Burchauthor=N.+IR.+Camposauthor=H.+Carabinauthor=R.+C%C3%A1rdenasauthor=J.+Carapetisauthor=D.+Carpenterauthor=V.+Casoauthor=C.+Casta%C3%B1eda-Orjuelaauthor=R.+Castroauthor=F.+Catal%C3%A1-L%C3%B3pezauthor=F.+Cavalleriauthor=J.+Changauthor=F.+Charlsonauthor=X.+Cheauthor=H.+Chenauthor=Y.+Chenauthor=J.+Chenauthor=Z.+Chenauthor=P.+Chiangauthor=O.+Chimed-Ochirauthor=R.+Chowdhuryauthor=H.+Christensenauthor=C.+Christophiauthor=T.+Chuangauthor=S.+Chughauthor=M.+Cirilloauthor=M.+Coatesauthor=L.+Coffengauthor=M.+Coggeshallauthor=A.+Cohenauthor=V.+Colistroauthor=S.+Colquhounauthor=M.+Colomarauthor=L.+Cooperauthor=C.+Cooperauthor=L.+Coppolaauthor=M.+Cortinovisauthor=K.+Courvilleauthor=B.+Cowieauthor=M.+Criquiauthor=J.+Crumpauthor=L.+Cuevas-Nasuauthor=I.+da+Costa+Leiteauthor=K.+Dabhadkarauthor=L.+Dandonaauthor=R.+Dandonaauthor=E.+Dansereauauthor=P.+Darganauthor=A.+Dayamaauthor=V.+De+la+Cruz-G%C3%B3ngoraauthor=S.+de+la+Vegaauthor=D.+De+Leoauthor=L.+Degenhardtauthor=B.+del+Pozo-Cruzauthor=R.+Dellavalleauthor=K.+Deribeauthor=D.+Des+Jarlaisauthor=M.+Dessalegnauthor=G.+deVeberauthor=S.+Dharmaratneauthor=M.+Dheraniauthor=J.+Diaz-Ortegaauthor=C.+Diaz-Torneauthor=D.+Dickerauthor=E.+Dingauthor=K.+Dokovaauthor=E.+Dorseyauthor=T.+Driscollauthor=L.+Duanauthor=H.+Duberauthor=A.+Durraniauthor=B.+Ebelauthor=K.+Edmondauthor=R.+Ellenbogenauthor=Y.+Elshrekauthor=S.+Ermakovauthor=H.+Erskineauthor=B.+Eshratiauthor=A.+Esteghamatiauthor=K.+Estepauthor=T.+F%C3%BCrstauthor=S.+Fahimiauthor=A.+Fahrionauthor=E.+Faraonauthor=F.+Farzadfarauthor=D.+Fayauthor=A.+Feiglauthor=V.+Feiginauthor=M.+Felicioauthor=S.+Fereshtehnejadauthor=J.+Fernandesauthor=A.+Ferrariauthor=T.+Flemingauthor=N.+Foigtauthor=K.+Foremanauthor=M.+Forouzanfarauthor=F.+Fowkesauthor=U.+Paleoauthor=R.+Franklinauthor=N.+Futranauthor=L.+Gaffikinauthor=K.+Gambashidzeauthor=F.+Gankp%C3%A9author=F.+Garc%C3%ADa-Guerraauthor=A.+Garciaauthor=J.+Geleijnseauthor=B.+Gessnerauthor=K.+Gibneyauthor=R.+Gillumauthor=S.+Gilmourauthor=I.+Ginawiauthor=M.+Giroudauthor=E.+Glaserauthor=S.+Goenkaauthor=H.+Gomez+Dantesauthor=P.+Gonaauthor=D.+Gonzalez-Medinaauthor=C.+Guinovartauthor=R.+Guptaauthor=R.+Guptaauthor=R.+Gosselinauthor=C.+Gotayauthor=A.+Gotoauthor=H.+Goudaauthor=N.+Graetzauthor=K.+Greenwellauthor=H.+Gugnaniauthor=D.+Gunnellauthor=R.+Guti%C3%A9rrezauthor=J.+Haagsmaauthor=N.+Hafezi-Nejadauthor=H.+Haganauthor=M.+Hagstromerauthor=Y.+Halasaauthor=R.+Hamadehauthor=H.+Hamavidauthor=M.+Hammamiauthor=J.+Hancockauthor=G.+Hankeyauthor=G.+Hansenauthor=H.+Harbauthor=H.+Harewoodauthor=J.+Haroauthor=R.+Havmoellerauthor=R.+Hayauthor=S.+Hayauthor=M.+Hedayatiauthor=P.+IB+Herediaauthor=K.+Heutonauthor=P.+Heydarpourauthor=H.+Higashiauthor=M.+Hijarauthor=H.+Hoekauthor=H.+Hoffmanauthor=J.+Hornbergerauthor=H.+Hosgoodauthor=M.+Hossainauthor=P.+Hotezauthor=D.+Hoyauthor=M.+Hsairiauthor=G.+Huauthor=J.+Huangauthor=M.+Huffmanauthor=A.+Hughesauthor=A.+Husseiniauthor=C.+Huynhauthor=M.+Iannaroneauthor=K.+Iburgauthor=B.+Idrisovauthor=N.+Ikedaauthor=K.+Innosauthor=M.+Inoueauthor=F.+Islamiauthor=S.+Ismayilovaauthor=K.+Jacobsenauthor=S.+Jassalauthor=S.+Jayaramanauthor=P.+Jensenauthor=V.+Jhaauthor=G.+Jiangauthor=Y.+Jiangauthor=J.+Jonasauthor=J.+Josephauthor=K.+Juelauthor=E.+Kabagambeauthor=H.+Kanauthor=A.+Karchauthor=C.+Karimkhaniauthor=G.+Karthikeyanauthor=N.+Kassebaumauthor=A.+Kaulauthor=N.+Kawakamiauthor=K.+Kazanjanauthor=D.+Kaziauthor=A.+Kempauthor=A.+Kengneauthor=A.+Kerenauthor=M.+Kereselidzeauthor=Y.+Khaderauthor=S.+Khalifaauthor=E.+Khanauthor=G.+Khanauthor=Y.+Khangauthor=C.+Kielingauthor=Y.+Kinfuauthor=J.+Kingeauthor=D.+Kimauthor=S.+Kimauthor=M.+Kivipeltoauthor=L.+Knibbsauthor=A.+Knudsenauthor=Y.+Kokuboauthor=S.+Kosenauthor=M.+Kotagalauthor=M.+Kravchenkoauthor=S.+Krishnaswamiauthor=H.+Kruegerauthor=D.+B.+Kuateauthor=E.+Kuipersauthor=B.+B.+Kucukauthor=C.+Kulkarniauthor=V.+Kulkarniauthor=K.+Kumarauthor=R.+Kumarauthor=G.+Kwanauthor=H.+Kyuauthor=T.+Laiauthor=B.+A.+Lakshmanaauthor=R.+Lallooauthor=T.+Lallukkaauthor=H.+Lamauthor=Q.+Lanauthor=V.+Lansinghauthor=H.+Larsonauthor=A.+Larssonauthor=P.+Lavadosauthor=A.+Lawrynowiczauthor=J.+Leasherauthor=J.+Leeauthor=J.+Leighauthor=M.+Leinsaluauthor=R.+Leungauthor=C.+Levitzauthor=B.+Liauthor=Y.+Liauthor=Y.+Liauthor=C.+Liddellauthor=S.+Limauthor=G.+de+Limaauthor=M.+Lindauthor=S.+Lipshultzauthor=S.+Liuauthor=Y.+Liuauthor=B.+Lloydauthor=K.+Lofgrenauthor=G.+Logroscinoauthor=S.+Londonauthor=J.+Lortet-Tieulentauthor=P.+Lotufoauthor=R.+Lucasauthor=R.+Luneviciusauthor=R.+Lyonsauthor=S.+Maauthor=V.+Machadoauthor=M.+MacIntyreauthor=M.+Mackayauthor=J.+MacLachlanauthor=C.+Magis-Rodriguezauthor=A.+Mahdiauthor=M.+Majdanauthor=R.+Malekzadehauthor=S.+Mangalamauthor=C.+Mapomaauthor=M.+Marapeauthor=W.+Marcenesauthor=C.+Margonoauthor=G.+Marksauthor=M.+Marzanauthor=J.+Masciauthor=M.+Mashalauthor=F.+Masiyeauthor=A.+Mason-Jonesauthor=R.+Matzopolousauthor=B.+Mayosiauthor=T.+Mazorodzeauthor=J.+McGrathauthor=A.+McKayauthor=M.+McKeeauthor=A.+McLainauthor=P.+Meaneyauthor=M.+Mehndirattaauthor=F.+Mejia-Rodriguezauthor=Y.+Melakuauthor=M.+Meltzerauthor=Z.+Memishauthor=W.+Mendozaauthor=G.+Mensahauthor=A.+Meretojaauthor=F.+Mhimbiraauthor=T.+Millerauthor=E.+Millsauthor=A.+Misganawauthor=S.+Mishraauthor=C.+Mockauthor=T.+Moffittauthor=N.+Mohamed+Ibrahimauthor=K.+Mohammadauthor=A.+Mokdadauthor=G.+Molaauthor=L.+Monastaauthor=J.+L.+Monisauthor=J.+Monta%C3%B1ez+Hernandezauthor=M.+Monticoauthor=T.+Montineauthor=M.+Mooneyauthor=A.+Mooreauthor=M.+Moradi-Lakehauthor=A.+Moranauthor=R.+Moriauthor=J.+Moschandreasauthor=W.+Moturiauthor=M.+Moyerauthor=D.+Mozaffarianauthor=U.+Muellerauthor=M.+Mukaigawaraauthor=E.+Mullanyauthor=J.+Murrayauthor=A.+Mustaphaauthor=P.+Naghaviauthor=A.+Naheedauthor=K.+Naidooauthor=L.+Naldiauthor=D.+Nandauthor=V.+Nangiaauthor=K.+Narayanauthor=D.+Nashauthor=J.+Nasherauthor=C.+Nejjariauthor=R.+Nelsonauthor=M.+Neuhouserauthor=S.+Neupaneauthor=P.+Newcombauthor=L.+Newmanauthor=C.+Newtonauthor=M.+Ngauthor=F.+Ngalesoniauthor=G.+Nguyenauthor=N.+Nguyenauthor=M.+Nisarauthor=S.+Nolteauthor=O.+Norheimauthor=R.+Normanauthor=B.+Norrvingauthor=L.+Nyakarahukaauthor=S.+Odellauthor=M.+O%E2%80%99Donnellauthor=T.+Ohkuboauthor=S.+Ohnoauthor=B.+Olusanyaauthor=S.+Omerauthor=J.+Opioauthor=O.+Orisakweauthor=K.+Ortbladauthor=A.+Ortizauthor=M.+Otayzaauthor=A.+Painauthor=J.+Pandianauthor=C.+Paneloauthor=J.+Panniyammakalauthor=C.+Papachristouauthor=A.+Paternina+Caicedoauthor=S.+Pattenauthor=G.+Pattonauthor=V.+Paulauthor=B.+Pavlinauthor=N.+Pearceauthor=C.+Pellegriniauthor=D.+Pereiraauthor=S.+Peressonauthor=R.+Perez-Padillaauthor=F.+Perez-Ruizauthor=N.+Pericoauthor=A.+Pervaizauthor=K.+Pesudovsauthor=C.+Petersonauthor=M.+Petzoldauthor=B.+Phillipsauthor=D.+Phillipsauthor=M.+Phillipsauthor=D.+Plassauthor=F.+Pielauthor=D.+Poenaruauthor=S.+Polinderauthor=S.+Popovaauthor=R.+Poultonauthor=F.+Pourmalekauthor=D.+Prabhakaranauthor=D.+Qatoauthor=A.+Quezadaauthor=D.+Quistbergauthor=F.+Rabitoauthor=A.+Rafayauthor=K.+Rahimiauthor=V.+Rahimi-Movagharauthor=S.+Rahmanauthor=M.+Rajuauthor=I.+Rakovacauthor=S.+Ranaauthor=A.+Refaatauthor=G.+Remuzziauthor=A.+Ribeiroauthor=S.+Ricciauthor=P.+Riccioauthor=L.+Richardsonauthor=J.+Richardusauthor=B.+Robertsauthor=D.+Robertsauthor=M.+Robinsonauthor=A.+Rocaauthor=A.+Rodriguezauthor=D.+Rojas-Ruedaauthor=L.+Ronfaniauthor=R.+Roomauthor=G.+Rothauthor=D.+Rothenbacherauthor=D.+Rothsteinauthor=J.+Rowleyauthor=N.+Royauthor=G.+Ruhagoauthor=L.+Rushtonauthor=S.+Sambandamauthor=K.+S%C3%B8reideauthor=M.+Saeediauthor=S.+Sahaauthor=R.+Sahathevanauthor=M.+Sahraianauthor=B.+Sahleauthor=J.+Salomonauthor=D.+Salvoauthor=G.+Samonteauthor=U.+Sampsonauthor=J.+Sanabriaauthor=L.+Sandarauthor=I.+Santosauthor=M.+Satpathyauthor=M.+Sawhneyauthor=M.+Saylanauthor=P.+Scarboroughauthor=B.+Sch%C3%B6ttkerauthor=J.+Schmidtauthor=I.+Schneiderauthor=A.+Schumacherauthor=D.+Schwebelauthor=J.+Scottauthor=S.+Sepanlouauthor=E.+Servan-Moriauthor=K.+Shackelfordauthor=A.+Shaheenauthor=S.+Shahrazauthor=M.+Shakh-Nazarovaauthor=S.+Shangguanauthor=J.+Sheauthor=S.+Sheikhbahaeiauthor=D.+Shepardauthor=K.+Shibuyaauthor=Y.+Shinoharaauthor=K.+Shishaniauthor=I.+Shiueauthor=R.+Shivakotiauthor=M.+Shrimeauthor=I.+Sigfusdottirauthor=D.+Silberbergauthor=A.+Silvaauthor=E.+Simardauthor=S.+Sindiauthor=J.+Singhauthor=L.+Singhauthor=E.+Siosonauthor=V.+Skirbekkauthor=K.+Sliwaauthor=S.+Soauthor=M.+Soljakauthor=S.+Sonejiauthor=S.+Soshnikovauthor=L.+Sposatoauthor=C.+Sreeramareddyauthor=J.+Stanawayauthor=V.+Stathopoulouauthor=K.+Steenlandauthor=C.+Steinauthor=C.+Steinerauthor=A.+Stevensauthor=H.+St%C3%B6cklauthor=K.+Straifauthor=K.+Stroumpoulisauthor=L.+Sturuaauthor=B.+Sunguyaauthor=S.+Swaminathanauthor=M.+Swaroopauthor=B.+Sykesauthor=K.+Tabbauthor=K.+Takahashiauthor=R.+Talongwaauthor=F.+Tanauthor=D.+Tanneauthor=M.+Tannerauthor=M.+Tavakkoliauthor=B.+Aoauthor=C.+Teixeiraauthor=T.+Templinauthor=E.+Tenkorangauthor=A.+Terkawiauthor=B.+Thomasauthor=A.+Thorne-Lymanauthor=A.+Thriftauthor=G.+Thurstonauthor=T.+Tillmannauthor=D.+Tirschwellauthor=I.+Tleyjehauthor=M.+Tonelliauthor=F.+Topouzisauthor=J.+Towbinauthor=H.+Toyoshimaauthor=J.+Traebertauthor=B.+Tranauthor=T.+Truelsenauthor=U.+Trujilloauthor=M.+Trilliniauthor=D.+Z.+Tsalaauthor=M.+Tsilimbarisauthor=E.+Tuzcuauthor=C.+Ubedaauthor=U.+Uchenduauthor=K.+Ukwajaauthor=E.+Undurragaauthor=A.+Vallelyauthor=S.+van+de+Vijverauthor=C.+van+Goolauthor=Y.+Varakinauthor=T.+Vasankariauthor=A.+Vasconcelosauthor=M.+Vavilalaauthor=N.+Venketasubramanianauthor=L.+Vijayakumarauthor=S.+Villalpandoauthor=F.+Violanteauthor=V.+Vlassovauthor=G.+Wagnerauthor=S.+Wallerauthor=J.+Wangauthor=L.+Wangauthor=X.+Wangauthor=Y.+Wangauthor=T.+Warouwauthor=S.+Weichenthalauthor=E.+Weiderpassauthor=R.+Weintraubauthor=W.+Wenzhiauthor=A.+Werdeckerauthor=K.+Wessellsauthor=R.+Westermanauthor=H.+Whitefordauthor=J.+Wilkinsonauthor=T.+Williamsauthor=S.+Woldeyohannesauthor=C.+Wolfeauthor=T.+Wolockauthor=A.+Woolfauthor=J.+Wongauthor=J.+Wrightauthor=S.+Wulfauthor=B.+Wurtzauthor=G.+Xuauthor=Y.+Yangauthor=Y.+Yanoauthor=H.+Yatsuyaauthor=P.+Yipauthor=N.+Yonemotoauthor=S.+Yoonauthor=M.+Younisauthor=C.+Yuauthor=K.+Yun+Jinauthor=S.+Zaki+Melauthor=M.+Zamakhsharyauthor=H.+Zeebauthor=Y.+Zhangauthor=Y.+Zhaoauthor=Y.+Zhengauthor=J.+Zhuauthor=S.+Zhuauthor=D.+Zoniesauthor=X.+Zouauthor=J.+Zuntauthor=T.+Vosauthor=A.+Lopezauthor=C.+Murrayauthor=GBD+2013+Mortality+and+Causes+of+Death+Collaborators&title=Global%2C+regional%2C+and+national+age-sex+specific+all-cause+and+cause-specific+mortality+for+240+causes+of+death%2C+1990%E2%80%932013%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2013&doi=10.1016%2FS0140-6736%2814%2961682-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2814%2961682-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252814%252961682-2%26sid%3Dliteratum%253Aachs%26aulast%3DNaghavi%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLozano%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DVollset%26aufirst%3DS.%26aulast%3DOzgoren%26aufirst%3DA.%26aulast%3DAbdalla%26aufirst%3DS.%26aulast%3DAbd-Allah%26aufirst%3DF.%26aulast%3DAbdel%26aufirst%3DA.%2BMI.%26aulast%3DAbera%26aufirst%3DS.%26aulast%3DAboyans%26aufirst%3DV.%26aulast%3DAbraham%26aufirst%3DB.%26aulast%3DAbraham%26aufirst%3DJ.%26aulast%3DAbuabara%26aufirst%3DK.%26aulast%3DAbubakar%26aufirst%3DI.%26aulast%3DAbu-Raddad%26aufirst%3DL.%26aulast%3DAbu-Rmeileh%26aufirst%3DN.%26aulast%3DAchoki%26aufirst%3DT.%26aulast%3DAdelekan%26aufirst%3DA.%26aulast%3DAdemi%26aufirst%3DZ.%26aulast%3DAdofo%26aufirst%3DK.%26aulast%3DAdou%26aufirst%3DA.%26aulast%3DAdsuar%26aufirst%3DJ.%26aulast%3D%25C3%2584rnlov%26aufirst%3DJ.%26aulast%3DAgardh%26aufirst%3DE.%26aulast%3DAkena%26aufirst%3DD.%26aulast%3DAl%2BKhabouri%26aufirst%3DM.%26aulast%3DAlasfoor%26aufirst%3DD.%26aulast%3DAlbittar%26aufirst%3DM.%26aulast%3DAlegretti%26aufirst%3DM.%26aulast%3DAleman%26aufirst%3DA.%26aulast%3DAlemu%26aufirst%3DZ.%26aulast%3DAlfonso-Cristancho%26aufirst%3DR.%26aulast%3DAlhabib%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DR.%26aulast%3DAlla%26aufirst%3DF.%26aulast%3DAl%2BLami%26aufirst%3DF.%26aulast%3DAllebeck%26aufirst%3DP.%26aulast%3DAlMazroa%26aufirst%3DM.%26aulast%3DAl-Shahi%2BSalman%26aufirst%3DR.%26aulast%3DAlsharif%26aufirst%3DU.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DAlviz-Guzman%26aufirst%3DN.%26aulast%3DAmankwaa%26aufirst%3DA.%26aulast%3DAmare%26aufirst%3DA.%26aulast%3DAmeli%26aufirst%3DO.%26aulast%3DAmini%26aufirst%3DH.%26aulast%3DAmmar%26aufirst%3DW.%26aulast%3DAnderson%26aufirst%3DH.%26aulast%3DAnderson%26aufirst%3DB.%26aulast%3DAntonio%26aufirst%3DC.%26aulast%3DAnwari%26aufirst%3DP.%26aulast%3DApfel%26aufirst%3DH.%26aulast%3DArgeseanu%2BCunningham%26aufirst%3DS.%26aulast%3DArsic%2BArsenijevic%26aufirst%3DV.%26aulast%3DArtaman%26aufirst%3DA.%26aulast%3DAsad%26aufirst%3DM.%26aulast%3DAsghar%26aufirst%3DR.%26aulast%3DAssadi%26aufirst%3DR.%26aulast%3DAtkins%26aufirst%3DL.%26aulast%3DAtkinson%26aufirst%3DC.%26aulast%3DBadawi%26aufirst%3DA.%26aulast%3DBahit%26aufirst%3DM.%26aulast%3DBakfalouni%26aufirst%3DT.%26aulast%3DBalakrishnan%26aufirst%3DK.%26aulast%3DBalalla%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DBarber%26aufirst%3DR.%26aulast%3DBarker-Collo%26aufirst%3DS.%26aulast%3DBarquera%26aufirst%3DS.%26aulast%3DBarregard%26aufirst%3DL.%26aulast%3DBarrero%26aufirst%3DL.%26aulast%3DBarrientos-Gutierrez%26aufirst%3DT.%26aulast%3DBasu%26aufirst%3DA.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DBasulaiman%26aufirst%3DM.%26aulast%3DBeardsley%26aufirst%3DJ.%26aulast%3DBedi%26aufirst%3DN.%26aulast%3DBeghi%26aufirst%3DE.%26aulast%3DBekele%26aufirst%3DT.%26aulast%3DBell%26aufirst%3DM.%26aulast%3DBenjet%26aufirst%3DC.%26aulast%3DBennett%26aufirst%3DD.%26aulast%3DBensenor%26aufirst%3DI.%26aulast%3DBenzian%26aufirst%3DH.%26aulast%3DBertozzi-Villa%26aufirst%3DA.%26aulast%3DBeyene%26aufirst%3DT.%26aulast%3DBhala%26aufirst%3DN.%26aulast%3DBhalla%26aufirst%3DA.%26aulast%3DBhutta%26aufirst%3DZ.%26aulast%3DBikbov%26aufirst%3DB.%26aulast%3DBin%2BAbdulhak%26aufirst%3DA.%26aulast%3DBiryukov%26aufirst%3DS.%26aulast%3DBlore%26aufirst%3DJ.%26aulast%3DBlyth%26aufirst%3DF.%26aulast%3DBohensky%26aufirst%3DM.%26aulast%3DBorges%26aufirst%3DG.%26aulast%3DBose%26aufirst%3DD.%26aulast%3DBoufous%26aufirst%3DS.%26aulast%3DBourne%26aufirst%3DR.%26aulast%3DBoyers%26aufirst%3DL.%26aulast%3DBrainin%26aufirst%3DM.%26aulast%3DBrauer%26aufirst%3DM.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DBrazinova%26aufirst%3DA.%26aulast%3DBreitborde%26aufirst%3DN.%26aulast%3DBrenner%26aufirst%3DH.%26aulast%3DBriggs%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DBrugha%26aufirst%3DT.%26aulast%3DBuckle%26aufirst%3DG.%26aulast%3DBui%26aufirst%3DL.%26aulast%3DBukhman%26aufirst%3DG.%26aulast%3DBurch%26aufirst%3DM.%26aulast%3DCampos%26aufirst%3DN.%2BIR.%26aulast%3DCarabin%26aufirst%3DH.%26aulast%3DC%25C3%25A1rdenas%26aufirst%3DR.%26aulast%3DCarapetis%26aufirst%3DJ.%26aulast%3DCarpenter%26aufirst%3DD.%26aulast%3DCaso%26aufirst%3DV.%26aulast%3DCasta%25C3%25B1eda-Orjuela%26aufirst%3DC.%26aulast%3DCastro%26aufirst%3DR.%26aulast%3DCatal%25C3%25A1-L%25C3%25B3pez%26aufirst%3DF.%26aulast%3DCavalleri%26aufirst%3DF.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DCharlson%26aufirst%3DF.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DChimed-Ochir%26aufirst%3DO.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DChristensen%26aufirst%3DH.%26aulast%3DChristophi%26aufirst%3DC.%26aulast%3DChuang%26aufirst%3DT.%26aulast%3DChugh%26aufirst%3DS.%26aulast%3DCirillo%26aufirst%3DM.%26aulast%3DCoates%26aufirst%3DM.%26aulast%3DCoffeng%26aufirst%3DL.%26aulast%3DCoggeshall%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DA.%26aulast%3DColistro%26aufirst%3DV.%26aulast%3DColquhoun%26aufirst%3DS.%26aulast%3DColomar%26aufirst%3DM.%26aulast%3DCooper%26aufirst%3DL.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DCoppola%26aufirst%3DL.%26aulast%3DCortinovis%26aufirst%3DM.%26aulast%3DCourville%26aufirst%3DK.%26aulast%3DCowie%26aufirst%3DB.%26aulast%3DCriqui%26aufirst%3DM.%26aulast%3DCrump%26aufirst%3DJ.%26aulast%3DCuevas-Nasu%26aufirst%3DL.%26aulast%3Dda%2BCosta%2BLeite%26aufirst%3DI.%26aulast%3DDabhadkar%26aufirst%3DK.%26aulast%3DDandona%26aufirst%3DL.%26aulast%3DDandona%26aufirst%3DR.%26aulast%3DDansereau%26aufirst%3DE.%26aulast%3DDargan%26aufirst%3DP.%26aulast%3DDayama%26aufirst%3DA.%26aulast%3DDe%2Bla%2BCruz-G%25C3%25B3ngora%26aufirst%3DV.%26aulast%3Dde%2Bla%2BVega%26aufirst%3DS.%26aulast%3DDe%2BLeo%26aufirst%3DD.%26aulast%3DDegenhardt%26aufirst%3DL.%26aulast%3Ddel%2BPozo-Cruz%26aufirst%3DB.%26aulast%3DDellavalle%26aufirst%3DR.%26aulast%3DDeribe%26aufirst%3DK.%26aulast%3DDes%2BJarlais%26aufirst%3DD.%26aulast%3DDessalegn%26aufirst%3DM.%26aulast%3DdeVeber%26aufirst%3DG.%26aulast%3DDharmaratne%26aufirst%3DS.%26aulast%3DDherani%26aufirst%3DM.%26aulast%3DDiaz-Ortega%26aufirst%3DJ.%26aulast%3DDiaz-Torne%26aufirst%3DC.%26aulast%3DDicker%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DE.%26aulast%3DDokova%26aufirst%3DK.%26aulast%3DDorsey%26aufirst%3DE.%26aulast%3DDriscoll%26aufirst%3DT.%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DDuber%26aufirst%3DH.%26aulast%3DDurrani%26aufirst%3DA.%26aulast%3DEbel%26aufirst%3DB.%26aulast%3DEdmond%26aufirst%3DK.%26aulast%3DEllenbogen%26aufirst%3DR.%26aulast%3DElshrek%26aufirst%3DY.%26aulast%3DErmakov%26aufirst%3DS.%26aulast%3DErskine%26aufirst%3DH.%26aulast%3DEshrati%26aufirst%3DB.%26aulast%3DEsteghamati%26aufirst%3DA.%26aulast%3DEstep%26aufirst%3DK.%26aulast%3DF%25C3%25BCrst%26aufirst%3DT.%26aulast%3DFahimi%26aufirst%3DS.%26aulast%3DFahrion%26aufirst%3DA.%26aulast%3DFaraon%26aufirst%3DE.%26aulast%3DFarzadfar%26aufirst%3DF.%26aulast%3DFay%26aufirst%3DD.%26aulast%3DFeigl%26aufirst%3DA.%26aulast%3DFeigin%26aufirst%3DV.%26aulast%3DFelicio%26aufirst%3DM.%26aulast%3DFereshtehnejad%26aufirst%3DS.%26aulast%3DFernandes%26aufirst%3DJ.%26aulast%3DFerrari%26aufirst%3DA.%26aulast%3DFleming%26aufirst%3DT.%26aulast%3DFoigt%26aufirst%3DN.%26aulast%3DForeman%26aufirst%3DK.%26aulast%3DForouzanfar%26aufirst%3DM.%26aulast%3DFowkes%26aufirst%3DF.%26aulast%3DPaleo%26aufirst%3DU.%26aulast%3DFranklin%26aufirst%3DR.%26aulast%3DFutran%26aufirst%3DN.%26aulast%3DGaffikin%26aufirst%3DL.%26aulast%3DGambashidze%26aufirst%3DK.%26aulast%3DGankp%25C3%25A9%26aufirst%3DF.%26aulast%3DGarc%25C3%25ADa-Guerra%26aufirst%3DF.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DGeleijnse%26aufirst%3DJ.%26aulast%3DGessner%26aufirst%3DB.%26aulast%3DGibney%26aufirst%3DK.%26aulast%3DGillum%26aufirst%3DR.%26aulast%3DGilmour%26aufirst%3DS.%26aulast%3DGinawi%26aufirst%3DI.%26aulast%3DGiroud%26aufirst%3DM.%26aulast%3DGlaser%26aufirst%3DE.%26aulast%3DGoenka%26aufirst%3DS.%26aulast%3DGomez%2BDantes%26aufirst%3DH.%26aulast%3DGona%26aufirst%3DP.%26aulast%3DGonzalez-Medina%26aufirst%3DD.%26aulast%3DGuinovart%26aufirst%3DC.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DR.%26aulast%3DGotay%26aufirst%3DC.%26aulast%3DGoto%26aufirst%3DA.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DGraetz%26aufirst%3DN.%26aulast%3DGreenwell%26aufirst%3DK.%26aulast%3DGugnani%26aufirst%3DH.%26aulast%3DGunnell%26aufirst%3DD.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DR.%26aulast%3DHaagsma%26aufirst%3DJ.%26aulast%3DHafezi-Nejad%26aufirst%3DN.%26aulast%3DHagan%26aufirst%3DH.%26aulast%3DHagstromer%26aufirst%3DM.%26aulast%3DHalasa%26aufirst%3DY.%26aulast%3DHamadeh%26aufirst%3DR.%26aulast%3DHamavid%26aufirst%3DH.%26aulast%3DHammami%26aufirst%3DM.%26aulast%3DHancock%26aufirst%3DJ.%26aulast%3DHankey%26aufirst%3DG.%26aulast%3DHansen%26aufirst%3DG.%26aulast%3DHarb%26aufirst%3DH.%26aulast%3DHarewood%26aufirst%3DH.%26aulast%3DHaro%26aufirst%3DJ.%26aulast%3DHavmoeller%26aufirst%3DR.%26aulast%3DHay%26aufirst%3DR.%26aulast%3DHay%26aufirst%3DS.%26aulast%3DHedayati%26aufirst%3DM.%26aulast%3DHeredia%26aufirst%3DP.%2BIB%26aulast%3DHeuton%26aufirst%3DK.%26aulast%3DHeydarpour%26aufirst%3DP.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DHijar%26aufirst%3DM.%26aulast%3DHoek%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DH.%26aulast%3DHornberger%26aufirst%3DJ.%26aulast%3DHosgood%26aufirst%3DH.%26aulast%3DHossain%26aufirst%3DM.%26aulast%3DHotez%26aufirst%3DP.%26aulast%3DHoy%26aufirst%3DD.%26aulast%3DHsairi%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DHuffman%26aufirst%3DM.%26aulast%3DHughes%26aufirst%3DA.%26aulast%3DHusseini%26aufirst%3DA.%26aulast%3DHuynh%26aufirst%3DC.%26aulast%3DIannarone%26aufirst%3DM.%26aulast%3DIburg%26aufirst%3DK.%26aulast%3DIdrisov%26aufirst%3DB.%26aulast%3DIkeda%26aufirst%3DN.%26aulast%3DInnos%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIslami%26aufirst%3DF.%26aulast%3DIsmayilova%26aufirst%3DS.%26aulast%3DJacobsen%26aufirst%3DK.%26aulast%3DJassal%26aufirst%3DS.%26aulast%3DJayaraman%26aufirst%3DS.%26aulast%3DJensen%26aufirst%3DP.%26aulast%3DJha%26aufirst%3DV.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJonas%26aufirst%3DJ.%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DJuel%26aufirst%3DK.%26aulast%3DKabagambe%26aufirst%3DE.%26aulast%3DKan%26aufirst%3DH.%26aulast%3DKarch%26aufirst%3DA.%26aulast%3DKarimkhani%26aufirst%3DC.%26aulast%3DKarthikeyan%26aufirst%3DG.%26aulast%3DKassebaum%26aufirst%3DN.%26aulast%3DKaul%26aufirst%3DA.%26aulast%3DKawakami%26aufirst%3DN.%26aulast%3DKazanjan%26aufirst%3DK.%26aulast%3DKazi%26aufirst%3DD.%26aulast%3DKemp%26aufirst%3DA.%26aulast%3DKengne%26aufirst%3DA.%26aulast%3DKeren%26aufirst%3DA.%26aulast%3DKereselidze%26aufirst%3DM.%26aulast%3DKhader%26aufirst%3DY.%26aulast%3DKhalifa%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DE.%26aulast%3DKhan%26aufirst%3DG.%26aulast%3DKhang%26aufirst%3DY.%26aulast%3DKieling%26aufirst%3DC.%26aulast%3DKinfu%26aufirst%3DY.%26aulast%3DKinge%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKivipelto%26aufirst%3DM.%26aulast%3DKnibbs%26aufirst%3DL.%26aulast%3DKnudsen%26aufirst%3DA.%26aulast%3DKokubo%26aufirst%3DY.%26aulast%3DKosen%26aufirst%3DS.%26aulast%3DKotagal%26aufirst%3DM.%26aulast%3DKravchenko%26aufirst%3DM.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DKrueger%26aufirst%3DH.%26aulast%3DKuate%26aufirst%3DD.%2BB.%26aulast%3DKuipers%26aufirst%3DE.%26aulast%3DKucuk%26aufirst%3DB.%2BB.%26aulast%3DKulkarni%26aufirst%3DC.%26aulast%3DKulkarni%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DKwan%26aufirst%3DG.%26aulast%3DKyu%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DT.%26aulast%3DLakshmana%26aufirst%3DB.%2BA.%26aulast%3DLalloo%26aufirst%3DR.%26aulast%3DLallukka%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLan%26aufirst%3DQ.%26aulast%3DLansingh%26aufirst%3DV.%26aulast%3DLarson%26aufirst%3DH.%26aulast%3DLarsson%26aufirst%3DA.%26aulast%3DLavados%26aufirst%3DP.%26aulast%3DLawrynowicz%26aufirst%3DA.%26aulast%3DLeasher%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLeigh%26aufirst%3DJ.%26aulast%3DLeinsalu%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DR.%26aulast%3DLevitz%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiddell%26aufirst%3DC.%26aulast%3DLim%26aufirst%3DS.%26aulast%3Dde%2BLima%26aufirst%3DG.%26aulast%3DLind%26aufirst%3DM.%26aulast%3DLipshultz%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLloyd%26aufirst%3DB.%26aulast%3DLofgren%26aufirst%3DK.%26aulast%3DLogroscino%26aufirst%3DG.%26aulast%3DLondon%26aufirst%3DS.%26aulast%3DLortet-Tieulent%26aufirst%3DJ.%26aulast%3DLotufo%26aufirst%3DP.%26aulast%3DLucas%26aufirst%3DR.%26aulast%3DLunevicius%26aufirst%3DR.%26aulast%3DLyons%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMachado%26aufirst%3DV.%26aulast%3DMacIntyre%26aufirst%3DM.%26aulast%3DMackay%26aufirst%3DM.%26aulast%3DMacLachlan%26aufirst%3DJ.%26aulast%3DMagis-Rodriguez%26aufirst%3DC.%26aulast%3DMahdi%26aufirst%3DA.%26aulast%3DMajdan%26aufirst%3DM.%26aulast%3DMalekzadeh%26aufirst%3DR.%26aulast%3DMangalam%26aufirst%3DS.%26aulast%3DMapoma%26aufirst%3DC.%26aulast%3DMarape%26aufirst%3DM.%26aulast%3DMarcenes%26aufirst%3DW.%26aulast%3DMargono%26aufirst%3DC.%26aulast%3DMarks%26aufirst%3DG.%26aulast%3DMarzan%26aufirst%3DM.%26aulast%3DMasci%26aufirst%3DJ.%26aulast%3DMashal%26aufirst%3DM.%26aulast%3DMasiye%26aufirst%3DF.%26aulast%3DMason-Jones%26aufirst%3DA.%26aulast%3DMatzopolous%26aufirst%3DR.%26aulast%3DMayosi%26aufirst%3DB.%26aulast%3DMazorodze%26aufirst%3DT.%26aulast%3DMcGrath%26aufirst%3DJ.%26aulast%3DMcKay%26aufirst%3DA.%26aulast%3DMcKee%26aufirst%3DM.%26aulast%3DMcLain%26aufirst%3DA.%26aulast%3DMeaney%26aufirst%3DP.%26aulast%3DMehndiratta%26aufirst%3DM.%26aulast%3DMejia-Rodriguez%26aufirst%3DF.%26aulast%3DMelaku%26aufirst%3DY.%26aulast%3DMeltzer%26aufirst%3DM.%26aulast%3DMemish%26aufirst%3DZ.%26aulast%3DMendoza%26aufirst%3DW.%26aulast%3DMensah%26aufirst%3DG.%26aulast%3DMeretoja%26aufirst%3DA.%26aulast%3DMhimbira%26aufirst%3DF.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DMills%26aufirst%3DE.%26aulast%3DMisganaw%26aufirst%3DA.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DMock%26aufirst%3DC.%26aulast%3DMoffitt%26aufirst%3DT.%26aulast%3DMohamed%2BIbrahim%26aufirst%3DN.%26aulast%3DMohammad%26aufirst%3DK.%26aulast%3DMokdad%26aufirst%3DA.%26aulast%3DMola%26aufirst%3DG.%26aulast%3DMonasta%26aufirst%3DL.%26aulast%3DMonis%26aufirst%3DJ.%2BL.%26aulast%3DMonta%25C3%25B1ez%2BHernandez%26aufirst%3DJ.%26aulast%3DMontico%26aufirst%3DM.%26aulast%3DMontine%26aufirst%3DT.%26aulast%3DMooney%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DMoradi-Lakeh%26aufirst%3DM.%26aulast%3DMoran%26aufirst%3DA.%26aulast%3DMori%26aufirst%3DR.%26aulast%3DMoschandreas%26aufirst%3DJ.%26aulast%3DMoturi%26aufirst%3DW.%26aulast%3DMoyer%26aufirst%3DM.%26aulast%3DMozaffarian%26aufirst%3DD.%26aulast%3DMueller%26aufirst%3DU.%26aulast%3DMukaigawara%26aufirst%3DM.%26aulast%3DMullany%26aufirst%3DE.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DMustapha%26aufirst%3DA.%26aulast%3DNaghavi%26aufirst%3DP.%26aulast%3DNaheed%26aufirst%3DA.%26aulast%3DNaidoo%26aufirst%3DK.%26aulast%3DNaldi%26aufirst%3DL.%26aulast%3DNand%26aufirst%3DD.%26aulast%3DNangia%26aufirst%3DV.%26aulast%3DNarayan%26aufirst%3DK.%26aulast%3DNash%26aufirst%3DD.%26aulast%3DNasher%26aufirst%3DJ.%26aulast%3DNejjari%26aufirst%3DC.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DNeuhouser%26aufirst%3DM.%26aulast%3DNeupane%26aufirst%3DS.%26aulast%3DNewcomb%26aufirst%3DP.%26aulast%3DNewman%26aufirst%3DL.%26aulast%3DNewton%26aufirst%3DC.%26aulast%3DNg%26aufirst%3DM.%26aulast%3DNgalesoni%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DNisar%26aufirst%3DM.%26aulast%3DNolte%26aufirst%3DS.%26aulast%3DNorheim%26aufirst%3DO.%26aulast%3DNorman%26aufirst%3DR.%26aulast%3DNorrving%26aufirst%3DB.%26aulast%3DNyakarahuka%26aufirst%3DL.%26aulast%3DOdell%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DM.%26aulast%3DOhkubo%26aufirst%3DT.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DOlusanya%26aufirst%3DB.%26aulast%3DOmer%26aufirst%3DS.%26aulast%3DOpio%26aufirst%3DJ.%26aulast%3DOrisakwe%26aufirst%3DO.%26aulast%3DOrtblad%26aufirst%3DK.%26aulast%3DOrtiz%26aufirst%3DA.%26aulast%3DOtayza%26aufirst%3DM.%26aulast%3DPain%26aufirst%3DA.%26aulast%3DPandian%26aufirst%3DJ.%26aulast%3DPanelo%26aufirst%3DC.%26aulast%3DPanniyammakal%26aufirst%3DJ.%26aulast%3DPapachristou%26aufirst%3DC.%26aulast%3DPaternina%2BCaicedo%26aufirst%3DA.%26aulast%3DPatten%26aufirst%3DS.%26aulast%3DPatton%26aufirst%3DG.%26aulast%3DPaul%26aufirst%3DV.%26aulast%3DPavlin%26aufirst%3DB.%26aulast%3DPearce%26aufirst%3DN.%26aulast%3DPellegrini%26aufirst%3DC.%26aulast%3DPereira%26aufirst%3DD.%26aulast%3DPeresson%26aufirst%3DS.%26aulast%3DPerez-Padilla%26aufirst%3DR.%26aulast%3DPerez-Ruiz%26aufirst%3DF.%26aulast%3DPerico%26aufirst%3DN.%26aulast%3DPervaiz%26aufirst%3DA.%26aulast%3DPesudovs%26aufirst%3DK.%26aulast%3DPeterson%26aufirst%3DC.%26aulast%3DPetzold%26aufirst%3DM.%26aulast%3DPhillips%26aufirst%3DB.%26aulast%3DPhillips%26aufirst%3DD.%26aulast%3DPhillips%26aufirst%3DM.%26aulast%3DPlass%26aufirst%3DD.%26aulast%3DPiel%26aufirst%3DF.%26aulast%3DPoenaru%26aufirst%3DD.%26aulast%3DPolinder%26aufirst%3DS.%26aulast%3DPopova%26aufirst%3DS.%26aulast%3DPoulton%26aufirst%3DR.%26aulast%3DPourmalek%26aufirst%3DF.%26aulast%3DPrabhakaran%26aufirst%3DD.%26aulast%3DQato%26aufirst%3DD.%26aulast%3DQuezada%26aufirst%3DA.%26aulast%3DQuistberg%26aufirst%3DD.%26aulast%3DRabito%26aufirst%3DF.%26aulast%3DRafay%26aufirst%3DA.%26aulast%3DRahimi%26aufirst%3DK.%26aulast%3DRahimi-Movaghar%26aufirst%3DV.%26aulast%3DRahman%26aufirst%3DS.%26aulast%3DRaju%26aufirst%3DM.%26aulast%3DRakovac%26aufirst%3DI.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DRefaat%26aufirst%3DA.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DRicci%26aufirst%3DS.%26aulast%3DRiccio%26aufirst%3DP.%26aulast%3DRichardson%26aufirst%3DL.%26aulast%3DRichardus%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DB.%26aulast%3DRoberts%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DM.%26aulast%3DRoca%26aufirst%3DA.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DRojas-Rueda%26aufirst%3DD.%26aulast%3DRonfani%26aufirst%3DL.%26aulast%3DRoom%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DG.%26aulast%3DRothenbacher%26aufirst%3DD.%26aulast%3DRothstein%26aufirst%3DD.%26aulast%3DRowley%26aufirst%3DJ.%26aulast%3DRoy%26aufirst%3DN.%26aulast%3DRuhago%26aufirst%3DG.%26aulast%3DRushton%26aufirst%3DL.%26aulast%3DSambandam%26aufirst%3DS.%26aulast%3DS%25C3%25B8reide%26aufirst%3DK.%26aulast%3DSaeedi%26aufirst%3DM.%26aulast%3DSaha%26aufirst%3DS.%26aulast%3DSahathevan%26aufirst%3DR.%26aulast%3DSahraian%26aufirst%3DM.%26aulast%3DSahle%26aufirst%3DB.%26aulast%3DSalomon%26aufirst%3DJ.%26aulast%3DSalvo%26aufirst%3DD.%26aulast%3DSamonte%26aufirst%3DG.%26aulast%3DSampson%26aufirst%3DU.%26aulast%3DSanabria%26aufirst%3DJ.%26aulast%3DSandar%26aufirst%3DL.%26aulast%3DSantos%26aufirst%3DI.%26aulast%3DSatpathy%26aufirst%3DM.%26aulast%3DSawhney%26aufirst%3DM.%26aulast%3DSaylan%26aufirst%3DM.%26aulast%3DScarborough%26aufirst%3DP.%26aulast%3DSch%25C3%25B6ttker%26aufirst%3DB.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DSchneider%26aufirst%3DI.%26aulast%3DSchumacher%26aufirst%3DA.%26aulast%3DSchwebel%26aufirst%3DD.%26aulast%3DScott%26aufirst%3DJ.%26aulast%3DSepanlou%26aufirst%3DS.%26aulast%3DServan-Mori%26aufirst%3DE.%26aulast%3DShackelford%26aufirst%3DK.%26aulast%3DShaheen%26aufirst%3DA.%26aulast%3DShahraz%26aufirst%3DS.%26aulast%3DShakh-Nazarova%26aufirst%3DM.%26aulast%3DShangguan%26aufirst%3DS.%26aulast%3DShe%26aufirst%3DJ.%26aulast%3DSheikhbahaei%26aufirst%3DS.%26aulast%3DShepard%26aufirst%3DD.%26aulast%3DShibuya%26aufirst%3DK.%26aulast%3DShinohara%26aufirst%3DY.%26aulast%3DShishani%26aufirst%3DK.%26aulast%3DShiue%26aufirst%3DI.%26aulast%3DShivakoti%26aufirst%3DR.%26aulast%3DShrime%26aufirst%3DM.%26aulast%3DSigfusdottir%26aufirst%3DI.%26aulast%3DSilberberg%26aufirst%3DD.%26aulast%3DSilva%26aufirst%3DA.%26aulast%3DSimard%26aufirst%3DE.%26aulast%3DSindi%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DL.%26aulast%3DSioson%26aufirst%3DE.%26aulast%3DSkirbekk%26aufirst%3DV.%26aulast%3DSliwa%26aufirst%3DK.%26aulast%3DSo%26aufirst%3DS.%26aulast%3DSoljak%26aufirst%3DM.%26aulast%3DSoneji%26aufirst%3DS.%26aulast%3DSoshnikov%26aufirst%3DS.%26aulast%3DSposato%26aufirst%3DL.%26aulast%3DSreeramareddy%26aufirst%3DC.%26aulast%3DStanaway%26aufirst%3DJ.%26aulast%3DStathopoulou%26aufirst%3DV.%26aulast%3DSteenland%26aufirst%3DK.%26aulast%3DStein%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DC.%26aulast%3DStevens%26aufirst%3DA.%26aulast%3DSt%25C3%25B6ckl%26aufirst%3DH.%26aulast%3DStraif%26aufirst%3DK.%26aulast%3DStroumpoulis%26aufirst%3DK.%26aulast%3DSturua%26aufirst%3DL.%26aulast%3DSunguya%26aufirst%3DB.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DSwaroop%26aufirst%3DM.%26aulast%3DSykes%26aufirst%3DB.%26aulast%3DTabb%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DTalongwa%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DF.%26aulast%3DTanne%26aufirst%3DD.%26aulast%3DTanner%26aufirst%3DM.%26aulast%3DTavakkoli%26aufirst%3DM.%26aulast%3DAo%26aufirst%3DB.%26aulast%3DTeixeira%26aufirst%3DC.%26aulast%3DTemplin%26aufirst%3DT.%26aulast%3DTenkorang%26aufirst%3DE.%26aulast%3DTerkawi%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DB.%26aulast%3DThorne-Lyman%26aufirst%3DA.%26aulast%3DThrift%26aufirst%3DA.%26aulast%3DThurston%26aufirst%3DG.%26aulast%3DTillmann%26aufirst%3DT.%26aulast%3DTirschwell%26aufirst%3DD.%26aulast%3DTleyjeh%26aufirst%3DI.%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DTopouzis%26aufirst%3DF.%26aulast%3DTowbin%26aufirst%3DJ.%26aulast%3DToyoshima%26aufirst%3DH.%26aulast%3DTraebert%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DB.%26aulast%3DTruelsen%26aufirst%3DT.%26aulast%3DTrujillo%26aufirst%3DU.%26aulast%3DTrillini%26aufirst%3DM.%26aulast%3DTsala%26aufirst%3DD.%2BZ.%26aulast%3DTsilimbaris%26aufirst%3DM.%26aulast%3DTuzcu%26aufirst%3DE.%26aulast%3DUbeda%26aufirst%3DC.%26aulast%3DUchendu%26aufirst%3DU.%26aulast%3DUkwaja%26aufirst%3DK.%26aulast%3DUndurraga%26aufirst%3DE.%26aulast%3DVallely%26aufirst%3DA.%26aulast%3Dvan%2Bde%2BVijver%26aufirst%3DS.%26aulast%3Dvan%2BGool%26aufirst%3DC.%26aulast%3DVarakin%26aufirst%3DY.%26aulast%3DVasankari%26aufirst%3DT.%26aulast%3DVasconcelos%26aufirst%3DA.%26aulast%3DVavilala%26aufirst%3DM.%26aulast%3DVenketasubramanian%26aufirst%3DN.%26aulast%3DVijayakumar%26aufirst%3DL.%26aulast%3DVillalpando%26aufirst%3DS.%26aulast%3DViolante%26aufirst%3DF.%26aulast%3DVlassov%26aufirst%3DV.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DWaller%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWarouw%26aufirst%3DT.%26aulast%3DWeichenthal%26aufirst%3DS.%26aulast%3DWeiderpass%26aufirst%3DE.%26aulast%3DWeintraub%26aufirst%3DR.%26aulast%3DWenzhi%26aufirst%3DW.%26aulast%3DWerdecker%26aufirst%3DA.%26aulast%3DWessells%26aufirst%3DK.%26aulast%3DWesterman%26aufirst%3DR.%26aulast%3DWhiteford%26aufirst%3DH.%26aulast%3DWilkinson%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DT.%26aulast%3DWoldeyohannes%26aufirst%3DS.%26aulast%3DWolfe%26aufirst%3DC.%26aulast%3DWolock%26aufirst%3DT.%26aulast%3DWoolf%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DWulf%26aufirst%3DS.%26aulast%3DWurtz%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYano%26aufirst%3DY.%26aulast%3DYatsuya%26aufirst%3DH.%26aulast%3DYip%26aufirst%3DP.%26aulast%3DYonemoto%26aufirst%3DN.%26aulast%3DYoon%26aufirst%3DS.%26aulast%3DYounis%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DYun%2BJin%26aufirst%3DK.%26aulast%3DZaki%2BMel%26aufirst%3DS.%26aulast%3DZamakhshary%26aufirst%3DM.%26aulast%3DZeeb%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DZonies%26aufirst%3DD.%26aulast%3DZou%26aufirst%3DX.%26aulast%3DZunt%26aufirst%3DJ.%26aulast%3DVos%26aufirst%3DT.%26aulast%3DLopez%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3D%26atitle%3DGlobal%252C%2520regional%252C%2520and%2520national%2520age-sex%2520specific%2520all-cause%2520and%2520cause-specific%2520mortality%2520for%2520240%2520causes%2520of%2520death%252C%25201990%25E2%2580%25932013%253A%2520a%2520systematic%2520analysis%2520for%2520the%2520Global%2520Burden%2520of%2520Disease%2520Study%25202013%26jtitle%3DLancet%26date%3D2015%26volume%3D385%26spage%3D117%26epage%3D171%26doi%3D10.1016%2FS0140-6736%2814%2961682-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Murray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasoglu, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abd-Allah, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboyans, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abubakar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu-Raddad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu-Rmeileh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achoki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ademi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adsuar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afshin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agardh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alasfoor, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albittar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alegretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alemu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso-Cristancho, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alhabib, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allebeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almazroa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsharif, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvis-Guzman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amare, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amini, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnlöv, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arsic Arsenijevic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artaman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asghar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assadi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awuah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachman, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badawi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakrishnan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker-Collo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barquera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barregard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basulaiman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beardsley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beghi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekele, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benjet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensenor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernabé, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi-Villa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyene, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhala, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhutta, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienhoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikbov, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biryukov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blosser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blyth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohensky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolliger, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bora, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boufous, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brainin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brazinova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitborde, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchbinder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulchis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulloch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos-Nonato, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carabin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carapetis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cárdenas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caso, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castañeda-Orjuela, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalá-López, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalleri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Çavlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadha, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimed-Ochir, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coggeshall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colistro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colquhoun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortinovis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criqui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuevas-Nasu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danawi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandona, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandona, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dargan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davitoiu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Leo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degenhardt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo-Cruz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellavalle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deribe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Des Jarlais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessalegn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharmaratne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dherani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Torné, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmond, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elshrek, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermakov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erskine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eshrati, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteghamati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estep, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farzadfar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feigin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fereshtehnejad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzmaurice, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaxman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foigt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forouzanfar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowkes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paleo, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fürst, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabbe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaffikin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gankpé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geleijnse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gething, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibney, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giroud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giussani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez Dantes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gona, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Medina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graetz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gugnani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutiérrez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haagsma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafezi-Nejad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halasa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamadeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamavid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hankey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havmoeller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heredia-Pi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heydarpour, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hijar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosgood, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hossain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsairi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husseini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannarone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iburg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islami, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jassal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeemon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jha, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karema, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karimkhani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karthikeyan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassebaum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazanjan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kengne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khader, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalifa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieling, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinfu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivipelto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knibbs, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuate Defo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucuk Bicer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuipers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalloo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallukka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansingh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrynowicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leasher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leigh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipshultz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lofgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logroscino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Looker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lortet-Tieulent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotufo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunevicius, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macintyre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majdan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malekzadeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcenes, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margono, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masci, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mashal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzopoulos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazorodze, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcgill, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcgrath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mckee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mclain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meaney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehndiratta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mekonnen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melaku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Memish, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meretoja, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mhimbira, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed Ibrahim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokdad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monasta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montañez Hernandez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradi-Lakeh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschandreas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moturi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mozaffarian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Msemburi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaigawara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullany, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdoch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naghavi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naheed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naidoo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nangia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nejjari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neupane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngalesoni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norheim, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norrving, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyakarahuka, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olusanya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortblad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panelo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papachristou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Padilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Ruiz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perico, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervaiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesudovs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plass, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poenaru, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polinder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pope, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pourmalek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakaran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quistberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razavi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refaat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remuzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnikoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas-Rueda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronfani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothenbacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruhago, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeedi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahraian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satpathy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawhney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöttker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwebel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seedat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepanlou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serina, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Servan-Mori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackelford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaheen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahraz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shamah Levy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangguan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikhbahaei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shishani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiue, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrime, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigfusdottir, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sindi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skirbekk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slepak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soneji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Søreide, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soshnikov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sposato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreeramareddy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanaway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathopoulou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stovner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroumpoulis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunguya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaroop, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tandon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavakkoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Te Ao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tediosi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temesgen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Templin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ten Have, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenkorang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terkawi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorne-Lyman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thrift, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurston, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topouzis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trillini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truelsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsilimbaris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuzcu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchendu, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukwaja, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Undurraga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, B. WH.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijver, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van, G. CH.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasankari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venketasubramanian, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Violante, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlassov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollset, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warouw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weichenthal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiderpass, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weintraub, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzhi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werdecker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteford, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yentür, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonemoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonies, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GBD 2013 Mortality and Causes of Death Collaborators</span><span> </span><span class="NLM_article-title">Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">386</span><span class="NLM_x">, </span> <span class="NLM_fpage">2145</span><span class="NLM_x">–</span> <span class="NLM_lpage">2191</span><span class="refDoi"> DOI: 10.1016/S0140-6736(15)61340-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0140-6736%2815%2961340-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2015&pages=2145-2191&author=C.+Murrayauthor=R.+Barberauthor=K.+Foremanauthor=O.+A.+Abbasogluauthor=F.+Abd-Allahauthor=S.+Aberaauthor=V.+Aboyansauthor=J.+Abrahamauthor=I.+Abubakarauthor=L.+Abu-Raddadauthor=N.+Abu-Rmeilehauthor=T.+Achokiauthor=I.+Ackermanauthor=Z.+Ademiauthor=A.+Adouauthor=J.+Adsuarauthor=A.+Afshinauthor=E.+Agardhauthor=S.+Alamauthor=D.+Alasfoorauthor=M.+Albittarauthor=M.+Alegrettiauthor=Z.+Alemuauthor=R.+Alfonso-Cristanchoauthor=S.+Alhabibauthor=R.+Aliauthor=F.+Allaauthor=P.+Allebeckauthor=M.+Almazroaauthor=U.+Alsharifauthor=E.+Alvarezauthor=N.+Alvis-Guzmanauthor=A.+Amareauthor=E.+Amehauthor=H.+Aminiauthor=W.+Ammarauthor=H.+Andersonauthor=B.+Andersonauthor=C.+Antonioauthor=P.+Anwariauthor=J.+Arnl%C3%B6vauthor=V.+Arsic+Arsenijevicauthor=A.+Artamanauthor=R.+Asgharauthor=R.+Assadiauthor=L.+Atkinsauthor=M.+Avilaauthor=B.+Awuahauthor=V.+Bachmanauthor=A.+Badawiauthor=M.+Bahitauthor=K.+Balakrishnanauthor=A.+Banerjeeauthor=S.+Barker-Colloauthor=S.+Barqueraauthor=L.+Barregardauthor=L.+Barreroauthor=A.+Basuauthor=S.+Basuauthor=M.+Basulaimanauthor=J.+Beardsleyauthor=N.+Bediauthor=E.+Beghiauthor=T.+Bekeleauthor=M.+Bellauthor=C.+Benjetauthor=D.+Bennettauthor=I.+Bensenorauthor=H.+Benzianauthor=E.+Bernab%C3%A9author=A.+Bertozzi-Villaauthor=T.+Beyeneauthor=N.+Bhalaauthor=A.+Bhallaauthor=Z.+Bhuttaauthor=K.+Bienhoffauthor=B.+Bikbovauthor=S.+Biryukovauthor=J.+Bloreauthor=C.+Blosserauthor=F.+Blythauthor=M.+Bohenskyauthor=I.+Bolligerauthor=B.+B.+Boraauthor=N.+Bornsteinauthor=D.+Boseauthor=S.+Boufousauthor=R.+Bourneauthor=L.+Boyersauthor=M.+Braininauthor=C.+Brayneauthor=A.+Brazinovaauthor=N.+Breitbordeauthor=H.+Brennerauthor=A.+Briggsauthor=P.+Brooksauthor=J.+Brownauthor=T.+Brughaauthor=R.+Buchbinderauthor=G.+Buckleauthor=C.+Budkeauthor=A.+Bulchisauthor=A.+Bullochauthor=I.+Campos-Nonatoauthor=H.+Carabinauthor=J.+Carapetisauthor=R.+C%C3%A1rdenasauthor=D.+Carpenterauthor=V.+Casoauthor=C.+Casta%C3%B1eda-Orjuelaauthor=R.+Castroauthor=F.+Catal%C3%A1-L%C3%B3pezauthor=F.+Cavalleriauthor=A.+%C3%87avlinauthor=V.+Chadhaauthor=J.+Changauthor=F.+Charlsonauthor=H.+Chenauthor=W.+Chenauthor=P.+Chiangauthor=O.+Chimed-Ochirauthor=R.+Chowdhuryauthor=H.+Christensenauthor=C.+Christophiauthor=M.+Cirilloauthor=M.+Coatesauthor=L.+Coffengauthor=M.+Coggeshallauthor=V.+Colistroauthor=S.+Colquhounauthor=G.+Cookeauthor=C.+Cooperauthor=L.+Cooperauthor=L.+Coppolaauthor=M.+Cortinovisauthor=M.+Criquiauthor=J.+Crumpauthor=L.+Cuevas-Nasuauthor=H.+Danawiauthor=L.+Dandonaauthor=R.+Dandonaauthor=E.+Dansereauauthor=P.+Darganauthor=G.+Daveyauthor=A.+Davisauthor=D.+Davitoiuauthor=A.+Dayamaauthor=D.+De+Leoauthor=L.+Degenhardtauthor=B.+Del+Pozo-Cruzauthor=R.+Dellavalleauthor=K.+Deribeauthor=S.+Derrettauthor=D.+Des+Jarlaisauthor=M.+Dessalegnauthor=S.+Dharmaratneauthor=M.+Dheraniauthor=C.+Diaz-Torn%C3%A9author=D.+Dickerauthor=E.+Dingauthor=K.+Dokovaauthor=E.+Dorseyauthor=T.+Driscollauthor=L.+Duanauthor=H.+Duberauthor=B.+Ebelauthor=K.+Edmondauthor=Y.+Elshrekauthor=M.+Endresauthor=S.+Ermakovauthor=H.+Erskineauthor=B.+Eshratiauthor=A.+Esteghamatiauthor=K.+Estepauthor=E.+Faraonauthor=F.+Farzadfarauthor=D.+Fayauthor=V.+Feiginauthor=D.+Felsonauthor=S.+Fereshtehnejadauthor=J.+Fernandesauthor=A.+Ferrariauthor=C.+Fitzmauriceauthor=A.+Flaxmanauthor=T.+Flemingauthor=N.+Foigtauthor=M.+Forouzanfarauthor=F.+Fowkesauthor=U.+Paleoauthor=R.+Franklinauthor=T.+F%C3%BCrstauthor=B.+Gabbeauthor=L.+Gaffikinauthor=F.+Gankp%C3%A9author=J.+Geleijnseauthor=B.+Gessnerauthor=P.+Gethingauthor=K.+Gibneyauthor=M.+Giroudauthor=G.+Giussaniauthor=H.+Gomez+Dantesauthor=P.+Gonaauthor=D.+Gonz%C3%A1lez-Medinaauthor=R.+Gosselinauthor=C.+Gotayauthor=A.+Gotoauthor=H.+Goudaauthor=N.+Graetzauthor=H.+Gugnaniauthor=R.+Guptaauthor=R.+Guptaauthor=R.+Guti%C3%A9rrezauthor=J.+Haagsmaauthor=N.+Hafezi-Nejadauthor=H.+Haganauthor=Y.+Halasaauthor=R.+Hamadehauthor=H.+Hamavidauthor=M.+Hammamiauthor=J.+Hancockauthor=G.+Hankeyauthor=G.+Hansenauthor=Y.+Haoauthor=H.+Harbauthor=J.+Haroauthor=R.+Havmoellerauthor=S.+Hayauthor=R.+Hayauthor=I.+Heredia-Piauthor=K.+Heutonauthor=P.+Heydarpourauthor=H.+Higashiauthor=M.+Hijarauthor=H.+Hoekauthor=H.+Hoffmanauthor=H.+Hosgoodauthor=M.+Hossainauthor=P.+Hotezauthor=D.+Hoyauthor=M.+Hsairiauthor=G.+Huauthor=C.+Huangauthor=J.+Huangauthor=A.+Husseiniauthor=C.+Huynhauthor=M.+Iannaroneauthor=K.+Iburgauthor=K.+Innosauthor=M.+Inoueauthor=F.+Islamiauthor=K.+Jacobsenauthor=D.+Jarvisauthor=S.+Jassalauthor=S.+Jeeauthor=P.+Jeemonauthor=P.+Jensenauthor=V.+Jhaauthor=G.+Jiangauthor=Y.+Jiangauthor=J.+Jonasauthor=K.+Juelauthor=H.+Kanauthor=A.+Karchauthor=C.+Karemaauthor=C.+Karimkhaniauthor=G.+Karthikeyanauthor=N.+Kassebaumauthor=A.+Kaulauthor=N.+Kawakamiauthor=K.+Kazanjanauthor=A.+Kempauthor=A.+Kengneauthor=A.+Kerenauthor=Y.+Khaderauthor=S.+Khalifaauthor=E.+Khanauthor=G.+Khanauthor=Y.+Khangauthor=C.+Kielingauthor=D.+Kimauthor=S.+Kimauthor=Y.+Kimauthor=Y.+Kinfuauthor=J.+Kingeauthor=M.+Kivipeltoauthor=L.+Knibbsauthor=A.+Knudsenauthor=Y.+Kokuboauthor=S.+Kosenauthor=S.+Krishnaswamiauthor=B.+Kuate+Defoauthor=B.+Kucuk+Bicerauthor=E.+Kuipersauthor=C.+Kulkarniauthor=V.+Kulkarniauthor=G.+Kumarauthor=H.+Kyuauthor=T.+Laiauthor=R.+Lallooauthor=T.+Lallukkaauthor=H.+Lamauthor=Q.+Lanauthor=V.+Lansinghauthor=A.+Larssonauthor=A.+Lawrynowiczauthor=J.+Leasherauthor=J.+Leighauthor=R.+Leungauthor=C.+Levitzauthor=B.+Liauthor=Y.+Liauthor=Y.+Liauthor=S.+Limauthor=M.+Lindauthor=S.+Lipshultzauthor=S.+Liuauthor=Y.+Liuauthor=B.+Lloydauthor=K.+Lofgrenauthor=G.+Logroscinoauthor=K.+Lookerauthor=J.+Lortet-Tieulentauthor=P.+Lotufoauthor=R.+Lozanoauthor=R.+Lucasauthor=R.+Luneviciusauthor=R.+Lyonsauthor=S.+Maauthor=M.+Macintyreauthor=M.+Mackayauthor=M.+Majdanauthor=R.+Malekzadehauthor=W.+Marcenesauthor=D.+Margolisauthor=C.+Margonoauthor=M.+Marzanauthor=J.+Masciauthor=M.+Mashalauthor=R.+Matzopoulosauthor=B.+Mayosiauthor=T.+Mazorodzeauthor=N.+Mcgillauthor=J.+Mcgrathauthor=M.+Mckeeauthor=A.+Mclainauthor=P.+Meaneyauthor=C.+Medinaauthor=M.+Mehndirattaauthor=W.+Mekonnenauthor=Y.+Melakuauthor=M.+Meltzerauthor=Z.+Memishauthor=G.+Mensahauthor=A.+Meretojaauthor=F.+Mhimbiraauthor=R.+Michaauthor=T.+Millerauthor=E.+Millsauthor=P.+Mitchellauthor=C.+Mockauthor=N.+Mohamed+Ibrahimauthor=K.+Mohammadauthor=A.+Mokdadauthor=G.+Molaauthor=L.+Monastaauthor=J.+Monta%C3%B1ez+Hernandezauthor=M.+Monticoauthor=T.+Montineauthor=M.+Mooneyauthor=A.+Mooreauthor=M.+Moradi-Lakehauthor=A.+Moranauthor=R.+Moriauthor=J.+Moschandreasauthor=W.+Moturiauthor=M.+Moyerauthor=D.+Mozaffarianauthor=W.+Msemburiauthor=U.+Muellerauthor=M.+Mukaigawaraauthor=E.+Mullanyauthor=M.+Murdochauthor=J.+Murrayauthor=K.+Murthyauthor=M.+Naghaviauthor=A.+Naheedauthor=K.+Naidooauthor=L.+Naldiauthor=D.+Nandauthor=V.+Nangiaauthor=K.+Narayanauthor=C.+Nejjariauthor=S.+Neupaneauthor=C.+Newtonauthor=M.+Ngauthor=F.+Ngalesoniauthor=G.+Nguyenauthor=M.+Nisarauthor=S.+Nolteauthor=O.+Norheimauthor=R.+Normanauthor=B.+Norrvingauthor=L.+Nyakarahukaauthor=I.+Ohauthor=T.+Ohkuboauthor=S.+Ohnoauthor=B.+Olusanyaauthor=J.+Opioauthor=K.+Ortbladauthor=A.+Ortizauthor=A.+Painauthor=J.+Pandianauthor=C.+Paneloauthor=C.+Papachristouauthor=E.+Parkauthor=J.+Parkauthor=S.+Pattenauthor=G.+Pattonauthor=V.+Paulauthor=B.+Pavlinauthor=N.+Pearceauthor=D.+Pereiraauthor=R.+Perez-Padillaauthor=F.+Perez-Ruizauthor=N.+Pericoauthor=A.+Pervaizauthor=K.+Pesudovsauthor=C.+Petersonauthor=M.+Petzoldauthor=M.+Phillipsauthor=B.+Phillipsauthor=D.+Phillipsauthor=F.+Pielauthor=D.+Plassauthor=D.+Poenaruauthor=S.+Polinderauthor=D.+Popeauthor=S.+Popovaauthor=R.+Poultonauthor=F.+Pourmalekauthor=D.+Prabhakaranauthor=N.+Prasadauthor=R.+Pullanauthor=D.+Qatoauthor=D.+Quistbergauthor=A.+Rafayauthor=K.+Rahimiauthor=S.+Rahmanauthor=M.+Rajuauthor=S.+Ranaauthor=H.+Razaviauthor=K.+Reddyauthor=A.+Refaatauthor=G.+Remuzziauthor=S.+Resnikoffauthor=A.+Ribeiroauthor=L.+Richardsonauthor=J.+Richardusauthor=D.+Robertsauthor=D.+Rojas-Ruedaauthor=L.+Ronfaniauthor=G.+Rothauthor=D.+Rothenbacherauthor=D.+Rothsteinauthor=J.+Rowleyauthor=N.+Royauthor=G.+Ruhagoauthor=M.+Saeediauthor=S.+Sahaauthor=M.+Sahraianauthor=U.+Sampsonauthor=J.+Sanabriaauthor=L.+Sandarauthor=I.+Santosauthor=M.+Satpathyauthor=M.+Sawhneyauthor=P.+Scarboroughauthor=I.+Schneiderauthor=B.+Sch%C3%B6ttkerauthor=A.+Schumacherauthor=D.+Schwebelauthor=J.+Scottauthor=S.+Seedatauthor=S.+Sepanlouauthor=P.+Serinaauthor=E.+Servan-Moriauthor=K.+Shackelfordauthor=A.+Shaheenauthor=S.+Shahrazauthor=T.+Shamah+Levyauthor=S.+Shangguanauthor=J.+Sheauthor=S.+Sheikhbahaeiauthor=P.+Shiauthor=K.+Shibuyaauthor=Y.+Shinoharaauthor=R.+Shiriauthor=K.+Shishaniauthor=I.+Shiueauthor=M.+Shrimeauthor=I.+Sigfusdottirauthor=D.+Silberbergauthor=E.+Simardauthor=S.+Sindiauthor=A.+Singhauthor=J.+Singhauthor=L.+Singhauthor=V.+Skirbekkauthor=E.+Slepakauthor=K.+Sliwaauthor=S.+Sonejiauthor=K.+S%C3%B8reideauthor=S.+Soshnikovauthor=L.+Sposatoauthor=C.+Sreeramareddyauthor=J.+Stanawayauthor=V.+Stathopoulouauthor=D.+Steinauthor=M.+Steinauthor=C.+Steinerauthor=T.+Steinerauthor=A.+Stevensauthor=A.+Stewartauthor=L.+Stovnerauthor=K.+Stroumpoulisauthor=B.+Sunguyaauthor=S.+Swaminathanauthor=M.+Swaroopauthor=B.+Sykesauthor=K.+Tabbauthor=K.+Takahashiauthor=N.+Tandonauthor=D.+Tanneauthor=M.+Tannerauthor=M.+Tavakkoliauthor=H.+Taylorauthor=B.+Te+Aoauthor=F.+Tediosiauthor=A.+Temesgenauthor=T.+Templinauthor=M.+Ten+Haveauthor=E.+Tenkorangauthor=A.+Terkawiauthor=B.+Thomsonauthor=A.+Thorne-Lymanauthor=A.+Thriftauthor=G.+Thurstonauthor=T.+Tillmannauthor=M.+Tonelliauthor=F.+Topouzisauthor=H.+Toyoshimaauthor=J.+Traebertauthor=B.+Tranauthor=M.+Trilliniauthor=T.+Truelsenauthor=M.+Tsilimbarisauthor=E.+Tuzcuauthor=U.+Uchenduauthor=K.+Ukwajaauthor=E.+Undurragaauthor=S.+Uzunauthor=B.+WH.+Vanauthor=S.+Vijverauthor=G.+CH.+vanauthor=O.+J.+Vanauthor=T.+Vasankariauthor=N.+Venketasubramanianauthor=F.+Violanteauthor=V.+Vlassovauthor=S.+Vollsetauthor=G.+Wagnerauthor=J.+Wagnerauthor=S.+Wallerauthor=X.+Wanauthor=H.+Wangauthor=J.+Wangauthor=L.+Wangauthor=T.+Warouwauthor=S.+Weichenthalauthor=E.+Weiderpassauthor=R.+Weintraubauthor=W.+Wenzhiauthor=A.+Werdeckerauthor=R.+Westermanauthor=H.+Whitefordauthor=J.+Wilkinsonauthor=T.+Williamsauthor=C.+Wolfeauthor=T.+Wolockauthor=A.+Woolfauthor=S.+Wulfauthor=B.+Wurtzauthor=G.+Xuauthor=L.+Yanauthor=Y.+Yanoauthor=P.+Yeauthor=G.+Yent%C3%BCrauthor=P.+Yipauthor=N.+Yonemotoauthor=S.+Yoonauthor=M.+Younisauthor=C.+Yuauthor=M.+Zakiauthor=Y.+Zhaoauthor=Y.+Zhengauthor=D.+Zoniesauthor=X.+Zouauthor=J.+Salomonauthor=A.+Lopezauthor=T.+Vosauthor=GBD+2013+Mortality+and+Causes+of+Death+Collaborators&title=Global%2C+regional%2C+and+national+disability-adjusted+life+years+%28DALYs%29+for+306+diseases+and+injuries+and+healthy+life+expectancy+%28HALE%29+for+188+countries%2C+1990%E2%80%932013%3A+quantifying+the+epidemiological+transition&doi=10.1016%2FS0140-6736%2815%2961340-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2815%2961340-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252815%252961340-X%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DBarber%26aufirst%3DR.%26aulast%3DForeman%26aufirst%3DK.%26aulast%3DAbbasoglu%26aufirst%3DO.%2BA.%26aulast%3DAbd-Allah%26aufirst%3DF.%26aulast%3DAbera%26aufirst%3DS.%26aulast%3DAboyans%26aufirst%3DV.%26aulast%3DAbraham%26aufirst%3DJ.%26aulast%3DAbubakar%26aufirst%3DI.%26aulast%3DAbu-Raddad%26aufirst%3DL.%26aulast%3DAbu-Rmeileh%26aufirst%3DN.%26aulast%3DAchoki%26aufirst%3DT.%26aulast%3DAckerman%26aufirst%3DI.%26aulast%3DAdemi%26aufirst%3DZ.%26aulast%3DAdou%26aufirst%3DA.%26aulast%3DAdsuar%26aufirst%3DJ.%26aulast%3DAfshin%26aufirst%3DA.%26aulast%3DAgardh%26aufirst%3DE.%26aulast%3DAlam%26aufirst%3DS.%26aulast%3DAlasfoor%26aufirst%3DD.%26aulast%3DAlbittar%26aufirst%3DM.%26aulast%3DAlegretti%26aufirst%3DM.%26aulast%3DAlemu%26aufirst%3DZ.%26aulast%3DAlfonso-Cristancho%26aufirst%3DR.%26aulast%3DAlhabib%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DR.%26aulast%3DAlla%26aufirst%3DF.%26aulast%3DAllebeck%26aufirst%3DP.%26aulast%3DAlmazroa%26aufirst%3DM.%26aulast%3DAlsharif%26aufirst%3DU.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DAlvis-Guzman%26aufirst%3DN.%26aulast%3DAmare%26aufirst%3DA.%26aulast%3DAmeh%26aufirst%3DE.%26aulast%3DAmini%26aufirst%3DH.%26aulast%3DAmmar%26aufirst%3DW.%26aulast%3DAnderson%26aufirst%3DH.%26aulast%3DAnderson%26aufirst%3DB.%26aulast%3DAntonio%26aufirst%3DC.%26aulast%3DAnwari%26aufirst%3DP.%26aulast%3DArnl%25C3%25B6v%26aufirst%3DJ.%26aulast%3DArsic%2BArsenijevic%26aufirst%3DV.%26aulast%3DArtaman%26aufirst%3DA.%26aulast%3DAsghar%26aufirst%3DR.%26aulast%3DAssadi%26aufirst%3DR.%26aulast%3DAtkins%26aufirst%3DL.%26aulast%3DAvila%26aufirst%3DM.%26aulast%3DAwuah%26aufirst%3DB.%26aulast%3DBachman%26aufirst%3DV.%26aulast%3DBadawi%26aufirst%3DA.%26aulast%3DBahit%26aufirst%3DM.%26aulast%3DBalakrishnan%26aufirst%3DK.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DBarker-Collo%26aufirst%3DS.%26aulast%3DBarquera%26aufirst%3DS.%26aulast%3DBarregard%26aufirst%3DL.%26aulast%3DBarrero%26aufirst%3DL.%26aulast%3DBasu%26aufirst%3DA.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DBasulaiman%26aufirst%3DM.%26aulast%3DBeardsley%26aufirst%3DJ.%26aulast%3DBedi%26aufirst%3DN.%26aulast%3DBeghi%26aufirst%3DE.%26aulast%3DBekele%26aufirst%3DT.%26aulast%3DBell%26aufirst%3DM.%26aulast%3DBenjet%26aufirst%3DC.%26aulast%3DBennett%26aufirst%3DD.%26aulast%3DBensenor%26aufirst%3DI.%26aulast%3DBenzian%26aufirst%3DH.%26aulast%3DBernab%25C3%25A9%26aufirst%3DE.%26aulast%3DBertozzi-Villa%26aufirst%3DA.%26aulast%3DBeyene%26aufirst%3DT.%26aulast%3DBhala%26aufirst%3DN.%26aulast%3DBhalla%26aufirst%3DA.%26aulast%3DBhutta%26aufirst%3DZ.%26aulast%3DBienhoff%26aufirst%3DK.%26aulast%3DBikbov%26aufirst%3DB.%26aulast%3DBiryukov%26aufirst%3DS.%26aulast%3DBlore%26aufirst%3DJ.%26aulast%3DBlosser%26aufirst%3DC.%26aulast%3DBlyth%26aufirst%3DF.%26aulast%3DBohensky%26aufirst%3DM.%26aulast%3DBolliger%26aufirst%3DI.%26aulast%3DBora%26aufirst%3DB.%2BB.%26aulast%3DBornstein%26aufirst%3DN.%26aulast%3DBose%26aufirst%3DD.%26aulast%3DBoufous%26aufirst%3DS.%26aulast%3DBourne%26aufirst%3DR.%26aulast%3DBoyers%26aufirst%3DL.%26aulast%3DBrainin%26aufirst%3DM.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DBrazinova%26aufirst%3DA.%26aulast%3DBreitborde%26aufirst%3DN.%26aulast%3DBrenner%26aufirst%3DH.%26aulast%3DBriggs%26aufirst%3DA.%26aulast%3DBrooks%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DBrugha%26aufirst%3DT.%26aulast%3DBuchbinder%26aufirst%3DR.%26aulast%3DBuckle%26aufirst%3DG.%26aulast%3DBudke%26aufirst%3DC.%26aulast%3DBulchis%26aufirst%3DA.%26aulast%3DBulloch%26aufirst%3DA.%26aulast%3DCampos-Nonato%26aufirst%3DI.%26aulast%3DCarabin%26aufirst%3DH.%26aulast%3DCarapetis%26aufirst%3DJ.%26aulast%3DC%25C3%25A1rdenas%26aufirst%3DR.%26aulast%3DCarpenter%26aufirst%3DD.%26aulast%3DCaso%26aufirst%3DV.%26aulast%3DCasta%25C3%25B1eda-Orjuela%26aufirst%3DC.%26aulast%3DCastro%26aufirst%3DR.%26aulast%3DCatal%25C3%25A1-L%25C3%25B3pez%26aufirst%3DF.%26aulast%3DCavalleri%26aufirst%3DF.%26aulast%3D%25C3%2587avlin%26aufirst%3DA.%26aulast%3DChadha%26aufirst%3DV.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DCharlson%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DChimed-Ochir%26aufirst%3DO.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DChristensen%26aufirst%3DH.%26aulast%3DChristophi%26aufirst%3DC.%26aulast%3DCirillo%26aufirst%3DM.%26aulast%3DCoates%26aufirst%3DM.%26aulast%3DCoffeng%26aufirst%3DL.%26aulast%3DCoggeshall%26aufirst%3DM.%26aulast%3DColistro%26aufirst%3DV.%26aulast%3DColquhoun%26aufirst%3DS.%26aulast%3DCooke%26aufirst%3DG.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DCooper%26aufirst%3DL.%26aulast%3DCoppola%26aufirst%3DL.%26aulast%3DCortinovis%26aufirst%3DM.%26aulast%3DCriqui%26aufirst%3DM.%26aulast%3DCrump%26aufirst%3DJ.%26aulast%3DCuevas-Nasu%26aufirst%3DL.%26aulast%3DDanawi%26aufirst%3DH.%26aulast%3DDandona%26aufirst%3DL.%26aulast%3DDandona%26aufirst%3DR.%26aulast%3DDansereau%26aufirst%3DE.%26aulast%3DDargan%26aufirst%3DP.%26aulast%3DDavey%26aufirst%3DG.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DDavitoiu%26aufirst%3DD.%26aulast%3DDayama%26aufirst%3DA.%26aulast%3DDe%2BLeo%26aufirst%3DD.%26aulast%3DDegenhardt%26aufirst%3DL.%26aulast%3DDel%2BPozo-Cruz%26aufirst%3DB.%26aulast%3DDellavalle%26aufirst%3DR.%26aulast%3DDeribe%26aufirst%3DK.%26aulast%3DDerrett%26aufirst%3DS.%26aulast%3DDes%2BJarlais%26aufirst%3DD.%26aulast%3DDessalegn%26aufirst%3DM.%26aulast%3DDharmaratne%26aufirst%3DS.%26aulast%3DDherani%26aufirst%3DM.%26aulast%3DDiaz-Torn%25C3%25A9%26aufirst%3DC.%26aulast%3DDicker%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DE.%26aulast%3DDokova%26aufirst%3DK.%26aulast%3DDorsey%26aufirst%3DE.%26aulast%3DDriscoll%26aufirst%3DT.%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DDuber%26aufirst%3DH.%26aulast%3DEbel%26aufirst%3DB.%26aulast%3DEdmond%26aufirst%3DK.%26aulast%3DElshrek%26aufirst%3DY.%26aulast%3DEndres%26aufirst%3DM.%26aulast%3DErmakov%26aufirst%3DS.%26aulast%3DErskine%26aufirst%3DH.%26aulast%3DEshrati%26aufirst%3DB.%26aulast%3DEsteghamati%26aufirst%3DA.%26aulast%3DEstep%26aufirst%3DK.%26aulast%3DFaraon%26aufirst%3DE.%26aulast%3DFarzadfar%26aufirst%3DF.%26aulast%3DFay%26aufirst%3DD.%26aulast%3DFeigin%26aufirst%3DV.%26aulast%3DFelson%26aufirst%3DD.%26aulast%3DFereshtehnejad%26aufirst%3DS.%26aulast%3DFernandes%26aufirst%3DJ.%26aulast%3DFerrari%26aufirst%3DA.%26aulast%3DFitzmaurice%26aufirst%3DC.%26aulast%3DFlaxman%26aufirst%3DA.%26aulast%3DFleming%26aufirst%3DT.%26aulast%3DFoigt%26aufirst%3DN.%26aulast%3DForouzanfar%26aufirst%3DM.%26aulast%3DFowkes%26aufirst%3DF.%26aulast%3DPaleo%26aufirst%3DU.%26aulast%3DFranklin%26aufirst%3DR.%26aulast%3DF%25C3%25BCrst%26aufirst%3DT.%26aulast%3DGabbe%26aufirst%3DB.%26aulast%3DGaffikin%26aufirst%3DL.%26aulast%3DGankp%25C3%25A9%26aufirst%3DF.%26aulast%3DGeleijnse%26aufirst%3DJ.%26aulast%3DGessner%26aufirst%3DB.%26aulast%3DGething%26aufirst%3DP.%26aulast%3DGibney%26aufirst%3DK.%26aulast%3DGiroud%26aufirst%3DM.%26aulast%3DGiussani%26aufirst%3DG.%26aulast%3DGomez%2BDantes%26aufirst%3DH.%26aulast%3DGona%26aufirst%3DP.%26aulast%3DGonz%25C3%25A1lez-Medina%26aufirst%3DD.%26aulast%3DGosselin%26aufirst%3DR.%26aulast%3DGotay%26aufirst%3DC.%26aulast%3DGoto%26aufirst%3DA.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DGraetz%26aufirst%3DN.%26aulast%3DGugnani%26aufirst%3DH.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DR.%26aulast%3DHaagsma%26aufirst%3DJ.%26aulast%3DHafezi-Nejad%26aufirst%3DN.%26aulast%3DHagan%26aufirst%3DH.%26aulast%3DHalasa%26aufirst%3DY.%26aulast%3DHamadeh%26aufirst%3DR.%26aulast%3DHamavid%26aufirst%3DH.%26aulast%3DHammami%26aufirst%3DM.%26aulast%3DHancock%26aufirst%3DJ.%26aulast%3DHankey%26aufirst%3DG.%26aulast%3DHansen%26aufirst%3DG.%26aulast%3DHao%26aufirst%3DY.%26aulast%3DHarb%26aufirst%3DH.%26aulast%3DHaro%26aufirst%3DJ.%26aulast%3DHavmoeller%26aufirst%3DR.%26aulast%3DHay%26aufirst%3DS.%26aulast%3DHay%26aufirst%3DR.%26aulast%3DHeredia-Pi%26aufirst%3DI.%26aulast%3DHeuton%26aufirst%3DK.%26aulast%3DHeydarpour%26aufirst%3DP.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DHijar%26aufirst%3DM.%26aulast%3DHoek%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DH.%26aulast%3DHosgood%26aufirst%3DH.%26aulast%3DHossain%26aufirst%3DM.%26aulast%3DHotez%26aufirst%3DP.%26aulast%3DHoy%26aufirst%3DD.%26aulast%3DHsairi%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DHusseini%26aufirst%3DA.%26aulast%3DHuynh%26aufirst%3DC.%26aulast%3DIannarone%26aufirst%3DM.%26aulast%3DIburg%26aufirst%3DK.%26aulast%3DInnos%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIslami%26aufirst%3DF.%26aulast%3DJacobsen%26aufirst%3DK.%26aulast%3DJarvis%26aufirst%3DD.%26aulast%3DJassal%26aufirst%3DS.%26aulast%3DJee%26aufirst%3DS.%26aulast%3DJeemon%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DP.%26aulast%3DJha%26aufirst%3DV.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJonas%26aufirst%3DJ.%26aulast%3DJuel%26aufirst%3DK.%26aulast%3DKan%26aufirst%3DH.%26aulast%3DKarch%26aufirst%3DA.%26aulast%3DKarema%26aufirst%3DC.%26aulast%3DKarimkhani%26aufirst%3DC.%26aulast%3DKarthikeyan%26aufirst%3DG.%26aulast%3DKassebaum%26aufirst%3DN.%26aulast%3DKaul%26aufirst%3DA.%26aulast%3DKawakami%26aufirst%3DN.%26aulast%3DKazanjan%26aufirst%3DK.%26aulast%3DKemp%26aufirst%3DA.%26aulast%3DKengne%26aufirst%3DA.%26aulast%3DKeren%26aufirst%3DA.%26aulast%3DKhader%26aufirst%3DY.%26aulast%3DKhalifa%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DE.%26aulast%3DKhan%26aufirst%3DG.%26aulast%3DKhang%26aufirst%3DY.%26aulast%3DKieling%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DKinfu%26aufirst%3DY.%26aulast%3DKinge%26aufirst%3DJ.%26aulast%3DKivipelto%26aufirst%3DM.%26aulast%3DKnibbs%26aufirst%3DL.%26aulast%3DKnudsen%26aufirst%3DA.%26aulast%3DKokubo%26aufirst%3DY.%26aulast%3DKosen%26aufirst%3DS.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DKuate%2BDefo%26aufirst%3DB.%26aulast%3DKucuk%2BBicer%26aufirst%3DB.%26aulast%3DKuipers%26aufirst%3DE.%26aulast%3DKulkarni%26aufirst%3DC.%26aulast%3DKulkarni%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DG.%26aulast%3DKyu%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DT.%26aulast%3DLalloo%26aufirst%3DR.%26aulast%3DLallukka%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLan%26aufirst%3DQ.%26aulast%3DLansingh%26aufirst%3DV.%26aulast%3DLarsson%26aufirst%3DA.%26aulast%3DLawrynowicz%26aufirst%3DA.%26aulast%3DLeasher%26aufirst%3DJ.%26aulast%3DLeigh%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DR.%26aulast%3DLevitz%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DLind%26aufirst%3DM.%26aulast%3DLipshultz%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLloyd%26aufirst%3DB.%26aulast%3DLofgren%26aufirst%3DK.%26aulast%3DLogroscino%26aufirst%3DG.%26aulast%3DLooker%26aufirst%3DK.%26aulast%3DLortet-Tieulent%26aufirst%3DJ.%26aulast%3DLotufo%26aufirst%3DP.%26aulast%3DLozano%26aufirst%3DR.%26aulast%3DLucas%26aufirst%3DR.%26aulast%3DLunevicius%26aufirst%3DR.%26aulast%3DLyons%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMacintyre%26aufirst%3DM.%26aulast%3DMackay%26aufirst%3DM.%26aulast%3DMajdan%26aufirst%3DM.%26aulast%3DMalekzadeh%26aufirst%3DR.%26aulast%3DMarcenes%26aufirst%3DW.%26aulast%3DMargolis%26aufirst%3DD.%26aulast%3DMargono%26aufirst%3DC.%26aulast%3DMarzan%26aufirst%3DM.%26aulast%3DMasci%26aufirst%3DJ.%26aulast%3DMashal%26aufirst%3DM.%26aulast%3DMatzopoulos%26aufirst%3DR.%26aulast%3DMayosi%26aufirst%3DB.%26aulast%3DMazorodze%26aufirst%3DT.%26aulast%3DMcgill%26aufirst%3DN.%26aulast%3DMcgrath%26aufirst%3DJ.%26aulast%3DMckee%26aufirst%3DM.%26aulast%3DMclain%26aufirst%3DA.%26aulast%3DMeaney%26aufirst%3DP.%26aulast%3DMedina%26aufirst%3DC.%26aulast%3DMehndiratta%26aufirst%3DM.%26aulast%3DMekonnen%26aufirst%3DW.%26aulast%3DMelaku%26aufirst%3DY.%26aulast%3DMeltzer%26aufirst%3DM.%26aulast%3DMemish%26aufirst%3DZ.%26aulast%3DMensah%26aufirst%3DG.%26aulast%3DMeretoja%26aufirst%3DA.%26aulast%3DMhimbira%26aufirst%3DF.%26aulast%3DMicha%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DMills%26aufirst%3DE.%26aulast%3DMitchell%26aufirst%3DP.%26aulast%3DMock%26aufirst%3DC.%26aulast%3DMohamed%2BIbrahim%26aufirst%3DN.%26aulast%3DMohammad%26aufirst%3DK.%26aulast%3DMokdad%26aufirst%3DA.%26aulast%3DMola%26aufirst%3DG.%26aulast%3DMonasta%26aufirst%3DL.%26aulast%3DMonta%25C3%25B1ez%2BHernandez%26aufirst%3DJ.%26aulast%3DMontico%26aufirst%3DM.%26aulast%3DMontine%26aufirst%3DT.%26aulast%3DMooney%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DMoradi-Lakeh%26aufirst%3DM.%26aulast%3DMoran%26aufirst%3DA.%26aulast%3DMori%26aufirst%3DR.%26aulast%3DMoschandreas%26aufirst%3DJ.%26aulast%3DMoturi%26aufirst%3DW.%26aulast%3DMoyer%26aufirst%3DM.%26aulast%3DMozaffarian%26aufirst%3DD.%26aulast%3DMsemburi%26aufirst%3DW.%26aulast%3DMueller%26aufirst%3DU.%26aulast%3DMukaigawara%26aufirst%3DM.%26aulast%3DMullany%26aufirst%3DE.%26aulast%3DMurdoch%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DMurthy%26aufirst%3DK.%26aulast%3DNaghavi%26aufirst%3DM.%26aulast%3DNaheed%26aufirst%3DA.%26aulast%3DNaidoo%26aufirst%3DK.%26aulast%3DNaldi%26aufirst%3DL.%26aulast%3DNand%26aufirst%3DD.%26aulast%3DNangia%26aufirst%3DV.%26aulast%3DNarayan%26aufirst%3DK.%26aulast%3DNejjari%26aufirst%3DC.%26aulast%3DNeupane%26aufirst%3DS.%26aulast%3DNewton%26aufirst%3DC.%26aulast%3DNg%26aufirst%3DM.%26aulast%3DNgalesoni%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DNisar%26aufirst%3DM.%26aulast%3DNolte%26aufirst%3DS.%26aulast%3DNorheim%26aufirst%3DO.%26aulast%3DNorman%26aufirst%3DR.%26aulast%3DNorrving%26aufirst%3DB.%26aulast%3DNyakarahuka%26aufirst%3DL.%26aulast%3DOh%26aufirst%3DI.%26aulast%3DOhkubo%26aufirst%3DT.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DOlusanya%26aufirst%3DB.%26aulast%3DOpio%26aufirst%3DJ.%26aulast%3DOrtblad%26aufirst%3DK.%26aulast%3DOrtiz%26aufirst%3DA.%26aulast%3DPain%26aufirst%3DA.%26aulast%3DPandian%26aufirst%3DJ.%26aulast%3DPanelo%26aufirst%3DC.%26aulast%3DPapachristou%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DPatten%26aufirst%3DS.%26aulast%3DPatton%26aufirst%3DG.%26aulast%3DPaul%26aufirst%3DV.%26aulast%3DPavlin%26aufirst%3DB.%26aulast%3DPearce%26aufirst%3DN.%26aulast%3DPereira%26aufirst%3DD.%26aulast%3DPerez-Padilla%26aufirst%3DR.%26aulast%3DPerez-Ruiz%26aufirst%3DF.%26aulast%3DPerico%26aufirst%3DN.%26aulast%3DPervaiz%26aufirst%3DA.%26aulast%3DPesudovs%26aufirst%3DK.%26aulast%3DPeterson%26aufirst%3DC.%26aulast%3DPetzold%26aufirst%3DM.%26aulast%3DPhillips%26aufirst%3DM.%26aulast%3DPhillips%26aufirst%3DB.%26aulast%3DPhillips%26aufirst%3DD.%26aulast%3DPiel%26aufirst%3DF.%26aulast%3DPlass%26aufirst%3DD.%26aulast%3DPoenaru%26aufirst%3DD.%26aulast%3DPolinder%26aufirst%3DS.%26aulast%3DPope%26aufirst%3DD.%26aulast%3DPopova%26aufirst%3DS.%26aulast%3DPoulton%26aufirst%3DR.%26aulast%3DPourmalek%26aufirst%3DF.%26aulast%3DPrabhakaran%26aufirst%3DD.%26aulast%3DPrasad%26aufirst%3DN.%26aulast%3DPullan%26aufirst%3DR.%26aulast%3DQato%26aufirst%3DD.%26aulast%3DQuistberg%26aufirst%3DD.%26aulast%3DRafay%26aufirst%3DA.%26aulast%3DRahimi%26aufirst%3DK.%26aulast%3DRahman%26aufirst%3DS.%26aulast%3DRaju%26aufirst%3DM.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DRazavi%26aufirst%3DH.%26aulast%3DReddy%26aufirst%3DK.%26aulast%3DRefaat%26aufirst%3DA.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DResnikoff%26aufirst%3DS.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DRichardson%26aufirst%3DL.%26aulast%3DRichardus%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DD.%26aulast%3DRojas-Rueda%26aufirst%3DD.%26aulast%3DRonfani%26aufirst%3DL.%26aulast%3DRoth%26aufirst%3DG.%26aulast%3DRothenbacher%26aufirst%3DD.%26aulast%3DRothstein%26aufirst%3DD.%26aulast%3DRowley%26aufirst%3DJ.%26aulast%3DRoy%26aufirst%3DN.%26aulast%3DRuhago%26aufirst%3DG.%26aulast%3DSaeedi%26aufirst%3DM.%26aulast%3DSaha%26aufirst%3DS.%26aulast%3DSahraian%26aufirst%3DM.%26aulast%3DSampson%26aufirst%3DU.%26aulast%3DSanabria%26aufirst%3DJ.%26aulast%3DSandar%26aufirst%3DL.%26aulast%3DSantos%26aufirst%3DI.%26aulast%3DSatpathy%26aufirst%3DM.%26aulast%3DSawhney%26aufirst%3DM.%26aulast%3DScarborough%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DI.%26aulast%3DSch%25C3%25B6ttker%26aufirst%3DB.%26aulast%3DSchumacher%26aufirst%3DA.%26aulast%3DSchwebel%26aufirst%3DD.%26aulast%3DScott%26aufirst%3DJ.%26aulast%3DSeedat%26aufirst%3DS.%26aulast%3DSepanlou%26aufirst%3DS.%26aulast%3DSerina%26aufirst%3DP.%26aulast%3DServan-Mori%26aufirst%3DE.%26aulast%3DShackelford%26aufirst%3DK.%26aulast%3DShaheen%26aufirst%3DA.%26aulast%3DShahraz%26aufirst%3DS.%26aulast%3DShamah%2BLevy%26aufirst%3DT.%26aulast%3DShangguan%26aufirst%3DS.%26aulast%3DShe%26aufirst%3DJ.%26aulast%3DSheikhbahaei%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DP.%26aulast%3DShibuya%26aufirst%3DK.%26aulast%3DShinohara%26aufirst%3DY.%26aulast%3DShiri%26aufirst%3DR.%26aulast%3DShishani%26aufirst%3DK.%26aulast%3DShiue%26aufirst%3DI.%26aulast%3DShrime%26aufirst%3DM.%26aulast%3DSigfusdottir%26aufirst%3DI.%26aulast%3DSilberberg%26aufirst%3DD.%26aulast%3DSimard%26aufirst%3DE.%26aulast%3DSindi%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DL.%26aulast%3DSkirbekk%26aufirst%3DV.%26aulast%3DSlepak%26aufirst%3DE.%26aulast%3DSliwa%26aufirst%3DK.%26aulast%3DSoneji%26aufirst%3DS.%26aulast%3DS%25C3%25B8reide%26aufirst%3DK.%26aulast%3DSoshnikov%26aufirst%3DS.%26aulast%3DSposato%26aufirst%3DL.%26aulast%3DSreeramareddy%26aufirst%3DC.%26aulast%3DStanaway%26aufirst%3DJ.%26aulast%3DStathopoulou%26aufirst%3DV.%26aulast%3DStein%26aufirst%3DD.%26aulast%3DStein%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DT.%26aulast%3DStevens%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DA.%26aulast%3DStovner%26aufirst%3DL.%26aulast%3DStroumpoulis%26aufirst%3DK.%26aulast%3DSunguya%26aufirst%3DB.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DSwaroop%26aufirst%3DM.%26aulast%3DSykes%26aufirst%3DB.%26aulast%3DTabb%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DTandon%26aufirst%3DN.%26aulast%3DTanne%26aufirst%3DD.%26aulast%3DTanner%26aufirst%3DM.%26aulast%3DTavakkoli%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DH.%26aulast%3DTe%2BAo%26aufirst%3DB.%26aulast%3DTediosi%26aufirst%3DF.%26aulast%3DTemesgen%26aufirst%3DA.%26aulast%3DTemplin%26aufirst%3DT.%26aulast%3DTen%2BHave%26aufirst%3DM.%26aulast%3DTenkorang%26aufirst%3DE.%26aulast%3DTerkawi%26aufirst%3DA.%26aulast%3DThomson%26aufirst%3DB.%26aulast%3DThorne-Lyman%26aufirst%3DA.%26aulast%3DThrift%26aufirst%3DA.%26aulast%3DThurston%26aufirst%3DG.%26aulast%3DTillmann%26aufirst%3DT.%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DTopouzis%26aufirst%3DF.%26aulast%3DToyoshima%26aufirst%3DH.%26aulast%3DTraebert%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DB.%26aulast%3DTrillini%26aufirst%3DM.%26aulast%3DTruelsen%26aufirst%3DT.%26aulast%3DTsilimbaris%26aufirst%3DM.%26aulast%3DTuzcu%26aufirst%3DE.%26aulast%3DUchendu%26aufirst%3DU.%26aulast%3DUkwaja%26aufirst%3DK.%26aulast%3DUndurraga%26aufirst%3DE.%26aulast%3DUzun%26aufirst%3DS.%26aulast%3DVan%26aufirst%3DB.%2BWH.%26aulast%3DVijver%26aufirst%3DS.%26aulast%3Dvan%26aufirst%3DG.%2BCH.%26aulast%3DVan%26aufirst%3DO.%2BJ.%26aulast%3DVasankari%26aufirst%3DT.%26aulast%3DVenketasubramanian%26aufirst%3DN.%26aulast%3DViolante%26aufirst%3DF.%26aulast%3DVlassov%26aufirst%3DV.%26aulast%3DVollset%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DWaller%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWarouw%26aufirst%3DT.%26aulast%3DWeichenthal%26aufirst%3DS.%26aulast%3DWeiderpass%26aufirst%3DE.%26aulast%3DWeintraub%26aufirst%3DR.%26aulast%3DWenzhi%26aufirst%3DW.%26aulast%3DWerdecker%26aufirst%3DA.%26aulast%3DWesterman%26aufirst%3DR.%26aulast%3DWhiteford%26aufirst%3DH.%26aulast%3DWilkinson%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DT.%26aulast%3DWolfe%26aufirst%3DC.%26aulast%3DWolock%26aufirst%3DT.%26aulast%3DWoolf%26aufirst%3DA.%26aulast%3DWulf%26aufirst%3DS.%26aulast%3DWurtz%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DYano%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DP.%26aulast%3DYent%25C3%25BCr%26aufirst%3DG.%26aulast%3DYip%26aufirst%3DP.%26aulast%3DYonemoto%26aufirst%3DN.%26aulast%3DYoon%26aufirst%3DS.%26aulast%3DYounis%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZaki%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DZonies%26aufirst%3DD.%26aulast%3DZou%26aufirst%3DX.%26aulast%3DSalomon%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DA.%26aulast%3DVos%26aufirst%3DT.%26aulast%3D%26atitle%3DGlobal%252C%2520regional%252C%2520and%2520national%2520disability-adjusted%2520life%2520years%2520%2528DALYs%2529%2520for%2520306%2520diseases%2520and%2520injuries%2520and%2520healthy%2520life%2520expectancy%2520%2528HALE%2529%2520for%2520188%2520countries%252C%25201990%25E2%2580%25932013%253A%2520quantifying%2520the%2520epidemiological%2520transition%26jtitle%3DLancet%26date%3D2015%26volume%3D386%26spage%3D2145%26epage%3D2191%26doi%3D10.1016%2FS0140-6736%2815%2961340-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Torreele, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdin Trunz, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweats, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazue, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bray, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecoul, B.</span><span> </span><span class="NLM_article-title">Fexinidazole - a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e923</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0000923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0000923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=21200426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=e923&author=E.+Torreeleauthor=B.+B.+Bourdin+Trunzauthor=D.+Tweatsauthor=M.+Kaiserauthor=R.+Brunauthor=G.+Mazueauthor=M.+A.+Brayauthor=B.+Pecoul&title=Fexinidazole+-+a+new+oral+nitroimidazole+drug+candidate+entering+clinical+development+for+the+treatment+of+sleeping+sickness&doi=10.1371%2Fjournal.pntd.0000923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Fexinidazole - a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness</span></div><div class="casAuthors">Torreele, Els; Trunz, Bernadette Bourdin; Tweats, David; Kaiser, Marcel; Brun, Reto; Mazue, Guy; Bray, Michael A.; Pecoul, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e923</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Human African trypanosomiasis (HAT), also known as sleeping sickness, is a fatal parasitic disease caused by trypanosomes.  Current treatment options for HAT are scarce, toxic, no longer effective, or very difficult to administer, in particular for the advanced, fatal stage of the disease (stage 2, chronic HAT).  New safe, effective and easy-to-use treatments are urgently needed.  Here it is shown that fexinidazole, a 2-substituted 5-nitroimidazole rediscovered by the Drugs for Neglected Diseases initiative (DNDi) after extensive compd. mining efforts of more than 700 new and existing nitroheterocycles, could be a short-course, safe and effective oral treatment curing both acute and chronic HAT and that could be implemented at the primary health care level.  To complete the preclin. development and meet the regulatory requirements before initiating human trials, the anti-parasitic properties and the pharmacokinetic, metabolic and toxicol. profile of fexinidazole have been assessed.  Methods and Findings: Std. in vitro and in vivo anti-parasitic activity assays were conducted to assess drug efficacy in exptl. models for HAT.  In parallel, a full range of preclin. pharmacol. and safety studies, as required by international regulatory guidelines before initiating human studies, have been conducted.  Fexinidazole is moderately active in vitro against African trypanosomes (IC50 against lab. strains and recent clin. isolates ranged between 0.16 and 0.93 μg/mL) and oral administration of fexinidazole at doses of 100 mg/kg/day for 4 days or 200 mg/kg/day for 5 days cured mice with acute and chronic infection resp., the latter being a model for the advanced and fatal stage of the disease when parasites have disseminated into the brain.  In lab. animals, fexinidazole is well absorbed after oral administration and readily distributes throughout the body, including the brain.  The abs. bioavailability of oral fexinidazole was 41% in mice, 30% in rats, and 10% in dogs.  Furthermore, fexinidazole is rapidly metabolised in vivo to at least two biol. active metabolites (a sulfoxide and a sulfone deriv.) that likely account for a significant portion of the therapeutic effect.  Key pharmacokinetic parameter after oral absorption in mice for fexinidazole and its sulfoxide and sulfone metabolites are a Cmax of 500, 14171 and 13651 ng/mL resp., and an AUC0-24 of 424, 45031 and 96286 h.ng/mL resp.  Essentially similar PK profiles were obsd. in rats and dogs.  Toxicol. studies (including safety pharmacol. and 4-wk repeated-dose toxicokinetics in rat and dog) have shown that fexinidazole is well tolerated.  The No Obsd. Adverse Event Levels in the 4-wk repeated dose toxicity studies in rats and dogs was 200 mg/kg/day in both species, with no issues of concern identified for doses up to 800 mg/kg/day.  While fexinidazole, like many nitroheterocycles, is mutagenic in the Ames test due to bacterial specific metab., it is not genotoxic to mammalian cells in vitro or in vivo as assessed in an in vitro micronucleus test on human lymphocytes, an in vivo mouse bone marrow micronucleus test, and an ex vivo unscheduled DNA synthesis test in rats.  Conclusions: The results of the preclin. pharmacol. and safety studies indicate that fexinidazole is a safe and effective oral drug candidate with no untoward effects that would preclude evaluation in man.  The drug has entered first-in-human phase I studies in Sept. 2009.  Fexinidazole is the first new clin. drug candidate with the potential for treating advanced-stage sleeping sickness in thirty years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkpYEKJhyyK7Vg90H21EOLACvtfcHk0ljWj1te80Ibqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFSktA%253D%253D&md5=7994f4610c816d1ba018d238e5c00759</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0000923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0000923%26sid%3Dliteratum%253Aachs%26aulast%3DTorreele%26aufirst%3DE.%26aulast%3DBourdin%2BTrunz%26aufirst%3DB.%2BB.%26aulast%3DTweats%26aufirst%3DD.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DMazue%26aufirst%3DG.%26aulast%3DBray%26aufirst%3DM.%2BA.%26aulast%3DPecoul%26aufirst%3DB.%26atitle%3DFexinidazole%2520-%2520a%2520new%2520oral%2520nitroimidazole%2520drug%2520candidate%2520entering%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520sleeping%2520sickness%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2010%26volume%3D4%26spage%3De923%26doi%3D10.1371%2Fjournal.pntd.0000923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Burri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nkunku, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merolle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span> </span><span class="NLM_article-title">Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by <i>Trypanosoma brucei gambiense</i>: a randomised trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1425</span><span class="refDoi"> DOI: 10.1016/S0140-6736(00)02141-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0140-6736%2800%2902141-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2000&pages=1419-1425&author=C.+Burriauthor=S.+Nkunkuauthor=A.+Merolleauthor=T.+Smithauthor=J.+Blumauthor=R.+Brun&title=Efficacy+of+new%2C+concise+schedule+for+melarsoprol+in+treatment+of+sleeping+sickness+caused+by+Trypanosoma+brucei+gambiense%3A+a+randomised+trial&doi=10.1016%2FS0140-6736%2800%2902141-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2800%2902141-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252800%252902141-3%26sid%3Dliteratum%253Aachs%26aulast%3DBurri%26aufirst%3DC.%26aulast%3DNkunku%26aufirst%3DS.%26aulast%3DMerolle%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DBlum%26aufirst%3DJ.%26aulast%3DBrun%26aufirst%3DR.%26atitle%3DEfficacy%2520of%2520new%252C%2520concise%2520schedule%2520for%2520melarsoprol%2520in%2520treatment%2520of%2520sleeping%2520sickness%2520caused%2520by%2520Trypanosoma%2520brucei%2520gambiense%253A%2520a%2520randomised%2520trial%26jtitle%3DLancet%26date%3D2000%26volume%3D355%26spage%3D1419%26epage%3D1425%26doi%3D10.1016%2FS0140-6736%2800%2902141-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Burri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeramian, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merolle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serge, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mpanya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutumba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesu, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilenge, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubaki, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mpoto, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munungu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manuel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josenando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohlig, G.</span><span> </span><span class="NLM_article-title">Efficacy, safety, and dose of pafuramidine, a new oral drug for treatment of first stage sleeping sickness, in a phase 2a clinical study and phase 2b randomized clinical studies</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0004362</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0004362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0004362" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=e0004362&author=C.+Burriauthor=P.+D.+Yeramianauthor=J.+L.+Allenauthor=A.+Merolleauthor=K.+K.+Sergeauthor=A.+Mpanyaauthor=P.+Lutumbaauthor=V.+K.+Mesuauthor=C.+M.+Bilengeauthor=J.-P.+Lubakiauthor=A.+M.+Mpotoauthor=M.+Thompsonauthor=B.+Mununguauthor=F.+Manuelauthor=T.+Josenandoauthor=S.+Bernhardauthor=C.+A.+Olsonauthor=J.+Blumauthor=R.+R.+Tidwellauthor=G.+Pohlig&title=Efficacy%2C+safety%2C+and+dose+of+pafuramidine%2C+a+new+oral+drug+for+treatment+of+first+stage+sleeping+sickness%2C+in+a+phase+2a+clinical+study+and+phase+2b+randomized+clinical+studies&doi=10.1371%2Fjournal.pntd.0004362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0004362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0004362%26sid%3Dliteratum%253Aachs%26aulast%3DBurri%26aufirst%3DC.%26aulast%3DYeramian%26aufirst%3DP.%2BD.%26aulast%3DAllen%26aufirst%3DJ.%2BL.%26aulast%3DMerolle%26aufirst%3DA.%26aulast%3DSerge%26aufirst%3DK.%2BK.%26aulast%3DMpanya%26aufirst%3DA.%26aulast%3DLutumba%26aufirst%3DP.%26aulast%3DMesu%26aufirst%3DV.%2BK.%26aulast%3DBilenge%26aufirst%3DC.%2BM.%26aulast%3DLubaki%26aufirst%3DJ.-P.%26aulast%3DMpoto%26aufirst%3DA.%2BM.%26aulast%3DThompson%26aufirst%3DM.%26aulast%3DMunungu%26aufirst%3DB.%26aulast%3DManuel%26aufirst%3DF.%26aulast%3DJosenando%26aufirst%3DT.%26aulast%3DBernhard%26aufirst%3DS.%26aulast%3DOlson%26aufirst%3DC.%2BA.%26aulast%3DBlum%26aufirst%3DJ.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26aulast%3DPohlig%26aufirst%3DG.%26atitle%3DEfficacy%252C%2520safety%252C%2520and%2520dose%2520of%2520pafuramidine%252C%2520a%2520new%2520oral%2520drug%2520for%2520treatment%2520of%2520first%2520stage%2520sleeping%2520sickness%252C%2520in%2520a%2520phase%25202a%2520clinical%2520study%2520and%2520phase%25202b%2520randomized%2520clinical%2520studies%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2016%26volume%3D10%26spage%3De0004362%26doi%3D10.1371%2Fjournal.pntd.0004362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Pohlig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhard, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mpanya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubaki, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mpoto, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munungu, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">N’Tombe, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deo, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutantu, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuikumbi, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintwo, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munungi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macharia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilenge, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesu, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dituvanga, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, C. A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of pafuramidine versus pentamidine maleate for treatment of first stage sleeping sickness in a randomized, comparator-controlled, international phase 3 clinical trial</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0004363</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0004363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0004363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=26882015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtlSrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=e0004363&author=G.+Pohligauthor=S.+C.+Bernhardauthor=J.+Blumauthor=C.+Burriauthor=A.+Mpanyaauthor=J.-P.+Lubakiauthor=A.+M.+Mpotoauthor=B.+F.+Mununguauthor=P.+M.+N%E2%80%99Tombeauthor=G.+K.+Deoauthor=P.+N.+Mutantuauthor=F.+M.+Kuikumbiauthor=A.+F.+Mintwoauthor=A.+K.+Munungiauthor=A.+Dalaauthor=S.+Machariaauthor=C.+M.+Bilengeauthor=V.+K.+Mesuauthor=J.+R.+Francoauthor=N.+D.+Dituvangaauthor=R.+R.+Tidwellauthor=C.+A.+Olson&title=Efficacy+and+safety+of+pafuramidine+versus+pentamidine+maleate+for+treatment+of+first+stage+sleeping+sickness+in+a+randomized%2C+comparator-controlled%2C+international+phase+3+clinical+trial&doi=10.1371%2Fjournal.pntd.0004363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of pafuramidine versus pentamidine maleate for treatment of first stage sleeping sickness in a randomized, comparator-controlled, international phase 3 clinical trial</span></div><div class="casAuthors">Pohlig, Gabriele; Bernhard, Sonja C.; Blum, Johannes; Burri, Christian; Mpanya, Alain; Lubaki, Jean-Pierre Fina; Mpoto, Alfred Mpoo; Munungu, Blaise Fungula; N'tombe, Patrick Mangoni; Deo, Gratias Kambau Manesa; Mutantu, Pierre Nsele; Kuikumbi, Florent Mbo; Mintwo, Alain Fukinsia; Munungi, Augustin Kayeye; Dala, Amadeu; Macharia, Stephen; Bilenge, Constantin Miaka Mia; Mesu, Victor Kande Betu Ku; Franco, Jose Ramon; Dituvanga, Ndinga Dieyi; Tidwell, Richard R.; Olson, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0004363/1-e0004363/17</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background Sleeping sickness (human African trypanosomiasis [HAT]) is a neglected tropical disease with limited treatment options that currently require parenteral administration.  In previous studies, orally administered pafuramidine was well tolerated in healthy patients (for up to 21 days) and stage 1 HAT patients (for up to 10 days), and demonstrated efficacy comparable to pentamidine.  Methods This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis ref. center in Angola, one hospital in South Sudan, and four hospitals in the Democratic Republic of the Congo between August 2005 and Sept. 2009 to support the registration of pafuramidine for treatment of first stage HAT in collaboration with the United States Food and Drug Administration.  Patients were treated with either 100 mg of pafuramidine orally twice a day for 10 days or 4 mg/kg pentamidine i.m. once daily for 7 days to assess the efficacy and safety of pafuramidine vs. pentamidine.  Pregnant and lactating women as well as adolescents were included.  Findings/Conclusions The overall cure rate at 12 mo was 89% in the pafuramidine group and 95% in the pentamidine group; pafuramidine was non-inferior to pentamidine as the upper bound of the 95% confidence interval did not exceed 15%.  The safety profile of pafuramidine was superior to pentamidine; however, 3 patients in the pafuramidine group had glomerulonephritis or nephropathy approx. 8 wk post-treatment.  Two of these events were judged as possibly related to pafuramidine.  Despite good tolerability obsd. in preceding studies, the development program for pafuramidine was discontinued due to delayed post-treatment toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobYFq1MZ-6KLVg90H21EOLACvtfcHk0lgcCD1HIFIovw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtlSrt7g%253D&md5=4198d37a3054b1e05c007458de532dec</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0004363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0004363%26sid%3Dliteratum%253Aachs%26aulast%3DPohlig%26aufirst%3DG.%26aulast%3DBernhard%26aufirst%3DS.%2BC.%26aulast%3DBlum%26aufirst%3DJ.%26aulast%3DBurri%26aufirst%3DC.%26aulast%3DMpanya%26aufirst%3DA.%26aulast%3DLubaki%26aufirst%3DJ.-P.%26aulast%3DMpoto%26aufirst%3DA.%2BM.%26aulast%3DMunungu%26aufirst%3DB.%2BF.%26aulast%3DN%25E2%2580%2599Tombe%26aufirst%3DP.%2BM.%26aulast%3DDeo%26aufirst%3DG.%2BK.%26aulast%3DMutantu%26aufirst%3DP.%2BN.%26aulast%3DKuikumbi%26aufirst%3DF.%2BM.%26aulast%3DMintwo%26aufirst%3DA.%2BF.%26aulast%3DMunungi%26aufirst%3DA.%2BK.%26aulast%3DDala%26aufirst%3DA.%26aulast%3DMacharia%26aufirst%3DS.%26aulast%3DBilenge%26aufirst%3DC.%2BM.%26aulast%3DMesu%26aufirst%3DV.%2BK.%26aulast%3DFranco%26aufirst%3DJ.%2BR.%26aulast%3DDituvanga%26aufirst%3DN.%2BD.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26aulast%3DOlson%26aufirst%3DC.%2BA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520pafuramidine%2520versus%2520pentamidine%2520maleate%2520for%2520treatment%2520of%2520first%2520stage%2520sleeping%2520sickness%2520in%2520a%2520randomized%252C%2520comparator-controlled%252C%2520international%2520phase%25203%2520clinical%2520trial%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2016%26volume%3D10%26spage%3De0004363%26doi%3D10.1371%2Fjournal.pntd.0004363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span>Oxaborole SCYX-7158; <span class="NLM_publisher-name">Drugs for Neglected Diseases Initiative</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.dndi.org/diseases-projects/portfolio/scyx-7158/" class="extLink">http://www.dndi.org/diseases-projects/portfolio/scyx-7158/</a> (accessed March 21,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Oxaborole+SCYX-7158%3B+Drugs+for+Neglected+Diseases+Initiative%2C+2016%3B+http%3A%2F%2Fwww.dndi.org%2Fdiseases-projects%2Fportfolio%2Fscyx-7158%2F+%28accessed+March+21%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DOxaborole%2520SCYX-7158%26pub%3DDrugs%2520for%2520Neglected%2520Diseases%2520Initiative%26date%3D2016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nare, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacchi, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarlett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdulla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ang, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span> </span><span class="NLM_article-title">Discovery of novel benzoxaborole-based potent antitrypanosomal agents</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span><span class="refDoi"> DOI: 10.1021/ml100013s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100013s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1eqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=165-169&author=D.+Dingauthor=Y.+Zhaoauthor=Q.+Mengauthor=D.+Xieauthor=B.+Nareauthor=D.+Chenauthor=C.+J.+Bacchiauthor=N.+Yarlettauthor=Y.-K.+Zhangauthor=V.+Hernandezauthor=Y.+Xiaauthor=Y.+Freundauthor=M.+Abdullaauthor=K.-H.+Angauthor=J.+Ratnamauthor=J.+H.+McKerrowauthor=R.+T.+Jacobsauthor=H.+Zhouauthor=J.+J.+Plattner&title=Discovery+of+novel+benzoxaborole-based+potent+antitrypanosomal+agents&doi=10.1021%2Fml100013s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Benzoxaborole-Based Potent Antitrypanosomal Agents</span></div><div class="casAuthors">Ding, Dazhong; Zhao, Yaxue; Meng, Qingqing; Xie, Dongsheng; Nare, Bakela; Chen, Daitao; Bacchi, Cyrus J.; Yarlett, Nigel; Zhang, Yong-Kang; Hernandez, Vincent; Xia, Yi; Freund, Yvonne; Abdulla, Maha; Ang, Kean-Hooi; Ratnam, Joseline; McKerrow, James H.; Jacobs, Robert T.; Zhou, Huchen; Plattner, Jacob J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">165-169</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery of benzoxaborole antitrypanosomal agents and their structure-activity relationships on central linkage groups and different substitution patterns in the sulfur-linked series.  The compds. showed in vitro growth inhibition IC50 values as low as 0.02 μg/mL and in vivo efficacy in acute murine infection models against Trypanosoma brucei.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Y1XV9J9FOLVg90H21EOLACvtfcHk0ljFMdAzLt0kxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1eqs7o%253D&md5=dd910bb5bdbe3cf2029b6e3c28508486</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fml100013s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100013s%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DBacchi%26aufirst%3DC.%2BJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DAbdulla%26aufirst%3DM.%26aulast%3DAng%26aufirst%3DK.-H.%26aulast%3DRatnam%26aufirst%3DJ.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520benzoxaborole-based%2520potent%2520antitrypanosomal%2520agents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D165%26epage%3D169%26doi%3D10.1021%2Fml100013s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Jacobs, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nare, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sligar, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenks, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noe, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowling, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewerts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaukel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randolph, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacchi, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarlett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Don, R.</span><span> </span><span class="NLM_article-title">SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1151</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0001151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0001151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=21738803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlOgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=e1151&author=R.+T.+Jacobsauthor=B.+Nareauthor=S.+A.+Wringauthor=M.+D.+Orrauthor=D.+Chenauthor=J.+M.+Sligarauthor=M.+X.+Jenksauthor=R.+A.+Noeauthor=T.+S.+Bowlingauthor=L.+T.+Mercerauthor=C.+Rewertsauthor=E.+Gaukelauthor=J.+Owensauthor=R.+Parhamauthor=R.+Randolphauthor=B.+Beaudetauthor=C.+J.+Bacchiauthor=N.+Yarlettauthor=J.+J.+Plattnerauthor=Y.+Freundauthor=C.+Dingauthor=T.+Akamaauthor=Y.+K.+Zhangauthor=R.+Brunauthor=M.+Kaiserauthor=I.+Scandaleauthor=R.+Don&title=SCYX-7158%2C+an+orally-active+benzoxaborole+for+the+treatment+of+stage+2+human+African+trypanosomiasis&doi=10.1371%2Fjournal.pntd.0001151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 Human African trypanosomiasis</span></div><div class="casAuthors">Jacobs, Robert T.; Nare, Bakela; Wring, Stephen A.; Orr, Matthew D.; Chen, Daitao; Sligar, Jessica M.; Jenks, Matthew X.; Noe, Robert A.; Bowling, Tana S.; Mercer, Luke T.; Rewerts, Cindy; Gaukel, Eric; Owens, Jennifer; Parham, Robin; Randolph, Ryan; Beaudet, Beth; Bacchi, Cyrus J.; Yarlett, Nigel; Plattner, Jacob J.; Freund, Yvonne; Ding, Charles; Akama, Tsutomu; Zhang, Y.-K.; Brun, Reto; Kaiser, Marcel; Scandale, Ivan; Don, Robert</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1151</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Human African trypanosomiasis (HAT) is an important public health problem in sub-Saharan Africa, affecting hundreds of thousands of individuals.  An urgent need exists for the discovery and development of new, safe, and effective drugs to treat HAT, as existing therapies suffer from poor safety profiles, difficult treatment regimens, limited effectiveness, and a high cost of goods.  We have discovered and optimized a novel class of small-mol. boron-contg. compds., benzoxaboroles, to identify SCYX-7158 as an effective, safe and orally active treatment for HAT.  Methodol./Principal Findings: A drug discovery project employing integrated biol. screening, medicinal chem. and pharmacokinetic characterization identified SCYX-7158 as an optimized analog, as it is active in vitro against relevant strains of Trypanosoma brucei, including T. b. rhodesiense and T. b. gambiense, is efficacious in both stage 1 and stage 2 murine HAT models and has physicochem. and in vitro absorption, distribution, metab., elimination and toxicol. (ADMET) properties consistent with the compd. being orally available, metabolically stable and CNS permeable.  In a murine stage 2 study, SCYX-7158 is effective orally at doses as low as 12.5 mg/kg (QD × 7 days).  In vivo pharmacokinetic characterization of SCYX-7158 demonstrates that the compd. is highly bioavailable in rodents and non-human primates, has low i.v. plasma clearance and has a 24-h elimination half-life and a vol. of distribution that indicate good tissue distribution.  Most importantly, in rodents brain exposure of SCYX-7158 is high, with Cmax>10 μg/mL and AUC0-24 hr>100 μg*h/mL following a 25 mg/kg oral dose.  Furthermore, SCYX-7158 readily distributes into cerebrospinal fluid to achieve therapeutically relevant concns. in this compartment.  Conclusions/Significance: The biol. and pharmacokinetic properties of SCYX-7158 suggest that this compd. will be efficacious and safe to treat stage 2 HAT.  SCYX-7158 has been selected to enter preclin. studies, with expected progression to phase 1 clin. trials in 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdyaAga5lprVg90H21EOLACvtfcHk0lh82PKlT3_COQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlOgsLY%253D&md5=a54f2d57149e6714c7f6acf5f5280a7d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0001151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0001151%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DOrr%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DSligar%26aufirst%3DJ.%2BM.%26aulast%3DJenks%26aufirst%3DM.%2BX.%26aulast%3DNoe%26aufirst%3DR.%2BA.%26aulast%3DBowling%26aufirst%3DT.%2BS.%26aulast%3DMercer%26aufirst%3DL.%2BT.%26aulast%3DRewerts%26aufirst%3DC.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DOwens%26aufirst%3DJ.%26aulast%3DParham%26aufirst%3DR.%26aulast%3DRandolph%26aufirst%3DR.%26aulast%3DBeaudet%26aufirst%3DB.%26aulast%3DBacchi%26aufirst%3DC.%2BJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DDon%26aufirst%3DR.%26atitle%3DSCYX-7158%252C%2520an%2520orally-active%2520benzoxaborole%2520for%2520the%2520treatment%2520of%2520stage%25202%2520human%2520African%2520trypanosomiasis%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2011%26volume%3D5%26spage%3De1151%26doi%3D10.1371%2Fjournal.pntd.0001151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span>New Oral Drug Candidate for African Sleeping Sickness; <span class="NLM_publisher-name">Drugs for Neglected Diseases Initiative</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.dndi.org/2012/media-centre/press-releases/new-oral-drug-candidate-hat/" class="extLink">http://www.dndi.org/2012/media-centre/press-releases/new-oral-drug-candidate-hat/</a> (accessed March 7, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=New+Oral+Drug+Candidate+for+African+Sleeping+Sickness%3B+Drugs+for+Neglected+Diseases+Initiative%2C+2012%3B+http%3A%2F%2Fwww.dndi.org%2F2012%2Fmedia-centre%2Fpress-releases%2Fnew-oral-drug-candidate-hat%2F+%28accessed+March+7%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Oral%2520Drug%2520Candidate%2520for%2520African%2520Sleeping%2520Sickness%26pub%3DDrugs%2520for%2520Neglected%2520Diseases%2520Initiative%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Tarral, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blesson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordt, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torreele, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bray, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovsepian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evene, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felices, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strub-Wourgaft, N.</span><span> </span><span class="NLM_article-title">Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studies</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1007/s40262-014-0136-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1007%2Fs40262-014-0136-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=24535888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVCmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=565-580&author=A.+Tarralauthor=S.+Blessonauthor=O.+V.+Mordtauthor=E.+Torreeleauthor=D.+Sassellaauthor=M.+A.+Brayauthor=L.+Hovsepianauthor=E.+Eveneauthor=V.+Gualanoauthor=M.+Felicesauthor=N.+Strub-Wourgaft&title=Determination+of+an+optimal+dosing+regimen+for+fexinidazole%2C+a+novel+oral+drug+for+the+treatment+of+human+African+trypanosomiasis%3A+first-in-human+studies&doi=10.1007%2Fs40262-014-0136-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies</span></div><div class="casAuthors">Tarral, Antoine; Blesson, Severine; Mordt, Olaf Valverde; Torreele, Els; Sassella, Daniela; Bray, Michael A.; Hovsepian, Lionel; Evene, Eric; Gualano, Virginie; Felices, Mathieu; Strub-Wourgaft, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-580</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background and Objectives: Fexinidazole is a 5-nitroimidazole recently included in a clin. efficacy trial as an oral drug for the treatment of human African trypanosomiasis (HAT).  Preclin. studies showed it acts as a pharmacol. active pro-drug with two key active metabolites: sulfoxide and sulfone (the most active metabolite).  The present studies aimed to det. the best dose regimen for the treatment of stage 2 sleeping sickness patients, which could eventually also treat stage 1 patients.  Methods: Fexinidazole was assessed in 154 healthy adult male subjects of sub-Saharan African origin.  Three initial first-in-human studies and two addnl. studies assessed a single ascending dose and multiple ascending doses (both under fasted conditions), tablet vs. suspension formulation and food effect (fasted vs. high-fat meal and field-adapted food), and multiple ascending doses with a loading dose regimen under fed conditions.  Results: Fexinidazole was well-tolerated in a single dose from 100 to 3,600 mg, with quick absorption of the parent drug and rapid metab. into sulfoxide [time to max. concn. (tmax) 2-5 h] and sulfone (tmax 18-24 h).  The tablet formulation was approx. 25 % less bioavailable than the suspension, and food intake increased drug absorption and plasma concns. of fexinidazole and its two metabolites by approx. 200 %.  Fourteen-day multiple ascending dosing administered up to 3,600 mg/day in fasted conditions showed that fexinidazole was generally well-tolerated (mild to moderate, spontaneously reversible drug-related adverse events).  Following the high-fat food effect finding, another study was conducted to evaluate the impact of a low-fat regimen closer to that of the target population, showing that the type of meal does not influence fexinidazole absorption.  The last study showed that a loading dose of 1,800 mg/day for 4 days followed by a 1,200 mg/day regimen for 6 days with a normal meal provided the desired exposure of fexinidazole and its metabolites, particularly sulfone, with good tolerability.  Based on preclin. evidence from a chronic infection mouse model, systemic drug concns. obtained are expected to be clin. effective in stage 2 HAT.  Conclusions: These studies show that fexinidazole can be safely assessed in patients as a potential oral cure for both stages of HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpszDba_Qa2j7Vg90H21EOLACvtfcHk0lh82PKlT3_COQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVCmuro%253D&md5=29ec56e974111a2737fc3bfff67d9511</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs40262-014-0136-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-014-0136-3%26sid%3Dliteratum%253Aachs%26aulast%3DTarral%26aufirst%3DA.%26aulast%3DBlesson%26aufirst%3DS.%26aulast%3DMordt%26aufirst%3DO.%2BV.%26aulast%3DTorreele%26aufirst%3DE.%26aulast%3DSassella%26aufirst%3DD.%26aulast%3DBray%26aufirst%3DM.%2BA.%26aulast%3DHovsepian%26aufirst%3DL.%26aulast%3DEvene%26aufirst%3DE.%26aulast%3DGualano%26aufirst%3DV.%26aulast%3DFelices%26aufirst%3DM.%26aulast%3DStrub-Wourgaft%26aufirst%3DN.%26atitle%3DDetermination%2520of%2520an%2520optimal%2520dosing%2520regimen%2520for%2520fexinidazole%252C%2520a%2520novel%2520oral%2520drug%2520for%2520the%2520treatment%2520of%2520human%2520African%2520trypanosomiasis%253A%2520first-in-human%2520studies%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2014%26volume%3D53%26spage%3D565%26epage%3D580%26doi%3D10.1007%2Fs40262-014-0136-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ferrins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span> </span><span class="NLM_article-title">Drug discovery and human African trypanosomiasis: a disease less neglected?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1801</span><span class="NLM_x">–</span> <span class="NLM_lpage">1841</span><span class="refDoi"> DOI: 10.4155/fmc.13.162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.4155%2Ffmc.13.162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=24144414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CitLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1801-1841&author=L.+Ferrinsauthor=R.+Rahmaniauthor=J.+B.+Baell&title=Drug+discovery+and+human+African+trypanosomiasis%3A+a+disease+less+neglected%3F&doi=10.4155%2Ffmc.13.162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery and human African trypanosomiasis: a disease less neglected?</span></div><div class="casAuthors">Ferrins, Lori; Rahmani, Raphael; Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1801-1841</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Human African trypanosomiasis (HAT) has been neglected for a long time.  The most recent drug to treat this disease, eflornithine, was approved by the US FDA in 2000.  Current treatments exhibit numerous problematic side effects and are often ineffective against the debilitating CNS resident stage of the disease.  Fortunately, several partnerships and initiatives have been formed over the last 20 years in an effort to eradicate HAT, along with a no. of other neglected diseases.  This has led to an increasing no. of foundations and research institutions that are currently working on the development of new drugs for HAT and tools with which to diagnose and treat patients.  New biochem. pathways as therapeutic targets are emerging, accompanied by increasing nos. of new antitrypanosomal compd. classes.  The future looks promising that this collaborative approach will facilitate eagerly awaited breakthroughs in the treatment of HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolcnA5AyU6nbVg90H21EOLACvtfcHk0lh82PKlT3_COQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CitLzK&md5=89e0f13e2bd1f3bdb4821ba513754069</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.162%26sid%3Dliteratum%253Aachs%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DRahmani%26aufirst%3DR.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DDrug%2520discovery%2520and%2520human%2520African%2520trypanosomiasis%253A%2520a%2520disease%2520less%2520neglected%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1801%26epage%3D1841%26doi%3D10.4155%2Ffmc.13.162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Feldman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D.</span><span> </span><span class="NLM_article-title">Myocarditis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">1388</span><span class="NLM_x">–</span> <span class="NLM_lpage">1398</span><span class="refDoi"> DOI: 10.1056/NEJM200011093431908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1056%2FNEJM200011093431908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=11070105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A280%3ADC%252BD3M7ksVSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2000&pages=1388-1398&author=A.+M.+Feldmanauthor=D.+McNamara&title=Myocarditis&doi=10.1056%2FNEJM200011093431908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Myocarditis</span></div><div class="casAuthors">Feldman A M; McNamara D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1388-98</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8MybU-tno2zEC-75aqa5AfW6udTcc2eb7gc8EKmWyM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7ksVSitg%253D%253D&md5=2e06776cb3325a8bf86b10d20aeb0cd9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1056%2FNEJM200011093431908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200011093431908%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DA.%2BM.%26aulast%3DMcNamara%26aufirst%3DD.%26atitle%3DMyocarditis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2000%26volume%3D343%26spage%3D1388%26epage%3D1398%26doi%3D10.1056%2FNEJM200011093431908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Pecoul, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batista, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stobbaerts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilasanjuan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinazo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrico, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottazzi, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotez, P. J.</span><span> </span><span class="NLM_article-title">The BENEFIT trial: where do we go from here?</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0004343</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0004343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0004343" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=e0004343&author=B.+Pecoulauthor=C.+Batistaauthor=E.+Stobbaertsauthor=I.+Ribeiroauthor=R.+Vilasanjuanauthor=J.+Gasconauthor=M.+J.+Pinazoauthor=S.+Morianaauthor=S.+Goldauthor=A.+Pereiroauthor=M.+Navarroauthor=F.+Torricoauthor=M.+E.+Bottazziauthor=P.+J.+Hotez&title=The+BENEFIT+trial%3A+where+do+we+go+from+here%3F&doi=10.1371%2Fjournal.pntd.0004343"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0004343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0004343%26sid%3Dliteratum%253Aachs%26aulast%3DPecoul%26aufirst%3DB.%26aulast%3DBatista%26aufirst%3DC.%26aulast%3DStobbaerts%26aufirst%3DE.%26aulast%3DRibeiro%26aufirst%3DI.%26aulast%3DVilasanjuan%26aufirst%3DR.%26aulast%3DGascon%26aufirst%3DJ.%26aulast%3DPinazo%26aufirst%3DM.%2BJ.%26aulast%3DMoriana%26aufirst%3DS.%26aulast%3DGold%26aufirst%3DS.%26aulast%3DPereiro%26aufirst%3DA.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DTorrico%26aufirst%3DF.%26aulast%3DBottazzi%26aufirst%3DM.%2BE.%26aulast%3DHotez%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520BENEFIT%2520trial%253A%2520where%2520do%2520we%2520go%2520from%2520here%253F%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2016%26volume%3D10%26spage%3De0004343%26doi%3D10.1371%2Fjournal.pntd.0004343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bern, C.</span><span> </span><span class="NLM_article-title">Chagas’ disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span><span class="refDoi"> DOI: 10.1056/NEJMra1410150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1056%2FNEJMra1410150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=26222561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=456-466&author=C.+Bern&title=Chagas%E2%80%99+disease&doi=10.1056%2FNEJMra1410150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Chagas' disease</span></div><div class="casAuthors">Bern, Caryn</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">456-466</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Chagas' disease is caused by the protozoan parasite Trypanosomacruzi, which is transmitted when the infected feces of the triatomine vector are inoculated through a bite site or through an intact mucous membrane of the mammalian host (Fig. 1).  Vectorborne transmission is limited to areas of North America, Central America, and South America.  Both in endemic and in nonendemic areas, other infection routes include transfusion, organ and bone marrow transplantation, and congenital transmission.  Outbreaks attributed to contaminated food or drink have been reported in northern South America, where transmission cycles involving wild vector populations and mammalian reservoir hosts are prominent.  Infection is lifelong in the absence of effective treatment.  The most important consequence of T. cruzi infection is cardiomyopathy, which occurs in 20 to 30% of infected persons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZRsRJ4Kkx3rVg90H21EOLACvtfcHk0ljEiPAV9dDgYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLvN&md5=effffe0a68130e3ae87d9648dfe5c5fd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1410150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1410150%26sid%3Dliteratum%253Aachs%26aulast%3DBern%26aufirst%3DC.%26atitle%3DChagas%25E2%2580%2599%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D456%26epage%3D466%26doi%3D10.1056%2FNEJMra1410150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Morillo, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin-Neto, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avezum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosa-Estani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassi, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villena, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiroz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guhl, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeks, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao-Melacini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pogue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazdins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusuf, S.</span><span> </span><span class="NLM_article-title">Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1306</span><span class="refDoi"> DOI: 10.1056/NEJMoa1507574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1056%2FNEJMoa1507574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=26323937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=1295-1306&author=C.+A.+Morilloauthor=J.+A.+Marin-Netoauthor=A.+Avezumauthor=S.+Sosa-Estaniauthor=A.+J.+Rassiauthor=F.+Rosasauthor=E.+Villenaauthor=R.+Quirozauthor=R.+Bonillaauthor=C.+Brittoauthor=F.+Guhlauthor=E.+Velazquezauthor=L.+Bonillaauthor=B.+Meeksauthor=P.+Rao-Melaciniauthor=J.+Pogueauthor=A.+Mattosauthor=J.+Lazdinsauthor=A.+Rassiauthor=S.+J.+Connollyauthor=S.+Yusuf&title=Randomized+trial+of+benznidazole+for+chronic+Chagas%E2%80%99+cardiomyopathy&doi=10.1056%2FNEJMoa1507574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized trial of benznidazole for chronic Chagas' cardiomyopathy</span></div><div class="casAuthors">Morillo, C. A.; Marin-Neto, J. A.; Avezum, A.; Sosa-Estani, S.; Rassi, A., Jr.; Rosas, F.; Villena, E.; Quiroz, R.; Bonilla, R.; Britto, C.; Guhl, F.; Velazquez, E.; Bonilla, L.; Meeks, B.; Rao-Melacini, P.; Pogue, J.; Mattos, A.; Lazdins, J.; Rassi, A.; Connolly, S. J.; Yusuf, S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1295-1306</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The role of trypanocidal therapy in patients with established Chagas' cardiomyopathy is unproven.  We conducted a prospective, multicenter, randomized study involving 2854 patients with Chagas' cardiomyopathy who received benznidazole or placebo for up to 80 days and were followed for a mean of 5.4 years.  The primary outcome in the time-to-event anal. was the first event of any of the components of the composite outcome of death, resuscitated cardiac arrest, sustained ventricular tachycardia, insertion of a pacemaker or implantable cardioverter-defibrillator, cardiac transplantation, new heart failure, stroke, or other thromboembolic event.  The primary outcome occurred in 394 patients (27.5%) in the benznidazole group and in 414 (29.1%) in the placebo group (hazard ratio, 0.93; 95% confidence interval [CI], 0.81 to 1.07; P = 0.31).  At baseline, a polymerase-chain-reaction (PCR) assay was performed on blood samples obtained from 1896 patients; 60.5% had pos. results for Trypanosoma cruzi on PCR.  The rates of conversion to neg. PCR results (PCR conversion) were 66.2% in the benznidazole group and 33.5% in the placebo group at the end of treatment, 55.4% and 35.3%, resp., at 2 years, and 46.7% and 33.1%, resp., at 5 years or more (P<0.001 for all comparisons).  The effect of treatment on PCR conversion varied according to geog. region: in Brazil, the odds ratio for PCR conversion was 3.03 (95% CI, 2.12 to 4.34) at 2 years and 1.87 (95% CI, 1.33 to 2.63) at 5 or more years; in Colombia and El Salvador, the odds ratio was 1.33 (95% CI, 0.90 to 1.98) at 2 years and 0.96 (95% CI, 0.63 to 1.45) at 5 or more years; and in Argentina and Bolivia, the odds ratio was 2.63 (95% CI, 1.89 to 3.66) at 2 years and 2.79 (95% CI, 1.99 to 3.92) at 5 or more years (P<0.001 for interaction).  However, the rates of PCR conversion did not correspond to effects on clin. outcome (P = 0.16 for interaction).  Trypanocidal therapy with benznidazole in patients with established Chagas' cardiomyopathy significantly reduced serum parasite detection but did not significantly reduce cardiac clin. deterioration through 5 years of follow-up.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz_0zFM1DyHLVg90H21EOLACvtfcHk0ljEiPAV9dDgYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSms7g%253D&md5=6386aadfc625824961ff33e01a93ab2e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1507574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1507574%26sid%3Dliteratum%253Aachs%26aulast%3DMorillo%26aufirst%3DC.%2BA.%26aulast%3DMarin-Neto%26aufirst%3DJ.%2BA.%26aulast%3DAvezum%26aufirst%3DA.%26aulast%3DSosa-Estani%26aufirst%3DS.%26aulast%3DRassi%26aufirst%3DA.%2BJ.%26aulast%3DRosas%26aufirst%3DF.%26aulast%3DVillena%26aufirst%3DE.%26aulast%3DQuiroz%26aufirst%3DR.%26aulast%3DBonilla%26aufirst%3DR.%26aulast%3DBritto%26aufirst%3DC.%26aulast%3DGuhl%26aufirst%3DF.%26aulast%3DVelazquez%26aufirst%3DE.%26aulast%3DBonilla%26aufirst%3DL.%26aulast%3DMeeks%26aufirst%3DB.%26aulast%3DRao-Melacini%26aufirst%3DP.%26aulast%3DPogue%26aufirst%3DJ.%26aulast%3DMattos%26aufirst%3DA.%26aulast%3DLazdins%26aufirst%3DJ.%26aulast%3DRassi%26aufirst%3DA.%26aulast%3DConnolly%26aufirst%3DS.%2BJ.%26aulast%3DYusuf%26aufirst%3DS.%26atitle%3DRandomized%2520trial%2520of%2520benznidazole%2520for%2520chronic%2520Chagas%25E2%2580%2599%2520cardiomyopathy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D1295%26epage%3D1306%26doi%3D10.1056%2FNEJMoa1507574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Sgambatti de Andrade, A. L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zicker, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Oliveira, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida e Silva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luquetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travassos, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Andrade, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimaraes de Andrade, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martelli, C. M.</span><span> </span><span class="NLM_article-title">Randomised trial of efficacy of benznidazole in treatment of early <i>Trypanosoma cruzi</i> infection</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">1407</span><span class="NLM_x">–</span> <span class="NLM_lpage">1413</span><span class="refDoi"> DOI: 10.1016/S0140-6736(96)04128-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0140-6736%2896%2904128-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1996&pages=1407-1413&author=A.+L.+S.+Sgambatti+de+Andradeauthor=F.+Zickerauthor=R.+M.+de+Oliveiraauthor=S.+Almeida+e+Silvaauthor=A.+Luquettiauthor=L.+R.+Travassosauthor=I.+C.+Almeidaauthor=S.+S.+de+Andradeauthor=J.+Guimaraes+de+Andradeauthor=C.+M.+Martelli&title=Randomised+trial+of+efficacy+of+benznidazole+in+treatment+of+early+Trypanosoma+cruzi+infection&doi=10.1016%2FS0140-6736%2896%2904128-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2896%2904128-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252896%252904128-1%26sid%3Dliteratum%253Aachs%26aulast%3DSgambatti%2Bde%2BAndrade%26aufirst%3DA.%2BL.%2BS.%26aulast%3DZicker%26aufirst%3DF.%26aulast%3Dde%2BOliveira%26aufirst%3DR.%2BM.%26aulast%3DAlmeida%2Be%2BSilva%26aufirst%3DS.%26aulast%3DLuquetti%26aufirst%3DA.%26aulast%3DTravassos%26aufirst%3DL.%2BR.%26aulast%3DAlmeida%26aufirst%3DI.%2BC.%26aulast%3Dde%2BAndrade%26aufirst%3DS.%2BS.%26aulast%3DGuimaraes%2Bde%2BAndrade%26aufirst%3DJ.%26aulast%3DMartelli%26aufirst%3DC.%2BM.%26atitle%3DRandomised%2520trial%2520of%2520efficacy%2520of%2520benznidazole%2520in%2520treatment%2520of%2520early%2520Trypanosoma%2520cruzi%2520infection%26jtitle%3DLancet%26date%3D1996%26volume%3D348%26spage%3D1407%26epage%3D1413%26doi%3D10.1016%2FS0140-6736%2896%2904128-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Sosa Estani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segura, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcel, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yampotis, C.</span><span> </span><span class="NLM_article-title">Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas’ disease</span> <span class="citation_source-journal">Am. J. Trop. Med. Hyg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1998&pages=526-529&author=S.+Sosa+Estaniauthor=E.+L.+Seguraauthor=A.+M.+Ruizauthor=E.+Velazquezauthor=B.+M.+Porcelauthor=C.+Yampotis&title=Efficacy+of+chemotherapy+with+benznidazole+in+children+in+the+indeterminate+phase+of+Chagas%E2%80%99+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSosa%2BEstani%26aufirst%3DS.%26aulast%3DSegura%26aufirst%3DE.%2BL.%26aulast%3DRuiz%26aufirst%3DA.%2BM.%26aulast%3DVelazquez%26aufirst%3DE.%26aulast%3DPorcel%26aufirst%3DB.%2BM.%26aulast%3DYampotis%26aufirst%3DC.%26atitle%3DEfficacy%2520of%2520chemotherapy%2520with%2520benznidazole%2520in%2520children%2520in%2520the%2520indeterminate%2520phase%2520of%2520Chagas%25E2%2580%2599%2520disease%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D1998%26volume%3D59%26spage%3D526%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Pena, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantizani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso-Padilla, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardera, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colmenarejo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotillo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roquero, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Dios-Anton, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barroso, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherstnev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewry, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiandor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. J.</span><span> </span><span class="NLM_article-title">New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">8771</span><span class="refDoi"> DOI: 10.1038/srep08771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1038%2Fsrep08771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=25740547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKhur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=8771&author=I.+Penaauthor=M.+P.+Manzanoauthor=J.+Cantizaniauthor=A.+Kesslerauthor=J.+Alonso-Padillaauthor=A.+I.+Barderaauthor=E.+Alvarezauthor=G.+Colmenarejoauthor=I.+Cotilloauthor=I.+Roqueroauthor=F.+de+Dios-Antonauthor=V.+Barrosoauthor=A.+Rodriguezauthor=D.+W.+Grayauthor=M.+Navarroauthor=V.+Kumarauthor=A.+Sherstnevauthor=D.+H.+Drewryauthor=J.+R.+Brownauthor=J.+M.+Fiandorauthor=J.+J.+Martin&title=New+compound+sets+identified+from+high+throughput+phenotypic+screening+against+three+kinetoplastid+parasites%3A+an+open+resource&doi=10.1038%2Fsrep08771"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource</span></div><div class="casAuthors">Pena, Imanol; Pilar Manzano, M.; Cantizani, Juan; Kessler, Albane; Alonso-Padilla, Julio; Bardera, Ana I.; Alvarez, Emilio; Colmenarejo, Gonzalo; Cotillo, Ignacio; Roquero, Irene; de Dios-Anton, Francisco; Barroso, Vanessa; Rodriguez, Ana; Gray, David W.; Navarro, Miguel; Kumar, Vinod; Sherstnev, Alexander; Drewry, David H.; Brown, James R.; Fiandor, Jose M.; Martin, J. Julio</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8771</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Using whole-cell phenotypic assays, the GlaxoSmithKline high-throughput screening (HTS) diversity set of 1.8 million compds. was screened against the three kinetoplastids most relevant to human disease, i.e.  Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.  Secondary confirmatory and orthogonal intracellular anti-parasiticidal assays were conducted, and the potential for non-specific cytotoxicity detd.  Hit compds. were chem. clustered and triaged for desirable physicochem. properties.  The hypothetical biol. target space covered by these diversity sets was investigated through bioinformatics methodologies.  Consequently, three anti-kinetoplastid chem. boxes of ∼200 compds. each were assembled.  Functional analyses of these compds. suggest a wide array of potential modes of action against kinetoplastid kinases, proteases and cytochromes as well as potential host-pathogen targets.  This is the first published parallel high throughput screening of a pharma compd. collection against kinetoplastids.  The compd. sets are provided as an open resource for future lead discovery programs, and to address important research questions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAQjKOCN5nErVg90H21EOLACvtfcHk0lgLr6d6prqZ-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKhur7M&md5=c28afb0ae168147ee70d1f9cc905d272</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsrep08771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep08771%26sid%3Dliteratum%253Aachs%26aulast%3DPena%26aufirst%3DI.%26aulast%3DManzano%26aufirst%3DM.%2BP.%26aulast%3DCantizani%26aufirst%3DJ.%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DAlonso-Padilla%26aufirst%3DJ.%26aulast%3DBardera%26aufirst%3DA.%2BI.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DColmenarejo%26aufirst%3DG.%26aulast%3DCotillo%26aufirst%3DI.%26aulast%3DRoquero%26aufirst%3DI.%26aulast%3Dde%2BDios-Anton%26aufirst%3DF.%26aulast%3DBarroso%26aufirst%3DV.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DSherstnev%26aufirst%3DA.%26aulast%3DDrewry%26aufirst%3DD.%2BH.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DFiandor%26aufirst%3DJ.%2BM.%26aulast%3DMartin%26aufirst%3DJ.%2BJ.%26atitle%3DNew%2520compound%2520sets%2520identified%2520from%2520high%2520throughput%2520phenotypic%2520screening%2520against%2520three%2520kinetoplastid%2520parasites%253A%2520an%2520open%2520resource%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D8771%26doi%3D10.1038%2Fsrep08771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Finding new collaboration models for enabling neglected tropical disease drug discovery</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2866</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0002866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0002866" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=e2866&author=M.+P.+Pollastri&title=Finding+new+collaboration+models+for+enabling+neglected+tropical+disease+drug+discovery&doi=10.1371%2Fjournal.pntd.0002866"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0002866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0002866%26sid%3Dliteratum%253Aachs%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DFinding%2520new%2520collaboration%2520models%2520for%2520enabling%2520neglected%2520tropical%2520disease%2520drug%2520discovery%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26spage%3De2866%26doi%3D10.1371%2Fjournal.pntd.0002866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Brand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleghorn, L. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallyburton, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norcross, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinks, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayliss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrie, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frearson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlamb, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, M. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span> </span><span class="NLM_article-title">Discovery of a novel class of orally active trypanocidal <i>N</i>-myristoyltransferase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1021/jm201091t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201091t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=140-152&author=S.+Brandauthor=L.+A.+T.+Cleghornauthor=S.+P.+McElroyauthor=D.+A.+Robinsonauthor=V.+C.+Smithauthor=I.+Hallyburtonauthor=J.+R.+Harrisonauthor=N.+R.+Norcrossauthor=D.+Spinksauthor=T.+Baylissauthor=S.+Norvalauthor=L.+Stojanovskiauthor=L.+S.+Torrieauthor=J.+A.+Frearsonauthor=R.+Brenkauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=K.+D.+Readauthor=P.+G.+Wyattauthor=I.+H.+Gilbert&title=Discovery+of+a+novel+class+of+orally+active+trypanocidal+N-myristoyltransferase+inhibitors&doi=10.1021%2Fjm201091t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors</span></div><div class="casAuthors">Brand, Stephen; Cleghorn, Laura A. T.; McElroy, Stuart P.; Robinson, David A.; Smith, Victoria C.; Hallyburton, Irene; Harrison, Justin R.; Norcross, Neil R.; Spinks, Daniel; Bayliss, Tracy; Norval, Suzanne; Stojanovski, Laste; Torrie, Leah S.; Frearson, Julie A.; Brenk, Ruth; Fairlamb, Alan H.; Ferguson, Michael A. J.; Read, Kevin D.; Wyatt, Paul G.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-152</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) represents a promising drug target for human African trypanosomiasis (HAT), which is caused by the parasitic protozoa Trypanosoma brucei.  We report the optimization of a high throughput screening hit (1) to give a lead mol. DDD85646 (63), which has potent activity against the enzyme (IC50 = 2 nM) and T. brucei (EC50 = 2 nM) in culture.  The compd. has good oral pharmacokinetics and cures rodent models of peripheral HAT infection.  This compd. provides an excellent tool for validation of T. brucei NMT as a drug target for HAT as well as a valuable lead for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCg4lhwv5cTrVg90H21EOLACvtfcHk0lgJT7cJHvhOvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurvK&md5=1479aed07e07e99f58de9012c7ec6631</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm201091t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201091t%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DMcElroy%26aufirst%3DS.%2BP.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DV.%2BC.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DHarrison%26aufirst%3DJ.%2BR.%26aulast%3DNorcross%26aufirst%3DN.%2BR.%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DBayliss%26aufirst%3DT.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520orally%2520active%2520trypanocidal%2520N-myristoyltransferase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D140%26epage%3D152%26doi%3D10.1021%2Fjm201091t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Brand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norcross, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrie, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallyburton, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scullion, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeons, F. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Aalten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frearson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlamb, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, M. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span> </span><span class="NLM_article-title">Lead optimization of a pyrazole sulfonamide series of <i>Trypanosoma brucei N</i>-myristoyltransferase inhibitors: Identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9855</span><span class="NLM_x">–</span> <span class="NLM_lpage">9869</span><span class="refDoi"> DOI: 10.1021/jm500809c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500809c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKqu7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9855-9869&author=S.+Brandauthor=N.+R.+Norcrossauthor=S.+Thompsonauthor=J.+R.+Harrisonauthor=V.+C.+Smithauthor=D.+A.+Robinsonauthor=L.+S.+Torrieauthor=S.+P.+McElroyauthor=I.+Hallyburtonauthor=S.+Norvalauthor=P.+Scullionauthor=L.+Stojanovskiauthor=F.+R.+C.+Simeonsauthor=D.+van+Aaltenauthor=J.+A.+Frearsonauthor=R.+Brenkauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=P.+G.+Wyattauthor=I.+H.+Gilbertauthor=K.+D.+Read&title=Lead+optimization+of+a+pyrazole+sulfonamide+series+of+Trypanosoma+brucei+N-myristoyltransferase+inhibitors%3A+Identification+and+evaluation+of+CNS+penetrant+compounds+as+potential+treatments+for+stage+2+human+African+trypanosomiasis&doi=10.1021%2Fjm500809c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization of a Pyrazole Sulfonamide Series of Trypanosoma brucei N-Myristoyltransferase Inhibitors: Identification and Evaluation of CNS Penetrant Compounds as Potential Treatments for Stage 2 Human African Trypanosomiasis</span></div><div class="casAuthors">Brand, Stephen; Norcross, Neil R.; Thompson, Stephen; Harrison, Justin R.; Smith, Victoria C.; Robinson, David A.; Torrie, Leah S.; McElroy, Stuart P.; Hallyburton, Irene; Norval, Suzanne; Scullion, Paul; Stojanovski, Laste; Simeons, Frederick R. C.; van Aalten, Daan; Frearson, Julie A.; Brenk, Ruth; Fairlamb, Alan H.; Ferguson, Michael A. J.; Wyatt, Paul G.; Gilbert, Ian H.; Read, Kevin D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9855-9869</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Trypanosoma brucei N-myristoyltransferase (TbNMT) is an attractive therapeutic target for the treatment of human African trypanosomiasis (HAT).  From previous studies, we identified pyrazole sulfonamide, DDD85646 (1), a potent inhibitor of TbNMT.  Although this compd. represents an excellent lead, poor central nervous system (CNS) exposure restricts its use to the hemolymphatic form (stage 1) of the disease.  With a clear clin. need for new drug treatments for HAT that address both the hemolymphatic and CNS stages of the disease, a chem. campaign was initiated to address the shortfalls of this series.  This paper describes modifications to the pyrazole sulfonamides which markedly improved blood-brain barrier permeability, achieved by reducing polar surface area and capping the sulfonamide.  Moreover, replacing the core arom. with a flexible linker significantly improved selectivity.  This led to the discovery of DDD100097 (40) which demonstrated partial efficacy in a stage 2 (CNS) mouse model of HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodUmJfaDwY-LVg90H21EOLACvtfcHk0lgJT7cJHvhOvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKqu7rP&md5=6d6f5e8618aa3b7017b789f89d9540a5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm500809c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500809c%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DNorcross%26aufirst%3DN.%2BR.%26aulast%3DThompson%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DJ.%2BR.%26aulast%3DSmith%26aufirst%3DV.%2BC.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DMcElroy%26aufirst%3DS.%2BP.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DScullion%26aufirst%3DP.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRead%26aufirst%3DK.%2BD.%26atitle%3DLead%2520optimization%2520of%2520a%2520pyrazole%2520sulfonamide%2520series%2520of%2520Trypanosoma%2520brucei%2520N-myristoyltransferase%2520inhibitors%253A%2520Identification%2520and%2520evaluation%2520of%2520CNS%2520penetrant%2520compounds%2520as%2520potential%2520treatments%2520for%2520stage%25202%2520human%2520African%2520trypanosomiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9855%26epage%3D9869%26doi%3D10.1021%2Fjm500809c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Cleghorn, L. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeons, F. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kime, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collie, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rycker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallyburton, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frearson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span> </span><span class="NLM_article-title">Discovery of indoline-2-carboxamide derivatives as a new class of brain-penetrant inhibitors of <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7695</span><span class="NLM_x">–</span> <span class="NLM_lpage">7706</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00596</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00596" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKqsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7695-7706&author=L.+A.+T.+Cleghornauthor=S.+Albrechtauthor=L.+Stojanovskiauthor=F.+R.+J.+Simeonsauthor=S.+Norvalauthor=R.+Kimeauthor=I.+T.+Collieauthor=M.+De+Ryckerauthor=L.+Campbellauthor=I.+Hallyburtonauthor=J.+A.+Frearsonauthor=P.+G.+Wyattauthor=K.+D.+Readauthor=I.+H.+Gilbert&title=Discovery+of+indoline-2-carboxamide+derivatives+as+a+new+class+of+brain-penetrant+inhibitors+of+Trypanosoma+brucei&doi=10.1021%2Facs.jmedchem.5b00596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei</span></div><div class="casAuthors">Cleghorn, Laura A. T.; Albrecht, Sebastien; Stojanovski, Laste; Simeons, Frederick R. J.; Norval, Suzanne; Kime, Robert; Collie, Iain T.; De Rycker, Manu; Campbell, Lorna; Hallyburton, Irene; Frearson, Julie A.; Wyatt, Paul G.; Read, Kevin D.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7695-7706</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is an urgent need for new, brain penetrant small mols. that target the central nervous system second stage of human African trypanosomiasis (HAT).  We report that a series of novel indoline-2-carboxamides have been identified as inhibitors of Trypanosoma brucei from screening of a focused protease library against Trypanosoma brucei brucei in culture.  We describe the optimization and characterization of this series.  Potent antiproliferative activity was obsd.  The series demonstrated excellent pharmacokinetic properties, full cures in a stage 1 mouse model of HAT, and a partial cure in a stage 2 mouse model of HAT.  Lack of tolerability prevented delivery of a fully curative regimen in the stage 2 mouse model and thus further progress of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX7MyowtO8XrVg90H21EOLACvtfcHk0lgJT7cJHvhOvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKqsrfF&md5=263eaa55034dfc0cc6a89917bc919393</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00596%26sid%3Dliteratum%253Aachs%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DAlbrecht%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BJ.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DKime%26aufirst%3DR.%26aulast%3DCollie%26aufirst%3DI.%2BT.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DL.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DDiscovery%2520of%2520indoline-2-carboxamide%2520derivatives%2520as%2520a%2520new%2520class%2520of%2520brain-penetrant%2520inhibitors%2520of%2520Trypanosoma%2520brucei%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7695%26epage%3D7706%26doi%3D10.1021%2Facs.jmedchem.5b00596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Spinks, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luksch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrie, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collie, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallyburton, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frearson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span> </span><span class="NLM_article-title">Development of small-molecule <i>Trypanosoma brucei N</i>-myristoyltransferase inhibitors: discovery and optimization of a novel binding mode</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1821</span><span class="NLM_x">–</span> <span class="NLM_lpage">1836</span><span class="refDoi"> DOI: 10.1002/cmdc.201500301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1002%2Fcmdc.201500301" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1821-1836&author=D.+Spinksauthor=V.+Smithauthor=S.+Thompsonauthor=D.+A.+Robinsonauthor=T.+Lukschauthor=A.+Smithauthor=L.+S.+Torrieauthor=S.+McElroyauthor=L.+Stojanovskiauthor=S.+Norvalauthor=I.+T.+Collieauthor=I.+Hallyburtonauthor=B.+Raoauthor=S.+Brandauthor=R.+Brenkauthor=J.+A.+Frearsonauthor=K.+D.+Readauthor=P.+G.+Wyattauthor=I.+H.+Gilbert&title=Development+of+small-molecule+Trypanosoma+brucei+N-myristoyltransferase+inhibitors%3A+discovery+and+optimization+of+a+novel+binding+mode&doi=10.1002%2Fcmdc.201500301"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500301%26sid%3Dliteratum%253Aachs%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DV.%26aulast%3DThompson%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DLuksch%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DMcElroy%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DCollie%26aufirst%3DI.%2BT.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DRao%26aufirst%3DB.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DDevelopment%2520of%2520small-molecule%2520Trypanosoma%2520brucei%2520N-myristoyltransferase%2520inhibitors%253A%2520discovery%2520and%2520optimization%2520of%2520a%2520novel%2520binding%2520mode%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1821%26epage%3D1836%26doi%3D10.1002%2Fcmdc.201500301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Tatipaka, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norcross, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulverson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranade, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagendar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creason, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duster, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molteni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glynne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span> </span><span class="NLM_article-title">Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span><span class="refDoi"> DOI: 10.1021/jm401178t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401178t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKqtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=828-835&author=H.+B.+Tatipakaauthor=J.+R.+Gillespieauthor=A.+K.+Chatterjeeauthor=N.+R.+Norcrossauthor=M.+A.+Hulversonauthor=R.+M.+Ranadeauthor=P.+Nagendarauthor=S.+A.+Creasonauthor=J.+McQueenauthor=N.+A.+Dusterauthor=A.+Nagleauthor=F.+Supekauthor=V.+Molteniauthor=T.+Wenzlerauthor=R.+Brunauthor=R.+Glynneauthor=F.+S.+Bucknerauthor=M.+H.+Gelb&title=Substituted+2-phenylimidazopyridines%3A+a+new+class+of+drug+leads+for+human+African+trypanosomiasis&doi=10.1021%2Fjm401178t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 2-Phenylimidazopyridines: A New Class of Drug Leads for Human African Trypanosomiasis</span></div><div class="casAuthors">Tatipaka, Hari Babu; Gillespie, J. Robert; Chatterjee, Arnab K.; Norcross, Neil R.; Hulverson, Matthew A.; Ranade, Ranae M.; Nagendar, Pendem; Creason, Sharon A.; McQueen, Joshua; Duster, Nicole A.; Nagle, Advait; Supek, Frantisek; Molteni, Valentina; Wenzler, Tanja; Brun, Reto; Glynne, Richard; Buckner, Frederick S.; Gelb, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">828-835</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A phenotypic screen of a compd. library for antiparasitic activity on Trypanosoma brucei, the causative agent of human African trypanosomiasis, led to the identification of substituted 2-(3-aminophenyl)-oxazolopyridines as a starting point for hit-to-lead medicinal chem.  A total of 110 analogs were prepd., which led to the identification of I, a substituted 2-(3-aminophenyl)-imidazopyridine.  This compd. showed antiparasitic activity in vitro with an EC50 of 2 nM and displayed reasonable druglike properties when tested in a no. of in vitro assays.  I was orally bioavailable and displayed good plasma and brain exposure in mice.  I cured mice infected with Trypanosoma brucei when dosed orally down to 2.5 mg/kg.  Given its potent antiparasitic properties and its ease of synthesis, I represents a new lead for the development of drugs to treat human African trypanosomiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKqZdMjPCMsrVg90H21EOLACvtfcHk0lgzAVn9r6ySqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKqtLzK&md5=3ed810c038784126456b0d6d93f099eb</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm401178t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401178t%26sid%3Dliteratum%253Aachs%26aulast%3DTatipaka%26aufirst%3DH.%2BB.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DNorcross%26aufirst%3DN.%2BR.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DRanade%26aufirst%3DR.%2BM.%26aulast%3DNagendar%26aufirst%3DP.%26aulast%3DCreason%26aufirst%3DS.%2BA.%26aulast%3DMcQueen%26aufirst%3DJ.%26aulast%3DDuster%26aufirst%3DN.%2BA.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DSupek%26aufirst%3DF.%26aulast%3DMolteni%26aufirst%3DV.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26atitle%3DSubstituted%25202-phenylimidazopyridines%253A%2520a%2520new%2520class%2520of%2520drug%2520leads%2520for%2520human%2520African%2520trypanosomiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D828%26epage%3D835%26doi%3D10.1021%2Fjm401178t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Patel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karver, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guyett, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullenberger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncal, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatanib-derived lead compound for trypanosomiasis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3820</span><span class="NLM_x">–</span> <span class="NLM_lpage">3832</span><span class="refDoi"> DOI: 10.1021/jm400349k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400349k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtFSitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3820-3832&author=G.+Patelauthor=C.+E.+Karverauthor=R.+Beheraauthor=P.+J.+Guyettauthor=C.+Sullenbergerauthor=P.+Edwardsauthor=N.+E.+Roncalauthor=K.+Mensa-Wilmotauthor=M.+P.+Pollastri&title=Kinase+scaffold+repurposing+for+neglected+disease+drug+discovery%3A+discovery+of+an+efficacious%2C+lapatanib-derived+lead+compound+for+trypanosomiasis&doi=10.1021%2Fjm400349k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Scaffold Repurposing for Neglected Disease Drug Discovery: Discovery of an Efficacious, Lapatanib-Derived Lead Compound for Trypanosomiasis</span></div><div class="casAuthors">Patel, Gautam; Karver, Caitlin E.; Behera, Ranjan; Guyett, Paul J.; Sullenberger, Catherine; Edwards, Peter; Roncal, Norma E.; Mensa-Wilmot, Kojo; Pollastri, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3820-3832</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lapatinib analogs such as I (X = O, CH2) were prepd. as trypanocidal agents for use as lead compds. in the development of treatments for human African trypanosomiasis which do not require i.v. administration.  Lapatinib was previously shown to kill T. brucei with low micromolar EC50 values; analogs replacing the methylfurylquinazoline moiety with a heteroarylsulfonylphenylquinazolinyl moiety were prepd. and tested against both T. brucei and human hepatocarcinoma cells.  4-Anilinoquinazolines, particularly I (X = O) (NEU617), were found to be highly potent and orally bioavailable inhibitors of trypanosome replication.  I (X = O) blocks duplication of the kinetoplast and arrests cytokinesis in T. brucei, which may make it useful as a chem. tool for studying regulation of the trypanosome cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoliwtzx67q77Vg90H21EOLACvtfcHk0lgzAVn9r6ySqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtFSitLo%253D&md5=dd278f3bc7c671330e40de210392a278</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm400349k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400349k%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DG.%26aulast%3DKarver%26aufirst%3DC.%2BE.%26aulast%3DBehera%26aufirst%3DR.%26aulast%3DGuyett%26aufirst%3DP.%2BJ.%26aulast%3DSullenberger%26aufirst%3DC.%26aulast%3DEdwards%26aufirst%3DP.%26aulast%3DRoncal%26aufirst%3DN.%2BE.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DKinase%2520scaffold%2520repurposing%2520for%2520neglected%2520disease%2520drug%2520discovery%253A%2520discovery%2520of%2520an%2520efficacious%252C%2520lapatanib-derived%2520lead%2520compound%2520for%2520trypanosomiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3820%26epage%3D3832%26doi%3D10.1021%2Fjm400349k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Seixas, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo-Arratta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saldivia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas-Barros, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlanga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Establishment of a structure-activity relationship of 1<i>H</i>-imidazo[4,5-<i>c</i>]quinoline-based kinase inhibitor NVP-BEZ235 as a lead for African sleeping sickness</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4834</span><span class="NLM_x">–</span> <span class="NLM_lpage">4848</span><span class="refDoi"> DOI: 10.1021/jm500361r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500361r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4834-4848&author=J.+D.+Seixasauthor=S.+A.+Luengo-Arrattaauthor=R.+Diazauthor=M.+Saldiviaauthor=D.+I.+Rojas-Barrosauthor=P.+Manzanoauthor=S.+Gonzalezauthor=M.+Berlangaauthor=T.+K.+Smithauthor=M.+Navarroauthor=M.+P.+Pollastri&title=Establishment+of+a+structure-activity+relationship+of+1H-imidazo%5B4%2C5-c%5Dquinoline-based+kinase+inhibitor+NVP-BEZ235+as+a+lead+for+African+sleeping+sickness&doi=10.1021%2Fjm500361r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm500361r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500361r%26sid%3Dliteratum%253Aachs%26aulast%3DSeixas%26aufirst%3DJ.%2BD.%26aulast%3DLuengo-Arratta%26aufirst%3DS.%2BA.%26aulast%3DDiaz%26aufirst%3DR.%26aulast%3DSaldivia%26aufirst%3DM.%26aulast%3DRojas-Barros%26aufirst%3DD.%2BI.%26aulast%3DManzano%26aufirst%3DP.%26aulast%3DGonzalez%26aufirst%3DS.%26aulast%3DBerlanga%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DT.%2BK.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DEstablishment%2520of%2520a%2520structure-activity%2520relationship%2520of%25201H-imidazo%255B4%252C5-c%255Dquinoline-based%2520kinase%2520inhibitor%2520NVP-BEZ235%2520as%2520a%2520lead%2520for%2520African%2520sleeping%2520sickness%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4834%26epage%3D4848%26doi%3D10.1021%2Fjm500361r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Bakunov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakunova, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghebru, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbovetz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span> </span><span class="NLM_article-title">Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1<i>H</i>-1,2,3-triazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span><span class="refDoi"> DOI: 10.1021/jm901178d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901178d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGrt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=254-272&author=S.+A.+Bakunovauthor=S.+M.+Bakunovaauthor=T.+Wenzlerauthor=M.+Ghebruauthor=K.+A.+Werbovetzauthor=R.+Brunauthor=R.+R.+Tidwell&title=Synthesis+and+antiprotozoal+activity+of+cationic+1%2C4-diphenyl-1H-1%2C2%2C3-triazoles&doi=10.1021%2Fjm901178d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antiprotozoal Activity of Cationic 1,4-Diphenyl-1H-1,2,3-triazoles</span></div><div class="casAuthors">Bakunov, Stanislav A.; Bakunova, Svetlana M.; Wenzler, Tanja; Ghebru, Maedot; Werbovetz, Karl A.; Brun, Reto; Tidwell, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">254-272</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel dicationic triazoles, e.g. I and II, were synthesized by the Pinner method from the corresponding dinitriles, prepd. via the copper(I)-catalyzed azide-alkyne cycloaddn. (CuAAC).  The type and the placement of cationic moieties as well as the nature of arom. substituents influenced in vitro antiprotozoal activities of dicationic triazoles against Trypanosoma brucei rhodesiense, Plasmodium falciparum, and Leishmania donovani and their cytotoxicity for mammalian cells.  Eight congeners displayed antitrypanosomal IC50 values below 10 nM.  Thirty-nine dications were more potent against P.  Falciparum than pentamidine (IC50 = 58 nM), and eight analogs were more active than artemisinin (IC50 = 6 nM).  Diimidazoline II exhibited antiplasmodial IC50 value of 0.6 nM.  Seven congeners administered at 4 × 5 mg/kg by the i.p. route cured at least three out of four animals in the acute mouse model of African trypanosomiasis.  At 4 × 1 mg/kg, diamidine I displayed better antitrypanosomal efficacy than melarsoprol, curing all infected mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEgbnsLWzRuLVg90H21EOLACvtfcHk0ljVIyEp7lW91g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGrt7rJ&md5=d882c1d6ecc49bcead46056b2498bd12</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm901178d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901178d%26sid%3Dliteratum%253Aachs%26aulast%3DBakunov%26aufirst%3DS.%2BA.%26aulast%3DBakunova%26aufirst%3DS.%2BM.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DGhebru%26aufirst%3DM.%26aulast%3DWerbovetz%26aufirst%3DK.%2BA.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DSynthesis%2520and%2520antiprotozoal%2520activity%2520of%2520cationic%25201%252C4-diphenyl-1H-1%252C2%252C3-triazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D254%26epage%3D272%26doi%3D10.1021%2Fjm901178d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Patrick, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakunov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakunova, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barszcz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykin, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbovetz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span> </span><span class="NLM_article-title">Synthesis and antiprotozoal activities of benzyl phenyl ether diamidine derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.06.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.ejmech.2013.06.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=23871911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVejtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=310-324&author=D.+A.+Patrickauthor=S.+A.+Bakunovauthor=S.+M.+Bakunovaauthor=S.+K.+Jonesauthor=T.+Wenzlerauthor=T.+Barszczauthor=A.+Kumarauthor=D.+W.+Boykinauthor=K.+A.+Werbovetzauthor=R.+Brunauthor=R.+R.+Tidwell&title=Synthesis+and+antiprotozoal+activities+of+benzyl+phenyl+ether+diamidine+derivatives&doi=10.1016%2Fj.ejmech.2013.06.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiprotozoal activities of benzyl phenyl ether diamidine derivatives</span></div><div class="casAuthors">Patrick, Donald A.; Bakunov, Stanislav A.; Bakunova, Svetlana M.; Jones, Susan Kilgore; Wenzler, Tanja; Barszcz, Todd; Kumar, Arvind; Boykin, David W.; Werbovetz, Karl A.; Brun, Reto; Tidwell, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">310-324</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Sixty-two cationic benzyl Ph ether derivs. (36 amidines and 26 prodrugs) were prepd. and assayed for activities in vitro and in vivo against Trypanosoma brucei rhodesiense (STIB900), and in vitro against Plasmodium falciparum (K1) and Leishmania donovani axenic amastigotes.  3-Amidinobenzyl 4-amidino-2-iodo-6-methoxyphenyl ether dihydrochloride (IC50 = 3.0 nM) and seven other compds. exhibited IC50 values below 10 nM against T. b. rhodesiense in vitro.  The 2-bromo-4,4'-diamidino analog I [R1 = R4 = 4-C(NH2):NH, R2 = Br, R3 = H] (IC50 = 4.0 nM) and 12 other analogs were more potent than pentamidine (IC50 = 46 nM) against P. falciparum.  The 3',4-diamidino-2,6-diiodo analog I [R1 = 4-C(NH2):NH, R2 = R3 = I, R4 = 3-C(NH2):NH] (IC50 = 1.4 μM) and two other compds. were more effective than pentamidine (IC50 = 1.8 μM) against L. donovani.  A prodrug, 3',4-bis(N''-methoxy)amidino-2-bromo deriv. I [R1 = 4-C(NH2):NOMe, R2 = Br, R3 = H, R4 = 3-C(NH2):NOMe], was the most efficacious against trypanosome infected mice, attaining 4/4 cures in four daily 25 mg/kg oral doses, and the 2-chloro-4,4'-diamidine I [R1 = R4 = 4-C(NH2):NH, R2 = Cl, R3 = H] cured 3/4 mice in four daily 5 mg/kg i.p. doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqctvCGGa4JorVg90H21EOLACvtfcHk0ljVIyEp7lW91g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVejtLrL&md5=8596590e8dd5c29f99f99acc485e76c2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.06.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.06.033%26sid%3Dliteratum%253Aachs%26aulast%3DPatrick%26aufirst%3DD.%2BA.%26aulast%3DBakunov%26aufirst%3DS.%2BA.%26aulast%3DBakunova%26aufirst%3DS.%2BM.%26aulast%3DJones%26aufirst%3DS.%2BK.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DBarszcz%26aufirst%3DT.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DBoykin%26aufirst%3DD.%2BW.%26aulast%3DWerbovetz%26aufirst%3DK.%2BA.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DSynthesis%2520and%2520antiprotozoal%2520activities%2520of%2520benzyl%2520phenyl%2520ether%2520diamidine%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D67%26spage%3D310%26epage%3D324%26doi%3D10.1016%2Fj.ejmech.2013.06.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Reid, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Premalatha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershkovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbovetz, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and antitrypanosomal evaluation of derivatives of <i>N</i>-benzyl-1,2-dihydroquinolin-6-ols: effect of core substitutions and salt formation</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.bmc.2010.11.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=513-523&author=C.+S.+Reidauthor=D.+A.+Patrickauthor=S.+Heauthor=J.+Fotieauthor=K.+Premalathaauthor=R.+R.+Tidwellauthor=M.+Z.+Wangauthor=Q.+Liuauthor=P.+Gershkovichauthor=K.+M.+Wasanauthor=T.+Wenzlerauthor=R.+Brunauthor=K.+A.+Werbovetz&title=Synthesis+and+antitrypanosomal+evaluation+of+derivatives+of+N-benzyl-1%2C2-dihydroquinolin-6-ols%3A+effect+of+core+substitutions+and+salt+formation&doi=10.1016%2Fj.bmc.2010.11.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DC.%2BS.%26aulast%3DPatrick%26aufirst%3DD.%2BA.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DFotie%26aufirst%3DJ.%26aulast%3DPremalatha%26aufirst%3DK.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26aulast%3DWang%26aufirst%3DM.%2BZ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGershkovich%26aufirst%3DP.%26aulast%3DWasan%26aufirst%3DK.%2BM.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DWerbovetz%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520antitrypanosomal%2520evaluation%2520of%2520derivatives%2520of%2520N-benzyl-1%252C2-dihydroquinolin-6-ols%253A%2520effect%2520of%2520core%2520substitutions%2520and%2520salt%2520formation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D513%26epage%3D523%26doi%3D10.1016%2Fj.bmc.2010.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Lavrado, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreira, R.</span><span> </span><span class="NLM_article-title">Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6256</span><span class="NLM_x">–</span> <span class="NLM_lpage">6260</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.bmcl.2012.07.104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6256-6260&author=J.+Lavradoauthor=Z.+Mackeyauthor=E.+Hansellauthor=J.+H.+McKerrowauthor=A.+Pauloauthor=R.+Moreira&title=Antitrypanosomal+and+cysteine+protease+inhibitory+activities+of+alkyldiamine+cryptolepine+derivatives&doi=10.1016%2Fj.bmcl.2012.07.104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.104%26sid%3Dliteratum%253Aachs%26aulast%3DLavrado%26aufirst%3DJ.%26aulast%3DMackey%26aufirst%3DZ.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DPaulo%26aufirst%3DA.%26aulast%3DMoreira%26aufirst%3DR.%26atitle%3DAntitrypanosomal%2520and%2520cysteine%2520protease%2520inhibitory%2520activities%2520of%2520alkyldiamine%2520cryptolepine%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6256%26epage%3D6260%26doi%3D10.1016%2Fj.bmcl.2012.07.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Keenan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Best, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berven, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Geldern, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerfoot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McManus, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span> </span><span class="NLM_article-title">Analogues of fenarimol are potent inhibitors of <i>Trypanosoma cruzi</i> and are efficacious in a murine model of Chagas disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4189</span><span class="NLM_x">–</span> <span class="NLM_lpage">4204</span><span class="refDoi"> DOI: 10.1021/jm2015809</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2015809" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4189-4204&author=M.+Keenanauthor=M.+J.+Abbottauthor=P.+W.+Alexanderauthor=T.+Armstrongauthor=W.+M.+Bestauthor=B.+Bervenauthor=A.+Boteroauthor=J.+H.+Chaplinauthor=S.+A.+Charmanauthor=E.+Chatelainauthor=T.+W.+von+Geldernauthor=M.+Kerfootauthor=A.+Khongauthor=T.+Nguyenauthor=J.+D.+McManusauthor=J.+Morizziauthor=E.+Ryanauthor=I.+Scandaleauthor=R.+A.+Thompsonauthor=S.+Z.+Wangauthor=K.+L.+White&title=Analogues+of+fenarimol+are+potent+inhibitors+of+Trypanosoma+cruzi+and+are+efficacious+in+a+murine+model+of+Chagas+disease&doi=10.1021%2Fjm2015809"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm2015809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2015809%26sid%3Dliteratum%253Aachs%26aulast%3DKeenan%26aufirst%3DM.%26aulast%3DAbbott%26aufirst%3DM.%2BJ.%26aulast%3DAlexander%26aufirst%3DP.%2BW.%26aulast%3DArmstrong%26aufirst%3DT.%26aulast%3DBest%26aufirst%3DW.%2BM.%26aulast%3DBerven%26aufirst%3DB.%26aulast%3DBotero%26aufirst%3DA.%26aulast%3DChaplin%26aufirst%3DJ.%2BH.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3Dvon%2BGeldern%26aufirst%3DT.%2BW.%26aulast%3DKerfoot%26aufirst%3DM.%26aulast%3DKhong%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DMcManus%26aufirst%3DJ.%2BD.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DThompson%26aufirst%3DR.%2BA.%26aulast%3DWang%26aufirst%3DS.%2BZ.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26atitle%3DAnalogues%2520of%2520fenarimol%2520are%2520potent%2520inhibitors%2520of%2520Trypanosoma%2520cruzi%2520and%2520are%2520efficacious%2520in%2520a%2520murine%2520model%2520of%2520Chagas%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4189%26epage%3D4204%26doi%3D10.1021%2Fjm2015809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Keenan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Best, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerfoot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregg, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Geldern, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, E.</span><span> </span><span class="NLM_article-title">Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of <i>Trypanosoma cruzi</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1756</span><span class="NLM_x">–</span> <span class="NLM_lpage">1763</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.01.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.bmc.2013.01.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1756-1763&author=M.+Keenanauthor=P.+W.+Alexanderauthor=H.+Diaoauthor=W.+M.+Bestauthor=A.+Khongauthor=M.+Kerfootauthor=R.+C.+A.+Thompsonauthor=K.+L.+Whiteauthor=D.+M.+Shacklefordauthor=E.+Ryanauthor=A.+D.+Greggauthor=S.+A.+Charmanauthor=T.+W.+von+Geldernauthor=I.+Scandaleauthor=E.+Chatelain&title=Design%2C+structure-activity+relationship+and+in+vivo+efficacy+of+piperazine+analogues+of+fenarimol+as+inhibitors+of+Trypanosoma+cruzi&doi=10.1016%2Fj.bmc.2013.01.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.01.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.01.050%26sid%3Dliteratum%253Aachs%26aulast%3DKeenan%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DP.%2BW.%26aulast%3DDiao%26aufirst%3DH.%26aulast%3DBest%26aufirst%3DW.%2BM.%26aulast%3DKhong%26aufirst%3DA.%26aulast%3DKerfoot%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DR.%2BC.%2BA.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DGregg%26aufirst%3DA.%2BD.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3Dvon%2BGeldern%26aufirst%3DT.%2BW.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DChatelain%26aufirst%3DE.%26atitle%3DDesign%252C%2520structure-activity%2520relationship%2520and%2520in%2520vivo%2520efficacy%2520of%2520piperazine%2520analogues%2520of%2520fenarimol%2520as%2520inhibitors%2520of%2520Trypanosoma%2520cruzi%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D1756%26epage%3D1763%26doi%3D10.1016%2Fj.bmc.2013.01.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Keenan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Best, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornwall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Geldern, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span> </span><span class="NLM_article-title">Two analogues of fenarimol show curative activity in an experimental model of Chagas disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">10158</span><span class="NLM_x">–</span> <span class="NLM_lpage">10170</span><span class="refDoi"> DOI: 10.1021/jm401610c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401610c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10158-10170&author=M.+Keenanauthor=J.+H.+Chaplinauthor=P.+W.+Alexanderauthor=M.+J.+Abbottauthor=W.+M.+Bestauthor=A.+Khongauthor=A.+Boteroauthor=C.+Perezauthor=S.+Cornwallauthor=R.+A.+Thompsonauthor=K.+L.+Whiteauthor=D.+M.+Shacklefordauthor=M.+Koltunauthor=F.+C.+K.+Chiuauthor=J.+Morizziauthor=E.+Ryanauthor=M.+Campbellauthor=T.+W.+von+Geldernauthor=I.+Scandaleauthor=E.+Chatelainauthor=S.+A.+Charman&title=Two+analogues+of+fenarimol+show+curative+activity+in+an+experimental+model+of+Chagas+disease&doi=10.1021%2Fjm401610c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm401610c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401610c%26sid%3Dliteratum%253Aachs%26aulast%3DKeenan%26aufirst%3DM.%26aulast%3DChaplin%26aufirst%3DJ.%2BH.%26aulast%3DAlexander%26aufirst%3DP.%2BW.%26aulast%3DAbbott%26aufirst%3DM.%2BJ.%26aulast%3DBest%26aufirst%3DW.%2BM.%26aulast%3DKhong%26aufirst%3DA.%26aulast%3DBotero%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DCornwall%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DR.%2BA.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DKoltun%26aufirst%3DM.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3Dvon%2BGeldern%26aufirst%3DT.%2BW.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26atitle%3DTwo%2520analogues%2520of%2520fenarimol%2520show%2520curative%2520activity%2520in%2520an%2520experimental%2520model%2520of%2520Chagas%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10158%26epage%3D10170%26doi%3D10.1021%2Fjm401610c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Andriani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beatty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtemanche, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juda, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wawrzak, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepesheva, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Antitrypanosomal lead discovery: Identification of a ligand-efficient inhibitor of <i>Trypanosoma cruzi</i> CYP51 and parasite growth</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2556</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span><span class="refDoi"> DOI: 10.1021/jm400012e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400012e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2556-2567&author=G.+Andrianiauthor=E.+Amataauthor=J.+Beattyauthor=Z.+Clementsauthor=B.+J.+Coffeyauthor=G.+Courtemancheauthor=W.+Devineauthor=J.+Erathauthor=C.+E.+Judaauthor=Z.+Wawrzakauthor=J.+T.+Woodauthor=G.+I.+Lepeshevaauthor=A.+Rodriguezauthor=M.+P.+Pollastri&title=Antitrypanosomal+lead+discovery%3A+Identification+of+a+ligand-efficient+inhibitor+of+Trypanosoma+cruzi+CYP51+and+parasite+growth&doi=10.1021%2Fjm400012e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Antitrypanosomal Lead Discovery: Identification of a Ligand-Efficient Inhibitor of Trypanosoma cruzi CYP51 and Parasite Growth</span></div><div class="casAuthors">Andriani, Grasiella; Amata, Emanuele; Beatty, Joel; Clements, Zeke; Coffey, Brian J.; Courtemanche, Gilles; Devine, William; Erath, Jessey; Juda, Cristin E.; Wawrzak, Zdzislaw; Wood, JodiAnne T.; Lepesheva, Galina I.; Rodriguez, Ana; Pollastri, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2556-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chagas disease is caused by the intracellular protozoan parasite Trypanosomal cruzi, and current drugs are lacking in terms of desired safety and efficacy profiles.  Following on a recently reported high-throughput screening campaign, we have explored initial structure-activity relationships around a class of imidazole-based compds.  This profiling has uncovered compds. I (NEU321) and II (NEU704), which are potent against in vitro cultures of T. cruzi and are greater than 160-fold selective over host cells.  We report in vitro drug metab. and properties profiling of I and show that this chemotype inhibits the T. cruzi CYP51 enzyme, an observation confirmed by X-ray crystallog. anal.  We compare the binding orientation of I to that of other, previously reported inhibitors.  We show that I displays a significantly better ligand efficiency and a shorter synthetic route over previously disclosed CYP51 inhibitors, and should therefore be considered a promising lead compd. for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXiYoPMZe0O7Vg90H21EOLACvtfcHk0linZTN1nK1xQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWgs7g%253D&md5=60961c236abad895171a41e36a04aae7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm400012e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400012e%26sid%3Dliteratum%253Aachs%26aulast%3DAndriani%26aufirst%3DG.%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DBeatty%26aufirst%3DJ.%26aulast%3DClements%26aufirst%3DZ.%26aulast%3DCoffey%26aufirst%3DB.%2BJ.%26aulast%3DCourtemanche%26aufirst%3DG.%26aulast%3DDevine%26aufirst%3DW.%26aulast%3DErath%26aufirst%3DJ.%26aulast%3DJuda%26aufirst%3DC.%2BE.%26aulast%3DWawrzak%26aufirst%3DZ.%26aulast%3DWood%26aufirst%3DJ.%2BT.%26aulast%3DLepesheva%26aufirst%3DG.%2BI.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DAntitrypanosomal%2520lead%2520discovery%253A%2520Identification%2520of%2520a%2520ligand-efficient%2520inhibitor%2520of%2520Trypanosoma%2520cruzi%2520CYP51%2520and%2520parasite%2520growth%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2556%26epage%3D2567%26doi%3D10.1021%2Fjm400012e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Choi, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvet, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunatilleke, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podust, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roush, W. R.</span><span> </span><span class="NLM_article-title">Rational development of 4-aminopyridyl-based inhibitors targeting <i>Trypanosoma cruzi</i> CYP51 as anti-Chagas agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7651</span><span class="NLM_x">–</span> <span class="NLM_lpage">7668</span><span class="refDoi"> DOI: 10.1021/jm401067s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401067s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7651-7668&author=J.+Y.+Choiauthor=C.+M.+Calvetauthor=S.+S.+Gunatillekeauthor=C.+Ruizauthor=M.+D.+Cameronauthor=J.+H.+McKerrowauthor=L.+M.+Podustauthor=W.+R.+Roush&title=Rational+development+of+4-aminopyridyl-based+inhibitors+targeting+Trypanosoma+cruzi+CYP51+as+anti-Chagas+agents&doi=10.1021%2Fjm401067s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm401067s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401067s%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DCalvet%26aufirst%3DC.%2BM.%26aulast%3DGunatilleke%26aufirst%3DS.%2BS.%26aulast%3DRuiz%26aufirst%3DC.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DPodust%26aufirst%3DL.%2BM.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DRational%2520development%2520of%25204-aminopyridyl-based%2520inhibitors%2520targeting%2520Trypanosoma%2520cruzi%2520CYP51%2520as%2520anti-Chagas%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7651%26epage%3D7668%26doi%3D10.1021%2Fjm401067s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Vieira, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvet, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siqueira-Neto, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roush, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podust, L. M.</span><span> </span><span class="NLM_article-title">Binding mode and potency of <i>N</i>-indolyloxopyridinyl-4-aminopropanyl-based inhibitors targeting <i>Trypanosoma cruzi</i> CYP51</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10162</span><span class="NLM_x">–</span> <span class="NLM_lpage">10175</span><span class="refDoi"> DOI: 10.1021/jm501568b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501568b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10162-10175&author=D.+F.+Vieiraauthor=J.+Y.+Choiauthor=C.+M.+Calvetauthor=J.+L.+Siqueira-Netoauthor=J.+B.+Johnstonauthor=D.+Kellarauthor=J.+Gutauthor=M.+D.+Cameronauthor=J.+H.+McKerrowauthor=W.+R.+Roushauthor=L.+M.+Podust&title=Binding+mode+and+potency+of+N-indolyloxopyridinyl-4-aminopropanyl-based+inhibitors+targeting+Trypanosoma+cruzi+CYP51&doi=10.1021%2Fjm501568b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm501568b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501568b%26sid%3Dliteratum%253Aachs%26aulast%3DVieira%26aufirst%3DD.%2BF.%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DCalvet%26aufirst%3DC.%2BM.%26aulast%3DSiqueira-Neto%26aufirst%3DJ.%2BL.%26aulast%3DJohnston%26aufirst%3DJ.%2BB.%26aulast%3DKellar%26aufirst%3DD.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DPodust%26aufirst%3DL.%2BM.%26atitle%3DBinding%2520mode%2520and%2520potency%2520of%2520N-indolyloxopyridinyl-4-aminopropanyl-based%2520inhibitors%2520targeting%2520Trypanosoma%2520cruzi%2520CYP51%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10162%26epage%3D10175%26doi%3D10.1021%2Fjm501568b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Caminos, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panozzo-Zenere, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekwani, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadie, G. R.</span><span> </span><span class="NLM_article-title">Synthesis and antikinetoplastid activity of a series of <i>N</i>,<i>N</i>′-substituted diamines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1712</span><span class="NLM_x">–</span> <span class="NLM_lpage">1715</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.bmcl.2011.12.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1712-1715&author=A.+P.+Caminosauthor=E.+A.+Panozzo-Zenereauthor=S.+R.+Wilkinsonauthor=B.+L.+Tekwaniauthor=G.+R.+Labadie&title=Synthesis+and+antikinetoplastid+activity+of+a+series+of+N%2CN%E2%80%B2-substituted+diamines&doi=10.1016%2Fj.bmcl.2011.12.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.101%26sid%3Dliteratum%253Aachs%26aulast%3DCaminos%26aufirst%3DA.%2BP.%26aulast%3DPanozzo-Zenere%26aufirst%3DE.%2BA.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DLabadie%26aufirst%3DG.%2BR.%26atitle%3DSynthesis%2520and%2520antikinetoplastid%2520activity%2520of%2520a%2520series%2520of%2520N%252CN%25E2%2580%25B2-substituted%2520diamines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1712%26epage%3D1715%26doi%3D10.1016%2Fj.bmcl.2011.12.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Devine, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodring, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncal, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leed, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciotti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Protozoan parasite growth inhibitors discovered by cross-screening yield potent scaffolds for lead discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5537</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5522-5537&author=W.+Devineauthor=J.+L.+Woodringauthor=U.+Swaminathanauthor=E.+Amataauthor=G.+Patelauthor=J.+Erathauthor=N.+E.+Roncalauthor=P.+J.+Leeauthor=S.+E.+Leedauthor=A.+Rodriguezauthor=K.+Mensa-Wilmotauthor=R.+J.+Sciottiauthor=M.+P.+Pollastri&title=Protozoan+parasite+growth+inhibitors+discovered+by+cross-screening+yield+potent+scaffolds+for+lead+discovery&doi=10.1021%2Facs.jmedchem.5b00515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Protozoan parasite growth inhibitors discovered by cross-screening yield potent scaffolds for lead discovery</span></div><div class="casAuthors">Devine, William; Woodring, Jennifer L.; Swaminathan, Uma; Amata, Emanuele; Patel, Gautam; Erath, Jessey; Roncal, Norma E.; Lee, Patricia J.; Leed, Susan E.; Rodriguez, Ana; Mensa-Wilmot, Kojo; Sciotti, Richard J.; Pollastri, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5522-5537</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tropical protozoal infections are a significant cause of morbidity and mortality worldwide; four in particular (human African trypanosomiasis (HAT), Chagas disease, cutaneous leishmaniasis, and malaria) have an estd. combined burden of over 87 million disability-adjusted life years.  New drugs are needed for each of these diseases.  Building on the previous identification of NEU-617 as a potent and nontoxic inhibitor of proliferation for the HAT pathogen (Trypanosoma brucei), the authors have now tested this class of analogs against other protozoal species: T. cruzi (Chagas disease), Leishmania major (cutaneous leishmaniasis), and Plasmodium falciparum (malaria).  Based on hits identified in this screening campaign, the authors describe the prepn. of several replacements for the quinazoline scaffold and report these inhibitors' biol. activities against these parasites.  In doing this, the authors have identified several potent proliferation inhibitors for each pathogen, such as NEU-924, I, for T. cruzi and NEU-1017, II, for L. major and P. falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbrXR55ZLJ7Vg90H21EOLACvtfcHk0liMe3T0P7mmuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7bN&md5=76fef909165981d8e542d28a5ee59c12</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00515%26sid%3Dliteratum%253Aachs%26aulast%3DDevine%26aufirst%3DW.%26aulast%3DWoodring%26aufirst%3DJ.%2BL.%26aulast%3DSwaminathan%26aufirst%3DU.%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DG.%26aulast%3DErath%26aufirst%3DJ.%26aulast%3DRoncal%26aufirst%3DN.%2BE.%26aulast%3DLee%26aufirst%3DP.%2BJ.%26aulast%3DLeed%26aufirst%3DS.%2BE.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26aulast%3DSciotti%26aufirst%3DR.%2BJ.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DProtozoan%2520parasite%2520growth%2520inhibitors%2520discovered%2520by%2520cross-screening%2520yield%2520potent%2520scaffolds%2520for%2520lead%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5522%26epage%3D5537%26doi%3D10.1021%2Facs.jmedchem.5b00515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Di Pietro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente-Garcia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berenguer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayago, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.ejmech.2015.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=26479031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKhu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2015&pages=120-137&author=O.+Di+Pietroauthor=E.+Vicente-Garciaauthor=M.+C.+Taylorauthor=D.+Berenguerauthor=E.+Viaynaauthor=A.+Lanzoniauthor=I.+Solaauthor=H.+Sayagoauthor=C.+Rieraauthor=R.+Fisaauthor=M.+V.+Closauthor=B.+Perezauthor=J.+M.+Kellyauthor=R.+Lavillaauthor=D.+Munoz-Torrero&title=Multicomponent+reaction-based+synthesis+and+biological+evaluation+of+tricyclic+heterofused+quinolines+with+multi-trypanosomatid+activity&doi=10.1016%2Fj.ejmech.2015.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity</span></div><div class="casAuthors">Di Pietro, Ornella; Vicente-Garcia, Esther; Taylor, Martin C.; Berenguer, Diana; Viayna, Elisabet; Lanzoni, Anna; Sola, Irene; Sayago, Helena; Riera, Cristina; Fisa, Roser; Clos, M. Victoria; Perez, Belen; Kelly, John M.; Lavilla, Rodolfo; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">120-137</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Human African trypanosomiasis (HAT), Chagas disease and leishmaniasis, which are caused by the trypanosomatids Trypanosoma brucei, Trypanosoma cruzi and Leishmania species, are among the most deadly neglected tropical diseases.  The development of drugs that are active against several trypanosomatids is appealing from a clin. and economic viewpoint, and seems feasible, as these parasites share metabolic pathways and hence might be treatable by common drugs.  From benzonaphthyridine (I), an inhibitor of acetylcholinesterase (AChE) for which we have found a remarkable trypanocidal activity, we have designed and synthesized novel benzo[h][1,6]naphthyridines, pyrrolo[3,2-c]quinolines, azepino[3,2-c]quinolines, and pyrano[3,2-c]quinolines through 2-4-step sequences featuring an initial multicomponent Povarov reaction as the key step.  To assess the therapeutic potential of the novel compds., we have evaluated their in vitro activity against T. brucei, T. cruzi, and Leishmania infantum, as well as their brain permeability, which is of specific interest for the treatment of late-stage HAT.  To assess their potential toxicity, we have detd. their cytotoxicity against rat myoblast L6 cells and their AChE inhibitory activity.  Several tricyclic heterofused quinoline derivs. were found to display an interesting multi-trypanosomatid profile, with one-digit micromolar potencies against two of these parasites and two-digit micromolar potency against the other.  Pyranoquinoline (II), which displays IC50 values of 1.5 μM, 6.1 μM and 29.2 μM against T. brucei, L. infantum and T. cruzi, resp., brain permeability, better drug-like properties (lower lipophilicity and mol. wt. and higher CNS MPO desirability score) than hit 1, and the lowest AChE inhibitory activity of the series (IC50 > 30 μM), emerges as an interesting multi-trypanosomatid lead, amenable to further optimization particularly in terms of its selectivity index over mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSElDBXWPo0LVg90H21EOLACvtfcHk0liMe3T0P7mmuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKhu7bK&md5=8e483f32d39b7526dceac3ad35e8cd38</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DVicente-Garcia%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DM.%2BC.%26aulast%3DBerenguer%26aufirst%3DD.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DLanzoni%26aufirst%3DA.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DSayago%26aufirst%3DH.%26aulast%3DRiera%26aufirst%3DC.%26aulast%3DFisa%26aufirst%3DR.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DPerez%26aufirst%3DB.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26atitle%3DMulticomponent%2520reaction-based%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520tricyclic%2520heterofused%2520quinolines%2520with%2520multi-trypanosomatid%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D105%26spage%3D120%26epage%3D137%26doi%3D10.1016%2Fj.ejmech.2015.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Gros, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orenes Lorente, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardley, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattray, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wharton, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croft, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz-Perez, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Pacanowska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span> </span><span class="NLM_article-title">Evaluation of azasterols as anti-parasitics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6094</span><span class="NLM_x">–</span> <span class="NLM_lpage">6103</span><span class="refDoi"> DOI: 10.1021/jm060290f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060290f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BD28Xptleltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6094-6103&author=L.+Grosauthor=S.+Orenes+Lorenteauthor=C.+Jimenezauthor=V.+Yardleyauthor=L.+Rattrayauthor=H.+Whartonauthor=S.+Littleauthor=S.+L.+Croftauthor=L.+M.+Ruiz-Perezauthor=D.+Gonzalez-Pacanowskaauthor=I.+H.+Gilbert&title=Evaluation+of+azasterols+as+anti-parasitics&doi=10.1021%2Fjm060290f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Azasterols as Anti-Parasitics</span></div><div class="casAuthors">Gros, Ludovic; Lorente, Silvia Orenes; Jimenez Jimenez, Carmen; Yardley, Vanessa; Rattray, Lauren; Wharton, Hayley; Little, Susan; Croft, Simon L.; Ruiz-Perez, Luis M.; Gonzalez-Pacanowska, Dolores; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6094-6103</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this article, the design and synthesis of some novel azasterols is described, followed by their evaluation against Trypanosoma brucei rhodesiense, T. cruzi, Leishmania donovani, and Plasmodium falciparum, the causative agents of human African trypanosomiasis, Chagas disease, leishmaniasis, and malaria, resp.  Some of the compds. showed antiparasitic activity.  In particular, a no. of compds. appeared to very potently inhibit the growth of the blood stream form T. b. rhodesiense, with one compd. giving an IC50 value of 12 nM.  Clear structure activity relationships could be discerned.  These compds. represent important leads for further optimization.  Azasterols have previously been shown to inhibit sterol biosynthesis in T. cruzi and L. donovani by the inhibition of the enzyme sterol 24-methyltransferase.  However, in this case, none of the compds. showed inhibition of the enzyme.  Therefore, these compds. have an unknown mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF-KBlrYBQcrVg90H21EOLACvtfcHk0liMe3T0P7mmuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xptleltrg%253D&md5=07e735f1df4e90217397039b211db49f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm060290f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060290f%26sid%3Dliteratum%253Aachs%26aulast%3DGros%26aufirst%3DL.%26aulast%3DOrenes%2BLorente%26aufirst%3DS.%26aulast%3DJimenez%26aufirst%3DC.%26aulast%3DYardley%26aufirst%3DV.%26aulast%3DRattray%26aufirst%3DL.%26aulast%3DWharton%26aufirst%3DH.%26aulast%3DLittle%26aufirst%3DS.%26aulast%3DCroft%26aufirst%3DS.%2BL.%26aulast%3DRuiz-Perez%26aufirst%3DL.%2BM.%26aulast%3DGonzalez-Pacanowska%26aufirst%3DD.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DEvaluation%2520of%2520azasterols%2520as%2520anti-parasitics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6094%26epage%3D6103%26doi%3D10.1021%2Fjm060290f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Velasquez, A. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francisco, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohatsu, A. A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, F. A. d. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, R. G. d. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiari, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Almeida, M. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaac, V. L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicarelli, R. M. B.</span><span> </span><span class="NLM_article-title">Synthesis and tripanocidal activity of ferrocenyl and benzyl diamines against <i>Trypanosoma brucei</i> and <i>Trypanosoma cruzi</i></span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1707</span><span class="NLM_x">–</span> <span class="NLM_lpage">1710</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.02.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.bmcl.2014.02.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1707-1710&author=A.+M.+A.+Velasquezauthor=A.+I.+Franciscoauthor=A.+A.+N.+Kohatsuauthor=F.+A.+d.+J.+Silvaauthor=D.+F.+Rodriguesauthor=R.+G.+d.+S.+Teixeiraauthor=B.+G.+Chiariauthor=M.+G.+J.+de+Almeidaauthor=V.+L.+B.+Isaacauthor=M.+D.+Vargasauthor=R.+M.+B.+Cicarelli&title=Synthesis+and+tripanocidal+activity+of+ferrocenyl+and+benzyl+diamines+against+Trypanosoma+brucei+and+Trypanosoma+cruzi&doi=10.1016%2Fj.bmcl.2014.02.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.02.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.02.046%26sid%3Dliteratum%253Aachs%26aulast%3DVelasquez%26aufirst%3DA.%2BM.%2BA.%26aulast%3DFrancisco%26aufirst%3DA.%2BI.%26aulast%3DKohatsu%26aufirst%3DA.%2BA.%2BN.%26aulast%3DSilva%26aufirst%3DF.%2BA.%2Bd.%2BJ.%26aulast%3DRodrigues%26aufirst%3DD.%2BF.%26aulast%3DTeixeira%26aufirst%3DR.%2BG.%2Bd.%2BS.%26aulast%3DChiari%26aufirst%3DB.%2BG.%26aulast%3Dde%2BAlmeida%26aufirst%3DM.%2BG.%2BJ.%26aulast%3DIsaac%26aufirst%3DV.%2BL.%2BB.%26aulast%3DVargas%26aufirst%3DM.%2BD.%26aulast%3DCicarelli%26aufirst%3DR.%2BM.%2BB.%26atitle%3DSynthesis%2520and%2520tripanocidal%2520activity%2520of%2520ferrocenyl%2520and%2520benzyl%2520diamines%2520against%2520Trypanosoma%2520brucei%2520and%2520Trypanosoma%2520cruzi%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1707%26epage%3D1710%26doi%3D10.1016%2Fj.bmcl.2014.02.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Bosc, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouray, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cojean, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiseau, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas-Junior, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraes, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grellier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, J.</span><span> </span><span class="NLM_article-title">Highly improved antiparasitic activity after introduction of an <i>N</i>-benzylimidazole moiety on protein farnesyltransferase inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.ejmech.2015.12.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=26774924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC28Xns1Wiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2016&pages=173-186&author=D.+Boscauthor=E.+Mourayauthor=S.+Cojeanauthor=C.+H.+Francoauthor=P.+M.+Loiseauauthor=L.+H.+Freitas-Juniorauthor=C.+B.+Moraesauthor=P.+Grellierauthor=J.+Dubois&title=Highly+improved+antiparasitic+activity+after+introduction+of+an+N-benzylimidazole+moiety+on+protein+farnesyltransferase+inhibitors&doi=10.1016%2Fj.ejmech.2015.12.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors</span></div><div class="casAuthors">Bosc, Damien; Mouray, Elisabeth; Cojean, Sandrine; Franco, Caio Haddad; Loiseau, Philippe M.; Freitas-Junior, Lucio H.; Moraes, Carolina Borsoi; Grellier, Philippe; Dubois, Joelle</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">173-186</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In our search for new protein farnesyltransferase inhibitors with improved antiparasitic activities, we modified our previously developed 3-arylthiophene series of inhibitors by replacing the thioisopropyl group by different substituted imidazolylmethanamino moieties.  Twenty four new derivs. were synthesized and evaluated against human and parasite farnesyltransferases, and their anti-parasitic activity was detd. against Plasmodium falciparum, Trypanosoma brucei, Trypanosoma cruzi, and Leishmania donovani.  Introduction of a N-p-substituted-benzylimidazole led to significantly increase the inhibition of parasite proliferation in the submicromolar range.  The structure of the best inhibitors was parasite dependent.  Three compds. possess IC50 values at the same range as the ref. miltefosine against L. donovani proliferation and other new derivs. display high level of anti-trypanosomal activity against T. cruzi, higher or in the same order of magnitude as the ref. compds. benznidazole and nifurtimox.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMV7teVjretLVg90H21EOLACvtfcHk0liFFctA69SHdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xns1Wiug%253D%253D&md5=fcd7740879733a2b9326ebd81b81328d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DBosc%26aufirst%3DD.%26aulast%3DMouray%26aufirst%3DE.%26aulast%3DCojean%26aufirst%3DS.%26aulast%3DFranco%26aufirst%3DC.%2BH.%26aulast%3DLoiseau%26aufirst%3DP.%2BM.%26aulast%3DFreitas-Junior%26aufirst%3DL.%2BH.%26aulast%3DMoraes%26aufirst%3DC.%2BB.%26aulast%3DGrellier%26aufirst%3DP.%26aulast%3DDubois%26aufirst%3DJ.%26atitle%3DHighly%2520improved%2520antiparasitic%2520activity%2520after%2520introduction%2520of%2520an%2520N-benzylimidazole%2520moiety%2520on%2520protein%2520farnesyltransferase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D109%26spage%3D173%26epage%3D186%26doi%3D10.1016%2Fj.ejmech.2015.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Papadopoulou, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomer, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span> </span><span class="NLM_article-title">3-Nitrotriazole-based piperazides as potent antitrypanosomal agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.08.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.ejmech.2015.08.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=325-334&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=I.+P.+O%E2%80%99Sheaauthor=S.+R.+Wilkinsonauthor=M.+Kaiser&title=3-Nitrotriazole-based+piperazides+as+potent+antitrypanosomal+agents&doi=10.1016%2Fj.ejmech.2015.08.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.08.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.08.042%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DI.%2BP.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DKaiser%26aufirst%3DM.%26atitle%3D3-Nitrotriazole-based%2520piperazides%2520as%2520potent%2520antitrypanosomal%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D325%26epage%3D334%26doi%3D10.1016%2Fj.ejmech.2015.08.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Papadopoulou, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomer, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span> </span><span class="NLM_article-title">Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.ejmech.2014.09.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=79-88&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=S.+R.+Wilkinsonauthor=M.+Kaiser&title=Novel+nitro%28triazole%2Fimidazole%29-based+heteroarylamides%2Fsulfonamides+as+potential+antitrypanosomal+agents&doi=10.1016%2Fj.ejmech.2014.09.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.045%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DKaiser%26aufirst%3DM.%26atitle%3DNovel%2520nitro%2528triazole%252Fimidazole%2529-based%2520heteroarylamides%252Fsulfonamides%2520as%2520potential%2520antitrypanosomal%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D79%26epage%3D88%26doi%3D10.1016%2Fj.ejmech.2014.09.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Brimacombe, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasquez-Valdivieso, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNae, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fothergill-Gilmore, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michels, P. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeonov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxer, M. B.</span><span> </span><span class="NLM_article-title">Identification of ML251, a potent inhibitor of <i>T. brucei</i> and <i>T. cruzi</i> phosphofructokinase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1021/ml400259d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400259d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=12-17&author=K.+R.+Brimacombeauthor=M.+J.+Walshauthor=L.+Liuauthor=M.+G.+Vasquez-Valdiviesoauthor=H.+P.+Morganauthor=I.+McNaeauthor=L.+A.+Fothergill-Gilmoreauthor=P.+A.+M.+Michelsauthor=D.+S.+Auldauthor=A.+Simeonovauthor=M.+D.+Walkinshawauthor=M.+Shenauthor=M.+B.+Boxer&title=Identification+of+ML251%2C+a+potent+inhibitor+of+T.+brucei+and+T.+cruzi+phosphofructokinase&doi=10.1021%2Fml400259d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fml400259d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400259d%26sid%3Dliteratum%253Aachs%26aulast%3DBrimacombe%26aufirst%3DK.%2BR.%26aulast%3DWalsh%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DVasquez-Valdivieso%26aufirst%3DM.%2BG.%26aulast%3DMorgan%26aufirst%3DH.%2BP.%26aulast%3DMcNae%26aufirst%3DI.%26aulast%3DFothergill-Gilmore%26aufirst%3DL.%2BA.%26aulast%3DMichels%26aufirst%3DP.%2BA.%2BM.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DBoxer%26aufirst%3DM.%2BB.%26atitle%3DIdentification%2520of%2520ML251%252C%2520a%2520potent%2520inhibitor%2520of%2520T.%2520brucei%2520and%2520T.%2520cruzi%2520phosphofructokinase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D12%26epage%3D17%26doi%3D10.1021%2Fml400259d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Woodring, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leed, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciotti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Evaluation of aromatic 6-substituted thienopyrimidines as scaffolds against parasites that cause trypanosomiasis, leishmaniasis, and malaria</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span><span class="refDoi"> DOI: 10.1039/C4MD00441H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1039%2FC4MD00441H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=25685309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFegt7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=339-346&author=J.+L.+Woodringauthor=G.+Patelauthor=J.+Erathauthor=R.+Beheraauthor=P.+J.+Leeauthor=S.+E.+Leedauthor=A.+Rodriguezauthor=R.+J.+Sciottiauthor=K.+Mensa-Wilmotauthor=M.+P.+Pollastri&title=Evaluation+of+aromatic+6-substituted+thienopyrimidines+as+scaffolds+against+parasites+that+cause+trypanosomiasis%2C+leishmaniasis%2C+and+malaria&doi=10.1039%2FC4MD00441H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of aromatic 6-substituted thienopyrimidines as scaffolds against parasites that cause trypanosomiasis, leishmaniasis, and malaria</span></div><div class="casAuthors">Woodring, Jennifer L.; Patel, Gautam; Erath, Jessey; Behera, Ranjan; Lee, Patricia J.; Leed, Susan E.; Rodriguez, Ana; Sciotti, Richard J.; Mensa-Wilmot, Kojo; Pollastri, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-346</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Target repurposing is a proven method for finding new lead compds. that target Trypanosoma brucei, the causative agent of human African trypanosomiasis.  Due to the recent discovery of a lapatinib-derived analog 2 with excellent potency against T. brucei (EC50 = 42 nM) and selectivity over human host cells, we have explored other classes of human tyrosine kinase inhibitor scaffolds in order to expand the range of chemotypes for pursuit.  Following library expansion, we found compd. 11e to have an EC50 of 84 nM against T. brucei cells while maintaining selectivity over human hepatocytes.  In addn., the library was tested against causative agents of Chagas' disease, leishmaniasis, and malaria.  Two analogs with sub-micromolar potencies for T. cruzi (4j) and Plasmodium falciparum (11j) were discovered, along with an analog with considerable potency against Leishmania major amastigotes (4e).  Besides identifying new and potent protozoan growth inhibitors, these data highlight the value of concurrent screening of a chem. library against different protozoan parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhNEhEzrySvbVg90H21EOLACvtfcHk0lguqqu4pB-17Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFegt7%252FM&md5=9a9d6c171e8411f14c794b18360f2526</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1039%2FC4MD00441H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00441H%26sid%3Dliteratum%253Aachs%26aulast%3DWoodring%26aufirst%3DJ.%2BL.%26aulast%3DPatel%26aufirst%3DG.%26aulast%3DErath%26aufirst%3DJ.%26aulast%3DBehera%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DP.%2BJ.%26aulast%3DLeed%26aufirst%3DS.%2BE.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DSciotti%26aufirst%3DR.%2BJ.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DEvaluation%2520of%2520aromatic%25206-substituted%2520thienopyrimidines%2520as%2520scaffolds%2520against%2520parasites%2520that%2520cause%2520trypanosomiasis%252C%2520leishmaniasis%252C%2520and%2520malaria%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D339%26epage%3D346%26doi%3D10.1039%2FC4MD00441H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Patrick, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismail, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arafa, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandharkar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbovetz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykin, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span> </span><span class="NLM_article-title">Synthesis and antiprotozoal activity of dicationic <i>m</i>-terphenyl and 1,3-dipyridylbenzene derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5473</span><span class="NLM_x">–</span> <span class="NLM_lpage">5494</span><span class="refDoi"> DOI: 10.1021/jm400508e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400508e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5473-5494&author=D.+A.+Patrickauthor=M.+A.+Ismailauthor=R.+K.+Arafaauthor=T.+Wenzlerauthor=X.+Zhuauthor=T.+Pandharkarauthor=S.+K.+Jonesauthor=K.+A.+Werbovetzauthor=R.+Brunauthor=D.+W.+Boykinauthor=R.+R.+Tidwell&title=Synthesis+and+antiprotozoal+activity+of+dicationic+m-terphenyl+and+1%2C3-dipyridylbenzene+derivatives&doi=10.1021%2Fjm400508e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm400508e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400508e%26sid%3Dliteratum%253Aachs%26aulast%3DPatrick%26aufirst%3DD.%2BA.%26aulast%3DIsmail%26aufirst%3DM.%2BA.%26aulast%3DArafa%26aufirst%3DR.%2BK.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DPandharkar%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DS.%2BK.%26aulast%3DWerbovetz%26aufirst%3DK.%2BA.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DBoykin%26aufirst%3DD.%2BW.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DSynthesis%2520and%2520antiprotozoal%2520activity%2520of%2520dicationic%2520m-terphenyl%2520and%25201%252C3-dipyridylbenzene%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5473%26epage%3D5494%26doi%3D10.1021%2Fjm400508e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Sykes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moawad, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganame, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioset, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span> </span><span class="NLM_article-title">Identification of compounds with anti-proliferative activity against <i>Trypanosoma brucei brucei</i> strain 427 by a whole cell viability based HTS campaign</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1896</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0001896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0001896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=23209849" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=e1896&author=M.+L.+Sykesauthor=J.+B.+Baellauthor=M.+Kaiserauthor=E.+Chatelainauthor=S.+R.+Moawadauthor=D.+Ganameauthor=J.-R.+Iosetauthor=V.+M.+Avery&title=Identification+of+compounds+with+anti-proliferative+activity+against+Trypanosoma+brucei+brucei+strain+427+by+a+whole+cell+viability+based+HTS+campaign&doi=10.1371%2Fjournal.pntd.0001896"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0001896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0001896%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DMoawad%26aufirst%3DS.%2BR.%26aulast%3DGaname%26aufirst%3DD.%26aulast%3DIoset%26aufirst%3DJ.-R.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26atitle%3DIdentification%2520of%2520compounds%2520with%2520anti-proliferative%2520activity%2520against%2520Trypanosoma%2520brucei%2520brucei%2520strain%2520427%2520by%2520a%2520whole%2520cell%2520viability%2520based%2520HTS%2520campaign%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2012%26volume%3D6%26spage%3De1896%26doi%3D10.1371%2Fjournal.pntd.0001896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Ferrins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teston, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almohaywi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span> </span><span class="NLM_article-title">3-(Oxazolo[4,5-<i>b</i>]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid <i>Trypanosoma brucei</i>, the causative agent for human African trypanosomiasis</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.ejmech.2013.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=23831695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Sktb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2013&pages=450-465&author=L.+Ferrinsauthor=R.+Rahmaniauthor=M.+L.+Sykesauthor=A.+J.+Jonesauthor=V.+M.+Averyauthor=E.+Testonauthor=B.+Almohaywiauthor=J.+X.+Yinauthor=J.+Smithauthor=C.+Hylandauthor=K.+L.+Whiteauthor=E.+Ryanauthor=M.+Campbellauthor=S.+A.+Charmanauthor=M.+Kaiserauthor=J.+B.+Baell&title=3-%28Oxazolo%5B4%2C5-b%5Dpyridin-2-yl%29anilides+as+a+novel+class+of+potent+inhibitors+for+the+kinetoplastid+Trypanosoma+brucei%2C+the+causative+agent+for+human+African+trypanosomiasis&doi=10.1016%2Fj.ejmech.2013.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis</span></div><div class="casAuthors">Ferrins, Lori; Rahmani, Raphael; Sykes, Melissa L.; Jones, Amy J.; Avery, Vicky M.; Teston, Eliott; Almohaywi, Basmah; Yin, Jie Xiang; Smith, Jason; Hyland, Chris; White, Karen L.; Ryan, Eileen; Campbell, Michael; Charman, Susan A.; Kaiser, Marcel; Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">450-465</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A whole organism high-throughput screen of approx. 87,000 compds. against Trypanosoma brucei brucei led to the recent discovery of several novel compd. classes with low micromolar activity against this organism and without appreciable cytotoxicity to mammalian cells.  Herein we report a structure-activity relation (SAR) investigation around one of these hit classes, the 3-(oxazolo[4,5-b]pyridin-2-yl)anilides.  Sharp SAR is revealed, with our most active compd. (I) exhibiting an IC50 of 91 nM against the human pathogenic strain T.b. rhodesiense and being more than 700 times less toxic towards the L6 mammalian cell line.  Physicochem. properties are attractive for many compds. in this series.  For the most potent representatives, we show that soly. and metabolic stability are key parameters to target during future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruFGlHJ2ScL7Vg90H21EOLACvtfcHk0lguqqu4pB-17Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Sktb7L&md5=12ad544172d828822118646b5b95bf6d</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DRahmani%26aufirst%3DR.%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DTeston%26aufirst%3DE.%26aulast%3DAlmohaywi%26aufirst%3DB.%26aulast%3DYin%26aufirst%3DJ.%2BX.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DHyland%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3D3-%2528Oxazolo%255B4%252C5-b%255Dpyridin-2-yl%2529anilides%2520as%2520a%2520novel%2520class%2520of%2520potent%2520inhibitors%2520for%2520the%2520kinetoplastid%2520Trypanosoma%2520brucei%252C%2520the%2520causative%2520agent%2520for%2520human%2520African%2520trypanosomiasis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D66%26spage%3D450%26epage%3D465%26doi%3D10.1016%2Fj.ejmech.2013.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Rashad, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. A.</span><span> </span><span class="NLM_article-title">Facile synthesis and preliminary structure-activity analysis of new sulfonamides against <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">496</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span><span class="refDoi"> DOI: 10.1021/ml400487t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400487t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=496-500&author=A.+A.+Rashadauthor=A.+J.+Jonesauthor=V.+M.+Averyauthor=J.+Baellauthor=P.+A.+Keller&title=Facile+synthesis+and+preliminary+structure-activity+analysis+of+new+sulfonamides+against+Trypanosoma+brucei&doi=10.1021%2Fml400487t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fml400487t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400487t%26sid%3Dliteratum%253Aachs%26aulast%3DRashad%26aufirst%3DA.%2BA.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DP.%2BA.%26atitle%3DFacile%2520synthesis%2520and%2520preliminary%2520structure-activity%2520analysis%2520of%2520new%2520sulfonamides%2520against%2520Trypanosoma%2520brucei%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D496%26epage%3D500%26doi%3D10.1021%2Fml400487t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Manos-Turvey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, R. J.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of phenoxymethylbenzamide analogues as anti-trypanosomal agents</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.1039/C4MD00406J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1039%2FC4MD00406J" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=403-406&author=A.+Manos-Turveyauthor=E.+E.+Watsonauthor=M.+L.+Sykesauthor=A.+J.+Jonesauthor=J.+B.+Baellauthor=M.+Kaiserauthor=V.+M.+Averyauthor=R.+J.+Payne&title=Synthesis+and+evaluation+of+phenoxymethylbenzamide+analogues+as+anti-trypanosomal+agents&doi=10.1039%2FC4MD00406J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1039%2FC4MD00406J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00406J%26sid%3Dliteratum%253Aachs%26aulast%3DManos-Turvey%26aufirst%3DA.%26aulast%3DWatson%26aufirst%3DE.%2BE.%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DPayne%26aufirst%3DR.%2BJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520phenoxymethylbenzamide%2520analogues%2520as%2520anti-trypanosomal%2520agents%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D403%26epage%3D406%26doi%3D10.1039%2FC4MD00406J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Rahmani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganame, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span> </span><span class="NLM_article-title">6-Arylpyrazine-2-carboxamides: a new core for <i>Trypanosoma brucei</i> inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6753</span><span class="NLM_x">–</span> <span class="NLM_lpage">6765</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00438</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6753-6765&author=R.+Rahmaniauthor=K.+Banauthor=A.+J.+Jonesauthor=L.+Ferrinsauthor=D.+Ganameauthor=M.+L.+Sykesauthor=V.+M.+Averyauthor=K.+L.+Whiteauthor=E.+Ryanauthor=M.+Kaiserauthor=S.+A.+Charmanauthor=J.+B.+Baell&title=6-Arylpyrazine-2-carboxamides%3A+a+new+core+for+Trypanosoma+brucei+inhibitors&doi=10.1021%2Facs.jmedchem.5b00438"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00438%26sid%3Dliteratum%253Aachs%26aulast%3DRahmani%26aufirst%3DR.%26aulast%3DBan%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DGaname%26aufirst%3DD.%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3D6-Arylpyrazine-2-carboxamides%253A%2520a%2520new%2520core%2520for%2520Trypanosoma%2520brucei%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6753%26epage%3D6765%26doi%3D10.1021%2Facs.jmedchem.5b00438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Ferrins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, C. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span> </span><span class="NLM_article-title">Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6393</span><span class="NLM_x">–</span> <span class="NLM_lpage">6402</span><span class="refDoi"> DOI: 10.1021/jm500191u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500191u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6393-6402&author=L.+Ferrinsauthor=M.+Gazdikauthor=R.+Rahmaniauthor=S.+Vargheseauthor=M.+L.+Sykesauthor=A.+J.+Jonesauthor=V.+M.+Averyauthor=K.+L.+Whiteauthor=E.+Ryanauthor=S.+A.+Charmanauthor=M.+Kaiserauthor=C.+A.+S.+Bergstromauthor=J.+B.+Baell&title=Pyridyl+benzamides+as+a+novel+class+of+potent+inhibitors+for+the+kinetoplastid+Trypanosoma+brucei&doi=10.1021%2Fjm500191u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm500191u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500191u%26sid%3Dliteratum%253Aachs%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DGazdik%26aufirst%3DM.%26aulast%3DRahmani%26aufirst%3DR.%26aulast%3DVarghese%26aufirst%3DS.%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DBergstrom%26aufirst%3DC.%2BA.%2BS.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DPyridyl%2520benzamides%2520as%2520a%2520novel%2520class%2520of%2520potent%2520inhibitors%2520for%2520the%2520kinetoplastid%2520Trypanosoma%2520brucei%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6393%26epage%3D6402%26doi%3D10.1021%2Fjm500191u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Baell, J.; Piggott, M.; Russell, S.; Toynton, A.; Rahmani, R.; Ferrins, L.; Nguyen, N.</span><span> </span><span class="NLM_article-title">Heterocyclic compounds and use of same</span>. WO 2015172196 A1, 20151119, 20150513,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Baell&author=M.+Piggott&author=S.+Russell&author=A.+Toynton&author=R.+Rahmani&author=L.+Ferrins&author=N.+Nguyen&title=Heterocyclic+compounds+and+use+of+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%26atitle%3DHeterocyclic%2520compounds%2520and%2520use%2520of%2520same%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgOhnG8Ru0qLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Walczynski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderveld, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glinka, R.</span><span> </span><span class="NLM_article-title">Histamine H1 receptor ligands. Part I. Novel thiazol-4-ylethanamine derivatives: synthesis and in vitro pharmacology</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span><span class="refDoi"> DOI: 10.1016/S0014-827X(99)00060-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0014-827X%2899%2900060-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10510850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFClsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=533-541&author=K.+Walczynskiauthor=H.+Timmermanauthor=O.+P.+Zuiderveldauthor=M.+Q.+Zhangauthor=R.+Glinka&title=Histamine+H1+receptor+ligands.+Part+I.+Novel+thiazol-4-ylethanamine+derivatives%3A+synthesis+and+in+vitro+pharmacology&doi=10.1016%2FS0014-827X%2899%2900060-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H1 receptor ligands. Part I. Novel thiazol-4-ylethanamine derivatives: synthesis and in vitro pharmacology</span></div><div class="casAuthors">Walczynski, K.; Timmerman, H.; Zuiderveld, O. P.; Zhang, M. Q.; Glinka, R.</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">533-541</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">A series of 2-substituted thiazol-4-ylethanamines have been synthesized and tested for their histaminergic H1-receptor activities.  The compds. with 2-Ph substitution, regardless of the different physicochem. properties of the meta-substituents at the Ph ring, showed weak H1-agonistic activity with pD2 values ranging from 4.35 to 5.36.  When the Ph group was replaced by a benzyl group, the resulting compds. all exhibited weak H1-antagonistic activity (pA2: 4.14-4.82).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR2iX_bbC4RLVg90H21EOLACvtfcHk0ljK9D8w82rMbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFClsrs%253D&md5=a508efa178299cbe6eb3f28b7e29ef42</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2899%2900060-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252899%252900060-9%26sid%3Dliteratum%253Aachs%26aulast%3DWalczynski%26aufirst%3DK.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DZuiderveld%26aufirst%3DO.%2BP.%26aulast%3DZhang%26aufirst%3DM.%2BQ.%26aulast%3DGlinka%26aufirst%3DR.%26atitle%3DHistamine%2520H1%2520receptor%2520ligands.%2520Part%2520I.%2520Novel%2520thiazol-4-ylethanamine%2520derivatives%253A%2520synthesis%2520and%2520in%2520vitro%2520pharmacology%26jtitle%3DFarmaco%26date%3D1999%26volume%3D54%26spage%3D533%26epage%3D541%26doi%3D10.1016%2FS0014-827X%2899%2900060-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Ahangar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alipour, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pashapour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foroumadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emami, S.</span><span> </span><span class="NLM_article-title">1-[(2-Arylthiazol-4-yl)methyl]azoles as a new class of anticonvulsants: design, synthesis, in vivo screening, and in silico drug-like properties</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span><span class="refDoi"> DOI: 10.1111/j.1747-0285.2011.01211.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1111%2Fj.1747-0285.2011.01211.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=21827633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2nsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2011&pages=844-852&author=N.+Ahangarauthor=A.+Ayatiauthor=E.+Alipourauthor=A.+Pashapourauthor=A.+Foroumadiauthor=S.+Emami&title=1-%5B%282-Arylthiazol-4-yl%29methyl%5Dazoles+as+a+new+class+of+anticonvulsants%3A+design%2C+synthesis%2C+in+vivo+screening%2C+and+in+silico+drug-like+properties&doi=10.1111%2Fj.1747-0285.2011.01211.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">1-[(2-arylthiazol-4-yl)methyl]azoles as a new class of anticonvulsants: design, synthesis, in vivo screening, and in silico drug-like properties</span></div><div class="casAuthors">Ahangar, Nematollah; Ayati, Adile; Alipour, Eskandar; Pashapour, Arsalan; Foroumadi, Alireza; Emami, Saeed</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">844-852</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A series of novel thiazole incorporated (arylalkyl)azoles were synthesized and screened for their anticonvulsant properties using maximal electroshock and pentylenetetrazole models in mice.  Among target compds., 1-[(2-(4-chlorophenyl)thiazol-4-yl)methyl]-1H-imidazole, 1-[(2-phenylthiazol-4-yl)methyl]-1H-1,2,4-triazole, and its 4-chlorophenyl analog were able to display noticeable anticonvulsant activity in both pentylenetetrazole and maximal electroshock tests with percentage protection range of 33-100%.  A computational study was carried out for prediction of pharmacokinetics properties and drug-likeness.  The structure-activity relationship and in silico drug relevant properties confirmed that the compds. were within the range set by Lipinski's rule-of-five, and possessing favorable physicochem. properties for acting as CNS-drugs, making them potentially promising agents for epilepsy therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoarS45gXaESLVg90H21EOLACvtfcHk0ljK9D8w82rMbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2nsrrF&md5=51a76a0e5a2ccf1fce7533fb86b124f1</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01211.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01211.x%26sid%3Dliteratum%253Aachs%26aulast%3DAhangar%26aufirst%3DN.%26aulast%3DAyati%26aufirst%3DA.%26aulast%3DAlipour%26aufirst%3DE.%26aulast%3DPashapour%26aufirst%3DA.%26aulast%3DForoumadi%26aufirst%3DA.%26aulast%3DEmami%26aufirst%3DS.%26atitle%3D1-%255B%25282-Arylthiazol-4-yl%2529methyl%255Dazoles%2520as%2520a%2520new%2520class%2520of%2520anticonvulsants%253A%2520design%252C%2520synthesis%252C%2520in%2520vivo%2520screening%252C%2520and%2520in%2520silico%2520drug-like%2520properties%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2011%26volume%3D78%26spage%3D844%26epage%3D852%26doi%3D10.1111%2Fj.1747-0285.2011.01211.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Huntress, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, K.,  III</span><span> </span><span class="NLM_article-title">Conversion of 2-phenyl-4-chloromethylthiazole to 2-phenyl-4-hydroxymethyl-5-chlorothiazole</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1943</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1667</span><span class="NLM_x">–</span> <span class="NLM_lpage">1670</span><span class="refDoi"> DOI: 10.1021/ja01249a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01249a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1943&pages=1667-1670&author=E.+H.+Huntressauthor=K.+Pfister&title=Conversion+of+2-phenyl-4-chloromethylthiazole+to+2-phenyl-4-hydroxymethyl-5-chlorothiazole&doi=10.1021%2Fja01249a002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fja01249a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01249a002%26sid%3Dliteratum%253Aachs%26aulast%3DHuntress%26aufirst%3DE.%2BH.%26aulast%3DPfister%26aufirst%3DK.%26atitle%3DConversion%2520of%25202-phenyl-4-chloromethylthiazole%2520to%25202-phenyl-4-hydroxymethyl-5-chlorothiazole%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1943%26volume%3D65%26spage%3D1667%26epage%3D1670%26doi%3D10.1021%2Fja01249a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Satoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, Z.</span><span> </span><span class="NLM_article-title">Reduction of organic compounds with sodium borohydride-transition metal salt systems. I. Reduction of organic nitrile, nitro and amide compounds to primary amines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4555</span><span class="NLM_x">–</span> <span class="NLM_lpage">4558</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)88749-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0040-4039%2801%2988749-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1969&pages=4555-4558&author=T.+Satohauthor=S.+Suzukiauthor=Y.+Suzukiauthor=Y.+Miyajiauthor=Z.+Imai&title=Reduction+of+organic+compounds+with+sodium+borohydride-transition+metal+salt+systems.+I.+Reduction+of+organic+nitrile%2C+nitro+and+amide+compounds+to+primary+amines&doi=10.1016%2FS0040-4039%2801%2988749-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2988749-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252988749-9%26sid%3Dliteratum%253Aachs%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DMiyaji%26aufirst%3DY.%26aulast%3DImai%26aufirst%3DZ.%26atitle%3DReduction%2520of%2520organic%2520compounds%2520with%2520sodium%2520borohydride-transition%2520metal%2520salt%2520systems.%2520I.%2520Reduction%2520of%2520organic%2520nitrile%252C%2520nitro%2520and%2520amide%2520compounds%2520to%2520primary%2520amines%26jtitle%3DTetrahedron%2520Lett.%26date%3D1969%26volume%3D10%26spage%3D4555%26epage%3D4558%26doi%3D10.1016%2FS0040-4039%2801%2988749-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Caddick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A. K. d. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M. R. V.</span><span> </span><span class="NLM_article-title">A generic approach for the catalytic reduction of nitriles</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5417</span><span class="NLM_x">–</span> <span class="NLM_lpage">5423</span><span class="refDoi"> DOI: 10.1016/S0040-4020(03)00858-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0040-4020%2803%2900858-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1egtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=5417-5423&author=S.+Caddickauthor=D.+B.+Juddauthor=A.+K.+d.+K.+Lewisauthor=M.+T.+Reichauthor=M.+R.+V.+Williams&title=A+generic+approach+for+the+catalytic+reduction+of+nitriles&doi=10.1016%2FS0040-4020%2803%2900858-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A generic approach for the catalytic reduction of nitriles</span></div><div class="casAuthors">Caddick, Stephen; Judd, Duncan B.; Lewis, Alexandra K. de K.; Reich, Melanie T.; Williams, Meredith R. V.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">5417-5423</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The scope of Ni boride mediated redn. of nitriles was extended further to gave Boc protected amines via a mild catalytic process.  It is noteworthy that the toxicity of this procedure is greatly reduced due to its catalytic nature in NiCl2 used in combination with excess NaBH4.  The protocol is marked by its resilience towards air and moisture and hence an easy and general practical protocol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmQHRUoYQkTbVg90H21EOLACvtfcHk0lgT3OPMc3GHSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1egtbc%253D&md5=e114a7d22c8bde215fe3692d86861c09</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2803%2900858-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252803%252900858-5%26sid%3Dliteratum%253Aachs%26aulast%3DCaddick%26aufirst%3DS.%26aulast%3DJudd%26aufirst%3DD.%2BB.%26aulast%3DLewis%26aufirst%3DA.%2BK.%2Bd.%2BK.%26aulast%3DReich%26aufirst%3DM.%2BT.%26aulast%3DWilliams%26aufirst%3DM.%2BR.%2BV.%26atitle%3DA%2520generic%2520approach%2520for%2520the%2520catalytic%2520reduction%2520of%2520nitriles%26jtitle%3DTetrahedron%26date%3D2003%26volume%3D59%26spage%3D5417%26epage%3D5423%26doi%3D10.1016%2FS0040-4020%2803%2900858-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Bachmann, S.; Flohr, A.; Zbinden, K. G.; Koerner, M.; Kuhn, B.; Peters, J.-U.; Rudolph, M.</span><span> </span><span class="NLM_article-title">Preparation of substituted pyrazole carboxamides as PDE10 modulators</span>. 201213598848, 20130059833, 20120830,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Bachmann&author=A.+Flohr&author=K.+G.+Zbinden&author=M.+Koerner&author=B.+Kuhn&author=J.-U.+Peters&author=M.+Rudolph&title=Preparation+of+substituted+pyrazole+carboxamides+as+PDE10+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBachmann%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520substituted%2520pyrazole%2520carboxamides%2520as%2520PDE10%2520modulators%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Duspara, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batey, R. A.</span><span> </span><span class="NLM_article-title">Synthesis and reactivity of <i>N</i>-alkyl carbamoylimidazoles: development of <i>N</i>-methyl carbamoylimidazole as a methyl isocyanate equivalent</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">10362</span><span class="NLM_x">–</span> <span class="NLM_lpage">10368</span><span class="refDoi"> DOI: 10.1021/jo302084a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo302084a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFChs77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=10362-10368&author=P.+A.+Dusparaauthor=M.+S.+Islamauthor=A.+J.+Loughauthor=R.+A.+Batey&title=Synthesis+and+reactivity+of+N-alkyl+carbamoylimidazoles%3A+development+of+N-methyl+carbamoylimidazole+as+a+methyl+isocyanate+equivalent&doi=10.1021%2Fjo302084a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Reactivity of N-Alkyl Carbamoylimidazoles: Development of N-Methyl Carbamoylimidazole as a Methyl Isocyanate Equivalent</span></div><div class="casAuthors">Duspara, Petar A.; Islam, Md. Sadequl; Lough, Alan J.; Batey, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10362-10368</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A high-yielding synthesis of N-methylcarbamoylimidazole from 1,1-carbonyldiimidazole (CDI) and MeNH3Cl is described.  The product is a cryst., readily storable, water-stable compd. that reacts as a Me isocyanate (MIC) substitute.  Reaction of N-methylcarbamoylimidazole in the presence of a base such as triethylamine occurs with nucleophiles such as amines, protected and unprotected amino acids, thiols, and alcs.  The product N-methylureas, carbamates, and thiocarbamates are obtained in good to excellent yields, with reactions occurring in either org. solvents or water.  The protocol for the synthesis of N-methylcarbamoylimidazole is both scalable and general, occurring in quant. yield at scales ranging from 300 mg to 20 g.  The success of this method relies upon the reaction of CDI with the ammonium salt rather than the free amine, resulting in a significant improvement in the yield of N-methylcarbamoylimidazole.  The reaction presumably involves a proton transfer from MeNH3Cl to the CDI, which results in the release of MeNH2 with simultaneous activation of the CDI as its protonated form.  Other primary ammonium hydrochloride salts, including protected α-amino acid salts, give excellent yields of the corresponding N-alkylcarbamoylimidazoles and serve as alkyl isocyanate surrogates.  The resultant N-alkylcarbamoylimidazoles can be converted to ureas in high yields without the formation of intermediary isocyanates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoorREoj6WubVg90H21EOLACvtfcHk0lgT3OPMc3GHSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFChs77M&md5=d08c052e4b74e1a90e9c84300cb72aa9</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjo302084a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo302084a%26sid%3Dliteratum%253Aachs%26aulast%3DDuspara%26aufirst%3DP.%2BA.%26aulast%3DIslam%26aufirst%3DM.%2BS.%26aulast%3DLough%26aufirst%3DA.%2BJ.%26aulast%3DBatey%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520reactivity%2520of%2520N-alkyl%2520carbamoylimidazoles%253A%2520development%2520of%2520N-methyl%2520carbamoylimidazole%2520as%2520a%2520methyl%2520isocyanate%2520equivalent%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2012%26volume%3D77%26spage%3D10362%26epage%3D10368%26doi%3D10.1021%2Fjo302084a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Gandy, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIldowie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasik, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomonczyk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millar, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tindiglia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Iverson, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piggott, M. J.</span><span> </span><span class="NLM_article-title">Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt’s lymphoma cytotoxicity</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1039/c0md00108b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1039%2Fc0md00108b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=287-293&author=M.+N.+Gandyauthor=M.+McIldowieauthor=K.+Lewisauthor=A.+M.+Wasikauthor=D.+Salomonczykauthor=K.+Waggauthor=Z.+A.+Millarauthor=D.+Tindigliaauthor=P.+Huotauthor=T.+Johnstonauthor=S.+Thieleauthor=B.+Nguyenauthor=N.+M.+Barnesauthor=J.+M.+Brotchieauthor=M.+T.+Martin-Iversonauthor=J.+Nashauthor=J.+Gordonauthor=M.+J.+Piggott&title=Redesigning+the+designer+drug+ecstasy%3A+non-psychoactive+MDMA+analogues+exhibiting+Burkitt%E2%80%99s+lymphoma+cytotoxicity&doi=10.1039%2Fc0md00108b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1039%2Fc0md00108b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0md00108b%26sid%3Dliteratum%253Aachs%26aulast%3DGandy%26aufirst%3DM.%2BN.%26aulast%3DMcIldowie%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DK.%26aulast%3DWasik%26aufirst%3DA.%2BM.%26aulast%3DSalomonczyk%26aufirst%3DD.%26aulast%3DWagg%26aufirst%3DK.%26aulast%3DMillar%26aufirst%3DZ.%2BA.%26aulast%3DTindiglia%26aufirst%3DD.%26aulast%3DHuot%26aufirst%3DP.%26aulast%3DJohnston%26aufirst%3DT.%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DBarnes%26aufirst%3DN.%2BM.%26aulast%3DBrotchie%26aufirst%3DJ.%2BM.%26aulast%3DMartin-Iverson%26aufirst%3DM.%2BT.%26aulast%3DNash%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DJ.%26aulast%3DPiggott%26aufirst%3DM.%2BJ.%26atitle%3DRedesigning%2520the%2520designer%2520drug%2520ecstasy%253A%2520non-psychoactive%2520MDMA%2520analogues%2520exhibiting%2520Burkitt%25E2%2580%2599s%2520lymphoma%2520cytotoxicity%26jtitle%3DMedChemComm%26date%3D2010%26volume%3D1%26spage%3D287%26epage%3D293%26doi%3D10.1039%2Fc0md00108b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Han, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, H.-G.</span><span> </span><span class="NLM_article-title">Exploration of novel 2-alkylimino-1,3-thiazolines: T-type calcium channel inhibitory activity</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span><span class="refDoi"> DOI: 10.1021/cc100041m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc100041m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVSmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=518-530&author=M.+Hanauthor=K.+D.+Namauthor=D.+Shinauthor=N.+Jeongauthor=H.-G.+Hahn&title=Exploration+of+novel+2-alkylimino-1%2C3-thiazolines%3A+T-type+calcium+channel+inhibitory+activity&doi=10.1021%2Fcc100041m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of novel 2-alkylimino-1,3-thiazolines: T-type calcium channel inhibitory activity</span></div><div class="casAuthors">Han, Minsoo; Nam, Kee Dal; Shin, Dongyun; Jeong, Nakcheol; Hahn, Hoh-Gyu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">518-530</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have developed combinatorial libraries of new 2-alkylimino-1,3-thiazolines with four diversity points, consisting of more than 500 compds., in a parallel synthetic fashion.  The synthetic strategy was based on the construction of a large library aimed at the discovery of new compds. with T-type calcium channel inhibitory activity through structure modifications of hit compd. I.  The syntheses of the compds. of Chemset A with four diversity points were accomplished by the condensation of thioureas with α-haloketones having two diversity points each.  A library of phthalimidyl 1,3-thiazolines was synthesized to provide Chemset B, which allowed the introduction of other diversity points through the nucleophilic character of the amino nitrogen.  A sublibrary, Chemset C, was constructed from the libraries of Chemset A and Chemset B by functionalization of the C-4 position of the 1,3-thiazoline ring.  The products contg. ester or acid groups at the C-4 position of the 1,3-thiazoline ring were used in amide synthesis to give a new sublibrary within Chemset C.  Deprotection of the phthalimidyl moiety and followed by the reaction with benzoyl chloride gave the corresponding sublibrary in Chemset C.  Another sublibrary which includes secondary amino derivs. was obtained by redn. of the amide moiety or reductive amination with Ph aldehyde.  The selected compds. from the generated libraries were evaluated with respect to inhibition of T-type calcium channels, where some of them have exhibited promising activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoso183a9ek-LVg90H21EOLACvtfcHk0lgfgbmvx7Ju8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVSmurY%253D&md5=13d971c1afdd7c853b115df6b88b17ec</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fcc100041m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc100041m%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DM.%26aulast%3DNam%26aufirst%3DK.%2BD.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DJeong%26aufirst%3DN.%26aulast%3DHahn%26aufirst%3DH.-G.%26atitle%3DExploration%2520of%2520novel%25202-alkylimino-1%252C3-thiazolines%253A%2520T-type%2520calcium%2520channel%2520inhibitory%2520activity%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2010%26volume%3D12%26spage%3D518%26epage%3D530%26doi%3D10.1021%2Fcc100041m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Song, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Y.</span><span> </span><span class="NLM_article-title">Preparation of alkyl carbamate of 1-protected indole-3-methylamine as a precursor of indole-3-methylamine</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2735</span><span class="NLM_x">–</span> <span class="NLM_lpage">2748</span><span class="refDoi"> DOI: 10.1080/00397910500287967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1080%2F00397910500287967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyitLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=2735-2748&author=H.+Songauthor=W.+Chenauthor=Y.+Wangauthor=Y.+Qin&title=Preparation+of+alkyl+carbamate+of+1-protected+indole-3-methylamine+as+a+precursor+of+indole-3-methylamine&doi=10.1080%2F00397910500287967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of Alkyl Carbamate of 1-Protected Indole-3-methylamine as a Precursor of Indole-3-methylamine</span></div><div class="casAuthors">Song, Hao; Chen, Wei; Wang, Yin; Qin, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2735-2748</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A series of alkyl carbamates of 1-protected indole-3-methylamines, thiophenylmethylamines and pyrrolylmethylamines were prepd. from the corresponding acetamides in good to excellent yields via diacetoxyiodobenzene-promoted Hofmann rearrangement.  For a successful Hofmann rearrangement, an electron-withdrawing group on position 1 of indolylacetamide and pyrrolylacetamide was required.  Tert.-Bu 1-tosylindol-3-ylmethylcarbamate was demonstrated to serve well as a stable precursor of 1-protected indole-3-methylamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoimt8iouiB6LVg90H21EOLACvtfcHk0lgfgbmvx7Ju8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyitLfP&md5=d92565a04d466b4e413acf12b6f4829b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1080%2F00397910500287967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910500287967%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DQin%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520alkyl%2520carbamate%2520of%25201-protected%2520indole-3-methylamine%2520as%2520a%2520precursor%2520of%2520indole-3-methylamine%26jtitle%3DSynth.%2520Commun.%26date%3D2005%26volume%3D35%26spage%3D2735%26epage%3D2748%26doi%3D10.1080%2F00397910500287967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Guiles, J.; Jarvis, T.; Strong, S.; Sun, X.</span><span> </span><span class="NLM_article-title">Preparation of azolylureas as antibacterials</span>. 2007-US16566, 2008011191, 20070723,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+Guiles&author=T.+Jarvis&author=S.+Strong&author=X.+Sun&title=Preparation+of+azolylureas+as+antibacterials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuiles%26aufirst%3DJ.%26atitle%3DPreparation%2520of%2520azolylureas%2520as%2520antibacterials%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Bischofberger, N. W.; Kim, C. U.; Krawczyk, S. H.; McGee, L. R.; Postich, M. J.; Yang, W.</span><span> </span><span class="NLM_article-title">Preparation of thiepane alditols for inhibiting and detecting HIV protease</span>. 1995-552429, 6034118, 19951103,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=N.+W.+Bischofberger&author=C.+U.+Kim&author=S.+H.+Krawczyk&author=L.+R.+McGee&author=M.+J.+Postich&author=W.+Yang&title=Preparation+of+thiepane+alditols+for+inhibiting+and+detecting+HIV+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBischofberger%26aufirst%3DN.%2BW.%26atitle%3DPreparation%2520of%2520thiepane%2520alditols%2520for%2520inhibiting%2520and%2520detecting%2520HIV%2520protease%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Zheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikulin, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konkar, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vansal, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shams, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feller, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span> </span><span class="NLM_article-title">2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-<i>c</i>]pyridines: novel selective β<sub>3</sub>-adrenoceptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2287</span><span class="NLM_x">–</span> <span class="NLM_lpage">2294</span><span class="refDoi"> DOI: 10.1021/jm990012z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990012z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2287-2294&author=W.+Zhengauthor=V.+I.+Nikulinauthor=A.+A.+Konkarauthor=S.+S.+Vansalauthor=G.+Shamsauthor=D.+R.+Fellerauthor=D.+D.+Miller&title=2-Amino-4-benzyl-4%2C5%2C6%2C7-tetrahydrothiazolo%5B5%2C4-c%5Dpyridines%3A+novel+selective+%CE%B23-adrenoceptor+agonists&doi=10.1021%2Fjm990012z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm990012z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990012z%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DNikulin%26aufirst%3DV.%2BI.%26aulast%3DKonkar%26aufirst%3DA.%2BA.%26aulast%3DVansal%26aufirst%3DS.%2BS.%26aulast%3DShams%26aufirst%3DG.%26aulast%3DFeller%26aufirst%3DD.%2BR.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3D2-Amino-4-benzyl-4%252C5%252C6%252C7-tetrahydrothiazolo%255B5%252C4-c%255Dpyridines%253A%2520novel%2520selective%2520%25CE%25B23-adrenoceptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2287%26epage%3D2294%26doi%3D10.1021%2Fjm990012z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Li, W.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-T.</span><span> </span><span class="NLM_article-title">One-pot tandem copper-catalyzed library synthesis of 1-thiazolyl-1,2,3-triazoles as anticancer agents</span> <span class="citation_source-journal">ACS Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1021/co1000234</span> </span><div class="citationLinks">[<a href="/doi/10.1021/co1000234" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWhtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=72-78&author=W.-T.+Liauthor=W.-H.+Wuauthor=C.-H.+Tangauthor=R.+Taiauthor=S.-T.+Chen&title=One-pot+tandem+copper-catalyzed+library+synthesis+of+1-thiazolyl-1%2C2%2C3-triazoles+as+anticancer+agents&doi=10.1021%2Fco1000234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">One-Pot Tandem Copper-Catalyzed Library Synthesis of 1-Thiazolyl-1,2,3-triazoles as Anticancer Agents</span></div><div class="casAuthors">Li, Wen-Tai; Wu, Wan-Hsun; Tang, Chien-Hsiang; Tai, Ready; Chen, Shui-Tein</div><div class="citationInfo"><span class="NLM_cas:title">ACS Combinatorial Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-78</span>CODEN:
                <span class="NLM_cas:coden">ACSCCC</span>;
        ISSN:<span class="NLM_cas:issn">2156-8944</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One-pot tandem copper-catalyzed azidation and CuAAC reactions that afford 1-thiazolyl-1,2,3-triazoles with anticancer activity have been developed.  By utilizing this one-pot synthetic strategy, a library of 1-thiazolyl-1,2,3-triazoles were constructed in search of the potent lead compd.  Furthermore, 1-thiazolyl-1,2,3-triazoles were evaluated for anticancer activity against the multidrug-resistant cancer cells MES-SA/Dx5.  Most of the 1-thiazolyl-1,2,3-triazoles revealed cytotoxic effect against cancer cells at micromolar to low micromolar range.  Testing some of the most potent compds. against the normal cell line Vero showed no significant toxicity (except one) to normal cells.  This result indicates that these compds. possessed good potency and selectivity to cancer cells over normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVXZWIC6kHWbVg90H21EOLACvtfcHk0lgfgbmvx7Ju8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWhtr7P&md5=13690df8d59be811dd3377242269869d</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fco1000234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fco1000234%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.-T.%26aulast%3DWu%26aufirst%3DW.-H.%26aulast%3DTang%26aufirst%3DC.-H.%26aulast%3DTai%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DS.-T.%26atitle%3DOne-pot%2520tandem%2520copper-catalyzed%2520library%2520synthesis%2520of%25201-thiazolyl-1%252C2%252C3-triazoles%2520as%2520anticancer%2520agents%26jtitle%3DACS%2520Comb.%2520Sci.%26date%3D2011%26volume%3D13%26spage%3D72%26epage%3D78%26doi%3D10.1021%2Fco1000234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Alonso-Padilla, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotillo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presa, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantizani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardera, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span> </span><span class="NLM_article-title">Automated high-content assay for compounds selectively toxic to <i>Trypanosoma cruzi</i> in a myoblastic cell line</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0003493</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0003493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0003493" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=e0003493&author=J.+Alonso-Padillaauthor=I.+Cotilloauthor=J.+L.+Presaauthor=J.+Cantizaniauthor=I.+Penaauthor=A.+I.+Barderaauthor=J.+J.+Martinauthor=A.+Rodriguez&title=Automated+high-content+assay+for+compounds+selectively+toxic+to+Trypanosoma+cruzi+in+a+myoblastic+cell+line&doi=10.1371%2Fjournal.pntd.0003493"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0003493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0003493%26sid%3Dliteratum%253Aachs%26aulast%3DAlonso-Padilla%26aufirst%3DJ.%26aulast%3DCotillo%26aufirst%3DI.%26aulast%3DPresa%26aufirst%3DJ.%2BL.%26aulast%3DCantizani%26aufirst%3DJ.%26aulast%3DPena%26aufirst%3DI.%26aulast%3DBardera%26aufirst%3DA.%2BI.%26aulast%3DMartin%26aufirst%3DJ.%2BJ.%26aulast%3DRodriguez%26aufirst%3DA.%26atitle%3DAutomated%2520high-content%2520assay%2520for%2520compounds%2520selectively%2520toxic%2520to%2520Trypanosoma%2520cruzi%2520in%2520a%2520myoblastic%2520cell%2520line%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2015%26volume%3D9%26spage%3De0003493%26doi%3D10.1371%2Fjournal.pntd.0003493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span><span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lg7i-xHEAb1qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Orhan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sener, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasdemir, D.</span><span> </span><span class="NLM_article-title">Inhibitory activity of marine sponge-derived natural products against parasitic protozoa</span> <span class="citation_source-journal">Mar. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.3390/md8010047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.3390%2Fmd8010047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=20161970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=47-58&author=I.+Orhanauthor=B.+Senerauthor=M.+Kaiserauthor=R.+Brunauthor=D.+Tasdemir&title=Inhibitory+activity+of+marine+sponge-derived+natural+products+against+parasitic+protozoa&doi=10.3390%2Fmd8010047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory activity of marine sponge-derived natural products against parasitic protozoa</span></div><div class="casAuthors">Orhan, Ilkay; Sener, Bilge; Kaiser, Marcel; Brun, Reto; Tasdemir, Deniz</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-58</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI Center</span>)
        </div><div class="casAbstract">In this study, thirteen sponge-derived terpenoids, including five linear furanoterpenes: furospinulosin-1 (1), furospinulosin-2 (2), furospongin-1 (3), furospongin-4 (4), and demethylfurospongin-4 (5); four linear meroterpenes: 2-(hexaprenylmethyl)-2-methylchromenol (6), 4-hydroxy-3-octaprenylbenzoic acid (7), 4-hydroxy-3-tetraprenyl-phenylacetic acid (8), and heptaprenyl-p-quinol (9); a linear triterpene, squalene (10); two spongian-type diterpenes dorisenone D (11) and 11β-acetoxyspongi-12-en-16-one (12); a scalarane-type sesterterpene; 12-epi-deoxoscalarin (13), as well as an indole alkaloid, tryptophol (14) were screened for their in vitro activity against four parasitic protozoa; Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani and Plasmodium falciparum.  Cytotoxic potential of the compds. on mammalian cells was also assessed.  All compds. were active against T. brucei rhodesiense, with compd. 8 being the most potent (IC50 0.60 μg/mL), whereas 9 and 12 were the most active compds. against T. cruzi, with IC50 values around 4 μg/mL.  Compd. 12 showed the strongest leishmanicidal activity (IC50 0.75 μg/mL), which was comparable to that of miltefosine (IC50 0.20 μg/mL).  The best antiplasmodial effect was exerted by compd. 11 (IC50 0.43 μg/mL), followed by compds. 7, 10, and 12 with IC50 values around 1 μg/mL.  Compds. 9, 11 and 12 exhibited, besides their antiprotozoal activity, also some cytotoxicity, whereas all other compds. had low or no cytotoxicity towards the mammalian cell line.  This is the first report of antiprotozoal activity of marine metabolites 1-14, and points out the potential of marine sponges in discovery of new antiprotozoal lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZH_2IUgeQXLVg90H21EOLACvtfcHk0lg7i-xHEAb1qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSksLs%253D&md5=60d08cc8b73ea6a824d752eeac514b4a</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.3390%2Fmd8010047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd8010047%26sid%3Dliteratum%253Aachs%26aulast%3DOrhan%26aufirst%3DI.%26aulast%3DSener%26aufirst%3DB.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DTasdemir%26aufirst%3DD.%26atitle%3DInhibitory%2520activity%2520of%2520marine%2520sponge-derived%2520natural%2520products%2520against%2520parasitic%2520protozoa%26jtitle%3DMar.%2520Drugs%26date%3D2010%26volume%3D8%26spage%3D47%26epage%3D58%26doi%3D10.3390%2Fmd8010047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span>Target Product Profile—Sleeping Sickness; <span class="NLM_publisher-name">Drugs for Neglected Diseases initiative</span>.<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.dndi.org/diseases-projects/hat/hat-target-product-profile/" class="extLink">http://www.dndi.org/diseases-projects/hat/hat-target-product-profile/</a> (accessed August 17, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Target+Product+Profile%E2%80%94Sleeping+Sickness%3B+Drugs+for+Neglected+Diseases+initiative.+2016%3B+http%3A%2F%2Fwww.dndi.org%2Fdiseases-projects%2Fhat%2Fhat-target-product-profile%2F+%28accessed+August+17%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DTarget%2520Product%2520Profile%25E2%2580%2594Sleeping%2520Sickness%26pub%3DDrugs%2520for%2520Neglected%2520Diseases%2520initiative%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">De Rycker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. W.</span><span> </span><span class="NLM_article-title">Identification of trypanocidal activity for known clinical compounds using a new <i>Trypanosoma cruzi</i> hit-discovery screening cascade</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0004584</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0004584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0004584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=27082760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVKmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=e0004584&author=M.+De+Ryckerauthor=J.+Thomasauthor=J.+Rileyauthor=S.+J.+Broughauthor=T.+J.+Milesauthor=D.+W.+Gray&title=Identification+of+trypanocidal+activity+for+known+clinical+compounds+using+a+new+Trypanosoma+cruzi+hit-discovery+screening+cascade&doi=10.1371%2Fjournal.pntd.0004584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of trypanocidal activity for known clinical compounds using a new Trypanosoma cruzi hit-discovery screening cascade</span></div><div class="casAuthors">De Rycker, Manu; Thomas, John; Riley, Jennifer; Brough, Stephen J.; Miles, Tim J.; Gray, David W.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0004584/1-e0004584/19</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chagas disease is a significant health problem in Latin America and the available treatments have significant issues in terms of toxicity and efficacy.  There is thus an urgent need to develop new treatments either via a repurposing strategy or through the development of new chem. entities.  A key first step is the identification of compds. with anti-Trypanosoma cruzi activity from compd. libraries.  Here we describe a hit discovery screening cascade designed to specifically identify hits that have the appropriate anti-parasitic properties to warrant further development.  The cascade consists of a primary imaging-based assay followed by newly developed and appropriately scaled secondary assays to predict the cidality and rate-of-kill of the compds.  Finally, we incorporated a cytochrome P 450 CYP51 biochem. assay to remove compds. that owe their phenotypic response to inhibition of this enzyme.  We report the use of the cascade in profiling two small libraries contg. clin. tested compds. and identify Clemastine, Azelastine, Ifenprodil, Ziprasidone and Clofibrate as mols. having appropriate profiles.  Anal. of clin. derived pharmacokinetic and toxicity data indicates that none of these are appropriate for repurposing but they may represent suitable start points for further optimization for the treatment of Chagas disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNvQvW9Gmu27Vg90H21EOLACvtfcHk0li9OKzEcCeuCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVKmtbo%253D&md5=50bdf03204f45c2ef74ac81ea40a263f</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0004584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0004584%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DRiley%26aufirst%3DJ.%26aulast%3DBrough%26aufirst%3DS.%2BJ.%26aulast%3DMiles%26aufirst%3DT.%2BJ.%26aulast%3DGray%26aufirst%3DD.%2BW.%26atitle%3DIdentification%2520of%2520trypanocidal%2520activity%2520for%2520known%2520clinical%2520compounds%2520using%2520a%2520new%2520Trypanosoma%2520cruzi%2520hit-discovery%2520screening%2520cascade%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2016%26volume%3D10%26spage%3De0004584%26doi%3D10.1371%2Fjournal.pntd.0004584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Lepesheva, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterman, M. R.</span><span> </span><span class="NLM_article-title">Targeting <i>Trypanosoma cruzi</i> sterol 14α-demethylase (CYP51)</span> <span class="citation_source-journal">Adv. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1016/B978-0-12-385863-4.00004-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FB978-0-12-385863-4.00004-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=21820552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A280%3ADC%252BC3MjktlCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2011&pages=65-87&author=G.+I.+Lepeshevaauthor=F.+Villaltaauthor=M.+R.+Waterman&title=Targeting+Trypanosoma+cruzi+sterol+14%CE%B1-demethylase+%28CYP51%29&doi=10.1016%2FB978-0-12-385863-4.00004-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Trypanosoma cruzi sterol 14α-demethylase (CYP51)</span></div><div class="casAuthors">Lepesheva Galina I; Villalta Fernando; Waterman Michael R</div><div class="citationInfo"><span class="NLM_cas:title">Advances in parasitology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">There are at least two obvious features that must be considered upon targeting specific metabolic pathways/enzymes for drug development: the pathway must be essential and the enzyme must allow the design of pharmacologically useful inhibitors.  Here, we describe Trypanosoma cruzi sterol 14α-demethylase as a promising target for anti-Chagasic chemotherapy.  The use of anti-fungal azoles, which block sterol biosynthesis and therefore membrane formation in fungi, against the protozoan parasite has turned out to be highly successful: a broad spectrum anti-fungal drug, the triazole compound posaconazole, is now entering phase II clinical trials for treatment of Chagas disease.  This review summarizes comparative information on anti-fungal azoles and novel inhibitory scaffolds selective for Trypanosomatidae sterol 14α-demethylase through the lens of recent structure/functional characterization of the target enzyme.  We believe our studies open wide opportunities for rational design of novel, pathogen-specific and therefore more potent and efficient anti-trypanosomal drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0YKdn5Th59xcr74wzj5o5fW6udTcc2eYbUXjuBXwUEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjktlCjsA%253D%253D&md5=d468cde2272c6a2dfc145a7dd75f009c</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-385863-4.00004-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-385863-4.00004-6%26sid%3Dliteratum%253Aachs%26aulast%3DLepesheva%26aufirst%3DG.%2BI.%26aulast%3DVillalta%26aufirst%3DF.%26aulast%3DWaterman%26aufirst%3DM.%2BR.%26atitle%3DTargeting%2520Trypanosoma%2520cruzi%2520sterol%252014%25CE%25B1-demethylase%2520%2528CYP51%2529%26jtitle%3DAdv.%2520Parasitol.%26date%3D2011%26volume%3D75%26spage%3D65%26epage%3D87%26doi%3D10.1016%2FB978-0-12-385863-4.00004-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Moraes, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardini, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araujo-Junior, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas-Junior, L. H.</span><span> </span><span class="NLM_article-title">Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against <i>Trypanosoma cruzi</i>: implications for Chagas disease drug discovery and development</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">4703</span><span class="refDoi"> DOI: 10.1038/srep04703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1038%2Fsrep04703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=24736467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A280%3ADC%252BC2cnkt1yhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=4703&author=C.+B.+Moraesauthor=M.+A.+Giardiniauthor=H.+Kimauthor=C.+H.+Francoauthor=A.+M.+Araujo-Juniorauthor=S.+Schenkmanauthor=E.+Chatelainauthor=L.+H.+Freitas-Junior&title=Nitroheterocyclic+compounds+are+more+efficacious+than+CYP51+inhibitors+against+Trypanosoma+cruzi%3A+implications+for+Chagas+disease+drug+discovery+and+development&doi=10.1038%2Fsrep04703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development</span></div><div class="casAuthors">Moraes Carolina B; Freitas-Junior Lucio H; Giardini Miriam A; Kim Hwayoung; Franco Caio H; Araujo-Junior Adalberto M; Schenkman Sergio; Chatelain Eric</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4703</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Advocacy for better drugs and access to treatment has boosted the interest in drug discovery and development for Chagas disease, a chronic infection caused by the genetically heterogeneous parasite, Trypanosoma cruzi.  In this work new in vitro assays were used to gain a better understanding of the antitrypanosomal properties of the most advanced antichagasic lead and clinical compounds, the nitroheterocyclics benznidazole, nifurtimox and fexinidazole sulfone, the oxaborole AN4169, and four ergosterol biosynthesis inhibitors--posaconazole, ravuconazole, EPL-BS967 and EPL-BS1246.  Two types of assays were developed: one for evaluation of potency and efficacy in dose-response against a panel of T. cruzi stocks representing all current discrete typing units (DTUs), and a time-kill assay.  Although less potent, the nitroheterocyclics and the oxaborole showed broad efficacy against all T. cruzi tested and were rapidly trypanocidal, whilst ergosterol biosynthesis inhibitors showed variable activity that was both compound- and strain-specific, and were unable to eradicate intracellular infection even after 7 days of continuous compound exposure at most efficacious concentrations.  These findings contest previous reports of variable responses to nitroderivatives among different T. cruzi strains and further challenge the introduction of ergosterol biosynthesis inhibitors as new single chemotherapeutic agents for the treatment of Chagas disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSC0uKaIdi8tC-bLEOO4dYpfW6udTcc2eYbUXjuBXwUEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnkt1yhtA%253D%253D&md5=032b0723cce633d789e16f1538be8daf</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fsrep04703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep04703%26sid%3Dliteratum%253Aachs%26aulast%3DMoraes%26aufirst%3DC.%2BB.%26aulast%3DGiardini%26aufirst%3DM.%2BA.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DFranco%26aufirst%3DC.%2BH.%26aulast%3DAraujo-Junior%26aufirst%3DA.%2BM.%26aulast%3DSchenkman%26aufirst%3DS.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DFreitas-Junior%26aufirst%3DL.%2BH.%26atitle%3DNitroheterocyclic%2520compounds%2520are%2520more%2520efficacious%2520than%2520CYP51%2520inhibitors%2520against%2520Trypanosoma%2520cruzi%253A%2520implications%2520for%2520Chagas%2520disease%2520drug%2520discovery%2520and%2520development%26jtitle%3DSci.%2520Rep.%26date%3D2014%26volume%3D4%26spage%3D4703%26doi%3D10.1038%2Fsrep04703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Riley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voice, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caballero, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, D.</span><span> </span><span class="NLM_article-title">Development of a fluorescence-based <i>Trypanosoma cruzi</i> CYP51 inhibition assay for effective compound triaging in drug discovery programmes for Chagas disease</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0004014</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0004014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0004014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=e0004014&author=J.+Rileyauthor=S.+Brandauthor=K.+D.+Readauthor=M.+Voiceauthor=I.+Caballeroauthor=D.+Calvo&title=Development+of+a+fluorescence-based+Trypanosoma+cruzi+CYP51+inhibition+assay+for+effective+compound+triaging+in+drug+discovery+programmes+for+Chagas+disease&doi=10.1371%2Fjournal.pntd.0004014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0004014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0004014%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DJ.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DVoice%26aufirst%3DM.%26aulast%3DCaballero%26aufirst%3DI.%26aulast%3DCalvo%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520a%2520fluorescence-based%2520Trypanosoma%2520cruzi%2520CYP51%2520inhibition%2520assay%2520for%2520effective%2520compound%2520triaging%2520in%2520drug%2520discovery%2520programmes%2520for%2520Chagas%2520disease%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2015%26volume%3D9%26spage%3De0004014%26doi%3D10.1371%2Fjournal.pntd.0004014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span><span class="refDoi"> DOI: 10.1038/nrd3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery&doi=10.1038%2Fnrd3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0lgYTwaI_5aMzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D929%26epage%3D939%26doi%3D10.1038%2Fnrd3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Coteron, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esquivias, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Mazouni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokkonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katneni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhamidipati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Diaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathod, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, M. A.</span><span> </span><span class="NLM_article-title">Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent <i>Plasmodium falciparum</i> dihydroorotate dehydrogenase inhibitors with clinical candidate potential</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5540</span><span class="NLM_x">–</span> <span class="NLM_lpage">5561</span><span class="refDoi"> DOI: 10.1021/jm200592f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200592f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVehsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5540-5561&author=J.+M.+Coteronauthor=M.+Marcoauthor=J.+Esquiviasauthor=X.+Dengauthor=K.+L.+Whiteauthor=J.+Whiteauthor=M.+Koltunauthor=F.+El+Mazouniauthor=S.+Kokkondaauthor=K.+Katneniauthor=R.+Bhamidipatiauthor=D.+M.+Shacklefordauthor=I.+Angulo-Barturenauthor=S.+B.+Ferrerauthor=M.+B.+Jimenez-Diazauthor=F.-J.+Gamoauthor=E.+J.+Goldsmithauthor=W.+N.+Charmanauthor=I.+Bathurstauthor=D.+Floydauthor=D.+Matthewsauthor=J.+N.+Burrowsauthor=P.+K.+Rathodauthor=S.+A.+Charmanauthor=M.+A.+Phillips&title=Structure-guided+lead+optimization+of+triazolopyrimidine-ring+substituents+identifies+potent+Plasmodium+falciparum+dihydroorotate+dehydrogenase+inhibitors+with+clinical+candidate+potential&doi=10.1021%2Fjm200592f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential</span></div><div class="casAuthors">Coteron, Jose M.; Marco, Maria; Esquivias, Jorge; Deng, Xiaoyi; White, Karen L.; White, John; Koltun, Maria; El Mazouni, Farah; Kokkonda, Sreekanth; Katneni, Kasiram; Bhamidipati, Ravi; Shackleford, David M.; Angulo-Barturen, Inigo; Ferrer, Santiago B.; Jimenez-Diaz, Maria Belen; Gamo, Francisco-Javier; Goldsmith, Elizabeth J.; Charman, William N.; Bathurst, Ian; Floyd, David; Matthews, David; Burrows, Jeremy N.; Rathod, Pradipsinh K.; Charman, Susan A.; Phillips, Margaret A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5540-5561</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug therapy is the mainstay of antimalarial therapy, yet current drugs are threatened by the development of resistance.  In an effort to identify new potential antimalarials, we have undertaken a lead optimization program around our previously identified triazolopyrimidine-based series of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors.  The X-ray structure of PfDHODH was used to inform the medicinal chem. program allowing the identification of a potent and selective inhibitor (DSM265) that acts through DHODH inhibition to kill both sensitive and drug resistant strains of the parasite.  This compd. has similar potency to chloroquine in the humanized SCID mouse P. falciparum model, can be synthesized by a simple route, and rodent pharmacokinetic studies demonstrated it has excellent oral bioavailability, a long half-life and low clearance.  These studies have identified the first candidate in the triazolopyrimidine series to meet previously established progression criteria for efficacy and ADME properties, justifying further development of this compd. toward clin. candidate status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVpPPR2Tcs9rVg90H21EOLACvtfcHk0lgYTwaI_5aMzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVehsbg%253D&md5=d92f71aeda04fbbbbcd8905a657df011</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm200592f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200592f%26sid%3Dliteratum%253Aachs%26aulast%3DCoteron%26aufirst%3DJ.%2BM.%26aulast%3DMarco%26aufirst%3DM.%26aulast%3DEsquivias%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DKoltun%26aufirst%3DM.%26aulast%3DEl%2BMazouni%26aufirst%3DF.%26aulast%3DKokkonda%26aufirst%3DS.%26aulast%3DKatneni%26aufirst%3DK.%26aulast%3DBhamidipati%26aufirst%3DR.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DFerrer%26aufirst%3DS.%2BB.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DGamo%26aufirst%3DF.-J.%26aulast%3DGoldsmith%26aufirst%3DE.%2BJ.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DFloyd%26aufirst%3DD.%26aulast%3DMatthews%26aufirst%3DD.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26atitle%3DStructure-guided%2520lead%2520optimization%2520of%2520triazolopyrimidine-ring%2520substituents%2520identifies%2520potent%2520Plasmodium%2520falciparum%2520dihydroorotate%2520dehydrogenase%2520inhibitors%2520with%2520clinical%2520candidate%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5540%26epage%3D5561%26doi%3D10.1021%2Fjm200592f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Balani, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. W.</span><span> </span><span class="NLM_article-title">Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1059</span><span class="NLM_x">–</span> <span class="NLM_lpage">1062</span><span class="refDoi"> DOI: 10.1124/dmd.30.10.1059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1124%2Fdmd.30.10.1059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=1059-1062&author=S.+K.+Balaniauthor=T.+Zhuauthor=T.+J.+Yangauthor=Z.+Liuauthor=B.+Heauthor=F.+W.+Lee&title=Effective+dosing+regimen+of+1-aminobenzotriazole+for+inhibition+of+antipyrine+clearance+in+rats%2C+dogs%2C+and+monkeys&doi=10.1124%2Fdmd.30.10.1059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1124%2Fdmd.30.10.1059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.30.10.1059%26sid%3Dliteratum%253Aachs%26aulast%3DBalani%26aufirst%3DS.%2BK.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DT.%2BJ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DF.%2BW.%26atitle%3DEffective%2520dosing%2520regimen%2520of%25201-aminobenzotriazole%2520for%2520inhibition%2520of%2520antipyrine%2520clearance%2520in%2520rats%252C%2520dogs%252C%2520and%2520monkeys%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D1059%26epage%3D1062%26doi%3D10.1124%2Fdmd.30.10.1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Balani, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardoza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, D.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. W.</span><span> </span><span class="NLM_article-title">Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in guinea pigs and mice using serial sampling</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1092</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span><span class="refDoi"> DOI: 10.1124/dmd.104.000349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1124%2Fdmd.104.000349" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=1092-1095&author=S.+K.+Balaniauthor=P.+Liauthor=J.+Nguyenauthor=K.+Cardozaauthor=H.+Zengauthor=D.-X.+Muauthor=J.-T.+Wuauthor=L.-S.+Ganauthor=F.+W.+Lee&title=Effective+dosing+regimen+of+1-aminobenzotriazole+for+inhibition+of+antipyrine+clearance+in+guinea+pigs+and+mice+using+serial+sampling&doi=10.1124%2Fdmd.104.000349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.000349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.000349%26sid%3Dliteratum%253Aachs%26aulast%3DBalani%26aufirst%3DS.%2BK.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DJ.%26aulast%3DCardoza%26aufirst%3DK.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DMu%26aufirst%3DD.-X.%26aulast%3DWu%26aufirst%3DJ.-T.%26aulast%3DGan%26aufirst%3DL.-S.%26aulast%3DLee%26aufirst%3DF.%2BW.%26atitle%3DEffective%2520dosing%2520regimen%2520of%25201-aminobenzotriazole%2520for%2520inhibition%2520of%2520antipyrine%2520clearance%2520in%2520guinea%2520pigs%2520and%2520mice%2520using%2520serial%2520sampling%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D1092%26epage%3D1095%26doi%3D10.1124%2Fdmd.104.000349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Bustamante, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarleton, R. L.</span><span> </span><span class="NLM_article-title">Potential new clinical therapies for Chagas disease</span> <span class="citation_source-journal">Expert Rev. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span><span class="refDoi"> DOI: 10.1586/17512433.2014.909282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1586%2F17512433.2014.909282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=24716790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtFWru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=317-325&author=J.+M.+Bustamanteauthor=R.+L.+Tarleton&title=Potential+new+clinical+therapies+for+Chagas+disease&doi=10.1586%2F17512433.2014.909282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Potential new clinical therapies for Chagas disease</span></div><div class="casAuthors">Bustamante, Juan M.; Tarleton, Rick L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-325</span>CODEN:
                <span class="NLM_cas:coden">ERCPAG</span>;
        ISSN:<span class="NLM_cas:issn">1751-2433</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Chagas disease is the highest impact parasitic disease in the Americas but often goes untreated due to the shortcomings of currently available therapeutics.  Thus there is an urgent need for new treatment options and growing interest in drug development for the infection.  This review summarizes some of the recent advances and failures in this realm, with particular emphasis on recently published studies and unpublished results presented at a recent Chagas Drug Discovery Consortium meeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQK8zR2uYlsLVg90H21EOLACvtfcHk0liUHtjiCxmrmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtFWru78%253D&md5=a248bc0bed6626b027a3d27f264544c4</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1586%2F17512433.2014.909282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F17512433.2014.909282%26sid%3Dliteratum%253Aachs%26aulast%3DBustamante%26aufirst%3DJ.%2BM.%26aulast%3DTarleton%26aufirst%3DR.%2BL.%26atitle%3DPotential%2520new%2520clinical%2520therapies%2520for%2520Chagas%2520disease%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Pharmacol.%26date%3D2014%26volume%3D7%26spage%3D317%26epage%3D325%26doi%3D10.1586%2F17512433.2014.909282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Patrick, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiser, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span> </span><span class="NLM_article-title">Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against <i>Trypanosoma brucei rhodesiense</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2451</span><span class="NLM_x">–</span> <span class="NLM_lpage">2465</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.bmc.2016.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=27102161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtlegtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2451-2465&author=D.+A.+Patrickauthor=T.+Wenzlerauthor=S.+Yangauthor=P.+T.+Weiserauthor=M.+Z.+Wangauthor=R.+Brunauthor=R.+R.+Tidwell&title=Synthesis+of+novel+amide+and+urea+derivatives+of+thiazol-2-ethylamines+and+their+activity+against+Trypanosoma+brucei+rhodesiense&doi=10.1016%2Fj.bmc.2016.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense</span></div><div class="casAuthors">Patrick, Donald A.; Wenzler, Tanja; Yang, Sihyung; Weiser, Patrick T.; Wang, Michael Zhuo; Brun, Reto; Tidwell, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2451-2465</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">2-(2-Benzamido)ethyl-4-phenylthiazole I was one of 1035 mols. (grouped into 115 distinct scaffolds) found to be inhibitory to Trypanosoma brucei, the pathogen causing human African trypanosomiasis, at concns. below 3.6 μM and nontoxic to mammalian (Huh7) cells in a phenotypic high-throughput screen of a 700,000 compd. library performed by the Genomics Institute of the Novartis Research Foundation (GNF).  Compd. I and 72 analogs were synthesized in this lab. by one of two general pathways.  These plus 10 com. available analogs were tested against T. brucei rhodesiense STIB900 and L6 rat myoblast cells (for cytotoxicity) in vitro.  Forty-four derivs. were more potent than I, including eight with IC50 values below 100 nM.  The most potent and most selective for the parasite was the urea analog 2-(2-piperidin-1-ylamido)ethyl-4-(3-fluorophenyl)thiazole II (IC50 = 9 nM, SI > 18,000).  None of 33 compds. tested were able to cure mice infected with the parasite; however, seven compds. caused temporary redns. of parasitemia (≥97%) but with subsequent relapses.  The lack of in vivo efficacy was at least partially due to their poor metabolic stability, as demonstrated by the short half-lives of 15 analogs against mouse and human liver microsomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV78D13zDrJ7Vg90H21EOLACvtfcHk0liUHtjiCxmrmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtlegtLk%253D&md5=d371dc632576f40e4002cd96b67c5a77</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DPatrick%26aufirst%3DD.%2BA.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DWeiser%26aufirst%3DP.%2BT.%26aulast%3DWang%26aufirst%3DM.%2BZ.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DSynthesis%2520of%2520novel%2520amide%2520and%2520urea%2520derivatives%2520of%2520thiazol-2-ethylamines%2520and%2520their%2520activity%2520against%2520Trypanosoma%2520brucei%2520rhodesiense%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D2451%26epage%3D2465%26doi%3D10.1016%2Fj.bmc.2016.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0liUHtjiCxmrmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Bruck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamberton, A. H.</span><span> </span><span class="NLM_article-title">Nitramines and nitramides. IX. The acid-catalyzed decomposition of <i>O</i>-methyl-<i>N</i>-isopropylnitramine</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1955</span><span class="NLM_x">, </span> <span class="NLM_fpage">3997</span><span class="NLM_x">–</span> <span class="NLM_lpage">4002</span><span class="refDoi"> DOI: 10.1039/jr9550003997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1039%2Fjr9550003997" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1955&pages=3997-4002&author=P.+Bruckauthor=A.+H.+Lamberton&title=Nitramines+and+nitramides.+IX.+The+acid-catalyzed+decomposition+of+O-methyl-N-isopropylnitramine&doi=10.1039%2Fjr9550003997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1039%2Fjr9550003997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fjr9550003997%26sid%3Dliteratum%253Aachs%26aulast%3DBruck%26aufirst%3DP.%26aulast%3DLamberton%26aufirst%3DA.%2BH.%26atitle%3DNitramines%2520and%2520nitramides.%2520IX.%2520The%2520acid-catalyzed%2520decomposition%2520of%2520O-methyl-N-isopropylnitramine%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1955%26spage%3D3997%26epage%3D4002%26doi%3D10.1039%2Fjr9550003997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Gonzalez Cabrera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douelle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, T.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nchinda, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younis, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witty, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chibale, K.</span><span> </span><span class="NLM_article-title">Novel orally active antimalarial thiazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7713</span><span class="NLM_x">–</span> <span class="NLM_lpage">7719</span><span class="refDoi"> DOI: 10.1021/jm201108k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201108k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7713-7719&author=D.+Gonzalez+Cabreraauthor=F.+Douelleauthor=T.-S.+Fengauthor=A.+T.+Nchindaauthor=Y.+Younisauthor=K.+L.+Whiteauthor=Q.+Wuauthor=E.+Ryanauthor=J.+N.+Burrowsauthor=D.+Watersonauthor=M.+J.+Wittyauthor=S.+Wittlinauthor=S.+A.+Charmanauthor=K.+Chibale&title=Novel+orally+active+antimalarial+thiazoles&doi=10.1021%2Fjm201108k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fjm201108k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201108k%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%2BCabrera%26aufirst%3DD.%26aulast%3DDouelle%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DT.-S.%26aulast%3DNchinda%26aufirst%3DA.%2BT.%26aulast%3DYounis%26aufirst%3DY.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DWitty%26aufirst%3DM.%2BJ.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DNovel%2520orally%2520active%2520antimalarial%2520thiazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7713%26epage%3D7719%26doi%3D10.1021%2Fjm201108k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Bischofberger, N. W.; Kim, C. U.; Krawczyk, S. H.; McGee, L. R.; Postich, M. J.; Yang, W.</span><span> </span><span class="NLM_article-title">Preparation of thiepanes as HIV protease inhibitors</span>. 1996-740568, 5811450, 19961031,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=N.+W.+Bischofberger&author=C.+U.+Kim&author=S.+H.+Krawczyk&author=L.+R.+McGee&author=M.+J.+Postich&author=W.+Yang&title=Preparation+of+thiepanes+as+HIV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBischofberger%26aufirst%3DN.%2BW.%26atitle%3DPreparation%2520of%2520thiepanes%2520as%2520HIV%2520protease%2520inhibitors%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Jimenez, J.-M.; Collier, P. N.</span><span> </span><span class="NLM_article-title">Preparation of pyrazolopyridines as inhibitors of protein kinase</span>. 2010-US33720, 2010129668, 20100505,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.-M.+Jimenez&author=P.+N.+Collier&title=Preparation+of+pyrazolopyridines+as+inhibitors+of+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJimenez%26aufirst%3DJ.-M.%26atitle%3DPreparation%2520of%2520pyrazolopyridines%2520as%2520inhibitors%2520of%2520protein%2520kinase%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Swapna Varghese, Raphaël Rahmani, Stephanie Russell, Girdhar Singh Deora, Lori Ferrins, Arthur Toynton, Amy Jones, Melissa Sykes, Albane Kessler, Amanda Eufrásio, Artur Torres Cordeiro, Julian Sherman, Ana Rodriguez, Vicky M. Avery, Matthew J. Piggott, <span class="NLM_string-name hlFld-ContribAuthor">Jonathan B. Baell</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent N-Ethylurea Pyrazole Derivatives as Dual Inhibitors of Trypanosoma brucei and Trypanosoma cruzi. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 278-285. <a href="https://doi.org/10.1021/acsmedchemlett.9b00218" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00218%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BPotent%252BN-Ethylurea%252BPyrazole%252BDerivatives%252Bas%252BDual%252BInhibitors%252Bof%252BTrypanosoma%252Bbrucei%252Band%252BTrypanosoma%252Bcruzi%26aulast%3DVarghese%26aufirst%3DSwapna%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D29052019%26date%3D09092019%26date%3D11092019%26date%3D09092019%26volume%3D11%26issue%3D3%26spage%3D278%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maciej Dawidowski, Vishal C. Kalel, Valeria Napolitano, Roberto Fino, Kenji Schorpp, Leonidas Emmanouilidis, Dominik Lenhart, Michael Ostertag, Marcel Kaiser, Marta Kolonko, Bettina Tippler, Wolfgang Schliebs, Grzegorz Dubin, Pascal Mäser, Igor V. Tetko, Kamyar Hadian, Oliver Plettenburg, Ralf Erdmann, Michael Sattler, <span class="NLM_string-name hlFld-ContribAuthor">Grzegorz M. Popowicz</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship in Pyrazolo[4,3-c]pyridines, First Inhibitors of PEX14–PEX5 Protein–Protein Interaction with Trypanocidal Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (2)
                                     , 847-879. <a href="https://doi.org/10.1021/acs.jmedchem.9b01876" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01876</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01876%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252Bin%252BPyrazolo%25255B4%25252C3-c%25255Dpyridines%25252C%252BFirst%252BInhibitors%252Bof%252BPEX14%2525E2%252580%252593PEX5%252BProtein%2525E2%252580%252593Protein%252BInteraction%252Bwith%252BTrypanocidal%252BActivity%26aulast%3DDawidowski%26aufirst%3DMaciej%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D12112019%26date%3D06012020%26date%3D20122019%26volume%3D63%26issue%3D2%26spage%3D847%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fabian Hulpia, Kristof Van Hecke, Cristiane França da Silva, Denise da Gama Jaen Batista, Louis Maes, Guy Caljon, Maria de Nazaré C. Soeiro, <span class="NLM_string-name hlFld-ContribAuthor">Serge Van Calenbergh</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel 7-Aryl 7-Deazapurine 3′-Deoxy-ribofuranosyl Nucleosides with Potent Activity against Trypanosoma cruzi. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9287-9300. <a href="https://doi.org/10.1021/acs.jmedchem.8b00999" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00999%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252B7-Aryl%252B7-Deazapurine%252B3%2525E2%252580%2525B2-Deoxy-ribofuranosyl%252BNucleosides%252Bwith%252BPotent%252BActivity%252Bagainst%252BTrypanosoma%252Bcruzi%26aulast%3DHulpia%26aufirst%3DFabian%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D23062018%26date%3D03102018%26date%3D20092018%26volume%3D61%26issue%3D20%26spage%3D9287%26epage%3D9300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maude Giroud, Uwe Dietzel, Lilli Anselm, David Banner, Andreas Kuglstatter, Jörg Benz, Jean-Baptiste Blanc, Delphine Gaufreteau, Haixia Liu, Xianfeng Lin, August Stich, Bernd Kuhn, Franz Schuler, Marcel Kaiser, Reto Brun, Tanja Schirmeister, Caroline Kisker, François Diederich, <span class="NLM_string-name hlFld-ContribAuthor">Wolfgang Haap</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing a Library of Human Cathepsin L Ligands: Identification of Macrocyclic Lactams as Potent Rhodesain and Trypanosoma brucei Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3350-3369. <a href="https://doi.org/10.1021/acs.jmedchem.7b01869" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01869</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01869%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRepurposing%252Ba%252BLibrary%252Bof%252BHuman%252BCathepsin%252BL%252BLigands%25253A%252BIdentification%252Bof%252BMacrocyclic%252BLactams%252Bas%252BPotent%252BRhodesain%252Band%252BTrypanosoma%252Bbrucei%252BInhibitors%26aulast%3DGiroud%26aufirst%3DMaude%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D28122017%26date%3D13042018%26date%3D29032018%26volume%3D61%26issue%3D8%26spage%3D3350%26epage%3D3369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maude Giroud, Bernd Kuhn, Sarah Saint-Auret, Christoph Kuratli, Rainer E. Martin, Franz Schuler, François Diederich, Marcel Kaiser, Reto Brun, Tanja Schirmeister, <span class="NLM_string-name hlFld-ContribAuthor">Wolfgang Haap</span>. </span><span class="cited-content_cbyCitation_article-title">2H-1,2,3-Triazole-Based Dipeptidyl Nitriles: Potent, Selective, and Trypanocidal Rhodesain Inhibitors by Structure-Based Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3370-3388. <a href="https://doi.org/10.1021/acs.jmedchem.7b01870" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01870</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01870%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2H-1%25252C2%25252C3-Triazole-Based%252BDipeptidyl%252BNitriles%25253A%252BPotent%25252C%252BSelective%25252C%252Band%252BTrypanocidal%252BRhodesain%252BInhibitors%252Bby%252BStructure-Based%252BDesign%26aulast%3DGiroud%26aufirst%3DMaude%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D28122017%26date%3D06042018%26date%3D29032018%26volume%3D61%26issue%3D8%26spage%3D3370%26epage%3D3388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sally-Ann  Poulsen</span>  . </span><span class="cited-content_cbyCitation_article-title">Editorial: Excellence in Medicinal Chemistry from Australia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (20)
                                     , 8253-8256. <a href="https://doi.org/10.1021/acs.jmedchem.7b01439" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01439</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01439%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEditorial%25253A%252BExcellence%252Bin%252BMedicinal%252BChemistry%252Bfrom%252BAustralia%26aulast%3DPoulsen%26aufirst%3DSally-Ann%26date%3D2017%26date%3D2017%26date%3D06102017%26date%3D09102017%26date%3D26102017%26volume%3D60%26issue%3D20%26spage%3D8253%26epage%3D8256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel G.  Silva</span>, <span class="hlFld-ContribAuthor ">J. Robert  Gillespie</span>, <span class="hlFld-ContribAuthor ">Ranae M.  Ranade</span>, <span class="hlFld-ContribAuthor ">Zackary M.  Herbst</span>, <span class="hlFld-ContribAuthor ">Uyen T. T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Frederick S.  Buckner</span>, <span class="hlFld-ContribAuthor ">Carlos A.  Montanari</span>, and <span class="hlFld-ContribAuthor ">Michael H.  Gelb</span>  . </span><span class="cited-content_cbyCitation_article-title">New Class of Antitrypanosomal Agents Based on Imidazopyridines. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (7)
                                     , 766-770. <a href="https://doi.org/10.1021/acsmedchemlett.7b00202" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00202%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252BClass%252Bof%252BAntitrypanosomal%252BAgents%252BBased%252Bon%252BImidazopyridines%26aulast%3DSilva%26aufirst%3DDaniel%2BG.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D17052017%26date%3D27062017%26date%3D29062017%26date%3D13072017%26date%3D27062017%26volume%3D8%26issue%3D7%26spage%3D766%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donald A.  Patrick</span>, <span class="hlFld-ContribAuthor ">J. Robert  Gillespie</span>, <span class="hlFld-ContribAuthor ">Joshua  McQueen</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Hulverson</span>, <span class="hlFld-ContribAuthor ">Ranae M.  Ranade</span>, <span class="hlFld-ContribAuthor ">Sharon A.  Creason</span>, <span class="hlFld-ContribAuthor ">Zackary M.  Herbst</span>, <span class="hlFld-ContribAuthor ">Michael H.  Gelb</span>, <span class="hlFld-ContribAuthor ">Frederick S.  Buckner</span>, and <span class="hlFld-ContribAuthor ">Richard R.  Tidwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Urea Derivatives of 2-Aryl-benzothiazol-5-amines: A New Class of Potential Drugs for Human African Trypanosomiasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (3)
                                     , 957-971. <a href="https://doi.org/10.1021/acs.jmedchem.6b01163" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01163%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorg.%2520Med.%2520Chem.%26volume%3D24%26spage%3D2451%26epage%3D2465%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUrea%252BDerivatives%252Bof%252B2-Aryl-benzothiazol-5-amines%25253A%252BA%252BNew%252BClass%252Bof%252BPotential%252BDrugs%252Bfor%252BHuman%252BAfrican%252BTrypanosomiasis%26aulast%3DPatrick%26aufirst%3DDonald%2BA.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D01082016%26date%3D19122016%26date%3D09022017%26volume%3D60%26issue%3D3%26spage%3D957%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koichi  Narita</span>, <span class="hlFld-ContribAuthor ">Keisuke  Suganuma</span>, <span class="hlFld-ContribAuthor ">Toshihiro  Murata</span>, <span class="hlFld-ContribAuthor ">Ryutaro  Kondo</span>, <span class="hlFld-ContribAuthor ">Hiroka  Satoh</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Watanabe</span>, <span class="hlFld-ContribAuthor ">Kenroh  Sasaki</span>, <span class="hlFld-ContribAuthor ">Noboru  Inoue</span>, <span class="hlFld-ContribAuthor ">Yuichi  Yoshimura</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of trypanocidal activity of derivatives of naturally occurring 2,5-diphenyloxazoles. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>42 </em>, 116253. <a href="https://doi.org/10.1016/j.bmc.2021.116253" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116253%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Btrypanocidal%252Bactivity%252Bof%252Bderivatives%252Bof%252Bnaturally%252Boccurring%252B2%25252C5-diphenyloxazoles%26aulast%3DNarita%26aufirst%3DKoichi%26date%3D2021%26volume%3D42%26spage%3D116253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beata  Donarska</span>, <span class="hlFld-ContribAuthor ">Marta  Świtalska</span>, <span class="hlFld-ContribAuthor ">Wojciech  Płaziński</span>, <span class="hlFld-ContribAuthor ">Joanna  Wietrzyk</span>, <span class="hlFld-ContribAuthor ">Krzysztof Z.  Łączkowski</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of the dichloro-substitution on antiproliferative activity of phthalimide-thiazole derivatives. Rational design, synthesis, elastase, caspase 3/7, and EGFR tyrosine kinase activity and molecular modeling study. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>110 </em>, 104819. <a href="https://doi.org/10.1016/j.bioorg.2021.104819" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104819%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DEffect%252Bof%252Bthe%252Bdichloro-substitution%252Bon%252Bantiproliferative%252Bactivity%252Bof%252Bphthalimide-thiazole%252Bderivatives.%252BRational%252Bdesign%25252C%252Bsynthesis%25252C%252Belastase%25252C%252Bcaspase%252B3%25252F7%25252C%252Band%252BEGFR%252Btyrosine%252Bkinase%252Bactivity%252Band%252Bmolecular%252Bmodeling%252Bstudy%26aulast%3DDonarska%26aufirst%3DBeata%26date%3D2021%26volume%3D110%26spage%3D104819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel G.  Silva</span>, <span class="hlFld-ContribAuthor ">Anna  Junker</span>, <span class="hlFld-ContribAuthor ">Shaiani M. G.  Melo</span>, <span class="hlFld-ContribAuthor ">Fernando  Fumagalli</span>, <span class="hlFld-ContribAuthor ">J. Robert  Gillespie</span>, <span class="hlFld-ContribAuthor ">Nora  Molasky</span>, <span class="hlFld-ContribAuthor ">Frederick S.  Buckner</span>, <span class="hlFld-ContribAuthor ">An  Matheeussen</span>, <span class="hlFld-ContribAuthor ">Guy  Caljon</span>, <span class="hlFld-ContribAuthor ">Louis  Maes</span>, <span class="hlFld-ContribAuthor ">Flavio S.  Emery</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure−Activity Relationships of Imidazopyridine/Pyrimidine‐ and Furopyridine‐Based Anti‐infective Agents against Trypanosomiases. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (6)
                                     , 966-975. <a href="https://doi.org/10.1002/cmdc.202000616" title="DOI URL">https://doi.org/10.1002/cmdc.202000616</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000616%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252588%252592Activity%252BRelationships%252Bof%252BImidazopyridine%25252FPyrimidine%2525E2%252580%252590%252Band%252BFuropyridine%2525E2%252580%252590Based%252BAnti%2525E2%252580%252590infective%252BAgents%252Bagainst%252BTrypanosomiases%26aulast%3DSilva%26aufirst%3DDaniel%2BG.%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D6%26spage%3D966%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swapna  Varghese</span>, <span class="hlFld-ContribAuthor ">Raphaël  Rahmani</span>, <span class="hlFld-ContribAuthor ">Damien R.  Drew</span>, <span class="hlFld-ContribAuthor ">James G.  Beeson</span>, <span class="hlFld-ContribAuthor ">Jake  Baum</span>, <span class="hlFld-ContribAuthor ">Brian J.  Smith</span>, <span class="hlFld-ContribAuthor ">Jonathan B.  Baell</span>. </span><span class="cited-content_cbyCitation_article-title">Structure‐Activity Studies of Truncated Latrunculin Analogues with Antimalarial Activity. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (4)
                                     , 679-693. <a href="https://doi.org/10.1002/cmdc.202000399" title="DOI URL">https://doi.org/10.1002/cmdc.202000399</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000399%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DStructure%2525E2%252580%252590Activity%252BStudies%252Bof%252BTruncated%252BLatrunculin%252BAnalogues%252Bwith%252BAntimalarial%252BActivity%26aulast%3DVarghese%26aufirst%3DSwapna%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D4%26spage%3D679%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ronald W.  Brown</span>, <span class="hlFld-ContribAuthor ">Ashraf M.  Abdel-Megeed</span>, <span class="hlFld-ContribAuthor ">Paul A.  Keller</span>, <span class="hlFld-ContribAuthor ">Amy J.  Jones</span>, <span class="hlFld-ContribAuthor ">Melissa L.  Sykes</span>, <span class="hlFld-ContribAuthor ">Marcel  Kaiser</span>, <span class="hlFld-ContribAuthor ">Jonathan B.  Baell</span>, <span class="hlFld-ContribAuthor ">Vicky M.  Avery</span>, <span class="hlFld-ContribAuthor ">Christopher J. T.  Hyland</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of thiazolyl–benzothiophenamides as potential agents for African sleeping sickness. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 1413-1422. <a href="https://doi.org/10.1039/D0MD00277A" title="DOI URL">https://doi.org/10.1039/D0MD00277A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00277A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00277A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DInvestigation%252Bof%252Bthiazolyl%2525E2%252580%252593benzothiophenamides%252Bas%252Bpotential%252Bagents%252Bfor%252BAfrican%252Bsleeping%252Bsickness%26aulast%3DBrown%26aufirst%3DRonald%2BW.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D12%26spage%3D1413%26epage%3D1422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James P.  Hagen</span>, <span class="hlFld-ContribAuthor ">Grant  Darner</span>, <span class="hlFld-ContribAuthor ">Samuel  Anderson</span>, <span class="hlFld-ContribAuthor ">Katie  Higgins</span>, <span class="hlFld-ContribAuthor ">Derek A.  Leas</span>, <span class="hlFld-ContribAuthor ">Ananya  Mitra</span>, <span class="hlFld-ContribAuthor ">Victoria  Mashinson</span>, <span class="hlFld-ContribAuthor ">Tasloach  Wol</span>, <span class="hlFld-ContribAuthor ">Carlos  Vera-Esquivel</span>, <span class="hlFld-ContribAuthor ">Bret  Belter</span>, <span class="hlFld-ContribAuthor ">Monica  Cal</span>, <span class="hlFld-ContribAuthor ">Marcel  Kaiser</span>, <span class="hlFld-ContribAuthor ">Alexander  Wallick</span>, <span class="hlFld-ContribAuthor ">Rosalie C.  Warner</span>, <span class="hlFld-ContribAuthor ">Paul H.  Davis</span>. </span><span class="cited-content_cbyCitation_article-title">Activity of diphenyl ether benzyl amines against Human African Trypanosomiasis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>97 </em>, 103590. <a href="https://doi.org/10.1016/j.bioorg.2020.103590" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103590</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103590%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DActivity%252Bof%252Bdiphenyl%252Bether%252Bbenzyl%252Bamines%252Bagainst%252BHuman%252BAfrican%252BTrypanosomiasis%26aulast%3DHagen%26aufirst%3DJames%2BP.%26date%3D2020%26volume%3D97%26spage%3D103590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markos-Orestis  Georgiadis</span>, <span class="hlFld-ContribAuthor ">Violeta  Kourbeli</span>, <span class="hlFld-ContribAuthor ">Ioannis P.  Papanastasiou</span>, <span class="hlFld-ContribAuthor ">Andrew  Tsotinis</span>, <span class="hlFld-ContribAuthor ">Martin C.  Taylor</span>, <span class="hlFld-ContribAuthor ">John M.  Kelly</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of novel 2,4-disubstituted arylthiazoles against
              T. brucei. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     , 72-84. <a href="https://doi.org/10.1039/C9MD00478E" title="DOI URL">https://doi.org/10.1039/C9MD00478E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00478E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00478E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252B2%25252C4-disubstituted%252Barylthiazoles%252Bagainst%252BT.%252Bbrucei%26aulast%3DGeorgiadis%26aufirst%3DMarkos-Orestis%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D72%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samir  Chtita</span>, <span class="hlFld-ContribAuthor ">Mounir  Ghamali</span>, <span class="hlFld-ContribAuthor ">Abdellah  Ousaa</span>, <span class="hlFld-ContribAuthor ">Adnane  Aouidate</span>, <span class="hlFld-ContribAuthor ">Assia  Belhassan</span>, <span class="hlFld-ContribAuthor ">Abdelali Idrissi  Taourati</span>, <span class="hlFld-ContribAuthor ">Vijay Hariram  Masand</span>, <span class="hlFld-ContribAuthor ">Mohammed  Bouachrine</span>, <span class="hlFld-ContribAuthor ">Tahar  Lakhlifi</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR study of anti-Human African Trypanosomiasis activity for 2-phenylimidazopyridines derivatives using DFT and Lipinski's descriptors. </span><span class="cited-content_cbyCitation_journal-name">Heliyon</span><span> <strong>2019,</strong> <em>5 </em>
                                    (3)
                                     , e01304. <a href="https://doi.org/10.1016/j.heliyon.2019.e01304" title="DOI URL">https://doi.org/10.1016/j.heliyon.2019.e01304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.heliyon.2019.e01304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.heliyon.2019.e01304%26sid%3Dliteratum%253Aachs%26jtitle%3DHeliyon%26atitle%3DQSAR%252Bstudy%252Bof%252Banti-Human%252BAfrican%252BTrypanosomiasis%252Bactivity%252Bfor%252B2-phenylimidazopyridines%252Bderivatives%252Busing%252BDFT%252Band%252BLipinski%252527s%252Bdescriptors%26aulast%3DChtita%26aufirst%3DSamir%26date%3D2019%26volume%3D5%26issue%3D3%26spage%3De01304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clinton G. L.  Veale</span>. </span><span class="cited-content_cbyCitation_article-title">Unpacking the Pathogen Box—An Open Source Tool for Fighting Neglected Tropical Disease. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (4)
                                     , 386-453. <a href="https://doi.org/10.1002/cmdc.201800755" title="DOI URL">https://doi.org/10.1002/cmdc.201800755</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800755%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DUnpacking%252Bthe%252BPathogen%252BBox%2525E2%252580%252594An%252BOpen%252BSource%252BTool%252Bfor%252BFighting%252BNeglected%252BTropical%252BDisease%26aulast%3DVeale%26aufirst%3DClinton%2BG.%2BL.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D4%26spage%3D386%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabian  Hulpia</span>, <span class="hlFld-ContribAuthor ">Gustavo Daniel  Campagnaro</span>, <span class="hlFld-ContribAuthor ">Mirko  Scortichini</span>, <span class="hlFld-ContribAuthor ">Kristof  Van Hecke</span>, <span class="hlFld-ContribAuthor ">Louis  Maes</span>, <span class="hlFld-ContribAuthor ">Harry P.  de Koning</span>, <span class="hlFld-ContribAuthor ">Guy  Caljon</span>, <span class="hlFld-ContribAuthor ">Serge  Van Calenbergh</span>. </span><span class="cited-content_cbyCitation_article-title">Revisiting tubercidin against kinetoplastid parasites: Aromatic substitutions at position 7 improve activity and reduce toxicity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 689-705. <a href="https://doi.org/10.1016/j.ejmech.2018.12.050" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.050%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRevisiting%252Btubercidin%252Bagainst%252Bkinetoplastid%252Bparasites%25253A%252BAromatic%252Bsubstitutions%252Bat%252Bposition%252B7%252Bimprove%252Bactivity%252Band%252Breduce%252Btoxicity%26aulast%3DHulpia%26aufirst%3DFabian%26date%3D2019%26volume%3D164%26spage%3D689%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Kryshchyshyn</span>, <span class="hlFld-ContribAuthor ">Oleg  Devinyak</span>, <span class="hlFld-ContribAuthor ">Danylo  Kaminskyy</span>, <span class="hlFld-ContribAuthor ">Philippe  Grellier</span>, <span class="hlFld-ContribAuthor ">Roman  Lesyk</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Predictive QSAR Models of 4-Thiazolidinones Antitrypanosomal Activity Using Modern Machine Learning Algorithms. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2018,</strong> <em>37 </em>
                                    (5)
                                     , 1700078. <a href="https://doi.org/10.1002/minf.201700078" title="DOI URL">https://doi.org/10.1002/minf.201700078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201700078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201700078%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DDevelopment%252Bof%252BPredictive%252BQSAR%252BModels%252Bof%252B4-Thiazolidinones%252BAntitrypanosomal%252BActivity%252BUsing%252BModern%252BMachine%252BLearning%252BAlgorithms%26aulast%3DKryshchyshyn%26aufirst%3DAnna%26date%3D2018%26date%3D2017%26volume%3D37%26issue%3D5%26spage%3D1700078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiri  Kos</span>, <span class="hlFld-ContribAuthor ">Iva  Kapustikova</span>, <span class="hlFld-ContribAuthor ">Carol  Clements</span>, <span class="hlFld-ContribAuthor ">Alexander I.  Gray</span>, <span class="hlFld-ContribAuthor ">Josef  Jampilek</span>. </span><span class="cited-content_cbyCitation_article-title">3-Hydroxynaphthalene-2-carboxanilides and their antitrypanosomal activity. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2018,</strong> <em>149 </em>
                                    (5)
                                     , 887-892. <a href="https://doi.org/10.1007/s00706-017-2099-1" title="DOI URL">https://doi.org/10.1007/s00706-017-2099-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-017-2099-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-017-2099-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3D3-Hydroxynaphthalene-2-carboxanilides%252Band%252Btheir%252Bantitrypanosomal%252Bactivity%26aulast%3DKos%26aufirst%3DJiri%26date%3D2018%26date%3D2018%26volume%3D149%26issue%3D5%26spage%3D887%26epage%3D892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra  Duffy</span>, <span class="hlFld-ContribAuthor ">Melissa L.  Sykes</span>, <span class="hlFld-ContribAuthor ">Amy J.  Jones</span>, <span class="hlFld-ContribAuthor ">Todd B.  Shelper</span>, <span class="hlFld-ContribAuthor ">Moana  Simpson</span>, <span class="hlFld-ContribAuthor ">Rebecca  Lang</span>, <span class="hlFld-ContribAuthor ">Sally-Ann  Poulsen</span>, <span class="hlFld-ContribAuthor ">Brad E.  Sleebs</span>, <span class="hlFld-ContribAuthor ">Vicky M.  Avery</span>. </span><span class="cited-content_cbyCitation_article-title">Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2017,</strong> <em>61 </em>
                                    (9)
                                     <a href="https://doi.org/10.1128/AAC.00379-17" title="DOI URL">https://doi.org/10.1128/AAC.00379-17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00379-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00379-17%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DScreening%252Bthe%252BMedicines%252Bfor%252BMalaria%252BVenture%252BPathogen%252BBox%252Bacross%252BMultiple%252BPathogens%252BReclassifies%252BStarting%252BPoints%252Bfor%252BOpen-Source%252BDrug%252BDiscovery%26aulast%3DDuffy%26aufirst%3DSandra%26date%3D2017%26volume%3D61%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiyong  Chen</span>, <span class="hlFld-ContribAuthor ">Yiming  Cao</span>, <span class="hlFld-ContribAuthor ">Zeyu  Tian</span>, <span class="hlFld-ContribAuthor ">Xuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Wenjin  Xu</span>, <span class="hlFld-ContribAuthor ">Jia  Yang</span>, <span class="hlFld-ContribAuthor ">Hanbing  Teng</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient reduction of N -substituted carbonylimidazolides into formamides by NaBH 4. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (22)
                                     , 2166-2170. <a href="https://doi.org/10.1016/j.tetlet.2017.04.072" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.04.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.04.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.04.072%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Befficient%252Breduction%252Bof%252BN%252B-substituted%252Bcarbonylimidazolides%252Binto%252Bformamides%252Bby%252BNaBH%252B4%26aulast%3DChen%26aufirst%3DZhiyong%26date%3D2017%26volume%3D58%26issue%3D22%26spage%3D2166%26epage%3D2170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0032.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of drugs investigated or currently used for the treatment of HAT and/or Chagas disease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Hit from a HTS of the WEHI compound library against <i>T. b. brucei</i><a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> providing the inspiration for this study. SI = selectivity index = IC<sub>50</sub> mammalian cell line/IC<sub>50</sub> trypanosome; HEK = human embryonic kidney cells, L6 is a rat skeletal muscle cell line.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Initial Literature Synthesis<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> of Key Primary Amine <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) NaOH, EtOAc, 50%; (b) Br<sub>2</sub>, MeOH 48%; (c) <i>i</i>-PrOH, HCl, 75%; (d) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, 48%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Improved Synthesis of Primary Amine Hydrochloride <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) (1) acetone, (2) H<sub>2</sub>SO<sub>4</sub>, 85%; (b) KCN, DMF, 90%; (c) (1) NaBH<sub>4</sub>, NiCl<sub>2</sub>·H<sub>2</sub>O, Boc<sub>2</sub>O, MeOH, (2) NEt<sub>3</sub>, 82%; (d) HCl/H<sub>2</sub>O, dioxane, quant</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Alternative Synthesis of Primary Amine <b>8</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) NaHCO<sub>3</sub>, EtOH, reflux, 76%; (b) LiAlH<sub>4</sub>, THF, −78 °C, 71%; (c) MsCl, NEt<sub>3</sub>, THF, 96% (crude); (d) NaN<sub>3</sub>, THF, reflux, 86%; (e) Pd/C, H<sub>2</sub>, MeOH, 99%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Target Amides, Carbamates, Ureas, Sulfonamide, and Sulfamide<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) <b>19</b>, NEt<sub>3</sub>, DCM, 57–85%*; (b) <b>20</b>, DCC, HOBt, or <b>20</b>, HBTU, 24–87%*; (c) <b>22</b>, n = 1, NEt<sub>3</sub>, DCM, 92%, <b>22</b>, n = 2, NEt<sub>3</sub>, DCM, 71%; (d) PhSO<sub>2</sub>Cl, NEt<sub>3</sub>, DCM, 40%, DIPEA, DCM, 32%; (e) <b>26</b>, NEt<sub>3</sub>, DCM, 41%; (f) CDI, MeCN, DMF, 69%; (g) ROH, NaH, DMF, 32–55%*; (h) HNR<sup>1</sup>R<sup>2</sup>, NEt<sub>3</sub>, DCM, 55–68%*. *See <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for individual reaction yields. Isopropylmethylamine was prepared by reductive amination of acetone.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Initial Route to 2-(2-Pyridyl)thiazole Targets<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) (1) acetone, 1,3-dichloroacetone (<b>9</b>), (2) H<sub>2</sub>SO<sub>4</sub>, 33%; (b) KCN, DMF, 70 °C, 74%; (c) BH<sub>3</sub>-THF, MeOH, 25%, NEt<sub>3</sub>, PhCOCl, 84% <i>or</i> cyclopentanecarbonyl chloride, 59%.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Alternative Route to Target Amides Involving a Hofmann Rearrangement<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) MeOH, reflux, 22–60%*; (b) conc NH<sub>3</sub>, THF, 45–75%*; (c) PhI(OAc)<sub>2</sub>, H<sub>2</sub>O/dioxane, 85%; (d) PhI(OAc)<sub>2</sub>, MeOH, <b>46a</b> 59%, <b>46b</b> 70%; (e) 4 M HCl, reflux, quant; (f) NEt<sub>3</sub>, PhCOCl (41–89%) <i>or</i> cyclopentanecarbonyl chloride (31–54%)*. Py = pyridyl. *See <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for individual reaction yields.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0012.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. First Attempted Synthesis of a 2-Bromothiazole Synthon<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions, and yields: (a) acetone, reflux, 82%; (b) (1) H<sub>2</sub>SO<sub>4</sub>, NaNO<sub>2</sub>, (2) HBr; (c) KCN, DMF, 31% (two steps); (d) (1) BH<sub>3</sub>–THF, MeOH, (2) HCl, 0%; (e) (1) NaBH<sub>4</sub>, NiCl<sub>2</sub>·H<sub>2</sub>O, Boc<sub>2</sub>O, MeOH, (2) NEt<sub>3</sub>, 0%.</p></p></figure><figure data-id="sch8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0013.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Divergent Synthesis of Variously 2-Arylated Thiazoles<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents, conditions and yields (a) thiourea (<b>48</b>), MeOH, reflux, 89%; (b) NaNO<sub>2</sub>, HBr <i>or</i> NaNO<sub>2</sub>, HCl, NaBr, 0%; (c) KSCN, EtOH, 78%; (d) HBr, AcOH, reflux, 86%; (e) ArB(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, PhMe, H<sub>2</sub>O, 80 °C, 40–62%, <i>or</i> ArB(OH)<sub>2</sub>, PdCl<sub>2</sub>dppf, TBAB, K<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O 4:1, μw, 49–73%*; (f) (1) H<sub>2</sub>NNH<sub>2</sub>.H<sub>2</sub>O, MeOH, reflux, (2) CDI, MeCN/DMF, 30–70% (two steps); (g) piperidine, NEt<sub>3</sub>, 55–70%; (h) H<sub>2</sub>NNH<sub>2</sub>.H<sub>2</sub>O, EtOH, 69%; (i) (1) <i>p</i>-nitrophenyl chloroformate, NEt<sub>3</sub>, DCM, (2) piperidine, 84% (<b>63a</b>); (j) (1) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, EtOH, reflux, (2) ClCOR, NEt<sub>3</sub>, EtOAc*. *See <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for individual reaction yields.</p></p></figure><figure data-id="sch9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0014.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Putative in Vitro Metabolism of <b>21Bb</b> in NADPH-Supplemented Human and Mouse Liver Microsomes, Based on LCMS and MS/MS Analysis (Stereochemistry of the sp<sup>3</sup>-C Hydroxylations Is Ignored in This Scheme)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vivo efficacy study. Balb/c mice infected with the trypomastigote form of transgenic <i>T. cruzi</i> Brazil strain expressing firefly luciferase<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> were treated by oral gavage with vehicle (PBS with 2% methylcellulose and 0.5% Tween 80, once daily) or twice daily <b>64a</b> (50 mg/kg, preceded by ip ABT 50 mg/kg 30 min prior) or benznidazole (100 mg/kg, once daily). (A) Parasite load from day 0 of treatment (5 days post infection). On imaging days, mice were anesthetized before being injected ip with 150 mg/kg of <span class="smallcaps smallerCapital">d</span>-luciferin potassium salt (Goldbio) dissolved in PBS. Mice were imaged 5–10 min after injection of luciferin with an IVIS 100 in vivo imaging system. The group of mice treated with <b>64a</b> and ABT are shown in panel B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/medium/jm-2016-00442q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0005.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of isomeric thiazoles: <b>64a</b> from the current work and <b>70</b> from Tidwell and co-workers.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-21/acs.jmedchem.6b00442/20161104/images/large/jm-2016-00442q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00442&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i197">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46217" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46217" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 94 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>Trypanosomiasis, Human African (Sleeping Sickness), Fact Sheet; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.who.int/mediacentre/factsheets/fs259/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs259/en/</a> (accessed March 21, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Trypanosomiasis%2C+Human+African+%28Sleeping+Sickness%29%2C+Fact+Sheet%3B+World+Health+Organization%3A+Geneva%2C+2016%3B+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs259%2Fen%2F+%28accessed+March+21%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DTrypanosomiasis%252C%2520Human%2520African%2520%2528Sleeping%2520Sickness%2529%252C%2520Fact%2520Sheet%26pub%3DWorld%2520Health%2520Organization%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span>Chagas Disease (American Trypanosomiasis), Fact Sheet; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.who.int/mediacentre/factsheets/fs340/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs340/en/</a> (accessed March 21, 2106).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chagas+Disease+%28American+Trypanosomiasis%29%2C+Fact+Sheet%3B+World+Health+Organization%3A+Geneva%2C+2016%3B+http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs340%2Fen%2F+%28accessed+March+21%2C+2106%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DChagas%2520Disease%2520%2528American%2520Trypanosomiasis%2529%252C%2520Fact%2520Sheet%26pub%3DWorld%2520Health%2520Organization%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Willyard, C.</span><span> </span><span class="NLM_article-title">Putting sleeping sickness to bed</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1038/nm0111-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1038%2Fnm0111-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=21217663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFWnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=14-17&author=C.+Willyard&title=Putting+sleeping+sickness+to+bed&doi=10.1038%2Fnm0111-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Putting sleeping sickness to bed</span></div><div class="casAuthors">Willyard, Cassandra</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-17</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">For most people, a single bite from a parasite-infected tsetse fly can trigger a slow, agonizing and sometimes fatal disease known as African sleeping sickness.  But new research shows that some people, as well as baboons and other great apes, are naturally resistant to infection.  Cassandra Willyard awakens to the possibility of using existing immunity to engineer new therapies and transgenic livestock.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZo0JS5fan97Vg90H21EOLACvtfcHk0liIsMrvSzuFqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFWnsQ%253D%253D&md5=b81f90a3257acde2f22cbd1843abba5e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm0111-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0111-14%26sid%3Dliteratum%253Aachs%26aulast%3DWillyard%26aufirst%3DC.%26atitle%3DPutting%2520sleeping%2520sickness%2520to%2520bed%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D14%26epage%3D17%26doi%3D10.1038%2Fnm0111-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span>East African Trypanosomiasis FAQs; <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.cdc.gov/parasites/sleepingsickness/gen_info/faqs-east.html" class="extLink">http://www.cdc.gov/parasites/sleepingsickness/gen_info/faqs-east.html</a> (accessed March 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=East+African+Trypanosomiasis+FAQs%3B+Centers+for+Disease+Control+and+Prevention%3A+Atlanta%2C+GA%2C+2012%3B+http%3A%2F%2Fwww.cdc.gov%2Fparasites%2Fsleepingsickness%2Fgen_info%2Ffaqs-east.html+%28accessed+March+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DEast%2520African%2520Trypanosomiasis%2520FAQs%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2012%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span>West African Trypanosomiasis FAQs; <span class="NLM_publisher-name">Centers for Disease Control</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.cdc.gov/parasites/sleepingsickness/gen_info/faqs-west.html" class="extLink">http://www.cdc.gov/parasites/sleepingsickness/gen_info/faqs-west.html</a> (accessed March 20,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=West+African+Trypanosomiasis+FAQs%3B+Centers+for+Disease+Control%3A+Atlanta%2C+GA%2C+2012%3B+http%3A%2F%2Fwww.cdc.gov%2Fparasites%2Fsleepingsickness%2Fgen_info%2Ffaqs-west.html+%28accessed+March+20%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DWest%2520African%2520Trypanosomiasis%2520FAQs%26pub%3DCenters%2520for%2520Disease%2520Control%26date%3D2012%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Naghavi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollset, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozgoren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdalla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abd-Allah, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel, A. MI.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboyans, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abuabara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abubakar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu-Raddad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu-Rmeileh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achoki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelekan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ademi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adofo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adsuar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ärnlov, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agardh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akena, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al Khabouri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alasfoor, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albittar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alegretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alemu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso-Cristancho, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alhabib, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al Lami, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allebeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">AlMazroa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Shahi Salman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsharif, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alviz-Guzman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amankwaa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amare, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameli, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amini, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apfel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argeseanu Cunningham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arsic Arsenijevic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artaman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asghar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assadi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badawi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakfalouni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakrishnan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balalla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker-Collo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barquera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barregard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrientos-Gutierrez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basulaiman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beardsley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beghi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekele, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benjet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensenor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi-Villa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyene, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhala, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhutta, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikbov, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bin Abdulhak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biryukov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blyth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohensky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boufous, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brainin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brazinova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitborde, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukhman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, N. IR.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carabin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cárdenas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carapetis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caso, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castañeda-Orjuela, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalá-López, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalleri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimed-Ochir, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chugh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coggeshall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colistro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colquhoun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colomar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortinovis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courville, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criqui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuevas-Nasu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Costa Leite, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dabhadkar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandona, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandona, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dargan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De la Cruz-Góngora, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de la Vega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Leo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degenhardt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Pozo-Cruz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellavalle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deribe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Des Jarlais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessalegn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deVeber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharmaratne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dherani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Ortega, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Torne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durrani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmond, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellenbogen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elshrek, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermakov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erskine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eshrati, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteghamati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estep, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fürst, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahimi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahrion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farzadfar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feigl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feigin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felicio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fereshtehnejad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foigt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forouzanfar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowkes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paleo, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaffikin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambashidze, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gankpé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Guerra, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geleijnse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibney, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillum, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmour, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginawi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giroud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goenka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez Dantes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gona, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Medina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guinovart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graetz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenwell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gugnani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunnell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutiérrez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haagsma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafezi-Nejad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagstromer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halasa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamadeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamavid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hankey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harewood, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havmoeller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedayati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heredia, P. IB</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heydarpour, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hijar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosgood, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hossain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsairi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husseini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannarone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iburg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idrisov, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islami, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismayilova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jassal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jha, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabagambe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karimkhani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karthikeyan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassebaum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazanjan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kengne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kereselidze, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khader, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalifa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieling, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinfu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivipelto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knibbs, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotagal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kravchenko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuate, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuipers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucuk, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakshmana, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalloo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallukka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansingh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavados, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrynowicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leasher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leigh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leinsalu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lima, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipshultz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lofgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logroscino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lortet-Tieulent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotufo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunevicius, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machado, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLachlan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magis-Rodriguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahdi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majdan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malekzadeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangalam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mapoma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marape, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcenes, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margono, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masci, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mashal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masiye, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason-Jones, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzopolous, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazorodze, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meaney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehndiratta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mejia-Rodriguez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melaku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Memish, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meretoja, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mhimbira, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misganaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffitt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed Ibrahim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokdad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monasta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monis, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montañez Hernandez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradi-Lakeh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschandreas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moturi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mozaffarian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaigawara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullany, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustapha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naghavi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naheed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naidoo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nangia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nejjari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuhouser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neupane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngalesoni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norheim, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norrving, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyakarahuka, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olusanya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orisakwe, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortblad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otayza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panelo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panniyammakal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papachristou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paternina Caicedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peresson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Padilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Ruiz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perico, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervaiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesudovs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plass, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poenaru, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polinder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pourmalek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakaran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quezada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quistberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabito, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimi-Movaghar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakovac, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refaat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remuzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas-Rueda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronfani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Room, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothenbacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruhago, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rushton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambandam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Søreide, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeedi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahathevan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahraian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samonte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satpathy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawhney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saylan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöttker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwebel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepanlou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Servan-Mori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackelford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaheen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahraz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakh-Nazarova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangguan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikhbahaei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shishani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiue, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shivakoti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrime, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigfusdottir, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sindi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sioson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skirbekk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soljak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soneji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soshnikov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sposato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreeramareddy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanaway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathopoulou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steenland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stöckl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straif, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroumpoulis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturua, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunguya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaroop, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talongwa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavakkoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Templin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenkorang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terkawi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorne-Lyman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thrift, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurston, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirschwell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tleyjeh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topouzis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Towbin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truelsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trillini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsala, D. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsilimbaris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuzcu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubeda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchendu, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukwaja, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Undurraga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallely, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Vijver, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gool, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varakin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasankari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasconcelos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vavilala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venketasubramanian, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijayakumar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalpando, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Violante, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlassov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warouw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weichenthal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiderpass, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weintraub, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzhi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werdecker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessells, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteford, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woldeyohannes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatsuya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonemoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun Jin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaki Mel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamakhshary, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeeb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonies, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GBD 2013 Mortality and Causes of Death Collaborators</span><span> </span><span class="NLM_article-title">Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1016/S0140-6736(14)61682-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0140-6736%2814%2961682-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2015&pages=117-171&author=M.+Naghaviauthor=H.+Wangauthor=R.+Lozanoauthor=A.+Davisauthor=X.+Liangauthor=M.+Zhouauthor=S.+Vollsetauthor=A.+Ozgorenauthor=S.+Abdallaauthor=F.+Abd-Allahauthor=A.+MI.+Abdelauthor=S.+Aberaauthor=V.+Aboyansauthor=B.+Abrahamauthor=J.+Abrahamauthor=K.+Abuabaraauthor=I.+Abubakarauthor=L.+Abu-Raddadauthor=N.+Abu-Rmeilehauthor=T.+Achokiauthor=A.+Adelekanauthor=Z.+Ademiauthor=K.+Adofoauthor=A.+Adouauthor=J.+Adsuarauthor=J.+%C3%84rnlovauthor=E.+Agardhauthor=D.+Akenaauthor=M.+Al+Khabouriauthor=D.+Alasfoorauthor=M.+Albittarauthor=M.+Alegrettiauthor=A.+Alemanauthor=Z.+Alemuauthor=R.+Alfonso-Cristanchoauthor=S.+Alhabibauthor=M.+Aliauthor=R.+Aliauthor=F.+Allaauthor=F.+Al+Lamiauthor=P.+Allebeckauthor=M.+AlMazroaauthor=R.+Al-Shahi+Salmanauthor=U.+Alsharifauthor=E.+Alvarezauthor=N.+Alviz-Guzmanauthor=A.+Amankwaaauthor=A.+Amareauthor=O.+Ameliauthor=H.+Aminiauthor=W.+Ammarauthor=H.+Andersonauthor=B.+Andersonauthor=C.+Antonioauthor=P.+Anwariauthor=H.+Apfelauthor=S.+Argeseanu+Cunninghamauthor=V.+Arsic+Arsenijevicauthor=A.+Artamanauthor=M.+Asadauthor=R.+Asgharauthor=R.+Assadiauthor=L.+Atkinsauthor=C.+Atkinsonauthor=A.+Badawiauthor=M.+Bahitauthor=T.+Bakfalouniauthor=K.+Balakrishnanauthor=S.+Balallaauthor=A.+Banerjeeauthor=R.+Barberauthor=S.+Barker-Colloauthor=S.+Barqueraauthor=L.+Barregardauthor=L.+Barreroauthor=T.+Barrientos-Gutierrezauthor=A.+Basuauthor=S.+Basuauthor=M.+Basulaimanauthor=J.+Beardsleyauthor=N.+Bediauthor=E.+Beghiauthor=T.+Bekeleauthor=M.+Bellauthor=C.+Benjetauthor=D.+Bennettauthor=I.+Bensenorauthor=H.+Benzianauthor=A.+Bertozzi-Villaauthor=T.+Beyeneauthor=N.+Bhalaauthor=A.+Bhallaauthor=Z.+Bhuttaauthor=B.+Bikbovauthor=A.+Bin+Abdulhakauthor=S.+Biryukovauthor=J.+Bloreauthor=F.+Blythauthor=M.+Bohenskyauthor=G.+Borgesauthor=D.+Boseauthor=S.+Boufousauthor=R.+Bourneauthor=L.+Boyersauthor=M.+Braininauthor=M.+Brauerauthor=C.+Brayneauthor=A.+Brazinovaauthor=N.+Breitbordeauthor=H.+Brennerauthor=A.+Briggsauthor=J.+Brownauthor=T.+Brughaauthor=G.+Buckleauthor=L.+Buiauthor=G.+Bukhmanauthor=M.+Burchauthor=N.+IR.+Camposauthor=H.+Carabinauthor=R.+C%C3%A1rdenasauthor=J.+Carapetisauthor=D.+Carpenterauthor=V.+Casoauthor=C.+Casta%C3%B1eda-Orjuelaauthor=R.+Castroauthor=F.+Catal%C3%A1-L%C3%B3pezauthor=F.+Cavalleriauthor=J.+Changauthor=F.+Charlsonauthor=X.+Cheauthor=H.+Chenauthor=Y.+Chenauthor=J.+Chenauthor=Z.+Chenauthor=P.+Chiangauthor=O.+Chimed-Ochirauthor=R.+Chowdhuryauthor=H.+Christensenauthor=C.+Christophiauthor=T.+Chuangauthor=S.+Chughauthor=M.+Cirilloauthor=M.+Coatesauthor=L.+Coffengauthor=M.+Coggeshallauthor=A.+Cohenauthor=V.+Colistroauthor=S.+Colquhounauthor=M.+Colomarauthor=L.+Cooperauthor=C.+Cooperauthor=L.+Coppolaauthor=M.+Cortinovisauthor=K.+Courvilleauthor=B.+Cowieauthor=M.+Criquiauthor=J.+Crumpauthor=L.+Cuevas-Nasuauthor=I.+da+Costa+Leiteauthor=K.+Dabhadkarauthor=L.+Dandonaauthor=R.+Dandonaauthor=E.+Dansereauauthor=P.+Darganauthor=A.+Dayamaauthor=V.+De+la+Cruz-G%C3%B3ngoraauthor=S.+de+la+Vegaauthor=D.+De+Leoauthor=L.+Degenhardtauthor=B.+del+Pozo-Cruzauthor=R.+Dellavalleauthor=K.+Deribeauthor=D.+Des+Jarlaisauthor=M.+Dessalegnauthor=G.+deVeberauthor=S.+Dharmaratneauthor=M.+Dheraniauthor=J.+Diaz-Ortegaauthor=C.+Diaz-Torneauthor=D.+Dickerauthor=E.+Dingauthor=K.+Dokovaauthor=E.+Dorseyauthor=T.+Driscollauthor=L.+Duanauthor=H.+Duberauthor=A.+Durraniauthor=B.+Ebelauthor=K.+Edmondauthor=R.+Ellenbogenauthor=Y.+Elshrekauthor=S.+Ermakovauthor=H.+Erskineauthor=B.+Eshratiauthor=A.+Esteghamatiauthor=K.+Estepauthor=T.+F%C3%BCrstauthor=S.+Fahimiauthor=A.+Fahrionauthor=E.+Faraonauthor=F.+Farzadfarauthor=D.+Fayauthor=A.+Feiglauthor=V.+Feiginauthor=M.+Felicioauthor=S.+Fereshtehnejadauthor=J.+Fernandesauthor=A.+Ferrariauthor=T.+Flemingauthor=N.+Foigtauthor=K.+Foremanauthor=M.+Forouzanfarauthor=F.+Fowkesauthor=U.+Paleoauthor=R.+Franklinauthor=N.+Futranauthor=L.+Gaffikinauthor=K.+Gambashidzeauthor=F.+Gankp%C3%A9author=F.+Garc%C3%ADa-Guerraauthor=A.+Garciaauthor=J.+Geleijnseauthor=B.+Gessnerauthor=K.+Gibneyauthor=R.+Gillumauthor=S.+Gilmourauthor=I.+Ginawiauthor=M.+Giroudauthor=E.+Glaserauthor=S.+Goenkaauthor=H.+Gomez+Dantesauthor=P.+Gonaauthor=D.+Gonzalez-Medinaauthor=C.+Guinovartauthor=R.+Guptaauthor=R.+Guptaauthor=R.+Gosselinauthor=C.+Gotayauthor=A.+Gotoauthor=H.+Goudaauthor=N.+Graetzauthor=K.+Greenwellauthor=H.+Gugnaniauthor=D.+Gunnellauthor=R.+Guti%C3%A9rrezauthor=J.+Haagsmaauthor=N.+Hafezi-Nejadauthor=H.+Haganauthor=M.+Hagstromerauthor=Y.+Halasaauthor=R.+Hamadehauthor=H.+Hamavidauthor=M.+Hammamiauthor=J.+Hancockauthor=G.+Hankeyauthor=G.+Hansenauthor=H.+Harbauthor=H.+Harewoodauthor=J.+Haroauthor=R.+Havmoellerauthor=R.+Hayauthor=S.+Hayauthor=M.+Hedayatiauthor=P.+IB+Herediaauthor=K.+Heutonauthor=P.+Heydarpourauthor=H.+Higashiauthor=M.+Hijarauthor=H.+Hoekauthor=H.+Hoffmanauthor=J.+Hornbergerauthor=H.+Hosgoodauthor=M.+Hossainauthor=P.+Hotezauthor=D.+Hoyauthor=M.+Hsairiauthor=G.+Huauthor=J.+Huangauthor=M.+Huffmanauthor=A.+Hughesauthor=A.+Husseiniauthor=C.+Huynhauthor=M.+Iannaroneauthor=K.+Iburgauthor=B.+Idrisovauthor=N.+Ikedaauthor=K.+Innosauthor=M.+Inoueauthor=F.+Islamiauthor=S.+Ismayilovaauthor=K.+Jacobsenauthor=S.+Jassalauthor=S.+Jayaramanauthor=P.+Jensenauthor=V.+Jhaauthor=G.+Jiangauthor=Y.+Jiangauthor=J.+Jonasauthor=J.+Josephauthor=K.+Juelauthor=E.+Kabagambeauthor=H.+Kanauthor=A.+Karchauthor=C.+Karimkhaniauthor=G.+Karthikeyanauthor=N.+Kassebaumauthor=A.+Kaulauthor=N.+Kawakamiauthor=K.+Kazanjanauthor=D.+Kaziauthor=A.+Kempauthor=A.+Kengneauthor=A.+Kerenauthor=M.+Kereselidzeauthor=Y.+Khaderauthor=S.+Khalifaauthor=E.+Khanauthor=G.+Khanauthor=Y.+Khangauthor=C.+Kielingauthor=Y.+Kinfuauthor=J.+Kingeauthor=D.+Kimauthor=S.+Kimauthor=M.+Kivipeltoauthor=L.+Knibbsauthor=A.+Knudsenauthor=Y.+Kokuboauthor=S.+Kosenauthor=M.+Kotagalauthor=M.+Kravchenkoauthor=S.+Krishnaswamiauthor=H.+Kruegerauthor=D.+B.+Kuateauthor=E.+Kuipersauthor=B.+B.+Kucukauthor=C.+Kulkarniauthor=V.+Kulkarniauthor=K.+Kumarauthor=R.+Kumarauthor=G.+Kwanauthor=H.+Kyuauthor=T.+Laiauthor=B.+A.+Lakshmanaauthor=R.+Lallooauthor=T.+Lallukkaauthor=H.+Lamauthor=Q.+Lanauthor=V.+Lansinghauthor=H.+Larsonauthor=A.+Larssonauthor=P.+Lavadosauthor=A.+Lawrynowiczauthor=J.+Leasherauthor=J.+Leeauthor=J.+Leighauthor=M.+Leinsaluauthor=R.+Leungauthor=C.+Levitzauthor=B.+Liauthor=Y.+Liauthor=Y.+Liauthor=C.+Liddellauthor=S.+Limauthor=G.+de+Limaauthor=M.+Lindauthor=S.+Lipshultzauthor=S.+Liuauthor=Y.+Liuauthor=B.+Lloydauthor=K.+Lofgrenauthor=G.+Logroscinoauthor=S.+Londonauthor=J.+Lortet-Tieulentauthor=P.+Lotufoauthor=R.+Lucasauthor=R.+Luneviciusauthor=R.+Lyonsauthor=S.+Maauthor=V.+Machadoauthor=M.+MacIntyreauthor=M.+Mackayauthor=J.+MacLachlanauthor=C.+Magis-Rodriguezauthor=A.+Mahdiauthor=M.+Majdanauthor=R.+Malekzadehauthor=S.+Mangalamauthor=C.+Mapomaauthor=M.+Marapeauthor=W.+Marcenesauthor=C.+Margonoauthor=G.+Marksauthor=M.+Marzanauthor=J.+Masciauthor=M.+Mashalauthor=F.+Masiyeauthor=A.+Mason-Jonesauthor=R.+Matzopolousauthor=B.+Mayosiauthor=T.+Mazorodzeauthor=J.+McGrathauthor=A.+McKayauthor=M.+McKeeauthor=A.+McLainauthor=P.+Meaneyauthor=M.+Mehndirattaauthor=F.+Mejia-Rodriguezauthor=Y.+Melakuauthor=M.+Meltzerauthor=Z.+Memishauthor=W.+Mendozaauthor=G.+Mensahauthor=A.+Meretojaauthor=F.+Mhimbiraauthor=T.+Millerauthor=E.+Millsauthor=A.+Misganawauthor=S.+Mishraauthor=C.+Mockauthor=T.+Moffittauthor=N.+Mohamed+Ibrahimauthor=K.+Mohammadauthor=A.+Mokdadauthor=G.+Molaauthor=L.+Monastaauthor=J.+L.+Monisauthor=J.+Monta%C3%B1ez+Hernandezauthor=M.+Monticoauthor=T.+Montineauthor=M.+Mooneyauthor=A.+Mooreauthor=M.+Moradi-Lakehauthor=A.+Moranauthor=R.+Moriauthor=J.+Moschandreasauthor=W.+Moturiauthor=M.+Moyerauthor=D.+Mozaffarianauthor=U.+Muellerauthor=M.+Mukaigawaraauthor=E.+Mullanyauthor=J.+Murrayauthor=A.+Mustaphaauthor=P.+Naghaviauthor=A.+Naheedauthor=K.+Naidooauthor=L.+Naldiauthor=D.+Nandauthor=V.+Nangiaauthor=K.+Narayanauthor=D.+Nashauthor=J.+Nasherauthor=C.+Nejjariauthor=R.+Nelsonauthor=M.+Neuhouserauthor=S.+Neupaneauthor=P.+Newcombauthor=L.+Newmanauthor=C.+Newtonauthor=M.+Ngauthor=F.+Ngalesoniauthor=G.+Nguyenauthor=N.+Nguyenauthor=M.+Nisarauthor=S.+Nolteauthor=O.+Norheimauthor=R.+Normanauthor=B.+Norrvingauthor=L.+Nyakarahukaauthor=S.+Odellauthor=M.+O%E2%80%99Donnellauthor=T.+Ohkuboauthor=S.+Ohnoauthor=B.+Olusanyaauthor=S.+Omerauthor=J.+Opioauthor=O.+Orisakweauthor=K.+Ortbladauthor=A.+Ortizauthor=M.+Otayzaauthor=A.+Painauthor=J.+Pandianauthor=C.+Paneloauthor=J.+Panniyammakalauthor=C.+Papachristouauthor=A.+Paternina+Caicedoauthor=S.+Pattenauthor=G.+Pattonauthor=V.+Paulauthor=B.+Pavlinauthor=N.+Pearceauthor=C.+Pellegriniauthor=D.+Pereiraauthor=S.+Peressonauthor=R.+Perez-Padillaauthor=F.+Perez-Ruizauthor=N.+Pericoauthor=A.+Pervaizauthor=K.+Pesudovsauthor=C.+Petersonauthor=M.+Petzoldauthor=B.+Phillipsauthor=D.+Phillipsauthor=M.+Phillipsauthor=D.+Plassauthor=F.+Pielauthor=D.+Poenaruauthor=S.+Polinderauthor=S.+Popovaauthor=R.+Poultonauthor=F.+Pourmalekauthor=D.+Prabhakaranauthor=D.+Qatoauthor=A.+Quezadaauthor=D.+Quistbergauthor=F.+Rabitoauthor=A.+Rafayauthor=K.+Rahimiauthor=V.+Rahimi-Movagharauthor=S.+Rahmanauthor=M.+Rajuauthor=I.+Rakovacauthor=S.+Ranaauthor=A.+Refaatauthor=G.+Remuzziauthor=A.+Ribeiroauthor=S.+Ricciauthor=P.+Riccioauthor=L.+Richardsonauthor=J.+Richardusauthor=B.+Robertsauthor=D.+Robertsauthor=M.+Robinsonauthor=A.+Rocaauthor=A.+Rodriguezauthor=D.+Rojas-Ruedaauthor=L.+Ronfaniauthor=R.+Roomauthor=G.+Rothauthor=D.+Rothenbacherauthor=D.+Rothsteinauthor=J.+Rowleyauthor=N.+Royauthor=G.+Ruhagoauthor=L.+Rushtonauthor=S.+Sambandamauthor=K.+S%C3%B8reideauthor=M.+Saeediauthor=S.+Sahaauthor=R.+Sahathevanauthor=M.+Sahraianauthor=B.+Sahleauthor=J.+Salomonauthor=D.+Salvoauthor=G.+Samonteauthor=U.+Sampsonauthor=J.+Sanabriaauthor=L.+Sandarauthor=I.+Santosauthor=M.+Satpathyauthor=M.+Sawhneyauthor=M.+Saylanauthor=P.+Scarboroughauthor=B.+Sch%C3%B6ttkerauthor=J.+Schmidtauthor=I.+Schneiderauthor=A.+Schumacherauthor=D.+Schwebelauthor=J.+Scottauthor=S.+Sepanlouauthor=E.+Servan-Moriauthor=K.+Shackelfordauthor=A.+Shaheenauthor=S.+Shahrazauthor=M.+Shakh-Nazarovaauthor=S.+Shangguanauthor=J.+Sheauthor=S.+Sheikhbahaeiauthor=D.+Shepardauthor=K.+Shibuyaauthor=Y.+Shinoharaauthor=K.+Shishaniauthor=I.+Shiueauthor=R.+Shivakotiauthor=M.+Shrimeauthor=I.+Sigfusdottirauthor=D.+Silberbergauthor=A.+Silvaauthor=E.+Simardauthor=S.+Sindiauthor=J.+Singhauthor=L.+Singhauthor=E.+Siosonauthor=V.+Skirbekkauthor=K.+Sliwaauthor=S.+Soauthor=M.+Soljakauthor=S.+Sonejiauthor=S.+Soshnikovauthor=L.+Sposatoauthor=C.+Sreeramareddyauthor=J.+Stanawayauthor=V.+Stathopoulouauthor=K.+Steenlandauthor=C.+Steinauthor=C.+Steinerauthor=A.+Stevensauthor=H.+St%C3%B6cklauthor=K.+Straifauthor=K.+Stroumpoulisauthor=L.+Sturuaauthor=B.+Sunguyaauthor=S.+Swaminathanauthor=M.+Swaroopauthor=B.+Sykesauthor=K.+Tabbauthor=K.+Takahashiauthor=R.+Talongwaauthor=F.+Tanauthor=D.+Tanneauthor=M.+Tannerauthor=M.+Tavakkoliauthor=B.+Aoauthor=C.+Teixeiraauthor=T.+Templinauthor=E.+Tenkorangauthor=A.+Terkawiauthor=B.+Thomasauthor=A.+Thorne-Lymanauthor=A.+Thriftauthor=G.+Thurstonauthor=T.+Tillmannauthor=D.+Tirschwellauthor=I.+Tleyjehauthor=M.+Tonelliauthor=F.+Topouzisauthor=J.+Towbinauthor=H.+Toyoshimaauthor=J.+Traebertauthor=B.+Tranauthor=T.+Truelsenauthor=U.+Trujilloauthor=M.+Trilliniauthor=D.+Z.+Tsalaauthor=M.+Tsilimbarisauthor=E.+Tuzcuauthor=C.+Ubedaauthor=U.+Uchenduauthor=K.+Ukwajaauthor=E.+Undurragaauthor=A.+Vallelyauthor=S.+van+de+Vijverauthor=C.+van+Goolauthor=Y.+Varakinauthor=T.+Vasankariauthor=A.+Vasconcelosauthor=M.+Vavilalaauthor=N.+Venketasubramanianauthor=L.+Vijayakumarauthor=S.+Villalpandoauthor=F.+Violanteauthor=V.+Vlassovauthor=G.+Wagnerauthor=S.+Wallerauthor=J.+Wangauthor=L.+Wangauthor=X.+Wangauthor=Y.+Wangauthor=T.+Warouwauthor=S.+Weichenthalauthor=E.+Weiderpassauthor=R.+Weintraubauthor=W.+Wenzhiauthor=A.+Werdeckerauthor=K.+Wessellsauthor=R.+Westermanauthor=H.+Whitefordauthor=J.+Wilkinsonauthor=T.+Williamsauthor=S.+Woldeyohannesauthor=C.+Wolfeauthor=T.+Wolockauthor=A.+Woolfauthor=J.+Wongauthor=J.+Wrightauthor=S.+Wulfauthor=B.+Wurtzauthor=G.+Xuauthor=Y.+Yangauthor=Y.+Yanoauthor=H.+Yatsuyaauthor=P.+Yipauthor=N.+Yonemotoauthor=S.+Yoonauthor=M.+Younisauthor=C.+Yuauthor=K.+Yun+Jinauthor=S.+Zaki+Melauthor=M.+Zamakhsharyauthor=H.+Zeebauthor=Y.+Zhangauthor=Y.+Zhaoauthor=Y.+Zhengauthor=J.+Zhuauthor=S.+Zhuauthor=D.+Zoniesauthor=X.+Zouauthor=J.+Zuntauthor=T.+Vosauthor=A.+Lopezauthor=C.+Murrayauthor=GBD+2013+Mortality+and+Causes+of+Death+Collaborators&title=Global%2C+regional%2C+and+national+age-sex+specific+all-cause+and+cause-specific+mortality+for+240+causes+of+death%2C+1990%E2%80%932013%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2013&doi=10.1016%2FS0140-6736%2814%2961682-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2814%2961682-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252814%252961682-2%26sid%3Dliteratum%253Aachs%26aulast%3DNaghavi%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLozano%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DVollset%26aufirst%3DS.%26aulast%3DOzgoren%26aufirst%3DA.%26aulast%3DAbdalla%26aufirst%3DS.%26aulast%3DAbd-Allah%26aufirst%3DF.%26aulast%3DAbdel%26aufirst%3DA.%2BMI.%26aulast%3DAbera%26aufirst%3DS.%26aulast%3DAboyans%26aufirst%3DV.%26aulast%3DAbraham%26aufirst%3DB.%26aulast%3DAbraham%26aufirst%3DJ.%26aulast%3DAbuabara%26aufirst%3DK.%26aulast%3DAbubakar%26aufirst%3DI.%26aulast%3DAbu-Raddad%26aufirst%3DL.%26aulast%3DAbu-Rmeileh%26aufirst%3DN.%26aulast%3DAchoki%26aufirst%3DT.%26aulast%3DAdelekan%26aufirst%3DA.%26aulast%3DAdemi%26aufirst%3DZ.%26aulast%3DAdofo%26aufirst%3DK.%26aulast%3DAdou%26aufirst%3DA.%26aulast%3DAdsuar%26aufirst%3DJ.%26aulast%3D%25C3%2584rnlov%26aufirst%3DJ.%26aulast%3DAgardh%26aufirst%3DE.%26aulast%3DAkena%26aufirst%3DD.%26aulast%3DAl%2BKhabouri%26aufirst%3DM.%26aulast%3DAlasfoor%26aufirst%3DD.%26aulast%3DAlbittar%26aufirst%3DM.%26aulast%3DAlegretti%26aufirst%3DM.%26aulast%3DAleman%26aufirst%3DA.%26aulast%3DAlemu%26aufirst%3DZ.%26aulast%3DAlfonso-Cristancho%26aufirst%3DR.%26aulast%3DAlhabib%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DR.%26aulast%3DAlla%26aufirst%3DF.%26aulast%3DAl%2BLami%26aufirst%3DF.%26aulast%3DAllebeck%26aufirst%3DP.%26aulast%3DAlMazroa%26aufirst%3DM.%26aulast%3DAl-Shahi%2BSalman%26aufirst%3DR.%26aulast%3DAlsharif%26aufirst%3DU.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DAlviz-Guzman%26aufirst%3DN.%26aulast%3DAmankwaa%26aufirst%3DA.%26aulast%3DAmare%26aufirst%3DA.%26aulast%3DAmeli%26aufirst%3DO.%26aulast%3DAmini%26aufirst%3DH.%26aulast%3DAmmar%26aufirst%3DW.%26aulast%3DAnderson%26aufirst%3DH.%26aulast%3DAnderson%26aufirst%3DB.%26aulast%3DAntonio%26aufirst%3DC.%26aulast%3DAnwari%26aufirst%3DP.%26aulast%3DApfel%26aufirst%3DH.%26aulast%3DArgeseanu%2BCunningham%26aufirst%3DS.%26aulast%3DArsic%2BArsenijevic%26aufirst%3DV.%26aulast%3DArtaman%26aufirst%3DA.%26aulast%3DAsad%26aufirst%3DM.%26aulast%3DAsghar%26aufirst%3DR.%26aulast%3DAssadi%26aufirst%3DR.%26aulast%3DAtkins%26aufirst%3DL.%26aulast%3DAtkinson%26aufirst%3DC.%26aulast%3DBadawi%26aufirst%3DA.%26aulast%3DBahit%26aufirst%3DM.%26aulast%3DBakfalouni%26aufirst%3DT.%26aulast%3DBalakrishnan%26aufirst%3DK.%26aulast%3DBalalla%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DBarber%26aufirst%3DR.%26aulast%3DBarker-Collo%26aufirst%3DS.%26aulast%3DBarquera%26aufirst%3DS.%26aulast%3DBarregard%26aufirst%3DL.%26aulast%3DBarrero%26aufirst%3DL.%26aulast%3DBarrientos-Gutierrez%26aufirst%3DT.%26aulast%3DBasu%26aufirst%3DA.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DBasulaiman%26aufirst%3DM.%26aulast%3DBeardsley%26aufirst%3DJ.%26aulast%3DBedi%26aufirst%3DN.%26aulast%3DBeghi%26aufirst%3DE.%26aulast%3DBekele%26aufirst%3DT.%26aulast%3DBell%26aufirst%3DM.%26aulast%3DBenjet%26aufirst%3DC.%26aulast%3DBennett%26aufirst%3DD.%26aulast%3DBensenor%26aufirst%3DI.%26aulast%3DBenzian%26aufirst%3DH.%26aulast%3DBertozzi-Villa%26aufirst%3DA.%26aulast%3DBeyene%26aufirst%3DT.%26aulast%3DBhala%26aufirst%3DN.%26aulast%3DBhalla%26aufirst%3DA.%26aulast%3DBhutta%26aufirst%3DZ.%26aulast%3DBikbov%26aufirst%3DB.%26aulast%3DBin%2BAbdulhak%26aufirst%3DA.%26aulast%3DBiryukov%26aufirst%3DS.%26aulast%3DBlore%26aufirst%3DJ.%26aulast%3DBlyth%26aufirst%3DF.%26aulast%3DBohensky%26aufirst%3DM.%26aulast%3DBorges%26aufirst%3DG.%26aulast%3DBose%26aufirst%3DD.%26aulast%3DBoufous%26aufirst%3DS.%26aulast%3DBourne%26aufirst%3DR.%26aulast%3DBoyers%26aufirst%3DL.%26aulast%3DBrainin%26aufirst%3DM.%26aulast%3DBrauer%26aufirst%3DM.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DBrazinova%26aufirst%3DA.%26aulast%3DBreitborde%26aufirst%3DN.%26aulast%3DBrenner%26aufirst%3DH.%26aulast%3DBriggs%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DBrugha%26aufirst%3DT.%26aulast%3DBuckle%26aufirst%3DG.%26aulast%3DBui%26aufirst%3DL.%26aulast%3DBukhman%26aufirst%3DG.%26aulast%3DBurch%26aufirst%3DM.%26aulast%3DCampos%26aufirst%3DN.%2BIR.%26aulast%3DCarabin%26aufirst%3DH.%26aulast%3DC%25C3%25A1rdenas%26aufirst%3DR.%26aulast%3DCarapetis%26aufirst%3DJ.%26aulast%3DCarpenter%26aufirst%3DD.%26aulast%3DCaso%26aufirst%3DV.%26aulast%3DCasta%25C3%25B1eda-Orjuela%26aufirst%3DC.%26aulast%3DCastro%26aufirst%3DR.%26aulast%3DCatal%25C3%25A1-L%25C3%25B3pez%26aufirst%3DF.%26aulast%3DCavalleri%26aufirst%3DF.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DCharlson%26aufirst%3DF.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DChimed-Ochir%26aufirst%3DO.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DChristensen%26aufirst%3DH.%26aulast%3DChristophi%26aufirst%3DC.%26aulast%3DChuang%26aufirst%3DT.%26aulast%3DChugh%26aufirst%3DS.%26aulast%3DCirillo%26aufirst%3DM.%26aulast%3DCoates%26aufirst%3DM.%26aulast%3DCoffeng%26aufirst%3DL.%26aulast%3DCoggeshall%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DA.%26aulast%3DColistro%26aufirst%3DV.%26aulast%3DColquhoun%26aufirst%3DS.%26aulast%3DColomar%26aufirst%3DM.%26aulast%3DCooper%26aufirst%3DL.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DCoppola%26aufirst%3DL.%26aulast%3DCortinovis%26aufirst%3DM.%26aulast%3DCourville%26aufirst%3DK.%26aulast%3DCowie%26aufirst%3DB.%26aulast%3DCriqui%26aufirst%3DM.%26aulast%3DCrump%26aufirst%3DJ.%26aulast%3DCuevas-Nasu%26aufirst%3DL.%26aulast%3Dda%2BCosta%2BLeite%26aufirst%3DI.%26aulast%3DDabhadkar%26aufirst%3DK.%26aulast%3DDandona%26aufirst%3DL.%26aulast%3DDandona%26aufirst%3DR.%26aulast%3DDansereau%26aufirst%3DE.%26aulast%3DDargan%26aufirst%3DP.%26aulast%3DDayama%26aufirst%3DA.%26aulast%3DDe%2Bla%2BCruz-G%25C3%25B3ngora%26aufirst%3DV.%26aulast%3Dde%2Bla%2BVega%26aufirst%3DS.%26aulast%3DDe%2BLeo%26aufirst%3DD.%26aulast%3DDegenhardt%26aufirst%3DL.%26aulast%3Ddel%2BPozo-Cruz%26aufirst%3DB.%26aulast%3DDellavalle%26aufirst%3DR.%26aulast%3DDeribe%26aufirst%3DK.%26aulast%3DDes%2BJarlais%26aufirst%3DD.%26aulast%3DDessalegn%26aufirst%3DM.%26aulast%3DdeVeber%26aufirst%3DG.%26aulast%3DDharmaratne%26aufirst%3DS.%26aulast%3DDherani%26aufirst%3DM.%26aulast%3DDiaz-Ortega%26aufirst%3DJ.%26aulast%3DDiaz-Torne%26aufirst%3DC.%26aulast%3DDicker%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DE.%26aulast%3DDokova%26aufirst%3DK.%26aulast%3DDorsey%26aufirst%3DE.%26aulast%3DDriscoll%26aufirst%3DT.%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DDuber%26aufirst%3DH.%26aulast%3DDurrani%26aufirst%3DA.%26aulast%3DEbel%26aufirst%3DB.%26aulast%3DEdmond%26aufirst%3DK.%26aulast%3DEllenbogen%26aufirst%3DR.%26aulast%3DElshrek%26aufirst%3DY.%26aulast%3DErmakov%26aufirst%3DS.%26aulast%3DErskine%26aufirst%3DH.%26aulast%3DEshrati%26aufirst%3DB.%26aulast%3DEsteghamati%26aufirst%3DA.%26aulast%3DEstep%26aufirst%3DK.%26aulast%3DF%25C3%25BCrst%26aufirst%3DT.%26aulast%3DFahimi%26aufirst%3DS.%26aulast%3DFahrion%26aufirst%3DA.%26aulast%3DFaraon%26aufirst%3DE.%26aulast%3DFarzadfar%26aufirst%3DF.%26aulast%3DFay%26aufirst%3DD.%26aulast%3DFeigl%26aufirst%3DA.%26aulast%3DFeigin%26aufirst%3DV.%26aulast%3DFelicio%26aufirst%3DM.%26aulast%3DFereshtehnejad%26aufirst%3DS.%26aulast%3DFernandes%26aufirst%3DJ.%26aulast%3DFerrari%26aufirst%3DA.%26aulast%3DFleming%26aufirst%3DT.%26aulast%3DFoigt%26aufirst%3DN.%26aulast%3DForeman%26aufirst%3DK.%26aulast%3DForouzanfar%26aufirst%3DM.%26aulast%3DFowkes%26aufirst%3DF.%26aulast%3DPaleo%26aufirst%3DU.%26aulast%3DFranklin%26aufirst%3DR.%26aulast%3DFutran%26aufirst%3DN.%26aulast%3DGaffikin%26aufirst%3DL.%26aulast%3DGambashidze%26aufirst%3DK.%26aulast%3DGankp%25C3%25A9%26aufirst%3DF.%26aulast%3DGarc%25C3%25ADa-Guerra%26aufirst%3DF.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DGeleijnse%26aufirst%3DJ.%26aulast%3DGessner%26aufirst%3DB.%26aulast%3DGibney%26aufirst%3DK.%26aulast%3DGillum%26aufirst%3DR.%26aulast%3DGilmour%26aufirst%3DS.%26aulast%3DGinawi%26aufirst%3DI.%26aulast%3DGiroud%26aufirst%3DM.%26aulast%3DGlaser%26aufirst%3DE.%26aulast%3DGoenka%26aufirst%3DS.%26aulast%3DGomez%2BDantes%26aufirst%3DH.%26aulast%3DGona%26aufirst%3DP.%26aulast%3DGonzalez-Medina%26aufirst%3DD.%26aulast%3DGuinovart%26aufirst%3DC.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DR.%26aulast%3DGotay%26aufirst%3DC.%26aulast%3DGoto%26aufirst%3DA.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DGraetz%26aufirst%3DN.%26aulast%3DGreenwell%26aufirst%3DK.%26aulast%3DGugnani%26aufirst%3DH.%26aulast%3DGunnell%26aufirst%3DD.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DR.%26aulast%3DHaagsma%26aufirst%3DJ.%26aulast%3DHafezi-Nejad%26aufirst%3DN.%26aulast%3DHagan%26aufirst%3DH.%26aulast%3DHagstromer%26aufirst%3DM.%26aulast%3DHalasa%26aufirst%3DY.%26aulast%3DHamadeh%26aufirst%3DR.%26aulast%3DHamavid%26aufirst%3DH.%26aulast%3DHammami%26aufirst%3DM.%26aulast%3DHancock%26aufirst%3DJ.%26aulast%3DHankey%26aufirst%3DG.%26aulast%3DHansen%26aufirst%3DG.%26aulast%3DHarb%26aufirst%3DH.%26aulast%3DHarewood%26aufirst%3DH.%26aulast%3DHaro%26aufirst%3DJ.%26aulast%3DHavmoeller%26aufirst%3DR.%26aulast%3DHay%26aufirst%3DR.%26aulast%3DHay%26aufirst%3DS.%26aulast%3DHedayati%26aufirst%3DM.%26aulast%3DHeredia%26aufirst%3DP.%2BIB%26aulast%3DHeuton%26aufirst%3DK.%26aulast%3DHeydarpour%26aufirst%3DP.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DHijar%26aufirst%3DM.%26aulast%3DHoek%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DH.%26aulast%3DHornberger%26aufirst%3DJ.%26aulast%3DHosgood%26aufirst%3DH.%26aulast%3DHossain%26aufirst%3DM.%26aulast%3DHotez%26aufirst%3DP.%26aulast%3DHoy%26aufirst%3DD.%26aulast%3DHsairi%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DHuffman%26aufirst%3DM.%26aulast%3DHughes%26aufirst%3DA.%26aulast%3DHusseini%26aufirst%3DA.%26aulast%3DHuynh%26aufirst%3DC.%26aulast%3DIannarone%26aufirst%3DM.%26aulast%3DIburg%26aufirst%3DK.%26aulast%3DIdrisov%26aufirst%3DB.%26aulast%3DIkeda%26aufirst%3DN.%26aulast%3DInnos%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIslami%26aufirst%3DF.%26aulast%3DIsmayilova%26aufirst%3DS.%26aulast%3DJacobsen%26aufirst%3DK.%26aulast%3DJassal%26aufirst%3DS.%26aulast%3DJayaraman%26aufirst%3DS.%26aulast%3DJensen%26aufirst%3DP.%26aulast%3DJha%26aufirst%3DV.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJonas%26aufirst%3DJ.%26aulast%3DJoseph%26aufirst%3DJ.%26aulast%3DJuel%26aufirst%3DK.%26aulast%3DKabagambe%26aufirst%3DE.%26aulast%3DKan%26aufirst%3DH.%26aulast%3DKarch%26aufirst%3DA.%26aulast%3DKarimkhani%26aufirst%3DC.%26aulast%3DKarthikeyan%26aufirst%3DG.%26aulast%3DKassebaum%26aufirst%3DN.%26aulast%3DKaul%26aufirst%3DA.%26aulast%3DKawakami%26aufirst%3DN.%26aulast%3DKazanjan%26aufirst%3DK.%26aulast%3DKazi%26aufirst%3DD.%26aulast%3DKemp%26aufirst%3DA.%26aulast%3DKengne%26aufirst%3DA.%26aulast%3DKeren%26aufirst%3DA.%26aulast%3DKereselidze%26aufirst%3DM.%26aulast%3DKhader%26aufirst%3DY.%26aulast%3DKhalifa%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DE.%26aulast%3DKhan%26aufirst%3DG.%26aulast%3DKhang%26aufirst%3DY.%26aulast%3DKieling%26aufirst%3DC.%26aulast%3DKinfu%26aufirst%3DY.%26aulast%3DKinge%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKivipelto%26aufirst%3DM.%26aulast%3DKnibbs%26aufirst%3DL.%26aulast%3DKnudsen%26aufirst%3DA.%26aulast%3DKokubo%26aufirst%3DY.%26aulast%3DKosen%26aufirst%3DS.%26aulast%3DKotagal%26aufirst%3DM.%26aulast%3DKravchenko%26aufirst%3DM.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DKrueger%26aufirst%3DH.%26aulast%3DKuate%26aufirst%3DD.%2BB.%26aulast%3DKuipers%26aufirst%3DE.%26aulast%3DKucuk%26aufirst%3DB.%2BB.%26aulast%3DKulkarni%26aufirst%3DC.%26aulast%3DKulkarni%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DKwan%26aufirst%3DG.%26aulast%3DKyu%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DT.%26aulast%3DLakshmana%26aufirst%3DB.%2BA.%26aulast%3DLalloo%26aufirst%3DR.%26aulast%3DLallukka%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLan%26aufirst%3DQ.%26aulast%3DLansingh%26aufirst%3DV.%26aulast%3DLarson%26aufirst%3DH.%26aulast%3DLarsson%26aufirst%3DA.%26aulast%3DLavados%26aufirst%3DP.%26aulast%3DLawrynowicz%26aufirst%3DA.%26aulast%3DLeasher%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLeigh%26aufirst%3DJ.%26aulast%3DLeinsalu%26aufirst%3DM.%26aulast%3DLeung%26aufirst%3DR.%26aulast%3DLevitz%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiddell%26aufirst%3DC.%26aulast%3DLim%26aufirst%3DS.%26aulast%3Dde%2BLima%26aufirst%3DG.%26aulast%3DLind%26aufirst%3DM.%26aulast%3DLipshultz%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLloyd%26aufirst%3DB.%26aulast%3DLofgren%26aufirst%3DK.%26aulast%3DLogroscino%26aufirst%3DG.%26aulast%3DLondon%26aufirst%3DS.%26aulast%3DLortet-Tieulent%26aufirst%3DJ.%26aulast%3DLotufo%26aufirst%3DP.%26aulast%3DLucas%26aufirst%3DR.%26aulast%3DLunevicius%26aufirst%3DR.%26aulast%3DLyons%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMachado%26aufirst%3DV.%26aulast%3DMacIntyre%26aufirst%3DM.%26aulast%3DMackay%26aufirst%3DM.%26aulast%3DMacLachlan%26aufirst%3DJ.%26aulast%3DMagis-Rodriguez%26aufirst%3DC.%26aulast%3DMahdi%26aufirst%3DA.%26aulast%3DMajdan%26aufirst%3DM.%26aulast%3DMalekzadeh%26aufirst%3DR.%26aulast%3DMangalam%26aufirst%3DS.%26aulast%3DMapoma%26aufirst%3DC.%26aulast%3DMarape%26aufirst%3DM.%26aulast%3DMarcenes%26aufirst%3DW.%26aulast%3DMargono%26aufirst%3DC.%26aulast%3DMarks%26aufirst%3DG.%26aulast%3DMarzan%26aufirst%3DM.%26aulast%3DMasci%26aufirst%3DJ.%26aulast%3DMashal%26aufirst%3DM.%26aulast%3DMasiye%26aufirst%3DF.%26aulast%3DMason-Jones%26aufirst%3DA.%26aulast%3DMatzopolous%26aufirst%3DR.%26aulast%3DMayosi%26aufirst%3DB.%26aulast%3DMazorodze%26aufirst%3DT.%26aulast%3DMcGrath%26aufirst%3DJ.%26aulast%3DMcKay%26aufirst%3DA.%26aulast%3DMcKee%26aufirst%3DM.%26aulast%3DMcLain%26aufirst%3DA.%26aulast%3DMeaney%26aufirst%3DP.%26aulast%3DMehndiratta%26aufirst%3DM.%26aulast%3DMejia-Rodriguez%26aufirst%3DF.%26aulast%3DMelaku%26aufirst%3DY.%26aulast%3DMeltzer%26aufirst%3DM.%26aulast%3DMemish%26aufirst%3DZ.%26aulast%3DMendoza%26aufirst%3DW.%26aulast%3DMensah%26aufirst%3DG.%26aulast%3DMeretoja%26aufirst%3DA.%26aulast%3DMhimbira%26aufirst%3DF.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DMills%26aufirst%3DE.%26aulast%3DMisganaw%26aufirst%3DA.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DMock%26aufirst%3DC.%26aulast%3DMoffitt%26aufirst%3DT.%26aulast%3DMohamed%2BIbrahim%26aufirst%3DN.%26aulast%3DMohammad%26aufirst%3DK.%26aulast%3DMokdad%26aufirst%3DA.%26aulast%3DMola%26aufirst%3DG.%26aulast%3DMonasta%26aufirst%3DL.%26aulast%3DMonis%26aufirst%3DJ.%2BL.%26aulast%3DMonta%25C3%25B1ez%2BHernandez%26aufirst%3DJ.%26aulast%3DMontico%26aufirst%3DM.%26aulast%3DMontine%26aufirst%3DT.%26aulast%3DMooney%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DMoradi-Lakeh%26aufirst%3DM.%26aulast%3DMoran%26aufirst%3DA.%26aulast%3DMori%26aufirst%3DR.%26aulast%3DMoschandreas%26aufirst%3DJ.%26aulast%3DMoturi%26aufirst%3DW.%26aulast%3DMoyer%26aufirst%3DM.%26aulast%3DMozaffarian%26aufirst%3DD.%26aulast%3DMueller%26aufirst%3DU.%26aulast%3DMukaigawara%26aufirst%3DM.%26aulast%3DMullany%26aufirst%3DE.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DMustapha%26aufirst%3DA.%26aulast%3DNaghavi%26aufirst%3DP.%26aulast%3DNaheed%26aufirst%3DA.%26aulast%3DNaidoo%26aufirst%3DK.%26aulast%3DNaldi%26aufirst%3DL.%26aulast%3DNand%26aufirst%3DD.%26aulast%3DNangia%26aufirst%3DV.%26aulast%3DNarayan%26aufirst%3DK.%26aulast%3DNash%26aufirst%3DD.%26aulast%3DNasher%26aufirst%3DJ.%26aulast%3DNejjari%26aufirst%3DC.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DNeuhouser%26aufirst%3DM.%26aulast%3DNeupane%26aufirst%3DS.%26aulast%3DNewcomb%26aufirst%3DP.%26aulast%3DNewman%26aufirst%3DL.%26aulast%3DNewton%26aufirst%3DC.%26aulast%3DNg%26aufirst%3DM.%26aulast%3DNgalesoni%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DNisar%26aufirst%3DM.%26aulast%3DNolte%26aufirst%3DS.%26aulast%3DNorheim%26aufirst%3DO.%26aulast%3DNorman%26aufirst%3DR.%26aulast%3DNorrving%26aufirst%3DB.%26aulast%3DNyakarahuka%26aufirst%3DL.%26aulast%3DOdell%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DM.%26aulast%3DOhkubo%26aufirst%3DT.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DOlusanya%26aufirst%3DB.%26aulast%3DOmer%26aufirst%3DS.%26aulast%3DOpio%26aufirst%3DJ.%26aulast%3DOrisakwe%26aufirst%3DO.%26aulast%3DOrtblad%26aufirst%3DK.%26aulast%3DOrtiz%26aufirst%3DA.%26aulast%3DOtayza%26aufirst%3DM.%26aulast%3DPain%26aufirst%3DA.%26aulast%3DPandian%26aufirst%3DJ.%26aulast%3DPanelo%26aufirst%3DC.%26aulast%3DPanniyammakal%26aufirst%3DJ.%26aulast%3DPapachristou%26aufirst%3DC.%26aulast%3DPaternina%2BCaicedo%26aufirst%3DA.%26aulast%3DPatten%26aufirst%3DS.%26aulast%3DPatton%26aufirst%3DG.%26aulast%3DPaul%26aufirst%3DV.%26aulast%3DPavlin%26aufirst%3DB.%26aulast%3DPearce%26aufirst%3DN.%26aulast%3DPellegrini%26aufirst%3DC.%26aulast%3DPereira%26aufirst%3DD.%26aulast%3DPeresson%26aufirst%3DS.%26aulast%3DPerez-Padilla%26aufirst%3DR.%26aulast%3DPerez-Ruiz%26aufirst%3DF.%26aulast%3DPerico%26aufirst%3DN.%26aulast%3DPervaiz%26aufirst%3DA.%26aulast%3DPesudovs%26aufirst%3DK.%26aulast%3DPeterson%26aufirst%3DC.%26aulast%3DPetzold%26aufirst%3DM.%26aulast%3DPhillips%26aufirst%3DB.%26aulast%3DPhillips%26aufirst%3DD.%26aulast%3DPhillips%26aufirst%3DM.%26aulast%3DPlass%26aufirst%3DD.%26aulast%3DPiel%26aufirst%3DF.%26aulast%3DPoenaru%26aufirst%3DD.%26aulast%3DPolinder%26aufirst%3DS.%26aulast%3DPopova%26aufirst%3DS.%26aulast%3DPoulton%26aufirst%3DR.%26aulast%3DPourmalek%26aufirst%3DF.%26aulast%3DPrabhakaran%26aufirst%3DD.%26aulast%3DQato%26aufirst%3DD.%26aulast%3DQuezada%26aufirst%3DA.%26aulast%3DQuistberg%26aufirst%3DD.%26aulast%3DRabito%26aufirst%3DF.%26aulast%3DRafay%26aufirst%3DA.%26aulast%3DRahimi%26aufirst%3DK.%26aulast%3DRahimi-Movaghar%26aufirst%3DV.%26aulast%3DRahman%26aufirst%3DS.%26aulast%3DRaju%26aufirst%3DM.%26aulast%3DRakovac%26aufirst%3DI.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DRefaat%26aufirst%3DA.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DRicci%26aufirst%3DS.%26aulast%3DRiccio%26aufirst%3DP.%26aulast%3DRichardson%26aufirst%3DL.%26aulast%3DRichardus%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DB.%26aulast%3DRoberts%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DM.%26aulast%3DRoca%26aufirst%3DA.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DRojas-Rueda%26aufirst%3DD.%26aulast%3DRonfani%26aufirst%3DL.%26aulast%3DRoom%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DG.%26aulast%3DRothenbacher%26aufirst%3DD.%26aulast%3DRothstein%26aufirst%3DD.%26aulast%3DRowley%26aufirst%3DJ.%26aulast%3DRoy%26aufirst%3DN.%26aulast%3DRuhago%26aufirst%3DG.%26aulast%3DRushton%26aufirst%3DL.%26aulast%3DSambandam%26aufirst%3DS.%26aulast%3DS%25C3%25B8reide%26aufirst%3DK.%26aulast%3DSaeedi%26aufirst%3DM.%26aulast%3DSaha%26aufirst%3DS.%26aulast%3DSahathevan%26aufirst%3DR.%26aulast%3DSahraian%26aufirst%3DM.%26aulast%3DSahle%26aufirst%3DB.%26aulast%3DSalomon%26aufirst%3DJ.%26aulast%3DSalvo%26aufirst%3DD.%26aulast%3DSamonte%26aufirst%3DG.%26aulast%3DSampson%26aufirst%3DU.%26aulast%3DSanabria%26aufirst%3DJ.%26aulast%3DSandar%26aufirst%3DL.%26aulast%3DSantos%26aufirst%3DI.%26aulast%3DSatpathy%26aufirst%3DM.%26aulast%3DSawhney%26aufirst%3DM.%26aulast%3DSaylan%26aufirst%3DM.%26aulast%3DScarborough%26aufirst%3DP.%26aulast%3DSch%25C3%25B6ttker%26aufirst%3DB.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DSchneider%26aufirst%3DI.%26aulast%3DSchumacher%26aufirst%3DA.%26aulast%3DSchwebel%26aufirst%3DD.%26aulast%3DScott%26aufirst%3DJ.%26aulast%3DSepanlou%26aufirst%3DS.%26aulast%3DServan-Mori%26aufirst%3DE.%26aulast%3DShackelford%26aufirst%3DK.%26aulast%3DShaheen%26aufirst%3DA.%26aulast%3DShahraz%26aufirst%3DS.%26aulast%3DShakh-Nazarova%26aufirst%3DM.%26aulast%3DShangguan%26aufirst%3DS.%26aulast%3DShe%26aufirst%3DJ.%26aulast%3DSheikhbahaei%26aufirst%3DS.%26aulast%3DShepard%26aufirst%3DD.%26aulast%3DShibuya%26aufirst%3DK.%26aulast%3DShinohara%26aufirst%3DY.%26aulast%3DShishani%26aufirst%3DK.%26aulast%3DShiue%26aufirst%3DI.%26aulast%3DShivakoti%26aufirst%3DR.%26aulast%3DShrime%26aufirst%3DM.%26aulast%3DSigfusdottir%26aufirst%3DI.%26aulast%3DSilberberg%26aufirst%3DD.%26aulast%3DSilva%26aufirst%3DA.%26aulast%3DSimard%26aufirst%3DE.%26aulast%3DSindi%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DL.%26aulast%3DSioson%26aufirst%3DE.%26aulast%3DSkirbekk%26aufirst%3DV.%26aulast%3DSliwa%26aufirst%3DK.%26aulast%3DSo%26aufirst%3DS.%26aulast%3DSoljak%26aufirst%3DM.%26aulast%3DSoneji%26aufirst%3DS.%26aulast%3DSoshnikov%26aufirst%3DS.%26aulast%3DSposato%26aufirst%3DL.%26aulast%3DSreeramareddy%26aufirst%3DC.%26aulast%3DStanaway%26aufirst%3DJ.%26aulast%3DStathopoulou%26aufirst%3DV.%26aulast%3DSteenland%26aufirst%3DK.%26aulast%3DStein%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DC.%26aulast%3DStevens%26aufirst%3DA.%26aulast%3DSt%25C3%25B6ckl%26aufirst%3DH.%26aulast%3DStraif%26aufirst%3DK.%26aulast%3DStroumpoulis%26aufirst%3DK.%26aulast%3DSturua%26aufirst%3DL.%26aulast%3DSunguya%26aufirst%3DB.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DSwaroop%26aufirst%3DM.%26aulast%3DSykes%26aufirst%3DB.%26aulast%3DTabb%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DTalongwa%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DF.%26aulast%3DTanne%26aufirst%3DD.%26aulast%3DTanner%26aufirst%3DM.%26aulast%3DTavakkoli%26aufirst%3DM.%26aulast%3DAo%26aufirst%3DB.%26aulast%3DTeixeira%26aufirst%3DC.%26aulast%3DTemplin%26aufirst%3DT.%26aulast%3DTenkorang%26aufirst%3DE.%26aulast%3DTerkawi%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DB.%26aulast%3DThorne-Lyman%26aufirst%3DA.%26aulast%3DThrift%26aufirst%3DA.%26aulast%3DThurston%26aufirst%3DG.%26aulast%3DTillmann%26aufirst%3DT.%26aulast%3DTirschwell%26aufirst%3DD.%26aulast%3DTleyjeh%26aufirst%3DI.%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DTopouzis%26aufirst%3DF.%26aulast%3DTowbin%26aufirst%3DJ.%26aulast%3DToyoshima%26aufirst%3DH.%26aulast%3DTraebert%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DB.%26aulast%3DTruelsen%26aufirst%3DT.%26aulast%3DTrujillo%26aufirst%3DU.%26aulast%3DTrillini%26aufirst%3DM.%26aulast%3DTsala%26aufirst%3DD.%2BZ.%26aulast%3DTsilimbaris%26aufirst%3DM.%26aulast%3DTuzcu%26aufirst%3DE.%26aulast%3DUbeda%26aufirst%3DC.%26aulast%3DUchendu%26aufirst%3DU.%26aulast%3DUkwaja%26aufirst%3DK.%26aulast%3DUndurraga%26aufirst%3DE.%26aulast%3DVallely%26aufirst%3DA.%26aulast%3Dvan%2Bde%2BVijver%26aufirst%3DS.%26aulast%3Dvan%2BGool%26aufirst%3DC.%26aulast%3DVarakin%26aufirst%3DY.%26aulast%3DVasankari%26aufirst%3DT.%26aulast%3DVasconcelos%26aufirst%3DA.%26aulast%3DVavilala%26aufirst%3DM.%26aulast%3DVenketasubramanian%26aufirst%3DN.%26aulast%3DVijayakumar%26aufirst%3DL.%26aulast%3DVillalpando%26aufirst%3DS.%26aulast%3DViolante%26aufirst%3DF.%26aulast%3DVlassov%26aufirst%3DV.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DWaller%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWarouw%26aufirst%3DT.%26aulast%3DWeichenthal%26aufirst%3DS.%26aulast%3DWeiderpass%26aufirst%3DE.%26aulast%3DWeintraub%26aufirst%3DR.%26aulast%3DWenzhi%26aufirst%3DW.%26aulast%3DWerdecker%26aufirst%3DA.%26aulast%3DWessells%26aufirst%3DK.%26aulast%3DWesterman%26aufirst%3DR.%26aulast%3DWhiteford%26aufirst%3DH.%26aulast%3DWilkinson%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DT.%26aulast%3DWoldeyohannes%26aufirst%3DS.%26aulast%3DWolfe%26aufirst%3DC.%26aulast%3DWolock%26aufirst%3DT.%26aulast%3DWoolf%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DWright%26aufirst%3DJ.%26aulast%3DWulf%26aufirst%3DS.%26aulast%3DWurtz%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYano%26aufirst%3DY.%26aulast%3DYatsuya%26aufirst%3DH.%26aulast%3DYip%26aufirst%3DP.%26aulast%3DYonemoto%26aufirst%3DN.%26aulast%3DYoon%26aufirst%3DS.%26aulast%3DYounis%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DYun%2BJin%26aufirst%3DK.%26aulast%3DZaki%2BMel%26aufirst%3DS.%26aulast%3DZamakhshary%26aufirst%3DM.%26aulast%3DZeeb%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DZonies%26aufirst%3DD.%26aulast%3DZou%26aufirst%3DX.%26aulast%3DZunt%26aufirst%3DJ.%26aulast%3DVos%26aufirst%3DT.%26aulast%3DLopez%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3D%26atitle%3DGlobal%252C%2520regional%252C%2520and%2520national%2520age-sex%2520specific%2520all-cause%2520and%2520cause-specific%2520mortality%2520for%2520240%2520causes%2520of%2520death%252C%25201990%25E2%2580%25932013%253A%2520a%2520systematic%2520analysis%2520for%2520the%2520Global%2520Burden%2520of%2520Disease%2520Study%25202013%26jtitle%3DLancet%26date%3D2015%26volume%3D385%26spage%3D117%26epage%3D171%26doi%3D10.1016%2FS0140-6736%2814%2961682-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Murray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbasoglu, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abd-Allah, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboyans, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abubakar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu-Raddad, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abu-Rmeileh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achoki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ademi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adsuar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afshin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agardh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alasfoor, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albittar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alegretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alemu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso-Cristancho, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alhabib, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alla, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allebeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almazroa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alsharif, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvis-Guzman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amare, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amini, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnlöv, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arsic Arsenijevic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artaman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asghar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assadi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awuah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachman, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badawi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balakrishnan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker-Collo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barquera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barregard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrero, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basulaiman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beardsley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beghi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bekele, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benjet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensenor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernabé, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertozzi-Villa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyene, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhala, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhutta, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienhoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikbov, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biryukov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blore, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blosser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blyth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohensky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolliger, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bora, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boufous, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brainin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brayne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brazinova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitborde, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugha, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchbinder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulchis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulloch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos-Nonato, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carabin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carapetis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cárdenas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caso, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castañeda-Orjuela, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalá-López, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalleri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Çavlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chadha, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chimed-Ochir, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coggeshall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colistro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colquhoun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortinovis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criqui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuevas-Nasu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danawi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandona, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dandona, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansereau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dargan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davitoiu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Leo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degenhardt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Pozo-Cruz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dellavalle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deribe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derrett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Des Jarlais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dessalegn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharmaratne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dherani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Torné, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dokova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driscoll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duber, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmond, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elshrek, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermakov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erskine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eshrati, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esteghamati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estep, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farzadfar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feigin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fereshtehnejad, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzmaurice, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaxman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foigt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forouzanfar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowkes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paleo, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fürst, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabbe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaffikin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gankpé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geleijnse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gething, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibney, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giroud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giussani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez Dantes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gona, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González-Medina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graetz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gugnani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutiérrez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haagsma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafezi-Nejad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halasa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamadeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamavid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hankey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harb, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Havmoeller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heredia-Pi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heydarpour, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hijar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosgood, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hossain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsairi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husseini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannarone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iburg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islami, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jassal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeemon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jha, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karema, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karimkhani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karthikeyan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassebaum, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazanjan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kengne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khader, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khalifa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieling, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinfu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kivipelto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knibbs, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuate Defo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucuk Bicer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuipers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalloo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallukka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansingh, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrynowicz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leasher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leigh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipshultz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lofgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logroscino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Looker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lortet-Tieulent, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotufo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunevicius, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macintyre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majdan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malekzadeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcenes, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margono, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masci, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mashal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzopoulos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazorodze, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcgill, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcgrath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mckee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mclain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meaney, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehndiratta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mekonnen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melaku, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Memish, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meretoja, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mhimbira, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed Ibrahim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokdad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monasta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montañez Hernandez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moradi-Lakeh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschandreas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moturi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mozaffarian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Msemburi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaigawara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullany, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdoch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naghavi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naheed, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naidoo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nangia, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nejjari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neupane, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngalesoni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norheim, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norrving, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyakarahuka, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohkubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olusanya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortblad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panelo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papachristou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patten, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Padilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Ruiz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perico, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervaiz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesudovs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plass, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poenaru, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polinder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pope, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pourmalek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakaran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qato, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quistberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razavi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refaat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remuzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnikoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas-Rueda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronfani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothenbacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruhago, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeedi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahraian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satpathy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawhney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schöttker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwebel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seedat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepanlou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serina, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Servan-Mori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackelford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaheen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahraz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shamah Levy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangguan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">She, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikhbahaei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shishani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiue, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrime, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigfusdottir, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silberberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sindi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skirbekk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slepak, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soneji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Søreide, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soshnikov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sposato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreeramareddy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanaway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathopoulou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stovner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroumpoulis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunguya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaroop, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabb, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tandon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanne, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavakkoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Te Ao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tediosi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temesgen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Templin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ten Have, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenkorang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terkawi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorne-Lyman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thrift, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurston, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topouzis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traebert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trillini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truelsen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsilimbaris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuzcu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchendu, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ukwaja, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Undurraga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, B. WH.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vijver, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van, G. CH.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasankari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venketasubramanian, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Violante, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlassov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollset, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warouw, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weichenthal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiderpass, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weintraub, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzhi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werdecker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteford, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wurtz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yentür, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonemoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonies, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GBD 2013 Mortality and Causes of Death Collaborators</span><span> </span><span class="NLM_article-title">Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">386</span><span class="NLM_x">, </span> <span class="NLM_fpage">2145</span><span class="NLM_x">–</span> <span class="NLM_lpage">2191</span><span class="refDoi"> DOI: 10.1016/S0140-6736(15)61340-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0140-6736%2815%2961340-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=386&publication_year=2015&pages=2145-2191&author=C.+Murrayauthor=R.+Barberauthor=K.+Foremanauthor=O.+A.+Abbasogluauthor=F.+Abd-Allahauthor=S.+Aberaauthor=V.+Aboyansauthor=J.+Abrahamauthor=I.+Abubakarauthor=L.+Abu-Raddadauthor=N.+Abu-Rmeilehauthor=T.+Achokiauthor=I.+Ackermanauthor=Z.+Ademiauthor=A.+Adouauthor=J.+Adsuarauthor=A.+Afshinauthor=E.+Agardhauthor=S.+Alamauthor=D.+Alasfoorauthor=M.+Albittarauthor=M.+Alegrettiauthor=Z.+Alemuauthor=R.+Alfonso-Cristanchoauthor=S.+Alhabibauthor=R.+Aliauthor=F.+Allaauthor=P.+Allebeckauthor=M.+Almazroaauthor=U.+Alsharifauthor=E.+Alvarezauthor=N.+Alvis-Guzmanauthor=A.+Amareauthor=E.+Amehauthor=H.+Aminiauthor=W.+Ammarauthor=H.+Andersonauthor=B.+Andersonauthor=C.+Antonioauthor=P.+Anwariauthor=J.+Arnl%C3%B6vauthor=V.+Arsic+Arsenijevicauthor=A.+Artamanauthor=R.+Asgharauthor=R.+Assadiauthor=L.+Atkinsauthor=M.+Avilaauthor=B.+Awuahauthor=V.+Bachmanauthor=A.+Badawiauthor=M.+Bahitauthor=K.+Balakrishnanauthor=A.+Banerjeeauthor=S.+Barker-Colloauthor=S.+Barqueraauthor=L.+Barregardauthor=L.+Barreroauthor=A.+Basuauthor=S.+Basuauthor=M.+Basulaimanauthor=J.+Beardsleyauthor=N.+Bediauthor=E.+Beghiauthor=T.+Bekeleauthor=M.+Bellauthor=C.+Benjetauthor=D.+Bennettauthor=I.+Bensenorauthor=H.+Benzianauthor=E.+Bernab%C3%A9author=A.+Bertozzi-Villaauthor=T.+Beyeneauthor=N.+Bhalaauthor=A.+Bhallaauthor=Z.+Bhuttaauthor=K.+Bienhoffauthor=B.+Bikbovauthor=S.+Biryukovauthor=J.+Bloreauthor=C.+Blosserauthor=F.+Blythauthor=M.+Bohenskyauthor=I.+Bolligerauthor=B.+B.+Boraauthor=N.+Bornsteinauthor=D.+Boseauthor=S.+Boufousauthor=R.+Bourneauthor=L.+Boyersauthor=M.+Braininauthor=C.+Brayneauthor=A.+Brazinovaauthor=N.+Breitbordeauthor=H.+Brennerauthor=A.+Briggsauthor=P.+Brooksauthor=J.+Brownauthor=T.+Brughaauthor=R.+Buchbinderauthor=G.+Buckleauthor=C.+Budkeauthor=A.+Bulchisauthor=A.+Bullochauthor=I.+Campos-Nonatoauthor=H.+Carabinauthor=J.+Carapetisauthor=R.+C%C3%A1rdenasauthor=D.+Carpenterauthor=V.+Casoauthor=C.+Casta%C3%B1eda-Orjuelaauthor=R.+Castroauthor=F.+Catal%C3%A1-L%C3%B3pezauthor=F.+Cavalleriauthor=A.+%C3%87avlinauthor=V.+Chadhaauthor=J.+Changauthor=F.+Charlsonauthor=H.+Chenauthor=W.+Chenauthor=P.+Chiangauthor=O.+Chimed-Ochirauthor=R.+Chowdhuryauthor=H.+Christensenauthor=C.+Christophiauthor=M.+Cirilloauthor=M.+Coatesauthor=L.+Coffengauthor=M.+Coggeshallauthor=V.+Colistroauthor=S.+Colquhounauthor=G.+Cookeauthor=C.+Cooperauthor=L.+Cooperauthor=L.+Coppolaauthor=M.+Cortinovisauthor=M.+Criquiauthor=J.+Crumpauthor=L.+Cuevas-Nasuauthor=H.+Danawiauthor=L.+Dandonaauthor=R.+Dandonaauthor=E.+Dansereauauthor=P.+Darganauthor=G.+Daveyauthor=A.+Davisauthor=D.+Davitoiuauthor=A.+Dayamaauthor=D.+De+Leoauthor=L.+Degenhardtauthor=B.+Del+Pozo-Cruzauthor=R.+Dellavalleauthor=K.+Deribeauthor=S.+Derrettauthor=D.+Des+Jarlaisauthor=M.+Dessalegnauthor=S.+Dharmaratneauthor=M.+Dheraniauthor=C.+Diaz-Torn%C3%A9author=D.+Dickerauthor=E.+Dingauthor=K.+Dokovaauthor=E.+Dorseyauthor=T.+Driscollauthor=L.+Duanauthor=H.+Duberauthor=B.+Ebelauthor=K.+Edmondauthor=Y.+Elshrekauthor=M.+Endresauthor=S.+Ermakovauthor=H.+Erskineauthor=B.+Eshratiauthor=A.+Esteghamatiauthor=K.+Estepauthor=E.+Faraonauthor=F.+Farzadfarauthor=D.+Fayauthor=V.+Feiginauthor=D.+Felsonauthor=S.+Fereshtehnejadauthor=J.+Fernandesauthor=A.+Ferrariauthor=C.+Fitzmauriceauthor=A.+Flaxmanauthor=T.+Flemingauthor=N.+Foigtauthor=M.+Forouzanfarauthor=F.+Fowkesauthor=U.+Paleoauthor=R.+Franklinauthor=T.+F%C3%BCrstauthor=B.+Gabbeauthor=L.+Gaffikinauthor=F.+Gankp%C3%A9author=J.+Geleijnseauthor=B.+Gessnerauthor=P.+Gethingauthor=K.+Gibneyauthor=M.+Giroudauthor=G.+Giussaniauthor=H.+Gomez+Dantesauthor=P.+Gonaauthor=D.+Gonz%C3%A1lez-Medinaauthor=R.+Gosselinauthor=C.+Gotayauthor=A.+Gotoauthor=H.+Goudaauthor=N.+Graetzauthor=H.+Gugnaniauthor=R.+Guptaauthor=R.+Guptaauthor=R.+Guti%C3%A9rrezauthor=J.+Haagsmaauthor=N.+Hafezi-Nejadauthor=H.+Haganauthor=Y.+Halasaauthor=R.+Hamadehauthor=H.+Hamavidauthor=M.+Hammamiauthor=J.+Hancockauthor=G.+Hankeyauthor=G.+Hansenauthor=Y.+Haoauthor=H.+Harbauthor=J.+Haroauthor=R.+Havmoellerauthor=S.+Hayauthor=R.+Hayauthor=I.+Heredia-Piauthor=K.+Heutonauthor=P.+Heydarpourauthor=H.+Higashiauthor=M.+Hijarauthor=H.+Hoekauthor=H.+Hoffmanauthor=H.+Hosgoodauthor=M.+Hossainauthor=P.+Hotezauthor=D.+Hoyauthor=M.+Hsairiauthor=G.+Huauthor=C.+Huangauthor=J.+Huangauthor=A.+Husseiniauthor=C.+Huynhauthor=M.+Iannaroneauthor=K.+Iburgauthor=K.+Innosauthor=M.+Inoueauthor=F.+Islamiauthor=K.+Jacobsenauthor=D.+Jarvisauthor=S.+Jassalauthor=S.+Jeeauthor=P.+Jeemonauthor=P.+Jensenauthor=V.+Jhaauthor=G.+Jiangauthor=Y.+Jiangauthor=J.+Jonasauthor=K.+Juelauthor=H.+Kanauthor=A.+Karchauthor=C.+Karemaauthor=C.+Karimkhaniauthor=G.+Karthikeyanauthor=N.+Kassebaumauthor=A.+Kaulauthor=N.+Kawakamiauthor=K.+Kazanjanauthor=A.+Kempauthor=A.+Kengneauthor=A.+Kerenauthor=Y.+Khaderauthor=S.+Khalifaauthor=E.+Khanauthor=G.+Khanauthor=Y.+Khangauthor=C.+Kielingauthor=D.+Kimauthor=S.+Kimauthor=Y.+Kimauthor=Y.+Kinfuauthor=J.+Kingeauthor=M.+Kivipeltoauthor=L.+Knibbsauthor=A.+Knudsenauthor=Y.+Kokuboauthor=S.+Kosenauthor=S.+Krishnaswamiauthor=B.+Kuate+Defoauthor=B.+Kucuk+Bicerauthor=E.+Kuipersauthor=C.+Kulkarniauthor=V.+Kulkarniauthor=G.+Kumarauthor=H.+Kyuauthor=T.+Laiauthor=R.+Lallooauthor=T.+Lallukkaauthor=H.+Lamauthor=Q.+Lanauthor=V.+Lansinghauthor=A.+Larssonauthor=A.+Lawrynowiczauthor=J.+Leasherauthor=J.+Leighauthor=R.+Leungauthor=C.+Levitzauthor=B.+Liauthor=Y.+Liauthor=Y.+Liauthor=S.+Limauthor=M.+Lindauthor=S.+Lipshultzauthor=S.+Liuauthor=Y.+Liuauthor=B.+Lloydauthor=K.+Lofgrenauthor=G.+Logroscinoauthor=K.+Lookerauthor=J.+Lortet-Tieulentauthor=P.+Lotufoauthor=R.+Lozanoauthor=R.+Lucasauthor=R.+Luneviciusauthor=R.+Lyonsauthor=S.+Maauthor=M.+Macintyreauthor=M.+Mackayauthor=M.+Majdanauthor=R.+Malekzadehauthor=W.+Marcenesauthor=D.+Margolisauthor=C.+Margonoauthor=M.+Marzanauthor=J.+Masciauthor=M.+Mashalauthor=R.+Matzopoulosauthor=B.+Mayosiauthor=T.+Mazorodzeauthor=N.+Mcgillauthor=J.+Mcgrathauthor=M.+Mckeeauthor=A.+Mclainauthor=P.+Meaneyauthor=C.+Medinaauthor=M.+Mehndirattaauthor=W.+Mekonnenauthor=Y.+Melakuauthor=M.+Meltzerauthor=Z.+Memishauthor=G.+Mensahauthor=A.+Meretojaauthor=F.+Mhimbiraauthor=R.+Michaauthor=T.+Millerauthor=E.+Millsauthor=P.+Mitchellauthor=C.+Mockauthor=N.+Mohamed+Ibrahimauthor=K.+Mohammadauthor=A.+Mokdadauthor=G.+Molaauthor=L.+Monastaauthor=J.+Monta%C3%B1ez+Hernandezauthor=M.+Monticoauthor=T.+Montineauthor=M.+Mooneyauthor=A.+Mooreauthor=M.+Moradi-Lakehauthor=A.+Moranauthor=R.+Moriauthor=J.+Moschandreasauthor=W.+Moturiauthor=M.+Moyerauthor=D.+Mozaffarianauthor=W.+Msemburiauthor=U.+Muellerauthor=M.+Mukaigawaraauthor=E.+Mullanyauthor=M.+Murdochauthor=J.+Murrayauthor=K.+Murthyauthor=M.+Naghaviauthor=A.+Naheedauthor=K.+Naidooauthor=L.+Naldiauthor=D.+Nandauthor=V.+Nangiaauthor=K.+Narayanauthor=C.+Nejjariauthor=S.+Neupaneauthor=C.+Newtonauthor=M.+Ngauthor=F.+Ngalesoniauthor=G.+Nguyenauthor=M.+Nisarauthor=S.+Nolteauthor=O.+Norheimauthor=R.+Normanauthor=B.+Norrvingauthor=L.+Nyakarahukaauthor=I.+Ohauthor=T.+Ohkuboauthor=S.+Ohnoauthor=B.+Olusanyaauthor=J.+Opioauthor=K.+Ortbladauthor=A.+Ortizauthor=A.+Painauthor=J.+Pandianauthor=C.+Paneloauthor=C.+Papachristouauthor=E.+Parkauthor=J.+Parkauthor=S.+Pattenauthor=G.+Pattonauthor=V.+Paulauthor=B.+Pavlinauthor=N.+Pearceauthor=D.+Pereiraauthor=R.+Perez-Padillaauthor=F.+Perez-Ruizauthor=N.+Pericoauthor=A.+Pervaizauthor=K.+Pesudovsauthor=C.+Petersonauthor=M.+Petzoldauthor=M.+Phillipsauthor=B.+Phillipsauthor=D.+Phillipsauthor=F.+Pielauthor=D.+Plassauthor=D.+Poenaruauthor=S.+Polinderauthor=D.+Popeauthor=S.+Popovaauthor=R.+Poultonauthor=F.+Pourmalekauthor=D.+Prabhakaranauthor=N.+Prasadauthor=R.+Pullanauthor=D.+Qatoauthor=D.+Quistbergauthor=A.+Rafayauthor=K.+Rahimiauthor=S.+Rahmanauthor=M.+Rajuauthor=S.+Ranaauthor=H.+Razaviauthor=K.+Reddyauthor=A.+Refaatauthor=G.+Remuzziauthor=S.+Resnikoffauthor=A.+Ribeiroauthor=L.+Richardsonauthor=J.+Richardusauthor=D.+Robertsauthor=D.+Rojas-Ruedaauthor=L.+Ronfaniauthor=G.+Rothauthor=D.+Rothenbacherauthor=D.+Rothsteinauthor=J.+Rowleyauthor=N.+Royauthor=G.+Ruhagoauthor=M.+Saeediauthor=S.+Sahaauthor=M.+Sahraianauthor=U.+Sampsonauthor=J.+Sanabriaauthor=L.+Sandarauthor=I.+Santosauthor=M.+Satpathyauthor=M.+Sawhneyauthor=P.+Scarboroughauthor=I.+Schneiderauthor=B.+Sch%C3%B6ttkerauthor=A.+Schumacherauthor=D.+Schwebelauthor=J.+Scottauthor=S.+Seedatauthor=S.+Sepanlouauthor=P.+Serinaauthor=E.+Servan-Moriauthor=K.+Shackelfordauthor=A.+Shaheenauthor=S.+Shahrazauthor=T.+Shamah+Levyauthor=S.+Shangguanauthor=J.+Sheauthor=S.+Sheikhbahaeiauthor=P.+Shiauthor=K.+Shibuyaauthor=Y.+Shinoharaauthor=R.+Shiriauthor=K.+Shishaniauthor=I.+Shiueauthor=M.+Shrimeauthor=I.+Sigfusdottirauthor=D.+Silberbergauthor=E.+Simardauthor=S.+Sindiauthor=A.+Singhauthor=J.+Singhauthor=L.+Singhauthor=V.+Skirbekkauthor=E.+Slepakauthor=K.+Sliwaauthor=S.+Sonejiauthor=K.+S%C3%B8reideauthor=S.+Soshnikovauthor=L.+Sposatoauthor=C.+Sreeramareddyauthor=J.+Stanawayauthor=V.+Stathopoulouauthor=D.+Steinauthor=M.+Steinauthor=C.+Steinerauthor=T.+Steinerauthor=A.+Stevensauthor=A.+Stewartauthor=L.+Stovnerauthor=K.+Stroumpoulisauthor=B.+Sunguyaauthor=S.+Swaminathanauthor=M.+Swaroopauthor=B.+Sykesauthor=K.+Tabbauthor=K.+Takahashiauthor=N.+Tandonauthor=D.+Tanneauthor=M.+Tannerauthor=M.+Tavakkoliauthor=H.+Taylorauthor=B.+Te+Aoauthor=F.+Tediosiauthor=A.+Temesgenauthor=T.+Templinauthor=M.+Ten+Haveauthor=E.+Tenkorangauthor=A.+Terkawiauthor=B.+Thomsonauthor=A.+Thorne-Lymanauthor=A.+Thriftauthor=G.+Thurstonauthor=T.+Tillmannauthor=M.+Tonelliauthor=F.+Topouzisauthor=H.+Toyoshimaauthor=J.+Traebertauthor=B.+Tranauthor=M.+Trilliniauthor=T.+Truelsenauthor=M.+Tsilimbarisauthor=E.+Tuzcuauthor=U.+Uchenduauthor=K.+Ukwajaauthor=E.+Undurragaauthor=S.+Uzunauthor=B.+WH.+Vanauthor=S.+Vijverauthor=G.+CH.+vanauthor=O.+J.+Vanauthor=T.+Vasankariauthor=N.+Venketasubramanianauthor=F.+Violanteauthor=V.+Vlassovauthor=S.+Vollsetauthor=G.+Wagnerauthor=J.+Wagnerauthor=S.+Wallerauthor=X.+Wanauthor=H.+Wangauthor=J.+Wangauthor=L.+Wangauthor=T.+Warouwauthor=S.+Weichenthalauthor=E.+Weiderpassauthor=R.+Weintraubauthor=W.+Wenzhiauthor=A.+Werdeckerauthor=R.+Westermanauthor=H.+Whitefordauthor=J.+Wilkinsonauthor=T.+Williamsauthor=C.+Wolfeauthor=T.+Wolockauthor=A.+Woolfauthor=S.+Wulfauthor=B.+Wurtzauthor=G.+Xuauthor=L.+Yanauthor=Y.+Yanoauthor=P.+Yeauthor=G.+Yent%C3%BCrauthor=P.+Yipauthor=N.+Yonemotoauthor=S.+Yoonauthor=M.+Younisauthor=C.+Yuauthor=M.+Zakiauthor=Y.+Zhaoauthor=Y.+Zhengauthor=D.+Zoniesauthor=X.+Zouauthor=J.+Salomonauthor=A.+Lopezauthor=T.+Vosauthor=GBD+2013+Mortality+and+Causes+of+Death+Collaborators&title=Global%2C+regional%2C+and+national+disability-adjusted+life+years+%28DALYs%29+for+306+diseases+and+injuries+and+healthy+life+expectancy+%28HALE%29+for+188+countries%2C+1990%E2%80%932013%3A+quantifying+the+epidemiological+transition&doi=10.1016%2FS0140-6736%2815%2961340-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2815%2961340-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252815%252961340-X%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DBarber%26aufirst%3DR.%26aulast%3DForeman%26aufirst%3DK.%26aulast%3DAbbasoglu%26aufirst%3DO.%2BA.%26aulast%3DAbd-Allah%26aufirst%3DF.%26aulast%3DAbera%26aufirst%3DS.%26aulast%3DAboyans%26aufirst%3DV.%26aulast%3DAbraham%26aufirst%3DJ.%26aulast%3DAbubakar%26aufirst%3DI.%26aulast%3DAbu-Raddad%26aufirst%3DL.%26aulast%3DAbu-Rmeileh%26aufirst%3DN.%26aulast%3DAchoki%26aufirst%3DT.%26aulast%3DAckerman%26aufirst%3DI.%26aulast%3DAdemi%26aufirst%3DZ.%26aulast%3DAdou%26aufirst%3DA.%26aulast%3DAdsuar%26aufirst%3DJ.%26aulast%3DAfshin%26aufirst%3DA.%26aulast%3DAgardh%26aufirst%3DE.%26aulast%3DAlam%26aufirst%3DS.%26aulast%3DAlasfoor%26aufirst%3DD.%26aulast%3DAlbittar%26aufirst%3DM.%26aulast%3DAlegretti%26aufirst%3DM.%26aulast%3DAlemu%26aufirst%3DZ.%26aulast%3DAlfonso-Cristancho%26aufirst%3DR.%26aulast%3DAlhabib%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DR.%26aulast%3DAlla%26aufirst%3DF.%26aulast%3DAllebeck%26aufirst%3DP.%26aulast%3DAlmazroa%26aufirst%3DM.%26aulast%3DAlsharif%26aufirst%3DU.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DAlvis-Guzman%26aufirst%3DN.%26aulast%3DAmare%26aufirst%3DA.%26aulast%3DAmeh%26aufirst%3DE.%26aulast%3DAmini%26aufirst%3DH.%26aulast%3DAmmar%26aufirst%3DW.%26aulast%3DAnderson%26aufirst%3DH.%26aulast%3DAnderson%26aufirst%3DB.%26aulast%3DAntonio%26aufirst%3DC.%26aulast%3DAnwari%26aufirst%3DP.%26aulast%3DArnl%25C3%25B6v%26aufirst%3DJ.%26aulast%3DArsic%2BArsenijevic%26aufirst%3DV.%26aulast%3DArtaman%26aufirst%3DA.%26aulast%3DAsghar%26aufirst%3DR.%26aulast%3DAssadi%26aufirst%3DR.%26aulast%3DAtkins%26aufirst%3DL.%26aulast%3DAvila%26aufirst%3DM.%26aulast%3DAwuah%26aufirst%3DB.%26aulast%3DBachman%26aufirst%3DV.%26aulast%3DBadawi%26aufirst%3DA.%26aulast%3DBahit%26aufirst%3DM.%26aulast%3DBalakrishnan%26aufirst%3DK.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DBarker-Collo%26aufirst%3DS.%26aulast%3DBarquera%26aufirst%3DS.%26aulast%3DBarregard%26aufirst%3DL.%26aulast%3DBarrero%26aufirst%3DL.%26aulast%3DBasu%26aufirst%3DA.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DBasulaiman%26aufirst%3DM.%26aulast%3DBeardsley%26aufirst%3DJ.%26aulast%3DBedi%26aufirst%3DN.%26aulast%3DBeghi%26aufirst%3DE.%26aulast%3DBekele%26aufirst%3DT.%26aulast%3DBell%26aufirst%3DM.%26aulast%3DBenjet%26aufirst%3DC.%26aulast%3DBennett%26aufirst%3DD.%26aulast%3DBensenor%26aufirst%3DI.%26aulast%3DBenzian%26aufirst%3DH.%26aulast%3DBernab%25C3%25A9%26aufirst%3DE.%26aulast%3DBertozzi-Villa%26aufirst%3DA.%26aulast%3DBeyene%26aufirst%3DT.%26aulast%3DBhala%26aufirst%3DN.%26aulast%3DBhalla%26aufirst%3DA.%26aulast%3DBhutta%26aufirst%3DZ.%26aulast%3DBienhoff%26aufirst%3DK.%26aulast%3DBikbov%26aufirst%3DB.%26aulast%3DBiryukov%26aufirst%3DS.%26aulast%3DBlore%26aufirst%3DJ.%26aulast%3DBlosser%26aufirst%3DC.%26aulast%3DBlyth%26aufirst%3DF.%26aulast%3DBohensky%26aufirst%3DM.%26aulast%3DBolliger%26aufirst%3DI.%26aulast%3DBora%26aufirst%3DB.%2BB.%26aulast%3DBornstein%26aufirst%3DN.%26aulast%3DBose%26aufirst%3DD.%26aulast%3DBoufous%26aufirst%3DS.%26aulast%3DBourne%26aufirst%3DR.%26aulast%3DBoyers%26aufirst%3DL.%26aulast%3DBrainin%26aufirst%3DM.%26aulast%3DBrayne%26aufirst%3DC.%26aulast%3DBrazinova%26aufirst%3DA.%26aulast%3DBreitborde%26aufirst%3DN.%26aulast%3DBrenner%26aufirst%3DH.%26aulast%3DBriggs%26aufirst%3DA.%26aulast%3DBrooks%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DBrugha%26aufirst%3DT.%26aulast%3DBuchbinder%26aufirst%3DR.%26aulast%3DBuckle%26aufirst%3DG.%26aulast%3DBudke%26aufirst%3DC.%26aulast%3DBulchis%26aufirst%3DA.%26aulast%3DBulloch%26aufirst%3DA.%26aulast%3DCampos-Nonato%26aufirst%3DI.%26aulast%3DCarabin%26aufirst%3DH.%26aulast%3DCarapetis%26aufirst%3DJ.%26aulast%3DC%25C3%25A1rdenas%26aufirst%3DR.%26aulast%3DCarpenter%26aufirst%3DD.%26aulast%3DCaso%26aufirst%3DV.%26aulast%3DCasta%25C3%25B1eda-Orjuela%26aufirst%3DC.%26aulast%3DCastro%26aufirst%3DR.%26aulast%3DCatal%25C3%25A1-L%25C3%25B3pez%26aufirst%3DF.%26aulast%3DCavalleri%26aufirst%3DF.%26aulast%3D%25C3%2587avlin%26aufirst%3DA.%26aulast%3DChadha%26aufirst%3DV.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DCharlson%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DChiang%26aufirst%3DP.%26aulast%3DChimed-Ochir%26aufirst%3DO.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DChristensen%26aufirst%3DH.%26aulast%3DChristophi%26aufirst%3DC.%26aulast%3DCirillo%26aufirst%3DM.%26aulast%3DCoates%26aufirst%3DM.%26aulast%3DCoffeng%26aufirst%3DL.%26aulast%3DCoggeshall%26aufirst%3DM.%26aulast%3DColistro%26aufirst%3DV.%26aulast%3DColquhoun%26aufirst%3DS.%26aulast%3DCooke%26aufirst%3DG.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DCooper%26aufirst%3DL.%26aulast%3DCoppola%26aufirst%3DL.%26aulast%3DCortinovis%26aufirst%3DM.%26aulast%3DCriqui%26aufirst%3DM.%26aulast%3DCrump%26aufirst%3DJ.%26aulast%3DCuevas-Nasu%26aufirst%3DL.%26aulast%3DDanawi%26aufirst%3DH.%26aulast%3DDandona%26aufirst%3DL.%26aulast%3DDandona%26aufirst%3DR.%26aulast%3DDansereau%26aufirst%3DE.%26aulast%3DDargan%26aufirst%3DP.%26aulast%3DDavey%26aufirst%3DG.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DDavitoiu%26aufirst%3DD.%26aulast%3DDayama%26aufirst%3DA.%26aulast%3DDe%2BLeo%26aufirst%3DD.%26aulast%3DDegenhardt%26aufirst%3DL.%26aulast%3DDel%2BPozo-Cruz%26aufirst%3DB.%26aulast%3DDellavalle%26aufirst%3DR.%26aulast%3DDeribe%26aufirst%3DK.%26aulast%3DDerrett%26aufirst%3DS.%26aulast%3DDes%2BJarlais%26aufirst%3DD.%26aulast%3DDessalegn%26aufirst%3DM.%26aulast%3DDharmaratne%26aufirst%3DS.%26aulast%3DDherani%26aufirst%3DM.%26aulast%3DDiaz-Torn%25C3%25A9%26aufirst%3DC.%26aulast%3DDicker%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DE.%26aulast%3DDokova%26aufirst%3DK.%26aulast%3DDorsey%26aufirst%3DE.%26aulast%3DDriscoll%26aufirst%3DT.%26aulast%3DDuan%26aufirst%3DL.%26aulast%3DDuber%26aufirst%3DH.%26aulast%3DEbel%26aufirst%3DB.%26aulast%3DEdmond%26aufirst%3DK.%26aulast%3DElshrek%26aufirst%3DY.%26aulast%3DEndres%26aufirst%3DM.%26aulast%3DErmakov%26aufirst%3DS.%26aulast%3DErskine%26aufirst%3DH.%26aulast%3DEshrati%26aufirst%3DB.%26aulast%3DEsteghamati%26aufirst%3DA.%26aulast%3DEstep%26aufirst%3DK.%26aulast%3DFaraon%26aufirst%3DE.%26aulast%3DFarzadfar%26aufirst%3DF.%26aulast%3DFay%26aufirst%3DD.%26aulast%3DFeigin%26aufirst%3DV.%26aulast%3DFelson%26aufirst%3DD.%26aulast%3DFereshtehnejad%26aufirst%3DS.%26aulast%3DFernandes%26aufirst%3DJ.%26aulast%3DFerrari%26aufirst%3DA.%26aulast%3DFitzmaurice%26aufirst%3DC.%26aulast%3DFlaxman%26aufirst%3DA.%26aulast%3DFleming%26aufirst%3DT.%26aulast%3DFoigt%26aufirst%3DN.%26aulast%3DForouzanfar%26aufirst%3DM.%26aulast%3DFowkes%26aufirst%3DF.%26aulast%3DPaleo%26aufirst%3DU.%26aulast%3DFranklin%26aufirst%3DR.%26aulast%3DF%25C3%25BCrst%26aufirst%3DT.%26aulast%3DGabbe%26aufirst%3DB.%26aulast%3DGaffikin%26aufirst%3DL.%26aulast%3DGankp%25C3%25A9%26aufirst%3DF.%26aulast%3DGeleijnse%26aufirst%3DJ.%26aulast%3DGessner%26aufirst%3DB.%26aulast%3DGething%26aufirst%3DP.%26aulast%3DGibney%26aufirst%3DK.%26aulast%3DGiroud%26aufirst%3DM.%26aulast%3DGiussani%26aufirst%3DG.%26aulast%3DGomez%2BDantes%26aufirst%3DH.%26aulast%3DGona%26aufirst%3DP.%26aulast%3DGonz%25C3%25A1lez-Medina%26aufirst%3DD.%26aulast%3DGosselin%26aufirst%3DR.%26aulast%3DGotay%26aufirst%3DC.%26aulast%3DGoto%26aufirst%3DA.%26aulast%3DGouda%26aufirst%3DH.%26aulast%3DGraetz%26aufirst%3DN.%26aulast%3DGugnani%26aufirst%3DH.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DR.%26aulast%3DHaagsma%26aufirst%3DJ.%26aulast%3DHafezi-Nejad%26aufirst%3DN.%26aulast%3DHagan%26aufirst%3DH.%26aulast%3DHalasa%26aufirst%3DY.%26aulast%3DHamadeh%26aufirst%3DR.%26aulast%3DHamavid%26aufirst%3DH.%26aulast%3DHammami%26aufirst%3DM.%26aulast%3DHancock%26aufirst%3DJ.%26aulast%3DHankey%26aufirst%3DG.%26aulast%3DHansen%26aufirst%3DG.%26aulast%3DHao%26aufirst%3DY.%26aulast%3DHarb%26aufirst%3DH.%26aulast%3DHaro%26aufirst%3DJ.%26aulast%3DHavmoeller%26aufirst%3DR.%26aulast%3DHay%26aufirst%3DS.%26aulast%3DHay%26aufirst%3DR.%26aulast%3DHeredia-Pi%26aufirst%3DI.%26aulast%3DHeuton%26aufirst%3DK.%26aulast%3DHeydarpour%26aufirst%3DP.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DHijar%26aufirst%3DM.%26aulast%3DHoek%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DH.%26aulast%3DHosgood%26aufirst%3DH.%26aulast%3DHossain%26aufirst%3DM.%26aulast%3DHotez%26aufirst%3DP.%26aulast%3DHoy%26aufirst%3DD.%26aulast%3DHsairi%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DHusseini%26aufirst%3DA.%26aulast%3DHuynh%26aufirst%3DC.%26aulast%3DIannarone%26aufirst%3DM.%26aulast%3DIburg%26aufirst%3DK.%26aulast%3DInnos%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIslami%26aufirst%3DF.%26aulast%3DJacobsen%26aufirst%3DK.%26aulast%3DJarvis%26aufirst%3DD.%26aulast%3DJassal%26aufirst%3DS.%26aulast%3DJee%26aufirst%3DS.%26aulast%3DJeemon%26aufirst%3DP.%26aulast%3DJensen%26aufirst%3DP.%26aulast%3DJha%26aufirst%3DV.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJonas%26aufirst%3DJ.%26aulast%3DJuel%26aufirst%3DK.%26aulast%3DKan%26aufirst%3DH.%26aulast%3DKarch%26aufirst%3DA.%26aulast%3DKarema%26aufirst%3DC.%26aulast%3DKarimkhani%26aufirst%3DC.%26aulast%3DKarthikeyan%26aufirst%3DG.%26aulast%3DKassebaum%26aufirst%3DN.%26aulast%3DKaul%26aufirst%3DA.%26aulast%3DKawakami%26aufirst%3DN.%26aulast%3DKazanjan%26aufirst%3DK.%26aulast%3DKemp%26aufirst%3DA.%26aulast%3DKengne%26aufirst%3DA.%26aulast%3DKeren%26aufirst%3DA.%26aulast%3DKhader%26aufirst%3DY.%26aulast%3DKhalifa%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DE.%26aulast%3DKhan%26aufirst%3DG.%26aulast%3DKhang%26aufirst%3DY.%26aulast%3DKieling%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DKinfu%26aufirst%3DY.%26aulast%3DKinge%26aufirst%3DJ.%26aulast%3DKivipelto%26aufirst%3DM.%26aulast%3DKnibbs%26aufirst%3DL.%26aulast%3DKnudsen%26aufirst%3DA.%26aulast%3DKokubo%26aufirst%3DY.%26aulast%3DKosen%26aufirst%3DS.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DKuate%2BDefo%26aufirst%3DB.%26aulast%3DKucuk%2BBicer%26aufirst%3DB.%26aulast%3DKuipers%26aufirst%3DE.%26aulast%3DKulkarni%26aufirst%3DC.%26aulast%3DKulkarni%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DG.%26aulast%3DKyu%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DT.%26aulast%3DLalloo%26aufirst%3DR.%26aulast%3DLallukka%26aufirst%3DT.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLan%26aufirst%3DQ.%26aulast%3DLansingh%26aufirst%3DV.%26aulast%3DLarsson%26aufirst%3DA.%26aulast%3DLawrynowicz%26aufirst%3DA.%26aulast%3DLeasher%26aufirst%3DJ.%26aulast%3DLeigh%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DR.%26aulast%3DLevitz%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DLind%26aufirst%3DM.%26aulast%3DLipshultz%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLloyd%26aufirst%3DB.%26aulast%3DLofgren%26aufirst%3DK.%26aulast%3DLogroscino%26aufirst%3DG.%26aulast%3DLooker%26aufirst%3DK.%26aulast%3DLortet-Tieulent%26aufirst%3DJ.%26aulast%3DLotufo%26aufirst%3DP.%26aulast%3DLozano%26aufirst%3DR.%26aulast%3DLucas%26aufirst%3DR.%26aulast%3DLunevicius%26aufirst%3DR.%26aulast%3DLyons%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMacintyre%26aufirst%3DM.%26aulast%3DMackay%26aufirst%3DM.%26aulast%3DMajdan%26aufirst%3DM.%26aulast%3DMalekzadeh%26aufirst%3DR.%26aulast%3DMarcenes%26aufirst%3DW.%26aulast%3DMargolis%26aufirst%3DD.%26aulast%3DMargono%26aufirst%3DC.%26aulast%3DMarzan%26aufirst%3DM.%26aulast%3DMasci%26aufirst%3DJ.%26aulast%3DMashal%26aufirst%3DM.%26aulast%3DMatzopoulos%26aufirst%3DR.%26aulast%3DMayosi%26aufirst%3DB.%26aulast%3DMazorodze%26aufirst%3DT.%26aulast%3DMcgill%26aufirst%3DN.%26aulast%3DMcgrath%26aufirst%3DJ.%26aulast%3DMckee%26aufirst%3DM.%26aulast%3DMclain%26aufirst%3DA.%26aulast%3DMeaney%26aufirst%3DP.%26aulast%3DMedina%26aufirst%3DC.%26aulast%3DMehndiratta%26aufirst%3DM.%26aulast%3DMekonnen%26aufirst%3DW.%26aulast%3DMelaku%26aufirst%3DY.%26aulast%3DMeltzer%26aufirst%3DM.%26aulast%3DMemish%26aufirst%3DZ.%26aulast%3DMensah%26aufirst%3DG.%26aulast%3DMeretoja%26aufirst%3DA.%26aulast%3DMhimbira%26aufirst%3DF.%26aulast%3DMicha%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DMills%26aufirst%3DE.%26aulast%3DMitchell%26aufirst%3DP.%26aulast%3DMock%26aufirst%3DC.%26aulast%3DMohamed%2BIbrahim%26aufirst%3DN.%26aulast%3DMohammad%26aufirst%3DK.%26aulast%3DMokdad%26aufirst%3DA.%26aulast%3DMola%26aufirst%3DG.%26aulast%3DMonasta%26aufirst%3DL.%26aulast%3DMonta%25C3%25B1ez%2BHernandez%26aufirst%3DJ.%26aulast%3DMontico%26aufirst%3DM.%26aulast%3DMontine%26aufirst%3DT.%26aulast%3DMooney%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DMoradi-Lakeh%26aufirst%3DM.%26aulast%3DMoran%26aufirst%3DA.%26aulast%3DMori%26aufirst%3DR.%26aulast%3DMoschandreas%26aufirst%3DJ.%26aulast%3DMoturi%26aufirst%3DW.%26aulast%3DMoyer%26aufirst%3DM.%26aulast%3DMozaffarian%26aufirst%3DD.%26aulast%3DMsemburi%26aufirst%3DW.%26aulast%3DMueller%26aufirst%3DU.%26aulast%3DMukaigawara%26aufirst%3DM.%26aulast%3DMullany%26aufirst%3DE.%26aulast%3DMurdoch%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DMurthy%26aufirst%3DK.%26aulast%3DNaghavi%26aufirst%3DM.%26aulast%3DNaheed%26aufirst%3DA.%26aulast%3DNaidoo%26aufirst%3DK.%26aulast%3DNaldi%26aufirst%3DL.%26aulast%3DNand%26aufirst%3DD.%26aulast%3DNangia%26aufirst%3DV.%26aulast%3DNarayan%26aufirst%3DK.%26aulast%3DNejjari%26aufirst%3DC.%26aulast%3DNeupane%26aufirst%3DS.%26aulast%3DNewton%26aufirst%3DC.%26aulast%3DNg%26aufirst%3DM.%26aulast%3DNgalesoni%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DG.%26aulast%3DNisar%26aufirst%3DM.%26aulast%3DNolte%26aufirst%3DS.%26aulast%3DNorheim%26aufirst%3DO.%26aulast%3DNorman%26aufirst%3DR.%26aulast%3DNorrving%26aufirst%3DB.%26aulast%3DNyakarahuka%26aufirst%3DL.%26aulast%3DOh%26aufirst%3DI.%26aulast%3DOhkubo%26aufirst%3DT.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DOlusanya%26aufirst%3DB.%26aulast%3DOpio%26aufirst%3DJ.%26aulast%3DOrtblad%26aufirst%3DK.%26aulast%3DOrtiz%26aufirst%3DA.%26aulast%3DPain%26aufirst%3DA.%26aulast%3DPandian%26aufirst%3DJ.%26aulast%3DPanelo%26aufirst%3DC.%26aulast%3DPapachristou%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DPatten%26aufirst%3DS.%26aulast%3DPatton%26aufirst%3DG.%26aulast%3DPaul%26aufirst%3DV.%26aulast%3DPavlin%26aufirst%3DB.%26aulast%3DPearce%26aufirst%3DN.%26aulast%3DPereira%26aufirst%3DD.%26aulast%3DPerez-Padilla%26aufirst%3DR.%26aulast%3DPerez-Ruiz%26aufirst%3DF.%26aulast%3DPerico%26aufirst%3DN.%26aulast%3DPervaiz%26aufirst%3DA.%26aulast%3DPesudovs%26aufirst%3DK.%26aulast%3DPeterson%26aufirst%3DC.%26aulast%3DPetzold%26aufirst%3DM.%26aulast%3DPhillips%26aufirst%3DM.%26aulast%3DPhillips%26aufirst%3DB.%26aulast%3DPhillips%26aufirst%3DD.%26aulast%3DPiel%26aufirst%3DF.%26aulast%3DPlass%26aufirst%3DD.%26aulast%3DPoenaru%26aufirst%3DD.%26aulast%3DPolinder%26aufirst%3DS.%26aulast%3DPope%26aufirst%3DD.%26aulast%3DPopova%26aufirst%3DS.%26aulast%3DPoulton%26aufirst%3DR.%26aulast%3DPourmalek%26aufirst%3DF.%26aulast%3DPrabhakaran%26aufirst%3DD.%26aulast%3DPrasad%26aufirst%3DN.%26aulast%3DPullan%26aufirst%3DR.%26aulast%3DQato%26aufirst%3DD.%26aulast%3DQuistberg%26aufirst%3DD.%26aulast%3DRafay%26aufirst%3DA.%26aulast%3DRahimi%26aufirst%3DK.%26aulast%3DRahman%26aufirst%3DS.%26aulast%3DRaju%26aufirst%3DM.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DRazavi%26aufirst%3DH.%26aulast%3DReddy%26aufirst%3DK.%26aulast%3DRefaat%26aufirst%3DA.%26aulast%3DRemuzzi%26aufirst%3DG.%26aulast%3DResnikoff%26aufirst%3DS.%26aulast%3DRibeiro%26aufirst%3DA.%26aulast%3DRichardson%26aufirst%3DL.%26aulast%3DRichardus%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DD.%26aulast%3DRojas-Rueda%26aufirst%3DD.%26aulast%3DRonfani%26aufirst%3DL.%26aulast%3DRoth%26aufirst%3DG.%26aulast%3DRothenbacher%26aufirst%3DD.%26aulast%3DRothstein%26aufirst%3DD.%26aulast%3DRowley%26aufirst%3DJ.%26aulast%3DRoy%26aufirst%3DN.%26aulast%3DRuhago%26aufirst%3DG.%26aulast%3DSaeedi%26aufirst%3DM.%26aulast%3DSaha%26aufirst%3DS.%26aulast%3DSahraian%26aufirst%3DM.%26aulast%3DSampson%26aufirst%3DU.%26aulast%3DSanabria%26aufirst%3DJ.%26aulast%3DSandar%26aufirst%3DL.%26aulast%3DSantos%26aufirst%3DI.%26aulast%3DSatpathy%26aufirst%3DM.%26aulast%3DSawhney%26aufirst%3DM.%26aulast%3DScarborough%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DI.%26aulast%3DSch%25C3%25B6ttker%26aufirst%3DB.%26aulast%3DSchumacher%26aufirst%3DA.%26aulast%3DSchwebel%26aufirst%3DD.%26aulast%3DScott%26aufirst%3DJ.%26aulast%3DSeedat%26aufirst%3DS.%26aulast%3DSepanlou%26aufirst%3DS.%26aulast%3DSerina%26aufirst%3DP.%26aulast%3DServan-Mori%26aufirst%3DE.%26aulast%3DShackelford%26aufirst%3DK.%26aulast%3DShaheen%26aufirst%3DA.%26aulast%3DShahraz%26aufirst%3DS.%26aulast%3DShamah%2BLevy%26aufirst%3DT.%26aulast%3DShangguan%26aufirst%3DS.%26aulast%3DShe%26aufirst%3DJ.%26aulast%3DSheikhbahaei%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DP.%26aulast%3DShibuya%26aufirst%3DK.%26aulast%3DShinohara%26aufirst%3DY.%26aulast%3DShiri%26aufirst%3DR.%26aulast%3DShishani%26aufirst%3DK.%26aulast%3DShiue%26aufirst%3DI.%26aulast%3DShrime%26aufirst%3DM.%26aulast%3DSigfusdottir%26aufirst%3DI.%26aulast%3DSilberberg%26aufirst%3DD.%26aulast%3DSimard%26aufirst%3DE.%26aulast%3DSindi%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DL.%26aulast%3DSkirbekk%26aufirst%3DV.%26aulast%3DSlepak%26aufirst%3DE.%26aulast%3DSliwa%26aufirst%3DK.%26aulast%3DSoneji%26aufirst%3DS.%26aulast%3DS%25C3%25B8reide%26aufirst%3DK.%26aulast%3DSoshnikov%26aufirst%3DS.%26aulast%3DSposato%26aufirst%3DL.%26aulast%3DSreeramareddy%26aufirst%3DC.%26aulast%3DStanaway%26aufirst%3DJ.%26aulast%3DStathopoulou%26aufirst%3DV.%26aulast%3DStein%26aufirst%3DD.%26aulast%3DStein%26aufirst%3DM.%26aulast%3DSteiner%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DT.%26aulast%3DStevens%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DA.%26aulast%3DStovner%26aufirst%3DL.%26aulast%3DStroumpoulis%26aufirst%3DK.%26aulast%3DSunguya%26aufirst%3DB.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DSwaroop%26aufirst%3DM.%26aulast%3DSykes%26aufirst%3DB.%26aulast%3DTabb%26aufirst%3DK.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DTandon%26aufirst%3DN.%26aulast%3DTanne%26aufirst%3DD.%26aulast%3DTanner%26aufirst%3DM.%26aulast%3DTavakkoli%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DH.%26aulast%3DTe%2BAo%26aufirst%3DB.%26aulast%3DTediosi%26aufirst%3DF.%26aulast%3DTemesgen%26aufirst%3DA.%26aulast%3DTemplin%26aufirst%3DT.%26aulast%3DTen%2BHave%26aufirst%3DM.%26aulast%3DTenkorang%26aufirst%3DE.%26aulast%3DTerkawi%26aufirst%3DA.%26aulast%3DThomson%26aufirst%3DB.%26aulast%3DThorne-Lyman%26aufirst%3DA.%26aulast%3DThrift%26aufirst%3DA.%26aulast%3DThurston%26aufirst%3DG.%26aulast%3DTillmann%26aufirst%3DT.%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DTopouzis%26aufirst%3DF.%26aulast%3DToyoshima%26aufirst%3DH.%26aulast%3DTraebert%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DB.%26aulast%3DTrillini%26aufirst%3DM.%26aulast%3DTruelsen%26aufirst%3DT.%26aulast%3DTsilimbaris%26aufirst%3DM.%26aulast%3DTuzcu%26aufirst%3DE.%26aulast%3DUchendu%26aufirst%3DU.%26aulast%3DUkwaja%26aufirst%3DK.%26aulast%3DUndurraga%26aufirst%3DE.%26aulast%3DUzun%26aufirst%3DS.%26aulast%3DVan%26aufirst%3DB.%2BWH.%26aulast%3DVijver%26aufirst%3DS.%26aulast%3Dvan%26aufirst%3DG.%2BCH.%26aulast%3DVan%26aufirst%3DO.%2BJ.%26aulast%3DVasankari%26aufirst%3DT.%26aulast%3DVenketasubramanian%26aufirst%3DN.%26aulast%3DViolante%26aufirst%3DF.%26aulast%3DVlassov%26aufirst%3DV.%26aulast%3DVollset%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DWaller%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWarouw%26aufirst%3DT.%26aulast%3DWeichenthal%26aufirst%3DS.%26aulast%3DWeiderpass%26aufirst%3DE.%26aulast%3DWeintraub%26aufirst%3DR.%26aulast%3DWenzhi%26aufirst%3DW.%26aulast%3DWerdecker%26aufirst%3DA.%26aulast%3DWesterman%26aufirst%3DR.%26aulast%3DWhiteford%26aufirst%3DH.%26aulast%3DWilkinson%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DT.%26aulast%3DWolfe%26aufirst%3DC.%26aulast%3DWolock%26aufirst%3DT.%26aulast%3DWoolf%26aufirst%3DA.%26aulast%3DWulf%26aufirst%3DS.%26aulast%3DWurtz%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DYano%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DP.%26aulast%3DYent%25C3%25BCr%26aufirst%3DG.%26aulast%3DYip%26aufirst%3DP.%26aulast%3DYonemoto%26aufirst%3DN.%26aulast%3DYoon%26aufirst%3DS.%26aulast%3DYounis%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZaki%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DZonies%26aufirst%3DD.%26aulast%3DZou%26aufirst%3DX.%26aulast%3DSalomon%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DA.%26aulast%3DVos%26aufirst%3DT.%26aulast%3D%26atitle%3DGlobal%252C%2520regional%252C%2520and%2520national%2520disability-adjusted%2520life%2520years%2520%2528DALYs%2529%2520for%2520306%2520diseases%2520and%2520injuries%2520and%2520healthy%2520life%2520expectancy%2520%2528HALE%2529%2520for%2520188%2520countries%252C%25201990%25E2%2580%25932013%253A%2520quantifying%2520the%2520epidemiological%2520transition%26jtitle%3DLancet%26date%3D2015%26volume%3D386%26spage%3D2145%26epage%3D2191%26doi%3D10.1016%2FS0140-6736%2815%2961340-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Torreele, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdin Trunz, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweats, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazue, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bray, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecoul, B.</span><span> </span><span class="NLM_article-title">Fexinidazole - a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e923</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0000923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0000923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=21200426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFSktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=e923&author=E.+Torreeleauthor=B.+B.+Bourdin+Trunzauthor=D.+Tweatsauthor=M.+Kaiserauthor=R.+Brunauthor=G.+Mazueauthor=M.+A.+Brayauthor=B.+Pecoul&title=Fexinidazole+-+a+new+oral+nitroimidazole+drug+candidate+entering+clinical+development+for+the+treatment+of+sleeping+sickness&doi=10.1371%2Fjournal.pntd.0000923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Fexinidazole - a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness</span></div><div class="casAuthors">Torreele, Els; Trunz, Bernadette Bourdin; Tweats, David; Kaiser, Marcel; Brun, Reto; Mazue, Guy; Bray, Michael A.; Pecoul, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e923</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Human African trypanosomiasis (HAT), also known as sleeping sickness, is a fatal parasitic disease caused by trypanosomes.  Current treatment options for HAT are scarce, toxic, no longer effective, or very difficult to administer, in particular for the advanced, fatal stage of the disease (stage 2, chronic HAT).  New safe, effective and easy-to-use treatments are urgently needed.  Here it is shown that fexinidazole, a 2-substituted 5-nitroimidazole rediscovered by the Drugs for Neglected Diseases initiative (DNDi) after extensive compd. mining efforts of more than 700 new and existing nitroheterocycles, could be a short-course, safe and effective oral treatment curing both acute and chronic HAT and that could be implemented at the primary health care level.  To complete the preclin. development and meet the regulatory requirements before initiating human trials, the anti-parasitic properties and the pharmacokinetic, metabolic and toxicol. profile of fexinidazole have been assessed.  Methods and Findings: Std. in vitro and in vivo anti-parasitic activity assays were conducted to assess drug efficacy in exptl. models for HAT.  In parallel, a full range of preclin. pharmacol. and safety studies, as required by international regulatory guidelines before initiating human studies, have been conducted.  Fexinidazole is moderately active in vitro against African trypanosomes (IC50 against lab. strains and recent clin. isolates ranged between 0.16 and 0.93 μg/mL) and oral administration of fexinidazole at doses of 100 mg/kg/day for 4 days or 200 mg/kg/day for 5 days cured mice with acute and chronic infection resp., the latter being a model for the advanced and fatal stage of the disease when parasites have disseminated into the brain.  In lab. animals, fexinidazole is well absorbed after oral administration and readily distributes throughout the body, including the brain.  The abs. bioavailability of oral fexinidazole was 41% in mice, 30% in rats, and 10% in dogs.  Furthermore, fexinidazole is rapidly metabolised in vivo to at least two biol. active metabolites (a sulfoxide and a sulfone deriv.) that likely account for a significant portion of the therapeutic effect.  Key pharmacokinetic parameter after oral absorption in mice for fexinidazole and its sulfoxide and sulfone metabolites are a Cmax of 500, 14171 and 13651 ng/mL resp., and an AUC0-24 of 424, 45031 and 96286 h.ng/mL resp.  Essentially similar PK profiles were obsd. in rats and dogs.  Toxicol. studies (including safety pharmacol. and 4-wk repeated-dose toxicokinetics in rat and dog) have shown that fexinidazole is well tolerated.  The No Obsd. Adverse Event Levels in the 4-wk repeated dose toxicity studies in rats and dogs was 200 mg/kg/day in both species, with no issues of concern identified for doses up to 800 mg/kg/day.  While fexinidazole, like many nitroheterocycles, is mutagenic in the Ames test due to bacterial specific metab., it is not genotoxic to mammalian cells in vitro or in vivo as assessed in an in vitro micronucleus test on human lymphocytes, an in vivo mouse bone marrow micronucleus test, and an ex vivo unscheduled DNA synthesis test in rats.  Conclusions: The results of the preclin. pharmacol. and safety studies indicate that fexinidazole is a safe and effective oral drug candidate with no untoward effects that would preclude evaluation in man.  The drug has entered first-in-human phase I studies in Sept. 2009.  Fexinidazole is the first new clin. drug candidate with the potential for treating advanced-stage sleeping sickness in thirty years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkpYEKJhyyK7Vg90H21EOLACvtfcHk0livjV79bn2d6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFSktA%253D%253D&md5=7994f4610c816d1ba018d238e5c00759</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0000923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0000923%26sid%3Dliteratum%253Aachs%26aulast%3DTorreele%26aufirst%3DE.%26aulast%3DBourdin%2BTrunz%26aufirst%3DB.%2BB.%26aulast%3DTweats%26aufirst%3DD.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DMazue%26aufirst%3DG.%26aulast%3DBray%26aufirst%3DM.%2BA.%26aulast%3DPecoul%26aufirst%3DB.%26atitle%3DFexinidazole%2520-%2520a%2520new%2520oral%2520nitroimidazole%2520drug%2520candidate%2520entering%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520sleeping%2520sickness%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2010%26volume%3D4%26spage%3De923%26doi%3D10.1371%2Fjournal.pntd.0000923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Burri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nkunku, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merolle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span> </span><span class="NLM_article-title">Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by <i>Trypanosoma brucei gambiense</i>: a randomised trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1419</span><span class="NLM_x">–</span> <span class="NLM_lpage">1425</span><span class="refDoi"> DOI: 10.1016/S0140-6736(00)02141-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0140-6736%2800%2902141-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2000&pages=1419-1425&author=C.+Burriauthor=S.+Nkunkuauthor=A.+Merolleauthor=T.+Smithauthor=J.+Blumauthor=R.+Brun&title=Efficacy+of+new%2C+concise+schedule+for+melarsoprol+in+treatment+of+sleeping+sickness+caused+by+Trypanosoma+brucei+gambiense%3A+a+randomised+trial&doi=10.1016%2FS0140-6736%2800%2902141-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2800%2902141-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252800%252902141-3%26sid%3Dliteratum%253Aachs%26aulast%3DBurri%26aufirst%3DC.%26aulast%3DNkunku%26aufirst%3DS.%26aulast%3DMerolle%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DBlum%26aufirst%3DJ.%26aulast%3DBrun%26aufirst%3DR.%26atitle%3DEfficacy%2520of%2520new%252C%2520concise%2520schedule%2520for%2520melarsoprol%2520in%2520treatment%2520of%2520sleeping%2520sickness%2520caused%2520by%2520Trypanosoma%2520brucei%2520gambiense%253A%2520a%2520randomised%2520trial%26jtitle%3DLancet%26date%3D2000%26volume%3D355%26spage%3D1419%26epage%3D1425%26doi%3D10.1016%2FS0140-6736%2800%2902141-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Burri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeramian, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merolle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serge, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mpanya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutumba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesu, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilenge, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubaki, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mpoto, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munungu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manuel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josenando, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pohlig, G.</span><span> </span><span class="NLM_article-title">Efficacy, safety, and dose of pafuramidine, a new oral drug for treatment of first stage sleeping sickness, in a phase 2a clinical study and phase 2b randomized clinical studies</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0004362</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0004362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0004362" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=e0004362&author=C.+Burriauthor=P.+D.+Yeramianauthor=J.+L.+Allenauthor=A.+Merolleauthor=K.+K.+Sergeauthor=A.+Mpanyaauthor=P.+Lutumbaauthor=V.+K.+Mesuauthor=C.+M.+Bilengeauthor=J.-P.+Lubakiauthor=A.+M.+Mpotoauthor=M.+Thompsonauthor=B.+Mununguauthor=F.+Manuelauthor=T.+Josenandoauthor=S.+Bernhardauthor=C.+A.+Olsonauthor=J.+Blumauthor=R.+R.+Tidwellauthor=G.+Pohlig&title=Efficacy%2C+safety%2C+and+dose+of+pafuramidine%2C+a+new+oral+drug+for+treatment+of+first+stage+sleeping+sickness%2C+in+a+phase+2a+clinical+study+and+phase+2b+randomized+clinical+studies&doi=10.1371%2Fjournal.pntd.0004362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0004362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0004362%26sid%3Dliteratum%253Aachs%26aulast%3DBurri%26aufirst%3DC.%26aulast%3DYeramian%26aufirst%3DP.%2BD.%26aulast%3DAllen%26aufirst%3DJ.%2BL.%26aulast%3DMerolle%26aufirst%3DA.%26aulast%3DSerge%26aufirst%3DK.%2BK.%26aulast%3DMpanya%26aufirst%3DA.%26aulast%3DLutumba%26aufirst%3DP.%26aulast%3DMesu%26aufirst%3DV.%2BK.%26aulast%3DBilenge%26aufirst%3DC.%2BM.%26aulast%3DLubaki%26aufirst%3DJ.-P.%26aulast%3DMpoto%26aufirst%3DA.%2BM.%26aulast%3DThompson%26aufirst%3DM.%26aulast%3DMunungu%26aufirst%3DB.%26aulast%3DManuel%26aufirst%3DF.%26aulast%3DJosenando%26aufirst%3DT.%26aulast%3DBernhard%26aufirst%3DS.%26aulast%3DOlson%26aufirst%3DC.%2BA.%26aulast%3DBlum%26aufirst%3DJ.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26aulast%3DPohlig%26aufirst%3DG.%26atitle%3DEfficacy%252C%2520safety%252C%2520and%2520dose%2520of%2520pafuramidine%252C%2520a%2520new%2520oral%2520drug%2520for%2520treatment%2520of%2520first%2520stage%2520sleeping%2520sickness%252C%2520in%2520a%2520phase%25202a%2520clinical%2520study%2520and%2520phase%25202b%2520randomized%2520clinical%2520studies%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2016%26volume%3D10%26spage%3De0004362%26doi%3D10.1371%2Fjournal.pntd.0004362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Pohlig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhard, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mpanya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubaki, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mpoto, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munungu, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">N’Tombe, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deo, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutantu, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuikumbi, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintwo, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munungi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macharia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilenge, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesu, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dituvanga, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, C. A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of pafuramidine versus pentamidine maleate for treatment of first stage sleeping sickness in a randomized, comparator-controlled, international phase 3 clinical trial</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0004363</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0004363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0004363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=26882015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtlSrt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=e0004363&author=G.+Pohligauthor=S.+C.+Bernhardauthor=J.+Blumauthor=C.+Burriauthor=A.+Mpanyaauthor=J.-P.+Lubakiauthor=A.+M.+Mpotoauthor=B.+F.+Mununguauthor=P.+M.+N%E2%80%99Tombeauthor=G.+K.+Deoauthor=P.+N.+Mutantuauthor=F.+M.+Kuikumbiauthor=A.+F.+Mintwoauthor=A.+K.+Munungiauthor=A.+Dalaauthor=S.+Machariaauthor=C.+M.+Bilengeauthor=V.+K.+Mesuauthor=J.+R.+Francoauthor=N.+D.+Dituvangaauthor=R.+R.+Tidwellauthor=C.+A.+Olson&title=Efficacy+and+safety+of+pafuramidine+versus+pentamidine+maleate+for+treatment+of+first+stage+sleeping+sickness+in+a+randomized%2C+comparator-controlled%2C+international+phase+3+clinical+trial&doi=10.1371%2Fjournal.pntd.0004363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of pafuramidine versus pentamidine maleate for treatment of first stage sleeping sickness in a randomized, comparator-controlled, international phase 3 clinical trial</span></div><div class="casAuthors">Pohlig, Gabriele; Bernhard, Sonja C.; Blum, Johannes; Burri, Christian; Mpanya, Alain; Lubaki, Jean-Pierre Fina; Mpoto, Alfred Mpoo; Munungu, Blaise Fungula; N'tombe, Patrick Mangoni; Deo, Gratias Kambau Manesa; Mutantu, Pierre Nsele; Kuikumbi, Florent Mbo; Mintwo, Alain Fukinsia; Munungi, Augustin Kayeye; Dala, Amadeu; Macharia, Stephen; Bilenge, Constantin Miaka Mia; Mesu, Victor Kande Betu Ku; Franco, Jose Ramon; Dituvanga, Ndinga Dieyi; Tidwell, Richard R.; Olson, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0004363/1-e0004363/17</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background Sleeping sickness (human African trypanosomiasis [HAT]) is a neglected tropical disease with limited treatment options that currently require parenteral administration.  In previous studies, orally administered pafuramidine was well tolerated in healthy patients (for up to 21 days) and stage 1 HAT patients (for up to 10 days), and demonstrated efficacy comparable to pentamidine.  Methods This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis ref. center in Angola, one hospital in South Sudan, and four hospitals in the Democratic Republic of the Congo between August 2005 and Sept. 2009 to support the registration of pafuramidine for treatment of first stage HAT in collaboration with the United States Food and Drug Administration.  Patients were treated with either 100 mg of pafuramidine orally twice a day for 10 days or 4 mg/kg pentamidine i.m. once daily for 7 days to assess the efficacy and safety of pafuramidine vs. pentamidine.  Pregnant and lactating women as well as adolescents were included.  Findings/Conclusions The overall cure rate at 12 mo was 89% in the pafuramidine group and 95% in the pentamidine group; pafuramidine was non-inferior to pentamidine as the upper bound of the 95% confidence interval did not exceed 15%.  The safety profile of pafuramidine was superior to pentamidine; however, 3 patients in the pafuramidine group had glomerulonephritis or nephropathy approx. 8 wk post-treatment.  Two of these events were judged as possibly related to pafuramidine.  Despite good tolerability obsd. in preceding studies, the development program for pafuramidine was discontinued due to delayed post-treatment toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobYFq1MZ-6KLVg90H21EOLACvtfcHk0li6lowv_S9VNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtlSrt7g%253D&md5=4198d37a3054b1e05c007458de532dec</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0004363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0004363%26sid%3Dliteratum%253Aachs%26aulast%3DPohlig%26aufirst%3DG.%26aulast%3DBernhard%26aufirst%3DS.%2BC.%26aulast%3DBlum%26aufirst%3DJ.%26aulast%3DBurri%26aufirst%3DC.%26aulast%3DMpanya%26aufirst%3DA.%26aulast%3DLubaki%26aufirst%3DJ.-P.%26aulast%3DMpoto%26aufirst%3DA.%2BM.%26aulast%3DMunungu%26aufirst%3DB.%2BF.%26aulast%3DN%25E2%2580%2599Tombe%26aufirst%3DP.%2BM.%26aulast%3DDeo%26aufirst%3DG.%2BK.%26aulast%3DMutantu%26aufirst%3DP.%2BN.%26aulast%3DKuikumbi%26aufirst%3DF.%2BM.%26aulast%3DMintwo%26aufirst%3DA.%2BF.%26aulast%3DMunungi%26aufirst%3DA.%2BK.%26aulast%3DDala%26aufirst%3DA.%26aulast%3DMacharia%26aufirst%3DS.%26aulast%3DBilenge%26aufirst%3DC.%2BM.%26aulast%3DMesu%26aufirst%3DV.%2BK.%26aulast%3DFranco%26aufirst%3DJ.%2BR.%26aulast%3DDituvanga%26aufirst%3DN.%2BD.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26aulast%3DOlson%26aufirst%3DC.%2BA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520pafuramidine%2520versus%2520pentamidine%2520maleate%2520for%2520treatment%2520of%2520first%2520stage%2520sleeping%2520sickness%2520in%2520a%2520randomized%252C%2520comparator-controlled%252C%2520international%2520phase%25203%2520clinical%2520trial%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2016%26volume%3D10%26spage%3De0004363%26doi%3D10.1371%2Fjournal.pntd.0004363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span>Oxaborole SCYX-7158; <span class="NLM_publisher-name">Drugs for Neglected Diseases Initiative</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.dndi.org/diseases-projects/portfolio/scyx-7158/" class="extLink">http://www.dndi.org/diseases-projects/portfolio/scyx-7158/</a> (accessed March 21,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Oxaborole+SCYX-7158%3B+Drugs+for+Neglected+Diseases+Initiative%2C+2016%3B+http%3A%2F%2Fwww.dndi.org%2Fdiseases-projects%2Fportfolio%2Fscyx-7158%2F+%28accessed+March+21%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DOxaborole%2520SCYX-7158%26pub%3DDrugs%2520for%2520Neglected%2520Diseases%2520Initiative%26date%3D2016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ding, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nare, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacchi, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarlett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdulla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ang, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span> </span><span class="NLM_article-title">Discovery of novel benzoxaborole-based potent antitrypanosomal agents</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span><span class="refDoi"> DOI: 10.1021/ml100013s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100013s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1eqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=165-169&author=D.+Dingauthor=Y.+Zhaoauthor=Q.+Mengauthor=D.+Xieauthor=B.+Nareauthor=D.+Chenauthor=C.+J.+Bacchiauthor=N.+Yarlettauthor=Y.-K.+Zhangauthor=V.+Hernandezauthor=Y.+Xiaauthor=Y.+Freundauthor=M.+Abdullaauthor=K.-H.+Angauthor=J.+Ratnamauthor=J.+H.+McKerrowauthor=R.+T.+Jacobsauthor=H.+Zhouauthor=J.+J.+Plattner&title=Discovery+of+novel+benzoxaborole-based+potent+antitrypanosomal+agents&doi=10.1021%2Fml100013s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Benzoxaborole-Based Potent Antitrypanosomal Agents</span></div><div class="casAuthors">Ding, Dazhong; Zhao, Yaxue; Meng, Qingqing; Xie, Dongsheng; Nare, Bakela; Chen, Daitao; Bacchi, Cyrus J.; Yarlett, Nigel; Zhang, Yong-Kang; Hernandez, Vincent; Xia, Yi; Freund, Yvonne; Abdulla, Maha; Ang, Kean-Hooi; Ratnam, Joseline; McKerrow, James H.; Jacobs, Robert T.; Zhou, Huchen; Plattner, Jacob J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">165-169</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery of benzoxaborole antitrypanosomal agents and their structure-activity relationships on central linkage groups and different substitution patterns in the sulfur-linked series.  The compds. showed in vitro growth inhibition IC50 values as low as 0.02 μg/mL and in vivo efficacy in acute murine infection models against Trypanosoma brucei.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Y1XV9J9FOLVg90H21EOLACvtfcHk0li6lowv_S9VNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1eqs7o%253D&md5=dd910bb5bdbe3cf2029b6e3c28508486</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fml100013s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100013s%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DBacchi%26aufirst%3DC.%2BJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DAbdulla%26aufirst%3DM.%26aulast%3DAng%26aufirst%3DK.-H.%26aulast%3DRatnam%26aufirst%3DJ.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%2520novel%2520benzoxaborole-based%2520potent%2520antitrypanosomal%2520agents%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D165%26epage%3D169%26doi%3D10.1021%2Fml100013s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Jacobs, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nare, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wring, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sligar, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenks, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noe, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowling, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewerts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaukel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randolph, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacchi, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarlett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plattner, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Don, R.</span><span> </span><span class="NLM_article-title">SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1151</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0001151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0001151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=21738803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlOgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=e1151&author=R.+T.+Jacobsauthor=B.+Nareauthor=S.+A.+Wringauthor=M.+D.+Orrauthor=D.+Chenauthor=J.+M.+Sligarauthor=M.+X.+Jenksauthor=R.+A.+Noeauthor=T.+S.+Bowlingauthor=L.+T.+Mercerauthor=C.+Rewertsauthor=E.+Gaukelauthor=J.+Owensauthor=R.+Parhamauthor=R.+Randolphauthor=B.+Beaudetauthor=C.+J.+Bacchiauthor=N.+Yarlettauthor=J.+J.+Plattnerauthor=Y.+Freundauthor=C.+Dingauthor=T.+Akamaauthor=Y.+K.+Zhangauthor=R.+Brunauthor=M.+Kaiserauthor=I.+Scandaleauthor=R.+Don&title=SCYX-7158%2C+an+orally-active+benzoxaborole+for+the+treatment+of+stage+2+human+African+trypanosomiasis&doi=10.1371%2Fjournal.pntd.0001151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 Human African trypanosomiasis</span></div><div class="casAuthors">Jacobs, Robert T.; Nare, Bakela; Wring, Stephen A.; Orr, Matthew D.; Chen, Daitao; Sligar, Jessica M.; Jenks, Matthew X.; Noe, Robert A.; Bowling, Tana S.; Mercer, Luke T.; Rewerts, Cindy; Gaukel, Eric; Owens, Jennifer; Parham, Robin; Randolph, Ryan; Beaudet, Beth; Bacchi, Cyrus J.; Yarlett, Nigel; Plattner, Jacob J.; Freund, Yvonne; Ding, Charles; Akama, Tsutomu; Zhang, Y.-K.; Brun, Reto; Kaiser, Marcel; Scandale, Ivan; Don, Robert</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1151</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Human African trypanosomiasis (HAT) is an important public health problem in sub-Saharan Africa, affecting hundreds of thousands of individuals.  An urgent need exists for the discovery and development of new, safe, and effective drugs to treat HAT, as existing therapies suffer from poor safety profiles, difficult treatment regimens, limited effectiveness, and a high cost of goods.  We have discovered and optimized a novel class of small-mol. boron-contg. compds., benzoxaboroles, to identify SCYX-7158 as an effective, safe and orally active treatment for HAT.  Methodol./Principal Findings: A drug discovery project employing integrated biol. screening, medicinal chem. and pharmacokinetic characterization identified SCYX-7158 as an optimized analog, as it is active in vitro against relevant strains of Trypanosoma brucei, including T. b. rhodesiense and T. b. gambiense, is efficacious in both stage 1 and stage 2 murine HAT models and has physicochem. and in vitro absorption, distribution, metab., elimination and toxicol. (ADMET) properties consistent with the compd. being orally available, metabolically stable and CNS permeable.  In a murine stage 2 study, SCYX-7158 is effective orally at doses as low as 12.5 mg/kg (QD × 7 days).  In vivo pharmacokinetic characterization of SCYX-7158 demonstrates that the compd. is highly bioavailable in rodents and non-human primates, has low i.v. plasma clearance and has a 24-h elimination half-life and a vol. of distribution that indicate good tissue distribution.  Most importantly, in rodents brain exposure of SCYX-7158 is high, with Cmax>10 μg/mL and AUC0-24 hr>100 μg*h/mL following a 25 mg/kg oral dose.  Furthermore, SCYX-7158 readily distributes into cerebrospinal fluid to achieve therapeutically relevant concns. in this compartment.  Conclusions/Significance: The biol. and pharmacokinetic properties of SCYX-7158 suggest that this compd. will be efficacious and safe to treat stage 2 HAT.  SCYX-7158 has been selected to enter preclin. studies, with expected progression to phase 1 clin. trials in 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdyaAga5lprVg90H21EOLACvtfcHk0li6lowv_S9VNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlOgsLY%253D&md5=a54f2d57149e6714c7f6acf5f5280a7d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0001151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0001151%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DOrr%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DSligar%26aufirst%3DJ.%2BM.%26aulast%3DJenks%26aufirst%3DM.%2BX.%26aulast%3DNoe%26aufirst%3DR.%2BA.%26aulast%3DBowling%26aufirst%3DT.%2BS.%26aulast%3DMercer%26aufirst%3DL.%2BT.%26aulast%3DRewerts%26aufirst%3DC.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DOwens%26aufirst%3DJ.%26aulast%3DParham%26aufirst%3DR.%26aulast%3DRandolph%26aufirst%3DR.%26aulast%3DBeaudet%26aufirst%3DB.%26aulast%3DBacchi%26aufirst%3DC.%2BJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%2BK.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DDon%26aufirst%3DR.%26atitle%3DSCYX-7158%252C%2520an%2520orally-active%2520benzoxaborole%2520for%2520the%2520treatment%2520of%2520stage%25202%2520human%2520African%2520trypanosomiasis%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2011%26volume%3D5%26spage%3De1151%26doi%3D10.1371%2Fjournal.pntd.0001151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span>New Oral Drug Candidate for African Sleeping Sickness; <span class="NLM_publisher-name">Drugs for Neglected Diseases Initiative</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">; </span><a href="http://www.dndi.org/2012/media-centre/press-releases/new-oral-drug-candidate-hat/" class="extLink">http://www.dndi.org/2012/media-centre/press-releases/new-oral-drug-candidate-hat/</a> (accessed March 7, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=New+Oral+Drug+Candidate+for+African+Sleeping+Sickness%3B+Drugs+for+Neglected+Diseases+Initiative%2C+2012%3B+http%3A%2F%2Fwww.dndi.org%2F2012%2Fmedia-centre%2Fpress-releases%2Fnew-oral-drug-candidate-hat%2F+%28accessed+March+7%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Oral%2520Drug%2520Candidate%2520for%2520African%2520Sleeping%2520Sickness%26pub%3DDrugs%2520for%2520Neglected%2520Diseases%2520Initiative%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Tarral, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blesson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordt, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torreele, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassella, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bray, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hovsepian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evene, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gualano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felices, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strub-Wourgaft, N.</span><span> </span><span class="NLM_article-title">Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studies</span> <span class="citation_source-journal">Clin. Pharmacokinet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span><span class="refDoi"> DOI: 10.1007/s40262-014-0136-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1007%2Fs40262-014-0136-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=24535888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVCmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=565-580&author=A.+Tarralauthor=S.+Blessonauthor=O.+V.+Mordtauthor=E.+Torreeleauthor=D.+Sassellaauthor=M.+A.+Brayauthor=L.+Hovsepianauthor=E.+Eveneauthor=V.+Gualanoauthor=M.+Felicesauthor=N.+Strub-Wourgaft&title=Determination+of+an+optimal+dosing+regimen+for+fexinidazole%2C+a+novel+oral+drug+for+the+treatment+of+human+African+trypanosomiasis%3A+first-in-human+studies&doi=10.1007%2Fs40262-014-0136-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies</span></div><div class="casAuthors">Tarral, Antoine; Blesson, Severine; Mordt, Olaf Valverde; Torreele, Els; Sassella, Daniela; Bray, Michael A.; Hovsepian, Lionel; Evene, Eric; Gualano, Virginie; Felices, Mathieu; Strub-Wourgaft, Nathalie</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-580</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background and Objectives: Fexinidazole is a 5-nitroimidazole recently included in a clin. efficacy trial as an oral drug for the treatment of human African trypanosomiasis (HAT).  Preclin. studies showed it acts as a pharmacol. active pro-drug with two key active metabolites: sulfoxide and sulfone (the most active metabolite).  The present studies aimed to det. the best dose regimen for the treatment of stage 2 sleeping sickness patients, which could eventually also treat stage 1 patients.  Methods: Fexinidazole was assessed in 154 healthy adult male subjects of sub-Saharan African origin.  Three initial first-in-human studies and two addnl. studies assessed a single ascending dose and multiple ascending doses (both under fasted conditions), tablet vs. suspension formulation and food effect (fasted vs. high-fat meal and field-adapted food), and multiple ascending doses with a loading dose regimen under fed conditions.  Results: Fexinidazole was well-tolerated in a single dose from 100 to 3,600 mg, with quick absorption of the parent drug and rapid metab. into sulfoxide [time to max. concn. (tmax) 2-5 h] and sulfone (tmax 18-24 h).  The tablet formulation was approx. 25 % less bioavailable than the suspension, and food intake increased drug absorption and plasma concns. of fexinidazole and its two metabolites by approx. 200 %.  Fourteen-day multiple ascending dosing administered up to 3,600 mg/day in fasted conditions showed that fexinidazole was generally well-tolerated (mild to moderate, spontaneously reversible drug-related adverse events).  Following the high-fat food effect finding, another study was conducted to evaluate the impact of a low-fat regimen closer to that of the target population, showing that the type of meal does not influence fexinidazole absorption.  The last study showed that a loading dose of 1,800 mg/day for 4 days followed by a 1,200 mg/day regimen for 6 days with a normal meal provided the desired exposure of fexinidazole and its metabolites, particularly sulfone, with good tolerability.  Based on preclin. evidence from a chronic infection mouse model, systemic drug concns. obtained are expected to be clin. effective in stage 2 HAT.  Conclusions: These studies show that fexinidazole can be safely assessed in patients as a potential oral cure for both stages of HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpszDba_Qa2j7Vg90H21EOLACvtfcHk0lhO8rzBks5hjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVCmuro%253D&md5=29ec56e974111a2737fc3bfff67d9511</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs40262-014-0136-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-014-0136-3%26sid%3Dliteratum%253Aachs%26aulast%3DTarral%26aufirst%3DA.%26aulast%3DBlesson%26aufirst%3DS.%26aulast%3DMordt%26aufirst%3DO.%2BV.%26aulast%3DTorreele%26aufirst%3DE.%26aulast%3DSassella%26aufirst%3DD.%26aulast%3DBray%26aufirst%3DM.%2BA.%26aulast%3DHovsepian%26aufirst%3DL.%26aulast%3DEvene%26aufirst%3DE.%26aulast%3DGualano%26aufirst%3DV.%26aulast%3DFelices%26aufirst%3DM.%26aulast%3DStrub-Wourgaft%26aufirst%3DN.%26atitle%3DDetermination%2520of%2520an%2520optimal%2520dosing%2520regimen%2520for%2520fexinidazole%252C%2520a%2520novel%2520oral%2520drug%2520for%2520the%2520treatment%2520of%2520human%2520African%2520trypanosomiasis%253A%2520first-in-human%2520studies%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2014%26volume%3D53%26spage%3D565%26epage%3D580%26doi%3D10.1007%2Fs40262-014-0136-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ferrins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span> </span><span class="NLM_article-title">Drug discovery and human African trypanosomiasis: a disease less neglected?</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1801</span><span class="NLM_x">–</span> <span class="NLM_lpage">1841</span><span class="refDoi"> DOI: 10.4155/fmc.13.162</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.4155%2Ffmc.13.162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=24144414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CitLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1801-1841&author=L.+Ferrinsauthor=R.+Rahmaniauthor=J.+B.+Baell&title=Drug+discovery+and+human+African+trypanosomiasis%3A+a+disease+less+neglected%3F&doi=10.4155%2Ffmc.13.162"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery and human African trypanosomiasis: a disease less neglected?</span></div><div class="casAuthors">Ferrins, Lori; Rahmani, Raphael; Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1801-1841</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Human African trypanosomiasis (HAT) has been neglected for a long time.  The most recent drug to treat this disease, eflornithine, was approved by the US FDA in 2000.  Current treatments exhibit numerous problematic side effects and are often ineffective against the debilitating CNS resident stage of the disease.  Fortunately, several partnerships and initiatives have been formed over the last 20 years in an effort to eradicate HAT, along with a no. of other neglected diseases.  This has led to an increasing no. of foundations and research institutions that are currently working on the development of new drugs for HAT and tools with which to diagnose and treat patients.  New biochem. pathways as therapeutic targets are emerging, accompanied by increasing nos. of new antitrypanosomal compd. classes.  The future looks promising that this collaborative approach will facilitate eagerly awaited breakthroughs in the treatment of HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolcnA5AyU6nbVg90H21EOLACvtfcHk0lhO8rzBks5hjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CitLzK&md5=89e0f13e2bd1f3bdb4821ba513754069</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.4155%2Ffmc.13.162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.13.162%26sid%3Dliteratum%253Aachs%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DRahmani%26aufirst%3DR.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DDrug%2520discovery%2520and%2520human%2520African%2520trypanosomiasis%253A%2520a%2520disease%2520less%2520neglected%253F%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D1801%26epage%3D1841%26doi%3D10.4155%2Ffmc.13.162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Feldman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, D.</span><span> </span><span class="NLM_article-title">Myocarditis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">1388</span><span class="NLM_x">–</span> <span class="NLM_lpage">1398</span><span class="refDoi"> DOI: 10.1056/NEJM200011093431908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1056%2FNEJM200011093431908" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=11070105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A280%3ADC%252BD3M7ksVSitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2000&pages=1388-1398&author=A.+M.+Feldmanauthor=D.+McNamara&title=Myocarditis&doi=10.1056%2FNEJM200011093431908"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Myocarditis</span></div><div class="casAuthors">Feldman A M; McNamara D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">343</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1388-98</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8MybU-tno2zEC-75aqa5AfW6udTcc2ebyBUq7YYgeybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7ksVSitg%253D%253D&md5=2e06776cb3325a8bf86b10d20aeb0cd9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1056%2FNEJM200011093431908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM200011093431908%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DA.%2BM.%26aulast%3DMcNamara%26aufirst%3DD.%26atitle%3DMyocarditis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2000%26volume%3D343%26spage%3D1388%26epage%3D1398%26doi%3D10.1056%2FNEJM200011093431908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Pecoul, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batista, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stobbaerts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilasanjuan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinazo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereiro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrico, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottazzi, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotez, P. J.</span><span> </span><span class="NLM_article-title">The BENEFIT trial: where do we go from here?</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0004343</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0004343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0004343" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=e0004343&author=B.+Pecoulauthor=C.+Batistaauthor=E.+Stobbaertsauthor=I.+Ribeiroauthor=R.+Vilasanjuanauthor=J.+Gasconauthor=M.+J.+Pinazoauthor=S.+Morianaauthor=S.+Goldauthor=A.+Pereiroauthor=M.+Navarroauthor=F.+Torricoauthor=M.+E.+Bottazziauthor=P.+J.+Hotez&title=The+BENEFIT+trial%3A+where+do+we+go+from+here%3F&doi=10.1371%2Fjournal.pntd.0004343"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0004343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0004343%26sid%3Dliteratum%253Aachs%26aulast%3DPecoul%26aufirst%3DB.%26aulast%3DBatista%26aufirst%3DC.%26aulast%3DStobbaerts%26aufirst%3DE.%26aulast%3DRibeiro%26aufirst%3DI.%26aulast%3DVilasanjuan%26aufirst%3DR.%26aulast%3DGascon%26aufirst%3DJ.%26aulast%3DPinazo%26aufirst%3DM.%2BJ.%26aulast%3DMoriana%26aufirst%3DS.%26aulast%3DGold%26aufirst%3DS.%26aulast%3DPereiro%26aufirst%3DA.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DTorrico%26aufirst%3DF.%26aulast%3DBottazzi%26aufirst%3DM.%2BE.%26aulast%3DHotez%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520BENEFIT%2520trial%253A%2520where%2520do%2520we%2520go%2520from%2520here%253F%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2016%26volume%3D10%26spage%3De0004343%26doi%3D10.1371%2Fjournal.pntd.0004343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bern, C.</span><span> </span><span class="NLM_article-title">Chagas’ disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">456</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span><span class="refDoi"> DOI: 10.1056/NEJMra1410150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1056%2FNEJMra1410150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=26222561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=456-466&author=C.+Bern&title=Chagas%E2%80%99+disease&doi=10.1056%2FNEJMra1410150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Chagas' disease</span></div><div class="casAuthors">Bern, Caryn</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">456-466</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Chagas' disease is caused by the protozoan parasite Trypanosomacruzi, which is transmitted when the infected feces of the triatomine vector are inoculated through a bite site or through an intact mucous membrane of the mammalian host (Fig. 1).  Vectorborne transmission is limited to areas of North America, Central America, and South America.  Both in endemic and in nonendemic areas, other infection routes include transfusion, organ and bone marrow transplantation, and congenital transmission.  Outbreaks attributed to contaminated food or drink have been reported in northern South America, where transmission cycles involving wild vector populations and mammalian reservoir hosts are prominent.  Infection is lifelong in the absence of effective treatment.  The most important consequence of T. cruzi infection is cardiomyopathy, which occurs in 20 to 30% of infected persons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZRsRJ4Kkx3rVg90H21EOLACvtfcHk0ljuj9d9WpcZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLvN&md5=effffe0a68130e3ae87d9648dfe5c5fd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1410150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1410150%26sid%3Dliteratum%253Aachs%26aulast%3DBern%26aufirst%3DC.%26atitle%3DChagas%25E2%2580%2599%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D456%26epage%3D466%26doi%3D10.1056%2FNEJMra1410150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Morillo, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin-Neto, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avezum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosa-Estani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassi, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villena, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quiroz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guhl, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meeks, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao-Melacini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pogue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazdins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusuf, S.</span><span> </span><span class="NLM_article-title">Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1306</span><span class="refDoi"> DOI: 10.1056/NEJMoa1507574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1056%2FNEJMoa1507574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=26323937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=1295-1306&author=C.+A.+Morilloauthor=J.+A.+Marin-Netoauthor=A.+Avezumauthor=S.+Sosa-Estaniauthor=A.+J.+Rassiauthor=F.+Rosasauthor=E.+Villenaauthor=R.+Quirozauthor=R.+Bonillaauthor=C.+Brittoauthor=F.+Guhlauthor=E.+Velazquezauthor=L.+Bonillaauthor=B.+Meeksauthor=P.+Rao-Melaciniauthor=J.+Pogueauthor=A.+Mattosauthor=J.+Lazdinsauthor=A.+Rassiauthor=S.+J.+Connollyauthor=S.+Yusuf&title=Randomized+trial+of+benznidazole+for+chronic+Chagas%E2%80%99+cardiomyopathy&doi=10.1056%2FNEJMoa1507574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized trial of benznidazole for chronic Chagas' cardiomyopathy</span></div><div class="casAuthors">Morillo, C. A.; Marin-Neto, J. A.; Avezum, A.; Sosa-Estani, S.; Rassi, A., Jr.; Rosas, F.; Villena, E.; Quiroz, R.; Bonilla, R.; Britto, C.; Guhl, F.; Velazquez, E.; Bonilla, L.; Meeks, B.; Rao-Melacini, P.; Pogue, J.; Mattos, A.; Lazdins, J.; Rassi, A.; Connolly, S. J.; Yusuf, S.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1295-1306</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The role of trypanocidal therapy in patients with established Chagas' cardiomyopathy is unproven.  We conducted a prospective, multicenter, randomized study involving 2854 patients with Chagas' cardiomyopathy who received benznidazole or placebo for up to 80 days and were followed for a mean of 5.4 years.  The primary outcome in the time-to-event anal. was the first event of any of the components of the composite outcome of death, resuscitated cardiac arrest, sustained ventricular tachycardia, insertion of a pacemaker or implantable cardioverter-defibrillator, cardiac transplantation, new heart failure, stroke, or other thromboembolic event.  The primary outcome occurred in 394 patients (27.5%) in the benznidazole group and in 414 (29.1%) in the placebo group (hazard ratio, 0.93; 95% confidence interval [CI], 0.81 to 1.07; P = 0.31).  At baseline, a polymerase-chain-reaction (PCR) assay was performed on blood samples obtained from 1896 patients; 60.5% had pos. results for Trypanosoma cruzi on PCR.  The rates of conversion to neg. PCR results (PCR conversion) were 66.2% in the benznidazole group and 33.5% in the placebo group at the end of treatment, 55.4% and 35.3%, resp., at 2 years, and 46.7% and 33.1%, resp., at 5 years or more (P<0.001 for all comparisons).  The effect of treatment on PCR conversion varied according to geog. region: in Brazil, the odds ratio for PCR conversion was 3.03 (95% CI, 2.12 to 4.34) at 2 years and 1.87 (95% CI, 1.33 to 2.63) at 5 or more years; in Colombia and El Salvador, the odds ratio was 1.33 (95% CI, 0.90 to 1.98) at 2 years and 0.96 (95% CI, 0.63 to 1.45) at 5 or more years; and in Argentina and Bolivia, the odds ratio was 2.63 (95% CI, 1.89 to 3.66) at 2 years and 2.79 (95% CI, 1.99 to 3.92) at 5 or more years (P<0.001 for interaction).  However, the rates of PCR conversion did not correspond to effects on clin. outcome (P = 0.16 for interaction).  Trypanocidal therapy with benznidazole in patients with established Chagas' cardiomyopathy significantly reduced serum parasite detection but did not significantly reduce cardiac clin. deterioration through 5 years of follow-up.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz_0zFM1DyHLVg90H21EOLACvtfcHk0ljuj9d9WpcZVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSms7g%253D&md5=6386aadfc625824961ff33e01a93ab2e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1507574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1507574%26sid%3Dliteratum%253Aachs%26aulast%3DMorillo%26aufirst%3DC.%2BA.%26aulast%3DMarin-Neto%26aufirst%3DJ.%2BA.%26aulast%3DAvezum%26aufirst%3DA.%26aulast%3DSosa-Estani%26aufirst%3DS.%26aulast%3DRassi%26aufirst%3DA.%2BJ.%26aulast%3DRosas%26aufirst%3DF.%26aulast%3DVillena%26aufirst%3DE.%26aulast%3DQuiroz%26aufirst%3DR.%26aulast%3DBonilla%26aufirst%3DR.%26aulast%3DBritto%26aufirst%3DC.%26aulast%3DGuhl%26aufirst%3DF.%26aulast%3DVelazquez%26aufirst%3DE.%26aulast%3DBonilla%26aufirst%3DL.%26aulast%3DMeeks%26aufirst%3DB.%26aulast%3DRao-Melacini%26aufirst%3DP.%26aulast%3DPogue%26aufirst%3DJ.%26aulast%3DMattos%26aufirst%3DA.%26aulast%3DLazdins%26aufirst%3DJ.%26aulast%3DRassi%26aufirst%3DA.%26aulast%3DConnolly%26aufirst%3DS.%2BJ.%26aulast%3DYusuf%26aufirst%3DS.%26atitle%3DRandomized%2520trial%2520of%2520benznidazole%2520for%2520chronic%2520Chagas%25E2%2580%2599%2520cardiomyopathy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D1295%26epage%3D1306%26doi%3D10.1056%2FNEJMoa1507574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Sgambatti de Andrade, A. L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zicker, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Oliveira, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida e Silva, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luquetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travassos, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Andrade, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimaraes de Andrade, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martelli, C. M.</span><span> </span><span class="NLM_article-title">Randomised trial of efficacy of benznidazole in treatment of early <i>Trypanosoma cruzi</i> infection</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">1407</span><span class="NLM_x">–</span> <span class="NLM_lpage">1413</span><span class="refDoi"> DOI: 10.1016/S0140-6736(96)04128-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0140-6736%2896%2904128-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1996&pages=1407-1413&author=A.+L.+S.+Sgambatti+de+Andradeauthor=F.+Zickerauthor=R.+M.+de+Oliveiraauthor=S.+Almeida+e+Silvaauthor=A.+Luquettiauthor=L.+R.+Travassosauthor=I.+C.+Almeidaauthor=S.+S.+de+Andradeauthor=J.+Guimaraes+de+Andradeauthor=C.+M.+Martelli&title=Randomised+trial+of+efficacy+of+benznidazole+in+treatment+of+early+Trypanosoma+cruzi+infection&doi=10.1016%2FS0140-6736%2896%2904128-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2896%2904128-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252896%252904128-1%26sid%3Dliteratum%253Aachs%26aulast%3DSgambatti%2Bde%2BAndrade%26aufirst%3DA.%2BL.%2BS.%26aulast%3DZicker%26aufirst%3DF.%26aulast%3Dde%2BOliveira%26aufirst%3DR.%2BM.%26aulast%3DAlmeida%2Be%2BSilva%26aufirst%3DS.%26aulast%3DLuquetti%26aufirst%3DA.%26aulast%3DTravassos%26aufirst%3DL.%2BR.%26aulast%3DAlmeida%26aufirst%3DI.%2BC.%26aulast%3Dde%2BAndrade%26aufirst%3DS.%2BS.%26aulast%3DGuimaraes%2Bde%2BAndrade%26aufirst%3DJ.%26aulast%3DMartelli%26aufirst%3DC.%2BM.%26atitle%3DRandomised%2520trial%2520of%2520efficacy%2520of%2520benznidazole%2520in%2520treatment%2520of%2520early%2520Trypanosoma%2520cruzi%2520infection%26jtitle%3DLancet%26date%3D1996%26volume%3D348%26spage%3D1407%26epage%3D1413%26doi%3D10.1016%2FS0140-6736%2896%2904128-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Sosa Estani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segura, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porcel, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yampotis, C.</span><span> </span><span class="NLM_article-title">Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas’ disease</span> <span class="citation_source-journal">Am. J. Trop. Med. Hyg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1998&pages=526-529&author=S.+Sosa+Estaniauthor=E.+L.+Seguraauthor=A.+M.+Ruizauthor=E.+Velazquezauthor=B.+M.+Porcelauthor=C.+Yampotis&title=Efficacy+of+chemotherapy+with+benznidazole+in+children+in+the+indeterminate+phase+of+Chagas%E2%80%99+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSosa%2BEstani%26aufirst%3DS.%26aulast%3DSegura%26aufirst%3DE.%2BL.%26aulast%3DRuiz%26aufirst%3DA.%2BM.%26aulast%3DVelazquez%26aufirst%3DE.%26aulast%3DPorcel%26aufirst%3DB.%2BM.%26aulast%3DYampotis%26aufirst%3DC.%26atitle%3DEfficacy%2520of%2520chemotherapy%2520with%2520benznidazole%2520in%2520children%2520in%2520the%2520indeterminate%2520phase%2520of%2520Chagas%25E2%2580%2599%2520disease%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D1998%26volume%3D59%26spage%3D526%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Pena, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantizani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso-Padilla, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardera, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colmenarejo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotillo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roquero, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Dios-Anton, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barroso, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherstnev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewry, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiandor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. J.</span><span> </span><span class="NLM_article-title">New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">8771</span><span class="refDoi"> DOI: 10.1038/srep08771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1038%2Fsrep08771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=25740547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKhur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=8771&author=I.+Penaauthor=M.+P.+Manzanoauthor=J.+Cantizaniauthor=A.+Kesslerauthor=J.+Alonso-Padillaauthor=A.+I.+Barderaauthor=E.+Alvarezauthor=G.+Colmenarejoauthor=I.+Cotilloauthor=I.+Roqueroauthor=F.+de+Dios-Antonauthor=V.+Barrosoauthor=A.+Rodriguezauthor=D.+W.+Grayauthor=M.+Navarroauthor=V.+Kumarauthor=A.+Sherstnevauthor=D.+H.+Drewryauthor=J.+R.+Brownauthor=J.+M.+Fiandorauthor=J.+J.+Martin&title=New+compound+sets+identified+from+high+throughput+phenotypic+screening+against+three+kinetoplastid+parasites%3A+an+open+resource&doi=10.1038%2Fsrep08771"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource</span></div><div class="casAuthors">Pena, Imanol; Pilar Manzano, M.; Cantizani, Juan; Kessler, Albane; Alonso-Padilla, Julio; Bardera, Ana I.; Alvarez, Emilio; Colmenarejo, Gonzalo; Cotillo, Ignacio; Roquero, Irene; de Dios-Anton, Francisco; Barroso, Vanessa; Rodriguez, Ana; Gray, David W.; Navarro, Miguel; Kumar, Vinod; Sherstnev, Alexander; Drewry, David H.; Brown, James R.; Fiandor, Jose M.; Martin, J. Julio</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8771</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Using whole-cell phenotypic assays, the GlaxoSmithKline high-throughput screening (HTS) diversity set of 1.8 million compds. was screened against the three kinetoplastids most relevant to human disease, i.e.  Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.  Secondary confirmatory and orthogonal intracellular anti-parasiticidal assays were conducted, and the potential for non-specific cytotoxicity detd.  Hit compds. were chem. clustered and triaged for desirable physicochem. properties.  The hypothetical biol. target space covered by these diversity sets was investigated through bioinformatics methodologies.  Consequently, three anti-kinetoplastid chem. boxes of ∼200 compds. each were assembled.  Functional analyses of these compds. suggest a wide array of potential modes of action against kinetoplastid kinases, proteases and cytochromes as well as potential host-pathogen targets.  This is the first published parallel high throughput screening of a pharma compd. collection against kinetoplastids.  The compd. sets are provided as an open resource for future lead discovery programs, and to address important research questions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAQjKOCN5nErVg90H21EOLACvtfcHk0liyS1BmOpzpuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKhur7M&md5=c28afb0ae168147ee70d1f9cc905d272</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsrep08771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep08771%26sid%3Dliteratum%253Aachs%26aulast%3DPena%26aufirst%3DI.%26aulast%3DManzano%26aufirst%3DM.%2BP.%26aulast%3DCantizani%26aufirst%3DJ.%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DAlonso-Padilla%26aufirst%3DJ.%26aulast%3DBardera%26aufirst%3DA.%2BI.%26aulast%3DAlvarez%26aufirst%3DE.%26aulast%3DColmenarejo%26aufirst%3DG.%26aulast%3DCotillo%26aufirst%3DI.%26aulast%3DRoquero%26aufirst%3DI.%26aulast%3Dde%2BDios-Anton%26aufirst%3DF.%26aulast%3DBarroso%26aufirst%3DV.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DSherstnev%26aufirst%3DA.%26aulast%3DDrewry%26aufirst%3DD.%2BH.%26aulast%3DBrown%26aufirst%3DJ.%2BR.%26aulast%3DFiandor%26aufirst%3DJ.%2BM.%26aulast%3DMartin%26aufirst%3DJ.%2BJ.%26atitle%3DNew%2520compound%2520sets%2520identified%2520from%2520high%2520throughput%2520phenotypic%2520screening%2520against%2520three%2520kinetoplastid%2520parasites%253A%2520an%2520open%2520resource%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D8771%26doi%3D10.1038%2Fsrep08771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Finding new collaboration models for enabling neglected tropical disease drug discovery</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2866</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0002866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0002866" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=e2866&author=M.+P.+Pollastri&title=Finding+new+collaboration+models+for+enabling+neglected+tropical+disease+drug+discovery&doi=10.1371%2Fjournal.pntd.0002866"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0002866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0002866%26sid%3Dliteratum%253Aachs%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DFinding%2520new%2520collaboration%2520models%2520for%2520enabling%2520neglected%2520tropical%2520disease%2520drug%2520discovery%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26spage%3De2866%26doi%3D10.1371%2Fjournal.pntd.0002866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Brand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleghorn, L. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallyburton, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norcross, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinks, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayliss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrie, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frearson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlamb, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, M. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span> </span><span class="NLM_article-title">Discovery of a novel class of orally active trypanocidal <i>N</i>-myristoyltransferase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1021/jm201091t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201091t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=140-152&author=S.+Brandauthor=L.+A.+T.+Cleghornauthor=S.+P.+McElroyauthor=D.+A.+Robinsonauthor=V.+C.+Smithauthor=I.+Hallyburtonauthor=J.+R.+Harrisonauthor=N.+R.+Norcrossauthor=D.+Spinksauthor=T.+Baylissauthor=S.+Norvalauthor=L.+Stojanovskiauthor=L.+S.+Torrieauthor=J.+A.+Frearsonauthor=R.+Brenkauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=K.+D.+Readauthor=P.+G.+Wyattauthor=I.+H.+Gilbert&title=Discovery+of+a+novel+class+of+orally+active+trypanocidal+N-myristoyltransferase+inhibitors&doi=10.1021%2Fjm201091t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors</span></div><div class="casAuthors">Brand, Stephen; Cleghorn, Laura A. T.; McElroy, Stuart P.; Robinson, David A.; Smith, Victoria C.; Hallyburton, Irene; Harrison, Justin R.; Norcross, Neil R.; Spinks, Daniel; Bayliss, Tracy; Norval, Suzanne; Stojanovski, Laste; Torrie, Leah S.; Frearson, Julie A.; Brenk, Ruth; Fairlamb, Alan H.; Ferguson, Michael A. J.; Read, Kevin D.; Wyatt, Paul G.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-152</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">N-Myristoyltransferase (NMT) represents a promising drug target for human African trypanosomiasis (HAT), which is caused by the parasitic protozoa Trypanosoma brucei.  We report the optimization of a high throughput screening hit (1) to give a lead mol. DDD85646 (63), which has potent activity against the enzyme (IC50 = 2 nM) and T. brucei (EC50 = 2 nM) in culture.  The compd. has good oral pharmacokinetics and cures rodent models of peripheral HAT infection.  This compd. provides an excellent tool for validation of T. brucei NMT as a drug target for HAT as well as a valuable lead for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCg4lhwv5cTrVg90H21EOLACvtfcHk0lidJZK1zeI7ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurvK&md5=1479aed07e07e99f58de9012c7ec6631</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm201091t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201091t%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DMcElroy%26aufirst%3DS.%2BP.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DV.%2BC.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DHarrison%26aufirst%3DJ.%2BR.%26aulast%3DNorcross%26aufirst%3DN.%2BR.%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DBayliss%26aufirst%3DT.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520class%2520of%2520orally%2520active%2520trypanocidal%2520N-myristoyltransferase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D140%26epage%3D152%26doi%3D10.1021%2Fjm201091t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Brand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norcross, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrie, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallyburton, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scullion, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeons, F. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Aalten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frearson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlamb, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, M. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span> </span><span class="NLM_article-title">Lead optimization of a pyrazole sulfonamide series of <i>Trypanosoma brucei N</i>-myristoyltransferase inhibitors: Identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9855</span><span class="NLM_x">–</span> <span class="NLM_lpage">9869</span><span class="refDoi"> DOI: 10.1021/jm500809c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500809c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFKqu7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9855-9869&author=S.+Brandauthor=N.+R.+Norcrossauthor=S.+Thompsonauthor=J.+R.+Harrisonauthor=V.+C.+Smithauthor=D.+A.+Robinsonauthor=L.+S.+Torrieauthor=S.+P.+McElroyauthor=I.+Hallyburtonauthor=S.+Norvalauthor=P.+Scullionauthor=L.+Stojanovskiauthor=F.+R.+C.+Simeonsauthor=D.+van+Aaltenauthor=J.+A.+Frearsonauthor=R.+Brenkauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=P.+G.+Wyattauthor=I.+H.+Gilbertauthor=K.+D.+Read&title=Lead+optimization+of+a+pyrazole+sulfonamide+series+of+Trypanosoma+brucei+N-myristoyltransferase+inhibitors%3A+Identification+and+evaluation+of+CNS+penetrant+compounds+as+potential+treatments+for+stage+2+human+African+trypanosomiasis&doi=10.1021%2Fjm500809c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization of a Pyrazole Sulfonamide Series of Trypanosoma brucei N-Myristoyltransferase Inhibitors: Identification and Evaluation of CNS Penetrant Compounds as Potential Treatments for Stage 2 Human African Trypanosomiasis</span></div><div class="casAuthors">Brand, Stephen; Norcross, Neil R.; Thompson, Stephen; Harrison, Justin R.; Smith, Victoria C.; Robinson, David A.; Torrie, Leah S.; McElroy, Stuart P.; Hallyburton, Irene; Norval, Suzanne; Scullion, Paul; Stojanovski, Laste; Simeons, Frederick R. C.; van Aalten, Daan; Frearson, Julie A.; Brenk, Ruth; Fairlamb, Alan H.; Ferguson, Michael A. J.; Wyatt, Paul G.; Gilbert, Ian H.; Read, Kevin D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9855-9869</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Trypanosoma brucei N-myristoyltransferase (TbNMT) is an attractive therapeutic target for the treatment of human African trypanosomiasis (HAT).  From previous studies, we identified pyrazole sulfonamide, DDD85646 (1), a potent inhibitor of TbNMT.  Although this compd. represents an excellent lead, poor central nervous system (CNS) exposure restricts its use to the hemolymphatic form (stage 1) of the disease.  With a clear clin. need for new drug treatments for HAT that address both the hemolymphatic and CNS stages of the disease, a chem. campaign was initiated to address the shortfalls of this series.  This paper describes modifications to the pyrazole sulfonamides which markedly improved blood-brain barrier permeability, achieved by reducing polar surface area and capping the sulfonamide.  Moreover, replacing the core arom. with a flexible linker significantly improved selectivity.  This led to the discovery of DDD100097 (40) which demonstrated partial efficacy in a stage 2 (CNS) mouse model of HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodUmJfaDwY-LVg90H21EOLACvtfcHk0lidJZK1zeI7ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFKqu7rP&md5=6d6f5e8618aa3b7017b789f89d9540a5</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm500809c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500809c%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DNorcross%26aufirst%3DN.%2BR.%26aulast%3DThompson%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DJ.%2BR.%26aulast%3DSmith%26aufirst%3DV.%2BC.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DMcElroy%26aufirst%3DS.%2BP.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DScullion%26aufirst%3DP.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRead%26aufirst%3DK.%2BD.%26atitle%3DLead%2520optimization%2520of%2520a%2520pyrazole%2520sulfonamide%2520series%2520of%2520Trypanosoma%2520brucei%2520N-myristoyltransferase%2520inhibitors%253A%2520Identification%2520and%2520evaluation%2520of%2520CNS%2520penetrant%2520compounds%2520as%2520potential%2520treatments%2520for%2520stage%25202%2520human%2520African%2520trypanosomiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9855%26epage%3D9869%26doi%3D10.1021%2Fjm500809c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Cleghorn, L. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeons, F. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kime, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collie, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rycker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallyburton, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frearson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span> </span><span class="NLM_article-title">Discovery of indoline-2-carboxamide derivatives as a new class of brain-penetrant inhibitors of <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">7695</span><span class="NLM_x">–</span> <span class="NLM_lpage">7706</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00596</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00596" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFKqsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7695-7706&author=L.+A.+T.+Cleghornauthor=S.+Albrechtauthor=L.+Stojanovskiauthor=F.+R.+J.+Simeonsauthor=S.+Norvalauthor=R.+Kimeauthor=I.+T.+Collieauthor=M.+De+Ryckerauthor=L.+Campbellauthor=I.+Hallyburtonauthor=J.+A.+Frearsonauthor=P.+G.+Wyattauthor=K.+D.+Readauthor=I.+H.+Gilbert&title=Discovery+of+indoline-2-carboxamide+derivatives+as+a+new+class+of+brain-penetrant+inhibitors+of+Trypanosoma+brucei&doi=10.1021%2Facs.jmedchem.5b00596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei</span></div><div class="casAuthors">Cleghorn, Laura A. T.; Albrecht, Sebastien; Stojanovski, Laste; Simeons, Frederick R. J.; Norval, Suzanne; Kime, Robert; Collie, Iain T.; De Rycker, Manu; Campbell, Lorna; Hallyburton, Irene; Frearson, Julie A.; Wyatt, Paul G.; Read, Kevin D.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7695-7706</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is an urgent need for new, brain penetrant small mols. that target the central nervous system second stage of human African trypanosomiasis (HAT).  We report that a series of novel indoline-2-carboxamides have been identified as inhibitors of Trypanosoma brucei from screening of a focused protease library against Trypanosoma brucei brucei in culture.  We describe the optimization and characterization of this series.  Potent antiproliferative activity was obsd.  The series demonstrated excellent pharmacokinetic properties, full cures in a stage 1 mouse model of HAT, and a partial cure in a stage 2 mouse model of HAT.  Lack of tolerability prevented delivery of a fully curative regimen in the stage 2 mouse model and thus further progress of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX7MyowtO8XrVg90H21EOLACvtfcHk0liFfVa8EPWj3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFKqsrfF&md5=263eaa55034dfc0cc6a89917bc919393</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00596%26sid%3Dliteratum%253Aachs%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DAlbrecht%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BJ.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DKime%26aufirst%3DR.%26aulast%3DCollie%26aufirst%3DI.%2BT.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DCampbell%26aufirst%3DL.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DDiscovery%2520of%2520indoline-2-carboxamide%2520derivatives%2520as%2520a%2520new%2520class%2520of%2520brain-penetrant%2520inhibitors%2520of%2520Trypanosoma%2520brucei%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7695%26epage%3D7706%26doi%3D10.1021%2Facs.jmedchem.5b00596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Spinks, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luksch, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torrie, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McElroy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norval, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collie, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallyburton, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frearson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span> </span><span class="NLM_article-title">Development of small-molecule <i>Trypanosoma brucei N</i>-myristoyltransferase inhibitors: discovery and optimization of a novel binding mode</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1821</span><span class="NLM_x">–</span> <span class="NLM_lpage">1836</span><span class="refDoi"> DOI: 10.1002/cmdc.201500301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1002%2Fcmdc.201500301" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1821-1836&author=D.+Spinksauthor=V.+Smithauthor=S.+Thompsonauthor=D.+A.+Robinsonauthor=T.+Lukschauthor=A.+Smithauthor=L.+S.+Torrieauthor=S.+McElroyauthor=L.+Stojanovskiauthor=S.+Norvalauthor=I.+T.+Collieauthor=I.+Hallyburtonauthor=B.+Raoauthor=S.+Brandauthor=R.+Brenkauthor=J.+A.+Frearsonauthor=K.+D.+Readauthor=P.+G.+Wyattauthor=I.+H.+Gilbert&title=Development+of+small-molecule+Trypanosoma+brucei+N-myristoyltransferase+inhibitors%3A+discovery+and+optimization+of+a+novel+binding+mode&doi=10.1002%2Fcmdc.201500301"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500301%26sid%3Dliteratum%253Aachs%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DV.%26aulast%3DThompson%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DD.%2BA.%26aulast%3DLuksch%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DMcElroy%26aufirst%3DS.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DCollie%26aufirst%3DI.%2BT.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DRao%26aufirst%3DB.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DBrenk%26aufirst%3DR.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DDevelopment%2520of%2520small-molecule%2520Trypanosoma%2520brucei%2520N-myristoyltransferase%2520inhibitors%253A%2520discovery%2520and%2520optimization%2520of%2520a%2520novel%2520binding%2520mode%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1821%26epage%3D1836%26doi%3D10.1002%2Fcmdc.201500301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Tatipaka, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norcross, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulverson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranade, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagendar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creason, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duster, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supek, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molteni, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glynne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, M. H.</span><span> </span><span class="NLM_article-title">Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span><span class="refDoi"> DOI: 10.1021/jm401178t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401178t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKqtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=828-835&author=H.+B.+Tatipakaauthor=J.+R.+Gillespieauthor=A.+K.+Chatterjeeauthor=N.+R.+Norcrossauthor=M.+A.+Hulversonauthor=R.+M.+Ranadeauthor=P.+Nagendarauthor=S.+A.+Creasonauthor=J.+McQueenauthor=N.+A.+Dusterauthor=A.+Nagleauthor=F.+Supekauthor=V.+Molteniauthor=T.+Wenzlerauthor=R.+Brunauthor=R.+Glynneauthor=F.+S.+Bucknerauthor=M.+H.+Gelb&title=Substituted+2-phenylimidazopyridines%3A+a+new+class+of+drug+leads+for+human+African+trypanosomiasis&doi=10.1021%2Fjm401178t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 2-Phenylimidazopyridines: A New Class of Drug Leads for Human African Trypanosomiasis</span></div><div class="casAuthors">Tatipaka, Hari Babu; Gillespie, J. Robert; Chatterjee, Arnab K.; Norcross, Neil R.; Hulverson, Matthew A.; Ranade, Ranae M.; Nagendar, Pendem; Creason, Sharon A.; McQueen, Joshua; Duster, Nicole A.; Nagle, Advait; Supek, Frantisek; Molteni, Valentina; Wenzler, Tanja; Brun, Reto; Glynne, Richard; Buckner, Frederick S.; Gelb, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">828-835</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A phenotypic screen of a compd. library for antiparasitic activity on Trypanosoma brucei, the causative agent of human African trypanosomiasis, led to the identification of substituted 2-(3-aminophenyl)-oxazolopyridines as a starting point for hit-to-lead medicinal chem.  A total of 110 analogs were prepd., which led to the identification of I, a substituted 2-(3-aminophenyl)-imidazopyridine.  This compd. showed antiparasitic activity in vitro with an EC50 of 2 nM and displayed reasonable druglike properties when tested in a no. of in vitro assays.  I was orally bioavailable and displayed good plasma and brain exposure in mice.  I cured mice infected with Trypanosoma brucei when dosed orally down to 2.5 mg/kg.  Given its potent antiparasitic properties and its ease of synthesis, I represents a new lead for the development of drugs to treat human African trypanosomiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKqZdMjPCMsrVg90H21EOLACvtfcHk0liFfVa8EPWj3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKqtLzK&md5=3ed810c038784126456b0d6d93f099eb</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm401178t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401178t%26sid%3Dliteratum%253Aachs%26aulast%3DTatipaka%26aufirst%3DH.%2BB.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DNorcross%26aufirst%3DN.%2BR.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DRanade%26aufirst%3DR.%2BM.%26aulast%3DNagendar%26aufirst%3DP.%26aulast%3DCreason%26aufirst%3DS.%2BA.%26aulast%3DMcQueen%26aufirst%3DJ.%26aulast%3DDuster%26aufirst%3DN.%2BA.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DSupek%26aufirst%3DF.%26aulast%3DMolteni%26aufirst%3DV.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26atitle%3DSubstituted%25202-phenylimidazopyridines%253A%2520a%2520new%2520class%2520of%2520drug%2520leads%2520for%2520human%2520African%2520trypanosomiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D828%26epage%3D835%26doi%3D10.1021%2Fjm401178t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Patel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karver, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guyett, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullenberger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncal, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Kinase scaffold repurposing for neglected disease drug discovery: discovery of an efficacious, lapatanib-derived lead compound for trypanosomiasis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3820</span><span class="NLM_x">–</span> <span class="NLM_lpage">3832</span><span class="refDoi"> DOI: 10.1021/jm400349k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400349k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtFSitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3820-3832&author=G.+Patelauthor=C.+E.+Karverauthor=R.+Beheraauthor=P.+J.+Guyettauthor=C.+Sullenbergerauthor=P.+Edwardsauthor=N.+E.+Roncalauthor=K.+Mensa-Wilmotauthor=M.+P.+Pollastri&title=Kinase+scaffold+repurposing+for+neglected+disease+drug+discovery%3A+discovery+of+an+efficacious%2C+lapatanib-derived+lead+compound+for+trypanosomiasis&doi=10.1021%2Fjm400349k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Scaffold Repurposing for Neglected Disease Drug Discovery: Discovery of an Efficacious, Lapatanib-Derived Lead Compound for Trypanosomiasis</span></div><div class="casAuthors">Patel, Gautam; Karver, Caitlin E.; Behera, Ranjan; Guyett, Paul J.; Sullenberger, Catherine; Edwards, Peter; Roncal, Norma E.; Mensa-Wilmot, Kojo; Pollastri, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3820-3832</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Lapatinib analogs such as I (X = O, CH2) were prepd. as trypanocidal agents for use as lead compds. in the development of treatments for human African trypanosomiasis which do not require i.v. administration.  Lapatinib was previously shown to kill T. brucei with low micromolar EC50 values; analogs replacing the methylfurylquinazoline moiety with a heteroarylsulfonylphenylquinazolinyl moiety were prepd. and tested against both T. brucei and human hepatocarcinoma cells.  4-Anilinoquinazolines, particularly I (X = O) (NEU617), were found to be highly potent and orally bioavailable inhibitors of trypanosome replication.  I (X = O) blocks duplication of the kinetoplast and arrests cytokinesis in T. brucei, which may make it useful as a chem. tool for studying regulation of the trypanosome cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoliwtzx67q77Vg90H21EOLACvtfcHk0ljnC5YqnG0orQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtFSitLo%253D&md5=dd278f3bc7c671330e40de210392a278</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm400349k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400349k%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DG.%26aulast%3DKarver%26aufirst%3DC.%2BE.%26aulast%3DBehera%26aufirst%3DR.%26aulast%3DGuyett%26aufirst%3DP.%2BJ.%26aulast%3DSullenberger%26aufirst%3DC.%26aulast%3DEdwards%26aufirst%3DP.%26aulast%3DRoncal%26aufirst%3DN.%2BE.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DKinase%2520scaffold%2520repurposing%2520for%2520neglected%2520disease%2520drug%2520discovery%253A%2520discovery%2520of%2520an%2520efficacious%252C%2520lapatanib-derived%2520lead%2520compound%2520for%2520trypanosomiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3820%26epage%3D3832%26doi%3D10.1021%2Fjm400349k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Seixas, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo-Arratta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saldivia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas-Barros, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berlanga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Establishment of a structure-activity relationship of 1<i>H</i>-imidazo[4,5-<i>c</i>]quinoline-based kinase inhibitor NVP-BEZ235 as a lead for African sleeping sickness</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4834</span><span class="NLM_x">–</span> <span class="NLM_lpage">4848</span><span class="refDoi"> DOI: 10.1021/jm500361r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500361r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4834-4848&author=J.+D.+Seixasauthor=S.+A.+Luengo-Arrattaauthor=R.+Diazauthor=M.+Saldiviaauthor=D.+I.+Rojas-Barrosauthor=P.+Manzanoauthor=S.+Gonzalezauthor=M.+Berlangaauthor=T.+K.+Smithauthor=M.+Navarroauthor=M.+P.+Pollastri&title=Establishment+of+a+structure-activity+relationship+of+1H-imidazo%5B4%2C5-c%5Dquinoline-based+kinase+inhibitor+NVP-BEZ235+as+a+lead+for+African+sleeping+sickness&doi=10.1021%2Fjm500361r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm500361r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500361r%26sid%3Dliteratum%253Aachs%26aulast%3DSeixas%26aufirst%3DJ.%2BD.%26aulast%3DLuengo-Arratta%26aufirst%3DS.%2BA.%26aulast%3DDiaz%26aufirst%3DR.%26aulast%3DSaldivia%26aufirst%3DM.%26aulast%3DRojas-Barros%26aufirst%3DD.%2BI.%26aulast%3DManzano%26aufirst%3DP.%26aulast%3DGonzalez%26aufirst%3DS.%26aulast%3DBerlanga%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DT.%2BK.%26aulast%3DNavarro%26aufirst%3DM.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DEstablishment%2520of%2520a%2520structure-activity%2520relationship%2520of%25201H-imidazo%255B4%252C5-c%255Dquinoline-based%2520kinase%2520inhibitor%2520NVP-BEZ235%2520as%2520a%2520lead%2520for%2520African%2520sleeping%2520sickness%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4834%26epage%3D4848%26doi%3D10.1021%2Fjm500361r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Bakunov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakunova, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghebru, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbovetz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span> </span><span class="NLM_article-title">Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1<i>H</i>-1,2,3-triazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span><span class="refDoi"> DOI: 10.1021/jm901178d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901178d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGrt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=254-272&author=S.+A.+Bakunovauthor=S.+M.+Bakunovaauthor=T.+Wenzlerauthor=M.+Ghebruauthor=K.+A.+Werbovetzauthor=R.+Brunauthor=R.+R.+Tidwell&title=Synthesis+and+antiprotozoal+activity+of+cationic+1%2C4-diphenyl-1H-1%2C2%2C3-triazoles&doi=10.1021%2Fjm901178d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antiprotozoal Activity of Cationic 1,4-Diphenyl-1H-1,2,3-triazoles</span></div><div class="casAuthors">Bakunov, Stanislav A.; Bakunova, Svetlana M.; Wenzler, Tanja; Ghebru, Maedot; Werbovetz, Karl A.; Brun, Reto; Tidwell, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">254-272</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel dicationic triazoles, e.g. I and II, were synthesized by the Pinner method from the corresponding dinitriles, prepd. via the copper(I)-catalyzed azide-alkyne cycloaddn. (CuAAC).  The type and the placement of cationic moieties as well as the nature of arom. substituents influenced in vitro antiprotozoal activities of dicationic triazoles against Trypanosoma brucei rhodesiense, Plasmodium falciparum, and Leishmania donovani and their cytotoxicity for mammalian cells.  Eight congeners displayed antitrypanosomal IC50 values below 10 nM.  Thirty-nine dications were more potent against P.  Falciparum than pentamidine (IC50 = 58 nM), and eight analogs were more active than artemisinin (IC50 = 6 nM).  Diimidazoline II exhibited antiplasmodial IC50 value of 0.6 nM.  Seven congeners administered at 4 × 5 mg/kg by the i.p. route cured at least three out of four animals in the acute mouse model of African trypanosomiasis.  At 4 × 1 mg/kg, diamidine I displayed better antitrypanosomal efficacy than melarsoprol, curing all infected mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEgbnsLWzRuLVg90H21EOLACvtfcHk0ljnC5YqnG0orQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGrt7rJ&md5=d882c1d6ecc49bcead46056b2498bd12</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm901178d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901178d%26sid%3Dliteratum%253Aachs%26aulast%3DBakunov%26aufirst%3DS.%2BA.%26aulast%3DBakunova%26aufirst%3DS.%2BM.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DGhebru%26aufirst%3DM.%26aulast%3DWerbovetz%26aufirst%3DK.%2BA.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DSynthesis%2520and%2520antiprotozoal%2520activity%2520of%2520cationic%25201%252C4-diphenyl-1H-1%252C2%252C3-triazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D254%26epage%3D272%26doi%3D10.1021%2Fjm901178d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Patrick, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakunov, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakunova, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barszcz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykin, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbovetz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span> </span><span class="NLM_article-title">Synthesis and antiprotozoal activities of benzyl phenyl ether diamidine derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.06.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.ejmech.2013.06.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=23871911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVejtLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=310-324&author=D.+A.+Patrickauthor=S.+A.+Bakunovauthor=S.+M.+Bakunovaauthor=S.+K.+Jonesauthor=T.+Wenzlerauthor=T.+Barszczauthor=A.+Kumarauthor=D.+W.+Boykinauthor=K.+A.+Werbovetzauthor=R.+Brunauthor=R.+R.+Tidwell&title=Synthesis+and+antiprotozoal+activities+of+benzyl+phenyl+ether+diamidine+derivatives&doi=10.1016%2Fj.ejmech.2013.06.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiprotozoal activities of benzyl phenyl ether diamidine derivatives</span></div><div class="casAuthors">Patrick, Donald A.; Bakunov, Stanislav A.; Bakunova, Svetlana M.; Jones, Susan Kilgore; Wenzler, Tanja; Barszcz, Todd; Kumar, Arvind; Boykin, David W.; Werbovetz, Karl A.; Brun, Reto; Tidwell, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">310-324</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Sixty-two cationic benzyl Ph ether derivs. (36 amidines and 26 prodrugs) were prepd. and assayed for activities in vitro and in vivo against Trypanosoma brucei rhodesiense (STIB900), and in vitro against Plasmodium falciparum (K1) and Leishmania donovani axenic amastigotes.  3-Amidinobenzyl 4-amidino-2-iodo-6-methoxyphenyl ether dihydrochloride (IC50 = 3.0 nM) and seven other compds. exhibited IC50 values below 10 nM against T. b. rhodesiense in vitro.  The 2-bromo-4,4'-diamidino analog I [R1 = R4 = 4-C(NH2):NH, R2 = Br, R3 = H] (IC50 = 4.0 nM) and 12 other analogs were more potent than pentamidine (IC50 = 46 nM) against P. falciparum.  The 3',4-diamidino-2,6-diiodo analog I [R1 = 4-C(NH2):NH, R2 = R3 = I, R4 = 3-C(NH2):NH] (IC50 = 1.4 μM) and two other compds. were more effective than pentamidine (IC50 = 1.8 μM) against L. donovani.  A prodrug, 3',4-bis(N''-methoxy)amidino-2-bromo deriv. I [R1 = 4-C(NH2):NOMe, R2 = Br, R3 = H, R4 = 3-C(NH2):NOMe], was the most efficacious against trypanosome infected mice, attaining 4/4 cures in four daily 25 mg/kg oral doses, and the 2-chloro-4,4'-diamidine I [R1 = R4 = 4-C(NH2):NH, R2 = Cl, R3 = H] cured 3/4 mice in four daily 5 mg/kg i.p. doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqctvCGGa4JorVg90H21EOLACvtfcHk0lgigBBVvixXZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVejtLrL&md5=8596590e8dd5c29f99f99acc485e76c2</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.06.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.06.033%26sid%3Dliteratum%253Aachs%26aulast%3DPatrick%26aufirst%3DD.%2BA.%26aulast%3DBakunov%26aufirst%3DS.%2BA.%26aulast%3DBakunova%26aufirst%3DS.%2BM.%26aulast%3DJones%26aufirst%3DS.%2BK.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DBarszcz%26aufirst%3DT.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DBoykin%26aufirst%3DD.%2BW.%26aulast%3DWerbovetz%26aufirst%3DK.%2BA.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DSynthesis%2520and%2520antiprotozoal%2520activities%2520of%2520benzyl%2520phenyl%2520ether%2520diamidine%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D67%26spage%3D310%26epage%3D324%26doi%3D10.1016%2Fj.ejmech.2013.06.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Reid, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Premalatha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershkovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbovetz, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and antitrypanosomal evaluation of derivatives of <i>N</i>-benzyl-1,2-dihydroquinolin-6-ols: effect of core substitutions and salt formation</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span><span class="refDoi"> DOI: 10.1016/j.bmc.2010.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.bmc.2010.11.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=513-523&author=C.+S.+Reidauthor=D.+A.+Patrickauthor=S.+Heauthor=J.+Fotieauthor=K.+Premalathaauthor=R.+R.+Tidwellauthor=M.+Z.+Wangauthor=Q.+Liuauthor=P.+Gershkovichauthor=K.+M.+Wasanauthor=T.+Wenzlerauthor=R.+Brunauthor=K.+A.+Werbovetz&title=Synthesis+and+antitrypanosomal+evaluation+of+derivatives+of+N-benzyl-1%2C2-dihydroquinolin-6-ols%3A+effect+of+core+substitutions+and+salt+formation&doi=10.1016%2Fj.bmc.2010.11.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DReid%26aufirst%3DC.%2BS.%26aulast%3DPatrick%26aufirst%3DD.%2BA.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DFotie%26aufirst%3DJ.%26aulast%3DPremalatha%26aufirst%3DK.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26aulast%3DWang%26aufirst%3DM.%2BZ.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGershkovich%26aufirst%3DP.%26aulast%3DWasan%26aufirst%3DK.%2BM.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DWerbovetz%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520antitrypanosomal%2520evaluation%2520of%2520derivatives%2520of%2520N-benzyl-1%252C2-dihydroquinolin-6-ols%253A%2520effect%2520of%2520core%2520substitutions%2520and%2520salt%2520formation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D513%26epage%3D523%26doi%3D10.1016%2Fj.bmc.2010.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Lavrado, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackey, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreira, R.</span><span> </span><span class="NLM_article-title">Antitrypanosomal and cysteine protease inhibitory activities of alkyldiamine cryptolepine derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">6256</span><span class="NLM_x">–</span> <span class="NLM_lpage">6260</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.bmcl.2012.07.104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6256-6260&author=J.+Lavradoauthor=Z.+Mackeyauthor=E.+Hansellauthor=J.+H.+McKerrowauthor=A.+Pauloauthor=R.+Moreira&title=Antitrypanosomal+and+cysteine+protease+inhibitory+activities+of+alkyldiamine+cryptolepine+derivatives&doi=10.1016%2Fj.bmcl.2012.07.104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.104%26sid%3Dliteratum%253Aachs%26aulast%3DLavrado%26aufirst%3DJ.%26aulast%3DMackey%26aufirst%3DZ.%26aulast%3DHansell%26aufirst%3DE.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DPaulo%26aufirst%3DA.%26aulast%3DMoreira%26aufirst%3DR.%26atitle%3DAntitrypanosomal%2520and%2520cysteine%2520protease%2520inhibitory%2520activities%2520of%2520alkyldiamine%2520cryptolepine%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6256%26epage%3D6260%26doi%3D10.1016%2Fj.bmcl.2012.07.104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Keenan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Best, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berven, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Geldern, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerfoot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McManus, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span> </span><span class="NLM_article-title">Analogues of fenarimol are potent inhibitors of <i>Trypanosoma cruzi</i> and are efficacious in a murine model of Chagas disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4189</span><span class="NLM_x">–</span> <span class="NLM_lpage">4204</span><span class="refDoi"> DOI: 10.1021/jm2015809</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2015809" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4189-4204&author=M.+Keenanauthor=M.+J.+Abbottauthor=P.+W.+Alexanderauthor=T.+Armstrongauthor=W.+M.+Bestauthor=B.+Bervenauthor=A.+Boteroauthor=J.+H.+Chaplinauthor=S.+A.+Charmanauthor=E.+Chatelainauthor=T.+W.+von+Geldernauthor=M.+Kerfootauthor=A.+Khongauthor=T.+Nguyenauthor=J.+D.+McManusauthor=J.+Morizziauthor=E.+Ryanauthor=I.+Scandaleauthor=R.+A.+Thompsonauthor=S.+Z.+Wangauthor=K.+L.+White&title=Analogues+of+fenarimol+are+potent+inhibitors+of+Trypanosoma+cruzi+and+are+efficacious+in+a+murine+model+of+Chagas+disease&doi=10.1021%2Fjm2015809"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm2015809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2015809%26sid%3Dliteratum%253Aachs%26aulast%3DKeenan%26aufirst%3DM.%26aulast%3DAbbott%26aufirst%3DM.%2BJ.%26aulast%3DAlexander%26aufirst%3DP.%2BW.%26aulast%3DArmstrong%26aufirst%3DT.%26aulast%3DBest%26aufirst%3DW.%2BM.%26aulast%3DBerven%26aufirst%3DB.%26aulast%3DBotero%26aufirst%3DA.%26aulast%3DChaplin%26aufirst%3DJ.%2BH.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3Dvon%2BGeldern%26aufirst%3DT.%2BW.%26aulast%3DKerfoot%26aufirst%3DM.%26aulast%3DKhong%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DMcManus%26aufirst%3DJ.%2BD.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DThompson%26aufirst%3DR.%2BA.%26aulast%3DWang%26aufirst%3DS.%2BZ.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26atitle%3DAnalogues%2520of%2520fenarimol%2520are%2520potent%2520inhibitors%2520of%2520Trypanosoma%2520cruzi%2520and%2520are%2520efficacious%2520in%2520a%2520murine%2520model%2520of%2520Chagas%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4189%26epage%3D4204%26doi%3D10.1021%2Fjm2015809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Keenan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Best, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerfoot, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregg, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Geldern, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, E.</span><span> </span><span class="NLM_article-title">Design, structure-activity relationship and in vivo efficacy of piperazine analogues of fenarimol as inhibitors of <i>Trypanosoma cruzi</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1756</span><span class="NLM_x">–</span> <span class="NLM_lpage">1763</span><span class="refDoi"> DOI: 10.1016/j.bmc.2013.01.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.bmc.2013.01.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=1756-1763&author=M.+Keenanauthor=P.+W.+Alexanderauthor=H.+Diaoauthor=W.+M.+Bestauthor=A.+Khongauthor=M.+Kerfootauthor=R.+C.+A.+Thompsonauthor=K.+L.+Whiteauthor=D.+M.+Shacklefordauthor=E.+Ryanauthor=A.+D.+Greggauthor=S.+A.+Charmanauthor=T.+W.+von+Geldernauthor=I.+Scandaleauthor=E.+Chatelain&title=Design%2C+structure-activity+relationship+and+in+vivo+efficacy+of+piperazine+analogues+of+fenarimol+as+inhibitors+of+Trypanosoma+cruzi&doi=10.1016%2Fj.bmc.2013.01.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.01.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.01.050%26sid%3Dliteratum%253Aachs%26aulast%3DKeenan%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DP.%2BW.%26aulast%3DDiao%26aufirst%3DH.%26aulast%3DBest%26aufirst%3DW.%2BM.%26aulast%3DKhong%26aufirst%3DA.%26aulast%3DKerfoot%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DR.%2BC.%2BA.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DGregg%26aufirst%3DA.%2BD.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3Dvon%2BGeldern%26aufirst%3DT.%2BW.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DChatelain%26aufirst%3DE.%26atitle%3DDesign%252C%2520structure-activity%2520relationship%2520and%2520in%2520vivo%2520efficacy%2520of%2520piperazine%2520analogues%2520of%2520fenarimol%2520as%2520inhibitors%2520of%2520Trypanosoma%2520cruzi%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D1756%26epage%3D1763%26doi%3D10.1016%2Fj.bmc.2013.01.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Keenan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Best, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornwall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, F. C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morizzi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Geldern, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span> </span><span class="NLM_article-title">Two analogues of fenarimol show curative activity in an experimental model of Chagas disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">10158</span><span class="NLM_x">–</span> <span class="NLM_lpage">10170</span><span class="refDoi"> DOI: 10.1021/jm401610c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401610c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10158-10170&author=M.+Keenanauthor=J.+H.+Chaplinauthor=P.+W.+Alexanderauthor=M.+J.+Abbottauthor=W.+M.+Bestauthor=A.+Khongauthor=A.+Boteroauthor=C.+Perezauthor=S.+Cornwallauthor=R.+A.+Thompsonauthor=K.+L.+Whiteauthor=D.+M.+Shacklefordauthor=M.+Koltunauthor=F.+C.+K.+Chiuauthor=J.+Morizziauthor=E.+Ryanauthor=M.+Campbellauthor=T.+W.+von+Geldernauthor=I.+Scandaleauthor=E.+Chatelainauthor=S.+A.+Charman&title=Two+analogues+of+fenarimol+show+curative+activity+in+an+experimental+model+of+Chagas+disease&doi=10.1021%2Fjm401610c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm401610c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401610c%26sid%3Dliteratum%253Aachs%26aulast%3DKeenan%26aufirst%3DM.%26aulast%3DChaplin%26aufirst%3DJ.%2BH.%26aulast%3DAlexander%26aufirst%3DP.%2BW.%26aulast%3DAbbott%26aufirst%3DM.%2BJ.%26aulast%3DBest%26aufirst%3DW.%2BM.%26aulast%3DKhong%26aufirst%3DA.%26aulast%3DBotero%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DCornwall%26aufirst%3DS.%26aulast%3DThompson%26aufirst%3DR.%2BA.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DKoltun%26aufirst%3DM.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3Dvon%2BGeldern%26aufirst%3DT.%2BW.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26atitle%3DTwo%2520analogues%2520of%2520fenarimol%2520show%2520curative%2520activity%2520in%2520an%2520experimental%2520model%2520of%2520Chagas%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10158%26epage%3D10170%26doi%3D10.1021%2Fjm401610c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Andriani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beatty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clements, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtemanche, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devine, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juda, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wawrzak, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepesheva, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Antitrypanosomal lead discovery: Identification of a ligand-efficient inhibitor of <i>Trypanosoma cruzi</i> CYP51 and parasite growth</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">2556</span><span class="NLM_x">–</span> <span class="NLM_lpage">2567</span><span class="refDoi"> DOI: 10.1021/jm400012e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400012e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWgs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2556-2567&author=G.+Andrianiauthor=E.+Amataauthor=J.+Beattyauthor=Z.+Clementsauthor=B.+J.+Coffeyauthor=G.+Courtemancheauthor=W.+Devineauthor=J.+Erathauthor=C.+E.+Judaauthor=Z.+Wawrzakauthor=J.+T.+Woodauthor=G.+I.+Lepeshevaauthor=A.+Rodriguezauthor=M.+P.+Pollastri&title=Antitrypanosomal+lead+discovery%3A+Identification+of+a+ligand-efficient+inhibitor+of+Trypanosoma+cruzi+CYP51+and+parasite+growth&doi=10.1021%2Fjm400012e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Antitrypanosomal Lead Discovery: Identification of a Ligand-Efficient Inhibitor of Trypanosoma cruzi CYP51 and Parasite Growth</span></div><div class="casAuthors">Andriani, Grasiella; Amata, Emanuele; Beatty, Joel; Clements, Zeke; Coffey, Brian J.; Courtemanche, Gilles; Devine, William; Erath, Jessey; Juda, Cristin E.; Wawrzak, Zdzislaw; Wood, JodiAnne T.; Lepesheva, Galina I.; Rodriguez, Ana; Pollastri, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2556-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chagas disease is caused by the intracellular protozoan parasite Trypanosomal cruzi, and current drugs are lacking in terms of desired safety and efficacy profiles.  Following on a recently reported high-throughput screening campaign, we have explored initial structure-activity relationships around a class of imidazole-based compds.  This profiling has uncovered compds. I (NEU321) and II (NEU704), which are potent against in vitro cultures of T. cruzi and are greater than 160-fold selective over host cells.  We report in vitro drug metab. and properties profiling of I and show that this chemotype inhibits the T. cruzi CYP51 enzyme, an observation confirmed by X-ray crystallog. anal.  We compare the binding orientation of I to that of other, previously reported inhibitors.  We show that I displays a significantly better ligand efficiency and a shorter synthetic route over previously disclosed CYP51 inhibitors, and should therefore be considered a promising lead compd. for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXiYoPMZe0O7Vg90H21EOLACvtfcHk0lhGuKqlkfOhhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWgs7g%253D&md5=60961c236abad895171a41e36a04aae7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm400012e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400012e%26sid%3Dliteratum%253Aachs%26aulast%3DAndriani%26aufirst%3DG.%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DBeatty%26aufirst%3DJ.%26aulast%3DClements%26aufirst%3DZ.%26aulast%3DCoffey%26aufirst%3DB.%2BJ.%26aulast%3DCourtemanche%26aufirst%3DG.%26aulast%3DDevine%26aufirst%3DW.%26aulast%3DErath%26aufirst%3DJ.%26aulast%3DJuda%26aufirst%3DC.%2BE.%26aulast%3DWawrzak%26aufirst%3DZ.%26aulast%3DWood%26aufirst%3DJ.%2BT.%26aulast%3DLepesheva%26aufirst%3DG.%2BI.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DAntitrypanosomal%2520lead%2520discovery%253A%2520Identification%2520of%2520a%2520ligand-efficient%2520inhibitor%2520of%2520Trypanosoma%2520cruzi%2520CYP51%2520and%2520parasite%2520growth%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2556%26epage%3D2567%26doi%3D10.1021%2Fjm400012e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Choi, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvet, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunatilleke, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podust, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roush, W. R.</span><span> </span><span class="NLM_article-title">Rational development of 4-aminopyridyl-based inhibitors targeting <i>Trypanosoma cruzi</i> CYP51 as anti-Chagas agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7651</span><span class="NLM_x">–</span> <span class="NLM_lpage">7668</span><span class="refDoi"> DOI: 10.1021/jm401067s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401067s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7651-7668&author=J.+Y.+Choiauthor=C.+M.+Calvetauthor=S.+S.+Gunatillekeauthor=C.+Ruizauthor=M.+D.+Cameronauthor=J.+H.+McKerrowauthor=L.+M.+Podustauthor=W.+R.+Roush&title=Rational+development+of+4-aminopyridyl-based+inhibitors+targeting+Trypanosoma+cruzi+CYP51+as+anti-Chagas+agents&doi=10.1021%2Fjm401067s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm401067s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401067s%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DCalvet%26aufirst%3DC.%2BM.%26aulast%3DGunatilleke%26aufirst%3DS.%2BS.%26aulast%3DRuiz%26aufirst%3DC.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DPodust%26aufirst%3DL.%2BM.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DRational%2520development%2520of%25204-aminopyridyl-based%2520inhibitors%2520targeting%2520Trypanosoma%2520cruzi%2520CYP51%2520as%2520anti-Chagas%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7651%26epage%3D7668%26doi%3D10.1021%2Fjm401067s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Vieira, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvet, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siqueira-Neto, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gut, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKerrow, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roush, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podust, L. M.</span><span> </span><span class="NLM_article-title">Binding mode and potency of <i>N</i>-indolyloxopyridinyl-4-aminopropanyl-based inhibitors targeting <i>Trypanosoma cruzi</i> CYP51</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">10162</span><span class="NLM_x">–</span> <span class="NLM_lpage">10175</span><span class="refDoi"> DOI: 10.1021/jm501568b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501568b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10162-10175&author=D.+F.+Vieiraauthor=J.+Y.+Choiauthor=C.+M.+Calvetauthor=J.+L.+Siqueira-Netoauthor=J.+B.+Johnstonauthor=D.+Kellarauthor=J.+Gutauthor=M.+D.+Cameronauthor=J.+H.+McKerrowauthor=W.+R.+Roushauthor=L.+M.+Podust&title=Binding+mode+and+potency+of+N-indolyloxopyridinyl-4-aminopropanyl-based+inhibitors+targeting+Trypanosoma+cruzi+CYP51&doi=10.1021%2Fjm501568b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm501568b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501568b%26sid%3Dliteratum%253Aachs%26aulast%3DVieira%26aufirst%3DD.%2BF.%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DCalvet%26aufirst%3DC.%2BM.%26aulast%3DSiqueira-Neto%26aufirst%3DJ.%2BL.%26aulast%3DJohnston%26aufirst%3DJ.%2BB.%26aulast%3DKellar%26aufirst%3DD.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DMcKerrow%26aufirst%3DJ.%2BH.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DPodust%26aufirst%3DL.%2BM.%26atitle%3DBinding%2520mode%2520and%2520potency%2520of%2520N-indolyloxopyridinyl-4-aminopropanyl-based%2520inhibitors%2520targeting%2520Trypanosoma%2520cruzi%2520CYP51%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10162%26epage%3D10175%26doi%3D10.1021%2Fjm501568b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Caminos, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panozzo-Zenere, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekwani, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadie, G. R.</span><span> </span><span class="NLM_article-title">Synthesis and antikinetoplastid activity of a series of <i>N</i>,<i>N</i>′-substituted diamines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1712</span><span class="NLM_x">–</span> <span class="NLM_lpage">1715</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.bmcl.2011.12.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1712-1715&author=A.+P.+Caminosauthor=E.+A.+Panozzo-Zenereauthor=S.+R.+Wilkinsonauthor=B.+L.+Tekwaniauthor=G.+R.+Labadie&title=Synthesis+and+antikinetoplastid+activity+of+a+series+of+N%2CN%E2%80%B2-substituted+diamines&doi=10.1016%2Fj.bmcl.2011.12.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.101%26sid%3Dliteratum%253Aachs%26aulast%3DCaminos%26aufirst%3DA.%2BP.%26aulast%3DPanozzo-Zenere%26aufirst%3DE.%2BA.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DLabadie%26aufirst%3DG.%2BR.%26atitle%3DSynthesis%2520and%2520antikinetoplastid%2520activity%2520of%2520a%2520series%2520of%2520N%252CN%25E2%2580%25B2-substituted%2520diamines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1712%26epage%3D1715%26doi%3D10.1016%2Fj.bmcl.2011.12.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Devine, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodring, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaminathan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amata, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roncal, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leed, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciotti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Protozoan parasite growth inhibitors discovered by cross-screening yield potent scaffolds for lead discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5537</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5522-5537&author=W.+Devineauthor=J.+L.+Woodringauthor=U.+Swaminathanauthor=E.+Amataauthor=G.+Patelauthor=J.+Erathauthor=N.+E.+Roncalauthor=P.+J.+Leeauthor=S.+E.+Leedauthor=A.+Rodriguezauthor=K.+Mensa-Wilmotauthor=R.+J.+Sciottiauthor=M.+P.+Pollastri&title=Protozoan+parasite+growth+inhibitors+discovered+by+cross-screening+yield+potent+scaffolds+for+lead+discovery&doi=10.1021%2Facs.jmedchem.5b00515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Protozoan parasite growth inhibitors discovered by cross-screening yield potent scaffolds for lead discovery</span></div><div class="casAuthors">Devine, William; Woodring, Jennifer L.; Swaminathan, Uma; Amata, Emanuele; Patel, Gautam; Erath, Jessey; Roncal, Norma E.; Lee, Patricia J.; Leed, Susan E.; Rodriguez, Ana; Mensa-Wilmot, Kojo; Sciotti, Richard J.; Pollastri, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5522-5537</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tropical protozoal infections are a significant cause of morbidity and mortality worldwide; four in particular (human African trypanosomiasis (HAT), Chagas disease, cutaneous leishmaniasis, and malaria) have an estd. combined burden of over 87 million disability-adjusted life years.  New drugs are needed for each of these diseases.  Building on the previous identification of NEU-617 as a potent and nontoxic inhibitor of proliferation for the HAT pathogen (Trypanosoma brucei), the authors have now tested this class of analogs against other protozoal species: T. cruzi (Chagas disease), Leishmania major (cutaneous leishmaniasis), and Plasmodium falciparum (malaria).  Based on hits identified in this screening campaign, the authors describe the prepn. of several replacements for the quinazoline scaffold and report these inhibitors' biol. activities against these parasites.  In doing this, the authors have identified several potent proliferation inhibitors for each pathogen, such as NEU-924, I, for T. cruzi and NEU-1017, II, for L. major and P. falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbrXR55ZLJ7Vg90H21EOLACvtfcHk0lhUzNkWXKKDjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7bN&md5=76fef909165981d8e542d28a5ee59c12</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00515%26sid%3Dliteratum%253Aachs%26aulast%3DDevine%26aufirst%3DW.%26aulast%3DWoodring%26aufirst%3DJ.%2BL.%26aulast%3DSwaminathan%26aufirst%3DU.%26aulast%3DAmata%26aufirst%3DE.%26aulast%3DPatel%26aufirst%3DG.%26aulast%3DErath%26aufirst%3DJ.%26aulast%3DRoncal%26aufirst%3DN.%2BE.%26aulast%3DLee%26aufirst%3DP.%2BJ.%26aulast%3DLeed%26aufirst%3DS.%2BE.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26aulast%3DSciotti%26aufirst%3DR.%2BJ.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DProtozoan%2520parasite%2520growth%2520inhibitors%2520discovered%2520by%2520cross-screening%2520yield%2520potent%2520scaffolds%2520for%2520lead%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5522%26epage%3D5537%26doi%3D10.1021%2Facs.jmedchem.5b00515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Di Pietro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente-Garcia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berenguer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viayna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanzoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sayago, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clos, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavilla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Torrero, D.</span><span> </span><span class="NLM_article-title">Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.ejmech.2015.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=26479031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKhu7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2015&pages=120-137&author=O.+Di+Pietroauthor=E.+Vicente-Garciaauthor=M.+C.+Taylorauthor=D.+Berenguerauthor=E.+Viaynaauthor=A.+Lanzoniauthor=I.+Solaauthor=H.+Sayagoauthor=C.+Rieraauthor=R.+Fisaauthor=M.+V.+Closauthor=B.+Perezauthor=J.+M.+Kellyauthor=R.+Lavillaauthor=D.+Munoz-Torrero&title=Multicomponent+reaction-based+synthesis+and+biological+evaluation+of+tricyclic+heterofused+quinolines+with+multi-trypanosomatid+activity&doi=10.1016%2Fj.ejmech.2015.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity</span></div><div class="casAuthors">Di Pietro, Ornella; Vicente-Garcia, Esther; Taylor, Martin C.; Berenguer, Diana; Viayna, Elisabet; Lanzoni, Anna; Sola, Irene; Sayago, Helena; Riera, Cristina; Fisa, Roser; Clos, M. Victoria; Perez, Belen; Kelly, John M.; Lavilla, Rodolfo; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">120-137</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Human African trypanosomiasis (HAT), Chagas disease and leishmaniasis, which are caused by the trypanosomatids Trypanosoma brucei, Trypanosoma cruzi and Leishmania species, are among the most deadly neglected tropical diseases.  The development of drugs that are active against several trypanosomatids is appealing from a clin. and economic viewpoint, and seems feasible, as these parasites share metabolic pathways and hence might be treatable by common drugs.  From benzonaphthyridine (I), an inhibitor of acetylcholinesterase (AChE) for which we have found a remarkable trypanocidal activity, we have designed and synthesized novel benzo[h][1,6]naphthyridines, pyrrolo[3,2-c]quinolines, azepino[3,2-c]quinolines, and pyrano[3,2-c]quinolines through 2-4-step sequences featuring an initial multicomponent Povarov reaction as the key step.  To assess the therapeutic potential of the novel compds., we have evaluated their in vitro activity against T. brucei, T. cruzi, and Leishmania infantum, as well as their brain permeability, which is of specific interest for the treatment of late-stage HAT.  To assess their potential toxicity, we have detd. their cytotoxicity against rat myoblast L6 cells and their AChE inhibitory activity.  Several tricyclic heterofused quinoline derivs. were found to display an interesting multi-trypanosomatid profile, with one-digit micromolar potencies against two of these parasites and two-digit micromolar potency against the other.  Pyranoquinoline (II), which displays IC50 values of 1.5 μM, 6.1 μM and 29.2 μM against T. brucei, L. infantum and T. cruzi, resp., brain permeability, better drug-like properties (lower lipophilicity and mol. wt. and higher CNS MPO desirability score) than hit 1, and the lowest AChE inhibitory activity of the series (IC50 > 30 μM), emerges as an interesting multi-trypanosomatid lead, amenable to further optimization particularly in terms of its selectivity index over mammalian cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSElDBXWPo0LVg90H21EOLACvtfcHk0lhUzNkWXKKDjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKhu7bK&md5=8e483f32d39b7526dceac3ad35e8cd38</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DVicente-Garcia%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DM.%2BC.%26aulast%3DBerenguer%26aufirst%3DD.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DLanzoni%26aufirst%3DA.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DSayago%26aufirst%3DH.%26aulast%3DRiera%26aufirst%3DC.%26aulast%3DFisa%26aufirst%3DR.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DPerez%26aufirst%3DB.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DMunoz-Torrero%26aufirst%3DD.%26atitle%3DMulticomponent%2520reaction-based%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520tricyclic%2520heterofused%2520quinolines%2520with%2520multi-trypanosomatid%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D105%26spage%3D120%26epage%3D137%26doi%3D10.1016%2Fj.ejmech.2015.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Gros, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orenes Lorente, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardley, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattray, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wharton, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croft, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruiz-Perez, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Pacanowska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, I. H.</span><span> </span><span class="NLM_article-title">Evaluation of azasterols as anti-parasitics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6094</span><span class="NLM_x">–</span> <span class="NLM_lpage">6103</span><span class="refDoi"> DOI: 10.1021/jm060290f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060290f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BD28Xptleltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6094-6103&author=L.+Grosauthor=S.+Orenes+Lorenteauthor=C.+Jimenezauthor=V.+Yardleyauthor=L.+Rattrayauthor=H.+Whartonauthor=S.+Littleauthor=S.+L.+Croftauthor=L.+M.+Ruiz-Perezauthor=D.+Gonzalez-Pacanowskaauthor=I.+H.+Gilbert&title=Evaluation+of+azasterols+as+anti-parasitics&doi=10.1021%2Fjm060290f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Azasterols as Anti-Parasitics</span></div><div class="casAuthors">Gros, Ludovic; Lorente, Silvia Orenes; Jimenez Jimenez, Carmen; Yardley, Vanessa; Rattray, Lauren; Wharton, Hayley; Little, Susan; Croft, Simon L.; Ruiz-Perez, Luis M.; Gonzalez-Pacanowska, Dolores; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6094-6103</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this article, the design and synthesis of some novel azasterols is described, followed by their evaluation against Trypanosoma brucei rhodesiense, T. cruzi, Leishmania donovani, and Plasmodium falciparum, the causative agents of human African trypanosomiasis, Chagas disease, leishmaniasis, and malaria, resp.  Some of the compds. showed antiparasitic activity.  In particular, a no. of compds. appeared to very potently inhibit the growth of the blood stream form T. b. rhodesiense, with one compd. giving an IC50 value of 12 nM.  Clear structure activity relationships could be discerned.  These compds. represent important leads for further optimization.  Azasterols have previously been shown to inhibit sterol biosynthesis in T. cruzi and L. donovani by the inhibition of the enzyme sterol 24-methyltransferase.  However, in this case, none of the compds. showed inhibition of the enzyme.  Therefore, these compds. have an unknown mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF-KBlrYBQcrVg90H21EOLACvtfcHk0lgkMoYxo_z7-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xptleltrg%253D&md5=07e735f1df4e90217397039b211db49f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm060290f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060290f%26sid%3Dliteratum%253Aachs%26aulast%3DGros%26aufirst%3DL.%26aulast%3DOrenes%2BLorente%26aufirst%3DS.%26aulast%3DJimenez%26aufirst%3DC.%26aulast%3DYardley%26aufirst%3DV.%26aulast%3DRattray%26aufirst%3DL.%26aulast%3DWharton%26aufirst%3DH.%26aulast%3DLittle%26aufirst%3DS.%26aulast%3DCroft%26aufirst%3DS.%2BL.%26aulast%3DRuiz-Perez%26aufirst%3DL.%2BM.%26aulast%3DGonzalez-Pacanowska%26aufirst%3DD.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DEvaluation%2520of%2520azasterols%2520as%2520anti-parasitics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6094%26epage%3D6103%26doi%3D10.1021%2Fjm060290f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Velasquez, A. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francisco, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohatsu, A. A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, F. A. d. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixeira, R. G. d. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiari, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Almeida, M. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaac, V. L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicarelli, R. M. B.</span><span> </span><span class="NLM_article-title">Synthesis and tripanocidal activity of ferrocenyl and benzyl diamines against <i>Trypanosoma brucei</i> and <i>Trypanosoma cruzi</i></span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1707</span><span class="NLM_x">–</span> <span class="NLM_lpage">1710</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.02.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.bmcl.2014.02.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=1707-1710&author=A.+M.+A.+Velasquezauthor=A.+I.+Franciscoauthor=A.+A.+N.+Kohatsuauthor=F.+A.+d.+J.+Silvaauthor=D.+F.+Rodriguesauthor=R.+G.+d.+S.+Teixeiraauthor=B.+G.+Chiariauthor=M.+G.+J.+de+Almeidaauthor=V.+L.+B.+Isaacauthor=M.+D.+Vargasauthor=R.+M.+B.+Cicarelli&title=Synthesis+and+tripanocidal+activity+of+ferrocenyl+and+benzyl+diamines+against+Trypanosoma+brucei+and+Trypanosoma+cruzi&doi=10.1016%2Fj.bmcl.2014.02.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.02.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.02.046%26sid%3Dliteratum%253Aachs%26aulast%3DVelasquez%26aufirst%3DA.%2BM.%2BA.%26aulast%3DFrancisco%26aufirst%3DA.%2BI.%26aulast%3DKohatsu%26aufirst%3DA.%2BA.%2BN.%26aulast%3DSilva%26aufirst%3DF.%2BA.%2Bd.%2BJ.%26aulast%3DRodrigues%26aufirst%3DD.%2BF.%26aulast%3DTeixeira%26aufirst%3DR.%2BG.%2Bd.%2BS.%26aulast%3DChiari%26aufirst%3DB.%2BG.%26aulast%3Dde%2BAlmeida%26aufirst%3DM.%2BG.%2BJ.%26aulast%3DIsaac%26aufirst%3DV.%2BL.%2BB.%26aulast%3DVargas%26aufirst%3DM.%2BD.%26aulast%3DCicarelli%26aufirst%3DR.%2BM.%2BB.%26atitle%3DSynthesis%2520and%2520tripanocidal%2520activity%2520of%2520ferrocenyl%2520and%2520benzyl%2520diamines%2520against%2520Trypanosoma%2520brucei%2520and%2520Trypanosoma%2520cruzi%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D1707%26epage%3D1710%26doi%3D10.1016%2Fj.bmcl.2014.02.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Bosc, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouray, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cojean, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loiseau, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas-Junior, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraes, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grellier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, J.</span><span> </span><span class="NLM_article-title">Highly improved antiparasitic activity after introduction of an <i>N</i>-benzylimidazole moiety on protein farnesyltransferase inhibitors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.ejmech.2015.12.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=26774924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC28Xns1Wiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2016&pages=173-186&author=D.+Boscauthor=E.+Mourayauthor=S.+Cojeanauthor=C.+H.+Francoauthor=P.+M.+Loiseauauthor=L.+H.+Freitas-Juniorauthor=C.+B.+Moraesauthor=P.+Grellierauthor=J.+Dubois&title=Highly+improved+antiparasitic+activity+after+introduction+of+an+N-benzylimidazole+moiety+on+protein+farnesyltransferase+inhibitors&doi=10.1016%2Fj.ejmech.2015.12.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors</span></div><div class="casAuthors">Bosc, Damien; Mouray, Elisabeth; Cojean, Sandrine; Franco, Caio Haddad; Loiseau, Philippe M.; Freitas-Junior, Lucio H.; Moraes, Carolina Borsoi; Grellier, Philippe; Dubois, Joelle</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">173-186</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In our search for new protein farnesyltransferase inhibitors with improved antiparasitic activities, we modified our previously developed 3-arylthiophene series of inhibitors by replacing the thioisopropyl group by different substituted imidazolylmethanamino moieties.  Twenty four new derivs. were synthesized and evaluated against human and parasite farnesyltransferases, and their anti-parasitic activity was detd. against Plasmodium falciparum, Trypanosoma brucei, Trypanosoma cruzi, and Leishmania donovani.  Introduction of a N-p-substituted-benzylimidazole led to significantly increase the inhibition of parasite proliferation in the submicromolar range.  The structure of the best inhibitors was parasite dependent.  Three compds. possess IC50 values at the same range as the ref. miltefosine against L. donovani proliferation and other new derivs. display high level of anti-trypanosomal activity against T. cruzi, higher or in the same order of magnitude as the ref. compds. benznidazole and nifurtimox.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMV7teVjretLVg90H21EOLACvtfcHk0lgkMoYxo_z7-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xns1Wiug%253D%253D&md5=fcd7740879733a2b9326ebd81b81328d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DBosc%26aufirst%3DD.%26aulast%3DMouray%26aufirst%3DE.%26aulast%3DCojean%26aufirst%3DS.%26aulast%3DFranco%26aufirst%3DC.%2BH.%26aulast%3DLoiseau%26aufirst%3DP.%2BM.%26aulast%3DFreitas-Junior%26aufirst%3DL.%2BH.%26aulast%3DMoraes%26aufirst%3DC.%2BB.%26aulast%3DGrellier%26aufirst%3DP.%26aulast%3DDubois%26aufirst%3DJ.%26atitle%3DHighly%2520improved%2520antiparasitic%2520activity%2520after%2520introduction%2520of%2520an%2520N-benzylimidazole%2520moiety%2520on%2520protein%2520farnesyltransferase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D109%26spage%3D173%26epage%3D186%26doi%3D10.1016%2Fj.ejmech.2015.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Papadopoulou, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomer, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span> </span><span class="NLM_article-title">3-Nitrotriazole-based piperazides as potent antitrypanosomal agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.08.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.ejmech.2015.08.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2015&pages=325-334&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=I.+P.+O%E2%80%99Sheaauthor=S.+R.+Wilkinsonauthor=M.+Kaiser&title=3-Nitrotriazole-based+piperazides+as+potent+antitrypanosomal+agents&doi=10.1016%2Fj.ejmech.2015.08.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.08.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.08.042%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DI.%2BP.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DKaiser%26aufirst%3DM.%26atitle%3D3-Nitrotriazole-based%2520piperazides%2520as%2520potent%2520antitrypanosomal%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D103%26spage%3D325%26epage%3D334%26doi%3D10.1016%2Fj.ejmech.2015.08.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Papadopoulou, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomer, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span> </span><span class="NLM_article-title">Novel nitro(triazole/imidazole)-based heteroarylamides/sulfonamides as potential antitrypanosomal agents</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.ejmech.2014.09.045" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=79-88&author=M.+V.+Papadopoulouauthor=W.+D.+Bloomerauthor=H.+S.+Rosenzweigauthor=S.+R.+Wilkinsonauthor=M.+Kaiser&title=Novel+nitro%28triazole%2Fimidazole%29-based+heteroarylamides%2Fsulfonamides+as+potential+antitrypanosomal+agents&doi=10.1016%2Fj.ejmech.2014.09.045"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.045%26sid%3Dliteratum%253Aachs%26aulast%3DPapadopoulou%26aufirst%3DM.%2BV.%26aulast%3DBloomer%26aufirst%3DW.%2BD.%26aulast%3DRosenzweig%26aufirst%3DH.%2BS.%26aulast%3DWilkinson%26aufirst%3DS.%2BR.%26aulast%3DKaiser%26aufirst%3DM.%26atitle%3DNovel%2520nitro%2528triazole%252Fimidazole%2529-based%2520heteroarylamides%252Fsulfonamides%2520as%2520potential%2520antitrypanosomal%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D79%26epage%3D88%26doi%3D10.1016%2Fj.ejmech.2014.09.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Brimacombe, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasquez-Valdivieso, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNae, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fothergill-Gilmore, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michels, P. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeonov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxer, M. B.</span><span> </span><span class="NLM_article-title">Identification of ML251, a potent inhibitor of <i>T. brucei</i> and <i>T. cruzi</i> phosphofructokinase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span><span class="refDoi"> DOI: 10.1021/ml400259d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400259d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=12-17&author=K.+R.+Brimacombeauthor=M.+J.+Walshauthor=L.+Liuauthor=M.+G.+Vasquez-Valdiviesoauthor=H.+P.+Morganauthor=I.+McNaeauthor=L.+A.+Fothergill-Gilmoreauthor=P.+A.+M.+Michelsauthor=D.+S.+Auldauthor=A.+Simeonovauthor=M.+D.+Walkinshawauthor=M.+Shenauthor=M.+B.+Boxer&title=Identification+of+ML251%2C+a+potent+inhibitor+of+T.+brucei+and+T.+cruzi+phosphofructokinase&doi=10.1021%2Fml400259d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fml400259d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400259d%26sid%3Dliteratum%253Aachs%26aulast%3DBrimacombe%26aufirst%3DK.%2BR.%26aulast%3DWalsh%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DVasquez-Valdivieso%26aufirst%3DM.%2BG.%26aulast%3DMorgan%26aufirst%3DH.%2BP.%26aulast%3DMcNae%26aufirst%3DI.%26aulast%3DFothergill-Gilmore%26aufirst%3DL.%2BA.%26aulast%3DMichels%26aufirst%3DP.%2BA.%2BM.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26aulast%3DShen%26aufirst%3DM.%26aulast%3DBoxer%26aufirst%3DM.%2BB.%26atitle%3DIdentification%2520of%2520ML251%252C%2520a%2520potent%2520inhibitor%2520of%2520T.%2520brucei%2520and%2520T.%2520cruzi%2520phosphofructokinase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D12%26epage%3D17%26doi%3D10.1021%2Fml400259d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Woodring, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leed, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciotti, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mensa-Wilmot, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastri, M. P.</span><span> </span><span class="NLM_article-title">Evaluation of aromatic 6-substituted thienopyrimidines as scaffolds against parasites that cause trypanosomiasis, leishmaniasis, and malaria</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">346</span><span class="refDoi"> DOI: 10.1039/C4MD00441H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1039%2FC4MD00441H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=25685309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFegt7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=339-346&author=J.+L.+Woodringauthor=G.+Patelauthor=J.+Erathauthor=R.+Beheraauthor=P.+J.+Leeauthor=S.+E.+Leedauthor=A.+Rodriguezauthor=R.+J.+Sciottiauthor=K.+Mensa-Wilmotauthor=M.+P.+Pollastri&title=Evaluation+of+aromatic+6-substituted+thienopyrimidines+as+scaffolds+against+parasites+that+cause+trypanosomiasis%2C+leishmaniasis%2C+and+malaria&doi=10.1039%2FC4MD00441H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of aromatic 6-substituted thienopyrimidines as scaffolds against parasites that cause trypanosomiasis, leishmaniasis, and malaria</span></div><div class="casAuthors">Woodring, Jennifer L.; Patel, Gautam; Erath, Jessey; Behera, Ranjan; Lee, Patricia J.; Leed, Susan E.; Rodriguez, Ana; Sciotti, Richard J.; Mensa-Wilmot, Kojo; Pollastri, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-346</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Target repurposing is a proven method for finding new lead compds. that target Trypanosoma brucei, the causative agent of human African trypanosomiasis.  Due to the recent discovery of a lapatinib-derived analog 2 with excellent potency against T. brucei (EC50 = 42 nM) and selectivity over human host cells, we have explored other classes of human tyrosine kinase inhibitor scaffolds in order to expand the range of chemotypes for pursuit.  Following library expansion, we found compd. 11e to have an EC50 of 84 nM against T. brucei cells while maintaining selectivity over human hepatocytes.  In addn., the library was tested against causative agents of Chagas' disease, leishmaniasis, and malaria.  Two analogs with sub-micromolar potencies for T. cruzi (4j) and Plasmodium falciparum (11j) were discovered, along with an analog with considerable potency against Leishmania major amastigotes (4e).  Besides identifying new and potent protozoan growth inhibitors, these data highlight the value of concurrent screening of a chem. library against different protozoan parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhNEhEzrySvbVg90H21EOLACvtfcHk0lj0wOaD9M1Niw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFegt7%252FM&md5=9a9d6c171e8411f14c794b18360f2526</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1039%2FC4MD00441H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00441H%26sid%3Dliteratum%253Aachs%26aulast%3DWoodring%26aufirst%3DJ.%2BL.%26aulast%3DPatel%26aufirst%3DG.%26aulast%3DErath%26aufirst%3DJ.%26aulast%3DBehera%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DP.%2BJ.%26aulast%3DLeed%26aufirst%3DS.%2BE.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DSciotti%26aufirst%3DR.%2BJ.%26aulast%3DMensa-Wilmot%26aufirst%3DK.%26aulast%3DPollastri%26aufirst%3DM.%2BP.%26atitle%3DEvaluation%2520of%2520aromatic%25206-substituted%2520thienopyrimidines%2520as%2520scaffolds%2520against%2520parasites%2520that%2520cause%2520trypanosomiasis%252C%2520leishmaniasis%252C%2520and%2520malaria%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D339%26epage%3D346%26doi%3D10.1039%2FC4MD00441H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Patrick, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ismail, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arafa, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandharkar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbovetz, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykin, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span> </span><span class="NLM_article-title">Synthesis and antiprotozoal activity of dicationic <i>m</i>-terphenyl and 1,3-dipyridylbenzene derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5473</span><span class="NLM_x">–</span> <span class="NLM_lpage">5494</span><span class="refDoi"> DOI: 10.1021/jm400508e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400508e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5473-5494&author=D.+A.+Patrickauthor=M.+A.+Ismailauthor=R.+K.+Arafaauthor=T.+Wenzlerauthor=X.+Zhuauthor=T.+Pandharkarauthor=S.+K.+Jonesauthor=K.+A.+Werbovetzauthor=R.+Brunauthor=D.+W.+Boykinauthor=R.+R.+Tidwell&title=Synthesis+and+antiprotozoal+activity+of+dicationic+m-terphenyl+and+1%2C3-dipyridylbenzene+derivatives&doi=10.1021%2Fjm400508e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm400508e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400508e%26sid%3Dliteratum%253Aachs%26aulast%3DPatrick%26aufirst%3DD.%2BA.%26aulast%3DIsmail%26aufirst%3DM.%2BA.%26aulast%3DArafa%26aufirst%3DR.%2BK.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DPandharkar%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DS.%2BK.%26aulast%3DWerbovetz%26aufirst%3DK.%2BA.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DBoykin%26aufirst%3DD.%2BW.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DSynthesis%2520and%2520antiprotozoal%2520activity%2520of%2520dicationic%2520m-terphenyl%2520and%25201%252C3-dipyridylbenzene%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5473%26epage%3D5494%26doi%3D10.1021%2Fjm400508e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Sykes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moawad, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganame, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioset, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span> </span><span class="NLM_article-title">Identification of compounds with anti-proliferative activity against <i>Trypanosoma brucei brucei</i> strain 427 by a whole cell viability based HTS campaign</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1896</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0001896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0001896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=23209849" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=e1896&author=M.+L.+Sykesauthor=J.+B.+Baellauthor=M.+Kaiserauthor=E.+Chatelainauthor=S.+R.+Moawadauthor=D.+Ganameauthor=J.-R.+Iosetauthor=V.+M.+Avery&title=Identification+of+compounds+with+anti-proliferative+activity+against+Trypanosoma+brucei+brucei+strain+427+by+a+whole+cell+viability+based+HTS+campaign&doi=10.1371%2Fjournal.pntd.0001896"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0001896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0001896%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DMoawad%26aufirst%3DS.%2BR.%26aulast%3DGaname%26aufirst%3DD.%26aulast%3DIoset%26aufirst%3DJ.-R.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26atitle%3DIdentification%2520of%2520compounds%2520with%2520anti-proliferative%2520activity%2520against%2520Trypanosoma%2520brucei%2520brucei%2520strain%2520427%2520by%2520a%2520whole%2520cell%2520viability%2520based%2520HTS%2520campaign%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2012%26volume%3D6%26spage%3De1896%26doi%3D10.1371%2Fjournal.pntd.0001896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Ferrins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teston, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almohaywi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span> </span><span class="NLM_article-title">3-(Oxazolo[4,5-<i>b</i>]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid <i>Trypanosoma brucei</i>, the causative agent for human African trypanosomiasis</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2013.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.ejmech.2013.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=23831695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Sktb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2013&pages=450-465&author=L.+Ferrinsauthor=R.+Rahmaniauthor=M.+L.+Sykesauthor=A.+J.+Jonesauthor=V.+M.+Averyauthor=E.+Testonauthor=B.+Almohaywiauthor=J.+X.+Yinauthor=J.+Smithauthor=C.+Hylandauthor=K.+L.+Whiteauthor=E.+Ryanauthor=M.+Campbellauthor=S.+A.+Charmanauthor=M.+Kaiserauthor=J.+B.+Baell&title=3-%28Oxazolo%5B4%2C5-b%5Dpyridin-2-yl%29anilides+as+a+novel+class+of+potent+inhibitors+for+the+kinetoplastid+Trypanosoma+brucei%2C+the+causative+agent+for+human+African+trypanosomiasis&doi=10.1016%2Fj.ejmech.2013.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis</span></div><div class="casAuthors">Ferrins, Lori; Rahmani, Raphael; Sykes, Melissa L.; Jones, Amy J.; Avery, Vicky M.; Teston, Eliott; Almohaywi, Basmah; Yin, Jie Xiang; Smith, Jason; Hyland, Chris; White, Karen L.; Ryan, Eileen; Campbell, Michael; Charman, Susan A.; Kaiser, Marcel; Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">450-465</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A whole organism high-throughput screen of approx. 87,000 compds. against Trypanosoma brucei brucei led to the recent discovery of several novel compd. classes with low micromolar activity against this organism and without appreciable cytotoxicity to mammalian cells.  Herein we report a structure-activity relation (SAR) investigation around one of these hit classes, the 3-(oxazolo[4,5-b]pyridin-2-yl)anilides.  Sharp SAR is revealed, with our most active compd. (I) exhibiting an IC50 of 91 nM against the human pathogenic strain T.b. rhodesiense and being more than 700 times less toxic towards the L6 mammalian cell line.  Physicochem. properties are attractive for many compds. in this series.  For the most potent representatives, we show that soly. and metabolic stability are key parameters to target during future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruFGlHJ2ScL7Vg90H21EOLACvtfcHk0liAQAw86ZTA6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Sktb7L&md5=12ad544172d828822118646b5b95bf6d</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DRahmani%26aufirst%3DR.%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DTeston%26aufirst%3DE.%26aulast%3DAlmohaywi%26aufirst%3DB.%26aulast%3DYin%26aufirst%3DJ.%2BX.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DHyland%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3D3-%2528Oxazolo%255B4%252C5-b%255Dpyridin-2-yl%2529anilides%2520as%2520a%2520novel%2520class%2520of%2520potent%2520inhibitors%2520for%2520the%2520kinetoplastid%2520Trypanosoma%2520brucei%252C%2520the%2520causative%2520agent%2520for%2520human%2520African%2520trypanosomiasis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D66%26spage%3D450%26epage%3D465%26doi%3D10.1016%2Fj.ejmech.2013.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Rashad, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. A.</span><span> </span><span class="NLM_article-title">Facile synthesis and preliminary structure-activity analysis of new sulfonamides against <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">496</span><span class="NLM_x">–</span> <span class="NLM_lpage">500</span><span class="refDoi"> DOI: 10.1021/ml400487t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400487t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=496-500&author=A.+A.+Rashadauthor=A.+J.+Jonesauthor=V.+M.+Averyauthor=J.+Baellauthor=P.+A.+Keller&title=Facile+synthesis+and+preliminary+structure-activity+analysis+of+new+sulfonamides+against+Trypanosoma+brucei&doi=10.1021%2Fml400487t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fml400487t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400487t%26sid%3Dliteratum%253Aachs%26aulast%3DRashad%26aufirst%3DA.%2BA.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DKeller%26aufirst%3DP.%2BA.%26atitle%3DFacile%2520synthesis%2520and%2520preliminary%2520structure-activity%2520analysis%2520of%2520new%2520sulfonamides%2520against%2520Trypanosoma%2520brucei%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D496%26epage%3D500%26doi%3D10.1021%2Fml400487t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Manos-Turvey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, R. J.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of phenoxymethylbenzamide analogues as anti-trypanosomal agents</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">406</span><span class="refDoi"> DOI: 10.1039/C4MD00406J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1039%2FC4MD00406J" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=403-406&author=A.+Manos-Turveyauthor=E.+E.+Watsonauthor=M.+L.+Sykesauthor=A.+J.+Jonesauthor=J.+B.+Baellauthor=M.+Kaiserauthor=V.+M.+Averyauthor=R.+J.+Payne&title=Synthesis+and+evaluation+of+phenoxymethylbenzamide+analogues+as+anti-trypanosomal+agents&doi=10.1039%2FC4MD00406J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1039%2FC4MD00406J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MD00406J%26sid%3Dliteratum%253Aachs%26aulast%3DManos-Turvey%26aufirst%3DA.%26aulast%3DWatson%26aufirst%3DE.%2BE.%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DPayne%26aufirst%3DR.%2BJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520phenoxymethylbenzamide%2520analogues%2520as%2520anti-trypanosomal%2520agents%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D403%26epage%3D406%26doi%3D10.1039%2FC4MD00406J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Rahmani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganame, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span> </span><span class="NLM_article-title">6-Arylpyrazine-2-carboxamides: a new core for <i>Trypanosoma brucei</i> inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6753</span><span class="NLM_x">–</span> <span class="NLM_lpage">6765</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00438</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6753-6765&author=R.+Rahmaniauthor=K.+Banauthor=A.+J.+Jonesauthor=L.+Ferrinsauthor=D.+Ganameauthor=M.+L.+Sykesauthor=V.+M.+Averyauthor=K.+L.+Whiteauthor=E.+Ryanauthor=M.+Kaiserauthor=S.+A.+Charmanauthor=J.+B.+Baell&title=6-Arylpyrazine-2-carboxamides%3A+a+new+core+for+Trypanosoma+brucei+inhibitors&doi=10.1021%2Facs.jmedchem.5b00438"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00438%26sid%3Dliteratum%253Aachs%26aulast%3DRahmani%26aufirst%3DR.%26aulast%3DBan%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DGaname%26aufirst%3DD.%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3D6-Arylpyrazine-2-carboxamides%253A%2520a%2520new%2520core%2520for%2520Trypanosoma%2520brucei%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6753%26epage%3D6765%26doi%3D10.1021%2Facs.jmedchem.5b00438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Ferrins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, C. A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span> </span><span class="NLM_article-title">Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid <i>Trypanosoma brucei</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6393</span><span class="NLM_x">–</span> <span class="NLM_lpage">6402</span><span class="refDoi"> DOI: 10.1021/jm500191u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500191u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6393-6402&author=L.+Ferrinsauthor=M.+Gazdikauthor=R.+Rahmaniauthor=S.+Vargheseauthor=M.+L.+Sykesauthor=A.+J.+Jonesauthor=V.+M.+Averyauthor=K.+L.+Whiteauthor=E.+Ryanauthor=S.+A.+Charmanauthor=M.+Kaiserauthor=C.+A.+S.+Bergstromauthor=J.+B.+Baell&title=Pyridyl+benzamides+as+a+novel+class+of+potent+inhibitors+for+the+kinetoplastid+Trypanosoma+brucei&doi=10.1021%2Fjm500191u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm500191u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500191u%26sid%3Dliteratum%253Aachs%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DGazdik%26aufirst%3DM.%26aulast%3DRahmani%26aufirst%3DR.%26aulast%3DVarghese%26aufirst%3DS.%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DBergstrom%26aufirst%3DC.%2BA.%2BS.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3DPyridyl%2520benzamides%2520as%2520a%2520novel%2520class%2520of%2520potent%2520inhibitors%2520for%2520the%2520kinetoplastid%2520Trypanosoma%2520brucei%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6393%26epage%3D6402%26doi%3D10.1021%2Fjm500191u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Baell, J.; Piggott, M.; Russell, S.; Toynton, A.; Rahmani, R.; Ferrins, L.; Nguyen, N.</span><span> </span><span class="NLM_article-title">Heterocyclic compounds and use of same</span>. WO 2015172196 A1, 20151119, 20150513,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Baell&author=M.+Piggott&author=S.+Russell&author=A.+Toynton&author=R.+Rahmani&author=L.+Ferrins&author=N.+Nguyen&title=Heterocyclic+compounds+and+use+of+same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%26atitle%3DHeterocyclic%2520compounds%2520and%2520use%2520of%2520same%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span><span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0liAECSRwkORjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Walczynski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuiderveld, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glinka, R.</span><span> </span><span class="NLM_article-title">Histamine H1 receptor ligands. Part I. Novel thiazol-4-ylethanamine derivatives: synthesis and in vitro pharmacology</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span><span class="refDoi"> DOI: 10.1016/S0014-827X(99)00060-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0014-827X%2899%2900060-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10510850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFClsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1999&pages=533-541&author=K.+Walczynskiauthor=H.+Timmermanauthor=O.+P.+Zuiderveldauthor=M.+Q.+Zhangauthor=R.+Glinka&title=Histamine+H1+receptor+ligands.+Part+I.+Novel+thiazol-4-ylethanamine+derivatives%3A+synthesis+and+in+vitro+pharmacology&doi=10.1016%2FS0014-827X%2899%2900060-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Histamine H1 receptor ligands. Part I. Novel thiazol-4-ylethanamine derivatives: synthesis and in vitro pharmacology</span></div><div class="casAuthors">Walczynski, K.; Timmerman, H.; Zuiderveld, O. P.; Zhang, M. Q.; Glinka, R.</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">533-541</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">A series of 2-substituted thiazol-4-ylethanamines have been synthesized and tested for their histaminergic H1-receptor activities.  The compds. with 2-Ph substitution, regardless of the different physicochem. properties of the meta-substituents at the Ph ring, showed weak H1-agonistic activity with pD2 values ranging from 4.35 to 5.36.  When the Ph group was replaced by a benzyl group, the resulting compds. all exhibited weak H1-antagonistic activity (pA2: 4.14-4.82).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR2iX_bbC4RLVg90H21EOLACvtfcHk0liAECSRwkORjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFClsrs%253D&md5=a508efa178299cbe6eb3f28b7e29ef42</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2899%2900060-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252899%252900060-9%26sid%3Dliteratum%253Aachs%26aulast%3DWalczynski%26aufirst%3DK.%26aulast%3DTimmerman%26aufirst%3DH.%26aulast%3DZuiderveld%26aufirst%3DO.%2BP.%26aulast%3DZhang%26aufirst%3DM.%2BQ.%26aulast%3DGlinka%26aufirst%3DR.%26atitle%3DHistamine%2520H1%2520receptor%2520ligands.%2520Part%2520I.%2520Novel%2520thiazol-4-ylethanamine%2520derivatives%253A%2520synthesis%2520and%2520in%2520vitro%2520pharmacology%26jtitle%3DFarmaco%26date%3D1999%26volume%3D54%26spage%3D533%26epage%3D541%26doi%3D10.1016%2FS0014-827X%2899%2900060-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Ahangar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alipour, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pashapour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foroumadi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emami, S.</span><span> </span><span class="NLM_article-title">1-[(2-Arylthiazol-4-yl)methyl]azoles as a new class of anticonvulsants: design, synthesis, in vivo screening, and in silico drug-like properties</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span><span class="refDoi"> DOI: 10.1111/j.1747-0285.2011.01211.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1111%2Fj.1747-0285.2011.01211.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=21827633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2nsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2011&pages=844-852&author=N.+Ahangarauthor=A.+Ayatiauthor=E.+Alipourauthor=A.+Pashapourauthor=A.+Foroumadiauthor=S.+Emami&title=1-%5B%282-Arylthiazol-4-yl%29methyl%5Dazoles+as+a+new+class+of+anticonvulsants%3A+design%2C+synthesis%2C+in+vivo+screening%2C+and+in+silico+drug-like+properties&doi=10.1111%2Fj.1747-0285.2011.01211.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">1-[(2-arylthiazol-4-yl)methyl]azoles as a new class of anticonvulsants: design, synthesis, in vivo screening, and in silico drug-like properties</span></div><div class="casAuthors">Ahangar, Nematollah; Ayati, Adile; Alipour, Eskandar; Pashapour, Arsalan; Foroumadi, Alireza; Emami, Saeed</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">844-852</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A series of novel thiazole incorporated (arylalkyl)azoles were synthesized and screened for their anticonvulsant properties using maximal electroshock and pentylenetetrazole models in mice.  Among target compds., 1-[(2-(4-chlorophenyl)thiazol-4-yl)methyl]-1H-imidazole, 1-[(2-phenylthiazol-4-yl)methyl]-1H-1,2,4-triazole, and its 4-chlorophenyl analog were able to display noticeable anticonvulsant activity in both pentylenetetrazole and maximal electroshock tests with percentage protection range of 33-100%.  A computational study was carried out for prediction of pharmacokinetics properties and drug-likeness.  The structure-activity relationship and in silico drug relevant properties confirmed that the compds. were within the range set by Lipinski's rule-of-five, and possessing favorable physicochem. properties for acting as CNS-drugs, making them potentially promising agents for epilepsy therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoarS45gXaESLVg90H21EOLACvtfcHk0lhyZv8GzuebhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2nsrrF&md5=51a76a0e5a2ccf1fce7533fb86b124f1</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2011.01211.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2011.01211.x%26sid%3Dliteratum%253Aachs%26aulast%3DAhangar%26aufirst%3DN.%26aulast%3DAyati%26aufirst%3DA.%26aulast%3DAlipour%26aufirst%3DE.%26aulast%3DPashapour%26aufirst%3DA.%26aulast%3DForoumadi%26aufirst%3DA.%26aulast%3DEmami%26aufirst%3DS.%26atitle%3D1-%255B%25282-Arylthiazol-4-yl%2529methyl%255Dazoles%2520as%2520a%2520new%2520class%2520of%2520anticonvulsants%253A%2520design%252C%2520synthesis%252C%2520in%2520vivo%2520screening%252C%2520and%2520in%2520silico%2520drug-like%2520properties%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2011%26volume%3D78%26spage%3D844%26epage%3D852%26doi%3D10.1111%2Fj.1747-0285.2011.01211.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Huntress, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfister, K.,  III</span><span> </span><span class="NLM_article-title">Conversion of 2-phenyl-4-chloromethylthiazole to 2-phenyl-4-hydroxymethyl-5-chlorothiazole</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1943</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1667</span><span class="NLM_x">–</span> <span class="NLM_lpage">1670</span><span class="refDoi"> DOI: 10.1021/ja01249a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01249a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1943&pages=1667-1670&author=E.+H.+Huntressauthor=K.+Pfister&title=Conversion+of+2-phenyl-4-chloromethylthiazole+to+2-phenyl-4-hydroxymethyl-5-chlorothiazole&doi=10.1021%2Fja01249a002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fja01249a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01249a002%26sid%3Dliteratum%253Aachs%26aulast%3DHuntress%26aufirst%3DE.%2BH.%26aulast%3DPfister%26aufirst%3DK.%26atitle%3DConversion%2520of%25202-phenyl-4-chloromethylthiazole%2520to%25202-phenyl-4-hydroxymethyl-5-chlorothiazole%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1943%26volume%3D65%26spage%3D1667%26epage%3D1670%26doi%3D10.1021%2Fja01249a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Satoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaji, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, Z.</span><span> </span><span class="NLM_article-title">Reduction of organic compounds with sodium borohydride-transition metal salt systems. I. Reduction of organic nitrile, nitro and amide compounds to primary amines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1969</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4555</span><span class="NLM_x">–</span> <span class="NLM_lpage">4558</span><span class="refDoi"> DOI: 10.1016/S0040-4039(01)88749-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0040-4039%2801%2988749-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1969&pages=4555-4558&author=T.+Satohauthor=S.+Suzukiauthor=Y.+Suzukiauthor=Y.+Miyajiauthor=Z.+Imai&title=Reduction+of+organic+compounds+with+sodium+borohydride-transition+metal+salt+systems.+I.+Reduction+of+organic+nitrile%2C+nitro+and+amide+compounds+to+primary+amines&doi=10.1016%2FS0040-4039%2801%2988749-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2801%2988749-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252801%252988749-9%26sid%3Dliteratum%253Aachs%26aulast%3DSatoh%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DMiyaji%26aufirst%3DY.%26aulast%3DImai%26aufirst%3DZ.%26atitle%3DReduction%2520of%2520organic%2520compounds%2520with%2520sodium%2520borohydride-transition%2520metal%2520salt%2520systems.%2520I.%2520Reduction%2520of%2520organic%2520nitrile%252C%2520nitro%2520and%2520amide%2520compounds%2520to%2520primary%2520amines%26jtitle%3DTetrahedron%2520Lett.%26date%3D1969%26volume%3D10%26spage%3D4555%26epage%3D4558%26doi%3D10.1016%2FS0040-4039%2801%2988749-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Caddick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A. K. d. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M. R. V.</span><span> </span><span class="NLM_article-title">A generic approach for the catalytic reduction of nitriles</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5417</span><span class="NLM_x">–</span> <span class="NLM_lpage">5423</span><span class="refDoi"> DOI: 10.1016/S0040-4020(03)00858-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FS0040-4020%2803%2900858-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1egtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=5417-5423&author=S.+Caddickauthor=D.+B.+Juddauthor=A.+K.+d.+K.+Lewisauthor=M.+T.+Reichauthor=M.+R.+V.+Williams&title=A+generic+approach+for+the+catalytic+reduction+of+nitriles&doi=10.1016%2FS0040-4020%2803%2900858-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">A generic approach for the catalytic reduction of nitriles</span></div><div class="casAuthors">Caddick, Stephen; Judd, Duncan B.; Lewis, Alexandra K. de K.; Reich, Melanie T.; Williams, Meredith R. V.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">5417-5423</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The scope of Ni boride mediated redn. of nitriles was extended further to gave Boc protected amines via a mild catalytic process.  It is noteworthy that the toxicity of this procedure is greatly reduced due to its catalytic nature in NiCl2 used in combination with excess NaBH4.  The protocol is marked by its resilience towards air and moisture and hence an easy and general practical protocol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmQHRUoYQkTbVg90H21EOLACvtfcHk0lhyZv8GzuebhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1egtbc%253D&md5=e114a7d22c8bde215fe3692d86861c09</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2803%2900858-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252803%252900858-5%26sid%3Dliteratum%253Aachs%26aulast%3DCaddick%26aufirst%3DS.%26aulast%3DJudd%26aufirst%3DD.%2BB.%26aulast%3DLewis%26aufirst%3DA.%2BK.%2Bd.%2BK.%26aulast%3DReich%26aufirst%3DM.%2BT.%26aulast%3DWilliams%26aufirst%3DM.%2BR.%2BV.%26atitle%3DA%2520generic%2520approach%2520for%2520the%2520catalytic%2520reduction%2520of%2520nitriles%26jtitle%3DTetrahedron%26date%3D2003%26volume%3D59%26spage%3D5417%26epage%3D5423%26doi%3D10.1016%2FS0040-4020%2803%2900858-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Bachmann, S.; Flohr, A.; Zbinden, K. G.; Koerner, M.; Kuhn, B.; Peters, J.-U.; Rudolph, M.</span><span> </span><span class="NLM_article-title">Preparation of substituted pyrazole carboxamides as PDE10 modulators</span>. 201213598848, 20130059833, 20120830,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Bachmann&author=A.+Flohr&author=K.+G.+Zbinden&author=M.+Koerner&author=B.+Kuhn&author=J.-U.+Peters&author=M.+Rudolph&title=Preparation+of+substituted+pyrazole+carboxamides+as+PDE10+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBachmann%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520substituted%2520pyrazole%2520carboxamides%2520as%2520PDE10%2520modulators%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Duspara, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lough, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batey, R. A.</span><span> </span><span class="NLM_article-title">Synthesis and reactivity of <i>N</i>-alkyl carbamoylimidazoles: development of <i>N</i>-methyl carbamoylimidazole as a methyl isocyanate equivalent</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">10362</span><span class="NLM_x">–</span> <span class="NLM_lpage">10368</span><span class="refDoi"> DOI: 10.1021/jo302084a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo302084a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFChs77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=10362-10368&author=P.+A.+Dusparaauthor=M.+S.+Islamauthor=A.+J.+Loughauthor=R.+A.+Batey&title=Synthesis+and+reactivity+of+N-alkyl+carbamoylimidazoles%3A+development+of+N-methyl+carbamoylimidazole+as+a+methyl+isocyanate+equivalent&doi=10.1021%2Fjo302084a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Reactivity of N-Alkyl Carbamoylimidazoles: Development of N-Methyl Carbamoylimidazole as a Methyl Isocyanate Equivalent</span></div><div class="casAuthors">Duspara, Petar A.; Islam, Md. Sadequl; Lough, Alan J.; Batey, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10362-10368</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A high-yielding synthesis of N-methylcarbamoylimidazole from 1,1-carbonyldiimidazole (CDI) and MeNH3Cl is described.  The product is a cryst., readily storable, water-stable compd. that reacts as a Me isocyanate (MIC) substitute.  Reaction of N-methylcarbamoylimidazole in the presence of a base such as triethylamine occurs with nucleophiles such as amines, protected and unprotected amino acids, thiols, and alcs.  The product N-methylureas, carbamates, and thiocarbamates are obtained in good to excellent yields, with reactions occurring in either org. solvents or water.  The protocol for the synthesis of N-methylcarbamoylimidazole is both scalable and general, occurring in quant. yield at scales ranging from 300 mg to 20 g.  The success of this method relies upon the reaction of CDI with the ammonium salt rather than the free amine, resulting in a significant improvement in the yield of N-methylcarbamoylimidazole.  The reaction presumably involves a proton transfer from MeNH3Cl to the CDI, which results in the release of MeNH2 with simultaneous activation of the CDI as its protonated form.  Other primary ammonium hydrochloride salts, including protected α-amino acid salts, give excellent yields of the corresponding N-alkylcarbamoylimidazoles and serve as alkyl isocyanate surrogates.  The resultant N-alkylcarbamoylimidazoles can be converted to ureas in high yields without the formation of intermediary isocyanates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoorREoj6WubVg90H21EOLACvtfcHk0livv4KzFZfCfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFChs77M&md5=d08c052e4b74e1a90e9c84300cb72aa9</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjo302084a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo302084a%26sid%3Dliteratum%253Aachs%26aulast%3DDuspara%26aufirst%3DP.%2BA.%26aulast%3DIslam%26aufirst%3DM.%2BS.%26aulast%3DLough%26aufirst%3DA.%2BJ.%26aulast%3DBatey%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520reactivity%2520of%2520N-alkyl%2520carbamoylimidazoles%253A%2520development%2520of%2520N-methyl%2520carbamoylimidazole%2520as%2520a%2520methyl%2520isocyanate%2520equivalent%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2012%26volume%3D77%26spage%3D10362%26epage%3D10368%26doi%3D10.1021%2Fjo302084a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Gandy, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIldowie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasik, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salomonczyk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millar, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tindiglia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Iverson, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piggott, M. J.</span><span> </span><span class="NLM_article-title">Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt’s lymphoma cytotoxicity</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1039/c0md00108b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1039%2Fc0md00108b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=287-293&author=M.+N.+Gandyauthor=M.+McIldowieauthor=K.+Lewisauthor=A.+M.+Wasikauthor=D.+Salomonczykauthor=K.+Waggauthor=Z.+A.+Millarauthor=D.+Tindigliaauthor=P.+Huotauthor=T.+Johnstonauthor=S.+Thieleauthor=B.+Nguyenauthor=N.+M.+Barnesauthor=J.+M.+Brotchieauthor=M.+T.+Martin-Iversonauthor=J.+Nashauthor=J.+Gordonauthor=M.+J.+Piggott&title=Redesigning+the+designer+drug+ecstasy%3A+non-psychoactive+MDMA+analogues+exhibiting+Burkitt%E2%80%99s+lymphoma+cytotoxicity&doi=10.1039%2Fc0md00108b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1039%2Fc0md00108b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0md00108b%26sid%3Dliteratum%253Aachs%26aulast%3DGandy%26aufirst%3DM.%2BN.%26aulast%3DMcIldowie%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DK.%26aulast%3DWasik%26aufirst%3DA.%2BM.%26aulast%3DSalomonczyk%26aufirst%3DD.%26aulast%3DWagg%26aufirst%3DK.%26aulast%3DMillar%26aufirst%3DZ.%2BA.%26aulast%3DTindiglia%26aufirst%3DD.%26aulast%3DHuot%26aufirst%3DP.%26aulast%3DJohnston%26aufirst%3DT.%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DBarnes%26aufirst%3DN.%2BM.%26aulast%3DBrotchie%26aufirst%3DJ.%2BM.%26aulast%3DMartin-Iverson%26aufirst%3DM.%2BT.%26aulast%3DNash%26aufirst%3DJ.%26aulast%3DGordon%26aufirst%3DJ.%26aulast%3DPiggott%26aufirst%3DM.%2BJ.%26atitle%3DRedesigning%2520the%2520designer%2520drug%2520ecstasy%253A%2520non-psychoactive%2520MDMA%2520analogues%2520exhibiting%2520Burkitt%25E2%2580%2599s%2520lymphoma%2520cytotoxicity%26jtitle%3DMedChemComm%26date%3D2010%26volume%3D1%26spage%3D287%26epage%3D293%26doi%3D10.1039%2Fc0md00108b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Han, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, H.-G.</span><span> </span><span class="NLM_article-title">Exploration of novel 2-alkylimino-1,3-thiazolines: T-type calcium channel inhibitory activity</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span><span class="refDoi"> DOI: 10.1021/cc100041m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc100041m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVSmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=518-530&author=M.+Hanauthor=K.+D.+Namauthor=D.+Shinauthor=N.+Jeongauthor=H.-G.+Hahn&title=Exploration+of+novel+2-alkylimino-1%2C3-thiazolines%3A+T-type+calcium+channel+inhibitory+activity&doi=10.1021%2Fcc100041m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of novel 2-alkylimino-1,3-thiazolines: T-type calcium channel inhibitory activity</span></div><div class="casAuthors">Han, Minsoo; Nam, Kee Dal; Shin, Dongyun; Jeong, Nakcheol; Hahn, Hoh-Gyu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">518-530</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have developed combinatorial libraries of new 2-alkylimino-1,3-thiazolines with four diversity points, consisting of more than 500 compds., in a parallel synthetic fashion.  The synthetic strategy was based on the construction of a large library aimed at the discovery of new compds. with T-type calcium channel inhibitory activity through structure modifications of hit compd. I.  The syntheses of the compds. of Chemset A with four diversity points were accomplished by the condensation of thioureas with α-haloketones having two diversity points each.  A library of phthalimidyl 1,3-thiazolines was synthesized to provide Chemset B, which allowed the introduction of other diversity points through the nucleophilic character of the amino nitrogen.  A sublibrary, Chemset C, was constructed from the libraries of Chemset A and Chemset B by functionalization of the C-4 position of the 1,3-thiazoline ring.  The products contg. ester or acid groups at the C-4 position of the 1,3-thiazoline ring were used in amide synthesis to give a new sublibrary within Chemset C.  Deprotection of the phthalimidyl moiety and followed by the reaction with benzoyl chloride gave the corresponding sublibrary in Chemset C.  Another sublibrary which includes secondary amino derivs. was obtained by redn. of the amide moiety or reductive amination with Ph aldehyde.  The selected compds. from the generated libraries were evaluated with respect to inhibition of T-type calcium channels, where some of them have exhibited promising activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoso183a9ek-LVg90H21EOLACvtfcHk0livv4KzFZfCfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVSmurY%253D&md5=13d971c1afdd7c853b115df6b88b17ec</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fcc100041m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc100041m%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DM.%26aulast%3DNam%26aufirst%3DK.%2BD.%26aulast%3DShin%26aufirst%3DD.%26aulast%3DJeong%26aufirst%3DN.%26aulast%3DHahn%26aufirst%3DH.-G.%26atitle%3DExploration%2520of%2520novel%25202-alkylimino-1%252C3-thiazolines%253A%2520T-type%2520calcium%2520channel%2520inhibitory%2520activity%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2010%26volume%3D12%26spage%3D518%26epage%3D530%26doi%3D10.1021%2Fcc100041m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Song, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Y.</span><span> </span><span class="NLM_article-title">Preparation of alkyl carbamate of 1-protected indole-3-methylamine as a precursor of indole-3-methylamine</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2735</span><span class="NLM_x">–</span> <span class="NLM_lpage">2748</span><span class="refDoi"> DOI: 10.1080/00397910500287967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1080%2F00397910500287967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyitLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=2735-2748&author=H.+Songauthor=W.+Chenauthor=Y.+Wangauthor=Y.+Qin&title=Preparation+of+alkyl+carbamate+of+1-protected+indole-3-methylamine+as+a+precursor+of+indole-3-methylamine&doi=10.1080%2F00397910500287967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of Alkyl Carbamate of 1-Protected Indole-3-methylamine as a Precursor of Indole-3-methylamine</span></div><div class="casAuthors">Song, Hao; Chen, Wei; Wang, Yin; Qin, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2735-2748</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A series of alkyl carbamates of 1-protected indole-3-methylamines, thiophenylmethylamines and pyrrolylmethylamines were prepd. from the corresponding acetamides in good to excellent yields via diacetoxyiodobenzene-promoted Hofmann rearrangement.  For a successful Hofmann rearrangement, an electron-withdrawing group on position 1 of indolylacetamide and pyrrolylacetamide was required.  Tert.-Bu 1-tosylindol-3-ylmethylcarbamate was demonstrated to serve well as a stable precursor of 1-protected indole-3-methylamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoimt8iouiB6LVg90H21EOLACvtfcHk0livv4KzFZfCfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyitLfP&md5=d92565a04d466b4e413acf12b6f4829b</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1080%2F00397910500287967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397910500287967%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DQin%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520alkyl%2520carbamate%2520of%25201-protected%2520indole-3-methylamine%2520as%2520a%2520precursor%2520of%2520indole-3-methylamine%26jtitle%3DSynth.%2520Commun.%26date%3D2005%26volume%3D35%26spage%3D2735%26epage%3D2748%26doi%3D10.1080%2F00397910500287967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Guiles, J.; Jarvis, T.; Strong, S.; Sun, X.</span><span> </span><span class="NLM_article-title">Preparation of azolylureas as antibacterials</span>. 2007-US16566, 2008011191, 20070723,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+Guiles&author=T.+Jarvis&author=S.+Strong&author=X.+Sun&title=Preparation+of+azolylureas+as+antibacterials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuiles%26aufirst%3DJ.%26atitle%3DPreparation%2520of%2520azolylureas%2520as%2520antibacterials%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Bischofberger, N. W.; Kim, C. U.; Krawczyk, S. H.; McGee, L. R.; Postich, M. J.; Yang, W.</span><span> </span><span class="NLM_article-title">Preparation of thiepane alditols for inhibiting and detecting HIV protease</span>. 1995-552429, 6034118, 19951103,<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=N.+W.+Bischofberger&author=C.+U.+Kim&author=S.+H.+Krawczyk&author=L.+R.+McGee&author=M.+J.+Postich&author=W.+Yang&title=Preparation+of+thiepane+alditols+for+inhibiting+and+detecting+HIV+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBischofberger%26aufirst%3DN.%2BW.%26atitle%3DPreparation%2520of%2520thiepane%2520alditols%2520for%2520inhibiting%2520and%2520detecting%2520HIV%2520protease%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Zheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikulin, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konkar, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vansal, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shams, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feller, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span> </span><span class="NLM_article-title">2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-<i>c</i>]pyridines: novel selective β<sub>3</sub>-adrenoceptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">2287</span><span class="NLM_x">–</span> <span class="NLM_lpage">2294</span><span class="refDoi"> DOI: 10.1021/jm990012z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990012z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=2287-2294&author=W.+Zhengauthor=V.+I.+Nikulinauthor=A.+A.+Konkarauthor=S.+S.+Vansalauthor=G.+Shamsauthor=D.+R.+Fellerauthor=D.+D.+Miller&title=2-Amino-4-benzyl-4%2C5%2C6%2C7-tetrahydrothiazolo%5B5%2C4-c%5Dpyridines%3A+novel+selective+%CE%B23-adrenoceptor+agonists&doi=10.1021%2Fjm990012z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm990012z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990012z%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DNikulin%26aufirst%3DV.%2BI.%26aulast%3DKonkar%26aufirst%3DA.%2BA.%26aulast%3DVansal%26aufirst%3DS.%2BS.%26aulast%3DShams%26aufirst%3DG.%26aulast%3DFeller%26aufirst%3DD.%2BR.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3D2-Amino-4-benzyl-4%252C5%252C6%252C7-tetrahydrothiazolo%255B5%252C4-c%255Dpyridines%253A%2520novel%2520selective%2520%25CE%25B23-adrenoceptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D2287%26epage%3D2294%26doi%3D10.1021%2Fjm990012z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Li, W.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-T.</span><span> </span><span class="NLM_article-title">One-pot tandem copper-catalyzed library synthesis of 1-thiazolyl-1,2,3-triazoles as anticancer agents</span> <span class="citation_source-journal">ACS Comb. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span><span class="refDoi"> DOI: 10.1021/co1000234</span> </span><div class="citationLinks">[<a href="/doi/10.1021/co1000234" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWhtr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=72-78&author=W.-T.+Liauthor=W.-H.+Wuauthor=C.-H.+Tangauthor=R.+Taiauthor=S.-T.+Chen&title=One-pot+tandem+copper-catalyzed+library+synthesis+of+1-thiazolyl-1%2C2%2C3-triazoles+as+anticancer+agents&doi=10.1021%2Fco1000234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">One-Pot Tandem Copper-Catalyzed Library Synthesis of 1-Thiazolyl-1,2,3-triazoles as Anticancer Agents</span></div><div class="casAuthors">Li, Wen-Tai; Wu, Wan-Hsun; Tang, Chien-Hsiang; Tai, Ready; Chen, Shui-Tein</div><div class="citationInfo"><span class="NLM_cas:title">ACS Combinatorial Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-78</span>CODEN:
                <span class="NLM_cas:coden">ACSCCC</span>;
        ISSN:<span class="NLM_cas:issn">2156-8944</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One-pot tandem copper-catalyzed azidation and CuAAC reactions that afford 1-thiazolyl-1,2,3-triazoles with anticancer activity have been developed.  By utilizing this one-pot synthetic strategy, a library of 1-thiazolyl-1,2,3-triazoles were constructed in search of the potent lead compd.  Furthermore, 1-thiazolyl-1,2,3-triazoles were evaluated for anticancer activity against the multidrug-resistant cancer cells MES-SA/Dx5.  Most of the 1-thiazolyl-1,2,3-triazoles revealed cytotoxic effect against cancer cells at micromolar to low micromolar range.  Testing some of the most potent compds. against the normal cell line Vero showed no significant toxicity (except one) to normal cells.  This result indicates that these compds. possessed good potency and selectivity to cancer cells over normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVXZWIC6kHWbVg90H21EOLACvtfcHk0li8KdpizkV0PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWhtr7P&md5=13690df8d59be811dd3377242269869d</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fco1000234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fco1000234%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.-T.%26aulast%3DWu%26aufirst%3DW.-H.%26aulast%3DTang%26aufirst%3DC.-H.%26aulast%3DTai%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DS.-T.%26atitle%3DOne-pot%2520tandem%2520copper-catalyzed%2520library%2520synthesis%2520of%25201-thiazolyl-1%252C2%252C3-triazoles%2520as%2520anticancer%2520agents%26jtitle%3DACS%2520Comb.%2520Sci.%26date%3D2011%26volume%3D13%26spage%3D72%26epage%3D78%26doi%3D10.1021%2Fco1000234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Alonso-Padilla, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotillo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presa, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantizani, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pena, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardera, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span> </span><span class="NLM_article-title">Automated high-content assay for compounds selectively toxic to <i>Trypanosoma cruzi</i> in a myoblastic cell line</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0003493</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0003493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0003493" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=e0003493&author=J.+Alonso-Padillaauthor=I.+Cotilloauthor=J.+L.+Presaauthor=J.+Cantizaniauthor=I.+Penaauthor=A.+I.+Barderaauthor=J.+J.+Martinauthor=A.+Rodriguez&title=Automated+high-content+assay+for+compounds+selectively+toxic+to+Trypanosoma+cruzi+in+a+myoblastic+cell+line&doi=10.1371%2Fjournal.pntd.0003493"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0003493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0003493%26sid%3Dliteratum%253Aachs%26aulast%3DAlonso-Padilla%26aufirst%3DJ.%26aulast%3DCotillo%26aufirst%3DI.%26aulast%3DPresa%26aufirst%3DJ.%2BL.%26aulast%3DCantizani%26aufirst%3DJ.%26aulast%3DPena%26aufirst%3DI.%26aulast%3DBardera%26aufirst%3DA.%2BI.%26aulast%3DMartin%26aufirst%3DJ.%2BJ.%26aulast%3DRodriguez%26aufirst%3DA.%26atitle%3DAutomated%2520high-content%2520assay%2520for%2520compounds%2520selectively%2520toxic%2520to%2520Trypanosoma%2520cruzi%2520in%2520a%2520myoblastic%2520cell%2520line%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2015%26volume%3D9%26spage%3De0003493%26doi%3D10.1371%2Fjournal.pntd.0003493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span><span class="refDoi"> DOI: 10.1021/jm1013693</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design&doi=10.1021%2Fjm1013693"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0li8KdpizkV0PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591%26doi%3D10.1021%2Fjm1013693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Orhan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sener, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasdemir, D.</span><span> </span><span class="NLM_article-title">Inhibitory activity of marine sponge-derived natural products against parasitic protozoa</span> <span class="citation_source-journal">Mar. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span><span class="refDoi"> DOI: 10.3390/md8010047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.3390%2Fmd8010047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=20161970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=47-58&author=I.+Orhanauthor=B.+Senerauthor=M.+Kaiserauthor=R.+Brunauthor=D.+Tasdemir&title=Inhibitory+activity+of+marine+sponge-derived+natural+products+against+parasitic+protozoa&doi=10.3390%2Fmd8010047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitory activity of marine sponge-derived natural products against parasitic protozoa</span></div><div class="casAuthors">Orhan, Ilkay; Sener, Bilge; Kaiser, Marcel; Brun, Reto; Tasdemir, Deniz</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">47-58</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI Center</span>)
        </div><div class="casAbstract">In this study, thirteen sponge-derived terpenoids, including five linear furanoterpenes: furospinulosin-1 (1), furospinulosin-2 (2), furospongin-1 (3), furospongin-4 (4), and demethylfurospongin-4 (5); four linear meroterpenes: 2-(hexaprenylmethyl)-2-methylchromenol (6), 4-hydroxy-3-octaprenylbenzoic acid (7), 4-hydroxy-3-tetraprenyl-phenylacetic acid (8), and heptaprenyl-p-quinol (9); a linear triterpene, squalene (10); two spongian-type diterpenes dorisenone D (11) and 11β-acetoxyspongi-12-en-16-one (12); a scalarane-type sesterterpene; 12-epi-deoxoscalarin (13), as well as an indole alkaloid, tryptophol (14) were screened for their in vitro activity against four parasitic protozoa; Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani and Plasmodium falciparum.  Cytotoxic potential of the compds. on mammalian cells was also assessed.  All compds. were active against T. brucei rhodesiense, with compd. 8 being the most potent (IC50 0.60 μg/mL), whereas 9 and 12 were the most active compds. against T. cruzi, with IC50 values around 4 μg/mL.  Compd. 12 showed the strongest leishmanicidal activity (IC50 0.75 μg/mL), which was comparable to that of miltefosine (IC50 0.20 μg/mL).  The best antiplasmodial effect was exerted by compd. 11 (IC50 0.43 μg/mL), followed by compds. 7, 10, and 12 with IC50 values around 1 μg/mL.  Compds. 9, 11 and 12 exhibited, besides their antiprotozoal activity, also some cytotoxicity, whereas all other compds. had low or no cytotoxicity towards the mammalian cell line.  This is the first report of antiprotozoal activity of marine metabolites 1-14, and points out the potential of marine sponges in discovery of new antiprotozoal lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZH_2IUgeQXLVg90H21EOLACvtfcHk0lgox7JTwccFDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSksLs%253D&md5=60d08cc8b73ea6a824d752eeac514b4a</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.3390%2Fmd8010047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd8010047%26sid%3Dliteratum%253Aachs%26aulast%3DOrhan%26aufirst%3DI.%26aulast%3DSener%26aufirst%3DB.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DTasdemir%26aufirst%3DD.%26atitle%3DInhibitory%2520activity%2520of%2520marine%2520sponge-derived%2520natural%2520products%2520against%2520parasitic%2520protozoa%26jtitle%3DMar.%2520Drugs%26date%3D2010%26volume%3D8%26spage%3D47%26epage%3D58%26doi%3D10.3390%2Fmd8010047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span>Target Product Profile—Sleeping Sickness; <span class="NLM_publisher-name">Drugs for Neglected Diseases initiative</span>.<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://www.dndi.org/diseases-projects/hat/hat-target-product-profile/" class="extLink">http://www.dndi.org/diseases-projects/hat/hat-target-product-profile/</a> (accessed August 17, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Target+Product+Profile%E2%80%94Sleeping+Sickness%3B+Drugs+for+Neglected+Diseases+initiative.+2016%3B+http%3A%2F%2Fwww.dndi.org%2Fdiseases-projects%2Fhat%2Fhat-target-product-profile%2F+%28accessed+August+17%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DTarget%2520Product%2520Profile%25E2%2580%2594Sleeping%2520Sickness%26pub%3DDrugs%2520for%2520Neglected%2520Diseases%2520initiative%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">De Rycker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. W.</span><span> </span><span class="NLM_article-title">Identification of trypanocidal activity for known clinical compounds using a new <i>Trypanosoma cruzi</i> hit-discovery screening cascade</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0004584</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0004584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0004584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=27082760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtVKmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2016&pages=e0004584&author=M.+De+Ryckerauthor=J.+Thomasauthor=J.+Rileyauthor=S.+J.+Broughauthor=T.+J.+Milesauthor=D.+W.+Gray&title=Identification+of+trypanocidal+activity+for+known+clinical+compounds+using+a+new+Trypanosoma+cruzi+hit-discovery+screening+cascade&doi=10.1371%2Fjournal.pntd.0004584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of trypanocidal activity for known clinical compounds using a new Trypanosoma cruzi hit-discovery screening cascade</span></div><div class="casAuthors">De Rycker, Manu; Thomas, John; Riley, Jennifer; Brough, Stephen J.; Miles, Tim J.; Gray, David W.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0004584/1-e0004584/19</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chagas disease is a significant health problem in Latin America and the available treatments have significant issues in terms of toxicity and efficacy.  There is thus an urgent need to develop new treatments either via a repurposing strategy or through the development of new chem. entities.  A key first step is the identification of compds. with anti-Trypanosoma cruzi activity from compd. libraries.  Here we describe a hit discovery screening cascade designed to specifically identify hits that have the appropriate anti-parasitic properties to warrant further development.  The cascade consists of a primary imaging-based assay followed by newly developed and appropriately scaled secondary assays to predict the cidality and rate-of-kill of the compds.  Finally, we incorporated a cytochrome P 450 CYP51 biochem. assay to remove compds. that owe their phenotypic response to inhibition of this enzyme.  We report the use of the cascade in profiling two small libraries contg. clin. tested compds. and identify Clemastine, Azelastine, Ifenprodil, Ziprasidone and Clofibrate as mols. having appropriate profiles.  Anal. of clin. derived pharmacokinetic and toxicity data indicates that none of these are appropriate for repurposing but they may represent suitable start points for further optimization for the treatment of Chagas disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNvQvW9Gmu27Vg90H21EOLACvtfcHk0lgox7JTwccFDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtVKmtbo%253D&md5=50bdf03204f45c2ef74ac81ea40a263f</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0004584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0004584%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DRiley%26aufirst%3DJ.%26aulast%3DBrough%26aufirst%3DS.%2BJ.%26aulast%3DMiles%26aufirst%3DT.%2BJ.%26aulast%3DGray%26aufirst%3DD.%2BW.%26atitle%3DIdentification%2520of%2520trypanocidal%2520activity%2520for%2520known%2520clinical%2520compounds%2520using%2520a%2520new%2520Trypanosoma%2520cruzi%2520hit-discovery%2520screening%2520cascade%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2016%26volume%3D10%26spage%3De0004584%26doi%3D10.1371%2Fjournal.pntd.0004584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Lepesheva, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterman, M. R.</span><span> </span><span class="NLM_article-title">Targeting <i>Trypanosoma cruzi</i> sterol 14α-demethylase (CYP51)</span> <span class="citation_source-journal">Adv. Parasitol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1016/B978-0-12-385863-4.00004-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2FB978-0-12-385863-4.00004-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=21820552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A280%3ADC%252BC3MjktlCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2011&pages=65-87&author=G.+I.+Lepeshevaauthor=F.+Villaltaauthor=M.+R.+Waterman&title=Targeting+Trypanosoma+cruzi+sterol+14%CE%B1-demethylase+%28CYP51%29&doi=10.1016%2FB978-0-12-385863-4.00004-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Trypanosoma cruzi sterol 14α-demethylase (CYP51)</span></div><div class="casAuthors">Lepesheva Galina I; Villalta Fernando; Waterman Michael R</div><div class="citationInfo"><span class="NLM_cas:title">Advances in parasitology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">There are at least two obvious features that must be considered upon targeting specific metabolic pathways/enzymes for drug development: the pathway must be essential and the enzyme must allow the design of pharmacologically useful inhibitors.  Here, we describe Trypanosoma cruzi sterol 14α-demethylase as a promising target for anti-Chagasic chemotherapy.  The use of anti-fungal azoles, which block sterol biosynthesis and therefore membrane formation in fungi, against the protozoan parasite has turned out to be highly successful: a broad spectrum anti-fungal drug, the triazole compound posaconazole, is now entering phase II clinical trials for treatment of Chagas disease.  This review summarizes comparative information on anti-fungal azoles and novel inhibitory scaffolds selective for Trypanosomatidae sterol 14α-demethylase through the lens of recent structure/functional characterization of the target enzyme.  We believe our studies open wide opportunities for rational design of novel, pathogen-specific and therefore more potent and efficient anti-trypanosomal drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0YKdn5Th59xcr74wzj5o5fW6udTcc2eYKUIr6sLlsWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjktlCjsA%253D%253D&md5=d468cde2272c6a2dfc145a7dd75f009c</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-385863-4.00004-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-385863-4.00004-6%26sid%3Dliteratum%253Aachs%26aulast%3DLepesheva%26aufirst%3DG.%2BI.%26aulast%3DVillalta%26aufirst%3DF.%26aulast%3DWaterman%26aufirst%3DM.%2BR.%26atitle%3DTargeting%2520Trypanosoma%2520cruzi%2520sterol%252014%25CE%25B1-demethylase%2520%2528CYP51%2529%26jtitle%3DAdv.%2520Parasitol.%26date%3D2011%26volume%3D75%26spage%3D65%26epage%3D87%26doi%3D10.1016%2FB978-0-12-385863-4.00004-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Moraes, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardini, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araujo-Junior, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatelain, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas-Junior, L. H.</span><span> </span><span class="NLM_article-title">Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against <i>Trypanosoma cruzi</i>: implications for Chagas disease drug discovery and development</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">4703</span><span class="refDoi"> DOI: 10.1038/srep04703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1038%2Fsrep04703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=24736467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A280%3ADC%252BC2cnkt1yhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=4703&author=C.+B.+Moraesauthor=M.+A.+Giardiniauthor=H.+Kimauthor=C.+H.+Francoauthor=A.+M.+Araujo-Juniorauthor=S.+Schenkmanauthor=E.+Chatelainauthor=L.+H.+Freitas-Junior&title=Nitroheterocyclic+compounds+are+more+efficacious+than+CYP51+inhibitors+against+Trypanosoma+cruzi%3A+implications+for+Chagas+disease+drug+discovery+and+development&doi=10.1038%2Fsrep04703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development</span></div><div class="casAuthors">Moraes Carolina B; Freitas-Junior Lucio H; Giardini Miriam A; Kim Hwayoung; Franco Caio H; Araujo-Junior Adalberto M; Schenkman Sergio; Chatelain Eric</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4703</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Advocacy for better drugs and access to treatment has boosted the interest in drug discovery and development for Chagas disease, a chronic infection caused by the genetically heterogeneous parasite, Trypanosoma cruzi.  In this work new in vitro assays were used to gain a better understanding of the antitrypanosomal properties of the most advanced antichagasic lead and clinical compounds, the nitroheterocyclics benznidazole, nifurtimox and fexinidazole sulfone, the oxaborole AN4169, and four ergosterol biosynthesis inhibitors--posaconazole, ravuconazole, EPL-BS967 and EPL-BS1246.  Two types of assays were developed: one for evaluation of potency and efficacy in dose-response against a panel of T. cruzi stocks representing all current discrete typing units (DTUs), and a time-kill assay.  Although less potent, the nitroheterocyclics and the oxaborole showed broad efficacy against all T. cruzi tested and were rapidly trypanocidal, whilst ergosterol biosynthesis inhibitors showed variable activity that was both compound- and strain-specific, and were unable to eradicate intracellular infection even after 7 days of continuous compound exposure at most efficacious concentrations.  These findings contest previous reports of variable responses to nitroderivatives among different T. cruzi strains and further challenge the introduction of ergosterol biosynthesis inhibitors as new single chemotherapeutic agents for the treatment of Chagas disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSC0uKaIdi8tC-bLEOO4dYpfW6udTcc2eZCDIM7eHdqKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cnkt1yhtA%253D%253D&md5=032b0723cce633d789e16f1538be8daf</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fsrep04703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep04703%26sid%3Dliteratum%253Aachs%26aulast%3DMoraes%26aufirst%3DC.%2BB.%26aulast%3DGiardini%26aufirst%3DM.%2BA.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DFranco%26aufirst%3DC.%2BH.%26aulast%3DAraujo-Junior%26aufirst%3DA.%2BM.%26aulast%3DSchenkman%26aufirst%3DS.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DFreitas-Junior%26aufirst%3DL.%2BH.%26atitle%3DNitroheterocyclic%2520compounds%2520are%2520more%2520efficacious%2520than%2520CYP51%2520inhibitors%2520against%2520Trypanosoma%2520cruzi%253A%2520implications%2520for%2520Chagas%2520disease%2520drug%2520discovery%2520and%2520development%26jtitle%3DSci.%2520Rep.%26date%3D2014%26volume%3D4%26spage%3D4703%26doi%3D10.1038%2Fsrep04703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Riley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voice, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caballero, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, D.</span><span> </span><span class="NLM_article-title">Development of a fluorescence-based <i>Trypanosoma cruzi</i> CYP51 inhibition assay for effective compound triaging in drug discovery programmes for Chagas disease</span> <span class="citation_source-journal">PLoS Neglected Trop. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0004014</span><span class="refDoi"> DOI: 10.1371/journal.pntd.0004014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1371%2Fjournal.pntd.0004014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=e0004014&author=J.+Rileyauthor=S.+Brandauthor=K.+D.+Readauthor=M.+Voiceauthor=I.+Caballeroauthor=D.+Calvo&title=Development+of+a+fluorescence-based+Trypanosoma+cruzi+CYP51+inhibition+assay+for+effective+compound+triaging+in+drug+discovery+programmes+for+Chagas+disease&doi=10.1371%2Fjournal.pntd.0004014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0004014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0004014%26sid%3Dliteratum%253Aachs%26aulast%3DRiley%26aufirst%3DJ.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DVoice%26aufirst%3DM.%26aulast%3DCaballero%26aufirst%3DI.%26aulast%3DCalvo%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520a%2520fluorescence-based%2520Trypanosoma%2520cruzi%2520CYP51%2520inhibition%2520assay%2520for%2520effective%2520compound%2520triaging%2520in%2520drug%2520discovery%2520programmes%2520for%2520Chagas%2520disease%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2015%26volume%3D9%26spage%3De0004014%26doi%3D10.1371%2Fjournal.pntd.0004014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Smith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span> </span><span class="NLM_article-title">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">939</span><span class="refDoi"> DOI: 10.1038/nrd3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1038%2Fnrd3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=21119731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=929-939&author=D.+A.+Smithauthor=L.+Diauthor=E.+H.+Kerns&title=The+effect+of+plasma+protein+binding+on+in+vivo+efficacy%3A+misconceptions+in+drug+discovery&doi=10.1038%2Fnrd3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery</span></div><div class="casAuthors">Smith, Dennis A.; Di, Li; Kerns, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">929-939</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Data from in vitro plasma protein binding expts. that det. the fraction of protein-bound drug are frequently used in drug discovery to guide structure design and to prioritize compds. for in vivo studies.  However, we consider that these practices are usually misleading, because in vivo efficacy is detd. by the free (unbound) drug concn. surrounding the therapeutic target, not by the free drug fraction.  These practices yield no enhancement of the in vivo free drug concn.  So, decisions based on free drug fraction could result in the wrong compds. being advanced through drug discovery programs.  This Perspective provides guidance on the application of plasma protein binding information in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOa3ippodhGbVg90H21EOLACvtfcHk0liaj5qxWD3eAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2jurfI&md5=a45d00f68ab44580fa38a6acef49493a</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1038%2Fnrd3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3287%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DThe%2520effect%2520of%2520plasma%2520protein%2520binding%2520on%2520in%2520vivo%2520efficacy%253A%2520misconceptions%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D929%26epage%3D939%26doi%3D10.1038%2Fnrd3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Coteron, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esquivias, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Mazouni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokkonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katneni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhamidipati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Diaz, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamo, F.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, W. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathurst, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathod, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, M. A.</span><span> </span><span class="NLM_article-title">Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent <i>Plasmodium falciparum</i> dihydroorotate dehydrogenase inhibitors with clinical candidate potential</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5540</span><span class="NLM_x">–</span> <span class="NLM_lpage">5561</span><span class="refDoi"> DOI: 10.1021/jm200592f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200592f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVehsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5540-5561&author=J.+M.+Coteronauthor=M.+Marcoauthor=J.+Esquiviasauthor=X.+Dengauthor=K.+L.+Whiteauthor=J.+Whiteauthor=M.+Koltunauthor=F.+El+Mazouniauthor=S.+Kokkondaauthor=K.+Katneniauthor=R.+Bhamidipatiauthor=D.+M.+Shacklefordauthor=I.+Angulo-Barturenauthor=S.+B.+Ferrerauthor=M.+B.+Jimenez-Diazauthor=F.-J.+Gamoauthor=E.+J.+Goldsmithauthor=W.+N.+Charmanauthor=I.+Bathurstauthor=D.+Floydauthor=D.+Matthewsauthor=J.+N.+Burrowsauthor=P.+K.+Rathodauthor=S.+A.+Charmanauthor=M.+A.+Phillips&title=Structure-guided+lead+optimization+of+triazolopyrimidine-ring+substituents+identifies+potent+Plasmodium+falciparum+dihydroorotate+dehydrogenase+inhibitors+with+clinical+candidate+potential&doi=10.1021%2Fjm200592f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential</span></div><div class="casAuthors">Coteron, Jose M.; Marco, Maria; Esquivias, Jorge; Deng, Xiaoyi; White, Karen L.; White, John; Koltun, Maria; El Mazouni, Farah; Kokkonda, Sreekanth; Katneni, Kasiram; Bhamidipati, Ravi; Shackleford, David M.; Angulo-Barturen, Inigo; Ferrer, Santiago B.; Jimenez-Diaz, Maria Belen; Gamo, Francisco-Javier; Goldsmith, Elizabeth J.; Charman, William N.; Bathurst, Ian; Floyd, David; Matthews, David; Burrows, Jeremy N.; Rathod, Pradipsinh K.; Charman, Susan A.; Phillips, Margaret A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5540-5561</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug therapy is the mainstay of antimalarial therapy, yet current drugs are threatened by the development of resistance.  In an effort to identify new potential antimalarials, we have undertaken a lead optimization program around our previously identified triazolopyrimidine-based series of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors.  The X-ray structure of PfDHODH was used to inform the medicinal chem. program allowing the identification of a potent and selective inhibitor (DSM265) that acts through DHODH inhibition to kill both sensitive and drug resistant strains of the parasite.  This compd. has similar potency to chloroquine in the humanized SCID mouse P. falciparum model, can be synthesized by a simple route, and rodent pharmacokinetic studies demonstrated it has excellent oral bioavailability, a long half-life and low clearance.  These studies have identified the first candidate in the triazolopyrimidine series to meet previously established progression criteria for efficacy and ADME properties, justifying further development of this compd. toward clin. candidate status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVpPPR2Tcs9rVg90H21EOLACvtfcHk0lhVEy9voT-nHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVehsbg%253D&md5=d92f71aeda04fbbbbcd8905a657df011</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm200592f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200592f%26sid%3Dliteratum%253Aachs%26aulast%3DCoteron%26aufirst%3DJ.%2BM.%26aulast%3DMarco%26aufirst%3DM.%26aulast%3DEsquivias%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DKoltun%26aufirst%3DM.%26aulast%3DEl%2BMazouni%26aufirst%3DF.%26aulast%3DKokkonda%26aufirst%3DS.%26aulast%3DKatneni%26aufirst%3DK.%26aulast%3DBhamidipati%26aufirst%3DR.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DFerrer%26aufirst%3DS.%2BB.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DGamo%26aufirst%3DF.-J.%26aulast%3DGoldsmith%26aufirst%3DE.%2BJ.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DFloyd%26aufirst%3DD.%26aulast%3DMatthews%26aufirst%3DD.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DRathod%26aufirst%3DP.%2BK.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26atitle%3DStructure-guided%2520lead%2520optimization%2520of%2520triazolopyrimidine-ring%2520substituents%2520identifies%2520potent%2520Plasmodium%2520falciparum%2520dihydroorotate%2520dehydrogenase%2520inhibitors%2520with%2520clinical%2520candidate%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5540%26epage%3D5561%26doi%3D10.1021%2Fjm200592f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Balani, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. W.</span><span> </span><span class="NLM_article-title">Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1059</span><span class="NLM_x">–</span> <span class="NLM_lpage">1062</span><span class="refDoi"> DOI: 10.1124/dmd.30.10.1059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1124%2Fdmd.30.10.1059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=1059-1062&author=S.+K.+Balaniauthor=T.+Zhuauthor=T.+J.+Yangauthor=Z.+Liuauthor=B.+Heauthor=F.+W.+Lee&title=Effective+dosing+regimen+of+1-aminobenzotriazole+for+inhibition+of+antipyrine+clearance+in+rats%2C+dogs%2C+and+monkeys&doi=10.1124%2Fdmd.30.10.1059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1124%2Fdmd.30.10.1059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.30.10.1059%26sid%3Dliteratum%253Aachs%26aulast%3DBalani%26aufirst%3DS.%2BK.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DT.%2BJ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DF.%2BW.%26atitle%3DEffective%2520dosing%2520regimen%2520of%25201-aminobenzotriazole%2520for%2520inhibition%2520of%2520antipyrine%2520clearance%2520in%2520rats%252C%2520dogs%252C%2520and%2520monkeys%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D1059%26epage%3D1062%26doi%3D10.1124%2Fdmd.30.10.1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Balani, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardoza, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, D.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. W.</span><span> </span><span class="NLM_article-title">Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in guinea pigs and mice using serial sampling</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1092</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span><span class="refDoi"> DOI: 10.1124/dmd.104.000349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1124%2Fdmd.104.000349" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=1092-1095&author=S.+K.+Balaniauthor=P.+Liauthor=J.+Nguyenauthor=K.+Cardozaauthor=H.+Zengauthor=D.-X.+Muauthor=J.-T.+Wuauthor=L.-S.+Ganauthor=F.+W.+Lee&title=Effective+dosing+regimen+of+1-aminobenzotriazole+for+inhibition+of+antipyrine+clearance+in+guinea+pigs+and+mice+using+serial+sampling&doi=10.1124%2Fdmd.104.000349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1124%2Fdmd.104.000349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.104.000349%26sid%3Dliteratum%253Aachs%26aulast%3DBalani%26aufirst%3DS.%2BK.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DJ.%26aulast%3DCardoza%26aufirst%3DK.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DMu%26aufirst%3DD.-X.%26aulast%3DWu%26aufirst%3DJ.-T.%26aulast%3DGan%26aufirst%3DL.-S.%26aulast%3DLee%26aufirst%3DF.%2BW.%26atitle%3DEffective%2520dosing%2520regimen%2520of%25201-aminobenzotriazole%2520for%2520inhibition%2520of%2520antipyrine%2520clearance%2520in%2520guinea%2520pigs%2520and%2520mice%2520using%2520serial%2520sampling%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26spage%3D1092%26epage%3D1095%26doi%3D10.1124%2Fdmd.104.000349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Bustamante, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarleton, R. L.</span><span> </span><span class="NLM_article-title">Potential new clinical therapies for Chagas disease</span> <span class="citation_source-journal">Expert Rev. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span><span class="refDoi"> DOI: 10.1586/17512433.2014.909282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1586%2F17512433.2014.909282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=24716790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtFWru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=317-325&author=J.+M.+Bustamanteauthor=R.+L.+Tarleton&title=Potential+new+clinical+therapies+for+Chagas+disease&doi=10.1586%2F17512433.2014.909282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Potential new clinical therapies for Chagas disease</span></div><div class="casAuthors">Bustamante, Juan M.; Tarleton, Rick L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">317-325</span>CODEN:
                <span class="NLM_cas:coden">ERCPAG</span>;
        ISSN:<span class="NLM_cas:issn">1751-2433</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Chagas disease is the highest impact parasitic disease in the Americas but often goes untreated due to the shortcomings of currently available therapeutics.  Thus there is an urgent need for new treatment options and growing interest in drug development for the infection.  This review summarizes some of the recent advances and failures in this realm, with particular emphasis on recently published studies and unpublished results presented at a recent Chagas Drug Discovery Consortium meeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQK8zR2uYlsLVg90H21EOLACvtfcHk0lhVEy9voT-nHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtFWru78%253D&md5=a248bc0bed6626b027a3d27f264544c4</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1586%2F17512433.2014.909282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F17512433.2014.909282%26sid%3Dliteratum%253Aachs%26aulast%3DBustamante%26aufirst%3DJ.%2BM.%26aulast%3DTarleton%26aufirst%3DR.%2BL.%26atitle%3DPotential%2520new%2520clinical%2520therapies%2520for%2520Chagas%2520disease%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Pharmacol.%26date%3D2014%26volume%3D7%26spage%3D317%26epage%3D325%26doi%3D10.1586%2F17512433.2014.909282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Patrick, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenzler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiser, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidwell, R. R.</span><span> </span><span class="NLM_article-title">Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against <i>Trypanosoma brucei rhodesiense</i></span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2451</span><span class="NLM_x">–</span> <span class="NLM_lpage">2465</span><span class="refDoi"> DOI: 10.1016/j.bmc.2016.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1016%2Fj.bmc.2016.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=27102161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtlegtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=2451-2465&author=D.+A.+Patrickauthor=T.+Wenzlerauthor=S.+Yangauthor=P.+T.+Weiserauthor=M.+Z.+Wangauthor=R.+Brunauthor=R.+R.+Tidwell&title=Synthesis+of+novel+amide+and+urea+derivatives+of+thiazol-2-ethylamines+and+their+activity+against+Trypanosoma+brucei+rhodesiense&doi=10.1016%2Fj.bmc.2016.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel amide and urea derivatives of thiazol-2-ethylamines and their activity against Trypanosoma brucei rhodesiense</span></div><div class="casAuthors">Patrick, Donald A.; Wenzler, Tanja; Yang, Sihyung; Weiser, Patrick T.; Wang, Michael Zhuo; Brun, Reto; Tidwell, Richard R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2451-2465</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">2-(2-Benzamido)ethyl-4-phenylthiazole I was one of 1035 mols. (grouped into 115 distinct scaffolds) found to be inhibitory to Trypanosoma brucei, the pathogen causing human African trypanosomiasis, at concns. below 3.6 μM and nontoxic to mammalian (Huh7) cells in a phenotypic high-throughput screen of a 700,000 compd. library performed by the Genomics Institute of the Novartis Research Foundation (GNF).  Compd. I and 72 analogs were synthesized in this lab. by one of two general pathways.  These plus 10 com. available analogs were tested against T. brucei rhodesiense STIB900 and L6 rat myoblast cells (for cytotoxicity) in vitro.  Forty-four derivs. were more potent than I, including eight with IC50 values below 100 nM.  The most potent and most selective for the parasite was the urea analog 2-(2-piperidin-1-ylamido)ethyl-4-(3-fluorophenyl)thiazole II (IC50 = 9 nM, SI > 18,000).  None of 33 compds. tested were able to cure mice infected with the parasite; however, seven compds. caused temporary redns. of parasitemia (≥97%) but with subsequent relapses.  The lack of in vivo efficacy was at least partially due to their poor metabolic stability, as demonstrated by the short half-lives of 15 analogs against mouse and human liver microsomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV78D13zDrJ7Vg90H21EOLACvtfcHk0lg8oG27GB16LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtlegtLk%253D&md5=d371dc632576f40e4002cd96b67c5a77</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DPatrick%26aufirst%3DD.%2BA.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DWeiser%26aufirst%3DP.%2BT.%26aulast%3DWang%26aufirst%3DM.%2BZ.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DTidwell%26aufirst%3DR.%2BR.%26atitle%3DSynthesis%2520of%2520novel%2520amide%2520and%2520urea%2520derivatives%2520of%2520thiazol-2-ethylamines%2520and%2520their%2520activity%2520against%2520Trypanosoma%2520brucei%2520rhodesiense%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D2451%26epage%3D2465%26doi%3D10.1016%2Fj.bmc.2016.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lg8oG27GB16LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Bruck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamberton, A. H.</span><span> </span><span class="NLM_article-title">Nitramines and nitramides. IX. The acid-catalyzed decomposition of <i>O</i>-methyl-<i>N</i>-isopropylnitramine</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1955</span><span class="NLM_x">, </span> <span class="NLM_fpage">3997</span><span class="NLM_x">–</span> <span class="NLM_lpage">4002</span><span class="refDoi"> DOI: 10.1039/jr9550003997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;key=10.1039%2Fjr9550003997" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1955&pages=3997-4002&author=P.+Bruckauthor=A.+H.+Lamberton&title=Nitramines+and+nitramides.+IX.+The+acid-catalyzed+decomposition+of+O-methyl-N-isopropylnitramine&doi=10.1039%2Fjr9550003997"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1039%2Fjr9550003997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fjr9550003997%26sid%3Dliteratum%253Aachs%26aulast%3DBruck%26aufirst%3DP.%26aulast%3DLamberton%26aufirst%3DA.%2BH.%26atitle%3DNitramines%2520and%2520nitramides.%2520IX.%2520The%2520acid-catalyzed%2520decomposition%2520of%2520O-methyl-N-isopropylnitramine%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1955%26spage%3D3997%26epage%3D4002%26doi%3D10.1039%2Fjr9550003997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Gonzalez Cabrera, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douelle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, T.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nchinda, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younis, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witty, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittlin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chibale, K.</span><span> </span><span class="NLM_article-title">Novel orally active antimalarial thiazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7713</span><span class="NLM_x">–</span> <span class="NLM_lpage">7719</span><span class="refDoi"> DOI: 10.1021/jm201108k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201108k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7713-7719&author=D.+Gonzalez+Cabreraauthor=F.+Douelleauthor=T.-S.+Fengauthor=A.+T.+Nchindaauthor=Y.+Younisauthor=K.+L.+Whiteauthor=Q.+Wuauthor=E.+Ryanauthor=J.+N.+Burrowsauthor=D.+Watersonauthor=M.+J.+Wittyauthor=S.+Wittlinauthor=S.+A.+Charmanauthor=K.+Chibale&title=Novel+orally+active+antimalarial+thiazoles&doi=10.1021%2Fjm201108k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Fjm201108k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201108k%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%2BCabrera%26aufirst%3DD.%26aulast%3DDouelle%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DT.-S.%26aulast%3DNchinda%26aufirst%3DA.%2BT.%26aulast%3DYounis%26aufirst%3DY.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DWitty%26aufirst%3DM.%2BJ.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DNovel%2520orally%2520active%2520antimalarial%2520thiazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7713%26epage%3D7719%26doi%3D10.1021%2Fjm201108k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Bischofberger, N. W.; Kim, C. U.; Krawczyk, S. H.; McGee, L. R.; Postich, M. J.; Yang, W.</span><span> </span><span class="NLM_article-title">Preparation of thiepanes as HIV protease inhibitors</span>. 1996-740568, 5811450, 19961031,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=N.+W.+Bischofberger&author=C.+U.+Kim&author=S.+H.+Krawczyk&author=L.+R.+McGee&author=M.+J.+Postich&author=W.+Yang&title=Preparation+of+thiepanes+as+HIV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBischofberger%26aufirst%3DN.%2BW.%26atitle%3DPreparation%2520of%2520thiepanes%2520as%2520HIV%2520protease%2520inhibitors%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Jimenez, J.-M.; Collier, P. N.</span><span> </span><span class="NLM_article-title">Preparation of pyrazolopyridines as inhibitors of protein kinase</span>. 2010-US33720, 2010129668, 20100505,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.-M.+Jimenez&author=P.+N.+Collier&title=Preparation+of+pyrazolopyridines+as+inhibitors+of+protein+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJimenez%26aufirst%3DJ.-M.%26atitle%3DPreparation%2520of%2520pyrazolopyridines%2520as%2520inhibitors%2520of%2520protein%2520kinase%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i191"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00442">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_51113"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00442">10.1021/acs.jmedchem.6b00442</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SAR summary diagram, exemplar compound numbering schemes, intracellular <i>T. cruzi</i> rate-of-kill profiles, and comparison with related regioisomers (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00442/suppl_file/jm6b00442_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00442/suppl_file/jm6b00442_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00442/suppl_file/jm6b00442_si_001.pdf">jm6b00442_si_001.pdf (197.13 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00442/suppl_file/jm6b00442_si_002.csv">jm6b00442_si_002.csv (8.64 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00442&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-21%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00442%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00442" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991eafceda3cc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
